data_2rsm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rsm _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 108.93 -0.767 . . . . 73.430000000000007 108.93 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -124.61 154.9 70.01 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.005 1.322 . . . . 74.409999999999997 108.67 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.29 166.18 30.1 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.553 2.168 . . . . 61.520000000000003 111.02 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.51 173.39 16.95 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.872 -1.291 . . . . 74.430000000000007 109.872 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.93 166.44 23.64 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.439 -0.448 . . . . 74.349999999999994 110.2 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.02 80.61 1.58 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.5 -2.407 . . . . 74.209999999999994 104.5 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.57 -174.42 4.27 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.853 0.861 . . . . 73.230000000000004 111.463 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -143.94 164.33 30.88 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.761 1.224 . . . . 74.530000000000001 108.708 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 t -147.98 165.71 29.9 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.403 0.62 . . . . 75.239999999999995 110.88 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.09 156.11 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 126.869 2.068 . . . . 74.109999999999999 111.04 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -119.3 173.85 6.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.487 1.515 . . . . 72.439999999999998 109.715 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.2 m -64.21 172.45 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.338 0.655 . . . . 75.150000000000006 110.578 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.74 -21.23 52.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 114.327 1.232 . . . . 73.430000000000007 114.327 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.57 -69.57 3.27 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 107.587 -2.205 . . . . 52.340000000000003 107.587 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? . . . . . 0 C--O 1.235 0.336 0 N-CA-C 106.953 -1.499 . . . . 74.329999999999998 106.953 177.648 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 C--O 1.233 0.214 0 N-CA-C 112.763 0.653 . . . . 74.25 112.763 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.87 112.21 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.859 2.373 . . . . 71.120000000000005 108.661 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.67 104.66 16.59 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.201 -1.407 . . . . 71.510000000000005 107.201 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -65.79 104.79 1.13 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.485 1.514 . . . . 72.439999999999998 109.923 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -62.86 -27.45 69.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.065 0.765 . . . . 62.210000000000001 113.065 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 m -79.4 6.57 9.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.396 0.998 . . . . 75.420000000000002 111.257 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -117.64 11.34 13.69 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.7 1.6 . . . . 62.310000000000002 111.743 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.0 mt -111.78 165.17 12.29 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.469 1.108 . . . . 52.420000000000002 111.16 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -132.22 127.0 34.85 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.441 -2.059 . . . . 75.109999999999999 105.441 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.23 165.47 11.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.487 1.515 . . . . 74.340000000000003 110.85 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -140.35 160.54 39.74 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.46 1.504 . . . . 53.149999999999999 107.277 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -130.53 139.45 50.48 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.472 -0.566 . . . . 74.319999999999993 109.472 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 85.3 t . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 107.246 -1.39 . . . . 72.109999999999999 107.246 179.49 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.8 t30 . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 121.522 0.677 . . . . 73.420000000000002 110.741 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.9 t -68.03 112.48 5.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.28 -1.512 . . . . 74.140000000000001 107.588 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.4 t -94.57 139.77 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 104.269 -2.493 . . . . 71.430000000000007 104.269 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.52 138.45 49.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.348 -2.093 . . . . 72.430000000000007 105.348 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.2 tp -142.32 147.31 36.13 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.871 -1.529 . . . . 71.209999999999994 106.871 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.99 158.18 43.87 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.432 -0.951 . . . . 74.450000000000003 108.432 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -93.94 134.39 36.37 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.059 -2.2 . . . . 64.120000000000005 105.059 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.3 t -65.11 -65.97 1.66 Allowed Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 117.894 -1.051 . . . . 73.25 111.894 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.18 -35.41 52.59 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.744 2.296 . . . . 64.329999999999998 113.759 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 t -85.36 -21.13 29.01 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.777 0.658 . . . . 74.439999999999998 112.777 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.88 2.86 5.23 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.437 1.494 . . . . 63.119999999999997 114.525 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.5 mt -67.05 130.96 32.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 119.791 1.796 . . . . 60.109999999999999 107.087 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.6 t -112.61 153.45 14.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.463 1.105 . . . . 71.219999999999999 109.05 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -149.74 142.43 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.796 0.838 . . . . 72.519999999999996 110.059 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -124.92 106.84 10.29 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.19 1.796 . . . . 65.109999999999999 108.315 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 9.9 t -117.94 155.36 30.36 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.689 1.196 . . . . 74.450000000000003 110.159 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -155.03 100.66 2.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.594 -1.632 . . . . 63.229999999999997 106.594 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.48 -37.43 4.95 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 122.86 0.464 . . . . 72.109999999999999 111.413 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.8 p -139.04 176.73 8.44 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.983 0.913 . . . . 64.310000000000002 111.623 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -1.51 56.35 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.678 1.191 . . . . 75.340000000000003 111.011 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.4 m -98.2 115.75 28.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.132 1.373 . . . . 73.319999999999993 109.968 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.54 -53.89 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.874 0.869 . . . . 73.420000000000002 111.243 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -22.81 67.07 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.984 1.475 . . . . 60.219999999999999 114.984 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -77.75 -46.1 22.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.435 -2.061 . . . . 74.129999999999995 105.435 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -59.63 -37.3 78.26 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 118.397 -0.811 . . . . 75.519999999999996 109.974 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -54.88 -55.5 29.8 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.694 1.198 . . . . 71.430000000000007 108.582 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -54.64 -47.36 73.59 Favored 'General case' 0 CA--C 1.506 -0.733 0 O-C-N 121.641 -0.662 . . . . 71.420000000000002 112.366 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.8 mt -64.67 -36.8 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.596 -0.729 . . . . 75.450000000000003 110.443 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.24 -38.73 82.12 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.451 -0.781 . . . . 71.409999999999997 109.182 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -61.39 -49.38 77.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.617 1.167 . . . . 72.409999999999997 110.182 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -46.53 88.92 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.435 -0.793 . . . . 75.439999999999998 111.238 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.86 -37.42 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.107 1.321 . . . . 74.329999999999998 110.643 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.1 tp -65.67 -37.63 87.05 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.525 -0.734 . . . . 72.239999999999995 109.89 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -58.44 -42.11 86.61 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.703 0.801 . . . . 73.140000000000001 110.423 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -61.84 -43.47 98.77 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.426 0.631 . . . . 74.239999999999995 109.698 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -67.51 -42.46 82.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 113.915 1.08 . . . . 72.510000000000005 113.915 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.61 -32.77 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 123.219 0.608 . . . . 72.230000000000004 109.715 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -53.92 -60.75 2.92 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.702 0.683 . . . . 74.25 110.128 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 17.5 t -59.64 -32.59 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.784 0.834 . . . . 73.310000000000002 110.826 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -65.95 -22.64 66.49 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.516 1.053 . . . . 72.150000000000006 111.679 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -99.04 -36.92 9.55 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.4 1.08 . . . . 73.140000000000001 109.808 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -79.19 -16.78 56.05 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.523 1.129 . . . . 74.340000000000003 111.883 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.448 -0.54 0 C-N-CA 126.376 1.87 . . . . 75.319999999999993 108.692 -179.634 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 109.615 -0.513 . . . . 75.439999999999998 109.615 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -125.44 155.02 72.43 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.758 1.623 . . . . 72.409999999999997 108.961 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.62 166.06 29.18 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.6 2.2 . . . . 73.109999999999999 111.326 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.56 -178.32 35.37 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.177 -1.169 . . . . 73.140000000000001 110.177 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.6 ttt -138.14 162.27 34.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.842 1.257 . . . . 74.010000000000005 107.843 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.67 83.99 1.17 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.235 -2.506 . . . . 71.409999999999997 104.235 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.46 152.01 34.42 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.484 -0.561 . . . . 63.329999999999998 109.484 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 t -79.52 -174.51 4.29 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.603 0.716 . . . . 71.299999999999997 111.531 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.3 p -115.41 -175.85 2.8 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.642 1.577 . . . . 65.310000000000002 111.891 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.0 m -67.24 177.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.684 1.194 . . . . 71.439999999999998 109.303 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.02 164.02 28.25 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.71 0.804 . . . . 75.519999999999996 110.663 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 t -69.67 128.51 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.688 -1.597 . . . . 75.310000000000002 106.688 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.53 177.09 6.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.066 0.946 . . . . 73.310000000000002 111.581 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.13 -165.16 29.12 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 124.457 1.027 . . . . 62.420000000000002 111.916 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 . . . . . 0 C--O 1.232 0.176 0 C-N-CA 124.429 1.092 . . . . 71.409999999999997 111.362 -179.642 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 119.34 -0.362 . . . . 72.439999999999998 111.688 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -69.33 154.89 68.76 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.619 2.212 . . . . 65.450000000000003 109.262 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.0 mt -137.42 163.47 31.0 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.083 1.353 . . . . 72.219999999999999 113.728 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -119.84 101.85 8.17 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 106.891 -1.522 . . . . 75.129999999999995 106.891 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -61.06 -23.63 65.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.223 0.609 . . . . 71.319999999999993 112.53 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 m -87.97 10.38 19.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.993 1.317 . . . . 41.530000000000001 112.452 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -121.51 14.68 11.12 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.124 1.37 . . . . 74.230000000000004 111.095 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.2 mt -99.2 166.61 11.15 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.178 -0.951 . . . . 73.239999999999995 111.738 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -127.28 94.11 3.91 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.568 -0.901 . . . . 72.219999999999999 108.568 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -95.01 164.69 12.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.086 0.946 . . . . 75.439999999999998 112.689 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -143.17 171.09 14.56 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.707 2.803 . . . . 74.25 105.54 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -131.0 139.4 49.98 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 107.025 -1.472 . . . . 75.319999999999993 107.025 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.236 0.39 0 N-CA-C 109.27 -0.641 . . . . 64.239999999999995 109.27 -178.557 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 118.478 -0.772 . . . . 73.030000000000001 110.883 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.6 t -59.49 145.87 42.43 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.666 1.121 . . . . 75.200000000000003 110.91 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.6 t -120.44 149.83 23.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.311 1.845 . . . . 72.439999999999998 108.872 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.17 155.71 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.151 -1.796 . . . . 74.439999999999998 106.151 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.7 tp -141.3 148.54 39.93 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.152 -1.425 . . . . 73.239999999999995 107.152 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -143.51 130.68 20.75 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 125.473 1.509 . . . . 72.439999999999998 110.509 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -97.15 117.24 30.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.64 -1.985 . . . . 74.430000000000007 105.64 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.52 -59.96 11.3 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.069 -1.443 . . . . 74.519999999999996 111.921 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.47 -14.56 35.76 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.997 2.465 . . . . 73.340000000000003 116.611 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -111.69 -19.55 12.43 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.512 0.596 . . . . 75.129999999999995 111.236 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.13 21.22 69.78 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.007 0.813 . . . . 65.450000000000003 111.389 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -91.24 136.4 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 125.142 1.377 . . . . 74.310000000000002 107.805 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.01 137.41 57.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.069 -1.456 . . . . 72.430000000000007 107.069 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.0 p -136.75 151.39 27.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.961 -0.755 . . . . 62.530000000000001 108.961 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -110.16 125.62 53.22 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.166 -1.79 . . . . 71.510000000000005 106.166 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.1 t -138.54 132.13 30.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 118.374 0.534 . . . . 71.129999999999995 109.897 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -153.91 100.28 2.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.173 0.589 . . . . 71.299999999999997 109.494 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -115.77 -70.47 0.79 Allowed 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.309 -0.997 . . . . 73.140000000000001 108.309 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.5 p -73.04 177.59 4.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.391 1.476 . . . . 74.409999999999997 109.618 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -98.64 -20.14 17.15 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.254 -1.529 . . . . 75.430000000000007 108.802 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.3 m -79.09 132.2 36.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.328 2.251 . . . . 75.450000000000003 110.444 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.32 -55.86 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.7 0.8 . . . . 74.409999999999997 112.917 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.63 -39.85 74.35 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.853 1.206 . . . . 74.319999999999993 112.583 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -67.6 -43.28 80.85 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.755 -0.831 . . . . 73.219999999999999 108.755 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -64.89 -37.75 88.66 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.974 -0.751 . . . . 72.530000000000001 108.974 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -59.95 -52.06 67.04 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.225 1.01 . . . . 72.329999999999998 109.992 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -63.03 -32.23 73.55 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.505 1.502 . . . . 64.430000000000007 112.025 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.04 -46.33 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.307 -1.738 . . . . 74.409999999999997 106.307 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.27 78.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.976 0.91 . . . . 74.519999999999996 109.842 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -40.57 94.06 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.425 -0.583 . . . . 75.310000000000002 109.425 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.65 -53.17 61.12 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.599 -0.688 . . . . 73.530000000000001 109.739 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.5 p -66.56 -32.01 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 113.068 0.766 . . . . 75.109999999999999 113.068 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.7 tp -67.74 -30.64 70.17 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.348 -0.845 . . . . 74.299999999999997 109.823 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -58.99 -31.37 68.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.011 1.324 . . . . 75.010000000000005 110.726 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.55 -48.88 53.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.114 0.966 . . . . 73.239999999999995 109.062 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -60.26 -46.28 90.37 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.899 0.88 . . . . 72.329999999999998 110.284 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.4 t -64.39 -37.95 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 118.044 -0.979 . . . . 72.219999999999999 110.175 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.39 -61.37 2.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.894 1.224 . . . . 71.030000000000001 110.642 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.4 p -56.61 -37.23 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 O-C-N 123.886 0.741 . . . . 72.450000000000003 109.55 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -62.72 -35.82 81.0 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.012 0.745 . . . . 65.219999999999999 113.012 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -73.55 -41.55 62.82 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.725 -0.843 . . . . 73.329999999999998 108.725 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -79.28 -0.26 31.61 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.4 1.259 . . . . 74.519999999999996 114.4 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 C--N 1.325 -0.477 0 C-N-CA 125.72 1.608 . . . . 73.120000000000005 112.697 178.23 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 121.164 0.507 . . . . 75.230000000000004 109.803 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -102.18 155.87 35.93 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.342 1.457 . . . . 72.519999999999996 109.914 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.11 167.68 26.41 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.754 2.302 . . . . 71.409999999999997 110.919 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.16 168.85 13.51 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.701 -0.96 . . . . 74.219999999999999 110.701 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.9 ptm -77.58 165.86 23.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.368 0.667 . . . . 75.319999999999993 110.3 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.43 88.88 1.73 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.046 -2.205 . . . . 73.239999999999995 105.046 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.32 176.94 6.01 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.492 -0.559 . . . . 64.219999999999999 109.492 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.51 -171.73 2.91 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.483 0.713 . . . . 75.409999999999997 111.183 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.1 p -141.35 162.85 34.49 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.403 1.481 . . . . 74.340000000000003 108.48 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 m -119.04 173.14 5.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.047 1.339 . . . . 74.349999999999994 109.683 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.01 177.31 10.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.873 2.469 . . . . 72.200000000000003 106.755 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.6 t -90.53 142.91 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 121.384 -0.822 . . . . 73.519999999999996 109.046 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.05 168.2 10.23 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.169 0.587 . . . . 73.310000000000002 109.611 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.25 175.02 46.15 Favored Glycine 0 CA--C 1.523 0.545 0 O-C-N 121.401 -0.812 . . . . 43.420000000000002 112.813 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 . . . . . 0 C--O 1.235 0.338 0 C-N-CA 125.433 1.493 . . . . 75.209999999999994 107.018 179.329 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 C--O 1.239 0.501 0 N-CA-C 108.379 -0.971 . . . . 73.409999999999997 108.379 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.92 138.76 31.93 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.739 1.626 . . . . 74.120000000000005 112.204 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.2 mt -127.88 143.24 51.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.156 1.382 . . . . 71.329999999999998 111.295 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -120.69 103.81 9.41 Favored 'General case' 0 N--CA 1.461 0.085 0 C-N-CA 126.509 1.924 . . . . 51.420000000000002 107.935 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.15 -19.51 20.68 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.085 1.513 . . . . 75.239999999999995 115.085 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.8 m -83.39 -6.58 59.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.241 0.928 . . . . 73.540000000000006 111.937 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -114.23 0.83 14.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.579 1.152 . . . . 74.209999999999994 110.911 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 mt -102.65 154.97 18.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.098 0.559 . . . . 74.299999999999997 111.146 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -113.61 156.57 23.44 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.144 2.178 . . . . 63.119999999999997 108.243 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.58 165.07 30.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.532 1.933 . . . . 75.340000000000003 107.076 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -138.56 170.07 16.66 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.563 -0.903 . . . . 75.349999999999994 108.563 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -118.16 162.91 17.45 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.649 0.779 . . . . 75.439999999999998 111.833 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 102.567 -3.123 . . . . 75.040000000000006 102.567 178.61 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.457 -0.095 0 N-CA-C 106.998 -1.482 . . . . 74.409999999999997 106.998 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.6 t -154.4 144.13 21.64 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 104.499 -2.408 . . . . 75.230000000000004 104.499 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.78 134.57 64.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.437 -1.32 . . . . 72.129999999999995 107.437 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -118.88 130.36 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 106.667 -1.605 . . . . 71.530000000000001 106.667 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.2 tp -123.03 142.57 50.71 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.643 -0.873 . . . . 73.319999999999993 108.643 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -137.25 132.38 33.7 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.222 1.409 . . . . 73.25 109.695 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.19 134.17 34.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.657 1.183 . . . . 72.230000000000004 110.034 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.41 -59.9 1.5 Allowed Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 118.098 -0.953 . . . . 73.319999999999993 112.554 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.55 -18.85 60.25 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.643 2.229 . . . . 52.009999999999998 116.492 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.3 p -120.23 -10.42 9.37 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.403 1.261 . . . . 61.340000000000003 114.403 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.4 2.93 29.58 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.366 -1.241 . . . . 60.5 113.116 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.3 mt -64.54 134.6 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.98 1.89 . . . . 72.109999999999999 109.606 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.22 151.08 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 107.87 -1.159 . . . . 73.140000000000001 107.87 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p -152.6 154.9 7.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 120.979 -1.076 . . . . 71.120000000000005 108.644 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -122.26 134.44 54.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.778 -1.193 . . . . 73.450000000000003 107.778 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 29.1 m -137.19 150.84 48.18 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.492 1.117 . . . . 61.350000000000001 112.231 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -155.07 149.2 25.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.917 2.087 . . . . 75.340000000000003 108.321 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -162.41 -78.61 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.506 -1.665 . . . . 63.299999999999997 106.506 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 t -102.61 175.68 5.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.654 1.982 . . . . 75.109999999999999 109.072 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -84.74 -17.5 38.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.691 -1.147 . . . . 74.430000000000007 109.719 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.7 m -83.79 115.92 22.46 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.701 1.137 . . . . 75.25 111.946 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.91 -40.27 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 118.581 -0.723 . . . . 72.549999999999997 109.808 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -38.42 35.29 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.662 1.185 . . . . 63.25 112.078 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -76.28 -52.44 9.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.271 1.028 . . . . 72.329999999999998 109.022 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -52.23 -32.44 36.77 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.905 1.282 . . . . 75.540000000000006 111.158 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -54.47 -50.44 67.73 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.797 0.839 . . . . 75.349999999999994 109.978 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -75.09 -24.85 58.19 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.907 1.077 . . . . 74.319999999999993 113.907 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 94.7 mt -67.47 -48.33 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.243 -1.391 . . . . 75.439999999999998 107.243 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.45 99.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.554 -0.716 . . . . 71.319999999999993 110.888 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -63.55 -48.77 76.12 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 118.809 -0.615 . . . . 74.099999999999994 111.229 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -58.69 -41.03 85.32 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 117.395 -1.288 . . . . 73.299999999999997 111.688 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.7 -36.94 67.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.623 1.102 . . . . 75.530000000000001 111.141 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 tp -64.61 -38.2 90.19 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 118.741 -0.647 . . . . 70.230000000000004 110.67 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -57.15 -34.3 68.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.713 0.688 . . . . 74.040000000000006 110.381 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -68.36 -32.91 73.33 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.294 0.638 . . . . 72.150000000000006 110.64 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -77.9 -38.85 44.83 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.532 -0.544 . . . . 70.25 109.532 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.8 t -58.7 -40.4 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.683 -0.858 . . . . 73.519999999999996 108.683 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.31 -60.59 3.53 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.092 0.86 . . . . 64.209999999999994 109.419 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.99 -37.67 34.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 125.067 1.347 . . . . 72.129999999999995 110.452 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -69.83 -42.61 73.38 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.904 0.882 . . . . 75.299999999999997 111.343 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -68.92 -33.81 74.36 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.714 -0.847 . . . . 74.329999999999998 108.714 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.04 -50.88 15.05 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.52 0.728 . . . . 74.349999999999994 109.832 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 CA--C 1.532 0.278 0 C-N-CA 128.407 2.683 . . . . 72.340000000000003 111.062 -177.546 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 121.088 0.471 . . . . 75.209999999999994 110.204 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -116.02 157.86 43.93 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.938 1.695 . . . . 75.230000000000004 110.353 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.87 178.55 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.415 2.744 . . . . 74.230000000000004 111.288 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.55 -79.24 0.04 OUTLIER Glycine 0 C--N 1.339 0.722 0 N-CA-C 111.482 -0.647 . . . . 65.319999999999993 111.482 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 28.3 ptm -67.1 147.86 52.61 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.796 0.798 . . . . 75.019999999999996 110.494 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.4 71.64 0.65 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.828 1.251 . . . . 64.219999999999999 108.194 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.47 154.59 34.57 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.517 -0.919 . . . . 74.140000000000001 108.517 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.4 t -123.01 -176.02 3.31 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.602 1.161 . . . . 52.340000000000003 112.06 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -68.57 167.51 14.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.588 1.955 . . . . 74.400000000000006 110.031 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 m -66.11 145.45 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 121.353 -0.842 . . . . 75.219999999999999 108.762 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -74.89 175.9 7.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.317 1.047 . . . . 73.140000000000001 113.825 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.89 151.64 7.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 128.176 2.59 . . . . 75.109999999999999 108.96 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.57 153.87 20.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.789 0.268 . . . . 74.510000000000005 111.265 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.38 -83.07 0.37 Allowed Glycine 0 C--N 1.336 0.556 0 C-N-CA 125.022 1.296 . . . . 70.430000000000007 111.599 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.271 0 N-CA-C 108.647 -0.871 . . . . 75.129999999999995 108.647 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 112.761 0.652 . . . . 73.239999999999995 112.761 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.72 131.01 14.14 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.631 2.887 . . . . 74.010000000000005 111.821 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.0 mt -104.98 134.39 48.17 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.335 1.054 . . . . 75.239999999999995 109.041 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -73.25 107.5 5.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.804 -0.813 . . . . 72.540000000000006 108.804 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -59.09 -25.13 63.52 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 122.021 -0.424 . . . . 74.299999999999997 111.972 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 m -83.9 7.17 19.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.183 1.393 . . . . 70.430000000000007 112.7 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -116.24 -2.67 12.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.556 1.542 . . . . 73.439999999999998 109.8 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.78 138.61 40.8 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.539 -1.282 . . . . 75.319999999999993 107.539 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -103.3 134.8 46.09 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.066 -1.457 . . . . 74.010000000000005 107.066 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.51 164.74 11.65 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.113 1.765 . . . . 75.209999999999994 112.811 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -140.87 172.57 12.51 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.703 2.001 . . . . 74.0 109.833 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -134.4 158.61 43.4 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.504 1.121 . . . . 74.420000000000002 109.493 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.456 -0.151 0 N-CA-C 107.529 -1.286 . . . . 75.109999999999999 107.529 179.216 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 113.584 0.957 . . . . 73.049999999999997 113.584 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 t -65.36 130.12 42.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 118.992 0.814 . . . . 63.420000000000002 109.852 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.3 t -111.24 137.26 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 103.309 -2.849 . . . . 72.420000000000002 103.309 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -130.5 117.95 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 105.816 -1.92 . . . . 75.400000000000006 105.816 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.2 tp -135.4 150.61 49.93 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 104.701 -2.333 . . . . 72.150000000000006 104.701 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.5 158.69 43.8 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 123.942 0.897 . . . . 74.019999999999996 109.971 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -91.89 135.59 33.81 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.134 -2.173 . . . . 75.239999999999995 105.134 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.5 t -71.04 -61.94 2.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 119.864 1.211 . . . . 61.140000000000001 113.171 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.25 -25.11 72.07 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 121.68 1.587 . . . . 74.310000000000002 114.708 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 t -98.36 -16.7 19.2 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.281 0.492 . . . . 73.239999999999995 112.104 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.33 12.52 12.83 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.426 1.489 . . . . 61.140000000000001 113.257 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 62.3 mt -70.95 116.18 12.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 119.591 1.695 . . . . 72.310000000000002 106.527 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.3 t -105.32 146.4 12.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.68 -1.23 . . . . 72.129999999999995 107.68 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.12 148.08 17.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.051 -1.092 . . . . 72.120000000000005 108.051 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -120.85 107.04 12.23 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.747 1.219 . . . . 71.010000000000005 107.975 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 58.5 m -136.02 148.55 48.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.226 0.61 . . . . 74.140000000000001 110.211 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -155.48 150.6 26.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.624 -1.621 . . . . 73.450000000000003 106.624 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.79 -36.07 0.24 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.759 0.424 . . . . 74.209999999999994 110.455 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.8 p -123.63 -178.6 4.07 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.213 1.405 . . . . 74.450000000000003 108.457 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.76 -13.39 34.08 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.054 -0.721 . . . . 75.230000000000004 109.054 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -79.42 115.12 18.87 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.851 -1.166 . . . . 74.019999999999996 107.851 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.4 -41.34 84.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.94 -1.133 . . . . 74.349999999999994 107.94 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -56.5 -48.43 77.2 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.427 2.291 . . . . 72.120000000000005 110.371 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -65.88 -45.08 83.38 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.263 0.625 . . . . 75.129999999999995 109.465 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -64.0 -32.7 74.34 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.429 0.692 . . . . 73.239999999999995 111.249 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -59.61 -46.72 88.13 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.624 1.102 . . . . 75.120000000000005 110.336 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -58.87 -48.97 79.51 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 118.563 0.62 . . . . 74.040000000000006 110.553 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.6 mt -54.55 -48.79 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 O-C-N 124.417 1.073 . . . . 73.430000000000007 110.277 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.72 98.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 122.831 0.452 . . . . 70.129999999999995 111.418 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.4 ttm-85 -64.26 -46.62 82.92 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 118.224 -0.893 . . . . 74.120000000000005 110.28 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -50.71 69.8 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 119.438 1.017 . . . . 70.530000000000001 110.995 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.7 p -63.08 -33.39 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 120.178 1.354 . . . . 74.140000000000001 110.52 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.99 -42.19 90.1 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 120.998 -1.064 . . . . 70.349999999999994 108.486 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -56.8 -47.72 79.56 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.13 1.372 . . . . 73.409999999999997 110.569 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -59.64 -34.96 73.47 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.5 0.72 . . . . 64.109999999999999 110.403 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -79.62 -33.43 41.49 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.345 0.658 . . . . 71.109999999999999 111.812 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -74.01 -34.45 39.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 124.231 1.013 . . . . 75.450000000000003 109.763 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.01 -50.88 69.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.715 1.143 . . . . 73.5 109.019 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.8 t -57.97 -32.73 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.209 0.604 . . . . 64.230000000000004 109.661 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -77.34 -19.97 55.54 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.786 -1.196 . . . . 75.430000000000007 112.59 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -91.2 -22.32 20.69 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.992 0.814 . . . . 74.129999999999995 111.265 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -108.83 -17.17 14.0 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.995 0.816 . . . . 70.120000000000005 112.926 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.1 t . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 127.402 2.281 . . . . 62.039999999999999 108.13 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.101 -0.703 . . . . 70.219999999999999 109.101 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -109.38 151.73 42.28 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 124.444 1.098 . . . . 75.409999999999997 108.578 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.63 162.67 35.17 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.526 2.151 . . . . 71.140000000000001 110.561 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.58 172.58 37.67 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 109.196 -1.561 . . . . 71.209999999999994 109.196 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.3 tpt -134.46 135.28 42.37 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.772 -1.196 . . . . 72.329999999999998 107.772 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 64.57 1.11 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.618 1.167 . . . . 74.319999999999993 108.711 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.51 150.28 43.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.925 0.869 . . . . 71.310000000000002 109.227 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 t -93.59 129.1 39.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.189 -1.782 . . . . 74.040000000000006 106.189 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.1 t -69.05 -177.68 1.1 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.689 0.757 . . . . 65.439999999999998 109.67 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.9 m -94.72 -154.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.704 1.602 . . . . 75.239999999999995 110.682 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -131.6 171.13 13.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.568 2.747 . . . . 74.340000000000003 109.603 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.87 169.4 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.842 0.857 . . . . 74.329999999999998 109.69 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.53 152.72 23.87 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.061 0.846 . . . . 63.0 112.734 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.05 70.22 3.16 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 106.971 -2.452 . . . . 64.409999999999997 106.971 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 . . . . . 0 C--O 1.224 -0.28 0 C-N-CA 124.411 1.085 . . . . 75.030000000000001 109.863 -178.921 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 119.737 -0.173 . . . . 74.340000000000003 111.228 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.01 174.45 11.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.503 2.135 . . . . 65.329999999999998 110.93 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.6 133.87 5.84 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 104.224 -2.509 . . . . 61.210000000000001 104.224 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -66.31 116.15 7.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.18 1.178 . . . . 74.409999999999997 114.18 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CB ' ' HD2' ' A' ' 97' ' ' ARG . 13.7 pt-20 -65.39 -32.13 73.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.142 0.793 . . . . 74.329999999999998 113.142 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 m -76.38 1.62 15.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.526 0.565 . . . . 73.340000000000003 112.526 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -107.57 6.61 28.12 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.984 1.714 . . . . 71.040000000000006 110.582 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.3 mt -110.31 176.37 5.07 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.839 1.052 . . . . 74.120000000000005 113.839 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -127.01 130.19 49.54 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.958 -1.497 . . . . 71.409999999999997 106.958 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.59 159.69 34.74 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.86 1.264 . . . . 73.040000000000006 108.87 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -137.82 154.89 49.48 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.818 -1.178 . . . . 71.099999999999994 107.818 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -119.94 122.47 41.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.809 1.244 . . . . 75.340000000000003 108.547 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.235 0.324 0 CA-C-O 122.282 1.039 . . . . 71.439999999999998 109.797 -179.004 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 112.191 0.441 . . . . 73.439999999999998 112.191 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 m -67.9 135.06 51.89 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.727 -1.212 . . . . 73.25 107.727 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.36 154.28 20.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.685 -1.228 . . . . 71.299999999999997 107.685 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.4 147.79 21.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.327 -2.101 . . . . 75.420000000000002 105.327 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.7 tp -140.47 150.42 43.77 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.366 1.066 . . . . 73.120000000000005 108.999 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.28 157.99 44.72 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 112.502 0.556 . . . . 74.109999999999999 112.502 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -100.89 118.4 36.86 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 103.643 -2.725 . . . . 74.219999999999999 103.643 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -63.29 -54.08 47.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 120.253 1.388 . . . . 74.340000000000003 112.875 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.41 -13.02 34.88 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.843 2.362 . . . . 70.430000000000007 116.509 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.6 m -121.14 -6.22 9.45 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.078 1.308 . . . . 71.25 113.698 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.02 17.01 34.98 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 123.949 0.785 . . . . 70.209999999999994 114.915 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.5 mt -74.04 134.57 29.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 104.325 -2.472 . . . . 75.200000000000003 104.325 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t -130.23 137.16 57.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.824 -1.176 . . . . 73.439999999999998 107.824 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.67 147.93 28.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.676 -0.861 . . . . 75.519999999999996 108.676 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -122.68 118.49 28.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.479 1.112 . . . . 74.200000000000003 110.422 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 99.3 m -127.67 144.47 51.07 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.247 0.619 . . . . 74.219999999999999 110.986 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -155.62 120.42 4.75 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.468 1.107 . . . . 74.030000000000001 108.541 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.69 -71.67 0.27 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.086 0.954 . . . . 72.530000000000001 108.496 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 p -78.77 156.54 28.78 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.37 1.868 . . . . 73.310000000000002 113.614 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.14 -15.55 52.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.331 -0.618 . . . . 73.120000000000005 109.331 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.48 123.25 27.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.521 -1.288 . . . . 74.450000000000003 107.521 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.3 p -60.41 -46.38 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 119.157 0.889 . . . . 74.510000000000005 110.211 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -55.06 -42.21 72.44 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.422 1.889 . . . . 74.319999999999993 112.354 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -23.01 41.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.225 -0.893 . . . . 75.549999999999997 111.223 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -77.94 -42.91 31.49 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.581 -1.636 . . . . 73.010000000000005 106.581 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -52.17 -45.94 65.29 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.471 1.108 . . . . 72.409999999999997 109.0 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -59.67 -34.03 72.32 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-O 117.649 -1.167 . . . . 74.299999999999997 113.233 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.5 mt -64.32 -53.17 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 120.087 1.312 . . . . 64.450000000000003 108.402 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.05 -47.05 75.32 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 108.404 -0.961 . . . . 70.530000000000001 108.404 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.414 ' HD2' ' CB ' ' A' ' 45' ' ' GLU . 33.3 ttp85 -59.87 -39.56 85.68 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.383 1.073 . . . . 74.329999999999998 111.984 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -63.49 -57.52 9.94 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.96 1.304 . . . . 71.209999999999994 109.622 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.57 -29.21 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 112.106 0.41 . . . . 73.510000000000005 112.106 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.94 -46.76 89.4 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.648 -0.658 . . . . 75.019999999999996 109.554 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -59.01 -31.45 68.83 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.556 0.342 . . . . 73.510000000000005 111.451 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.26 -24.96 64.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.319 0.509 . . . . 73.200000000000003 112.079 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -88.03 -44.12 11.22 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.956 0.903 . . . . 75.530000000000001 110.138 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.39 -39.25 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 118.675 -0.679 . . . . 63.310000000000002 110.064 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -53.4 -66.68 0.35 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.651 0.739 . . . . 73.439999999999998 109.929 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.8 p -57.53 -30.48 36.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 118.174 -0.917 . . . . 74.310000000000002 111.144 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -59.9 -44.65 94.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.22 1.373 . . . . 74.150000000000006 110.199 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -75.66 -39.47 57.61 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.992 0.517 . . . . 74.519999999999996 110.731 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -65.12 -54.74 25.22 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.575 -0.528 . . . . 75.409999999999997 109.575 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 CA--C 1.545 0.781 0 C-N-CA 126.522 1.929 . . . . 64.109999999999999 106.889 178.52 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 109.836 -0.431 . . . . 73.239999999999995 109.836 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -125.37 155.74 71.18 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.967 1.707 . . . . 73.310000000000002 109.184 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.39 164.33 34.26 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.568 2.179 . . . . 64.430000000000007 111.428 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.61 169.73 16.47 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.499 -1.041 . . . . 74.030000000000001 110.499 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.2 mtt -82.01 163.36 22.17 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.721 -0.474 . . . . 73.530000000000001 109.721 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.93 74.41 1.26 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.325 -1.732 . . . . 65.549999999999997 106.325 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.61 176.89 6.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.894 0.854 . . . . 74.420000000000002 112.651 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -64.68 168.14 6.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.183 0.993 . . . . 63.350000000000001 110.528 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.5 p -130.48 178.86 6.29 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.819 1.248 . . . . 74.329999999999998 112.377 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.67 145.9 3.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.591 1.156 . . . . 73.439999999999998 109.908 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -71.95 -171.78 0.76 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.071 -0.968 . . . . 74.019999999999996 110.912 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 m -55.85 170.66 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 126.667 1.987 . . . . 74.430000000000007 114.753 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.52 172.91 12.48 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.607 1.563 . . . . 75.299999999999997 110.733 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.44 -79.26 0.56 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 109.969 -1.252 . . . . 62.5 109.969 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 . . . . . 0 C--O 1.236 0.343 0 C-N-CA 124.703 1.201 . . . . 74.319999999999993 109.609 179.561 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 109.343 -0.614 . . . . 74.099999999999994 109.343 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.09 129.34 20.39 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.516 2.81 . . . . 74.030000000000001 111.092 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.4 mt -117.75 121.25 40.33 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.487 1.115 . . . . 75.450000000000003 109.663 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -77.93 101.89 7.06 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.29 -1.004 . . . . 74.409999999999997 108.29 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.07 -29.14 60.11 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.213 0.46 . . . . 75.530000000000001 111.441 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -73.06 -3.78 28.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.178 0.991 . . . . 74.150000000000006 112.139 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -118.4 0.1 11.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.33 2.252 . . . . 75.340000000000003 110.663 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.9 mt -98.98 176.78 5.46 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.252 1.021 . . . . 74.120000000000005 109.388 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -138.4 148.13 44.13 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.76 -1.2 . . . . 73.519999999999996 107.76 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -141.76 164.83 29.14 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.786 1.234 . . . . 74.439999999999998 108.955 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -126.04 174.87 8.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.004 -0.739 . . . . 73.230000000000004 109.004 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -133.94 113.62 12.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.348 -1.353 . . . . 74.439999999999998 107.348 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.0 t . . . . . 0 C--N 1.33 -0.253 0 N-CA-C 105.929 -1.878 . . . . 74.340000000000003 105.929 -179.282 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 p30 . . . . . 0 N--CA 1.461 0.097 0 N-CA-C 106.06 -1.83 . . . . 75.019999999999996 106.06 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.8 t 178.45 133.8 0.08 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.651 2.781 . . . . 74.25 106.067 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.2 t -118.08 114.38 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 106.129 -1.804 . . . . 71.230000000000004 106.129 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.57 138.14 33.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.667 0.746 . . . . 72.510000000000005 109.303 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.8 tp -135.59 148.58 49.1 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.409 1.883 . . . . 74.329999999999998 107.889 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.71 158.4 44.48 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.479 -1.304 . . . . 75.209999999999994 107.479 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -106.84 119.27 38.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.585 -0.894 . . . . 74.409999999999997 108.585 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 t -57.36 -61.11 7.79 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.689 1.196 . . . . 71.129999999999995 110.103 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.77 -12.02 33.44 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.29 2.66 . . . . 75.239999999999995 116.832 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -120.83 -10.61 9.1 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.403 1.261 . . . . 73.549999999999997 114.403 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.78 -5.38 2.49 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.625 1.107 . . . . 50.130000000000003 114.754 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.6 mt -60.55 140.46 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 126.022 1.729 . . . . 73.530000000000001 108.128 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 t -126.02 142.57 42.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 105.792 -1.929 . . . . 74.530000000000001 105.792 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.56 139.58 16.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.497 -0.927 . . . . 73.239999999999995 108.497 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 113.7 17.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.37 1.468 . . . . 74.099999999999994 107.388 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.6 p -100.04 164.58 11.93 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.522 1.529 . . . . 73.430000000000007 111.741 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -155.8 120.67 4.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.138 1.775 . . . . 74.150000000000006 106.874 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.01 -47.54 0.13 Allowed 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.677 0.791 . . . . 75.109999999999999 110.082 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.7 p -128.13 -170.63 2.28 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.784 -1.561 . . . . 75.010000000000005 106.784 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.08 9.0 15.83 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.306 -0.871 . . . . 71.120000000000005 110.897 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 75.3 m -103.46 115.05 29.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.946 -1.131 . . . . 75.329999999999998 107.946 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.62 -43.05 77.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 123.54 0.736 . . . . 64.340000000000003 110.245 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.19 -30.63 64.7 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.643 1.11 . . . . 70.209999999999994 112.32 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -86.52 -48.39 8.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.749 -0.834 . . . . 74.310000000000002 108.749 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -60.95 -26.58 67.62 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.234 0.614 . . . . 74.140000000000001 110.751 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -57.16 -40.71 77.82 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.202 0.91 . . . . 74.109999999999999 110.093 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -73.6 -29.17 62.22 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 118.288 -1.365 . . . . 75.030000000000001 110.48 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.05 -45.18 95.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 124.381 1.072 . . . . 74.120000000000005 108.526 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.06 -45.22 94.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.858 0.361 . . . . 65.019999999999996 110.596 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -66.05 -48.17 71.92 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 122.65 0.38 . . . . 74.439999999999998 111.705 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -40.34 92.36 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 117.894 -1.05 . . . . 74.030000000000001 110.453 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.82 -37.79 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.278 0.944 . . . . 73.329999999999998 109.291 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.8 tp -61.11 -38.56 86.77 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.087 0.858 . . . . 71.310000000000002 110.854 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -57.06 -34.28 68.1 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.936 0.789 . . . . 75.239999999999995 111.384 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -67.49 -31.08 70.98 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.842 0.829 . . . . 74.019999999999996 109.97 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -77.68 -47.03 20.18 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.764 0.826 . . . . 75.230000000000004 110.948 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.1 t -62.18 -37.85 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 123.681 0.793 . . . . 71.150000000000006 109.964 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -52.24 -65.88 0.48 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.258 1.023 . . . . 54.409999999999997 110.296 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.63 -28.65 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.597 -0.69 . . . . 75.510000000000005 111.42 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -68.85 -40.19 79.51 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 119.123 0.874 . . . . 73.239999999999995 110.832 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -72.24 -45.24 61.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.722 0.809 . . . . 71.340000000000003 110.021 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -63.86 -53.9 43.32 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.289 0.636 . . . . 74.510000000000005 111.082 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.453 -0.301 0 C-N-CA 123.779 0.832 . . . . 73.329999999999998 111.836 -179.253 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 108.629 -0.878 . . . . 74.540000000000006 108.629 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -129.15 153.29 80.36 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.027 1.331 . . . . 74.439999999999998 110.235 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -80.8 177.1 8.36 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.63 2.887 . . . . 75.239999999999995 110.85 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.89 160.24 27.97 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.649 -1.38 . . . . 62.140000000000001 109.649 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -145.81 124.09 12.27 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.838 -1.912 . . . . 65.400000000000006 105.838 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.98 56.49 1.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.622 1.169 . . . . 72.230000000000004 108.573 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.41 139.3 58.53 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.537 -0.727 . . . . 62.210000000000001 109.114 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 t -88.36 -170.0 2.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.897 1.279 . . . . 64.209999999999994 110.517 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.9 p -136.08 178.0 7.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.594 1.558 . . . . 73.400000000000006 109.467 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.71 -179.43 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 126.377 1.871 . . . . 75.299999999999997 109.514 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -130.48 169.47 15.5 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.082 1.753 . . . . 73.319999999999993 110.996 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.59 147.74 7.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.242 1.017 . . . . 75.239999999999995 109.265 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.92 -166.62 1.38 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.099 -1.445 . . . . 74.299999999999997 107.099 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.28 179.94 25.56 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-O 121.999 0.777 . . . . 71.140000000000001 112.223 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 . . . . . 0 C--N 1.33 -0.255 0 C-N-CA 124.632 1.173 . . . . 73.310000000000002 110.162 179.815 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.24 0.605 0 N-CA-C 109.77 -0.455 . . . . 74.040000000000006 109.77 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -62.41 140.95 85.12 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.137 1.225 . . . . 72.420000000000002 110.622 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.3 123.23 12.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.124 -1.806 . . . . 74.439999999999998 106.124 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -85.24 117.86 24.44 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.618 1.167 . . . . 74.299999999999997 109.664 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.35 -29.13 69.83 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.823 1.046 . . . . 73.140000000000001 113.823 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -82.68 -10.48 58.9 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.454 1.102 . . . . 75.519999999999996 112.849 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -91.59 2.25 56.58 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.768 0.713 . . . . 73.310000000000002 111.568 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mt -102.73 174.5 5.86 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.122 1.369 . . . . 61.439999999999998 112.106 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -126.79 156.23 41.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.346 2.258 . . . . 72.140000000000001 105.807 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.45 157.31 46.84 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.602 -0.686 . . . . 71.230000000000004 111.861 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -126.89 140.17 52.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.408 1.083 . . . . 74.239999999999995 111.134 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -106.38 132.34 52.52 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.562 1.145 . . . . 63.210000000000001 108.096 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.235 0.318 0 N-CA-C 107.975 -1.121 . . . . 75.510000000000005 107.975 -179.337 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 111.455 0.169 . . . . 72.010000000000005 111.455 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -104.46 156.39 17.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.714 1.206 . . . . 64.450000000000003 109.504 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.95 142.22 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.537 1.535 . . . . 75.549999999999997 107.473 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -137.56 95.47 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.23 -1.396 . . . . 52.140000000000001 107.23 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.4 tp -93.46 152.4 19.11 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.727 0.411 . . . . 75.109999999999999 110.229 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -141.45 137.3 32.07 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 124.574 1.149 . . . . 73.530000000000001 110.346 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -87.84 132.93 34.0 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 105.468 -2.049 . . . . 71.450000000000003 105.468 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.63 -64.95 2.25 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 119.297 0.953 . . . . 74.319999999999993 111.846 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.54 -7.74 21.78 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.801 3.0 . . . . 73.400000000000006 116.13 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 m -113.3 -17.36 12.32 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.86 1.209 . . . . 75.230000000000004 112.213 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.11 -7.03 0.86 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.363 1.459 . . . . 70.310000000000002 115.725 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.76 136.93 25.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 120.038 1.919 . . . . 74.340000000000003 107.523 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.0 t -121.6 137.29 55.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.818 1.647 . . . . 71.239999999999995 106.772 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.0 p -146.88 148.11 17.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.542 -0.911 . . . . 74.310000000000002 108.542 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.48 134.08 41.11 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 122.523 0.329 . . . . 75.450000000000003 111.291 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.1 t -140.77 155.35 46.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.181 1.793 . . . . 73.420000000000002 108.547 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -150.75 100.78 2.86 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.496 1.918 . . . . 65.319999999999993 108.173 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -120.55 -15.55 8.47 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.768 1.396 . . . . 74.329999999999998 114.768 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.3 p -134.2 168.18 19.33 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.53 1.514 . . . . 74.439999999999998 110.824 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -79.96 -10.61 59.79 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.633 -0.667 . . . . 72.420000000000002 110.851 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.37 114.65 26.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.827 1.651 . . . . 75.140000000000001 110.231 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.35 -44.45 98.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-O 119.18 -0.438 . . . . 54.450000000000003 110.707 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -58.15 -45.45 87.4 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.381 0.537 . . . . 74.420000000000002 110.952 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -42.2 97.21 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.47 -0.937 . . . . 73.329999999999998 108.47 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.56 -27.47 68.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 118.613 -0.708 . . . . 73.219999999999999 109.987 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -62.22 -46.59 88.18 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.077 1.308 . . . . 74.140000000000001 107.843 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -60.36 -37.39 80.56 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.344 0.52 . . . . 74.010000000000005 110.222 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.48 -48.27 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 108.612 -0.884 . . . . 75.319999999999993 108.612 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.5 -35.49 80.65 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.673 -0.642 . . . . 73.439999999999998 110.538 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -63.71 -52.06 62.25 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 123.758 0.823 . . . . 75.120000000000005 111.282 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -43.35 94.21 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.643 1.11 . . . . 74.209999999999994 110.66 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.11 -33.09 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.503 1.047 . . . . 74.099999999999994 109.326 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.11 -33.13 75.08 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 120.839 -1.163 . . . . 71.310000000000002 108.962 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -58.75 -45.64 89.22 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.958 1.254 . . . . 75.239999999999995 107.951 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -56.47 -37.58 70.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.399 1.08 . . . . 73.120000000000005 109.684 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -72.4 -39.02 68.27 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.621 -0.674 . . . . 74.409999999999997 111.911 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.94 -39.29 85.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.564 -0.902 . . . . 60.549999999999997 108.564 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.12 -62.89 1.44 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.604 1.561 . . . . 75.430000000000007 110.799 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.4 p -60.8 -27.62 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 119.246 -0.407 . . . . 73.129999999999995 110.819 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -66.69 -36.19 81.92 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.585 0.63 . . . . 74.329999999999998 109.786 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -74.53 -42.78 58.25 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.423 -0.584 . . . . 73.109999999999999 109.423 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -67.83 -58.47 4.53 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.026 0.931 . . . . 73.310000000000002 111.748 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.451 -0.419 0 C-N-CA 125.384 1.474 . . . . 62.299999999999997 109.544 -179.111 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 107.723 -1.214 . . . . 75.329999999999998 107.723 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -123.65 152.39 65.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 124.405 1.082 . . . . 70.510000000000005 110.222 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -80.74 -179.54 5.23 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.929 3.086 . . . . 70.230000000000004 110.903 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.75 167.99 25.15 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.397 -1.481 . . . . 62.229999999999997 109.397 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -147.82 140.0 24.28 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.998 -1.852 . . . . 74.329999999999998 105.998 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.46 59.95 0.82 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.665 0.666 . . . . 72.230000000000004 111.053 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.78 140.07 42.15 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.624 -0.88 . . . . 74.25 108.624 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 t -73.87 164.55 26.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.524 1.13 . . . . 74.430000000000007 111.59 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 p -102.69 165.48 11.04 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.345 1.458 . . . . 72.329999999999998 108.593 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.07 143.28 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 107.521 -1.289 . . . . 75.329999999999998 107.521 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -62.12 139.24 58.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.439 0.638 . . . . 64.019999999999996 110.518 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -82.87 169.22 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 125.439 1.496 . . . . 73.239999999999995 109.293 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.25 149.68 36.71 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.47 2.308 . . . . 54.439999999999998 107.077 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -136.36 -57.29 0.06 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 125.38 1.467 . . . . 75.349999999999994 111.195 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 117.675 -1.155 . . . . 75.439999999999998 109.035 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 108.657 -0.868 . . . . 73.099999999999994 108.657 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.77 146.8 67.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.096 1.864 . . . . 73.140000000000001 111.927 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 mt -111.86 159.25 18.52 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.741 1.217 . . . . 74.400000000000006 111.533 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -115.01 101.37 8.94 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 108.096 -1.076 . . . . 74.239999999999995 108.096 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -66.12 -20.79 66.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.311 0.645 . . . . 74.310000000000002 112.71 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -84.4 3.29 36.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.932 1.693 . . . . 63.25 112.599 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -124.15 22.81 8.59 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.299 1.039 . . . . 71.510000000000005 111.203 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -112.31 162.0 16.01 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.295 -0.878 . . . . 73.099999999999994 108.81 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -126.13 95.1 4.28 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.423 1.489 . . . . 75.409999999999997 107.094 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -87.0 162.86 17.39 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.138 1.375 . . . . 74.150000000000006 112.271 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.7 172.2 13.98 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.919 -1.511 . . . . 72.019999999999996 106.919 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -130.97 155.91 46.01 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.509 1.124 . . . . 74.099999999999994 108.789 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 CA--C 1.531 0.243 0 CA-C-O 121.741 0.782 . . . . 64.140000000000001 109.512 -179.439 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 114.469 1.285 . . . . 74.109999999999999 114.469 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.5 m -63.81 160.03 18.21 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.202 1.001 . . . . 70.439999999999998 110.611 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.08 148.53 30.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.07 -1.456 . . . . 75.120000000000005 107.07 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 p -133.78 115.88 22.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 105.953 -1.869 . . . . 71.540000000000006 105.953 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.77 151.66 40.32 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.18 1.792 . . . . 75.400000000000006 106.881 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.23 151.57 36.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.178 0.991 . . . . 74.519999999999996 111.78 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -87.26 134.28 33.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.995 -1.483 . . . . 75.519999999999996 106.995 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.66 -59.35 4.75 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.796 -1.097 . . . . 72.450000000000003 111.909 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.06 -9.29 23.33 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 124.268 3.312 . . . . 75.329999999999998 116.227 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.4 m -118.24 -12.38 9.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.742 0.701 . . . . 73.340000000000003 112.124 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.07 14.56 18.25 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.64 1.114 . . . . 52.25 113.361 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.1 mt -67.02 131.16 32.82 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 N-CA-C 106.048 -1.834 . . . . 61.240000000000002 106.048 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.71 140.18 48.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.826 -1.176 . . . . 74.019999999999996 107.826 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.81 144.14 24.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.375 -0.972 . . . . 72.319999999999993 108.375 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.66 111.16 17.28 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 105.929 -1.878 . . . . 74.319999999999993 105.929 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 81.3 m -124.28 158.12 33.29 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.008 0.908 . . . . 73.420000000000002 111.394 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -155.43 145.43 21.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.451 1.9 . . . . 73.319999999999993 108.627 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -154.2 -35.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.843 -0.535 . . . . 74.349999999999994 109.651 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.6 p -138.91 -178.76 5.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.42 -0.955 . . . . 74.340000000000003 108.42 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -93.33 -5.77 48.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.595 -0.891 . . . . 74.329999999999998 108.595 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.0 m -79.79 114.99 19.13 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.951 1.7 . . . . 54.43 107.812 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.37 -38.33 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 121.958 -0.464 . . . . 63.509999999999998 110.173 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -62.35 -33.7 75.23 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.893 1.277 . . . . 73.239999999999995 110.73 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -76.86 -54.82 6.1 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.215 -1.032 . . . . 74.120000000000005 108.215 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -52.46 -36.03 53.86 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.668 -0.682 . . . . 73.340000000000003 110.125 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -57.84 -58.28 9.07 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 118.212 -0.899 . . . . 74.230000000000004 110.294 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.21 -32.94 74.71 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.935 1.243 . . . . 75.519999999999996 113.31 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.47 -50.93 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.235 -1.394 . . . . 75.239999999999995 107.235 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.07 75.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.459 -0.941 . . . . 60.240000000000002 108.459 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.34 -47.0 62.85 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.648 1.179 . . . . 74.420000000000002 111.582 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -45.58 82.45 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 117.423 -1.275 . . . . 75.510000000000005 111.75 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.35 -29.93 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 120.397 1.453 . . . . 73.030000000000001 110.738 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -44.17 96.9 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 107.898 -1.149 . . . . 71.430000000000007 107.898 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -54.95 -39.62 69.11 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.564 1.146 . . . . 75.019999999999996 110.913 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -67.39 -30.18 69.88 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.076 0.95 . . . . 72.439999999999998 110.312 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.13 -46.9 17.07 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.078 -1.014 . . . . 74.430000000000007 110.021 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.28 -30.38 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.454 -0.943 . . . . 74.030000000000001 108.454 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -57.86 -62.43 1.81 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.685 -1.598 . . . . 74.400000000000006 106.685 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.5 t -59.55 -29.53 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.649 0.779 . . . . 72.420000000000002 110.39 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -66.6 -34.6 78.24 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.276 1.398 . . . . 73.439999999999998 111.805 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -87.52 -31.16 20.08 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 109.068 -0.716 . . . . 73.120000000000005 109.068 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -80.89 -15.92 55.01 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.086 0.554 . . . . 73.150000000000006 110.853 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.444 -0.774 0 C-N-CA 125.433 1.493 . . . . 74.209999999999994 109.727 -178.867 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.335 -0.616 . . . . 74.150000000000006 109.335 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -89.37 153.99 48.67 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 123.722 0.809 . . . . 75.010000000000005 109.087 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.77 163.81 33.0 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.722 2.281 . . . . 75.010000000000005 110.839 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.26 -176.36 34.54 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.822 -1.311 . . . . 75.510000000000005 109.822 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 53.9 ttm -121.02 145.47 47.73 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.638 -1.245 . . . . 75.129999999999995 107.638 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.26 68.6 1.04 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.72 -1.956 . . . . 51.310000000000002 105.72 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.4 172.91 7.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.9 -0.407 . . . . 74.120000000000005 109.9 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 t -154.77 177.09 11.65 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 122.194 -0.316 . . . . 74.219999999999999 110.476 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.8 m -138.1 173.65 11.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.725 2.41 . . . . 74.450000000000003 107.597 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.17 178.87 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.469 1.907 . . . . 65.420000000000002 109.09 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -71.0 142.12 50.97 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.388 -1.708 . . . . 74.5 106.388 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.77 177.45 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.467 0.651 . . . . 74.120000000000005 110.828 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 174.26 11.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.83 -0.623 . . . . 74.120000000000005 110.875 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.63 162.87 32.3 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 107.442 -2.263 . . . . 74.010000000000005 107.442 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 122.334 1.064 . . . . 73.450000000000003 111.839 -179.826 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 119.075 -0.488 . . . . 75.319999999999993 109.807 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.2 151.41 73.56 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.075 2.517 . . . . 63.240000000000002 113.931 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.0 mt -123.13 110.41 15.25 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.255 1.422 . . . . 73.019999999999996 108.046 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -79.62 101.97 8.64 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.122 1.369 . . . . 75.319999999999993 110.276 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.8 -29.88 42.48 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.487 0.921 . . . . 73.340000000000003 113.487 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.5 -22.83 60.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.14 0.427 . . . . 71.129999999999995 111.24 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -89.22 -21.84 23.05 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.568 1.147 . . . . 74.209999999999994 110.476 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.7 mt -84.16 176.62 8.66 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.756 0.822 . . . . 74.510000000000005 110.112 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.19 140.73 49.96 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.608 -1.627 . . . . 75.400000000000006 106.608 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -129.04 157.11 42.63 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.716 1.206 . . . . 75.519999999999996 109.679 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -137.3 118.71 14.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.799 -1.556 . . . . 72.109999999999999 106.799 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -74.45 163.16 28.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.808 -1.996 . . . . 72.030000000000001 109.8 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.7 t . . . . . 0 C--N 1.332 -0.172 0 N-CA-C 107.697 -1.223 . . . . 74.099999999999994 107.697 -179.604 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 111.763 0.282 . . . . 75.310000000000002 111.763 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.17 159.21 26.8 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.347 -0.846 . . . . 61.25 108.959 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.26 130.27 60.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.169 -2.16 . . . . 73.140000000000001 105.169 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 t -121.28 119.97 60.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.746 -1.205 . . . . 74.140000000000001 107.746 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.8 tp -118.78 142.31 47.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.217 -1.401 . . . . 74.319999999999993 107.217 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.17 152.3 45.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.69 -1.226 . . . . 71.319999999999993 107.69 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -100.3 116.62 32.7 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.03 -2.211 . . . . 71.129999999999995 105.03 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.82 -56.75 22.77 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 117.74 -1.124 . . . . 74.530000000000001 112.04 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -69.25 -10.4 28.87 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.468 2.112 . . . . 74.439999999999998 114.885 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 m -120.43 -11.92 9.05 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.843 1.053 . . . . 74.030000000000001 113.843 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.08 -4.02 3.68 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 127.69 2.566 . . . . 73.510000000000005 115.633 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.56 135.81 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 119.295 1.547 . . . . 75.219999999999999 108.748 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 t -123.35 148.19 27.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 126.258 1.823 . . . . 74.519999999999996 107.124 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 p -145.61 146.29 19.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 106.447 -1.686 . . . . 74.209999999999994 106.447 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -123.86 119.13 28.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.019 -1.104 . . . . 75.25 108.019 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 91.5 m -128.57 152.26 48.52 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.684 0.754 . . . . 72.530000000000001 111.094 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -155.68 100.64 2.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.177 2.191 . . . . 74.120000000000005 106.155 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -111.31 -41.53 4.12 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.328 -0.858 . . . . 65.109999999999999 110.779 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.3 t -140.76 179.11 6.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.446 1.099 . . . . 52.299999999999997 109.921 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.93 11.94 12.31 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.43 1.092 . . . . 70.109999999999999 109.902 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.9 m -107.23 115.54 30.34 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.992 -1.114 . . . . 75.019999999999996 107.992 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.7 -47.87 81.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.411 0.685 . . . . 74.140000000000001 109.314 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -49.69 -54.09 20.74 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.295 1.438 . . . . 61.240000000000002 112.406 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.49 -46.12 87.57 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.5 0.72 . . . . 75.540000000000006 109.618 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -56.91 -37.71 71.83 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.635 0.652 . . . . 75.439999999999998 111.108 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -57.91 -36.88 73.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.83 0.741 . . . . 74.439999999999998 109.531 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -55.85 25.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.496 0.589 . . . . 74.219999999999999 109.734 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.6 mp -52.67 -47.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.777 -0.453 . . . . 75.420000000000002 109.777 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.54 -50.96 71.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.932 0.893 . . . . 74.019999999999996 111.98 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -60.97 -43.83 98.2 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.799 -0.619 . . . . 75.5 110.26 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.06 -59.32 5.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.572 -0.899 . . . . 73.450000000000003 108.572 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 p -60.1 -35.07 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.819 0.736 . . . . 74.340000000000003 112.937 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -65.07 -42.89 93.76 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 119.011 0.823 . . . . 72.439999999999998 110.279 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -52.01 -42.25 62.88 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.643 1.577 . . . . 74.409999999999997 112.612 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.34 -43.16 78.79 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.621 0.724 . . . . 70.510000000000005 110.38 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -73.79 -41.17 62.77 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.176 1.79 . . . . 73.200000000000003 112.412 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.86 -34.11 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 118.146 -0.93 . . . . 72.140000000000001 110.585 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -54.7 -59.54 4.57 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.565 1.529 . . . . 72.420000000000002 106.928 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.29 -34.49 27.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.315 1.846 . . . . 72.420000000000002 110.291 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -66.26 -39.19 89.29 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.593 -0.692 . . . . 75.129999999999995 110.715 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -78.05 -38.63 44.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.585 0.63 . . . . 74.409999999999997 110.063 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -68.41 -58.76 3.86 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.318 1.047 . . . . 75.019999999999996 112.641 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 m . . . . . 0 N--CA 1.452 -0.37 0 C-N-CA 125.583 1.553 . . . . 71.040000000000006 114.017 -177.08 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 109.428 -0.582 . . . . 64.299999999999997 109.428 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -111.92 155.47 43.22 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.666 1.186 . . . . 70.099999999999994 109.76 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.78 171.34 18.38 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.977 2.451 . . . . 65.420000000000002 111.412 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.06 -176.2 47.8 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.814 -0.915 . . . . 62.32 110.814 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 50.3 ttp -133.17 156.53 47.32 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.197 1.399 . . . . 74.209999999999994 108.034 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.36 120.68 4.49 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 102.468 -3.16 . . . . 75.409999999999997 102.468 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.94 175.71 5.35 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.907 0.883 . . . . 71.430000000000007 109.251 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 t -74.07 152.58 39.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.934 0.874 . . . . 73.239999999999995 110.779 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 p -84.61 -162.61 0.7 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 129.787 3.235 . . . . 71.120000000000005 112.284 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.69 149.35 4.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 O-C-N 121.038 -1.039 . . . . 72.310000000000002 108.933 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -81.42 -168.0 1.69 Allowed 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.814 0.816 . . . . 74.129999999999995 109.226 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.72 155.47 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 125.675 1.59 . . . . 74.010000000000005 107.032 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.07 172.12 7.63 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.256 -0.903 . . . . 74.329999999999998 111.325 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.49 160.27 28.7 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.973 -1.251 . . . . 71.439999999999998 109.973 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 121.14 0.495 . . . . 74.109999999999999 110.371 179.847 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 109.856 -0.424 . . . . 64.409999999999997 109.856 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.13 106.22 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.266 3.311 . . . . 73.519999999999996 115.868 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -80.8 149.91 29.41 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.785 -0.45 . . . . 73.409999999999997 109.785 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -103.81 106.7 17.29 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 106.959 -1.497 . . . . 74.040000000000006 106.959 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -60.15 -13.63 13.09 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 115.417 1.636 . . . . 73.430000000000007 115.417 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.9 m -95.99 -13.07 24.08 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.237 0.926 . . . . 70.329999999999998 111.394 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -93.99 3.16 55.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.002 2.121 . . . . 73.329999999999998 111.449 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mt -98.64 166.62 11.25 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.723 1.209 . . . . 63.329999999999998 109.784 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -133.99 98.02 4.04 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.677 1.191 . . . . 73.329999999999998 107.806 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.59 164.72 17.58 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.024 0.93 . . . . 72.239999999999995 112.727 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -132.35 124.87 29.61 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.955 -1.128 . . . . 74.439999999999998 107.955 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -88.22 101.01 13.42 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.757 -0.831 . . . . 74.230000000000004 108.757 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.1 t . . . . . 0 C--N 1.323 -0.556 0 N-CA-C 106.252 -1.759 . . . . 73.120000000000005 106.252 178.734 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 . . . . . 0 C--O 1.232 0.162 0 N-CA-C 109.325 -0.62 . . . . 71.209999999999994 109.325 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.5 p -155.48 111.52 3.12 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.231 0.612 . . . . 72.310000000000002 111.157 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.66 137.38 40.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 105.569 -2.012 . . . . 62.439999999999998 105.569 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.15 123.24 63.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.689 -1.967 . . . . 72.010000000000005 105.689 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.37 142.65 45.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.93 -1.137 . . . . 70.030000000000001 107.93 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -140.39 139.43 35.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.343 1.857 . . . . 74.439999999999998 110.575 -178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -103.07 124.08 47.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.026 -1.842 . . . . 75.030000000000001 106.026 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.58 -63.13 4.01 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 117.854 -1.07 . . . . 71.109999999999999 112.024 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.49 -11.62 32.8 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.909 2.406 . . . . 71.430000000000007 115.785 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -111.88 -13.51 13.65 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.091 0.86 . . . . 62.43 111.224 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.79 0.62 4.11 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.14 1.829 . . . . 52.119999999999997 115.616 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.7 mt -69.16 143.32 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 119.39 1.595 . . . . 74.409999999999997 109.376 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 t -136.56 136.94 48.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.229 -1.397 . . . . 63.329999999999998 107.229 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.07 147.74 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 121.543 -0.723 . . . . 75.209999999999994 109.259 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -129.64 107.52 9.51 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.431 1.092 . . . . 73.140000000000001 110.289 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 56.7 m -120.44 152.16 38.35 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.782 0.833 . . . . 62.149999999999999 109.86 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.69 100.41 2.08 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.79 1.236 . . . . 71.329999999999998 107.845 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -119.63 -14.04 9.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.359 0.664 . . . . 73.140000000000001 112.778 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.6 p -133.83 -176.83 4.3 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.18 0.992 . . . . 73.310000000000002 110.301 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -109.95 19.45 19.03 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.233 1.013 . . . . 75.049999999999997 112.644 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 t -125.63 132.02 52.55 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.44 1.096 . . . . 72.340000000000003 108.111 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.4 p -58.86 -47.25 90.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 N-CA-C 108.691 -0.855 . . . . 72.340000000000003 108.691 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -63.17 -25.87 68.54 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.892 1.071 . . . . 74.420000000000002 113.892 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -84.48 -44.73 13.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.033 -1.469 . . . . 71.319999999999993 107.033 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -64.34 -27.2 68.86 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.383 -0.823 . . . . 75.25 109.156 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -62.71 -58.3 7.95 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 126.351 1.86 . . . . 75.400000000000006 108.607 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -56.29 -37.21 69.55 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.141 0.428 . . . . 74.120000000000005 111.681 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 79.0 mt -63.9 -50.65 76.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.74 -0.837 . . . . 74.040000000000006 108.74 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.08 97.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.096 -0.478 . . . . 75.450000000000003 110.361 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -61.33 -49.14 78.17 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 118.699 0.681 . . . . 72.120000000000005 109.305 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -56.13 24.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.778 0.831 . . . . 74.340000000000003 110.452 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.36 -35.43 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 119.074 0.852 . . . . 64.430000000000007 111.544 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.1 tp -64.27 -41.19 97.04 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 121.187 -0.945 . . . . 72.349999999999994 109.15 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -58.3 -43.22 87.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.184 0.994 . . . . 72.319999999999993 109.672 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -60.81 -27.42 68.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.545 0.738 . . . . 74.209999999999994 111.234 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -88.09 -45.58 10.03 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.169 1.388 . . . . 74.219999999999999 111.84 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.6 t -63.35 -35.37 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 107.567 -1.272 . . . . 64.239999999999995 107.567 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.65 -64.23 0.9 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.71 1.204 . . . . 71.340000000000003 109.383 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.5 p -59.56 -30.53 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.518 -0.739 . . . . 71.109999999999999 111.727 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -68.87 -35.07 76.47 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.852 1.206 . . . . 63.520000000000003 111.203 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -83.08 -32.14 26.94 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.355 1.062 . . . . 74.340000000000003 109.869 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -77.11 -46.37 23.76 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.567 0.747 . . . . 72.239999999999995 110.281 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.45 -0.453 0 C-N-CA 123.641 0.776 . . . . 72.049999999999997 109.221 179.181 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 109.633 -0.506 . . . . 73.409999999999997 109.633 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -109.97 153.9 42.92 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.129 1.372 . . . . 74.400000000000006 109.497 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.61 168.64 23.31 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.805 2.337 . . . . 75.329999999999998 111.765 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.76 -172.33 39.27 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 109.866 -1.294 . . . . 64.239999999999995 109.866 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.2 mmt -125.44 158.9 33.25 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.65 1.18 . . . . 70.549999999999997 108.467 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.32 68.19 1.19 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.348 -1.352 . . . . 75.540000000000006 107.348 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.65 172.12 11.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.931 -0.577 . . . . 73.120000000000005 110.053 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.7 t -131.62 -173.23 3.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.844 0.858 . . . . 75.120000000000005 111.167 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.4 t -130.66 163.0 28.16 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.235 1.414 . . . . 64.540000000000006 109.632 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.0 m -67.6 -173.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.011 1.725 . . . . 75.010000000000005 112.293 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -132.45 176.87 8.05 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.423 1.889 . . . . 73.219999999999999 108.9 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.2 173.18 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 124.2 1.0 . . . . 74.349999999999994 110.57 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.84 162.86 28.27 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.773 -0.649 . . . . 75.439999999999998 111.569 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.85 141.07 15.36 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 106.069 -2.813 . . . . 43.509999999999998 106.069 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 118.365 1.082 . . . . 71.420000000000002 109.612 -179.467 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 118.959 -0.543 . . . . 75.310000000000002 111.212 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.51 159.0 55.26 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.452 2.768 . . . . 74.010000000000005 111.692 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 mt -136.91 122.34 19.5 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 123.189 0.595 . . . . 75.430000000000007 109.804 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -67.71 101.79 1.1 Allowed 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 106.839 -1.541 . . . . 73.439999999999998 106.839 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -57.34 -31.69 65.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.81 0.844 . . . . 73.409999999999997 112.361 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.2 m -77.56 -6.28 53.1 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.739 0.816 . . . . 62.240000000000002 112.686 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -99.83 7.11 45.22 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.235 1.414 . . . . 74.340000000000003 110.334 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mt -110.57 164.59 12.57 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.599 1.16 . . . . 75.340000000000003 110.456 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -120.96 137.73 54.48 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.167 -2.161 . . . . 70.200000000000003 105.167 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -123.78 155.19 38.39 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.818 1.647 . . . . 73.099999999999994 110.725 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -129.87 178.7 6.33 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.206 1.002 . . . . 74.349999999999994 108.829 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -135.43 163.5 29.9 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.476 1.91 . . . . 75.019999999999996 107.619 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.4 t . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 104.096 -2.557 . . . . 72.319999999999993 104.096 178.325 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 112.791 0.663 . . . . 73.549999999999997 112.791 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.9 m -64.25 144.61 57.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.031 1.333 . . . . 70.099999999999994 109.679 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.4 162.48 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 121.897 0.856 . . . . 75.030000000000001 109.96 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -141.34 156.26 21.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 126.996 2.118 . . . . 64.129999999999995 107.549 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.45 150.04 40.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.704 -1.961 . . . . 74.519999999999996 105.704 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.89 158.17 43.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.665 0.786 . . . . 72.340000000000003 109.337 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -107.34 126.38 52.38 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 104.828 -2.286 . . . . 75.510000000000005 104.828 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.1 t -68.28 -58.03 8.05 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 120.051 1.296 . . . . 73.25 111.593 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.09 -12.55 35.26 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.423 2.082 . . . . 73.439999999999998 115.628 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -112.4 -21.18 11.5 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.954 0.797 . . . . 70.040000000000006 109.719 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.39 -9.25 7.86 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.606 2.526 . . . . 74.510000000000005 113.686 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.7 mt -55.41 147.49 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.1 1.76 . . . . 72.109999999999999 109.918 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.2 t -134.35 146.94 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.468 1.507 . . . . 73.129999999999995 108.045 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -144.97 139.54 22.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.225 1.01 . . . . 70.430000000000007 108.896 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -110.64 127.89 55.46 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.156 1.382 . . . . 75.400000000000006 108.706 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.7 m -150.54 149.39 29.88 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.54 0.686 . . . . 73.430000000000007 112.799 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -155.23 139.72 16.85 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 129.584 3.154 . . . . 74.049999999999997 105.073 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -152.82 -68.97 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.719 -1.215 . . . . 70.319999999999993 107.719 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.0 p -77.93 151.66 33.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.564 1.146 . . . . 72.319999999999993 111.129 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -66.75 -25.83 66.69 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.83 0.678 . . . . 64.230000000000004 112.83 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 m -79.64 116.23 19.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.51 0.595 . . . . 75.010000000000005 109.845 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.8 p -54.07 -42.6 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.757 -0.831 . . . . 74.109999999999999 108.757 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.93 -44.42 78.35 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.132 0.973 . . . . 74.340000000000003 111.745 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -67.16 -39.55 86.51 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.043 -1.095 . . . . 73.439999999999998 108.043 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -60.86 -29.06 69.3 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.634 -0.698 . . . . 72.099999999999994 109.612 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -58.17 -40.91 82.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.801 1.182 . . . . 75.200000000000003 108.754 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -71.56 -46.51 59.23 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 125.098 1.359 . . . . 72.140000000000001 110.382 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 99.4 mt -56.97 -52.8 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.462 0.705 . . . . 72.319999999999993 111.277 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.5 -28.08 69.58 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.73 -0.606 . . . . 75.099999999999994 111.426 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -72.94 -45.76 56.28 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 118.554 -0.736 . . . . 74.439999999999998 109.883 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -64.82 -35.85 82.43 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.941 1.246 . . . . 74.200000000000003 111.101 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.3 p -71.79 -32.99 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 120.041 1.291 . . . . 74.230000000000004 108.375 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.4 tp -64.87 -32.77 74.64 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.602 -1.258 . . . . 64.040000000000006 107.602 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -55.75 -41.43 73.96 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.216 -0.661 . . . . 71.219999999999999 109.216 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -63.51 -39.58 94.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.733 0.697 . . . . 73.219999999999999 110.886 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -63.24 -48.19 79.27 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.773 0.829 . . . . 74.019999999999996 110.518 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 50.1 t -69.28 -41.01 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.872 0.869 . . . . 75.109999999999999 110.207 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.48 -62.01 1.89 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.183 1.393 . . . . 74.150000000000006 109.681 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.75 -22.44 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.027 0.931 . . . . 75.409999999999997 112.248 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -75.37 -27.2 59.04 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.771 -1.206 . . . . 74.450000000000003 111.293 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -98.94 -30.73 12.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.346 0.975 . . . . 74.540000000000006 109.655 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -75.89 -6.4 50.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.292 0.637 . . . . 71.219999999999999 110.597 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.237 0.401 0 C-N-CA 125.795 1.638 . . . . 73.420000000000002 110.145 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 C--O 1.233 0.2 0 N-CA-C 109.822 -0.436 . . . . 54.43 109.822 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -121.58 154.68 59.93 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.483 1.513 . . . . 75.099999999999994 109.411 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.54 169.65 22.06 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.745 2.297 . . . . 65.519999999999996 111.094 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.33 175.46 20.68 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.645 -1.382 . . . . 72.5 109.645 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.1 ttt -143.7 144.65 31.94 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.726 -1.212 . . . . 74.439999999999998 107.726 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.07 80.34 0.99 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.569 -1.641 . . . . 63.200000000000003 106.569 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.06 160.85 21.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.141 0.577 . . . . 75.400000000000006 110.807 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -103.31 -168.0 1.45 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.555 1.542 . . . . 74.430000000000007 108.29 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.3 p -124.37 -177.26 3.74 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.447 1.499 . . . . 65.239999999999995 109.977 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.72 157.96 41.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 125.203 1.401 . . . . 73.430000000000007 108.332 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.95 163.48 15.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.605 0.762 . . . . 61.109999999999999 110.987 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.0 -179.57 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.701 1.2 . . . . 72.310000000000002 108.788 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.06 161.22 20.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.956 1.302 . . . . 74.439999999999998 109.003 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.66 166.47 54.83 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.003 -1.239 . . . . 73.129999999999995 110.003 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? . . . . . 0 N--CA 1.47 0.535 0 C-N-CA 124.765 1.226 . . . . 74.200000000000003 110.067 -179.693 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 114.042 1.127 . . . . 73.450000000000003 114.042 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.04 154.6 33.23 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.907 2.405 . . . . 73.329999999999998 109.784 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.8 mt -134.35 136.81 43.67 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.717 0.807 . . . . 72.030000000000001 110.255 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.92 107.59 1.9 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.083 1.353 . . . . 72.340000000000003 108.668 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.58 -19.25 57.05 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.56 0.578 . . . . 72.25 112.56 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.9 m -85.27 -1.91 57.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.497 1.044 . . . . 63.420000000000002 112.033 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -114.63 -4.97 12.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.925 1.239 . . . . 74.549999999999997 112.585 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mt -86.33 140.99 29.55 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.911 -1.885 . . . . 71.400000000000006 105.911 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -109.0 126.11 52.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.779 0.718 . . . . 74.129999999999995 109.416 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.57 164.49 12.48 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.325 1.05 . . . . 73.540000000000006 112.613 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -141.61 143.86 33.9 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.31 -1.737 . . . . 73.340000000000003 106.31 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -103.83 123.39 47.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.085 -1.821 . . . . 73.230000000000004 106.085 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.1 t . . . . . 0 C--N 1.331 -0.226 0 N-CA-C 106.05 -1.833 . . . . 74.129999999999995 106.05 -179.878 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.448 HD22 ' HB ' ' A' ' 89' ' ' VAL . 22.2 t-20 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 107.97 -1.122 . . . . 54.450000000000003 107.97 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.8 m -150.49 152.38 34.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.024 -1.473 . . . . 60.399999999999999 107.024 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.4 124.15 70.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.051 -2.203 . . . . 72.310000000000002 105.051 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.96 96.21 4.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.817 -2.29 . . . . 73.349999999999994 104.817 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.9 tp -91.86 139.54 30.56 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.203 -1.777 . . . . 73.310000000000002 106.203 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.25 141.15 45.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.76 1.224 . . . . 74.420000000000002 110.56 -177.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -95.79 133.29 40.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.856 -1.535 . . . . 63.009999999999998 106.856 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.7 t -70.73 -66.5 0.78 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.307 1.043 . . . . 75.420000000000002 111.438 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.41 -7.63 21.24 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.858 3.038 . . . . 71.230000000000004 116.177 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 t -114.54 -20.43 10.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.524 0.602 . . . . 70.430000000000007 110.91 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.54 -3.97 4.34 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.604 -1.109 . . . . 64.420000000000002 114.807 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.99 139.52 20.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.261 -1.385 . . . . 73.129999999999995 107.261 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.64 147.93 33.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.223 -1.399 . . . . 63.119999999999997 107.223 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.12 140.82 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.986 -1.487 . . . . 65.030000000000001 106.986 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.68 107.79 13.66 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 106.515 -1.661 . . . . 72.340000000000003 106.515 -178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 77.3 m -112.04 134.86 53.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 123.555 0.534 . . . . 74.430000000000007 110.567 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -147.28 109.87 4.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.66 2.384 . . . . 74.340000000000003 106.517 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -135.45 -20.71 1.59 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.49 1.116 . . . . 75.510000000000005 111.264 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.79 173.43 16.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.599 1.16 . . . . 73.409999999999997 107.914 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -86.63 -4.97 59.25 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.961 -1.087 . . . . 75.099999999999994 109.819 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.5 m -82.15 115.0 21.06 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.324 -1.362 . . . . 61.420000000000002 107.324 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.448 ' HB ' HD22 ' A' ' 68' ' ' ASN . 13.9 p -61.19 -38.7 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.796 -0.816 . . . . 73.420000000000002 108.796 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 93' ' ' ARG . 9.9 m-20 -63.42 -23.05 67.24 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 113.859 1.059 . . . . 73.219999999999999 113.859 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -87.71 -46.84 9.14 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.321 -0.992 . . . . 75.209999999999994 108.321 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.11 -43.7 91.93 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.746 0.818 . . . . 62.149999999999999 110.945 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.414 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 4.0 ptm180 -57.74 -46.42 84.48 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 113.06 0.763 . . . . 74.109999999999999 113.06 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -64.41 -36.76 85.2 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 119.541 -0.863 . . . . 74.120000000000005 111.717 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.2 mt -60.89 -49.92 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.112 -1.44 . . . . 63.25 107.112 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.43 68.11 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.476 0.71 . . . . 41.25 111.684 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.9 ttm-85 -61.18 -53.78 52.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.11 0.414 . . . . 75.340000000000003 110.959 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -61.97 -39.8 93.43 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.68 -0.676 . . . . 75.310000000000002 112.409 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.19 -27.15 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 120.482 1.492 . . . . 74.319999999999993 109.495 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.9 tp -65.62 -47.48 75.48 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 120.329 -1.482 . . . . 74.25 107.445 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -56.91 -39.23 74.05 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.678 -1.153 . . . . 72.239999999999995 111.891 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.17 -50.2 74.93 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.775 1.17 . . . . 65.549999999999997 110.303 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -68.17 -44.6 75.58 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.844 -0.616 . . . . 75.209999999999994 112.084 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.6 t -62.91 -37.98 80.68 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-O 118.648 -0.692 . . . . 74.519999999999996 109.789 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -56.2 -52.23 65.18 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-N 119.354 0.979 . . . . 74.439999999999998 110.382 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.96 -18.15 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 121.647 -0.658 . . . . 73.329999999999998 112.434 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -87.48 -19.68 27.63 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.621 1.568 . . . . 74.200000000000003 110.224 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.26 -46.69 5.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.75 2.02 . . . . 74.510000000000005 110.928 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -77.07 -25.95 52.95 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.703 0.683 . . . . 65.420000000000002 111.937 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 CA--C 1.539 0.523 0 C-N-CA 127.895 2.478 . . . . 75.430000000000007 106.631 179.059 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.306 -0.627 . . . . 74.439999999999998 109.306 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -118.43 156.53 50.95 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 125.423 1.489 . . . . 74.409999999999997 108.712 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.81 166.34 29.95 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.431 2.087 . . . . 75.310000000000002 111.491 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.12 -175.92 50.98 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.241 -1.143 . . . . 63.229999999999997 110.241 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 60.7 mtt -122.84 168.26 12.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.962 0.905 . . . . 70.120000000000005 110.04 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.16 132.16 9.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 102.063 -3.31 . . . . 73.439999999999998 102.063 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -130.08 177.44 7.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.594 -1.262 . . . . 53.229999999999997 107.594 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.27 176.33 5.34 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.574 -0.704 . . . . 73.510000000000005 110.189 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -124.58 170.88 10.48 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.466 1.107 . . . . 73.439999999999998 108.865 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.74 -175.26 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.6 1.16 . . . . 73.219999999999999 109.996 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -132.52 173.65 11.1 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.22 1.008 . . . . 74.310000000000002 109.53 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.0 149.35 10.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 124.153 0.981 . . . . 75.049999999999997 109.357 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.13 173.54 7.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.37 1.068 . . . . 73.420000000000002 111.518 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.18 176.17 16.25 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 107.873 -2.091 . . . . 73.219999999999999 107.873 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.3 mmp_? . . . . . 0 C--O 1.235 0.294 0 O-C-N 121.182 -1.187 . . . . 74.140000000000001 111.639 -179.057 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 113.056 0.761 . . . . 74.439999999999998 113.056 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.11 112.59 2.84 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.19 2.594 . . . . 64.430000000000007 112.042 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mt -91.29 140.95 29.29 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.638 -0.664 . . . . 73.239999999999995 110.849 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -89.53 106.35 18.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.642 -1.984 . . . . 73.310000000000002 105.642 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -60.04 -11.49 6.01 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 114.879 1.437 . . . . 73.540000000000006 114.879 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.4 m -101.15 -3.44 29.15 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.208 1.003 . . . . 71.310000000000002 111.595 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -96.59 -8.83 30.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.433 1.093 . . . . 71.109999999999999 110.556 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.06 175.26 6.93 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.347 1.459 . . . . 74.230000000000004 109.709 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -130.1 122.65 28.7 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.39 0.676 . . . . 75.010000000000005 109.825 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -105.26 160.09 15.37 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.275 1.03 . . . . 73.200000000000003 111.182 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -142.05 131.17 23.29 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.139 1.376 . . . . 75.530000000000001 108.896 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -88.41 163.04 16.18 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.665 1.186 . . . . 65.420000000000002 107.933 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 N--CA 1.455 -0.222 0 C-N-CA 124.285 1.034 . . . . 70.340000000000003 108.865 -178.996 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 122.056 0.932 . . . . 64.239999999999995 111.185 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.2 m -99.51 158.39 15.77 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.401 0.68 . . . . 71.530000000000001 109.299 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.4 t -140.74 135.83 34.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.925 1.69 . . . . 74.430000000000007 106.583 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.28 142.27 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.201 -1.407 . . . . 75.409999999999997 107.201 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.4 tp -131.57 146.74 52.36 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.697 1.199 . . . . 75.299999999999997 107.976 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.56 148.59 49.15 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.476 0.655 . . . . 75.129999999999995 110.15 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -93.92 118.67 31.8 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 104.243 -2.503 . . . . 71.439999999999998 104.243 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.19 -61.53 7.66 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 118.531 -0.747 . . . . 74.340000000000003 112.077 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -69.91 -9.78 26.87 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.793 2.329 . . . . 61.25 116.197 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 m -120.95 -10.33 9.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.438 1.472 . . . . 73.019999999999996 114.614 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.74 9.67 27.52 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.737 1.161 . . . . 74.420000000000002 114.725 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 mt -70.81 131.5 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 104.772 -2.307 . . . . 71.219999999999999 104.772 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.1 t -126.52 143.93 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.55 -1.278 . . . . 70.329999999999998 107.55 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.54 142.57 25.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.525 -0.917 . . . . 71.019999999999996 108.525 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -115.42 118.5 33.38 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.751 1.62 . . . . 73.0 110.154 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.0 p -116.55 143.42 45.62 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.397 0.544 . . . . 72.109999999999999 110.135 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -157.41 100.32 1.81 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.704 1.202 . . . . 74.510000000000005 108.813 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -135.34 -24.62 1.39 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 119.989 1.268 . . . . 74.329999999999998 114.017 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.2 p -124.29 171.6 9.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.576 0.75 . . . . 74.129999999999995 110.025 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -91.25 0.85 57.45 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.56 -0.533 . . . . 71.219999999999999 109.56 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.0 m -100.28 114.97 28.85 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.11 1.364 . . . . 73.439999999999998 107.961 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.2 p -59.42 -38.41 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.538 -0.912 . . . . 70.409999999999997 108.538 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -59.4 -40.52 86.9 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.048 1.739 . . . . 72.340000000000003 112.318 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -79.11 -29.76 43.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.492 0.717 . . . . 75.0 110.662 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -70.37 -40.44 73.99 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.275 -1.38 . . . . 72.510000000000005 107.275 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -48.61 -52.01 25.14 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.744 -1.223 . . . . 75.239999999999995 113.022 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -57.3 -35.16 69.48 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.174 0.897 . . . . 73.439999999999998 112.684 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.05 -50.39 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.221 1.008 . . . . 72.010000000000005 108.557 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.86 92.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 119.367 -0.349 . . . . 63.420000000000002 110.427 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -61.73 -51.65 67.51 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.051 0.541 . . . . 74.120000000000005 111.812 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -40.58 95.35 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 117.783 -1.103 . . . . 75.540000000000006 112.32 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.4 p -73.81 -38.77 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 119.676 1.126 . . . . 74.010000000000005 110.456 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.93 -44.99 96.45 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.86 -0.792 . . . . 74.439999999999998 108.86 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -50.28 -47.62 55.31 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 124.143 0.977 . . . . 73.319999999999993 112.095 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -59.27 -35.83 74.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.826 -1.171 . . . . 71.409999999999997 111.671 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -77.6 -33.55 53.79 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.586 1.154 . . . . 75.239999999999995 110.184 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.12 -51.7 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 C-N-CA 125.712 1.605 . . . . 73.140000000000001 108.171 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -61.62 2.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 126.263 1.825 . . . . 74.319999999999993 111.234 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.3 p -59.52 -28.9 41.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 119.489 -0.291 . . . . 63.009999999999998 111.758 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -66.82 -37.58 84.79 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.579 -1.326 . . . . 75.340000000000003 109.996 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -81.84 -40.98 21.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.809 -0.557 . . . . 73.200000000000003 110.629 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -74.65 -15.14 60.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.643 1.577 . . . . 71.230000000000004 112.611 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 124.918 1.287 . . . . 64.439999999999998 109.364 -179.258 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.272 -0.64 . . . . 75.409999999999997 109.272 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -79.57 158.07 73.97 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.884 -0.784 . . . . 74.519999999999996 108.884 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.91 -176.61 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.749 2.3 . . . . 75.099999999999994 110.049 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.84 147.67 43.4 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 109.602 -1.399 . . . . 65.109999999999999 109.602 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 70.8 mtm -134.79 173.74 11.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.203 1.401 . . . . 75.530000000000001 108.704 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.31 119.17 10.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 100.847 -3.761 . . . . 74.319999999999993 100.847 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -123.8 175.61 6.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.846 0.459 . . . . 74.319999999999993 109.969 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.6 t -61.76 141.59 57.8 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.347 0.659 . . . . 71.230000000000004 109.57 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.9 p -73.37 -174.98 1.78 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.794 1.238 . . . . 75.439999999999998 109.602 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.2 m -62.58 153.74 6.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 O-C-N 121.041 -1.037 . . . . 51.409999999999997 109.873 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -130.55 -176.39 3.96 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.297 1.439 . . . . 74.510000000000005 109.521 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 t -70.77 163.72 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 122.007 0.908 . . . . 62.009999999999998 110.946 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.94 168.51 13.87 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 127.792 2.437 . . . . 62.32 107.779 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.04 -174.31 50.28 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 109.055 -1.618 . . . . 73.129999999999995 109.055 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 . . . . . 0 C--O 1.235 0.291 0 CA-C-N 118.15 0.975 . . . . 72.439999999999998 109.706 179.289 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 C--O 1.234 0.262 0 N-CA-C 109.864 -0.421 . . . . 73.400000000000006 109.864 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.76 122.95 10.95 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.072 2.515 . . . . 61.210000000000001 111.664 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -112.28 147.74 35.64 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.641 1.177 . . . . 74.310000000000002 110.341 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -110.49 115.48 29.7 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.663 -1.236 . . . . 73.450000000000003 107.663 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.52 -28.24 69.51 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.851 0.75 . . . . 70.140000000000001 111.675 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 m -75.36 0.05 18.17 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.514 1.126 . . . . 71.209999999999994 111.471 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -117.64 5.76 12.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.107 1.363 . . . . 74.319999999999993 113.305 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.1 mt -107.87 176.0 5.29 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.732 -1.21 . . . . 75.209999999999994 107.732 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -138.6 112.46 8.43 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.124 0.57 . . . . 75.329999999999998 109.661 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 157.26 17.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.003 -1.48 . . . . 73.540000000000006 107.003 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -142.04 -179.67 6.36 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.733 -1.21 . . . . 63.43 107.733 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.04 162.97 27.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.844 1.258 . . . . 72.200000000000003 108.476 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.8 t . . . . . 0 C--O 1.238 0.485 0 C-N-CA 125.64 1.576 . . . . 75.329999999999998 108.909 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 108.697 -0.853 . . . . 74.230000000000004 108.697 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.7 p -156.67 103.71 2.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.906 -1.516 . . . . 74.25 106.906 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.0 t -94.38 158.73 2.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.16 -1.052 . . . . 73.129999999999995 108.16 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.02 146.35 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.49 1.116 . . . . 64.420000000000002 109.751 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.4 tp -146.12 149.7 34.52 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.447 1.499 . . . . 72.349999999999994 108.407 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -140.27 148.38 41.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.052 1.341 . . . . 74.150000000000006 109.812 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.02 126.06 46.16 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.564 1.546 . . . . 75.349999999999994 107.547 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.8 -56.1 5.01 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 118.084 -0.96 . . . . 72.120000000000005 111.511 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.31 -8.14 22.19 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.093 1.862 . . . . 71.030000000000001 116.081 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -120.73 -9.97 9.25 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.093 0.861 . . . . 64.549999999999997 112.614 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.78 4.14 9.71 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.518 -1.157 . . . . 63.020000000000003 115.132 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.1 mt -70.28 141.92 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 126.187 1.795 . . . . 75.439999999999998 107.746 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.6 148.08 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.745 1.218 . . . . 62.219999999999999 108.382 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.3 151.76 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.249 -0.648 . . . . 73.349999999999994 109.249 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -132.42 107.98 8.86 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.02 -1.474 . . . . 72.319999999999993 107.02 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.3 m -123.6 153.33 40.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 122.475 1.131 . . . . 60.420000000000002 112.869 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -154.3 148.41 25.81 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.909 2.084 . . . . 72.319999999999993 107.521 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -162.46 -26.79 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.159 0.983 . . . . 54.149999999999999 110.784 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.5 p -138.34 158.1 44.94 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.782 -0.574 . . . . 74.209999999999994 110.924 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -22.51 66.94 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.643 -0.661 . . . . 73.150000000000006 111.847 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -79.54 116.81 19.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.21 1.804 . . . . 72.200000000000003 112.217 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.4 p -58.72 -40.78 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.38 0.672 . . . . 63.109999999999999 110.162 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -58.72 -46.92 86.28 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.918 0.887 . . . . 74.400000000000006 111.425 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -65.06 -44.12 90.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.564 1.145 . . . . 70.540000000000006 109.837 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -61.36 -40.42 94.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.997 0.362 . . . . 72.430000000000007 110.353 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -59.09 -38.87 80.52 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.134 -0.936 . . . . 72.230000000000004 111.028 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -59.77 -48.22 82.54 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.383 0.992 . . . . 74.120000000000005 109.287 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.1 -48.2 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 123.844 0.858 . . . . 50.310000000000002 109.397 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.47 82.37 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.177 0.591 . . . . 74.099999999999994 110.343 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -62.39 -45.35 93.56 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.055 0.542 . . . . 72.340000000000003 110.12 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -55.65 -61.65 2.21 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.138 0.975 . . . . 75.409999999999997 109.202 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.73 -34.45 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.655 0.613 . . . . 75.010000000000005 112.655 -177.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.0 -47.78 81.64 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.032 0.933 . . . . 73.140000000000001 109.12 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -52.13 -41.41 62.5 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.937 0.895 . . . . 72.319999999999993 113.17 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.5 -33.15 75.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.609 0.719 . . . . 64.109999999999999 110.738 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -73.59 -34.45 65.08 Favored 'General case' 0 C--N 1.335 -0.053 0 O-C-N 121.355 -0.841 . . . . 75.25 110.137 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.1 t -68.07 -43.41 85.3 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 CA-C-O 118.354 -0.831 . . . . 71.200000000000003 109.112 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -50.28 -60.76 2.66 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.391 1.077 . . . . 74.310000000000002 109.604 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.96 -29.25 46.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-O 118.601 -0.714 . . . . 75.329999999999998 111.737 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -69.56 -38.79 77.56 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 120.104 1.32 . . . . 74.340000000000003 110.93 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -73.76 -56.08 5.43 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.472 -0.936 . . . . 74.540000000000006 108.472 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -67.82 -21.33 65.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 115.202 1.556 . . . . 74.129999999999995 115.202 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 C--N 1.327 -0.397 0 C-N-CA 125.708 1.603 . . . . 71.239999999999995 107.665 179.825 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 121.578 0.704 . . . . 75.430000000000007 112.169 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.25 152.72 92.37 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.125 -0.694 . . . . 74.340000000000003 109.125 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.68 3.8 5.13 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.448 2.765 . . . . 74.230000000000004 113.358 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.04 179.43 48.07 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.186 -1.966 . . . . 62.439999999999998 108.186 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 92.8 mtp -141.45 172.1 13.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.828 1.251 . . . . 71.510000000000005 107.975 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.48 144.69 25.54 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 101.571 -3.492 . . . . 72.099999999999994 101.571 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.58 173.52 11.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.314 -0.625 . . . . 74.010000000000005 109.314 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.4 t -77.35 179.53 6.37 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.343 -0.984 . . . . 63.119999999999997 108.343 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 m -142.38 150.04 40.17 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 106.803 -1.554 . . . . 74.230000000000004 106.803 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -66.33 169.95 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 123.75 0.82 . . . . 74.319999999999993 110.115 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -123.29 166.67 14.89 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.996 0.919 . . . . 73.239999999999995 108.814 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.9 m -112.13 -168.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.236 1.415 . . . . 72.400000000000006 108.506 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.49 -19.32 13.28 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.066 -0.493 . . . . 74.340000000000003 111.103 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.0 -107.68 2.11 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.164 -1.574 . . . . 62.100000000000001 109.164 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.334 -0.102 0 C-N-CA 125.942 1.697 . . . . 74.409999999999997 111.209 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 109.635 -0.506 . . . . 74.109999999999999 109.635 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.51 165.85 29.73 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.896 2.397 . . . . 74.420000000000002 113.696 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.423 0.2 OUTLIER -134.86 166.09 23.79 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.4 1.88 . . . . 72.510000000000005 111.541 179.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -120.16 101.56 7.91 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.103 -1.073 . . . . 71.340000000000003 108.103 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -67.28 -11.95 58.85 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.931 1.085 . . . . 75.120000000000005 113.931 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -0.66 57.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.159 1.384 . . . . 53.450000000000003 112.726 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -126.16 32.61 5.19 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.852 1.261 . . . . 75.540000000000006 109.757 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.1 mt -113.79 117.25 30.94 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.736 1.215 . . . . 73.310000000000002 108.036 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -102.76 103.95 14.22 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 104.802 -2.295 . . . . 74.120000000000005 104.802 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -84.63 163.78 19.06 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.537 1.062 . . . . 74.450000000000003 108.945 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -120.52 129.03 53.64 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.206 -1.776 . . . . 74.450000000000003 106.206 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -87.41 143.27 27.32 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.422 -0.955 . . . . 74.230000000000004 108.422 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 105.565 -2.013 . . . . 62.409999999999997 105.565 179.885 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.41 HD22 ' N ' ' A' ' 89' ' ' VAL . 33.4 t-20 . . . . . 0 C--O 1.237 0.403 0 N-CA-C 107.866 -1.161 . . . . 71.409999999999997 107.866 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.0 t -141.64 138.04 32.25 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.25 1.82 . . . . 63.240000000000002 106.491 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.7 t -121.67 150.56 24.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.709 -1.589 . . . . 73.329999999999998 106.709 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -137.71 128.91 39.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 102.699 -3.075 . . . . 63.240000000000002 102.699 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.1 tp -130.51 143.92 51.07 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.062 0.945 . . . . 73.209999999999994 110.633 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 143.98 31.42 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.261 -0.899 . . . . 74.030000000000001 112.631 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -86.4 121.0 28.34 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.266 -2.124 . . . . 74.310000000000002 105.266 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.44 -57.75 23.16 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.588 1.086 . . . . 74.409999999999997 112.123 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -59.33 -34.14 97.76 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.615 1.543 . . . . 64.430000000000007 114.905 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -93.66 -16.04 24.7 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.523 0.934 . . . . 75.239999999999995 113.523 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.07 23.83 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.565 1.555 . . . . 73.409999999999997 113.737 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.1 mt -70.27 120.82 18.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.049 -1.463 . . . . 71.120000000000005 107.049 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.7 t -111.23 128.51 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 126.385 1.874 . . . . 71.150000000000006 107.647 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.5 157.96 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 123.385 1.564 . . . . 73.099999999999994 108.018 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -141.28 139.68 33.72 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.877 -2.268 . . . . 73.230000000000004 104.877 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.7 t -138.65 163.69 31.45 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.224 -1.769 . . . . 61.219999999999999 106.224 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -155.09 149.22 25.89 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 104.848 -2.279 . . . . 73.540000000000006 104.848 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -170.98 -40.51 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.138 -0.458 . . . . 74.5 110.153 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 p -127.25 -177.45 4.07 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.399 0.619 . . . . 75.420000000000002 112.426 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.9 mtm-85 -103.77 -0.41 29.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.991 0.917 . . . . 75.25 110.943 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m -98.44 115.72 29.13 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.644 -1.243 . . . . 73.439999999999998 107.644 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.41 ' N ' HD22 ' A' ' 68' ' ' ASN . 7.6 p -55.97 -45.82 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 122.878 0.471 . . . . 74.349999999999994 109.82 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.63 -32.62 67.43 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.832 1.253 . . . . 71.430000000000007 112.618 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -82.13 -44.48 16.44 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 120.582 -1.324 . . . . 72.120000000000005 108.127 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -57.35 -36.8 71.64 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.593 0.757 . . . . 65.5 109.632 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -60.12 -51.19 70.67 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 118.144 -0.932 . . . . 74.340000000000003 109.604 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -64.58 -36.57 84.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.837 1.199 . . . . 73.25 112.482 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.62 -43.07 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.157 -0.683 . . . . 61.340000000000003 109.157 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.19 -38.11 87.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.046 0.538 . . . . 74.439999999999998 110.814 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.465 ' HG3' HH11 ' A' ' 97' ' ' ARG . 0.9 OUTLIER -57.6 -52.72 64.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.047 0.939 . . . . 75.140000000000001 111.858 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.78 97.37 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 119.379 -0.929 . . . . 75.030000000000001 112.524 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.83 -32.45 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 120.113 1.324 . . . . 72.219999999999999 111.388 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.1 tp -62.39 -40.29 95.98 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.523 -0.736 . . . . 75.099999999999994 109.447 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -57.44 -42.59 82.73 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.217 0.607 . . . . 73.5 110.097 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -61.11 -20.52 62.74 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.474 0.916 . . . . 71.109999999999999 113.474 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -87.54 -38.83 15.66 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.475 -0.766 . . . . 73.310000000000002 109.458 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.0 t -67.39 -31.98 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.479 -0.934 . . . . 70.129999999999995 108.479 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -52.93 -57.61 9.72 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.098 1.359 . . . . 73.409999999999997 108.116 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.34 -38.68 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.521 1.128 . . . . 74.25 109.375 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -62.85 -37.23 86.01 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.896 1.226 . . . . 74.239999999999995 110.449 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -75.79 -33.62 60.16 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.64 0.978 . . . . 74.439999999999998 113.64 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -108.33 -9.46 15.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 116.369 1.989 . . . . 75.349999999999994 116.369 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 C--N 1.32 -0.677 0 C-N-CA 126.569 1.948 . . . . 73.510000000000005 110.138 -178.991 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 121.113 0.482 . . . . 74.109999999999999 109.778 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -75.2 155.24 86.22 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.851 0.86 . . . . 74.230000000000004 110.399 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.58 175.96 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.122 2.548 . . . . 74.049999999999997 110.586 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.59 163.02 53.47 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.031 -0.827 . . . . 71.219999999999999 111.031 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 95.6 mtp -73.46 163.92 27.38 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.088 0.555 . . . . 53.520000000000003 110.438 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.63 71.96 1.37 Allowed 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 105.546 -2.02 . . . . 65.230000000000004 105.546 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.49 -172.1 1.71 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.056 -0.975 . . . . 75.219999999999999 111.032 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.91 172.63 2.18 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.316 1.047 . . . . 63.119999999999997 110.434 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -130.05 177.36 7.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.634 1.174 . . . . 74.409999999999997 109.47 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 m -63.69 137.0 25.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.785 1.634 . . . . 73.129999999999995 108.672 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -132.36 -176.7 4.17 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.601 1.16 . . . . 73.420000000000002 111.531 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.2 t -54.84 151.87 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.235 1.814 . . . . 73.109999999999999 108.396 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.06 -167.08 1.14 Allowed 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.106 0.962 . . . . 64.430000000000007 109.573 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.49 -171.93 2.02 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.357 1.455 . . . . 73.239999999999995 113.034 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? . . . . . 0 CA--C 1.513 -0.45 0 C-N-CA 123.417 0.687 . . . . 75.109999999999999 109.72 -179.409 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.236 0.384 0 CA-C-O 119.444 -0.312 . . . . 75.329999999999998 111.344 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.21 165.58 26.19 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.141 2.56 . . . . 64.040000000000006 112.211 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.413 0.2 OUTLIER -136.39 164.17 28.76 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 114.06 1.133 . . . . 74.25 114.06 -179.074 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.517 HD21 ' HB2' ' A' ' 47' ' ' GLU . 15.6 t30 -120.84 101.1 7.48 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 104.455 -2.424 . . . . 74.030000000000001 104.455 177.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.41 -14.17 25.98 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.417 1.087 . . . . 71.209999999999994 113.922 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -98.53 6.8 46.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.352 1.061 . . . . 74.519999999999996 110.8 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.517 ' HB2' HD21 ' A' ' 44' ' ' ASN . 6.7 tp10 -120.13 23.93 10.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.328 1.451 . . . . 74.420000000000002 110.178 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 mt -113.41 145.9 40.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.545 1.538 . . . . 75.329999999999998 107.388 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -116.74 106.44 13.51 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.036 -2.209 . . . . 75.540000000000006 105.036 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -100.89 154.05 18.99 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.414 1.085 . . . . 74.129999999999995 113.019 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -144.93 169.89 17.2 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.962 -1.125 . . . . 71.439999999999998 107.962 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -121.27 133.74 55.15 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.946 -1.872 . . . . 75.150000000000006 105.946 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.5 t . . . . . 0 C--N 1.331 -0.228 0 N-CA-C 107.315 -1.365 . . . . 71.219999999999999 107.315 -178.242 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.7 p30 . . . . . 0 N--CA 1.467 0.419 0 CA-C-O 118.573 -0.727 . . . . 75.439999999999998 112.476 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 55.6 m -67.17 142.1 57.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.082 0.856 . . . . 62.009999999999998 108.962 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.1 t -115.22 135.54 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.383 -2.081 . . . . 63.409999999999997 105.383 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.18 130.75 73.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 102.97 -2.974 . . . . 74.0 102.97 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.7 tp -139.01 151.58 46.93 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.123 0.569 . . . . 74.230000000000004 110.168 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 152.43 45.72 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 122.424 0.289 . . . . 75.140000000000001 110.458 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -95.61 122.95 38.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 103.326 -2.842 . . . . 75.200000000000003 103.326 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.48 -62.37 5.56 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 120.091 1.314 . . . . 71.200000000000003 112.017 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.6 -17.12 58.59 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.569 2.18 . . . . 63.450000000000003 115.581 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.21 -13.54 16.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.817 1.19 . . . . 75.450000000000003 110.665 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.41 -15.03 0.87 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.634 1.587 . . . . 61.149999999999999 115.498 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.1 mt -56.95 132.7 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.721 1.608 . . . . 73.299999999999997 110.851 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.2 t -124.14 138.39 53.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 126.868 2.067 . . . . 74.239999999999995 106.094 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.6 157.3 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.737 -0.468 . . . . 74.239999999999995 109.737 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -119.69 131.58 55.45 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 126.251 1.82 . . . . 75.510000000000005 109.134 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -141.24 153.61 45.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.186 0.994 . . . . 65.120000000000005 111.318 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -155.5 159.07 39.46 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 128.011 2.525 . . . . 64.549999999999997 107.356 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -161.8 -54.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.198 1.399 . . . . 73.120000000000005 108.321 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.47 179.13 6.22 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.89 0.853 . . . . 71.25 110.907 -178.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -13.23 62.28 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.753 0.821 . . . . 74.450000000000003 112.151 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.31 115.07 22.3 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.353 0.661 . . . . 72.150000000000006 112.777 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.82 -33.11 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.077 -1.453 . . . . 74.349999999999994 107.077 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.58 -38.36 84.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.178 1.791 . . . . 73.239999999999995 109.763 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.8 -52.29 9.79 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.683 -1.229 . . . . 75.0 107.683 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -52.8 -33.9 51.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.286 0.634 . . . . 73.25 110.104 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -59.26 -62.03 2.19 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.44 1.496 . . . . 73.400000000000006 108.19 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -62.67 -36.41 82.78 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 118.395 -0.812 . . . . 74.200000000000003 112.992 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.35 -51.44 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.245 -1.391 . . . . 74.400000000000006 107.245 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.54 -50.18 72.38 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.408 -0.59 . . . . 73.450000000000003 109.408 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -54.22 -39.93 67.19 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 118.035 -0.983 . . . . 73.109999999999999 112.164 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -44.6 47.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.288 -1.339 . . . . 74.239999999999995 110.831 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.16 -32.85 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.769 1.622 . . . . 74.329999999999998 112.256 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.5 tp -59.66 -35.8 75.14 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.485 -0.759 . . . . 73.150000000000006 109.434 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.76 -38.34 87.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.028 0.931 . . . . 73.099999999999994 109.479 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -68.12 -17.64 64.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.882 1.673 . . . . 64.140000000000001 111.136 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -97.17 -35.54 10.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.99 0.916 . . . . 71.219999999999999 109.001 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.5 t -69.16 -31.92 51.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.011 -1.107 . . . . 71.010000000000005 108.011 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -62.04 1.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.872 2.069 . . . . 62.32 109.174 177.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.64 -25.11 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 122.645 0.378 . . . . 70.129999999999995 111.475 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -77.77 -15.28 59.22 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.99 -1.069 . . . . 74.450000000000003 111.026 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -94.05 -42.31 9.09 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.045 1.338 . . . . 74.209999999999994 108.975 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -87.86 -14.58 39.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.781 1.03 . . . . 73.430000000000007 113.781 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.324 -0.517 0 C-N-CA 125.954 1.702 . . . . 74.120000000000005 108.049 179.625 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 109.16 -0.682 . . . . 75.010000000000005 109.16 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -123.47 154.7 66.18 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 125.314 1.446 . . . . 64.340000000000003 109.651 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.66 169.07 22.5 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.84 2.36 . . . . 61.039999999999999 111.441 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.22 171.02 49.83 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.434 -1.066 . . . . 53.0 110.434 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.3 tpt -154.72 142.65 20.1 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.411 -1.7 . . . . 74.519999999999996 106.411 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.12 65.75 0.77 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.022 0.929 . . . . 74.430000000000007 108.569 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 154.08 30.66 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.965 -0.46 . . . . 55.539999999999999 110.587 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -71.8 152.97 42.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.046 -0.724 . . . . 63.130000000000003 109.046 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -85.89 -170.62 3.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.021 1.728 . . . . 64.200000000000003 111.01 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 t -70.79 154.22 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.203 1.401 . . . . 65.129999999999995 109.36 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -90.5 -178.16 5.25 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.945 0.879 . . . . 73.150000000000006 109.788 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.24 165.92 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.785 1.634 . . . . 75.340000000000003 108.395 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.57 169.72 17.13 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.943 1.697 . . . . 75.519999999999996 108.122 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.7 76.76 1.34 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 107.867 -2.093 . . . . 75.349999999999994 107.867 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 108.102 -1.073 . . . . 71.230000000000004 108.102 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 119.41 -0.329 . . . . 72.450000000000003 111.279 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.21 99.11 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.197 2.598 . . . . 74.439999999999998 111.919 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.8 mt -89.86 133.35 34.79 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.951 1.3 . . . . 73.219999999999999 108.576 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -75.68 106.99 7.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.54 -0.911 . . . . 75.400000000000006 108.54 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -59.95 -9.86 3.48 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.003 1.483 . . . . 71.540000000000006 115.003 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -101.18 -14.23 17.81 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.036 1.334 . . . . 73.319999999999993 112.473 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -90.39 -4.11 57.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.849 1.26 . . . . 74.510000000000005 111.85 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mt -84.2 150.89 25.18 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.758 1.623 . . . . 74.099999999999994 113.722 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -103.45 105.69 16.01 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.519 1.128 . . . . 74.120000000000005 108.155 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -85.37 147.6 26.43 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.621 -1.252 . . . . 62.450000000000003 107.621 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -132.31 141.6 49.02 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.701 -1.222 . . . . 73.5 107.701 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -118.5 121.0 39.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.959 1.303 . . . . 73.319999999999993 108.621 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 C--O 1.238 0.457 0 N-CA-C 107.033 -1.469 . . . . 73.239999999999995 107.033 -179.074 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.5 m120 . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 105.982 -1.858 . . . . 74.439999999999998 105.982 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.9 t -98.89 169.42 9.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.134 -0.979 . . . . 73.409999999999997 110.011 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 t -139.19 143.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 104.594 -2.372 . . . . 72.400000000000006 104.594 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.258 9.6 p -137.63 124.86 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 101.729 -3.434 . . . . 65.120000000000005 101.729 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 tp -120.29 148.86 43.18 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.042 0.937 . . . . 74.209999999999994 108.987 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -138.69 129.07 25.87 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.25 1.02 . . . . 74.400000000000006 110.083 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -88.69 144.18 26.44 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.33 -2.1 . . . . 74.400000000000006 105.33 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.1 t -73.82 -71.6 0.21 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.776 -1.107 . . . . 70.140000000000001 112.465 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.31 -36.63 78.11 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.496 2.797 . . . . 73.010000000000005 113.526 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.9 t -77.96 -25.02 47.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.999 -0.28 . . . . 72.519999999999996 111.246 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.01 -0.08 6.51 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 119.189 -0.784 . . . . 70.040000000000006 113.435 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.7 mt -68.37 137.88 23.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 119.113 1.457 . . . . 73.25 107.22 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.4 t -131.6 139.74 49.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 106.872 -1.529 . . . . 73.150000000000006 106.872 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.61 147.14 16.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.91 -1.144 . . . . 65.420000000000002 107.91 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -123.22 127.97 49.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 125.401 1.48 . . . . 73.439999999999998 108.26 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 49.3 m -144.81 162.26 37.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.143 0.973 . . . . 72.140000000000001 110.896 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -155.07 156.16 35.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.362 2.265 . . . . 75.519999999999996 106.392 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -158.32 -74.4 0.08 Allowed 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 105.729 -1.952 . . . . 75.230000000000004 105.729 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.2 p -83.13 -179.3 7.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.942 0.877 . . . . 73.239999999999995 109.559 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -96.68 1.09 50.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.389 0.675 . . . . 74.0 109.314 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.6 m -96.72 115.47 27.49 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.974 1.31 . . . . 74.409999999999997 108.006 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.8 p -57.35 -42.58 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 109.506 -0.553 . . . . 75.299999999999997 109.506 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.64 -47.3 84.86 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.004 0.921 . . . . 75.109999999999999 112.196 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -67.72 -32.92 73.88 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.748 -0.595 . . . . 74.129999999999995 109.402 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -71.49 -29.25 64.6 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.24 -0.913 . . . . 75.049999999999997 109.204 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -63.15 -48.78 77.01 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.805 1.184 . . . . 74.120000000000005 109.869 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -57.82 -38.47 75.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.926 0.785 . . . . 74.239999999999995 112.051 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.69 -49.2 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.05 -1.093 . . . . 74.140000000000001 108.05 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.39 -47.04 86.96 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.927 0.891 . . . . 54.420000000000002 110.785 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -60.0 -45.53 92.43 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.644 0.778 . . . . 72.209999999999994 109.706 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -51.03 71.49 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.208 0.603 . . . . 72.430000000000007 110.72 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.58 -32.47 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.732 0.697 . . . . 74.340000000000003 110.909 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.1 tp -63.72 -40.3 96.41 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 120.616 -1.302 . . . . 72.340000000000003 110.187 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -54.5 -40.1 68.22 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.058 1.343 . . . . 75.239999999999995 111.95 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.95 -36.53 83.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.372 1.069 . . . . 74.0 111.503 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -76.45 -42.08 45.12 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.93 -0.481 . . . . 74.129999999999995 110.21 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.2 -32.26 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 118.609 -0.71 . . . . 74.329999999999998 110.442 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -58.68 -56.31 23.83 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.862 1.21 . . . . 72.230000000000004 108.252 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 68.3 t -58.45 -28.38 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.241 1.016 . . . . 75.239999999999995 110.745 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -74.35 -18.36 60.69 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.156 -0.965 . . . . 74.450000000000003 112.256 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -99.35 -49.89 4.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.294 1.438 . . . . 74.409999999999997 110.322 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -71.68 -16.51 62.24 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.015 0.746 . . . . 74.349999999999994 113.015 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 CA--C 1.539 0.541 0 C-N-CA 128.693 2.797 . . . . 54.210000000000001 106.99 179.776 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 99.3 mt . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 121.112 0.482 . . . . 64.299999999999997 110.162 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -67.01 155.18 90.89 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.427 0.691 . . . . 73.209999999999994 110.082 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.11 176.84 9.0 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.932 2.422 . . . . 73.400000000000006 110.936 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.51 172.07 32.26 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 121.741 0.634 . . . . 71.430000000000007 111.526 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -58.55 135.39 57.31 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.312 1.045 . . . . 74.219999999999999 109.395 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.19 30.01 4.58 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.225 1.41 . . . . 63.439999999999998 110.136 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.31 175.7 2.09 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.264 1.026 . . . . 64.409999999999997 109.865 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.6 t -87.76 170.59 11.09 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.98 -1.075 . . . . 73.239999999999995 108.954 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.0 m -139.83 146.28 39.17 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.646 -1.242 . . . . 74.239999999999995 107.646 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 t -68.57 133.33 31.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 125.427 1.491 . . . . 64.400000000000006 111.546 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -75.66 154.66 36.42 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.206 -1.035 . . . . 72.239999999999995 108.206 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.5 t -72.53 146.67 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.963 -1.086 . . . . 74.510000000000005 108.42 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.76 166.47 23.21 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.487 1.515 . . . . 65.219999999999999 107.75 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -136.43 73.23 0.44 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 123.931 0.777 . . . . 53.039999999999999 111.447 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 . . . . . 0 C--O 1.238 0.447 0 C-N-CA 124.593 1.157 . . . . 75.329999999999998 109.483 179.221 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 109.616 -0.512 . . . . 65.019999999999996 109.616 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.82 147.94 57.11 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.436 2.091 . . . . 75.129999999999995 109.702 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.62 138.35 22.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.161 -1.051 . . . . 74.030000000000001 108.161 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -91.9 111.01 22.38 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.488 1.515 . . . . 64.439999999999998 111.544 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -66.65 -25.92 66.81 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.964 1.706 . . . . 75.099999999999994 113.245 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -80.01 -11.19 59.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.423 1.01 . . . . 73.209999999999994 112.096 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -101.02 9.89 41.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.449 1.1 . . . . 75.200000000000003 111.315 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.3 175.82 5.58 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.359 -0.838 . . . . 73.310000000000002 112.847 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -125.38 135.63 52.61 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.424 2.29 . . . . 71.510000000000005 106.038 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -126.72 166.28 17.68 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.134 1.374 . . . . 72.319999999999993 111.464 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -137.66 177.51 7.81 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.025 1.33 . . . . 74.310000000000002 108.658 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -135.07 163.6 29.54 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.81 2.044 . . . . 73.310000000000002 107.256 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 106.479 -1.675 . . . . 70.450000000000003 106.479 179.787 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 m120 . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 109.395 -0.594 . . . . 75.439999999999998 109.395 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.3 p -150.18 154.73 38.51 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.693 -1.254 . . . . 71.409999999999997 107.939 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.3 152.49 27.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 123.813 0.845 . . . . 74.340000000000003 109.325 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.59 141.65 42.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.221 -1.399 . . . . 74.420000000000002 107.221 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.9 tp -129.03 154.6 46.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.495 0.718 . . . . 72.019999999999996 110.798 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 75' ' ' VAL . 1.5 tmtp? -143.71 155.59 44.26 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.369 1.068 . . . . 70.150000000000006 108.183 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -122.24 120.43 34.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.687 -1.968 . . . . 74.420000000000002 105.687 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.438 ' HA ' ' HE2' ' A' ' 73' ' ' LYS . 39.7 t -66.26 -56.46 16.1 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.746 1.218 . . . . 73.140000000000001 111.884 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.66 -12.96 38.0 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.634 2.222 . . . . 73.120000000000005 115.709 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 t -113.64 -16.44 12.34 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.846 0.748 . . . . 71.150000000000006 110.453 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.56 9.39 37.72 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.591 1.091 . . . . 63.340000000000003 113.662 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.8 mt -79.89 145.86 8.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.482 1.113 . . . . 74.209999999999994 108.283 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 t -131.3 143.69 39.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.103 -1.814 . . . . 75.319999999999993 106.103 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -146.95 155.06 11.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.283 -0.636 . . . . 75.019999999999996 109.283 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.87 133.23 41.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.415 -0.957 . . . . 73.310000000000002 108.415 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.98 160.35 41.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.153 0.981 . . . . 72.329999999999998 111.163 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -155.52 134.37 12.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.425 2.29 . . . . 75.439999999999998 106.001 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -153.13 -51.43 0.1 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.724 -0.843 . . . . 74.209999999999994 108.724 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.8 p -109.62 170.88 7.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.352 1.032 . . . . 72.450000000000003 110.825 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -92.38 -16.74 25.57 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.156 0.982 . . . . 73.420000000000002 108.901 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -78.94 115.79 18.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.495 -0.928 . . . . 61.32 108.495 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.2 p -62.96 -37.73 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.642 -1.244 . . . . 73.420000000000002 107.642 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.79 -49.62 72.69 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.664 1.586 . . . . 62.399999999999999 108.718 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.3 -48.24 62.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.655 0.782 . . . . 75.409999999999997 110.949 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -52.74 -38.05 60.29 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.753 0.821 . . . . 75.200000000000003 111.243 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -54.86 -48.45 72.89 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.823 0.738 . . . . 75.5 109.335 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -64.0 -37.2 86.54 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.517 -0.739 . . . . 73.109999999999999 111.389 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.3 mt -63.66 -47.31 91.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.362 -0.977 . . . . 75.510000000000005 108.362 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.88 97.77 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.206 0.602 . . . . 74.439999999999998 109.894 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -57.39 -44.58 84.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.838 0.855 . . . . 74.430000000000007 109.82 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.7 -55.57 33.09 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.409 0.684 . . . . 74.439999999999998 110.237 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.47 -23.8 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 113.677 0.992 . . . . 74.450000000000003 113.677 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.5 tp -70.38 -38.7 74.76 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.561 -1.337 . . . . 74.540000000000006 110.626 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -55.15 -47.92 74.42 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.756 1.222 . . . . 61.32 114.014 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.75 -28.73 70.17 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.372 0.669 . . . . 74.120000000000005 111.509 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -77.42 -35.96 53.63 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.236 -0.915 . . . . 75.239999999999995 110.115 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.1 t -67.07 -33.99 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.151 -1.055 . . . . 75.140000000000001 108.151 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -56.59 -47.23 80.02 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.889 1.222 . . . . 71.450000000000003 108.894 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.64 -15.14 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.555 1.142 . . . . 74.439999999999998 111.891 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -82.49 -22.19 35.21 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.759 -1.213 . . . . 72.25 109.7 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -96.85 -53.29 3.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.301 1.441 . . . . 74.219999999999999 109.825 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -72.45 -16.41 61.82 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.634 0.605 . . . . 70.450000000000003 112.634 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 126.587 1.955 . . . . 74.540000000000006 106.796 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--O 1.233 0.193 0 N-CA-C 109.864 -0.421 . . . . 74.439999999999998 109.864 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -127.23 156.85 74.04 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.078 1.751 . . . . 74.120000000000005 109.125 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.33 168.77 24.03 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.793 2.328 . . . . 71.340000000000003 111.787 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.71 -87.63 0.86 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.714 -1.355 . . . . 73.310000000000002 109.714 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.2 tpt -146.57 160.83 41.64 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.628 1.171 . . . . 73.140000000000001 107.896 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.54 61.73 1.15 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.304 1.041 . . . . 75.129999999999995 109.772 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.08 150.75 38.76 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.87 -0.789 . . . . 62.200000000000003 108.87 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.6 t -79.18 -178.98 6.46 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.772 0.796 . . . . 72.519999999999996 110.668 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 m -112.38 156.67 22.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.218 1.807 . . . . 73.510000000000005 106.914 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.7 t -118.11 159.53 18.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.302 -1.37 . . . . 72.299999999999997 107.302 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -102.66 138.77 39.13 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.513 -1.292 . . . . 71.430000000000007 107.513 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.01 146.75 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 122.006 0.908 . . . . 74.409999999999997 110.35 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.27 170.91 9.71 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 129.322 3.049 . . . . 73.030000000000001 106.342 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.16 -151.7 23.45 Favored Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 108.319 -1.912 . . . . 72.340000000000003 108.319 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.45 ' HD2' ' H ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.625 0 CA-C-O 121.755 0.788 . . . . 73.219999999999999 110.099 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 74.5 mt . . . . . 0 C--O 1.238 0.492 0 CA-C-O 119.38 -0.343 . . . . 75.409999999999997 111.79 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.26 150.68 59.53 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.145 2.564 . . . . 75.140000000000001 109.314 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.576 0.2 OUTLIER -122.6 150.86 42.07 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.329 -0.857 . . . . 73.200000000000003 112.074 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -94.56 107.77 19.75 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.529 1.532 . . . . 73.129999999999995 112.034 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -70.16 -19.26 63.21 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.601 0.963 . . . . 73.420000000000002 113.601 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.5 m -87.95 10.36 19.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.325 1.45 . . . . 75.109999999999999 112.015 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -128.12 -1.52 5.79 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.5 1.12 . . . . 74.310000000000002 111.55 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -103.42 160.68 14.5 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.917 -1.142 . . . . 70.310000000000002 107.917 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -103.83 156.28 17.95 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 126.46 1.904 . . . . 74.5 108.126 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.71 136.5 53.91 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.582 -0.896 . . . . 73.030000000000001 108.582 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -152.25 156.55 39.92 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.187 0.994 . . . . 74.439999999999998 111.004 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -135.55 164.36 28.0 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 127.037 2.135 . . . . 74.040000000000006 109.679 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 102.816 -3.031 . . . . 74.040000000000006 102.816 178.297 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 108.206 -1.035 . . . . 72.099999999999994 108.206 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.6 m -57.98 131.3 50.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.07 1.348 . . . . 75.040000000000006 112.176 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.1 t -122.53 136.3 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.116 -1.809 . . . . 73.349999999999994 106.116 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.84 153.24 29.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.132 -1.803 . . . . 75.439999999999998 106.132 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp -141.22 142.89 33.93 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.177 -1.416 . . . . 64.420000000000002 107.177 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -136.11 134.12 38.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.796 -1.557 . . . . 73.530000000000001 106.796 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -86.03 140.05 30.62 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.756 -1.202 . . . . 73.239999999999995 107.756 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.3 t -71.67 -62.18 1.79 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 120.394 1.452 . . . . 72.409999999999997 111.616 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -70.4 -8.7 24.22 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.247 2.631 . . . . 74.349999999999994 116.242 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.0 m -120.74 -13.32 8.71 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.673 0.67 . . . . 74.25 112.509 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.04 -13.59 0.34 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.502 1.525 . . . . 65.530000000000001 115.584 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.4 mt -49.06 123.39 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 128.058 2.543 . . . . 74.319999999999993 110.316 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.25 142.63 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.863 1.265 . . . . 75.5 109.961 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.24 150.52 22.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.439 1.496 . . . . 74.420000000000002 108.018 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -122.87 115.02 21.28 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.298 1.439 . . . . 74.420000000000002 108.392 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 77.0 m -124.62 136.5 53.98 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.435 1.016 . . . . 75.420000000000002 111.982 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -156.34 111.81 2.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.241 -1.763 . . . . 75.340000000000003 106.241 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -147.43 -68.26 0.25 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.208 -1.404 . . . . 74.439999999999998 107.208 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -70.74 147.22 49.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.998 0.427 . . . . 72.109999999999999 110.287 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -67.83 -26.35 66.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.154 -0.684 . . . . 75.019999999999996 109.154 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 m -79.27 115.63 19.04 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 126.519 1.928 . . . . 61.25 111.25 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.68 -32.91 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 107.605 -1.258 . . . . 61.32 107.605 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -37.03 70.24 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.415 0.686 . . . . 73.040000000000006 110.986 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -79.61 -48.19 14.18 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.879 1.272 . . . . 74.140000000000001 109.738 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -53.24 -36.12 60.72 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.913 0.778 . . . . 74.439999999999998 110.085 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -57.3 -54.29 48.51 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.142 0.977 . . . . 73.430000000000007 109.424 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -59.45 -41.15 88.97 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 118.274 -0.869 . . . . 71.010000000000005 110.499 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.7 -49.09 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 124.554 1.159 . . . . 74.230000000000004 108.872 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.17 -43.46 98.85 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.981 -0.449 . . . . 74.430000000000007 110.608 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.63 -49.85 73.55 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.814 0.445 . . . . 75.329999999999998 111.112 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -44.09 97.0 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 118.448 -0.787 . . . . 73.140000000000001 112.013 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.85 -36.88 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 119.645 1.111 . . . . 72.099999999999994 109.027 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.18 -39.01 88.56 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 118.616 -0.707 . . . . 75.230000000000004 110.496 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -59.21 -23.75 62.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.247 0.93 . . . . 64.340000000000003 111.933 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -78.45 -25.96 46.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.807 1.185 . . . . 73.030000000000001 109.506 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -82.0 -44.35 16.79 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.896 1.279 . . . . 64.120000000000005 110.963 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.2 t -58.79 -41.92 83.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 N-CA-C 108.335 -0.987 . . . . 72.519999999999996 108.335 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.19 -64.9 0.69 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.095 0.558 . . . . 73.409999999999997 111.809 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.43 -32.6 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.409 1.084 . . . . 75.329999999999998 111.095 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -67.29 -42.97 82.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.395 0.543 . . . . 71.5 109.775 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -67.79 -29.52 68.73 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.538 0.735 . . . . 71.230000000000004 109.501 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -79.56 -35.36 39.9 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.555 0.742 . . . . 75.230000000000004 111.62 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.161 1.384 . . . . 75.420000000000002 111.908 -176.977 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.446 -0.626 0 N-CA-C 108.041 -1.096 . . . . 71.549999999999997 108.041 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -125.48 152.4 71.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 125.04 1.336 . . . . 73.329999999999998 107.45 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.89 161.61 41.04 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.88 1.72 . . . . 70.349999999999994 109.92 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.56 165.49 20.63 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 108.021 -2.032 . . . . 42.109999999999999 108.021 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 42.5 ttm -144.69 130.91 19.55 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.548 -0.908 . . . . 74.530000000000001 108.548 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.9 58.99 0.92 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.576 -2.009 . . . . 72.310000000000002 105.576 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.27 178.21 7.57 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.548 1.139 . . . . 74.5 108.999 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.0 t -60.31 140.56 57.03 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.453 -1.314 . . . . 65.409999999999997 107.453 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 m -139.36 134.51 32.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.174 -1.788 . . . . 74.319999999999993 106.174 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.52 157.96 39.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.653 0.781 . . . . 75.340000000000003 109.272 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -144.61 172.91 12.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.159 1.383 . . . . 73.329999999999998 109.339 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.54 166.82 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.933 1.693 . . . . 72.010000000000005 107.828 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.04 175.24 9.75 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.658 1.183 . . . . 65.209999999999994 110.122 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -131.73 91.9 0.28 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.929 -1.268 . . . . 53.229999999999997 109.929 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 . . . . . 0 C--O 1.232 0.139 0 CA-C-N 117.508 0.654 . . . . 74.150000000000006 109.71 179.151 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 C--O 1.241 0.616 0 N-CA-C 109.86 -0.422 . . . . 71.349999999999994 109.86 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.95 160.84 46.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.668 1.579 . . . . 75.109999999999999 111.901 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.26 143.45 17.86 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 127.801 2.44 . . . . 71.530000000000001 104.429 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -114.67 102.28 9.88 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.037 0.935 . . . . 73.0 109.586 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -57.15 -27.6 62.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.373 0.533 . . . . 73.319999999999993 112.32 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -78.78 7.27 7.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.491 1.917 . . . . 73.099999999999994 112.981 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -127.0 4.87 6.5 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.616 1.566 . . . . 75.409999999999997 111.656 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.4 mt -94.01 176.66 6.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 122.119 0.961 . . . . 75.430000000000007 113.029 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -108.5 131.55 54.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 102.223 -3.251 . . . . 64.040000000000006 102.223 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -128.8 164.63 22.62 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.213 1.005 . . . . 73.120000000000005 108.545 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.65 160.62 42.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.384 -0.969 . . . . 71.549999999999997 108.384 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -109.7 135.64 50.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.131 1.372 . . . . 65.219999999999999 108.08 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.3 t . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 107.048 -1.464 . . . . 75.540000000000006 107.048 -178.717 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 . . . . . 0 CA--C 1.529 0.163 0 N-CA-C 107.936 -1.135 . . . . 70.25 107.936 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.9 m -143.47 148.76 36.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.985 1.714 . . . . 74.310000000000002 107.276 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t -144.63 157.3 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.891 -1.522 . . . . 73.310000000000002 106.891 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.17 139.61 26.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.766 -1.939 . . . . 73.25 105.766 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 tp -139.48 143.73 37.65 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.414 -1.328 . . . . 74.439999999999998 107.414 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -131.5 158.42 40.94 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 123.186 0.594 . . . . 74.329999999999998 109.407 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -104.16 114.45 28.7 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 102.443 -3.169 . . . . 74.109999999999999 102.443 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.99 -62.12 5.74 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 119.187 0.903 . . . . 75.430000000000007 111.69 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -65.04 -14.67 46.55 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.791 2.994 . . . . 53.439999999999998 116.622 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.2 t -112.3 -10.6 13.8 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.564 1.075 . . . . 72.099999999999994 111.123 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.2 3.47 6.67 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.268 1.413 . . . . 73.25 113.896 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -66.87 149.19 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 120.024 1.912 . . . . 74.439999999999998 108.179 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.4 t -136.69 135.32 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.154 -1.795 . . . . 73.319999999999993 106.154 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.0 146.94 24.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 106.888 -1.523 . . . . 74.040000000000006 106.888 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -127.44 119.75 26.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.136 0.974 . . . . 74.310000000000002 108.961 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.1 m -139.32 149.29 44.04 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.563 1.545 . . . . 72.329999999999998 109.767 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -155.11 121.25 5.21 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.455 -2.054 . . . . 72.349999999999994 105.455 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -133.22 -48.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.891 0.876 . . . . 75.530000000000001 110.769 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.3 p -101.73 158.33 16.19 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.51 1.124 . . . . 72.129999999999995 111.738 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -71.9 -30.21 65.14 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 118.065 -0.969 . . . . 74.049999999999997 111.373 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -79.44 123.92 27.98 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 119.917 1.235 . . . . 72.510000000000005 110.275 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.96 -38.77 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.346 1.058 . . . . 62.109999999999999 109.041 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -44.14 76.57 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.304 1.442 . . . . 75.409999999999997 110.721 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -40.23 62.04 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.718 0.807 . . . . 73.299999999999997 110.386 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -55.86 -32.94 64.08 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.741 0.7 . . . . 65.140000000000001 110.554 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -57.54 -45.19 85.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.593 0.633 . . . . 74.409999999999997 110.875 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -61.21 -31.76 71.53 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 118.679 0.672 . . . . 75.109999999999999 111.739 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.3 mt -74.06 -40.21 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.695 -0.854 . . . . 75.230000000000004 108.695 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.23 -47.59 73.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 122.897 0.479 . . . . 73.209999999999994 110.541 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -31.5 72.11 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 120.526 -0.47 . . . . 74.099999999999994 111.103 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -61.32 2.15 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.507 -1.294 . . . . 72.549999999999997 107.507 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -55.65 -35.83 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 118.683 0.674 . . . . 72.120000000000005 111.254 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.49 -32.57 74.06 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.455 -0.783 . . . . 71.329999999999998 111.474 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -61.17 -41.67 97.2 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 119.426 1.012 . . . . 74.239999999999995 110.531 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.81 -36.29 78.67 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.516 -0.92 . . . . 64.329999999999998 108.516 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -72.16 -51.8 19.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.433 -0.794 . . . . 75.430000000000007 111.403 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.06 -44.17 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 C-N-CA 124.352 1.061 . . . . 75.299999999999997 109.891 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -50.87 -63.74 1.03 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.003 0.921 . . . . 74.439999999999998 110.656 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.84 -24.56 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 112.589 0.589 . . . . 74.439999999999998 112.589 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -66.38 -45.28 80.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.617 1.099 . . . . 74.409999999999997 108.664 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -63.51 -46.22 87.07 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.513 -1.291 . . . . 75.329999999999998 107.513 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 -70.71 -3.27 17.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.219 1.407 . . . . 74.209999999999994 112.624 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 C--O 1.237 0.414 0 C-N-CA 124.416 1.086 . . . . 63.43 111.058 -179.611 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.219 0 N-CA-C 109.075 -1.61 . . . . 72.140000000000001 109.075 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 t -156.82 178.57 10.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 106.713 -1.588 . . . . 74.319999999999993 106.713 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 p -150.01 179.13 8.31 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.664 1.586 . . . . 73.329999999999998 108.512 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.76 179.0 48.76 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.82 -1.712 . . . . 73.420000000000002 108.82 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.0 t -156.22 172.34 18.63 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.749 -1.204 . . . . 74.310000000000002 107.749 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.1 m -159.91 95.83 1.2 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.766 1.227 . . . . 72.409999999999997 108.335 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.37 70.53 2.15 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 109.599 -1.4 . . . . 71.409999999999997 109.599 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -75.46 85.11 2.56 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.313 1.045 . . . . 74.219999999999999 110.007 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -76.8 174.34 10.62 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.79 -1.189 . . . . 63.439999999999998 107.79 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.05 172.88 45.09 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.209 -1.156 . . . . 74.519999999999996 110.209 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.57 168.08 20.54 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.153 1.781 . . . . 74.140000000000001 106.677 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.31 167.07 29.03 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.823 0.849 . . . . 73.340000000000003 109.004 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.34 163.87 34.19 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.94 1.296 . . . . 74.420000000000002 107.571 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.13 169.79 10.77 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 127.226 2.21 . . . . 75.219999999999999 107.111 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.71 170.3 17.26 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.72 1.608 . . . . 72.219999999999999 107.229 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -65.66 155.72 85.05 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 125.027 1.331 . . . . 74.329999999999998 110.903 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.52 169.7 21.94 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.468 2.112 . . . . 64.349999999999994 110.105 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.51 173.11 6.7 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.091 1.356 . . . . 54.049999999999997 109.698 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.8 168.97 18.59 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.61 0.764 . . . . 75.420000000000002 109.182 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -130.83 176.68 8.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.556 1.942 . . . . 73.430000000000007 108.93 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -124.61 154.9 70.01 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.005 1.322 . . . . 74.409999999999997 108.67 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.29 166.18 30.1 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.553 2.168 . . . . 61.520000000000003 111.02 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.51 173.39 16.95 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.872 -1.291 . . . . 74.430000000000007 109.872 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.93 166.44 23.64 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.439 -0.448 . . . . 74.349999999999994 110.2 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.02 80.61 1.58 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.5 -2.407 . . . . 74.209999999999994 104.5 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.57 -174.42 4.27 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.853 0.861 . . . . 73.230000000000004 111.463 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -143.94 164.33 30.88 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.761 1.224 . . . . 74.530000000000001 108.708 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 t -147.98 165.71 29.9 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.403 0.62 . . . . 75.239999999999995 110.88 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.09 156.11 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 126.869 2.068 . . . . 74.109999999999999 111.04 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -119.3 173.85 6.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.487 1.515 . . . . 72.439999999999998 109.715 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.2 m -64.21 172.45 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.338 0.655 . . . . 75.150000000000006 110.578 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.74 -21.23 52.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 114.327 1.232 . . . . 73.430000000000007 114.327 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.57 -69.57 3.27 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 107.587 -2.205 . . . . 52.340000000000003 107.587 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -80.32 175.43 10.66 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.953 -1.499 . . . . 74.329999999999998 106.953 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -151.87 4.28 0.41 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.289 0.636 . . . . 73.140000000000001 112.475 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.9 65.67 1.55 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 123.939 1.828 . . . . 72.409999999999997 111.003 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -59.84 5.08 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 112.748 -2.024 . . . . 75.219999999999999 108.277 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.14 163.59 35.43 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 121.932 1.755 . . . . 74.519999999999996 111.28 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.46 161.49 4.09 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 128.232 2.613 . . . . 63.310000000000002 107.442 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.9 mt 27.14 56.17 0.07 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 129.269 3.027 . . . . 75.439999999999998 112.269 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.6 mt -46.01 148.32 1.49 Allowed Pre-proline 0 C--O 1.233 0.214 0 C-N-CA 126.34 1.856 . . . . 74.25 112.763 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.87 112.21 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.859 2.373 . . . . 71.120000000000005 108.661 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.67 104.66 16.59 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.201 -1.407 . . . . 71.510000000000005 107.201 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -65.79 104.79 1.13 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.485 1.514 . . . . 72.439999999999998 109.923 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -62.86 -27.45 69.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.065 0.765 . . . . 62.210000000000001 113.065 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 m -79.4 6.57 9.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.396 0.998 . . . . 75.420000000000002 111.257 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -117.64 11.34 13.69 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.7 1.6 . . . . 62.310000000000002 111.743 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.0 mt -111.78 165.17 12.29 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.469 1.108 . . . . 52.420000000000002 111.16 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -132.22 127.0 34.85 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.441 -2.059 . . . . 75.109999999999999 105.441 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.23 165.47 11.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.487 1.515 . . . . 74.340000000000003 110.85 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -140.35 160.54 39.74 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.46 1.504 . . . . 53.149999999999999 107.277 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -130.53 139.45 50.48 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.472 -0.566 . . . . 74.319999999999993 109.472 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 85.3 t -88.49 135.97 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 107.246 -1.39 . . . . 72.109999999999999 107.246 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -122.18 -13.9 8.04 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.742 0.817 . . . . 74.129999999999995 110.211 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.51 -164.29 33.44 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 129.315 3.341 . . . . 73.219999999999999 105.003 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -137.23 149.67 47.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.294 -1.743 . . . . 74.329999999999998 106.294 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.03 176.77 49.11 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 109.792 -1.323 . . . . 73.129999999999995 109.792 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.25 117.07 3.83 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.092 1.862 . . . . 60.149999999999999 108.491 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.0 18.43 2.54 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 124.799 1.19 . . . . 62.439999999999998 112.762 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.48 -117.11 9.04 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.917 -1.273 . . . . 74.219999999999999 109.917 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -61.15 163.55 6.08 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.283 0.564 . . . . 72.540000000000006 110.286 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.91 -81.82 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.505 1.922 . . . . 64.209999999999994 110.421 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.5 m 41.99 80.33 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.656 2.382 . . . . 73.310000000000002 108.786 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -50.8 150.66 2.79 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.454 1.102 . . . . 64.439999999999998 112.651 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -113.85 166.24 11.77 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.096 0.959 . . . . 74.209999999999994 110.511 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -51.16 122.26 7.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.258 1.823 . . . . 62.210000000000001 109.112 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 p -156.99 163.16 39.41 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.789 -1.56 . . . . 71.329999999999998 106.789 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -78.95 30.06 0.2 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.115 0.87 . . . . 73.420000000000002 110.741 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.9 t -68.03 112.48 5.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.28 -1.512 . . . . 74.140000000000001 107.588 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.4 t -94.57 139.77 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 104.269 -2.493 . . . . 71.430000000000007 104.269 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.52 138.45 49.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.348 -2.093 . . . . 72.430000000000007 105.348 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.2 tp -142.32 147.31 36.13 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.871 -1.529 . . . . 71.209999999999994 106.871 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.99 158.18 43.87 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.432 -0.951 . . . . 74.450000000000003 108.432 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -93.94 134.39 36.37 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.059 -2.2 . . . . 64.120000000000005 105.059 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.3 t -65.11 -65.97 1.66 Allowed Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 117.894 -1.051 . . . . 73.25 111.894 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.18 -35.41 52.59 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.744 2.296 . . . . 64.329999999999998 113.759 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 t -85.36 -21.13 29.01 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.777 0.658 . . . . 74.439999999999998 112.777 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.88 2.86 5.23 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.437 1.494 . . . . 63.119999999999997 114.525 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.5 mt -67.05 130.96 32.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 119.791 1.796 . . . . 60.109999999999999 107.087 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.6 t -112.61 153.45 14.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.463 1.105 . . . . 71.219999999999999 109.05 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -149.74 142.43 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.796 0.838 . . . . 72.519999999999996 110.059 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -124.92 106.84 10.29 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.19 1.796 . . . . 65.109999999999999 108.315 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 9.9 t -117.94 155.36 30.36 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.689 1.196 . . . . 74.450000000000003 110.159 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -155.03 100.66 2.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.594 -1.632 . . . . 63.229999999999997 106.594 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.48 -37.43 4.95 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 122.86 0.464 . . . . 72.109999999999999 111.413 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.8 p -139.04 176.73 8.44 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.983 0.913 . . . . 64.310000000000002 111.623 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -1.51 56.35 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.678 1.191 . . . . 75.340000000000003 111.011 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.4 m -98.2 115.75 28.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.132 1.373 . . . . 73.319999999999993 109.968 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.54 -53.89 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.874 0.869 . . . . 73.420000000000002 111.243 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -22.81 67.07 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.984 1.475 . . . . 60.219999999999999 114.984 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -77.75 -46.1 22.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.435 -2.061 . . . . 74.129999999999995 105.435 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -59.63 -37.3 78.26 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 118.397 -0.811 . . . . 75.519999999999996 109.974 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -54.88 -55.5 29.8 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.694 1.198 . . . . 71.430000000000007 108.582 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -54.64 -47.36 73.59 Favored 'General case' 0 CA--C 1.506 -0.733 0 O-C-N 121.641 -0.662 . . . . 71.420000000000002 112.366 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.8 mt -64.67 -36.8 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.596 -0.729 . . . . 75.450000000000003 110.443 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.24 -38.73 82.12 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.451 -0.781 . . . . 71.409999999999997 109.182 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -61.39 -49.38 77.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.617 1.167 . . . . 72.409999999999997 110.182 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -46.53 88.92 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.435 -0.793 . . . . 75.439999999999998 111.238 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.86 -37.42 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.107 1.321 . . . . 74.329999999999998 110.643 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.1 tp -65.67 -37.63 87.05 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.525 -0.734 . . . . 72.239999999999995 109.89 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -58.44 -42.11 86.61 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.703 0.801 . . . . 73.140000000000001 110.423 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -61.84 -43.47 98.77 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.426 0.631 . . . . 74.239999999999995 109.698 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -67.51 -42.46 82.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 113.915 1.08 . . . . 72.510000000000005 113.915 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.61 -32.77 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 123.219 0.608 . . . . 72.230000000000004 109.715 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -53.92 -60.75 2.92 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.702 0.683 . . . . 74.25 110.128 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 17.5 t -59.64 -32.59 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.784 0.834 . . . . 73.310000000000002 110.826 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -65.95 -22.64 66.49 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.516 1.053 . . . . 72.150000000000006 111.679 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -99.04 -36.92 9.55 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.4 1.08 . . . . 73.140000000000001 109.808 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -79.19 -16.78 56.05 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.523 1.129 . . . . 74.340000000000003 111.883 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 t -135.07 -165.33 1.66 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.376 1.87 . . . . 75.319999999999993 108.692 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.92 -163.59 21.31 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.813 1.197 . . . . 51.039999999999999 111.918 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.98 -177.94 2.19 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 123.369 2.713 . . . . 74.129999999999995 110.466 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 76.0 p -127.47 97.31 4.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.546 -1.65 . . . . 73.409999999999997 106.546 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.9 t 58.22 74.16 0.44 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.851 1.26 . . . . 75.150000000000006 109.899 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 116.86 -2.078 . . . . 73.120000000000005 109.267 179.715 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 N-CA-C 109.084 -1.607 . . . . 63.409999999999997 109.084 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 m -134.64 154.49 51.5 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.951 -1.5 . . . . 75.109999999999999 106.951 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -58.3 -48.36 80.75 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.395 1.078 . . . . 61.32 113.764 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.37 104.39 1.22 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 106.944 -2.462 . . . . 65.129999999999995 106.944 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 p -151.27 162.78 40.28 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 121.9 -0.765 . . . . 74.209999999999994 109.637 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.7 t -157.79 174.14 15.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.485 1.514 . . . . 63.450000000000003 107.11 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.62 -179.33 48.28 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.717 -1.353 . . . . 61.210000000000001 109.717 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -156.43 160.38 39.55 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 108.374 -0.972 . . . . 75.319999999999993 108.374 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -140.35 179.47 6.63 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.207 1.803 . . . . 74.120000000000005 107.853 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.95 163.81 37.02 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 109.318 -1.513 . . . . 73.329999999999998 109.318 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 mp -85.36 172.28 11.2 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.877 -0.786 . . . . 74.010000000000005 108.877 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -143.85 166.96 23.46 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 106.986 -1.487 . . . . 74.0 106.986 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.89 143.61 29.92 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.56 -1.645 . . . . 71.420000000000002 106.56 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.54 167.37 2.24 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 128.672 2.789 . . . . 74.299999999999997 106.503 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.476 ' CG ' ' H ' ' A' ' 16' ' ' LYS . 33.5 tt0 -154.76 170.68 21.03 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.602 -1.259 . . . . 70.209999999999994 107.602 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.476 ' H ' ' CG ' ' A' ' 15' ' ' GLU . 2.9 pttt -66.97 167.52 13.82 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 128.562 2.745 . . . . 74.049999999999997 110.824 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -81.59 168.35 16.26 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.275 1.983 . . . . 74.310000000000002 110.236 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.82 173.7 12.02 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.929 -0.767 . . . . 71.310000000000002 108.929 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -146.11 173.77 11.9 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.022 1.329 . . . . 75.109999999999999 109.563 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.88 178.63 4.79 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.904 1.682 . . . . 75.439999999999998 109.615 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -125.44 155.02 72.43 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.758 1.623 . . . . 72.409999999999997 108.961 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.62 166.06 29.18 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.6 2.2 . . . . 73.109999999999999 111.326 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.56 -178.32 35.37 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.177 -1.169 . . . . 73.140000000000001 110.177 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.6 ttt -138.14 162.27 34.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.842 1.257 . . . . 74.010000000000005 107.843 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.67 83.99 1.17 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.235 -2.506 . . . . 71.409999999999997 104.235 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.46 152.01 34.42 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.484 -0.561 . . . . 63.329999999999998 109.484 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 t -79.52 -174.51 4.29 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.603 0.716 . . . . 71.299999999999997 111.531 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.3 p -115.41 -175.85 2.8 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.642 1.577 . . . . 65.310000000000002 111.891 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.0 m -67.24 177.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.684 1.194 . . . . 71.439999999999998 109.303 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.02 164.02 28.25 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.71 0.804 . . . . 75.519999999999996 110.663 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 t -69.67 128.51 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.688 -1.597 . . . . 75.310000000000002 106.688 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.53 177.09 6.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.066 0.946 . . . . 73.310000000000002 111.581 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.13 -165.16 29.12 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 124.457 1.027 . . . . 62.420000000000002 111.916 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -142.62 172.73 12.3 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.429 1.092 . . . . 71.409999999999997 111.362 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -155.28 162.27 40.92 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 106.425 -1.695 . . . . 72.120000000000005 106.425 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 40.29 62.25 1.36 Allowed 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.337 1.855 . . . . 73.439999999999998 111.118 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -65.32 1.31 Allowed Pre-proline 0 C--O 1.236 0.36 0 CA-C-O 117.974 -1.013 . . . . 73.120000000000005 109.501 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.33 135.89 38.26 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 120.902 1.068 . . . . 74.329999999999998 109.913 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.4 129.69 6.49 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.983 2.113 . . . . 72.239999999999995 105.841 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.4 mt 47.17 65.55 1.22 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 127.257 2.223 . . . . 72.340000000000003 112.096 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.7 mt -49.8 152.2 2.74 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 125.427 1.491 . . . . 72.439999999999998 111.688 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -69.33 154.89 68.76 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.619 2.212 . . . . 65.450000000000003 109.262 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.0 mt -137.42 163.47 31.0 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.083 1.353 . . . . 72.219999999999999 113.728 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -119.84 101.85 8.17 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 106.891 -1.522 . . . . 75.129999999999995 106.891 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -61.06 -23.63 65.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.223 0.609 . . . . 71.319999999999993 112.53 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 m -87.97 10.38 19.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.993 1.317 . . . . 41.530000000000001 112.452 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -121.51 14.68 11.12 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.124 1.37 . . . . 74.230000000000004 111.095 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.2 mt -99.2 166.61 11.15 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.178 -0.951 . . . . 73.239999999999995 111.738 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -127.28 94.11 3.91 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.568 -0.901 . . . . 72.219999999999999 108.568 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -95.01 164.69 12.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.086 0.946 . . . . 75.439999999999998 112.689 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -143.17 171.09 14.56 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.707 2.803 . . . . 74.25 105.54 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -131.0 139.4 49.98 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 107.025 -1.472 . . . . 75.319999999999993 107.025 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.08 136.54 22.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.27 -0.641 . . . . 64.239999999999995 109.27 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.59 -9.02 9.46 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.885 0.874 . . . . 71.340000000000003 112.029 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.88 -177.79 43.71 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 107.193 -2.363 . . . . 74.310000000000002 107.193 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -147.83 166.33 27.91 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.761 -1.57 . . . . 74.340000000000003 106.761 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.82 -169.96 44.34 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 109.734 -1.347 . . . . 65.510000000000005 109.734 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.43 -0.88 7.27 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.236 2.624 . . . . 72.540000000000006 113.96 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.55 5.61 24.22 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 119.809 1.186 . . . . 63.229999999999997 114.902 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -48.16 113.31 1.4 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 126.008 1.766 . . . . 74.530000000000001 111.766 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 56.3 15.25 1.85 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.078 1.751 . . . . 75.430000000000007 114.17 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.82 107.39 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.737 1.215 . . . . 61.210000000000001 111.369 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.5 p -72.37 -67.71 0.53 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.007 1.723 . . . . 63.420000000000002 111.344 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.85 84.07 0.21 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 129.226 3.01 . . . . 74.239999999999995 113.882 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -77.41 1.99 17.39 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.152 -0.967 . . . . 74.329999999999998 111.499 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.54 46.86 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 129.953 3.301 . . . . 75.299999999999997 113.242 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -84.93 115.69 22.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.67 -1.233 . . . . 74.010000000000005 107.67 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -105.27 -0.01 26.72 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.366 1.066 . . . . 73.030000000000001 110.883 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.6 t -59.49 145.87 42.43 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.666 1.121 . . . . 75.200000000000003 110.91 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.6 t -120.44 149.83 23.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.311 1.845 . . . . 72.439999999999998 108.872 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.17 155.71 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.151 -1.796 . . . . 74.439999999999998 106.151 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.7 tp -141.3 148.54 39.93 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.152 -1.425 . . . . 73.239999999999995 107.152 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -143.51 130.68 20.75 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 125.473 1.509 . . . . 72.439999999999998 110.509 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -97.15 117.24 30.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.64 -1.985 . . . . 74.430000000000007 105.64 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.52 -59.96 11.3 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.069 -1.443 . . . . 74.519999999999996 111.921 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.47 -14.56 35.76 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.997 2.465 . . . . 73.340000000000003 116.611 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -111.69 -19.55 12.43 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.512 0.596 . . . . 75.129999999999995 111.236 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.13 21.22 69.78 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.007 0.813 . . . . 65.450000000000003 111.389 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -91.24 136.4 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 125.142 1.377 . . . . 74.310000000000002 107.805 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.01 137.41 57.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.069 -1.456 . . . . 72.430000000000007 107.069 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.0 p -136.75 151.39 27.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.961 -0.755 . . . . 62.530000000000001 108.961 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -110.16 125.62 53.22 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.166 -1.79 . . . . 71.510000000000005 106.166 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.1 t -138.54 132.13 30.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 118.374 0.534 . . . . 71.129999999999995 109.897 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -153.91 100.28 2.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.173 0.589 . . . . 71.299999999999997 109.494 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -115.77 -70.47 0.79 Allowed 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.309 -0.997 . . . . 73.140000000000001 108.309 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.5 p -73.04 177.59 4.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.391 1.476 . . . . 74.409999999999997 109.618 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -98.64 -20.14 17.15 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.254 -1.529 . . . . 75.430000000000007 108.802 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.3 m -79.09 132.2 36.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.328 2.251 . . . . 75.450000000000003 110.444 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.32 -55.86 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.7 0.8 . . . . 74.409999999999997 112.917 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.63 -39.85 74.35 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.853 1.206 . . . . 74.319999999999993 112.583 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -67.6 -43.28 80.85 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.755 -0.831 . . . . 73.219999999999999 108.755 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -64.89 -37.75 88.66 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.974 -0.751 . . . . 72.530000000000001 108.974 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -59.95 -52.06 67.04 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.225 1.01 . . . . 72.329999999999998 109.992 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -63.03 -32.23 73.55 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.505 1.502 . . . . 64.430000000000007 112.025 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.04 -46.33 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.307 -1.738 . . . . 74.409999999999997 106.307 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.27 78.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.976 0.91 . . . . 74.519999999999996 109.842 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -40.57 94.06 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.425 -0.583 . . . . 75.310000000000002 109.425 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.65 -53.17 61.12 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.599 -0.688 . . . . 73.530000000000001 109.739 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.5 p -66.56 -32.01 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 113.068 0.766 . . . . 75.109999999999999 113.068 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.7 tp -67.74 -30.64 70.17 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.348 -0.845 . . . . 74.299999999999997 109.823 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -58.99 -31.37 68.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.011 1.324 . . . . 75.010000000000005 110.726 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.55 -48.88 53.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.114 0.966 . . . . 73.239999999999995 109.062 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -60.26 -46.28 90.37 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.899 0.88 . . . . 72.329999999999998 110.284 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.4 t -64.39 -37.95 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 118.044 -0.979 . . . . 72.219999999999999 110.175 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.39 -61.37 2.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.894 1.224 . . . . 71.030000000000001 110.642 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.4 p -56.61 -37.23 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 O-C-N 123.886 0.741 . . . . 72.450000000000003 109.55 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -62.72 -35.82 81.0 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.012 0.745 . . . . 65.219999999999999 113.012 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -73.55 -41.55 62.82 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.725 -0.843 . . . . 73.329999999999998 108.725 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -79.28 -0.26 31.61 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.4 1.259 . . . . 74.519999999999996 114.4 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.8 p -109.85 -17.0 13.75 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.72 1.608 . . . . 73.120000000000005 112.697 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.47 174.83 46.55 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 119.927 1.24 . . . . 71.109999999999999 112.454 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.64 173.44 9.94 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.928 2.419 . . . . 62.509999999999998 110.768 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 43.1 m -98.93 95.45 7.17 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.989 -1.115 . . . . 74.420000000000002 107.989 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.89 166.88 23.29 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.017 1.327 . . . . 62.5 109.68 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.29 0 N-CA-C 106.601 -2.6 . . . . 52.130000000000003 106.601 -179.669 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.05 0 N-CA-C 109.087 -1.605 . . . . 73.349999999999994 109.087 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 m -149.71 176.4 10.72 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.741 1.617 . . . . 75.420000000000002 107.078 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t -84.72 -88.08 0.11 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.588 -1.634 . . . . 72.129999999999995 106.588 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.8 179.13 48.77 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.583 -1.807 . . . . 72.129999999999995 108.583 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.2 p -152.29 155.72 38.25 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.381 1.072 . . . . 45.130000000000003 108.462 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.8 m -164.34 172.85 12.93 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.166 1.786 . . . . 74.230000000000004 107.638 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.17 157.15 25.94 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.14 -1.584 . . . . 75.109999999999999 109.14 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -84.32 158.52 21.14 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-O 121.909 0.861 . . . . 73.530000000000001 110.375 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -134.89 179.72 6.13 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 127.54 2.336 . . . . 75.209999999999994 106.508 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.38 145.38 10.85 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.257 -1.937 . . . . 62.509999999999998 108.257 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.2 mt -126.05 -178.26 4.24 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.343 1.457 . . . . 71.140000000000001 108.583 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.87 166.33 33.86 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.755 1.622 . . . . 62.119999999999997 108.46 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.15 160.4 41.88 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.583 -2.006 . . . . 73.329999999999998 105.583 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -164.24 166.84 20.63 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.658 1.583 . . . . 75.420000000000002 107.858 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.54 -172.66 2.37 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.185 1.794 . . . . 75.040000000000006 111.709 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 11.0 mmpt? -136.96 135.03 19.4 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 128.001 2.521 . . . . 73.200000000000003 104.541 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.4 164.3 35.66 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.072 1.848 . . . . 70.150000000000006 111.208 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.39 170.69 12.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.063 0.945 . . . . 74.349999999999994 111.045 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mp -110.53 169.55 8.67 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.369 1.468 . . . . 74.239999999999995 108.632 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.59 160.3 32.92 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.164 0.507 . . . . 75.230000000000004 109.803 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -102.18 155.87 35.93 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.342 1.457 . . . . 72.519999999999996 109.914 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.11 167.68 26.41 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.754 2.302 . . . . 71.409999999999997 110.919 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.16 168.85 13.51 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.701 -0.96 . . . . 74.219999999999999 110.701 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.9 ptm -77.58 165.86 23.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.368 0.667 . . . . 75.319999999999993 110.3 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.43 88.88 1.73 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.046 -2.205 . . . . 73.239999999999995 105.046 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.32 176.94 6.01 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.492 -0.559 . . . . 64.219999999999999 109.492 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.51 -171.73 2.91 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.483 0.713 . . . . 75.409999999999997 111.183 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.1 p -141.35 162.85 34.49 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.403 1.481 . . . . 74.340000000000003 108.48 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 m -119.04 173.14 5.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.047 1.339 . . . . 74.349999999999994 109.683 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.01 177.31 10.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.873 2.469 . . . . 72.200000000000003 106.755 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.6 t -90.53 142.91 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 121.384 -0.822 . . . . 73.519999999999996 109.046 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.05 168.2 10.23 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.169 0.587 . . . . 73.310000000000002 109.611 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.25 175.02 46.15 Favored Glycine 0 CA--C 1.523 0.545 0 O-C-N 121.401 -0.812 . . . . 43.420000000000002 112.813 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -135.01 138.45 43.97 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.433 1.493 . . . . 75.209999999999994 107.018 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -152.39 42.34 0.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.626 1.57 . . . . 73.310000000000002 108.076 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -149.19 45.59 0.98 Allowed 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.715 0.769 . . . . 74.310000000000002 111.169 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -62.38 3.73 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-O 117.67 -1.157 . . . . 73.510000000000005 108.476 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.97 116.24 4.04 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.961 1.774 . . . . 72.349999999999994 107.677 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.89 144.8 6.05 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.034 1.734 . . . . 73.129999999999995 106.79 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt -38.61 102.75 0.03 OUTLIER 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.726 2.01 . . . . 72.420000000000002 111.823 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -58.15 152.21 42.31 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 124.829 1.252 . . . . 73.409999999999997 108.379 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.92 138.76 31.93 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.739 1.626 . . . . 74.120000000000005 112.204 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.2 mt -127.88 143.24 51.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.156 1.382 . . . . 71.329999999999998 111.295 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -120.69 103.81 9.41 Favored 'General case' 0 N--CA 1.461 0.085 0 C-N-CA 126.509 1.924 . . . . 51.420000000000002 107.935 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.15 -19.51 20.68 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.085 1.513 . . . . 75.239999999999995 115.085 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.8 m -83.39 -6.58 59.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.241 0.928 . . . . 73.540000000000006 111.937 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -114.23 0.83 14.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.579 1.152 . . . . 74.209999999999994 110.911 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 mt -102.65 154.97 18.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.098 0.559 . . . . 74.299999999999997 111.146 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -113.61 156.57 23.44 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.144 2.178 . . . . 63.119999999999997 108.243 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.58 165.07 30.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.532 1.933 . . . . 75.340000000000003 107.076 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -138.56 170.07 16.66 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.563 -0.903 . . . . 75.349999999999994 108.563 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -118.16 162.91 17.45 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.649 0.779 . . . . 75.439999999999998 111.833 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.0 t -117.33 106.77 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 102.567 -3.123 . . . . 75.040000000000006 102.567 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 ttpp -134.35 26.52 3.8 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.168 1.387 . . . . 73.420000000000002 112.069 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.67 -169.79 34.57 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 108.595 -1.802 . . . . 63.100000000000001 108.595 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -114.9 160.92 18.95 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.492 1.117 . . . . 75.329999999999998 108.086 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.12 160.43 44.39 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 109.665 -1.374 . . . . 73.299999999999997 109.665 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -78.2 59.63 7.11 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.518 3.479 . . . . 73.209999999999994 110.573 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.65 118.03 0.85 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 107.844 -2.102 . . . . 41.299999999999997 107.844 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.22 21.33 0.86 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.876 1.227 . . . . 71.010000000000005 114.215 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -64.56 -20.71 66.4 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.629 1.215 . . . . 72.430000000000007 112.33 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -172.24 -176.22 1.57 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.433 2.693 . . . . 74.150000000000006 106.349 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -158.99 145.11 16.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.423 -1.695 . . . . 73.420000000000002 106.423 178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -159.26 167.72 28.26 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.619 1.168 . . . . 72.040000000000006 108.194 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.57 48.6 1.43 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.902 1.281 . . . . 72.219999999999999 108.749 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.1 p -71.04 104.63 3.06 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.052 -1.03 . . . . 64.200000000000003 110.88 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 t -74.0 -11.39 60.32 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.06 0.845 . . . . 71.450000000000003 112.337 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -143.65 99.93 3.5 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 125.781 1.632 . . . . 74.409999999999997 106.998 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.6 t -154.4 144.13 21.64 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 104.499 -2.408 . . . . 75.230000000000004 104.499 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.78 134.57 64.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.437 -1.32 . . . . 72.129999999999995 107.437 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -118.88 130.36 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 106.667 -1.605 . . . . 71.530000000000001 106.667 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.2 tp -123.03 142.57 50.71 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.643 -0.873 . . . . 73.319999999999993 108.643 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -137.25 132.38 33.7 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.222 1.409 . . . . 73.25 109.695 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.19 134.17 34.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.657 1.183 . . . . 72.230000000000004 110.034 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.41 -59.9 1.5 Allowed Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 118.098 -0.953 . . . . 73.319999999999993 112.554 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.55 -18.85 60.25 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.643 2.229 . . . . 52.009999999999998 116.492 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.3 p -120.23 -10.42 9.37 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.403 1.261 . . . . 61.340000000000003 114.403 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.4 2.93 29.58 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.366 -1.241 . . . . 60.5 113.116 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.3 mt -64.54 134.6 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.98 1.89 . . . . 72.109999999999999 109.606 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.22 151.08 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 107.87 -1.159 . . . . 73.140000000000001 107.87 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p -152.6 154.9 7.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 120.979 -1.076 . . . . 71.120000000000005 108.644 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -122.26 134.44 54.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.778 -1.193 . . . . 73.450000000000003 107.778 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 29.1 m -137.19 150.84 48.18 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.492 1.117 . . . . 61.350000000000001 112.231 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -155.07 149.2 25.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.917 2.087 . . . . 75.340000000000003 108.321 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -162.41 -78.61 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.506 -1.665 . . . . 63.299999999999997 106.506 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 t -102.61 175.68 5.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.654 1.982 . . . . 75.109999999999999 109.072 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -84.74 -17.5 38.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.691 -1.147 . . . . 74.430000000000007 109.719 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.7 m -83.79 115.92 22.46 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.701 1.137 . . . . 75.25 111.946 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.91 -40.27 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 118.581 -0.723 . . . . 72.549999999999997 109.808 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -38.42 35.29 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.662 1.185 . . . . 63.25 112.078 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -76.28 -52.44 9.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.271 1.028 . . . . 72.329999999999998 109.022 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -52.23 -32.44 36.77 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.905 1.282 . . . . 75.540000000000006 111.158 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -54.47 -50.44 67.73 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.797 0.839 . . . . 75.349999999999994 109.978 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -75.09 -24.85 58.19 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.907 1.077 . . . . 74.319999999999993 113.907 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 94.7 mt -67.47 -48.33 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.243 -1.391 . . . . 75.439999999999998 107.243 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.45 99.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.554 -0.716 . . . . 71.319999999999993 110.888 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -63.55 -48.77 76.12 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 118.809 -0.615 . . . . 74.099999999999994 111.229 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -58.69 -41.03 85.32 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 117.395 -1.288 . . . . 73.299999999999997 111.688 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.7 -36.94 67.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.623 1.102 . . . . 75.530000000000001 111.141 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 tp -64.61 -38.2 90.19 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 118.741 -0.647 . . . . 70.230000000000004 110.67 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -57.15 -34.3 68.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.713 0.688 . . . . 74.040000000000006 110.381 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -68.36 -32.91 73.33 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.294 0.638 . . . . 72.150000000000006 110.64 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -77.9 -38.85 44.83 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.532 -0.544 . . . . 70.25 109.532 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.8 t -58.7 -40.4 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.683 -0.858 . . . . 73.519999999999996 108.683 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.31 -60.59 3.53 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.092 0.86 . . . . 64.209999999999994 109.419 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.99 -37.67 34.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 125.067 1.347 . . . . 72.129999999999995 110.452 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -69.83 -42.61 73.38 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.904 0.882 . . . . 75.299999999999997 111.343 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -68.92 -33.81 74.36 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.714 -0.847 . . . . 74.329999999999998 108.714 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.04 -50.88 15.05 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.52 0.728 . . . . 74.349999999999994 109.832 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.0 m -129.42 98.91 5.01 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 128.407 2.683 . . . . 72.340000000000003 111.062 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.77 -179.35 10.89 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.172 0.891 . . . . 73.0 113.753 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.55 -18.0 58.38 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.44 2.76 . . . . 73.040000000000006 114.531 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.4 t 42.45 82.56 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.208 2.203 . . . . 71.420000000000002 112.633 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.1 p -74.46 84.12 1.99 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.315 0.646 . . . . 74.209999999999994 109.285 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.239 0 N-CA-C 108.543 -1.823 . . . . 64.25 108.543 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.076 0 N-CA-C 108.712 -1.755 . . . . 44.229999999999997 108.712 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -148.45 171.77 15.54 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.028 1.331 . . . . 72.450000000000003 107.508 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.2 m -131.62 169.35 16.26 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.895 1.278 . . . . 61.310000000000002 108.099 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.53 -178.39 45.32 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 108.327 -1.909 . . . . 72.340000000000003 108.327 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 p -149.89 175.75 11.37 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.693 0.797 . . . . 74.439999999999998 109.596 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.0 t -129.59 -132.95 0.21 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 104.266 -2.494 . . . . 74.040000000000006 104.266 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -135.41 170.37 23.02 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.563 -1.415 . . . . 73.219999999999999 109.563 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -80.67 51.51 1.51 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.63 0.772 . . . . 54.140000000000001 110.716 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -90.99 177.3 6.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.527 -0.916 . . . . 73.510000000000005 108.527 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.34 179.61 40.83 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.125 -1.19 . . . . 70.010000000000005 110.125 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.51 ' CD2' ' H ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -74.84 -167.43 0.58 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.484 1.114 . . . . 62.210000000000001 110.477 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.51 ' H ' ' CD2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -128.83 159.73 34.84 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.014 1.726 . . . . 71.510000000000005 107.372 178.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.27 148.9 24.88 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.125 -2.176 . . . . 65.219999999999999 105.125 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.12 -176.09 3.96 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.232 1.813 . . . . 75.129999999999995 106.859 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -139.24 178.02 7.49 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.961 -1.496 . . . . 65.340000000000003 106.961 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HE2' ' N ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -121.48 164.52 24.02 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 123.623 0.769 . . . . 62.409999999999997 111.633 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -82.07 172.65 11.68 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.977 2.452 . . . . 73.239999999999995 111.245 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.29 168.53 19.46 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.448 -0.945 . . . . 71.409999999999997 108.448 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.17 161.37 15.05 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.762 0.825 . . . . 74.450000000000003 109.506 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mp -74.84 171.96 13.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.473 1.109 . . . . 75.209999999999994 110.204 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -116.02 157.86 43.93 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.938 1.695 . . . . 75.230000000000004 110.353 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.87 178.55 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.415 2.744 . . . . 74.230000000000004 111.288 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.55 -79.24 0.04 OUTLIER Glycine 0 C--N 1.339 0.722 0 N-CA-C 111.482 -0.647 . . . . 65.319999999999993 111.482 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 28.3 ptm -67.1 147.86 52.61 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.796 0.798 . . . . 75.019999999999996 110.494 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.4 71.64 0.65 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.828 1.251 . . . . 64.219999999999999 108.194 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.47 154.59 34.57 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.517 -0.919 . . . . 74.140000000000001 108.517 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.4 t -123.01 -176.02 3.31 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.602 1.161 . . . . 52.340000000000003 112.06 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -68.57 167.51 14.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.588 1.955 . . . . 74.400000000000006 110.031 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 m -66.11 145.45 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 121.353 -0.842 . . . . 75.219999999999999 108.762 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -74.89 175.9 7.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.317 1.047 . . . . 73.140000000000001 113.825 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.89 151.64 7.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 128.176 2.59 . . . . 75.109999999999999 108.96 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.57 153.87 20.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.789 0.268 . . . . 74.510000000000005 111.265 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.38 -83.07 0.37 Allowed Glycine 0 C--N 1.336 0.556 0 C-N-CA 125.022 1.296 . . . . 70.430000000000007 111.599 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.06 151.93 28.97 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.647 -0.871 . . . . 75.129999999999995 108.647 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.06 20.39 0.87 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.561 1.944 . . . . 75.319999999999993 110.909 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -132.81 57.82 1.79 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 122.113 0.958 . . . . 72.340000000000003 111.9 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -63.05 0.31 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.01 -0.995 . . . . 74.239999999999995 111.829 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.25 99.07 0.47 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.521 2.148 . . . . 74.540000000000006 110.928 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.35 157.54 37.29 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.114 1.366 . . . . 71.150000000000006 109.711 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt 38.13 50.61 1.4 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 128.034 2.534 . . . . 75.420000000000002 111.172 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -56.02 148.83 37.53 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 115.567 -0.742 . . . . 73.239999999999995 112.761 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.72 131.01 14.14 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.631 2.887 . . . . 74.010000000000005 111.821 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.0 mt -104.98 134.39 48.17 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.335 1.054 . . . . 75.239999999999995 109.041 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -73.25 107.5 5.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.804 -0.813 . . . . 72.540000000000006 108.804 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -59.09 -25.13 63.52 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 122.021 -0.424 . . . . 74.299999999999997 111.972 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 m -83.9 7.17 19.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.183 1.393 . . . . 70.430000000000007 112.7 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -116.24 -2.67 12.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.556 1.542 . . . . 73.439999999999998 109.8 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.78 138.61 40.8 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.539 -1.282 . . . . 75.319999999999993 107.539 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -103.3 134.8 46.09 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.066 -1.457 . . . . 74.010000000000005 107.066 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.51 164.74 11.65 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.113 1.765 . . . . 75.209999999999994 112.811 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -140.87 172.57 12.51 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.703 2.001 . . . . 74.0 109.833 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -134.4 158.61 43.4 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.504 1.121 . . . . 74.420000000000002 109.493 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 t -135.57 106.55 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 107.529 -1.286 . . . . 75.109999999999999 107.529 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -87.96 2.42 51.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.577 0.954 . . . . 73.5 113.577 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.48 39.78 98.06 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 118.92 0.782 . . . . 42.240000000000002 111.806 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -121.11 164.36 16.97 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.246 1.018 . . . . 72.120000000000005 109.513 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.25 170.45 42.58 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 129.597 3.475 . . . . 62.240000000000002 106.451 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.83 -21.7 32.79 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.419 2.079 . . . . 70.430000000000007 113.654 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 134.31 -155.92 22.13 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.672 -1.771 . . . . 52.049999999999997 108.672 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.48 -152.81 18.84 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.406 -1.078 . . . . 74.129999999999995 110.406 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.6 161.21 4.8 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.553 1.141 . . . . 72.349999999999994 111.769 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.98 140.62 36.84 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.452 0.701 . . . . 55.399999999999999 110.216 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.6 t -100.47 172.43 7.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.733 1.213 . . . . 74.239999999999995 110.276 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -134.62 3.28 3.27 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.456 2.303 . . . . 73.310000000000002 110.089 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.2 73.91 9.21 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 107.618 -1.253 . . . . 73.099999999999994 107.618 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 p -63.73 156.45 27.02 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.697 0.799 . . . . 74.349999999999994 111.087 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -66.09 171.63 4.44 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.669 1.987 . . . . 73.230000000000004 110.281 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 65.95 -5.27 0.55 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.996 2.119 . . . . 73.049999999999997 113.584 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 t -65.36 130.12 42.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 118.992 0.814 . . . . 63.420000000000002 109.852 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.3 t -111.24 137.26 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 103.309 -2.849 . . . . 72.420000000000002 103.309 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -130.5 117.95 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 105.816 -1.92 . . . . 75.400000000000006 105.816 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.2 tp -135.4 150.61 49.93 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 104.701 -2.333 . . . . 72.150000000000006 104.701 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.5 158.69 43.8 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 123.942 0.897 . . . . 74.019999999999996 109.971 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -91.89 135.59 33.81 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.134 -2.173 . . . . 75.239999999999995 105.134 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.5 t -71.04 -61.94 2.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 119.864 1.211 . . . . 61.140000000000001 113.171 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.25 -25.11 72.07 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 121.68 1.587 . . . . 74.310000000000002 114.708 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 t -98.36 -16.7 19.2 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.281 0.492 . . . . 73.239999999999995 112.104 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.33 12.52 12.83 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.426 1.489 . . . . 61.140000000000001 113.257 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 62.3 mt -70.95 116.18 12.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 119.591 1.695 . . . . 72.310000000000002 106.527 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.3 t -105.32 146.4 12.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.68 -1.23 . . . . 72.129999999999995 107.68 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.12 148.08 17.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.051 -1.092 . . . . 72.120000000000005 108.051 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -120.85 107.04 12.23 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.747 1.219 . . . . 71.010000000000005 107.975 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 58.5 m -136.02 148.55 48.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.226 0.61 . . . . 74.140000000000001 110.211 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -155.48 150.6 26.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.624 -1.621 . . . . 73.450000000000003 106.624 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.79 -36.07 0.24 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.759 0.424 . . . . 74.209999999999994 110.455 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.8 p -123.63 -178.6 4.07 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.213 1.405 . . . . 74.450000000000003 108.457 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.76 -13.39 34.08 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.054 -0.721 . . . . 75.230000000000004 109.054 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -79.42 115.12 18.87 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.851 -1.166 . . . . 74.019999999999996 107.851 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.4 -41.34 84.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.94 -1.133 . . . . 74.349999999999994 107.94 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -56.5 -48.43 77.2 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.427 2.291 . . . . 72.120000000000005 110.371 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -65.88 -45.08 83.38 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.263 0.625 . . . . 75.129999999999995 109.465 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -64.0 -32.7 74.34 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.429 0.692 . . . . 73.239999999999995 111.249 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -59.61 -46.72 88.13 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.624 1.102 . . . . 75.120000000000005 110.336 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -58.87 -48.97 79.51 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 118.563 0.62 . . . . 74.040000000000006 110.553 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.6 mt -54.55 -48.79 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 O-C-N 124.417 1.073 . . . . 73.430000000000007 110.277 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.72 98.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 122.831 0.452 . . . . 70.129999999999995 111.418 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.4 ttm-85 -64.26 -46.62 82.92 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 118.224 -0.893 . . . . 74.120000000000005 110.28 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -50.71 69.8 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 119.438 1.017 . . . . 70.530000000000001 110.995 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.7 p -63.08 -33.39 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 120.178 1.354 . . . . 74.140000000000001 110.52 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.99 -42.19 90.1 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 120.998 -1.064 . . . . 70.349999999999994 108.486 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -56.8 -47.72 79.56 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.13 1.372 . . . . 73.409999999999997 110.569 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -59.64 -34.96 73.47 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.5 0.72 . . . . 64.109999999999999 110.403 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -79.62 -33.43 41.49 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.345 0.658 . . . . 71.109999999999999 111.812 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -74.01 -34.45 39.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 124.231 1.013 . . . . 75.450000000000003 109.763 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.01 -50.88 69.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.715 1.143 . . . . 73.5 109.019 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.8 t -57.97 -32.73 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.209 0.604 . . . . 64.230000000000004 109.661 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -77.34 -19.97 55.54 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.786 -1.196 . . . . 75.430000000000007 112.59 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -91.2 -22.32 20.69 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.992 0.814 . . . . 74.129999999999995 111.265 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -108.83 -17.17 14.0 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.995 0.816 . . . . 70.120000000000005 112.926 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.1 t -137.03 178.86 6.76 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.402 2.281 . . . . 62.039999999999999 108.13 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.57 -175.57 54.85 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.893 -1.129 . . . . 70.409999999999997 110.48 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.21 156.78 46.51 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.395 2.063 . . . . 75.349999999999994 111.107 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.8 m -136.07 -26.37 1.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.898 1.279 . . . . 72.420000000000002 111.186 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.3 m -140.33 175.25 9.75 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 128.137 2.575 . . . . 73.340000000000003 106.632 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 N-CA-C 108.418 -1.873 . . . . 74.25 108.418 -179.871 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.048 0 N-CA-C 108.327 -1.909 . . . . 65.239999999999995 108.327 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -149.68 169.51 20.84 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.051 1.34 . . . . 75.340000000000003 107.41 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.2 p -152.47 -84.12 0.08 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.914 -0.773 . . . . 74.530000000000001 108.914 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.24 -175.95 50.44 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 109.271 -1.532 . . . . 72.150000000000006 109.271 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.7 p -166.85 167.54 14.85 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.497 1.119 . . . . 70.219999999999999 108.254 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 56.4 p -168.19 173.0 8.18 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.573 1.549 . . . . 72.120000000000005 107.401 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.18 164.87 35.03 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.159 -1.176 . . . . 70.430000000000007 110.159 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.54 169.76 23.13 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 129.047 2.939 . . . . 64.219999999999999 105.609 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -145.2 170.46 16.22 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.605 -1.628 . . . . 75.439999999999998 106.605 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.51 -179.76 36.71 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.014 -1.634 . . . . 72.549999999999997 109.014 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.1 160.85 37.75 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.278 -1.378 . . . . 75.319999999999993 107.278 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -69.95 129.05 38.43 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 107.748 -1.205 . . . . 74.129999999999995 107.748 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.75 124.11 30.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.305 -1.739 . . . . 73.140000000000001 106.305 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.58 167.4 27.36 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.43 1.092 . . . . 65.239999999999995 108.404 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' OE1' ' HE3' ' A' ' 16' ' ' LYS 0.38 6.2 mm-40 -111.14 163.37 13.96 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.96 0.788 . . . . 73.400000000000006 111.322 178.217 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.429 ' CE ' ' N ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -79.02 153.46 77.45 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 115.971 -0.558 . . . . 74.099999999999994 109.985 -176.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.47 148.5 79.15 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.561 1.508 . . . . 74.310000000000002 109.228 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.07 176.48 8.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.021 1.328 . . . . 75.049999999999997 108.847 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.7 175.56 10.29 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.83 1.652 . . . . 72.219999999999999 108.891 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -124.84 171.94 9.74 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.625 1.57 . . . . 70.219999999999999 109.101 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -109.38 151.73 42.28 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 124.444 1.098 . . . . 75.409999999999997 108.578 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.63 162.67 35.17 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.526 2.151 . . . . 71.140000000000001 110.561 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.58 172.58 37.67 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 109.196 -1.561 . . . . 71.209999999999994 109.196 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.3 tpt -134.46 135.28 42.37 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.772 -1.196 . . . . 72.329999999999998 107.772 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 64.57 1.11 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.618 1.167 . . . . 74.319999999999993 108.711 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.51 150.28 43.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.925 0.869 . . . . 71.310000000000002 109.227 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 t -93.59 129.1 39.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.189 -1.782 . . . . 74.040000000000006 106.189 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.1 t -69.05 -177.68 1.1 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.689 0.757 . . . . 65.439999999999998 109.67 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.9 m -94.72 -154.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.704 1.602 . . . . 75.239999999999995 110.682 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -131.6 171.13 13.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.568 2.747 . . . . 74.340000000000003 109.603 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.87 169.4 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.842 0.857 . . . . 74.329999999999998 109.69 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.53 152.72 23.87 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.061 0.846 . . . . 63.0 112.734 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.05 70.22 3.16 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 106.971 -2.452 . . . . 64.409999999999997 106.971 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -136.33 -73.23 0.44 Allowed 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 124.411 1.085 . . . . 75.030000000000001 109.863 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp 46.65 36.42 3.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.396 1.078 . . . . 75.109999999999999 111.823 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -129.44 -7.62 4.69 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.672 2.389 . . . . 71.420000000000002 110.936 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -61.34 3.23 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.024 1.73 . . . . 73.239999999999995 114.209 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.71 139.33 43.78 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.413 2.075 . . . . 74.230000000000004 111.348 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 170.51 3.59 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.942 0.877 . . . . 71.5 110.558 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.445 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 62.8 mt 53.14 46.81 25.84 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 127.191 2.196 . . . . 72.430000000000007 109.459 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -56.67 154.7 16.73 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.671 1.588 . . . . 74.340000000000003 111.228 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.01 174.45 11.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.503 2.135 . . . . 65.329999999999998 110.93 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.6 133.87 5.84 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 104.224 -2.509 . . . . 61.210000000000001 104.224 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -66.31 116.15 7.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.18 1.178 . . . . 74.409999999999997 114.18 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CB ' ' HD2' ' A' ' 97' ' ' ARG . 13.7 pt-20 -65.39 -32.13 73.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.142 0.793 . . . . 74.329999999999998 113.142 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 m -76.38 1.62 15.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.526 0.565 . . . . 73.340000000000003 112.526 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -107.57 6.61 28.12 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.984 1.714 . . . . 71.040000000000006 110.582 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.3 mt -110.31 176.37 5.07 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.839 1.052 . . . . 74.120000000000005 113.839 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -127.01 130.19 49.54 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.958 -1.497 . . . . 71.409999999999997 106.958 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.59 159.69 34.74 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.86 1.264 . . . . 73.040000000000006 108.87 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -137.82 154.89 49.48 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.818 -1.178 . . . . 71.099999999999994 107.818 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -119.94 122.47 41.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.809 1.244 . . . . 75.340000000000003 108.547 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.83 120.03 36.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 122.282 1.039 . . . . 71.439999999999998 109.797 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.52 157.25 17.29 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.354 -1.35 . . . . 74.5 107.354 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.05 67.96 3.62 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.027 -1.629 . . . . 75.310000000000002 109.027 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -83.36 9.22 11.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 117.778 0.789 . . . . 74.329999999999998 112.524 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.61 173.51 44.45 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 109.509 -1.436 . . . . 73.310000000000002 109.509 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.19 1.27 6.2 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.003 3.136 . . . . 72.450000000000003 114.358 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.64 -47.43 3.64 Favored Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.11 -0.993 . . . . 74.310000000000002 110.955 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.16 -77.91 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 107.878 -2.089 . . . . 50.32 107.878 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -128.17 -60.98 1.12 Allowed 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.349 1.06 . . . . 74.530000000000001 108.366 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.33 140.23 20.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.123 -1.436 . . . . 72.129999999999995 107.123 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -162.11 171.48 17.4 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 105.903 -1.888 . . . . 74.409999999999997 105.903 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -142.68 164.13 30.94 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.817 -1.177 . . . . 73.209999999999994 108.406 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 49.76 23.27 0.97 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.24 2.216 . . . . 64.530000000000001 113.821 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 p -66.66 -49.28 66.68 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.094 1.757 . . . . 74.299999999999997 111.292 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 p -61.82 146.94 48.06 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.797 -0.816 . . . . 71.019999999999996 108.797 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 83.45 2.94 0.95 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.072 2.149 . . . . 73.439999999999998 112.191 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 m -67.9 135.06 51.89 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.727 -1.212 . . . . 73.25 107.727 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.36 154.28 20.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.685 -1.228 . . . . 71.299999999999997 107.685 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.4 147.79 21.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.327 -2.101 . . . . 75.420000000000002 105.327 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.7 tp -140.47 150.42 43.77 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.366 1.066 . . . . 73.120000000000005 108.999 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.28 157.99 44.72 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 112.502 0.556 . . . . 74.109999999999999 112.502 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -100.89 118.4 36.86 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 103.643 -2.725 . . . . 74.219999999999999 103.643 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -63.29 -54.08 47.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 120.253 1.388 . . . . 74.340000000000003 112.875 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.41 -13.02 34.88 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.843 2.362 . . . . 70.430000000000007 116.509 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.6 m -121.14 -6.22 9.45 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.078 1.308 . . . . 71.25 113.698 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.02 17.01 34.98 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 123.949 0.785 . . . . 70.209999999999994 114.915 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.5 mt -74.04 134.57 29.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 104.325 -2.472 . . . . 75.200000000000003 104.325 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t -130.23 137.16 57.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.824 -1.176 . . . . 73.439999999999998 107.824 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.67 147.93 28.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.676 -0.861 . . . . 75.519999999999996 108.676 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -122.68 118.49 28.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.479 1.112 . . . . 74.200000000000003 110.422 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 99.3 m -127.67 144.47 51.07 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.247 0.619 . . . . 74.219999999999999 110.986 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -155.62 120.42 4.75 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.468 1.107 . . . . 74.030000000000001 108.541 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.69 -71.67 0.27 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.086 0.954 . . . . 72.530000000000001 108.496 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 p -78.77 156.54 28.78 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.37 1.868 . . . . 73.310000000000002 113.614 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.14 -15.55 52.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.331 -0.618 . . . . 73.120000000000005 109.331 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.48 123.25 27.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.521 -1.288 . . . . 74.450000000000003 107.521 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.3 p -60.41 -46.38 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 119.157 0.889 . . . . 74.510000000000005 110.211 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -55.06 -42.21 72.44 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.422 1.889 . . . . 74.319999999999993 112.354 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -23.01 41.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.225 -0.893 . . . . 75.549999999999997 111.223 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -77.94 -42.91 31.49 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.581 -1.636 . . . . 73.010000000000005 106.581 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -52.17 -45.94 65.29 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.471 1.108 . . . . 72.409999999999997 109.0 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -59.67 -34.03 72.32 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-O 117.649 -1.167 . . . . 74.299999999999997 113.233 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.5 mt -64.32 -53.17 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 120.087 1.312 . . . . 64.450000000000003 108.402 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.05 -47.05 75.32 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 108.404 -0.961 . . . . 70.530000000000001 108.404 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.414 ' HD2' ' CB ' ' A' ' 45' ' ' GLU . 33.3 ttp85 -59.87 -39.56 85.68 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.383 1.073 . . . . 74.329999999999998 111.984 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -63.49 -57.52 9.94 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.96 1.304 . . . . 71.209999999999994 109.622 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.57 -29.21 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 112.106 0.41 . . . . 73.510000000000005 112.106 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.94 -46.76 89.4 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.648 -0.658 . . . . 75.019999999999996 109.554 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -59.01 -31.45 68.83 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.556 0.342 . . . . 73.510000000000005 111.451 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.26 -24.96 64.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.319 0.509 . . . . 73.200000000000003 112.079 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -88.03 -44.12 11.22 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.956 0.903 . . . . 75.530000000000001 110.138 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.39 -39.25 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 118.675 -0.679 . . . . 63.310000000000002 110.064 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 40' ' ' LEU . 5.4 t70 -53.4 -66.68 0.35 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.651 0.739 . . . . 73.439999999999998 109.929 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.8 p -57.53 -30.48 36.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 118.174 -0.917 . . . . 74.310000000000002 111.144 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -59.9 -44.65 94.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.22 1.373 . . . . 74.150000000000006 110.199 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -75.66 -39.47 57.61 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.992 0.517 . . . . 74.519999999999996 110.731 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -65.12 -54.74 25.22 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.575 -0.528 . . . . 75.409999999999997 109.575 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 66.1 m -84.18 -137.11 0.05 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.522 1.929 . . . . 64.109999999999999 106.889 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.55 -172.22 44.95 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 119.956 -1.715 . . . . 74.109999999999999 111.113 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.67 165.93 27.76 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.715 2.943 . . . . 74.549999999999997 112.203 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.1 p -112.04 -71.74 0.74 Allowed 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.973 0.909 . . . . 75.030000000000001 110.089 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.1 p -68.0 -5.01 15.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.332 1.453 . . . . 74.430000000000007 113.841 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.186 0 CA-C-O 115.965 -2.575 . . . . 70.439999999999998 110.611 -179.893 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.023 0 N-CA-C 108.991 -1.643 . . . . 42.229999999999997 108.991 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p -154.29 169.18 24.28 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.027 1.331 . . . . 65.019999999999996 107.576 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 m -135.58 177.64 7.66 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.86 1.264 . . . . 73.230000000000004 108.901 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.01 -179.89 36.94 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.199 -1.96 . . . . 75.319999999999993 108.199 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.1 m -155.94 169.56 24.15 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.712 1.205 . . . . 73.109999999999999 108.34 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.6 t -160.33 -179.7 7.92 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.99 1.316 . . . . 75.209999999999994 107.569 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.62 -178.07 42.45 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.226 -1.15 . . . . 73.340000000000003 110.226 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -143.63 163.27 33.71 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 106.547 -1.649 . . . . 72.340000000000003 106.547 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -125.46 150.54 47.25 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.244 0.618 . . . . 63.439999999999998 110.004 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.23 78.93 1.96 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 109.578 -1.409 . . . . 74.450000000000003 109.578 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.3 mt -65.22 141.37 58.67 Favored 'General case' 0 CA--C 1.526 0.055 0 N-CA-C 107.986 -1.116 . . . . 74.409999999999997 107.986 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.2 164.08 35.8 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.062 1.745 . . . . 53.32 108.461 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -131.06 167.01 19.8 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.078 1.351 . . . . 74.010000000000005 108.567 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.0 178.34 1.8 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 129.404 3.082 . . . . 73.030000000000001 106.074 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.453 ' CD ' ' HZ3' ' A' ' 16' ' ' LYS . 1.8 tm-20 -146.25 -177.91 5.86 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.913 -0.773 . . . . 74.209999999999994 108.913 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HZ3' ' CD ' ' A' ' 15' ' ' GLU . 34.9 mtmm -71.98 154.05 92.64 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.911 1.684 . . . . 72.409999999999997 110.748 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.54 166.73 28.74 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.348 2.032 . . . . 73.439999999999998 110.281 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 165.44 24.66 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.329 0.651 . . . . 74.349999999999994 110.412 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -99.19 171.59 7.9 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.589 1.156 . . . . 73.129999999999995 109.001 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -125.1 178.19 5.68 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.958 1.703 . . . . 73.239999999999995 109.836 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -125.37 155.74 71.18 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.967 1.707 . . . . 73.310000000000002 109.184 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.39 164.33 34.26 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.568 2.179 . . . . 64.430000000000007 111.428 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.61 169.73 16.47 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.499 -1.041 . . . . 74.030000000000001 110.499 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.2 mtt -82.01 163.36 22.17 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.721 -0.474 . . . . 73.530000000000001 109.721 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.93 74.41 1.26 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.325 -1.732 . . . . 65.549999999999997 106.325 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.61 176.89 6.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.894 0.854 . . . . 74.420000000000002 112.651 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -64.68 168.14 6.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.183 0.993 . . . . 63.350000000000001 110.528 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.5 p -130.48 178.86 6.29 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.819 1.248 . . . . 74.329999999999998 112.377 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.67 145.9 3.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.591 1.156 . . . . 73.439999999999998 109.908 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -71.95 -171.78 0.76 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.071 -0.968 . . . . 74.019999999999996 110.912 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 m -55.85 170.66 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 126.667 1.987 . . . . 74.430000000000007 114.753 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.52 172.91 12.48 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.607 1.563 . . . . 75.299999999999997 110.733 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.44 -79.26 0.56 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 109.969 -1.252 . . . . 62.5 109.969 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -168.43 167.43 11.82 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.703 1.201 . . . . 74.319999999999993 109.609 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.2 171.72 13.34 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.157 1.383 . . . . 65.25 109.197 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.09 21.19 12.21 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 119.808 3.262 . . . . 62.530000000000001 119.808 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -48.17 -57.91 9.3 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.865 1.266 . . . . 74.319999999999993 112.503 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -63.63 107.98 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.545 2.163 . . . . 74.150000000000006 110.236 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.27 163.3 39.19 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 125.365 1.466 . . . . 64.0 110.375 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.5 mt -64.67 81.94 0.04 OUTLIER 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.187 1.795 . . . . 74.5 112.29 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.8 mt -55.41 145.09 49.81 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.646 0.779 . . . . 74.099999999999994 109.343 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.09 129.34 20.39 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.516 2.81 . . . . 74.030000000000001 111.092 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.4 mt -117.75 121.25 40.33 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.487 1.115 . . . . 75.450000000000003 109.663 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -77.93 101.89 7.06 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.29 -1.004 . . . . 74.409999999999997 108.29 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.07 -29.14 60.11 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.213 0.46 . . . . 75.530000000000001 111.441 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -73.06 -3.78 28.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.178 0.991 . . . . 74.150000000000006 112.139 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -118.4 0.1 11.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.33 2.252 . . . . 75.340000000000003 110.663 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.9 mt -98.98 176.78 5.46 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.252 1.021 . . . . 74.120000000000005 109.388 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -138.4 148.13 44.13 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.76 -1.2 . . . . 73.519999999999996 107.76 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -141.76 164.83 29.14 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.786 1.234 . . . . 74.439999999999998 108.955 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -126.04 174.87 8.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.004 -0.739 . . . . 73.230000000000004 109.004 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -133.94 113.62 12.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.348 -1.353 . . . . 74.439999999999998 107.348 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.0 t -87.37 133.61 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.929 -1.878 . . . . 74.340000000000003 105.929 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -127.26 -2.37 6.31 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.2 1.0 . . . . 72.420000000000002 112.691 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.19 -157.09 27.02 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 107.863 -2.095 . . . . 74.340000000000003 107.863 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -63.92 163.63 11.69 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.836 0.855 . . . . 74.329999999999998 109.111 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.76 -175.88 32.25 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 109.655 -1.378 . . . . 73.129999999999995 109.655 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.27 169.45 20.71 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.549 2.166 . . . . 65.109999999999999 109.449 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.89 -51.33 0.83 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.066 -1.213 . . . . 72.209999999999994 110.066 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 148.56 -109.86 0.47 Allowed Glycine 0 C--N 1.332 0.33 0 N-CA-C 108.498 -1.841 . . . . 73.230000000000004 108.498 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -73.02 58.24 0.48 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.885 1.674 . . . . 73.299999999999997 112.632 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.4 21.56 2.07 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.443 1.497 . . . . 75.420000000000002 110.313 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.63 11.5 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.793 1 C-N-CA 132.271 4.228 . . . . 62.219999999999999 115.284 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -66.19 96.4 0.33 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.181 1.792 . . . . 75.409999999999997 110.046 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.23 2.63 14.97 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.076 -1.015 . . . . 73.230000000000004 112.479 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 p -59.57 122.63 14.54 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.212 1.369 . . . . 71.230000000000004 108.209 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.1 m -78.05 2.17 18.64 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.991 0.916 . . . . 64.129999999999995 113.009 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -156.87 143.77 18.58 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 127.697 2.399 . . . . 75.019999999999996 106.06 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.8 t 178.45 133.8 0.08 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.651 2.781 . . . . 74.25 106.067 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.2 t -118.08 114.38 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 106.129 -1.804 . . . . 71.230000000000004 106.129 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.57 138.14 33.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.667 0.746 . . . . 72.510000000000005 109.303 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.8 tp -135.59 148.58 49.1 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.409 1.883 . . . . 74.329999999999998 107.889 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.71 158.4 44.48 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.479 -1.304 . . . . 75.209999999999994 107.479 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -106.84 119.27 38.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.585 -0.894 . . . . 74.409999999999997 108.585 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 t -57.36 -61.11 7.79 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.689 1.196 . . . . 71.129999999999995 110.103 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.77 -12.02 33.44 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.29 2.66 . . . . 75.239999999999995 116.832 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -120.83 -10.61 9.1 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.403 1.261 . . . . 73.549999999999997 114.403 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.78 -5.38 2.49 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.625 1.107 . . . . 50.130000000000003 114.754 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.6 mt -60.55 140.46 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 126.022 1.729 . . . . 73.530000000000001 108.128 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 t -126.02 142.57 42.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 105.792 -1.929 . . . . 74.530000000000001 105.792 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.56 139.58 16.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.497 -0.927 . . . . 73.239999999999995 108.497 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 113.7 17.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.37 1.468 . . . . 74.099999999999994 107.388 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.6 p -100.04 164.58 11.93 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.522 1.529 . . . . 73.430000000000007 111.741 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -155.8 120.67 4.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.138 1.775 . . . . 74.150000000000006 106.874 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.01 -47.54 0.13 Allowed 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.677 0.791 . . . . 75.109999999999999 110.082 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.7 p -128.13 -170.63 2.28 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.784 -1.561 . . . . 75.010000000000005 106.784 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.08 9.0 15.83 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.306 -0.871 . . . . 71.120000000000005 110.897 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 75.3 m -103.46 115.05 29.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.946 -1.131 . . . . 75.329999999999998 107.946 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.62 -43.05 77.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 123.54 0.736 . . . . 64.340000000000003 110.245 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.19 -30.63 64.7 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.643 1.11 . . . . 70.209999999999994 112.32 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -86.52 -48.39 8.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.749 -0.834 . . . . 74.310000000000002 108.749 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -60.95 -26.58 67.62 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.234 0.614 . . . . 74.140000000000001 110.751 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -57.16 -40.71 77.82 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.202 0.91 . . . . 74.109999999999999 110.093 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -73.6 -29.17 62.22 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 118.288 -1.365 . . . . 75.030000000000001 110.48 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.05 -45.18 95.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 124.381 1.072 . . . . 74.120000000000005 108.526 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.06 -45.22 94.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.858 0.361 . . . . 65.019999999999996 110.596 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -66.05 -48.17 71.92 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 122.65 0.38 . . . . 74.439999999999998 111.705 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -40.34 92.36 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 117.894 -1.05 . . . . 74.030000000000001 110.453 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.82 -37.79 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.278 0.944 . . . . 73.329999999999998 109.291 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.8 tp -61.11 -38.56 86.77 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.087 0.858 . . . . 71.310000000000002 110.854 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -57.06 -34.28 68.1 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.936 0.789 . . . . 75.239999999999995 111.384 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -67.49 -31.08 70.98 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.842 0.829 . . . . 74.019999999999996 109.97 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -77.68 -47.03 20.18 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.764 0.826 . . . . 75.230000000000004 110.948 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.1 t -62.18 -37.85 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 123.681 0.793 . . . . 71.150000000000006 109.964 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -52.24 -65.88 0.48 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.258 1.023 . . . . 54.409999999999997 110.296 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.63 -28.65 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.597 -0.69 . . . . 75.510000000000005 111.42 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -68.85 -40.19 79.51 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 119.123 0.874 . . . . 73.239999999999995 110.832 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -72.24 -45.24 61.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.722 0.809 . . . . 71.340000000000003 110.021 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -63.86 -53.9 43.32 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.289 0.636 . . . . 74.510000000000005 111.082 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.2 t -71.78 161.93 30.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.779 0.832 . . . . 73.329999999999998 111.836 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.5 176.27 45.38 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.999 1.285 . . . . 64.109999999999999 110.63 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.96 157.47 56.74 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.686 2.257 . . . . 74.150000000000006 110.198 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.5 p -66.05 -7.78 19.41 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.768 1.395 . . . . 75.340000000000003 114.768 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.2 t -77.62 -97.03 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.415 1.886 . . . . 72.099999999999994 109.32 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 N-CA-C 107.848 -2.101 . . . . 64.019999999999996 107.848 -179.785 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.081 0 N-CA-C 109.174 -1.57 . . . . 72.049999999999997 109.174 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p -154.78 173.33 16.59 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.337 1.455 . . . . 71.409999999999997 107.478 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.2 t -159.84 172.37 17.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.852 1.661 . . . . 72.150000000000006 106.621 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.77 -179.56 35.26 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.515 -1.434 . . . . 55.340000000000003 109.515 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.6 t -159.19 166.14 32.1 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.283 1.433 . . . . 72.510000000000005 107.155 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.7 m -142.13 168.81 18.87 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.948 1.299 . . . . 63.340000000000003 109.799 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.48 148.2 19.59 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.79 -1.324 . . . . 63.240000000000002 109.79 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.65 162.36 17.98 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.024 0.53 . . . . 73.120000000000005 110.975 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -144.14 -179.93 6.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.242 2.217 . . . . 74.200000000000003 106.911 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.82 88.43 0.07 OUTLIER Glycine 0 C--N 1.341 0.807 0 CA-C-N 119.58 1.082 . . . . 72.349999999999994 114.209 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.84 171.47 15.08 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.583 -1.265 . . . . 74.439999999999998 107.583 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.11 166.6 27.75 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 125.637 1.575 . . . . 73.239999999999995 108.075 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.14 164.52 35.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.338 1.855 . . . . 74.400000000000006 106.765 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -159.24 163.83 35.52 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 127.253 2.221 . . . . 74.140000000000001 106.252 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -138.6 178.43 7.15 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.212 0.605 . . . . 74.230000000000004 110.225 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -75.43 158.15 83.83 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.47 1.508 . . . . 74.319999999999993 109.851 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.69 159.03 54.05 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.333 2.022 . . . . 72.019999999999996 111.732 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.02 178.83 7.96 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.352 1.061 . . . . 72.239999999999995 110.161 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -139.31 174.37 10.59 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 126.208 1.803 . . . . 71.319999999999993 109.657 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.85 177.84 7.33 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.883 2.073 . . . . 74.540000000000006 108.629 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -129.15 153.29 80.36 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.027 1.331 . . . . 74.439999999999998 110.235 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -80.8 177.1 8.36 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.63 2.887 . . . . 75.239999999999995 110.85 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.89 160.24 27.97 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.649 -1.38 . . . . 62.140000000000001 109.649 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -145.81 124.09 12.27 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.838 -1.912 . . . . 65.400000000000006 105.838 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.98 56.49 1.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.622 1.169 . . . . 72.230000000000004 108.573 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.41 139.3 58.53 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.537 -0.727 . . . . 62.210000000000001 109.114 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 t -88.36 -170.0 2.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.897 1.279 . . . . 64.209999999999994 110.517 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.9 p -136.08 178.0 7.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.594 1.558 . . . . 73.400000000000006 109.467 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.71 -179.43 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 126.377 1.871 . . . . 75.299999999999997 109.514 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -130.48 169.47 15.5 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.082 1.753 . . . . 73.319999999999993 110.996 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.59 147.74 7.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.242 1.017 . . . . 75.239999999999995 109.265 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.92 -166.62 1.38 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.099 -1.445 . . . . 74.299999999999997 107.099 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.28 179.94 25.56 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-O 121.999 0.777 . . . . 71.140000000000001 112.223 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -66.64 -40.02 88.53 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.632 1.173 . . . . 73.310000000000002 110.162 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp 54.05 28.35 8.68 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.899 1.28 . . . . 73.239999999999995 111.037 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -125.29 13.98 8.3 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.833 2.053 . . . . 75.230000000000004 111.575 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -56.4 28.67 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 126.012 1.725 . . . . 72.120000000000005 110.382 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.29 161.17 44.25 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.08 1.854 . . . . 73.310000000000002 110.387 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.73 161.36 41.37 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.752 2.021 . . . . 74.430000000000007 106.621 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.6 mt 30.11 64.51 0.15 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.348 2.259 . . . . 73.5 112.803 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.79 157.85 18.34 Favored Pre-proline 0 C--O 1.24 0.605 0 C-N-CA 127.475 2.31 . . . . 74.040000000000006 109.77 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -62.41 140.95 85.12 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.137 1.225 . . . . 72.420000000000002 110.622 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.3 123.23 12.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.124 -1.806 . . . . 74.439999999999998 106.124 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -85.24 117.86 24.44 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.618 1.167 . . . . 74.299999999999997 109.664 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.35 -29.13 69.83 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.823 1.046 . . . . 73.140000000000001 113.823 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -82.68 -10.48 58.9 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.454 1.102 . . . . 75.519999999999996 112.849 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -91.59 2.25 56.58 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.768 0.713 . . . . 73.310000000000002 111.568 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mt -102.73 174.5 5.86 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.122 1.369 . . . . 61.439999999999998 112.106 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -126.79 156.23 41.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.346 2.258 . . . . 72.140000000000001 105.807 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.45 157.31 46.84 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.602 -0.686 . . . . 71.230000000000004 111.861 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -126.89 140.17 52.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.408 1.083 . . . . 74.239999999999995 111.134 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -106.38 132.34 52.52 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.562 1.145 . . . . 63.210000000000001 108.096 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.1 t -88.06 120.86 37.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.975 -1.121 . . . . 75.510000000000005 107.975 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 95.62 10.3 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.917 0.887 . . . . 72.319999999999993 109.5 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.48 -88.99 1.02 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.42 -0.895 . . . . 73.200000000000003 113.171 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -140.13 157.97 44.79 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.24 1.416 . . . . 74.540000000000006 110.464 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.65 -168.89 32.56 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.516 2.008 . . . . 44.140000000000001 110.414 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -65.65 170.48 11.15 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.399 2.733 . . . . 74.230000000000004 110.739 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.26 160.14 9.91 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 123.594 0.616 . . . . 75.099999999999994 112.207 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.13 -82.16 0.31 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 106.865 -2.494 . . . . 64.530000000000001 106.865 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -66.93 129.47 40.0 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.322 -1.733 . . . . 71.409999999999997 106.322 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.37 164.67 5.34 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.829 -0.434 . . . . 55.229999999999997 109.829 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.3 t -60.1 131.8 51.94 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.69 -1.226 . . . . 64.120000000000005 107.69 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -132.17 126.22 33.11 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.625 -1.991 . . . . 75.310000000000002 105.625 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -62.41 -21.79 65.66 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 118.856 -0.592 . . . . 74.400000000000006 111.293 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.2 p -75.77 72.47 2.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.86 1.664 . . . . 73.040000000000006 110.778 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -65.88 -6.17 11.43 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.135 -0.978 . . . . 63.43 111.956 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -72.93 62.96 0.63 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.726 2.811 . . . . 72.010000000000005 111.455 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -104.46 156.39 17.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.714 1.206 . . . . 64.450000000000003 109.504 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.95 142.22 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.537 1.535 . . . . 75.549999999999997 107.473 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -137.56 95.47 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.23 -1.396 . . . . 52.140000000000001 107.23 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.4 tp -93.46 152.4 19.11 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.727 0.411 . . . . 75.109999999999999 110.229 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -141.45 137.3 32.07 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 124.574 1.149 . . . . 73.530000000000001 110.346 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -87.84 132.93 34.0 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 105.468 -2.049 . . . . 71.450000000000003 105.468 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.63 -64.95 2.25 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 119.297 0.953 . . . . 74.319999999999993 111.846 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.54 -7.74 21.78 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.801 3.0 . . . . 73.400000000000006 116.13 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 m -113.3 -17.36 12.32 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.86 1.209 . . . . 75.230000000000004 112.213 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.11 -7.03 0.86 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.363 1.459 . . . . 70.310000000000002 115.725 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.76 136.93 25.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 120.038 1.919 . . . . 74.340000000000003 107.523 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.0 t -121.6 137.29 55.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.818 1.647 . . . . 71.239999999999995 106.772 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.0 p -146.88 148.11 17.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.542 -0.911 . . . . 74.310000000000002 108.542 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.48 134.08 41.11 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 122.523 0.329 . . . . 75.450000000000003 111.291 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.1 t -140.77 155.35 46.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.181 1.793 . . . . 73.420000000000002 108.547 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -150.75 100.78 2.86 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.496 1.918 . . . . 65.319999999999993 108.173 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -120.55 -15.55 8.47 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.768 1.396 . . . . 74.329999999999998 114.768 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.3 p -134.2 168.18 19.33 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.53 1.514 . . . . 74.439999999999998 110.824 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -79.96 -10.61 59.79 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.633 -0.667 . . . . 72.420000000000002 110.851 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.37 114.65 26.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.827 1.651 . . . . 75.140000000000001 110.231 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.35 -44.45 98.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-O 119.18 -0.438 . . . . 54.450000000000003 110.707 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -58.15 -45.45 87.4 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.381 0.537 . . . . 74.420000000000002 110.952 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -42.2 97.21 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.47 -0.937 . . . . 73.329999999999998 108.47 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.56 -27.47 68.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 118.613 -0.708 . . . . 73.219999999999999 109.987 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -62.22 -46.59 88.18 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.077 1.308 . . . . 74.140000000000001 107.843 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -60.36 -37.39 80.56 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.344 0.52 . . . . 74.010000000000005 110.222 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.48 -48.27 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 108.612 -0.884 . . . . 75.319999999999993 108.612 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.5 -35.49 80.65 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.673 -0.642 . . . . 73.439999999999998 110.538 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -63.71 -52.06 62.25 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 123.758 0.823 . . . . 75.120000000000005 111.282 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -43.35 94.21 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.643 1.11 . . . . 74.209999999999994 110.66 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.11 -33.09 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.503 1.047 . . . . 74.099999999999994 109.326 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.11 -33.13 75.08 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 120.839 -1.163 . . . . 71.310000000000002 108.962 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -58.75 -45.64 89.22 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.958 1.254 . . . . 75.239999999999995 107.951 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -56.47 -37.58 70.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.399 1.08 . . . . 73.120000000000005 109.684 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -72.4 -39.02 68.27 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.621 -0.674 . . . . 74.409999999999997 111.911 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.94 -39.29 85.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.564 -0.902 . . . . 60.549999999999997 108.564 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.12 -62.89 1.44 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.604 1.561 . . . . 75.430000000000007 110.799 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.4 p -60.8 -27.62 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 119.246 -0.407 . . . . 73.129999999999995 110.819 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -66.69 -36.19 81.92 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.585 0.63 . . . . 74.329999999999998 109.786 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -74.53 -42.78 58.25 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.423 -0.584 . . . . 73.109999999999999 109.423 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -67.83 -58.47 4.53 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.026 0.931 . . . . 73.310000000000002 111.748 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.2 t -96.18 64.38 2.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.384 1.474 . . . . 62.299999999999997 109.544 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.95 159.67 27.42 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.271 0.939 . . . . 63.020000000000003 110.988 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.53 128.16 23.9 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.727 2.952 . . . . 74.329999999999998 109.126 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.3 m -143.72 160.72 40.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.589 0.756 . . . . 64.420000000000002 110.413 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.9 t -141.63 59.82 1.49 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 104.469 -2.419 . . . . 75.099999999999994 104.469 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.85 0 N-CA-C 103.835 -3.706 . . . . 72.140000000000001 103.835 -178.658 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.082 0 N-CA-C 108.338 -1.905 . . . . 74.209999999999994 108.338 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 m -140.69 167.63 21.71 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.156 -1.053 . . . . 70.219999999999999 108.156 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 p -153.67 172.83 16.65 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.999 1.319 . . . . 73.439999999999998 108.099 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.26 -179.41 38.43 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.476 -1.85 . . . . 61.009999999999998 108.476 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.3 p -160.61 -179.58 7.75 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.207 -1.034 . . . . 73.030000000000001 108.207 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 m -128.53 8.88 5.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.865 0.866 . . . . 70.230000000000004 112.123 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 56.73 -148.68 30.78 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.221 -0.752 . . . . 40.329999999999998 111.221 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 164.85 168.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 1 C-N-CA 132.549 4.34 . . . . 75.109999999999999 106.89 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -156.54 175.83 13.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.587 1.155 . . . . 74.140000000000001 108.061 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.9 162.38 35.76 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.524 1.059 . . . . 71.310000000000002 111.188 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.9 mt -149.23 167.0 27.2 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.839 1.656 . . . . 75.329999999999998 108.278 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -153.16 132.94 13.16 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 107.949 -1.13 . . . . 71.430000000000007 107.949 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.449 ' CD1' ' H ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -159.28 -176.65 5.93 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 128.216 2.606 . . . . 75.319999999999993 106.0 179.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.449 ' H ' ' CD1' ' A' ' 13' ' ' LEU . 0.0 OUTLIER 147.01 168.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 1 C-N-CA 135.885 5.674 . . . . 75.319999999999993 106.627 179.654 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -138.39 170.9 15.2 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.378 -1.341 . . . . 74.439999999999998 107.378 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.43 154.72 47.66 Favored Pre-proline 0 N--CA 1.45 -0.43 0 C-N-CA 125.634 1.574 . . . . 74.430000000000007 111.622 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.59 163.79 36.57 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.976 2.451 . . . . 74.200000000000003 109.216 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.7 164.27 31.49 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.672 1.189 . . . . 61.219999999999999 109.154 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -160.06 176.41 11.85 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 126.197 1.799 . . . . 74.540000000000006 109.003 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.9 174.77 10.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.251 2.22 . . . . 75.329999999999998 107.723 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -123.65 152.39 65.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 124.405 1.082 . . . . 70.510000000000005 110.222 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -80.74 -179.54 5.23 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.929 3.086 . . . . 70.230000000000004 110.903 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.75 167.99 25.15 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.397 -1.481 . . . . 62.229999999999997 109.397 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -147.82 140.0 24.28 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.998 -1.852 . . . . 74.329999999999998 105.998 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.46 59.95 0.82 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.665 0.666 . . . . 72.230000000000004 111.053 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.78 140.07 42.15 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.624 -0.88 . . . . 74.25 108.624 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 t -73.87 164.55 26.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.524 1.13 . . . . 74.430000000000007 111.59 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 p -102.69 165.48 11.04 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.345 1.458 . . . . 72.329999999999998 108.593 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.07 143.28 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 107.521 -1.289 . . . . 75.329999999999998 107.521 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -62.12 139.24 58.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.439 0.638 . . . . 64.019999999999996 110.518 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -82.87 169.22 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 125.439 1.496 . . . . 73.239999999999995 109.293 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.25 149.68 36.71 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.47 2.308 . . . . 54.439999999999998 107.077 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -136.36 -57.29 0.06 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 125.38 1.467 . . . . 75.349999999999994 111.195 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.81 144.01 23.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 117.675 -1.155 . . . . 75.439999999999998 109.035 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HA ' ' CE1' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -158.39 5.71 0.12 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.966 2.106 . . . . 72.530000000000001 114.566 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -122.24 33.18 5.54 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 126.195 1.798 . . . . 74.439999999999998 109.93 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.424 ' CE1' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -52.45 -63.43 2.24 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.883 1.273 . . . . 74.030000000000001 111.617 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.0 92.9 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.026 2.484 . . . . 71.430000000000007 108.829 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.52 135.93 11.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.921 1.689 . . . . 62.399999999999999 107.562 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.2 mt -64.88 103.16 0.68 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.301 -1.37 . . . . 75.430000000000007 107.301 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.59 145.25 70.09 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.657 -0.868 . . . . 73.099999999999994 108.657 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.77 146.8 67.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.096 1.864 . . . . 73.140000000000001 111.927 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 mt -111.86 159.25 18.52 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.741 1.217 . . . . 74.400000000000006 111.533 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -115.01 101.37 8.94 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 108.096 -1.076 . . . . 74.239999999999995 108.096 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -66.12 -20.79 66.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.311 0.645 . . . . 74.310000000000002 112.71 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -84.4 3.29 36.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.932 1.693 . . . . 63.25 112.599 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -124.15 22.81 8.59 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.299 1.039 . . . . 71.510000000000005 111.203 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -112.31 162.0 16.01 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.295 -0.878 . . . . 73.099999999999994 108.81 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -126.13 95.1 4.28 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.423 1.489 . . . . 75.409999999999997 107.094 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -87.0 162.86 17.39 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.138 1.375 . . . . 74.150000000000006 112.271 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.7 172.2 13.98 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.919 -1.511 . . . . 72.019999999999996 106.919 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -130.97 155.91 46.01 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.509 1.124 . . . . 74.099999999999994 108.789 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.4 t -100.44 145.42 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.741 0.782 . . . . 64.140000000000001 109.512 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -146.0 30.05 1.07 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.239 2.215 . . . . 73.5 107.237 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.01 -143.12 32.84 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 104.5 -3.44 . . . . 73.420000000000002 104.5 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 54.97 -85.28 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 127.098 2.159 . . . . 73.430000000000007 112.213 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.92 -161.77 32.22 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.285 -1.526 . . . . 65.230000000000004 109.285 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.51 15.25 0.68 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.511 2.808 . . . . 73.549999999999997 111.26 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.57 -153.74 19.63 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.176 -1.169 . . . . 33.299999999999997 110.176 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.34 -176.71 54.07 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 122.085 0.825 . . . . 64.209999999999994 111.766 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.68 -1.88 0.45 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.528 1.531 . . . . 64.230000000000004 114.8 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.37 -11.48 20.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.635 -1.174 . . . . 74.219999999999999 112.932 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.3 t -48.53 -57.49 6.09 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.636 1.107 . . . . 75.420000000000002 113.444 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -73.67 -8.44 55.98 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.121 -0.987 . . . . 74.219999999999999 113.229 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -85.46 58.51 5.08 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 120.256 1.389 . . . . 74.319999999999993 112.005 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.7 t -59.6 130.05 44.94 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 105.984 -1.858 . . . . 74.129999999999995 105.984 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 p -152.68 156.78 39.86 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.81 -0.556 . . . . 71.310000000000002 110.65 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -68.81 14.19 0.08 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.861 2.864 . . . . 74.109999999999999 114.469 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.5 m -63.81 160.03 18.21 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.202 1.001 . . . . 70.439999999999998 110.611 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.08 148.53 30.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.07 -1.456 . . . . 75.120000000000005 107.07 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 p -133.78 115.88 22.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 105.953 -1.869 . . . . 71.540000000000006 105.953 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.77 151.66 40.32 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.18 1.792 . . . . 75.400000000000006 106.881 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.23 151.57 36.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.178 0.991 . . . . 74.519999999999996 111.78 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -87.26 134.28 33.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.995 -1.483 . . . . 75.519999999999996 106.995 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.66 -59.35 4.75 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.796 -1.097 . . . . 72.450000000000003 111.909 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.06 -9.29 23.33 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 124.268 3.312 . . . . 75.329999999999998 116.227 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.4 m -118.24 -12.38 9.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.742 0.701 . . . . 73.340000000000003 112.124 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.07 14.56 18.25 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.64 1.114 . . . . 52.25 113.361 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.1 mt -67.02 131.16 32.82 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 N-CA-C 106.048 -1.834 . . . . 61.240000000000002 106.048 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.71 140.18 48.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.826 -1.176 . . . . 74.019999999999996 107.826 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.81 144.14 24.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.375 -0.972 . . . . 72.319999999999993 108.375 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.66 111.16 17.28 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 105.929 -1.878 . . . . 74.319999999999993 105.929 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 81.3 m -124.28 158.12 33.29 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.008 0.908 . . . . 73.420000000000002 111.394 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -155.43 145.43 21.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.451 1.9 . . . . 73.319999999999993 108.627 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -154.2 -35.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.843 -0.535 . . . . 74.349999999999994 109.651 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.6 p -138.91 -178.76 5.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.42 -0.955 . . . . 74.340000000000003 108.42 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -93.33 -5.77 48.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.595 -0.891 . . . . 74.329999999999998 108.595 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.0 m -79.79 114.99 19.13 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.951 1.7 . . . . 54.43 107.812 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.37 -38.33 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 121.958 -0.464 . . . . 63.509999999999998 110.173 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -62.35 -33.7 75.23 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.893 1.277 . . . . 73.239999999999995 110.73 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -76.86 -54.82 6.1 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.215 -1.032 . . . . 74.120000000000005 108.215 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -52.46 -36.03 53.86 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.668 -0.682 . . . . 73.340000000000003 110.125 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -57.84 -58.28 9.07 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 118.212 -0.899 . . . . 74.230000000000004 110.294 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.21 -32.94 74.71 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.935 1.243 . . . . 75.519999999999996 113.31 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.47 -50.93 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.235 -1.394 . . . . 75.239999999999995 107.235 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.07 75.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.459 -0.941 . . . . 60.240000000000002 108.459 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.34 -47.0 62.85 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.648 1.179 . . . . 74.420000000000002 111.582 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -45.58 82.45 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 117.423 -1.275 . . . . 75.510000000000005 111.75 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.35 -29.93 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 120.397 1.453 . . . . 73.030000000000001 110.738 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -44.17 96.9 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 107.898 -1.149 . . . . 71.430000000000007 107.898 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -54.95 -39.62 69.11 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.564 1.146 . . . . 75.019999999999996 110.913 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -67.39 -30.18 69.88 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.076 0.95 . . . . 72.439999999999998 110.312 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.13 -46.9 17.07 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.078 -1.014 . . . . 74.430000000000007 110.021 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.28 -30.38 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.454 -0.943 . . . . 74.030000000000001 108.454 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -57.86 -62.43 1.81 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.685 -1.598 . . . . 74.400000000000006 106.685 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.5 t -59.55 -29.53 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.649 0.779 . . . . 72.420000000000002 110.39 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -66.6 -34.6 78.24 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.276 1.398 . . . . 73.439999999999998 111.805 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -87.52 -31.16 20.08 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 109.068 -0.716 . . . . 73.120000000000005 109.068 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -80.89 -15.92 55.01 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.086 0.554 . . . . 73.150000000000006 110.853 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 m -155.17 101.34 2.23 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.433 1.493 . . . . 74.209999999999994 109.727 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -159.22 -170.06 23.32 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.016 -1.634 . . . . 74.540000000000006 109.016 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -77.16 13.11 1.6 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.062 3.175 . . . . 74.409999999999997 113.477 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.9 t -80.2 117.51 21.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 119.729 1.15 . . . . 74.510000000000005 109.491 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.4 m -82.87 83.47 7.75 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.295 -1.743 . . . . 72.010000000000005 106.295 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.832 0 N-CA-C 108.139 -1.984 . . . . 63.009999999999998 108.139 -179.553 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.192 0 N-CA-C 109.086 -1.606 . . . . 71.239999999999995 109.086 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.5 t -156.84 168.3 27.86 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.458 -1.682 . . . . 72.099999999999994 106.458 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -162.42 166.89 24.47 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.242 1.417 . . . . 65.409999999999997 108.258 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.2 135.26 1.86 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 107.684 -2.167 . . . . 74.200000000000003 107.684 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.7 m -146.49 163.22 36.42 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.707 1.203 . . . . 71.409999999999997 108.151 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.5 p -156.27 173.34 17.0 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.233 1.013 . . . . 64.510000000000005 108.349 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.09 175.03 39.96 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.689 -1.364 . . . . 74.409999999999997 109.689 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -156.66 113.57 3.1 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 106.037 -1.838 . . . . 73.319999999999993 106.037 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -56.73 -70.31 0.12 Allowed 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 124.023 0.929 . . . . 73.209999999999994 112.554 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.13 -176.59 37.69 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.203 -1.559 . . . . 71.120000000000005 109.203 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 mp -142.73 149.03 38.23 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.217 -1.772 . . . . 74.120000000000005 106.217 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -156.31 146.88 21.71 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.529 -1.286 . . . . 75.450000000000003 107.529 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.94 147.83 30.49 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 105.594 -2.002 . . . . 73.129999999999995 105.594 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.5 -172.45 2.45 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.188 2.595 . . . . 72.450000000000003 106.862 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 16' ' ' LYS . 8.0 tp10 -132.92 169.29 17.0 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 106.241 -1.763 . . . . 73.530000000000001 106.241 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.431 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -79.08 151.09 75.54 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 125.003 1.321 . . . . 74.409999999999997 108.927 -179.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.7 139.25 33.5 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.905 1.737 . . . . 71.430000000000007 108.482 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.15 156.93 38.13 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.144 -0.687 . . . . 60.439999999999998 109.144 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.9 mt -142.23 170.47 15.66 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.754 1.622 . . . . 74.319999999999993 107.744 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pp -139.68 167.96 20.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.62 1.568 . . . . 74.150000000000006 109.335 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -89.37 153.99 48.67 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 123.722 0.809 . . . . 75.010000000000005 109.087 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.77 163.81 33.0 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.722 2.281 . . . . 75.010000000000005 110.839 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.26 -176.36 34.54 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.822 -1.311 . . . . 75.510000000000005 109.822 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 53.9 ttm -121.02 145.47 47.73 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.638 -1.245 . . . . 75.129999999999995 107.638 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.26 68.6 1.04 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.72 -1.956 . . . . 51.310000000000002 105.72 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.4 172.91 7.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.9 -0.407 . . . . 74.120000000000005 109.9 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 t -154.77 177.09 11.65 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 122.194 -0.316 . . . . 74.219999999999999 110.476 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.8 m -138.1 173.65 11.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.725 2.41 . . . . 74.450000000000003 107.597 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.17 178.87 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.469 1.907 . . . . 65.420000000000002 109.09 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -71.0 142.12 50.97 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.388 -1.708 . . . . 74.5 106.388 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.77 177.45 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.467 0.651 . . . . 74.120000000000005 110.828 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 174.26 11.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.83 -0.623 . . . . 74.120000000000005 110.875 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.63 162.87 32.3 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 107.442 -2.263 . . . . 74.010000000000005 107.442 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -97.65 169.24 9.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.334 1.064 . . . . 73.450000000000003 111.839 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -144.97 19.93 1.61 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.858 2.463 . . . . 74.25 109.095 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -108.46 9.42 27.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.354 2.261 . . . . 64.219999999999999 113.014 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.32 -58.94 11.55 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-O 118.615 -0.707 . . . . 74.439999999999998 109.548 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.87 108.3 1.45 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.516 2.144 . . . . 64.340000000000003 110.408 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.0 164.24 24.36 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.442 1.097 . . . . 52.039999999999999 109.855 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.5 mt 48.38 52.45 13.51 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.509 2.324 . . . . 73.510000000000005 109.084 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp -56.12 149.66 34.52 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.494 1.918 . . . . 75.319999999999993 109.807 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.2 151.41 73.56 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.075 2.517 . . . . 63.240000000000002 113.931 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.0 mt -123.13 110.41 15.25 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.255 1.422 . . . . 73.019999999999996 108.046 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -79.62 101.97 8.64 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.122 1.369 . . . . 75.319999999999993 110.276 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.8 -29.88 42.48 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.487 0.921 . . . . 73.340000000000003 113.487 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.5 -22.83 60.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.14 0.427 . . . . 71.129999999999995 111.24 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -89.22 -21.84 23.05 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.568 1.147 . . . . 74.209999999999994 110.476 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.7 mt -84.16 176.62 8.66 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.756 0.822 . . . . 74.510000000000005 110.112 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.19 140.73 49.96 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.608 -1.627 . . . . 75.400000000000006 106.608 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -129.04 157.11 42.63 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.716 1.206 . . . . 75.519999999999996 109.679 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -137.3 118.71 14.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.799 -1.556 . . . . 72.109999999999999 106.799 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -74.45 163.16 28.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.808 -1.996 . . . . 72.030000000000001 109.8 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.7 t -129.74 126.21 62.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 107.697 -1.223 . . . . 74.099999999999994 107.697 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -127.19 -11.67 5.81 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.247 1.819 . . . . 72.439999999999998 111.029 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.32 149.87 7.29 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 126.573 2.035 . . . . 73.049999999999997 110.339 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -167.98 130.43 1.52 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.632 1.973 . . . . 75.299999999999997 106.21 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.44 168.1 31.78 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.773 -0.931 . . . . 62.350000000000001 110.773 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.82 -17.1 29.4 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.763 2.308 . . . . 74.420000000000002 113.957 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.7 -160.69 53.83 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 118.545 0.611 . . . . 74.329999999999998 112.478 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.4 -126.98 41.22 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.187 -1.565 . . . . 71.5 109.187 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -66.91 -17.18 64.78 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.753 0.649 . . . . 74.450000000000003 112.753 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.68 86.15 5.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 119.139 0.881 . . . . 71.010000000000005 109.21 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.3 p -69.51 86.66 0.45 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.125 0.97 . . . . 75.409999999999997 109.012 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.09 165.84 12.8 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.984 1.714 . . . . 73.319999999999993 110.777 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.38 81.29 2.01 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.871 -1.159 . . . . 71.5 107.871 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -78.72 152.34 31.61 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.088 -1.449 . . . . 72.010000000000005 107.088 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 p -157.52 167.15 31.01 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.058 -1.09 . . . . 73.329999999999998 108.058 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -74.54 44.82 0.22 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.834 1.653 . . . . 75.310000000000002 111.763 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.17 159.21 26.8 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.347 -0.846 . . . . 61.25 108.959 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.26 130.27 60.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.169 -2.16 . . . . 73.140000000000001 105.169 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 t -121.28 119.97 60.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.746 -1.205 . . . . 74.140000000000001 107.746 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.8 tp -118.78 142.31 47.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.217 -1.401 . . . . 74.319999999999993 107.217 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.17 152.3 45.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.69 -1.226 . . . . 71.319999999999993 107.69 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -100.3 116.62 32.7 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.03 -2.211 . . . . 71.129999999999995 105.03 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.82 -56.75 22.77 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 117.74 -1.124 . . . . 74.530000000000001 112.04 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -69.25 -10.4 28.87 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.468 2.112 . . . . 74.439999999999998 114.885 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 m -120.43 -11.92 9.05 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.843 1.053 . . . . 74.030000000000001 113.843 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.08 -4.02 3.68 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 127.69 2.566 . . . . 73.510000000000005 115.633 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.56 135.81 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 119.295 1.547 . . . . 75.219999999999999 108.748 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 t -123.35 148.19 27.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 126.258 1.823 . . . . 74.519999999999996 107.124 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 p -145.61 146.29 19.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 106.447 -1.686 . . . . 74.209999999999994 106.447 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -123.86 119.13 28.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.019 -1.104 . . . . 75.25 108.019 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 91.5 m -128.57 152.26 48.52 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.684 0.754 . . . . 72.530000000000001 111.094 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -155.68 100.64 2.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.177 2.191 . . . . 74.120000000000005 106.155 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -111.31 -41.53 4.12 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.328 -0.858 . . . . 65.109999999999999 110.779 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.3 t -140.76 179.11 6.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.446 1.099 . . . . 52.299999999999997 109.921 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.93 11.94 12.31 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.43 1.092 . . . . 70.109999999999999 109.902 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.9 m -107.23 115.54 30.34 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.992 -1.114 . . . . 75.019999999999996 107.992 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.7 -47.87 81.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.411 0.685 . . . . 74.140000000000001 109.314 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -49.69 -54.09 20.74 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.295 1.438 . . . . 61.240000000000002 112.406 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.49 -46.12 87.57 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.5 0.72 . . . . 75.540000000000006 109.618 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -56.91 -37.71 71.83 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.635 0.652 . . . . 75.439999999999998 111.108 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -57.91 -36.88 73.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.83 0.741 . . . . 74.439999999999998 109.531 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -55.85 25.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.496 0.589 . . . . 74.219999999999999 109.734 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.6 mp -52.67 -47.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.777 -0.453 . . . . 75.420000000000002 109.777 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.54 -50.96 71.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.932 0.893 . . . . 74.019999999999996 111.98 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -60.97 -43.83 98.2 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.799 -0.619 . . . . 75.5 110.26 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.06 -59.32 5.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.572 -0.899 . . . . 73.450000000000003 108.572 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 p -60.1 -35.07 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.819 0.736 . . . . 74.340000000000003 112.937 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -65.07 -42.89 93.76 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 119.011 0.823 . . . . 72.439999999999998 110.279 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -52.01 -42.25 62.88 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.643 1.577 . . . . 74.409999999999997 112.612 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.34 -43.16 78.79 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.621 0.724 . . . . 70.510000000000005 110.38 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -73.79 -41.17 62.77 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.176 1.79 . . . . 73.200000000000003 112.412 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.86 -34.11 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 118.146 -0.93 . . . . 72.140000000000001 110.585 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -54.7 -59.54 4.57 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.565 1.529 . . . . 72.420000000000002 106.928 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.29 -34.49 27.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.315 1.846 . . . . 72.420000000000002 110.291 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -66.26 -39.19 89.29 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.593 -0.692 . . . . 75.129999999999995 110.715 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -78.05 -38.63 44.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.585 0.63 . . . . 74.409999999999997 110.063 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -68.41 -58.76 3.86 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.318 1.047 . . . . 75.019999999999996 112.641 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 m -88.74 176.79 6.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.583 1.553 . . . . 71.040000000000006 114.017 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -118.7 172.09 14.38 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.351 1.453 . . . . 75.340000000000003 111.668 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.11 175.4 10.4 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.414 3.41 . . . . 74.439999999999998 111.272 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.3 m -83.45 -18.1 39.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.362 0.665 . . . . 64.340000000000003 111.767 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.9 m -147.84 166.74 26.68 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.601 0.76 . . . . 71.109999999999999 112.272 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 C-N-CA 127.004 2.24 . . . . 44.509999999999998 110.707 -179.543 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.14 0 N-CA-C 109.193 -1.563 . . . . 71.439999999999998 109.193 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -65.32 161.34 19.79 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.889 0.845 . . . . 74.329999999999998 110.191 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 t -71.22 -1.2 11.83 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.69 1.196 . . . . 62.409999999999997 112.377 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 63.59 -154.67 45.34 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 107.93 -2.068 . . . . 72.340000000000003 107.93 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -12.63 61.82 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 117.159 0.479 . . . . 73.0 111.153 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 46.19 43.0 10.73 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.634 1.573 . . . . 71.219999999999999 111.584 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.64 137.73 49.22 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.916 -0.874 . . . . 71.530000000000001 110.916 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -159.77 171.74 18.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.406 1.883 . . . . 75.439999999999998 107.1 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -132.6 179.12 6.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.237 1.015 . . . . 74.030000000000001 109.489 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.28 -178.65 37.93 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.312 -1.515 . . . . 71.400000000000006 109.312 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.06 165.62 21.51 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.895 0.855 . . . . 74.530000000000001 110.563 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.45 163.53 35.38 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.267 1.827 . . . . 75.239999999999995 108.734 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.72 168.8 16.58 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.859 1.663 . . . . 74.239999999999995 107.64 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.1 164.9 18.05 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.593 1.557 . . . . 74.340000000000003 107.698 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 16' ' ' LYS . 5.2 tp10 -93.13 177.93 5.9 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.955 0.902 . . . . 61.32 110.566 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.426 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -108.54 160.08 28.47 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 126.3 1.84 . . . . 74.209999999999994 111.188 -178.326 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -71.45 166.99 27.6 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.748 2.299 . . . . 71.150000000000006 109.73 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.69 175.93 5.99 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.907 1.283 . . . . 60.020000000000003 109.919 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.69 173.76 11.79 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.095 1.758 . . . . 74.409999999999997 109.544 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -134.2 174.88 10.02 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.339 1.856 . . . . 64.299999999999997 109.428 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -111.92 155.47 43.22 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.666 1.186 . . . . 70.099999999999994 109.76 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.78 171.34 18.38 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.977 2.451 . . . . 65.420000000000002 111.412 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.06 -176.2 47.8 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.814 -0.915 . . . . 62.32 110.814 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 50.3 ttp -133.17 156.53 47.32 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.197 1.399 . . . . 74.209999999999994 108.034 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.36 120.68 4.49 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 102.468 -3.16 . . . . 75.409999999999997 102.468 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.94 175.71 5.35 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.907 0.883 . . . . 71.430000000000007 109.251 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 t -74.07 152.58 39.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.934 0.874 . . . . 73.239999999999995 110.779 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 p -84.61 -162.61 0.7 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 129.787 3.235 . . . . 71.120000000000005 112.284 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.69 149.35 4.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 O-C-N 121.038 -1.039 . . . . 72.310000000000002 108.933 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -81.42 -168.0 1.69 Allowed 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.814 0.816 . . . . 74.129999999999995 109.226 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.72 155.47 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 125.675 1.59 . . . . 74.010000000000005 107.032 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.07 172.12 7.63 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.256 -0.903 . . . . 74.329999999999998 111.325 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.49 160.27 28.7 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.973 -1.251 . . . . 71.439999999999998 109.973 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -68.17 158.47 33.13 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.14 0.495 . . . . 74.109999999999999 110.371 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -147.47 167.99 23.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.193 2.197 . . . . 73.129999999999995 106.524 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.7 t70 46.96 54.7 8.87 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.593 1.957 . . . . 65.430000000000007 113.628 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -59.74 3.84 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 117.659 -1.162 . . . . 63.329999999999998 108.619 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.37 125.99 16.82 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.722 1.614 . . . . 75.049999999999997 109.452 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -140.88 157.49 45.3 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.588 1.555 . . . . 75.109999999999999 107.306 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.8 mt -75.98 101.61 5.3 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.272 -1.381 . . . . 55.25 107.272 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 pp -53.71 140.63 48.27 Favored Pre-proline 0 CA--C 1.541 0.63 0 O-C-N 123.827 0.704 . . . . 64.409999999999997 109.856 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.13 106.22 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.266 3.311 . . . . 73.519999999999996 115.868 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -80.8 149.91 29.41 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.785 -0.45 . . . . 73.409999999999997 109.785 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -103.81 106.7 17.29 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 106.959 -1.497 . . . . 74.040000000000006 106.959 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -60.15 -13.63 13.09 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 115.417 1.636 . . . . 73.430000000000007 115.417 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.9 m -95.99 -13.07 24.08 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.237 0.926 . . . . 70.329999999999998 111.394 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -93.99 3.16 55.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.002 2.121 . . . . 73.329999999999998 111.449 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mt -98.64 166.62 11.25 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.723 1.209 . . . . 63.329999999999998 109.784 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -133.99 98.02 4.04 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.677 1.191 . . . . 73.329999999999998 107.806 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.59 164.72 17.58 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.024 0.93 . . . . 72.239999999999995 112.727 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -132.35 124.87 29.61 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.955 -1.128 . . . . 74.439999999999998 107.955 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -88.22 101.01 13.42 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.757 -0.831 . . . . 74.230000000000004 108.757 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.45 157.51 2.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.252 -1.759 . . . . 73.120000000000005 106.252 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.6 pttm -164.88 130.49 2.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.352 -1.721 . . . . 74.120000000000005 106.352 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.13 -140.84 38.48 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.818 -0.913 . . . . 72.019999999999996 110.818 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -136.16 155.24 50.44 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.149 2.18 . . . . 73.319999999999993 106.317 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.94 172.49 53.03 Favored Glycine 0 CA--C 1.536 1.382 0 N-CA-C 110.246 -1.142 . . . . 65.530000000000001 110.246 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.6 80.87 2.22 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.565 2.843 . . . . 73.430000000000007 110.088 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -139.99 93.2 0.19 Allowed Glycine 0 C--N 1.332 0.336 0 N-CA-C 107.493 -2.243 . . . . 53.420000000000002 107.493 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.62 -155.56 45.26 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.154 -1.579 . . . . 62.299999999999997 109.154 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -137.44 135.5 36.94 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.222 -1.77 . . . . 64.329999999999998 106.222 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -157.78 175.58 13.7 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.921 1.288 . . . . 70.5 108.07 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 m -79.17 87.69 4.89 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.554 -1.276 . . . . 75.540000000000006 107.554 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -54.6 106.2 0.2 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.218 1.407 . . . . 74.430000000000007 109.706 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.1 mmtm -73.79 166.61 23.0 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.928 0.394 . . . . 71.230000000000004 110.139 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.9 t -118.73 13.94 13.35 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.281 1.432 . . . . 72.030000000000001 109.928 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.85 158.19 36.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.87 1.268 . . . . 72.109999999999999 108.201 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -83.46 155.83 23.21 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.325 -0.62 . . . . 71.209999999999994 109.325 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.5 p -155.48 111.52 3.12 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.231 0.612 . . . . 72.310000000000002 111.157 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.66 137.38 40.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 105.569 -2.012 . . . . 62.439999999999998 105.569 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.15 123.24 63.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.689 -1.967 . . . . 72.010000000000005 105.689 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.37 142.65 45.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.93 -1.137 . . . . 70.030000000000001 107.93 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -140.39 139.43 35.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.343 1.857 . . . . 74.439999999999998 110.575 -178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -103.07 124.08 47.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.026 -1.842 . . . . 75.030000000000001 106.026 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.58 -63.13 4.01 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 117.854 -1.07 . . . . 71.109999999999999 112.024 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.49 -11.62 32.8 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.909 2.406 . . . . 71.430000000000007 115.785 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -111.88 -13.51 13.65 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.091 0.86 . . . . 62.43 111.224 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.79 0.62 4.11 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.14 1.829 . . . . 52.119999999999997 115.616 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.7 mt -69.16 143.32 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 119.39 1.595 . . . . 74.409999999999997 109.376 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 t -136.56 136.94 48.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.229 -1.397 . . . . 63.329999999999998 107.229 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.07 147.74 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 121.543 -0.723 . . . . 75.209999999999994 109.259 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -129.64 107.52 9.51 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.431 1.092 . . . . 73.140000000000001 110.289 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 56.7 m -120.44 152.16 38.35 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.782 0.833 . . . . 62.149999999999999 109.86 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.69 100.41 2.08 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.79 1.236 . . . . 71.329999999999998 107.845 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -119.63 -14.04 9.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.359 0.664 . . . . 73.140000000000001 112.778 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.6 p -133.83 -176.83 4.3 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.18 0.992 . . . . 73.310000000000002 110.301 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -109.95 19.45 19.03 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.233 1.013 . . . . 75.049999999999997 112.644 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 t -125.63 132.02 52.55 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.44 1.096 . . . . 72.340000000000003 108.111 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.4 p -58.86 -47.25 90.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 N-CA-C 108.691 -0.855 . . . . 72.340000000000003 108.691 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -63.17 -25.87 68.54 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.892 1.071 . . . . 74.420000000000002 113.892 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -84.48 -44.73 13.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.033 -1.469 . . . . 71.319999999999993 107.033 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -64.34 -27.2 68.86 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.383 -0.823 . . . . 75.25 109.156 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -62.71 -58.3 7.95 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 126.351 1.86 . . . . 75.400000000000006 108.607 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -56.29 -37.21 69.55 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.141 0.428 . . . . 74.120000000000005 111.681 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 79.0 mt -63.9 -50.65 76.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.74 -0.837 . . . . 74.040000000000006 108.74 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.08 97.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.096 -0.478 . . . . 75.450000000000003 110.361 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -61.33 -49.14 78.17 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 118.699 0.681 . . . . 72.120000000000005 109.305 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -56.13 24.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.778 0.831 . . . . 74.340000000000003 110.452 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.36 -35.43 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 119.074 0.852 . . . . 64.430000000000007 111.544 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.1 tp -64.27 -41.19 97.04 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 121.187 -0.945 . . . . 72.349999999999994 109.15 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -58.3 -43.22 87.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.184 0.994 . . . . 72.319999999999993 109.672 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -60.81 -27.42 68.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.545 0.738 . . . . 74.209999999999994 111.234 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -88.09 -45.58 10.03 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.169 1.388 . . . . 74.219999999999999 111.84 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.6 t -63.35 -35.37 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 107.567 -1.272 . . . . 64.239999999999995 107.567 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.65 -64.23 0.9 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.71 1.204 . . . . 71.340000000000003 109.383 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.5 p -59.56 -30.53 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.518 -0.739 . . . . 71.109999999999999 111.727 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -68.87 -35.07 76.47 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.852 1.206 . . . . 63.520000000000003 111.203 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -83.08 -32.14 26.94 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.355 1.062 . . . . 74.340000000000003 109.869 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -77.11 -46.37 23.76 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.567 0.747 . . . . 72.239999999999995 110.281 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 t -76.12 174.14 10.43 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.641 0.776 . . . . 72.049999999999997 109.221 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.24 -105.34 2.81 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.369 -1.492 . . . . 74.329999999999998 109.369 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.54 116.25 4.64 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.142 1.895 . . . . 71.340000000000003 110.051 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 78.2 p -142.77 113.62 7.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.104 -1.813 . . . . 71.219999999999999 106.104 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.5 p -61.31 143.25 56.02 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 121.185 -0.947 . . . . 74.230000000000004 111.05 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.3 0 N-CA-C 109.8 -1.32 . . . . 74.019999999999996 109.8 179.544 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.386 0 N-CA-C 106.814 -2.514 . . . . 63.409999999999997 106.814 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t 53.14 42.04 32.16 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.5 1.65 . . . . 65.420000000000002 107.684 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 p -139.46 148.75 43.15 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.662 1.985 . . . . 72.230000000000004 108.725 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.17 -177.82 33.61 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 108.15 -1.98 . . . . 73.219999999999999 108.15 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.6 t -153.63 173.02 16.33 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.02 -1.104 . . . . 72.519999999999996 108.02 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.9 p -160.77 176.81 11.08 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.29 1.436 . . . . 74.25 108.573 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.01 167.97 40.62 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.618 -1.793 . . . . 72.420000000000002 108.618 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -158.52 168.83 25.88 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 117.966 0.883 . . . . 73.120000000000005 109.79 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -133.42 -159.74 0.99 Allowed 'General case' 0 C--O 1.243 0.741 0 C-N-CA 126.426 1.891 . . . . 74.239999999999995 106.409 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.68 -80.21 0.28 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 124.714 1.149 . . . . 72.120000000000005 111.436 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.9 mt 56.59 179.71 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.733 2.413 . . . . 74.340000000000003 111.63 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -159.31 118.08 2.89 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.612 -1.305 . . . . 74.310000000000002 108.338 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.413 ' C ' HE21 ' A' ' 14' ' ' GLN . 4.4 mm? -99.5 151.71 20.83 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 106.15 -1.796 . . . . 74.209999999999994 106.15 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.413 HE21 ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -159.04 133.67 8.0 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.046 0.927 . . . . 74.549999999999997 111.032 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' N ' ' CD ' ' A' ' 15' ' ' GLU . 12.9 mp0 -88.72 -175.63 4.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 128.724 2.81 . . . . 74.400000000000006 110.315 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -143.23 156.8 61.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 126.23 1.812 . . . . 74.120000000000005 109.506 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.18 175.23 11.2 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.747 2.298 . . . . 74.439999999999998 109.051 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -125.2 -174.74 3.13 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.164 1.385 . . . . 63.25 108.552 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.23 175.91 8.08 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.143 1.377 . . . . 73.120000000000005 108.557 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.64 176.05 7.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.014 1.726 . . . . 73.409999999999997 109.633 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -109.97 153.9 42.92 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.129 1.372 . . . . 74.400000000000006 109.497 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.61 168.64 23.31 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.805 2.337 . . . . 75.329999999999998 111.765 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.76 -172.33 39.27 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 109.866 -1.294 . . . . 64.239999999999995 109.866 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.2 mmt -125.44 158.9 33.25 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.65 1.18 . . . . 70.549999999999997 108.467 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.32 68.19 1.19 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.348 -1.352 . . . . 75.540000000000006 107.348 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.65 172.12 11.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.931 -0.577 . . . . 73.120000000000005 110.053 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.7 t -131.62 -173.23 3.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.844 0.858 . . . . 75.120000000000005 111.167 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.4 t -130.66 163.0 28.16 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.235 1.414 . . . . 64.540000000000006 109.632 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.0 m -67.6 -173.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.011 1.725 . . . . 75.010000000000005 112.293 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -132.45 176.87 8.05 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.423 1.889 . . . . 73.219999999999999 108.9 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.2 173.18 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 124.2 1.0 . . . . 74.349999999999994 110.57 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.84 162.86 28.27 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.773 -0.649 . . . . 75.439999999999998 111.569 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.85 141.07 15.36 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 106.069 -2.813 . . . . 43.509999999999998 106.069 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -140.02 172.82 12.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 118.365 1.082 . . . . 71.420000000000002 109.612 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -157.86 168.97 25.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.236 1.415 . . . . 73.420000000000002 107.297 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 40.27 65.71 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 127.464 2.306 . . . . 74.430000000000007 113.633 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.03 -59.79 2.64 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 114.048 -1.433 . . . . 74.140000000000001 111.157 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.98 157.32 42.91 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.091 1.861 . . . . 70.040000000000006 115.548 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.16 177.08 3.43 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.508 1.523 . . . . 62.219999999999999 109.424 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.6 mt 58.45 49.08 11.23 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 128.821 2.849 . . . . 71.349999999999994 108.918 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -48.83 145.05 6.61 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.545 1.538 . . . . 75.310000000000002 111.212 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.51 159.0 55.26 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.452 2.768 . . . . 74.010000000000005 111.692 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 mt -136.91 122.34 19.5 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 123.189 0.595 . . . . 75.430000000000007 109.804 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -67.71 101.79 1.1 Allowed 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 106.839 -1.541 . . . . 73.439999999999998 106.839 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -57.34 -31.69 65.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.81 0.844 . . . . 73.409999999999997 112.361 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.2 m -77.56 -6.28 53.1 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.739 0.816 . . . . 62.240000000000002 112.686 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -99.83 7.11 45.22 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.235 1.414 . . . . 74.340000000000003 110.334 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mt -110.57 164.59 12.57 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.599 1.16 . . . . 75.340000000000003 110.456 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -120.96 137.73 54.48 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.167 -2.161 . . . . 70.200000000000003 105.167 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -123.78 155.19 38.39 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.818 1.647 . . . . 73.099999999999994 110.725 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -129.87 178.7 6.33 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.206 1.002 . . . . 74.349999999999994 108.829 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -135.43 163.5 29.9 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.476 1.91 . . . . 75.019999999999996 107.619 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.4 t -114.59 133.5 60.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 104.096 -2.557 . . . . 72.319999999999993 104.096 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -138.54 152.98 48.69 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.842 -1.17 . . . . 74.209999999999994 107.842 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 90.77 -175.38 40.23 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.414 -1.475 . . . . 74.049999999999997 109.414 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -143.18 124.29 14.47 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 102.704 -3.073 . . . . 73.129999999999995 102.704 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.66 -176.06 31.31 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 118.588 0.631 . . . . 63.439999999999998 111.624 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.77 175.97 4.83 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.297 2.665 . . . . 71.209999999999994 111.715 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.23 -63.82 4.37 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 107.634 -2.186 . . . . 62.329999999999998 107.634 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.22 -3.95 40.79 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-N 117.363 0.582 . . . . 44.109999999999999 112.201 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -60.05 -10.4 4.22 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.083 2.553 . . . . 60.240000000000002 113.163 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.71 -23.9 3.01 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.436 1.494 . . . . 74.010000000000005 114.734 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 t -153.57 146.35 24.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 119.813 1.188 . . . . 71.510000000000005 108.811 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.1 41.25 0.51 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.832 1.253 . . . . 61.140000000000001 109.373 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -141.73 -6.2 1.01 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.613 1.565 . . . . 74.219999999999999 112.485 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -55.62 100.47 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.618 1.567 . . . . 72.219999999999999 110.863 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 t -159.32 163.83 35.34 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.213 1.805 . . . . 74.140000000000001 106.48 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 51.26 21.66 1.18 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.245 1.418 . . . . 73.549999999999997 112.791 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.9 m -64.25 144.61 57.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.031 1.333 . . . . 70.099999999999994 109.679 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.4 162.48 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 121.897 0.856 . . . . 75.030000000000001 109.96 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -141.34 156.26 21.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 126.996 2.118 . . . . 64.129999999999995 107.549 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.45 150.04 40.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.704 -1.961 . . . . 74.519999999999996 105.704 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.89 158.17 43.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.665 0.786 . . . . 72.340000000000003 109.337 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -107.34 126.38 52.38 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 104.828 -2.286 . . . . 75.510000000000005 104.828 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.1 t -68.28 -58.03 8.05 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 120.051 1.296 . . . . 73.25 111.593 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.09 -12.55 35.26 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.423 2.082 . . . . 73.439999999999998 115.628 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -112.4 -21.18 11.5 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.954 0.797 . . . . 70.040000000000006 109.719 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.39 -9.25 7.86 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.606 2.526 . . . . 74.510000000000005 113.686 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.7 mt -55.41 147.49 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.1 1.76 . . . . 72.109999999999999 109.918 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.2 t -134.35 146.94 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.468 1.507 . . . . 73.129999999999995 108.045 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -144.97 139.54 22.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.225 1.01 . . . . 70.430000000000007 108.896 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -110.64 127.89 55.46 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.156 1.382 . . . . 75.400000000000006 108.706 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.7 m -150.54 149.39 29.88 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.54 0.686 . . . . 73.430000000000007 112.799 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -155.23 139.72 16.85 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 129.584 3.154 . . . . 74.049999999999997 105.073 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -152.82 -68.97 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.719 -1.215 . . . . 70.319999999999993 107.719 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.0 p -77.93 151.66 33.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.564 1.146 . . . . 72.319999999999993 111.129 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -66.75 -25.83 66.69 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.83 0.678 . . . . 64.230000000000004 112.83 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 m -79.64 116.23 19.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.51 0.595 . . . . 75.010000000000005 109.845 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.8 p -54.07 -42.6 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.757 -0.831 . . . . 74.109999999999999 108.757 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.93 -44.42 78.35 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.132 0.973 . . . . 74.340000000000003 111.745 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -67.16 -39.55 86.51 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.043 -1.095 . . . . 73.439999999999998 108.043 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -60.86 -29.06 69.3 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.634 -0.698 . . . . 72.099999999999994 109.612 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -58.17 -40.91 82.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.801 1.182 . . . . 75.200000000000003 108.754 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -71.56 -46.51 59.23 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 125.098 1.359 . . . . 72.140000000000001 110.382 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 99.4 mt -56.97 -52.8 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.462 0.705 . . . . 72.319999999999993 111.277 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.5 -28.08 69.58 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.73 -0.606 . . . . 75.099999999999994 111.426 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -72.94 -45.76 56.28 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 118.554 -0.736 . . . . 74.439999999999998 109.883 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -64.82 -35.85 82.43 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.941 1.246 . . . . 74.200000000000003 111.101 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.3 p -71.79 -32.99 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 120.041 1.291 . . . . 74.230000000000004 108.375 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.4 tp -64.87 -32.77 74.64 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.602 -1.258 . . . . 64.040000000000006 107.602 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -55.75 -41.43 73.96 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.216 -0.661 . . . . 71.219999999999999 109.216 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -63.51 -39.58 94.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.733 0.697 . . . . 73.219999999999999 110.886 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -63.24 -48.19 79.27 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.773 0.829 . . . . 74.019999999999996 110.518 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 50.1 t -69.28 -41.01 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.872 0.869 . . . . 75.109999999999999 110.207 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.48 -62.01 1.89 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.183 1.393 . . . . 74.150000000000006 109.681 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.75 -22.44 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.027 0.931 . . . . 75.409999999999997 112.248 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -75.37 -27.2 59.04 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.771 -1.206 . . . . 74.450000000000003 111.293 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -98.94 -30.73 12.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.346 0.975 . . . . 74.540000000000006 109.655 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -75.89 -6.4 50.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.292 0.637 . . . . 71.219999999999999 110.597 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.02 174.0 11.1 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.795 1.638 . . . . 73.420000000000002 110.145 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -75.98 165.13 54.04 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.954 -1.259 . . . . 63.340000000000003 109.954 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.96 137.72 19.98 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.263 1.975 . . . . 75.329999999999998 107.268 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.4 p -143.07 176.96 8.7 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.21 -1.033 . . . . 73.349999999999994 108.21 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.5 175.59 5.49 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.523 1.129 . . . . 70.340000000000003 110.11 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 116.238 -2.423 . . . . 70.310000000000002 108.517 -179.82 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.036 0 N-CA-C 109.218 -1.553 . . . . 71.230000000000004 109.218 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -155.73 175.19 14.25 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.13 1.372 . . . . 72.109999999999999 107.499 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.1 m -155.23 173.66 16.3 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.593 1.557 . . . . 73.150000000000006 107.33 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.73 -179.41 47.86 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.157 -1.577 . . . . 74.409999999999997 109.157 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.2 p -150.73 179.27 8.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.069 1.347 . . . . 75.209999999999994 108.34 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.1 m -160.19 168.73 24.77 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.048 1.339 . . . . 75.310000000000002 108.363 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.22 137.61 8.72 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 107.379 -2.289 . . . . 55.329999999999998 107.379 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -81.16 79.57 7.79 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 117.805 0.802 . . . . 74.129999999999995 109.203 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -72.08 170.52 13.74 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.571 0.749 . . . . 74.349999999999994 110.091 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.58 140.88 2.98 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.874 -1.29 . . . . 70.099999999999994 109.874 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.7 mp -143.1 170.2 16.16 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.799 1.64 . . . . 74.140000000000001 107.441 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.63 159.61 43.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.273 1.429 . . . . 74.049999999999997 107.146 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -129.67 160.54 33.05 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.375 1.07 . . . . 74.329999999999998 108.363 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.01 164.04 4.09 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.06 2.544 . . . . 71.530000000000001 106.543 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.81 179.48 7.06 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.487 1.115 . . . . 74.310000000000002 108.149 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.42 155.41 44.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.61 1.164 . . . . 74.230000000000004 109.823 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.48 148.62 60.77 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.066 1.844 . . . . 74.25 109.013 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.81 161.47 29.55 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.701 -0.481 . . . . 72.340000000000003 109.701 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.6 mt -142.66 174.48 10.61 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.924 1.689 . . . . 73.409999999999997 108.113 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -114.83 177.33 4.69 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.599 1.559 . . . . 54.43 109.822 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -121.58 154.68 59.93 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.483 1.513 . . . . 75.099999999999994 109.411 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.54 169.65 22.06 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.745 2.297 . . . . 65.519999999999996 111.094 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.33 175.46 20.68 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.645 -1.382 . . . . 72.5 109.645 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.1 ttt -143.7 144.65 31.94 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.726 -1.212 . . . . 74.439999999999998 107.726 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.07 80.34 0.99 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.569 -1.641 . . . . 63.200000000000003 106.569 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.06 160.85 21.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.141 0.577 . . . . 75.400000000000006 110.807 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -103.31 -168.0 1.45 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.555 1.542 . . . . 74.430000000000007 108.29 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.3 p -124.37 -177.26 3.74 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.447 1.499 . . . . 65.239999999999995 109.977 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.72 157.96 41.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 125.203 1.401 . . . . 73.430000000000007 108.332 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.95 163.48 15.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.605 0.762 . . . . 61.109999999999999 110.987 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.0 -179.57 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.701 1.2 . . . . 72.310000000000002 108.788 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.06 161.22 20.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.956 1.302 . . . . 74.439999999999998 109.003 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.66 166.47 54.83 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.003 -1.239 . . . . 73.129999999999995 110.003 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -123.67 162.34 23.26 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.765 1.226 . . . . 74.200000000000003 110.067 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -161.77 176.93 10.38 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.667 1.187 . . . . 75.329999999999998 108.404 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t70 71.02 -53.72 0.67 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 127.276 2.23 . . . . 74.400000000000006 111.226 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -59.87 12.41 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.476 1.51 . . . . 75.420000000000002 109.107 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.66 111.73 2.87 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.268 1.979 . . . . 75.129999999999995 110.595 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.26 164.61 30.25 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.369 1.468 . . . . 74.439999999999998 108.641 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.5 mt 44.07 50.32 7.37 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.158 1.783 . . . . 75.099999999999994 111.393 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp -53.97 152.46 10.44 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.383 1.473 . . . . 73.450000000000003 114.042 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.04 154.6 33.23 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.907 2.405 . . . . 73.329999999999998 109.784 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.8 mt -134.35 136.81 43.67 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.717 0.807 . . . . 72.030000000000001 110.255 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.92 107.59 1.9 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.083 1.353 . . . . 72.340000000000003 108.668 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.58 -19.25 57.05 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.56 0.578 . . . . 72.25 112.56 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.9 m -85.27 -1.91 57.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.497 1.044 . . . . 63.420000000000002 112.033 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -114.63 -4.97 12.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.925 1.239 . . . . 74.549999999999997 112.585 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mt -86.33 140.99 29.55 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.911 -1.885 . . . . 71.400000000000006 105.911 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -109.0 126.11 52.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.779 0.718 . . . . 74.129999999999995 109.416 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.57 164.49 12.48 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.325 1.05 . . . . 73.540000000000006 112.613 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -141.61 143.86 33.9 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.31 -1.737 . . . . 73.340000000000003 106.31 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -103.83 123.39 47.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.085 -1.821 . . . . 73.230000000000004 106.085 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.1 t -88.0 106.44 16.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.05 -1.833 . . . . 74.129999999999995 106.05 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -70.84 31.84 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.509 2.323 . . . . 74.439999999999998 113.372 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.56 -99.76 1.88 Allowed Glycine 0 CA--C 1.523 0.551 0 O-C-N 120.263 -1.523 . . . . 75.299999999999997 110.551 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 50.29 8.37 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.124 2.57 . . . . 74.530000000000001 117.296 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.24 141.14 45.82 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 120.705 1.593 . . . . 75.420000000000002 111.486 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -64.81 162.01 33.74 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.478 2.786 . . . . 75.129999999999995 111.928 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.97 58.16 5.38 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.563 -1.815 . . . . 65.329999999999998 108.563 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.58 -178.55 48.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 107.28 -2.328 . . . . 62.350000000000001 107.28 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -122.06 -52.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.627 1.171 . . . . 73.340000000000003 108.058 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.74 -104.37 0.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.781 0.832 . . . . 72.019999999999996 109.09 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -16.1 2.01 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.696 2.399 . . . . 75.400000000000006 114.36 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -55.97 -26.65 49.13 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.228 1.411 . . . . 73.439999999999998 112.247 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -127.43 54.86 1.64 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 119.095 0.861 . . . . 73.230000000000004 110.592 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.8 m -77.96 72.75 4.51 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.423 -0.954 . . . . 65.219999999999999 108.423 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.9 t -84.23 -176.23 6.16 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.109 -1.441 . . . . 65.129999999999995 107.109 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.448 HD22 ' HB ' ' A' ' 89' ' ' VAL . 22.2 t-20 -152.63 124.08 7.71 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.97 -1.122 . . . . 54.450000000000003 107.97 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.8 m -150.49 152.38 34.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.024 -1.473 . . . . 60.399999999999999 107.024 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.4 124.15 70.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.051 -2.203 . . . . 72.310000000000002 105.051 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.96 96.21 4.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.817 -2.29 . . . . 73.349999999999994 104.817 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.9 tp -91.86 139.54 30.56 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.203 -1.777 . . . . 73.310000000000002 106.203 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.25 141.15 45.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.76 1.224 . . . . 74.420000000000002 110.56 -177.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -95.79 133.29 40.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.856 -1.535 . . . . 63.009999999999998 106.856 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.7 t -70.73 -66.5 0.78 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.307 1.043 . . . . 75.420000000000002 111.438 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.41 -7.63 21.24 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.858 3.038 . . . . 71.230000000000004 116.177 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 t -114.54 -20.43 10.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.524 0.602 . . . . 70.430000000000007 110.91 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.54 -3.97 4.34 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.604 -1.109 . . . . 64.420000000000002 114.807 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.99 139.52 20.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.261 -1.385 . . . . 73.129999999999995 107.261 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.64 147.93 33.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.223 -1.399 . . . . 63.119999999999997 107.223 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.12 140.82 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.986 -1.487 . . . . 65.030000000000001 106.986 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.68 107.79 13.66 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 106.515 -1.661 . . . . 72.340000000000003 106.515 -178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 77.3 m -112.04 134.86 53.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 123.555 0.534 . . . . 74.430000000000007 110.567 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -147.28 109.87 4.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.66 2.384 . . . . 74.340000000000003 106.517 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -135.45 -20.71 1.59 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.49 1.116 . . . . 75.510000000000005 111.264 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.79 173.43 16.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.599 1.16 . . . . 73.409999999999997 107.914 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -86.63 -4.97 59.25 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.961 -1.087 . . . . 75.099999999999994 109.819 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.5 m -82.15 115.0 21.06 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.324 -1.362 . . . . 61.420000000000002 107.324 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.448 ' HB ' HD22 ' A' ' 68' ' ' ASN . 13.9 p -61.19 -38.7 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.796 -0.816 . . . . 73.420000000000002 108.796 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 93' ' ' ARG . 9.9 m-20 -63.42 -23.05 67.24 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 113.859 1.059 . . . . 73.219999999999999 113.859 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -87.71 -46.84 9.14 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.321 -0.992 . . . . 75.209999999999994 108.321 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.11 -43.7 91.93 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.746 0.818 . . . . 62.149999999999999 110.945 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.414 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 4.0 ptm180 -57.74 -46.42 84.48 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 113.06 0.763 . . . . 74.109999999999999 113.06 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -64.41 -36.76 85.2 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 119.541 -0.863 . . . . 74.120000000000005 111.717 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.2 mt -60.89 -49.92 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.112 -1.44 . . . . 63.25 107.112 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.43 68.11 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.476 0.71 . . . . 41.25 111.684 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.9 ttm-85 -61.18 -53.78 52.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.11 0.414 . . . . 75.340000000000003 110.959 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -61.97 -39.8 93.43 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.68 -0.676 . . . . 75.310000000000002 112.409 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.19 -27.15 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 120.482 1.492 . . . . 74.319999999999993 109.495 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.9 tp -65.62 -47.48 75.48 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 120.329 -1.482 . . . . 74.25 107.445 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -56.91 -39.23 74.05 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.678 -1.153 . . . . 72.239999999999995 111.891 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.17 -50.2 74.93 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.775 1.17 . . . . 65.549999999999997 110.303 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -68.17 -44.6 75.58 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.844 -0.616 . . . . 75.209999999999994 112.084 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.6 t -62.91 -37.98 80.68 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-O 118.648 -0.692 . . . . 74.519999999999996 109.789 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -56.2 -52.23 65.18 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-N 119.354 0.979 . . . . 74.439999999999998 110.382 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.96 -18.15 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 121.647 -0.658 . . . . 73.329999999999998 112.434 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -87.48 -19.68 27.63 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.621 1.568 . . . . 74.200000000000003 110.224 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.26 -46.69 5.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.75 2.02 . . . . 74.510000000000005 110.928 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -77.07 -25.95 52.95 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.703 0.683 . . . . 65.420000000000002 111.937 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.1 m -145.19 -172.75 3.93 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.895 2.478 . . . . 75.430000000000007 106.631 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.61 172.01 44.31 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 120.983 -1.073 . . . . 72.219999999999999 111.627 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.59 -38.03 8.74 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.381 2.721 . . . . 75.209999999999994 108.983 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.2 m -72.21 175.74 5.81 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.455 1.502 . . . . 74.420000000000002 109.377 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.2 t -162.1 130.02 4.03 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.736 -1.95 . . . . 62.119999999999997 105.736 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.044 -1.42 . . . . 64.209999999999994 109.961 -179.533 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.195 0 N-CA-C 109.296 -1.522 . . . . 74.409999999999997 109.296 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 p -149.89 164.84 34.32 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.81 1.644 . . . . 61.530000000000001 106.823 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 m -144.78 165.17 28.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.735 1.214 . . . . 72.200000000000003 108.501 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.63 160.84 26.34 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.279 -1.928 . . . . 34.399999999999999 108.279 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.8 t -170.46 167.37 8.21 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.964 1.706 . . . . 64.310000000000002 106.838 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 p -163.87 149.91 11.29 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.024 0.93 . . . . 75.150000000000006 108.725 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.44 156.34 26.69 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 108.82 -1.712 . . . . 74.109999999999999 108.82 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -154.8 120.39 5.1 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 106.424 -1.695 . . . . 74.019999999999996 106.424 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 67.2 p-90 -140.3 -176.3 4.57 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.496 1.119 . . . . 73.239999999999995 108.946 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.81 160.17 31.02 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.516 -1.434 . . . . 52.5 109.516 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.2 mt -127.47 176.76 7.22 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.467 1.507 . . . . 71.430000000000007 109.76 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.95 166.19 33.22 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 127.335 2.254 . . . . 75.439999999999998 107.417 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.35 167.7 27.1 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.0 2.12 . . . . 62.409999999999997 106.428 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.77 142.25 31.87 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.625 -1.25 . . . . 72.099999999999994 107.625 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.96 -175.82 3.8 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.695 1.598 . . . . 74.200000000000003 108.706 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -135.98 139.66 31.01 Favored Pre-proline 0 N--CA 1.455 -0.203 0 C-N-CA 124.303 1.041 . . . . 73.219999999999999 109.242 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.77 173.49 13.36 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.119 3.213 . . . . 62.020000000000003 111.371 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.11 176.11 4.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.039 0.936 . . . . 74.519999999999996 110.656 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.57 173.89 7.78 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.54 1.536 . . . . 73.299999999999997 108.615 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.81 175.32 9.45 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.288 1.835 . . . . 74.439999999999998 109.306 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -118.43 156.53 50.95 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 125.423 1.489 . . . . 74.409999999999997 108.712 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.81 166.34 29.95 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.431 2.087 . . . . 75.310000000000002 111.491 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.12 -175.92 50.98 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.241 -1.143 . . . . 63.229999999999997 110.241 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 60.7 mtt -122.84 168.26 12.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.962 0.905 . . . . 70.120000000000005 110.04 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.16 132.16 9.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 102.063 -3.31 . . . . 73.439999999999998 102.063 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -130.08 177.44 7.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.594 -1.262 . . . . 53.229999999999997 107.594 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.27 176.33 5.34 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.574 -0.704 . . . . 73.510000000000005 110.189 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -124.58 170.88 10.48 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.466 1.107 . . . . 73.439999999999998 108.865 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.74 -175.26 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.6 1.16 . . . . 73.219999999999999 109.996 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -132.52 173.65 11.1 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.22 1.008 . . . . 74.310000000000002 109.53 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.0 149.35 10.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 124.153 0.981 . . . . 75.049999999999997 109.357 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.13 173.54 7.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.37 1.068 . . . . 73.420000000000002 111.518 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.18 176.17 16.25 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 107.873 -2.091 . . . . 73.219999999999999 107.873 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.3 mmp_? -131.25 177.55 7.38 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.182 -1.187 . . . . 74.140000000000001 111.639 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -150.7 179.43 8.2 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 129.404 3.082 . . . . 74.299999999999997 105.527 177.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.09 24.15 14.34 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.929 1.455 . . . . 74.239999999999995 114.929 177.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.78 -63.24 2.44 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.467 0.914 . . . . 74.510000000000005 113.467 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -67.67 101.95 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.707 2.271 . . . . 60.409999999999997 109.959 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -143.25 -166.4 2.3 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.509 1.124 . . . . 73.140000000000001 109.534 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.7 mt -137.33 90.32 2.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.988 2.115 . . . . 72.140000000000001 109.065 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 pp -63.43 153.77 81.38 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 126.69 1.996 . . . . 74.439999999999998 113.056 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.11 112.59 2.84 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.19 2.594 . . . . 64.430000000000007 112.042 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mt -91.29 140.95 29.29 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.638 -0.664 . . . . 73.239999999999995 110.849 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -89.53 106.35 18.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.642 -1.984 . . . . 73.310000000000002 105.642 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -60.04 -11.49 6.01 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 114.879 1.437 . . . . 73.540000000000006 114.879 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.4 m -101.15 -3.44 29.15 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.208 1.003 . . . . 71.310000000000002 111.595 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -96.59 -8.83 30.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.433 1.093 . . . . 71.109999999999999 110.556 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.06 175.26 6.93 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.347 1.459 . . . . 74.230000000000004 109.709 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -130.1 122.65 28.7 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.39 0.676 . . . . 75.010000000000005 109.825 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -105.26 160.09 15.37 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.275 1.03 . . . . 73.200000000000003 111.182 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -142.05 131.17 23.29 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.139 1.376 . . . . 75.530000000000001 108.896 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -88.41 163.04 16.18 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.665 1.186 . . . . 65.420000000000002 107.933 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.6 t -133.86 125.57 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.285 1.034 . . . . 70.340000000000003 108.865 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -119.49 -45.92 2.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.653 1.581 . . . . 74.150000000000006 108.97 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.44 79.98 0.05 OUTLIER Glycine 0 C--N 1.335 0.5 0 N-CA-C 108.888 -1.685 . . . . 64.010000000000005 108.888 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -77.18 109.28 10.92 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.363 -0.977 . . . . 72.549999999999997 108.363 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.75 -163.36 10.06 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 123.22 0.325 . . . . 64.239999999999995 112.507 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.68 13.57 0.94 Allowed 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.91 3.073 . . . . 64.040000000000006 112.578 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.37 -61.23 4.74 Favored Glycine 0 C--N 1.339 0.745 0 O-C-N 120.828 -1.17 . . . . 63.409999999999997 110.205 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.88 -175.01 16.23 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.223 1.392 . . . . 64.409999999999997 110.587 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -75.11 74.67 2.28 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.025 0.93 . . . . 74.530000000000001 108.962 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -146.22 166.96 24.69 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.472 1.509 . . . . 62.020000000000003 108.934 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.3 p -110.44 -1.98 16.79 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.243 1.017 . . . . 74.120000000000005 112.287 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -73.7 176.89 5.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.36 1.464 . . . . 71.120000000000005 111.031 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.28 96.55 3.4 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 105.044 -2.206 . . . . 75.0 105.044 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 p -68.92 9.01 0.44 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.387 2.275 . . . . 71.129999999999995 115.332 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 m -53.99 -17.89 3.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.75 2.02 . . . . 75.329999999999998 115.902 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -140.88 52.71 1.6 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.332 1.423 . . . . 64.239999999999995 111.185 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.2 m -99.51 158.39 15.77 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.401 0.68 . . . . 71.530000000000001 109.299 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.4 t -140.74 135.83 34.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.925 1.69 . . . . 74.430000000000007 106.583 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.28 142.27 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.201 -1.407 . . . . 75.409999999999997 107.201 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.4 tp -131.57 146.74 52.36 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.697 1.199 . . . . 75.299999999999997 107.976 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.56 148.59 49.15 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.476 0.655 . . . . 75.129999999999995 110.15 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -93.92 118.67 31.8 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 104.243 -2.503 . . . . 71.439999999999998 104.243 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.19 -61.53 7.66 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 118.531 -0.747 . . . . 74.340000000000003 112.077 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -69.91 -9.78 26.87 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.793 2.329 . . . . 61.25 116.197 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 m -120.95 -10.33 9.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.438 1.472 . . . . 73.019999999999996 114.614 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.74 9.67 27.52 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.737 1.161 . . . . 74.420000000000002 114.725 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 mt -70.81 131.5 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 104.772 -2.307 . . . . 71.219999999999999 104.772 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.1 t -126.52 143.93 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.55 -1.278 . . . . 70.329999999999998 107.55 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.54 142.57 25.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.525 -0.917 . . . . 71.019999999999996 108.525 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -115.42 118.5 33.38 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.751 1.62 . . . . 73.0 110.154 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.0 p -116.55 143.42 45.62 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.397 0.544 . . . . 72.109999999999999 110.135 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -157.41 100.32 1.81 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.704 1.202 . . . . 74.510000000000005 108.813 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -135.34 -24.62 1.39 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 119.989 1.268 . . . . 74.329999999999998 114.017 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.2 p -124.29 171.6 9.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.576 0.75 . . . . 74.129999999999995 110.025 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -91.25 0.85 57.45 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.56 -0.533 . . . . 71.219999999999999 109.56 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.0 m -100.28 114.97 28.85 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.11 1.364 . . . . 73.439999999999998 107.961 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.2 p -59.42 -38.41 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.538 -0.912 . . . . 70.409999999999997 108.538 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -59.4 -40.52 86.9 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.048 1.739 . . . . 72.340000000000003 112.318 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -79.11 -29.76 43.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.492 0.717 . . . . 75.0 110.662 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -70.37 -40.44 73.99 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.275 -1.38 . . . . 72.510000000000005 107.275 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -48.61 -52.01 25.14 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.744 -1.223 . . . . 75.239999999999995 113.022 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -57.3 -35.16 69.48 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.174 0.897 . . . . 73.439999999999998 112.684 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.05 -50.39 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.221 1.008 . . . . 72.010000000000005 108.557 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.86 92.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 119.367 -0.349 . . . . 63.420000000000002 110.427 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -61.73 -51.65 67.51 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.051 0.541 . . . . 74.120000000000005 111.812 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -40.58 95.35 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 117.783 -1.103 . . . . 75.540000000000006 112.32 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.4 p -73.81 -38.77 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 119.676 1.126 . . . . 74.010000000000005 110.456 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.93 -44.99 96.45 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.86 -0.792 . . . . 74.439999999999998 108.86 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -50.28 -47.62 55.31 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 124.143 0.977 . . . . 73.319999999999993 112.095 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -59.27 -35.83 74.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.826 -1.171 . . . . 71.409999999999997 111.671 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -77.6 -33.55 53.79 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.586 1.154 . . . . 75.239999999999995 110.184 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.12 -51.7 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 C-N-CA 125.712 1.605 . . . . 73.140000000000001 108.171 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -61.62 2.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 126.263 1.825 . . . . 74.319999999999993 111.234 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.3 p -59.52 -28.9 41.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 119.489 -0.291 . . . . 63.009999999999998 111.758 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -66.82 -37.58 84.79 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.579 -1.326 . . . . 75.340000000000003 109.996 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -81.84 -40.98 21.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.809 -0.557 . . . . 73.200000000000003 110.629 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -74.65 -15.14 60.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.643 1.577 . . . . 71.230000000000004 112.611 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 m -138.39 89.17 2.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.918 1.287 . . . . 64.439999999999998 109.364 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -168.21 178.09 42.03 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.196 -1.162 . . . . 52.43 110.196 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.18 163.05 39.91 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.457 2.105 . . . . 73.019999999999996 109.931 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.9 m -103.19 -42.93 5.61 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.992 0.917 . . . . 65.530000000000001 108.972 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.7 p -149.31 -2.8 0.43 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.047 0.758 . . . . 73.219999999999999 113.047 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.352 0 N-CA-C 108.246 -1.942 . . . . 72.219999999999999 108.246 -177.876 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.963 0 N-CA-C 108.411 -1.876 . . . . 74.5 108.411 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.92 -179.13 6.9 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.46 1.504 . . . . 74.310000000000002 107.481 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t -156.95 -166.68 2.15 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.128 -1.064 . . . . 73.019999999999996 108.128 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.85 171.7 22.29 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.769 1.652 . . . . 74.420000000000002 109.122 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.8 m -153.04 76.36 1.12 Allowed 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.667 -0.902 . . . . 74.409999999999997 108.891 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.3 p -68.31 153.07 44.47 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.871 -0.789 . . . . 74.540000000000006 108.871 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.63 -98.57 0.92 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 108.231 -1.948 . . . . 63.399999999999999 108.231 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.93 170.69 18.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.022 0.911 . . . . 74.099999999999994 110.838 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 30.9 p-90 -129.35 170.37 13.73 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.014 2.126 . . . . 74.230000000000004 107.956 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.41 -82.11 0.51 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.27 0.938 . . . . 74.200000000000003 112.035 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.4 mt 38.75 44.12 0.78 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.881 2.473 . . . . 65.450000000000003 114.971 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.3 157.79 18.07 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.304 -1.739 . . . . 71.319999999999993 106.304 177.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.98 150.53 35.66 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 105.936 -1.876 . . . . 74.430000000000007 105.936 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.3 139.17 26.89 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.188 -1.412 . . . . 75.420000000000002 107.188 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -148.92 164.22 35.16 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 126.158 1.783 . . . . 65.010000000000005 106.883 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -157.69 138.61 9.41 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 129.703 3.201 . . . . 75.010000000000005 103.528 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.92 152.21 68.43 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.507 1.471 . . . . 74.510000000000005 110.049 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.4 176.25 10.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.162 1.785 . . . . 70.340000000000003 107.874 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.2 tp -66.99 134.56 52.19 Favored 'General case' 0 CA--C 1.526 0.053 0 N-CA-C 107.884 -1.154 . . . . 72.209999999999994 107.884 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.33 167.34 20.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.797 1.639 . . . . 75.409999999999997 109.272 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -79.57 158.07 73.97 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.884 -0.784 . . . . 74.519999999999996 108.884 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.91 -176.61 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.749 2.3 . . . . 75.099999999999994 110.049 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.84 147.67 43.4 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 109.602 -1.399 . . . . 65.109999999999999 109.602 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 70.8 mtm -134.79 173.74 11.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.203 1.401 . . . . 75.530000000000001 108.704 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.31 119.17 10.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 100.847 -3.761 . . . . 74.319999999999993 100.847 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -123.8 175.61 6.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.846 0.459 . . . . 74.319999999999993 109.969 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.6 t -61.76 141.59 57.8 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.347 0.659 . . . . 71.230000000000004 109.57 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.9 p -73.37 -174.98 1.78 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.794 1.238 . . . . 75.439999999999998 109.602 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.2 m -62.58 153.74 6.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 O-C-N 121.041 -1.037 . . . . 51.409999999999997 109.873 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -130.55 -176.39 3.96 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.297 1.439 . . . . 74.510000000000005 109.521 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 t -70.77 163.72 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 122.007 0.908 . . . . 62.009999999999998 110.946 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.94 168.51 13.87 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 127.792 2.437 . . . . 62.32 107.779 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.04 -174.31 50.28 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 109.055 -1.618 . . . . 73.129999999999995 109.055 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -135.3 165.63 25.01 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.15 0.975 . . . . 72.439999999999998 109.706 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.87 -169.54 3.39 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.238 2.215 . . . . 74.450000000000003 105.893 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 52.8 26.42 4.54 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.281 1.832 . . . . 71.329999999999998 115.355 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -59.89 10.94 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 117.416 -1.278 . . . . 74.420000000000002 113.43 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.04 101.68 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.125 2.55 . . . . 75.319999999999993 107.557 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.64 173.78 16.33 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.645 1.178 . . . . 64.230000000000004 109.067 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.9 95.78 3.02 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.726 -1.212 . . . . 75.439999999999998 107.726 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.4 mt -56.51 145.03 61.55 Favored Pre-proline 0 C--O 1.234 0.262 0 N-CA-C 109.864 -0.421 . . . . 73.400000000000006 109.864 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.76 122.95 10.95 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.072 2.515 . . . . 61.210000000000001 111.664 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -112.28 147.74 35.64 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.641 1.177 . . . . 74.310000000000002 110.341 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -110.49 115.48 29.7 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.663 -1.236 . . . . 73.450000000000003 107.663 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.52 -28.24 69.51 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.851 0.75 . . . . 70.140000000000001 111.675 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 m -75.36 0.05 18.17 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.514 1.126 . . . . 71.209999999999994 111.471 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -117.64 5.76 12.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.107 1.363 . . . . 74.319999999999993 113.305 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.1 mt -107.87 176.0 5.29 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.732 -1.21 . . . . 75.209999999999994 107.732 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -138.6 112.46 8.43 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.124 0.57 . . . . 75.329999999999998 109.661 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 157.26 17.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.003 -1.48 . . . . 73.540000000000006 107.003 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -142.04 -179.67 6.36 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.733 -1.21 . . . . 63.43 107.733 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.04 162.97 27.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.844 1.258 . . . . 72.200000000000003 108.476 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.8 t -149.1 141.72 17.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.64 1.576 . . . . 75.329999999999998 108.909 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -114.71 -68.12 0.95 Allowed 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 104.661 -2.348 . . . . 74.420000000000002 104.661 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.47 136.41 4.21 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 107.532 -2.227 . . . . 73.120000000000005 107.532 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -159.1 -46.94 0.06 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.635 1.174 . . . . 72.129999999999995 109.712 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -105.33 -174.26 24.18 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.137 1.351 . . . . 53.450000000000003 110.914 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.92 3.68 1.84 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.415 3.41 . . . . 74.400000000000006 114.584 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.86 -149.05 34.52 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 110.663 -0.975 . . . . 44.409999999999997 110.663 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.11 25.96 25.98 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.997 -1.241 . . . . 73.099999999999994 109.997 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 54.75 45.55 26.46 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.11 1.364 . . . . 74.540000000000006 109.827 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -149.12 97.85 2.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.502 2.321 . . . . 73.409999999999997 105.659 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.81 76.9 2.75 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.457 1.503 . . . . 74.329999999999998 109.006 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -79.87 170.46 16.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.728 0.811 . . . . 60.119999999999997 110.577 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -83.87 -55.96 3.96 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 106.228 -1.767 . . . . 75.140000000000001 106.228 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 m -65.33 -38.5 90.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.989 1.316 . . . . 72.409999999999997 112.894 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 m 47.03 40.95 10.37 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.859 0.864 . . . . 70.049999999999997 110.919 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -70.47 125.26 26.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.098 -1.001 . . . . 74.230000000000004 108.697 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.7 p -156.67 103.71 2.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.906 -1.516 . . . . 74.25 106.906 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.0 t -94.38 158.73 2.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.16 -1.052 . . . . 73.129999999999995 108.16 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.02 146.35 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.49 1.116 . . . . 64.420000000000002 109.751 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.4 tp -146.12 149.7 34.52 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.447 1.499 . . . . 72.349999999999994 108.407 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -140.27 148.38 41.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.052 1.341 . . . . 74.150000000000006 109.812 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.02 126.06 46.16 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.564 1.546 . . . . 75.349999999999994 107.547 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.8 -56.1 5.01 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 118.084 -0.96 . . . . 72.120000000000005 111.511 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.31 -8.14 22.19 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.093 1.862 . . . . 71.030000000000001 116.081 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -120.73 -9.97 9.25 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.093 0.861 . . . . 64.549999999999997 112.614 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.78 4.14 9.71 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.518 -1.157 . . . . 63.020000000000003 115.132 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.1 mt -70.28 141.92 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 126.187 1.795 . . . . 75.439999999999998 107.746 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.6 148.08 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.745 1.218 . . . . 62.219999999999999 108.382 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.3 151.76 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.249 -0.648 . . . . 73.349999999999994 109.249 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -132.42 107.98 8.86 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.02 -1.474 . . . . 72.319999999999993 107.02 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.3 m -123.6 153.33 40.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 122.475 1.131 . . . . 60.420000000000002 112.869 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -154.3 148.41 25.81 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.909 2.084 . . . . 72.319999999999993 107.521 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -162.46 -26.79 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.159 0.983 . . . . 54.149999999999999 110.784 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.5 p -138.34 158.1 44.94 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.782 -0.574 . . . . 74.209999999999994 110.924 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -22.51 66.94 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.643 -0.661 . . . . 73.150000000000006 111.847 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -79.54 116.81 19.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.21 1.804 . . . . 72.200000000000003 112.217 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.4 p -58.72 -40.78 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.38 0.672 . . . . 63.109999999999999 110.162 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -58.72 -46.92 86.28 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.918 0.887 . . . . 74.400000000000006 111.425 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -65.06 -44.12 90.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.564 1.145 . . . . 70.540000000000006 109.837 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -61.36 -40.42 94.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.997 0.362 . . . . 72.430000000000007 110.353 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -59.09 -38.87 80.52 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.134 -0.936 . . . . 72.230000000000004 111.028 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -59.77 -48.22 82.54 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.383 0.992 . . . . 74.120000000000005 109.287 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.1 -48.2 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 123.844 0.858 . . . . 50.310000000000002 109.397 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.47 82.37 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.177 0.591 . . . . 74.099999999999994 110.343 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -62.39 -45.35 93.56 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.055 0.542 . . . . 72.340000000000003 110.12 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -55.65 -61.65 2.21 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.138 0.975 . . . . 75.409999999999997 109.202 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.73 -34.45 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.655 0.613 . . . . 75.010000000000005 112.655 -177.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.0 -47.78 81.64 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.032 0.933 . . . . 73.140000000000001 109.12 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -52.13 -41.41 62.5 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.937 0.895 . . . . 72.319999999999993 113.17 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.5 -33.15 75.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.609 0.719 . . . . 64.109999999999999 110.738 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -73.59 -34.45 65.08 Favored 'General case' 0 C--N 1.335 -0.053 0 O-C-N 121.355 -0.841 . . . . 75.25 110.137 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.1 t -68.07 -43.41 85.3 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 CA-C-O 118.354 -0.831 . . . . 71.200000000000003 109.112 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -50.28 -60.76 2.66 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.391 1.077 . . . . 74.310000000000002 109.604 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.96 -29.25 46.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-O 118.601 -0.714 . . . . 75.329999999999998 111.737 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -69.56 -38.79 77.56 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 120.104 1.32 . . . . 74.340000000000003 110.93 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -73.76 -56.08 5.43 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.472 -0.936 . . . . 74.540000000000006 108.472 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -67.82 -21.33 65.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 115.202 1.556 . . . . 74.129999999999995 115.202 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.9 t -142.03 76.07 1.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.708 1.603 . . . . 71.239999999999995 107.665 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.14 167.23 51.85 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 114.784 -1.098 . . . . 74.019999999999996 111.576 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.43 6.9 3.68 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.629 2.886 . . . . 74.430000000000007 113.161 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.7 p -144.17 -176.33 4.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.718 1.607 . . . . 60.020000000000003 109.681 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.5 m 57.92 15.47 3.11 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.261 1.949 . . . . 53.399999999999999 116.261 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 N-CA-C 108.46 -1.856 . . . . 72.340000000000003 108.46 -179.799 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.655 0 N-CA-C 110.575 -1.01 . . . . 63.020000000000003 110.575 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -91.84 72.93 5.72 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 124.33 1.052 . . . . 73.150000000000006 109.062 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.41 -11.02 59.04 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.444 0.905 . . . . 64.25 113.444 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.82 -58.48 3.04 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 125.504 1.526 . . . . 73.0 113.09 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.3 t 47.32 15.58 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.227 2.211 . . . . 63.350000000000001 116.411 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.1 m -93.44 174.03 7.41 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.477 1.111 . . . . 73.329999999999998 109.465 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.19 155.82 25.3 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.715 -1.354 . . . . 63.219999999999999 109.715 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -93.54 126.25 38.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 123.55 0.74 . . . . 73.200000000000003 109.006 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -149.5 -176.2 5.3 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.041 1.736 . . . . 71.400000000000006 107.681 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.96 -177.28 29.01 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.212 -1.555 . . . . 72.310000000000002 109.212 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.93 171.94 7.46 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.42 1.088 . . . . 75.549999999999997 108.375 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -136.25 101.45 4.69 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 108.517 -0.92 . . . . 74.230000000000004 108.517 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.26 150.08 19.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 105.763 -1.94 . . . . 62.530000000000001 105.763 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.83 150.72 15.63 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 126.315 1.846 . . . . 73.510000000000005 106.534 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' OE1' ' HE2' ' A' ' 16' ' ' LYS . 4.1 mm-40 -86.37 170.26 12.18 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.787 -0.365 . . . . 60.240000000000002 111.308 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.405 ' HE2' ' OE1' ' A' ' 15' ' ' GLU . 1.3 mppt? -112.43 155.18 44.1 Favored Pre-proline 0 CA--C 1.528 0.102 0 C-N-CA 124.495 1.118 . . . . 72.5 110.181 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.3 97.54 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.213 2.609 . . . . 74.200000000000003 106.867 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.95 -174.65 4.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.053 1.341 . . . . 73.219999999999999 109.923 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 tt -65.06 107.86 1.65 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 106.821 -1.548 . . . . 74.340000000000003 106.821 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -61.76 155.87 21.83 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.685 0.794 . . . . 75.430000000000007 112.169 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.25 152.72 92.37 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.125 -0.694 . . . . 74.340000000000003 109.125 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.68 3.8 5.13 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.448 2.765 . . . . 74.230000000000004 113.358 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.04 179.43 48.07 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.186 -1.966 . . . . 62.439999999999998 108.186 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 92.8 mtp -141.45 172.1 13.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.828 1.251 . . . . 71.510000000000005 107.975 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.48 144.69 25.54 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 101.571 -3.492 . . . . 72.099999999999994 101.571 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.58 173.52 11.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.314 -0.625 . . . . 74.010000000000005 109.314 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.4 t -77.35 179.53 6.37 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.343 -0.984 . . . . 63.119999999999997 108.343 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 m -142.38 150.04 40.17 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 106.803 -1.554 . . . . 74.230000000000004 106.803 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -66.33 169.95 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 123.75 0.82 . . . . 74.319999999999993 110.115 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -123.29 166.67 14.89 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.996 0.919 . . . . 73.239999999999995 108.814 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.9 m -112.13 -168.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.236 1.415 . . . . 72.400000000000006 108.506 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.49 -19.32 13.28 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.066 -0.493 . . . . 74.340000000000003 111.103 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.0 -107.68 2.11 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.164 -1.574 . . . . 62.100000000000001 109.164 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.18 151.86 4.77 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 125.942 1.697 . . . . 74.409999999999997 111.209 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -156.24 65.04 0.56 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 127.066 2.147 . . . . 73.010000000000005 105.695 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -165.62 23.54 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.898 0.479 . . . . 71.120000000000005 111.862 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -67.04 0.51 Allowed Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.191 1.796 . . . . 73.109999999999999 115.108 -177.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.41 99.16 0.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.48 2.12 . . . . 71.010000000000005 109.158 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.23 -170.01 2.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.029 2.132 . . . . 74.120000000000005 107.366 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.7 mt -91.15 110.49 21.76 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 103.047 -2.946 . . . . 73.430000000000007 103.047 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -82.45 155.48 68.93 Favored Pre-proline 0 C--N 1.322 -0.609 0 C-N-CA 123.531 0.732 . . . . 74.109999999999999 109.635 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.51 165.85 29.73 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.896 2.397 . . . . 74.420000000000002 113.696 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.423 0.2 OUTLIER -134.86 166.09 23.79 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.4 1.88 . . . . 72.510000000000005 111.541 179.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -120.16 101.56 7.91 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.103 -1.073 . . . . 71.340000000000003 108.103 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -67.28 -11.95 58.85 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.931 1.085 . . . . 75.120000000000005 113.931 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -0.66 57.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.159 1.384 . . . . 53.450000000000003 112.726 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -126.16 32.61 5.19 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.852 1.261 . . . . 75.540000000000006 109.757 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.1 mt -113.79 117.25 30.94 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.736 1.215 . . . . 73.310000000000002 108.036 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -102.76 103.95 14.22 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 104.802 -2.295 . . . . 74.120000000000005 104.802 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -84.63 163.78 19.06 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.537 1.062 . . . . 74.450000000000003 108.945 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -120.52 129.03 53.64 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.206 -1.776 . . . . 74.450000000000003 106.206 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -87.41 143.27 27.32 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.422 -0.955 . . . . 74.230000000000004 108.422 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.46 110.0 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 105.565 -2.013 . . . . 62.409999999999997 105.565 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -110.69 -7.8 14.64 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.73 0.812 . . . . 74.230000000000004 112.636 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.43 -152.0 10.28 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 108.431 -1.867 . . . . 74.530000000000001 108.431 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.7 t60 50.95 49.35 21.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.887 1.275 . . . . 71.420000000000002 111.025 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.72 160.87 53.81 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.153 -1.579 . . . . 74.319999999999993 109.153 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -78.13 30.49 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.724 3.616 . . . . 74.25 111.97 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.47 -173.16 49.61 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 109.885 -1.286 . . . . 71.349999999999994 109.885 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.7 -103.96 0.3 Allowed Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.667 -0.973 . . . . 63.509999999999998 110.667 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -79.0 166.28 22.52 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.682 0.753 . . . . 71.049999999999997 110.634 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.03 -5.19 16.15 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.605 1.162 . . . . 74.219999999999999 114.061 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.4 p -139.71 158.52 43.97 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 120.057 1.299 . . . . 71.420000000000002 108.66 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -126.88 28.05 5.89 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.615 1.966 . . . . 64.109999999999999 111.293 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -52.18 -41.97 63.06 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.224 0.61 . . . . 75.109999999999999 110.991 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -84.28 131.74 34.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.438 -2.06 . . . . 72.140000000000001 105.438 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.35 8.02 2.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.339 0.656 . . . . 73.299999999999997 112.694 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.41 HD22 ' N ' ' A' ' 89' ' ' VAL . 33.4 t-20 -84.61 107.35 16.78 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.866 -1.161 . . . . 71.409999999999997 107.866 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.0 t -141.64 138.04 32.25 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.25 1.82 . . . . 63.240000000000002 106.491 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.7 t -121.67 150.56 24.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.709 -1.589 . . . . 73.329999999999998 106.709 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -137.71 128.91 39.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 102.699 -3.075 . . . . 63.240000000000002 102.699 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.1 tp -130.51 143.92 51.07 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.062 0.945 . . . . 73.209999999999994 110.633 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 143.98 31.42 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.261 -0.899 . . . . 74.030000000000001 112.631 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -86.4 121.0 28.34 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.266 -2.124 . . . . 74.310000000000002 105.266 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.44 -57.75 23.16 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.588 1.086 . . . . 74.409999999999997 112.123 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -59.33 -34.14 97.76 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.615 1.543 . . . . 64.430000000000007 114.905 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -93.66 -16.04 24.7 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.523 0.934 . . . . 75.239999999999995 113.523 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.07 23.83 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.565 1.555 . . . . 73.409999999999997 113.737 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.1 mt -70.27 120.82 18.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.049 -1.463 . . . . 71.120000000000005 107.049 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.7 t -111.23 128.51 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 126.385 1.874 . . . . 71.150000000000006 107.647 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.5 157.96 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 123.385 1.564 . . . . 73.099999999999994 108.018 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -141.28 139.68 33.72 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.877 -2.268 . . . . 73.230000000000004 104.877 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.7 t -138.65 163.69 31.45 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.224 -1.769 . . . . 61.219999999999999 106.224 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -155.09 149.22 25.89 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 104.848 -2.279 . . . . 73.540000000000006 104.848 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -170.98 -40.51 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.138 -0.458 . . . . 74.5 110.153 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 p -127.25 -177.45 4.07 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.399 0.619 . . . . 75.420000000000002 112.426 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.9 mtm-85 -103.77 -0.41 29.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.991 0.917 . . . . 75.25 110.943 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m -98.44 115.72 29.13 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.644 -1.243 . . . . 73.439999999999998 107.644 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.41 ' N ' HD22 ' A' ' 68' ' ' ASN . 7.6 p -55.97 -45.82 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 122.878 0.471 . . . . 74.349999999999994 109.82 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.63 -32.62 67.43 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.832 1.253 . . . . 71.430000000000007 112.618 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -82.13 -44.48 16.44 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 120.582 -1.324 . . . . 72.120000000000005 108.127 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -57.35 -36.8 71.64 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.593 0.757 . . . . 65.5 109.632 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -60.12 -51.19 70.67 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 118.144 -0.932 . . . . 74.340000000000003 109.604 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -64.58 -36.57 84.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.837 1.199 . . . . 73.25 112.482 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.62 -43.07 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.157 -0.683 . . . . 61.340000000000003 109.157 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.19 -38.11 87.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.046 0.538 . . . . 74.439999999999998 110.814 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.465 ' HG3' HH11 ' A' ' 97' ' ' ARG . 0.9 OUTLIER -57.6 -52.72 64.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.047 0.939 . . . . 75.140000000000001 111.858 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.78 97.37 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 119.379 -0.929 . . . . 75.030000000000001 112.524 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.83 -32.45 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 120.113 1.324 . . . . 72.219999999999999 111.388 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.1 tp -62.39 -40.29 95.98 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.523 -0.736 . . . . 75.099999999999994 109.447 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -57.44 -42.59 82.73 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.217 0.607 . . . . 73.5 110.097 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -61.11 -20.52 62.74 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.474 0.916 . . . . 71.109999999999999 113.474 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -87.54 -38.83 15.66 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.475 -0.766 . . . . 73.310000000000002 109.458 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.0 t -67.39 -31.98 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.479 -0.934 . . . . 70.129999999999995 108.479 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -52.93 -57.61 9.72 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.098 1.359 . . . . 73.409999999999997 108.116 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.34 -38.68 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.521 1.128 . . . . 74.25 109.375 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -62.85 -37.23 86.01 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.896 1.226 . . . . 74.239999999999995 110.449 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -75.79 -33.62 60.16 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.64 0.978 . . . . 74.439999999999998 113.64 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -108.33 -9.46 15.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 116.369 1.989 . . . . 75.349999999999994 116.369 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.1 t -148.31 33.93 0.8 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 126.569 1.948 . . . . 73.510000000000005 110.138 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.8 176.31 3.4 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.053 1.181 . . . . 41.149999999999999 116.053 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.4 -17.52 58.1 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.987 3.125 . . . . 75.140000000000001 111.605 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.06 98.64 3.68 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 102.869 -3.011 . . . . 71.209999999999994 102.869 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 p -136.39 29.92 2.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.765 1.226 . . . . 70.420000000000002 110.413 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 C-N-CA 125.709 1.623 . . . . 53.539999999999999 111.056 179.646 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.129 0 N-CA-C 109.104 -1.599 . . . . 73.510000000000005 109.104 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m -63.02 150.54 42.19 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.722 0.761 . . . . 62.210000000000001 110.142 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 t -167.87 174.82 7.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.102 1.761 . . . . 73.430000000000007 106.499 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.11 172.28 14.01 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.408 1.004 . . . . 72.420000000000002 110.944 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 p -157.09 167.3 30.82 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.399 1.48 . . . . 74.209999999999994 107.841 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 p -150.21 145.33 26.18 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.086 0.857 . . . . 72.409999999999997 110.684 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.27 171.92 31.42 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 108.022 -2.031 . . . . 60.229999999999997 108.022 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.06 164.28 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.862 1.665 . . . . 65.239999999999995 106.837 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -136.1 179.62 6.24 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.077 1.351 . . . . 74.430000000000007 108.972 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.69 166.58 23.48 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.4 -1.48 . . . . 44.020000000000003 109.4 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.7 mt -139.62 176.9 8.34 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.515 1.526 . . . . 64.310000000000002 108.127 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -109.15 138.38 45.58 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.261 -1.015 . . . . 74.349999999999994 108.261 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.91 158.02 17.07 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 104.96 -2.237 . . . . 74.010000000000005 104.96 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.05 171.46 19.27 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.008 0.923 . . . . 74.109999999999999 109.791 -178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.61 -169.57 1.48 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.209 1.804 . . . . 72.219999999999999 112.057 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -139.15 152.76 70.44 Favored Pre-proline 0 CA--C 1.527 0.086 0 C-N-CA 125.13 1.372 . . . . 73.049999999999997 108.706 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.08 157.98 53.19 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.222 1.948 . . . . 72.109999999999999 110.904 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.84 -168.43 1.95 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.513 1.525 . . . . 73.340000000000003 109.638 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 pp -136.72 176.16 8.96 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.304 1.842 . . . . 74.310000000000002 108.769 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.6 mt -115.33 161.74 18.08 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.44 1.096 . . . . 74.109999999999999 109.778 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -75.2 155.24 86.22 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.851 0.86 . . . . 74.230000000000004 110.399 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.58 175.96 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.122 2.548 . . . . 74.049999999999997 110.586 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.59 163.02 53.47 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.031 -0.827 . . . . 71.219999999999999 111.031 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 95.6 mtp -73.46 163.92 27.38 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.088 0.555 . . . . 53.520000000000003 110.438 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.63 71.96 1.37 Allowed 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 105.546 -2.02 . . . . 65.230000000000004 105.546 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.49 -172.1 1.71 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.056 -0.975 . . . . 75.219999999999999 111.032 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.91 172.63 2.18 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.316 1.047 . . . . 63.119999999999997 110.434 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -130.05 177.36 7.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.634 1.174 . . . . 74.409999999999997 109.47 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 m -63.69 137.0 25.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.785 1.634 . . . . 73.129999999999995 108.672 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -132.36 -176.7 4.17 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.601 1.16 . . . . 73.420000000000002 111.531 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.2 t -54.84 151.87 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.235 1.814 . . . . 73.109999999999999 108.396 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.06 -167.08 1.14 Allowed 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.106 0.962 . . . . 64.430000000000007 109.573 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.49 -171.93 2.02 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.357 1.455 . . . . 73.239999999999995 113.034 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -132.24 170.64 14.74 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 123.417 0.687 . . . . 75.109999999999999 109.72 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -146.7 177.31 9.19 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.492 2.317 . . . . 73.109999999999999 105.819 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 44.04 61.83 2.19 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 125.904 1.682 . . . . 75.340000000000003 114.556 177.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.41 -59.25 1.65 Allowed Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.889 -1.053 . . . . 63.340000000000003 109.717 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.41 151.62 80.03 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.633 2.222 . . . . 74.439999999999998 111.86 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.04 160.49 42.97 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.72 2.008 . . . . 74.519999999999996 109.169 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.4 mt -71.43 94.13 1.23 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.13 0.572 . . . . 72.299999999999997 110.813 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -50.81 151.38 4.36 Favored Pre-proline 0 C--O 1.236 0.384 0 C-N-CA 125.228 1.411 . . . . 75.329999999999998 111.344 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.21 165.58 26.19 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.141 2.56 . . . . 64.040000000000006 112.211 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.413 0.2 OUTLIER -136.39 164.17 28.76 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 114.06 1.133 . . . . 74.25 114.06 -179.074 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.517 HD21 ' HB2' ' A' ' 47' ' ' GLU . 15.6 t30 -120.84 101.1 7.48 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 104.455 -2.424 . . . . 74.030000000000001 104.455 177.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.41 -14.17 25.98 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.417 1.087 . . . . 71.209999999999994 113.922 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -98.53 6.8 46.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.352 1.061 . . . . 74.519999999999996 110.8 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.517 ' HB2' HD21 ' A' ' 44' ' ' ASN . 6.7 tp10 -120.13 23.93 10.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.328 1.451 . . . . 74.420000000000002 110.178 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 mt -113.41 145.9 40.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.545 1.538 . . . . 75.329999999999998 107.388 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -116.74 106.44 13.51 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.036 -2.209 . . . . 75.540000000000006 105.036 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -100.89 154.05 18.99 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.414 1.085 . . . . 74.129999999999995 113.019 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -144.93 169.89 17.2 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.962 -1.125 . . . . 71.439999999999998 107.962 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -121.27 133.74 55.15 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.946 -1.872 . . . . 75.150000000000006 105.946 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.5 t -86.26 133.57 29.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 107.315 -1.365 . . . . 71.219999999999999 107.315 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -136.72 162.87 31.99 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.822 2.049 . . . . 73.230000000000004 106.143 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.31 -152.97 51.13 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 109.55 -1.42 . . . . 52.119999999999997 109.55 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -135.09 169.05 18.03 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.467 1.507 . . . . 75.200000000000003 108.029 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.41 173.24 35.4 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.062 -1.215 . . . . 61.240000000000002 110.062 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -71.43 174.92 10.14 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.992 2.461 . . . . 63.43 112.457 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.86 30.1 32.98 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.269 -0.878 . . . . 72.409999999999997 111.258 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.68 162.63 35.07 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 127.823 2.63 . . . . 71.230000000000004 106.8 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -152.06 -69.79 0.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.811 0.806 . . . . 73.230000000000004 110.584 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.67 -30.2 65.26 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.835 0.68 . . . . 75.400000000000006 112.835 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.0 p -77.36 57.18 1.46 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.235 1.814 . . . . 74.010000000000005 110.06 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -43.22 -14.92 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 118.772 2.878 . . . . 72.420000000000002 118.772 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -120.11 -17.14 8.43 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.533 1.515 . . . . 74.340000000000003 114.109 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 47.54 -6.64 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 119.549 3.166 . . . . 73.430000000000007 119.549 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.9 p -54.97 -0.55 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 130.486 3.515 . . . . 64.109999999999999 119.574 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -133.14 -6.13 3.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.27 1.395 . . . . 75.439999999999998 112.476 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 55.6 m -67.17 142.1 57.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.082 0.856 . . . . 62.009999999999998 108.962 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.1 t -115.22 135.54 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.383 -2.081 . . . . 63.409999999999997 105.383 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.18 130.75 73.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 102.97 -2.974 . . . . 74.0 102.97 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.7 tp -139.01 151.58 46.93 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.123 0.569 . . . . 74.230000000000004 110.168 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 152.43 45.72 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 122.424 0.289 . . . . 75.140000000000001 110.458 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -95.61 122.95 38.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 103.326 -2.842 . . . . 75.200000000000003 103.326 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.48 -62.37 5.56 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 120.091 1.314 . . . . 71.200000000000003 112.017 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.6 -17.12 58.59 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.569 2.18 . . . . 63.450000000000003 115.581 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.21 -13.54 16.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.817 1.19 . . . . 75.450000000000003 110.665 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.41 -15.03 0.87 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.634 1.587 . . . . 61.149999999999999 115.498 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.1 mt -56.95 132.7 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.721 1.608 . . . . 73.299999999999997 110.851 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.2 t -124.14 138.39 53.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 126.868 2.067 . . . . 74.239999999999995 106.094 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.6 157.3 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.737 -0.468 . . . . 74.239999999999995 109.737 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -119.69 131.58 55.45 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 126.251 1.82 . . . . 75.510000000000005 109.134 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -141.24 153.61 45.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.186 0.994 . . . . 65.120000000000005 111.318 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -155.5 159.07 39.46 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 128.011 2.525 . . . . 64.549999999999997 107.356 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -161.8 -54.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.198 1.399 . . . . 73.120000000000005 108.321 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.47 179.13 6.22 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.89 0.853 . . . . 71.25 110.907 -178.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -13.23 62.28 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.753 0.821 . . . . 74.450000000000003 112.151 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.31 115.07 22.3 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.353 0.661 . . . . 72.150000000000006 112.777 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.82 -33.11 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.077 -1.453 . . . . 74.349999999999994 107.077 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.58 -38.36 84.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.178 1.791 . . . . 73.239999999999995 109.763 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.8 -52.29 9.79 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.683 -1.229 . . . . 75.0 107.683 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -52.8 -33.9 51.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.286 0.634 . . . . 73.25 110.104 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -59.26 -62.03 2.19 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.44 1.496 . . . . 73.400000000000006 108.19 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -62.67 -36.41 82.78 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 118.395 -0.812 . . . . 74.200000000000003 112.992 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.35 -51.44 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.245 -1.391 . . . . 74.400000000000006 107.245 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.54 -50.18 72.38 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.408 -0.59 . . . . 73.450000000000003 109.408 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -54.22 -39.93 67.19 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 118.035 -0.983 . . . . 73.109999999999999 112.164 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -44.6 47.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.288 -1.339 . . . . 74.239999999999995 110.831 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.16 -32.85 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.769 1.622 . . . . 74.329999999999998 112.256 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.5 tp -59.66 -35.8 75.14 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.485 -0.759 . . . . 73.150000000000006 109.434 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.76 -38.34 87.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.028 0.931 . . . . 73.099999999999994 109.479 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -68.12 -17.64 64.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.882 1.673 . . . . 64.140000000000001 111.136 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -97.17 -35.54 10.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.99 0.916 . . . . 71.219999999999999 109.001 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.5 t -69.16 -31.92 51.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.011 -1.107 . . . . 71.010000000000005 108.011 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -62.04 1.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.872 2.069 . . . . 62.32 109.174 177.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.64 -25.11 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 122.645 0.378 . . . . 70.129999999999995 111.475 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -77.77 -15.28 59.22 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.99 -1.069 . . . . 74.450000000000003 111.026 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -94.05 -42.31 9.09 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.045 1.338 . . . . 74.209999999999994 108.975 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -87.86 -14.58 39.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.781 1.03 . . . . 73.430000000000007 113.781 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.5 t -146.97 -172.08 3.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.954 1.702 . . . . 74.120000000000005 108.049 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 158.3 -177.12 35.12 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.043 -1.223 . . . . 64.450000000000003 110.043 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.57 -44.89 2.77 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 121.9 1.733 . . . . 74.120000000000005 108.043 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -83.3 171.2 13.81 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.08 2.152 . . . . 75.129999999999995 109.45 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -155.74 130.55 9.19 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.343 -1.725 . . . . 73.209999999999994 106.343 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 N-CA-C 108.929 -1.668 . . . . 64.430000000000007 108.929 -179.829 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.071 0 N-CA-C 108.312 -1.915 . . . . 73.310000000000002 108.312 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m -139.91 152.25 46.25 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.394 -1.336 . . . . 74.200000000000003 107.394 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 p -73.4 -44.69 57.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.252 1.021 . . . . 74.040000000000006 110.424 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.65 170.66 30.88 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 108.636 -1.786 . . . . 71.319999999999993 108.636 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 m -49.52 -39.81 35.57 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.895 1.278 . . . . 74.230000000000004 112.639 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.3 m 55.36 -27.03 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 129.201 3.0 . . . . 73.140000000000001 119.051 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.75 147.39 46.33 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 120.068 1.304 . . . . 52.32 111.957 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -150.41 160.19 43.93 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 127.694 2.398 . . . . 73.129999999999995 106.199 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -98.58 162.36 13.18 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.307 -0.997 . . . . 73.400000000000006 108.307 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.66 98.6 0.88 Allowed Glycine 0 C--N 1.333 0.378 0 N-CA-C 109.209 -1.557 . . . . 74.430000000000007 109.209 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.8 mt -66.21 152.09 45.59 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.504 0.668 . . . . 74.409999999999997 109.357 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -77.27 124.44 27.85 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 107.312 -1.366 . . . . 73.0 107.312 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.58 156.1 18.04 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 104.883 -2.266 . . . . 74.019999999999996 104.883 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.44 178.59 6.03 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.37 1.868 . . . . 64.0 107.7 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.4 179.33 9.35 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.254 -1.017 . . . . 74.439999999999998 108.254 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 158.74 81.05 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.168 0.987 . . . . 65.040000000000006 109.957 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.74 169.53 21.75 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.976 1.784 . . . . 70.230000000000004 109.942 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.0 166.65 17.56 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.239 0.616 . . . . 72.439999999999998 110.664 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.62 172.1 7.9 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.776 1.63 . . . . 75.329999999999998 108.575 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pp -130.73 178.87 6.32 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.762 2.025 . . . . 75.010000000000005 109.16 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -123.47 154.7 66.18 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 125.314 1.446 . . . . 64.340000000000003 109.651 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.66 169.07 22.5 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.84 2.36 . . . . 61.039999999999999 111.441 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.22 171.02 49.83 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.434 -1.066 . . . . 53.0 110.434 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.3 tpt -154.72 142.65 20.1 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.411 -1.7 . . . . 74.519999999999996 106.411 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.12 65.75 0.77 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.022 0.929 . . . . 74.430000000000007 108.569 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 154.08 30.66 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.965 -0.46 . . . . 55.539999999999999 110.587 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -71.8 152.97 42.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.046 -0.724 . . . . 63.130000000000003 109.046 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -85.89 -170.62 3.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.021 1.728 . . . . 64.200000000000003 111.01 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 t -70.79 154.22 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.203 1.401 . . . . 65.129999999999995 109.36 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -90.5 -178.16 5.25 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.945 0.879 . . . . 73.150000000000006 109.788 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.24 165.92 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.785 1.634 . . . . 75.340000000000003 108.395 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.57 169.72 17.13 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.943 1.697 . . . . 75.519999999999996 108.122 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.7 76.76 1.34 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 107.867 -2.093 . . . . 75.349999999999994 107.867 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -75.1 0.09 Allowed 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.102 -1.073 . . . . 71.230000000000004 108.102 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -174.94 143.32 0.71 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 129.483 3.113 . . . . 73.219999999999999 104.024 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 34.58 62.69 0.49 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 127.138 2.175 . . . . 73.099999999999994 112.551 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.427 ' N ' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -66.12 -62.75 3.82 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 117.412 -1.28 . . . . 73.219999999999999 111.932 -179.348 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.6 105.74 0.96 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.092 2.528 . . . . 72.430000000000007 108.587 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.69 175.98 13.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.781 -0.575 . . . . 74.400000000000006 109.594 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.1 mt -73.13 87.62 1.42 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.203 -1.777 . . . . 70.239999999999995 106.203 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.9 mt -48.57 142.88 8.23 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 125.016 1.326 . . . . 72.450000000000003 111.279 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.21 99.11 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.197 2.598 . . . . 74.439999999999998 111.919 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.8 mt -89.86 133.35 34.79 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.951 1.3 . . . . 73.219999999999999 108.576 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -75.68 106.99 7.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.54 -0.911 . . . . 75.400000000000006 108.54 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -59.95 -9.86 3.48 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.003 1.483 . . . . 71.540000000000006 115.003 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -101.18 -14.23 17.81 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.036 1.334 . . . . 73.319999999999993 112.473 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -90.39 -4.11 57.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.849 1.26 . . . . 74.510000000000005 111.85 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mt -84.2 150.89 25.18 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.758 1.623 . . . . 74.099999999999994 113.722 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -103.45 105.69 16.01 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.519 1.128 . . . . 74.120000000000005 108.155 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -85.37 147.6 26.43 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.621 -1.252 . . . . 62.450000000000003 107.621 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -132.31 141.6 49.02 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.701 -1.222 . . . . 73.5 107.701 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -118.5 121.0 39.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.959 1.303 . . . . 73.319999999999993 108.621 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.89 131.38 35.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.033 -1.469 . . . . 73.239999999999995 107.033 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.17 164.16 29.87 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.228 1.411 . . . . 72.230000000000004 109.346 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.99 -82.86 1.08 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 106.536 -2.626 . . . . 53.020000000000003 106.536 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -146.04 168.67 20.37 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 127.806 2.442 . . . . 75.340000000000003 107.314 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -136.92 179.96 17.41 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.009 1.29 . . . . 71.519999999999996 111.193 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.428 ' HG3' ' HE2' ' A' ' 82' ' ' LYS . 97.3 Cg_endo -71.9 175.98 8.97 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.745 3.63 . . . . 75.0 111.842 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.43 -171.28 14.02 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.647 2.07 . . . . 54.340000000000003 110.305 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.38 15.69 62.69 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.505 1.05 . . . . 52.530000000000001 113.39 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.265 77.4 mm-40 56.72 -2.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 129.854 3.261 . . . . 74.450000000000003 116.627 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.96 -11.09 60.04 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.805 1.184 . . . . 72.230000000000004 109.06 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.2 p -127.61 122.2 32.5 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.399 1.879 . . . . 73.349999999999994 109.629 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -123.68 -14.05 7.34 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.547 1.539 . . . . 73.530000000000001 109.143 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -9.06 33.77 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.326 1.85 . . . . 74.129999999999995 112.549 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 p -106.86 14.81 26.2 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.825 1.65 . . . . 75.140000000000001 111.824 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 71.8 m -51.81 -19.36 1.65 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.137 1.532 . . . . 73.120000000000005 115.137 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -79.13 64.84 4.15 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 105.982 -1.858 . . . . 74.439999999999998 105.982 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.9 t -98.89 169.42 9.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.134 -0.979 . . . . 73.409999999999997 110.011 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 t -139.19 143.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 104.594 -2.372 . . . . 72.400000000000006 104.594 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.258 9.6 p -137.63 124.86 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 101.729 -3.434 . . . . 65.120000000000005 101.729 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 tp -120.29 148.86 43.18 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.042 0.937 . . . . 74.209999999999994 108.987 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -138.69 129.07 25.87 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.25 1.02 . . . . 74.400000000000006 110.083 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -88.69 144.18 26.44 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.33 -2.1 . . . . 74.400000000000006 105.33 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.1 t -73.82 -71.6 0.21 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.776 -1.107 . . . . 70.140000000000001 112.465 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.31 -36.63 78.11 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.496 2.797 . . . . 73.010000000000005 113.526 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.9 t -77.96 -25.02 47.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.999 -0.28 . . . . 72.519999999999996 111.246 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.01 -0.08 6.51 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 119.189 -0.784 . . . . 70.040000000000006 113.435 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.7 mt -68.37 137.88 23.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 119.113 1.457 . . . . 73.25 107.22 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.4 t -131.6 139.74 49.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 106.872 -1.529 . . . . 73.150000000000006 106.872 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.61 147.14 16.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.91 -1.144 . . . . 65.420000000000002 107.91 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.428 ' HE2' ' HG3' ' A' ' 58' ' ' PRO . 5.8 ptpp? -123.22 127.97 49.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 125.401 1.48 . . . . 73.439999999999998 108.26 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 49.3 m -144.81 162.26 37.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.143 0.973 . . . . 72.140000000000001 110.896 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -155.07 156.16 35.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.362 2.265 . . . . 75.519999999999996 106.392 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -158.32 -74.4 0.08 Allowed 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 105.729 -1.952 . . . . 75.230000000000004 105.729 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.2 p -83.13 -179.3 7.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.942 0.877 . . . . 73.239999999999995 109.559 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -96.68 1.09 50.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.389 0.675 . . . . 74.0 109.314 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.6 m -96.72 115.47 27.49 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.974 1.31 . . . . 74.409999999999997 108.006 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.8 p -57.35 -42.58 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 109.506 -0.553 . . . . 75.299999999999997 109.506 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.64 -47.3 84.86 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.004 0.921 . . . . 75.109999999999999 112.196 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -67.72 -32.92 73.88 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.748 -0.595 . . . . 74.129999999999995 109.402 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -71.49 -29.25 64.6 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.24 -0.913 . . . . 75.049999999999997 109.204 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -63.15 -48.78 77.01 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.805 1.184 . . . . 74.120000000000005 109.869 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -57.82 -38.47 75.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.926 0.785 . . . . 74.239999999999995 112.051 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.69 -49.2 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.05 -1.093 . . . . 74.140000000000001 108.05 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.39 -47.04 86.96 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.927 0.891 . . . . 54.420000000000002 110.785 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -60.0 -45.53 92.43 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.644 0.778 . . . . 72.209999999999994 109.706 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -51.03 71.49 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.208 0.603 . . . . 72.430000000000007 110.72 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.58 -32.47 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.732 0.697 . . . . 74.340000000000003 110.909 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.1 tp -63.72 -40.3 96.41 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 120.616 -1.302 . . . . 72.340000000000003 110.187 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -54.5 -40.1 68.22 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.058 1.343 . . . . 75.239999999999995 111.95 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.95 -36.53 83.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.372 1.069 . . . . 74.0 111.503 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -76.45 -42.08 45.12 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.93 -0.481 . . . . 74.129999999999995 110.21 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.2 -32.26 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 118.609 -0.71 . . . . 74.329999999999998 110.442 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -58.68 -56.31 23.83 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.862 1.21 . . . . 72.230000000000004 108.252 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 68.3 t -58.45 -28.38 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.241 1.016 . . . . 75.239999999999995 110.745 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -74.35 -18.36 60.69 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.156 -0.965 . . . . 74.450000000000003 112.256 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -99.35 -49.89 4.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.294 1.438 . . . . 74.409999999999997 110.322 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -71.68 -16.51 62.24 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.015 0.746 . . . . 74.349999999999994 113.015 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.8 t -142.48 175.5 9.74 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.693 2.797 . . . . 54.210000000000001 106.99 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 138.94 -78.17 0.31 Allowed Glycine 0 C--N 1.335 0.499 0 O-C-N 120.748 -1.22 . . . . 64.209999999999994 110.827 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.36 162.15 40.02 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.093 2.529 . . . . 74.299999999999997 109.254 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.72 80.73 1.83 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.455 -0.943 . . . . 74.439999999999998 108.455 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.3 p -83.28 162.89 21.01 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.556 -1.646 . . . . 64.209999999999994 106.556 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 N-CA-C 108.663 -1.775 . . . . 73.040000000000006 108.663 179.426 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.204 0 N-CA-C 109.116 -1.593 . . . . 42.229999999999997 109.116 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 t -155.03 176.08 13.0 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 106.586 -1.635 . . . . 74.219999999999999 106.586 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 t -159.69 169.37 23.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.546 1.539 . . . . 60.32 107.388 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.99 168.48 18.97 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.005 -1.238 . . . . 75.439999999999998 110.005 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.0 m -139.85 159.15 42.82 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.25 1.42 . . . . 72.209999999999994 107.91 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 p -155.52 159.82 40.04 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 121.608 -0.682 . . . . 72.099999999999994 109.639 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.42 92.07 1.64 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 106.904 -2.478 . . . . 73.010000000000005 106.904 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.37 80.55 0.37 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.108 0.963 . . . . 73.030000000000001 110.053 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -65.53 -175.98 0.3 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.34 2.256 . . . . 75.310000000000002 112.341 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.8 173.35 33.84 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 120.808 -1.183 . . . . 70.239999999999995 110.278 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.81 171.42 7.65 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.781 1.233 . . . . 70.120000000000005 109.401 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.419 ' CD ' HE22 ' A' ' 14' ' ' GLN . 0.2 OUTLIER -123.4 126.28 46.51 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 105.734 -1.95 . . . . 74.340000000000003 105.734 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.31 179.48 7.06 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.785 1.634 . . . . 75.140000000000001 107.296 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.419 HE22 ' CD ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -165.27 -175.5 3.65 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.48 1.512 . . . . 74.319999999999993 108.694 -179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.48 -171.42 2.14 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.632 1.573 . . . . 75.129999999999995 110.912 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -78.31 155.47 79.28 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.575 0.75 . . . . 74.540000000000006 109.493 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.38 167.61 21.85 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.867 1.711 . . . . 72.409999999999997 110.11 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.36 156.36 16.0 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.752 -0.658 . . . . 72.430000000000007 110.684 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 168.79 18.14 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.809 1.644 . . . . 71.219999999999999 109.595 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 99.3 mt -86.0 164.48 17.36 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.557 0.743 . . . . 64.299999999999997 110.162 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -67.01 155.18 90.89 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.427 0.691 . . . . 73.209999999999994 110.082 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.11 176.84 9.0 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.932 2.422 . . . . 73.400000000000006 110.936 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.51 172.07 32.26 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 121.741 0.634 . . . . 71.430000000000007 111.526 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -58.55 135.39 57.31 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.312 1.045 . . . . 74.219999999999999 109.395 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.19 30.01 4.58 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.225 1.41 . . . . 63.439999999999998 110.136 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.31 175.7 2.09 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.264 1.026 . . . . 64.409999999999997 109.865 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.6 t -87.76 170.59 11.09 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.98 -1.075 . . . . 73.239999999999995 108.954 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.0 m -139.83 146.28 39.17 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.646 -1.242 . . . . 74.239999999999995 107.646 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 t -68.57 133.33 31.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 125.427 1.491 . . . . 64.400000000000006 111.546 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -75.66 154.66 36.42 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.206 -1.035 . . . . 72.239999999999995 108.206 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.5 t -72.53 146.67 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.963 -1.086 . . . . 74.510000000000005 108.42 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.76 166.47 23.21 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.487 1.515 . . . . 65.219999999999999 107.75 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -136.43 73.23 0.44 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 123.931 0.777 . . . . 53.039999999999999 111.447 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 -146.14 168.73 20.27 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 124.593 1.157 . . . . 75.329999999999998 109.483 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -147.54 -178.44 6.25 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 127.338 2.255 . . . . 73.030000000000001 108.462 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 52.59 38.37 25.68 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.191 2.197 . . . . 71.230000000000004 116.247 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -64.4 3.08 Favored Pre-proline 0 CA--C 1.537 0.448 0 O-C-N 121.212 -0.93 . . . . 75.450000000000003 113.487 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.07 133.27 24.62 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.137 1.891 . . . . 72.439999999999998 110.781 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.14 173.18 3.96 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.882 0.739 . . . . 75.530000000000001 110.025 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.9 mt 53.23 82.0 0.08 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 127.657 2.383 . . . . 75.040000000000006 111.237 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.8 154.73 87.11 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 109.616 -0.512 . . . . 65.019999999999996 109.616 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.82 147.94 57.11 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.436 2.091 . . . . 75.129999999999995 109.702 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.62 138.35 22.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.161 -1.051 . . . . 74.030000000000001 108.161 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -91.9 111.01 22.38 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.488 1.515 . . . . 64.439999999999998 111.544 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -66.65 -25.92 66.81 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.964 1.706 . . . . 75.099999999999994 113.245 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -80.01 -11.19 59.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.423 1.01 . . . . 73.209999999999994 112.096 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -101.02 9.89 41.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.449 1.1 . . . . 75.200000000000003 111.315 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.3 175.82 5.58 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.359 -0.838 . . . . 73.310000000000002 112.847 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -125.38 135.63 52.61 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.424 2.29 . . . . 71.510000000000005 106.038 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -126.72 166.28 17.68 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.134 1.374 . . . . 72.319999999999993 111.464 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -137.66 177.51 7.81 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.025 1.33 . . . . 74.310000000000002 108.658 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -135.07 163.6 29.54 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.81 2.044 . . . . 73.310000000000002 107.256 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.38 117.09 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.479 -1.675 . . . . 70.450000000000003 106.479 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.48 11.17 38.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.41 1.084 . . . . 71.109999999999999 110.868 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.43 89.16 2.1 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 105.493 -3.043 . . . . 75.450000000000003 105.493 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -127.05 20.56 6.92 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.926 1.29 . . . . 73.219999999999999 110.754 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.27 170.7 38.54 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 128.537 2.97 . . . . 73.310000000000002 106.586 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.94 160.66 47.1 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.112 1.875 . . . . 60.409999999999997 110.519 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.69 -62.59 2.01 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 108.757 -1.737 . . . . 45.229999999999997 108.757 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.54 -59.78 1.6 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.879 1.704 . . . . 72.530000000000001 113.283 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -42.91 103.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 128.968 2.907 . . . . 75.120000000000005 110.32 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 47.82 34.94 4.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.977 1.311 . . . . 73.319999999999993 112.291 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.9 p 52.39 36.64 20.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.179 1.392 . . . . 64.409999999999997 111.533 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -51.65 100.82 0.03 OUTLIER 'General case' 0 C--N 1.342 0.241 0 C-N-CA 125.431 1.492 . . . . 71.299999999999997 112.723 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -66.94 -10.77 52.65 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.801 0.841 . . . . 71.150000000000006 111.514 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.3 p -122.16 123.56 41.8 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 106.189 -1.782 . . . . 71.329999999999998 106.189 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 m -72.59 45.66 0.14 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.294 1.837 . . . . 74.439999999999998 113.824 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -67.16 92.29 0.25 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.132 -0.98 . . . . 75.439999999999998 109.395 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.3 p -150.18 154.73 38.51 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.693 -1.254 . . . . 71.409999999999997 107.939 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.3 152.49 27.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 123.813 0.845 . . . . 74.340000000000003 109.325 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.59 141.65 42.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.221 -1.399 . . . . 74.420000000000002 107.221 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.9 tp -129.03 154.6 46.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.495 0.718 . . . . 72.019999999999996 110.798 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 75' ' ' VAL . 1.5 tmtp? -143.71 155.59 44.26 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.369 1.068 . . . . 70.150000000000006 108.183 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -122.24 120.43 34.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.687 -1.968 . . . . 74.420000000000002 105.687 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.438 ' HA ' ' HE2' ' A' ' 73' ' ' LYS . 39.7 t -66.26 -56.46 16.1 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.746 1.218 . . . . 73.140000000000001 111.884 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.66 -12.96 38.0 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.634 2.222 . . . . 73.120000000000005 115.709 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 t -113.64 -16.44 12.34 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.846 0.748 . . . . 71.150000000000006 110.453 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.56 9.39 37.72 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.591 1.091 . . . . 63.340000000000003 113.662 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.8 mt -79.89 145.86 8.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.482 1.113 . . . . 74.209999999999994 108.283 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 t -131.3 143.69 39.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.103 -1.814 . . . . 75.319999999999993 106.103 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -146.95 155.06 11.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.283 -0.636 . . . . 75.019999999999996 109.283 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.87 133.23 41.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.415 -0.957 . . . . 73.310000000000002 108.415 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.98 160.35 41.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.153 0.981 . . . . 72.329999999999998 111.163 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -155.52 134.37 12.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.425 2.29 . . . . 75.439999999999998 106.001 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -153.13 -51.43 0.1 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.724 -0.843 . . . . 74.209999999999994 108.724 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.8 p -109.62 170.88 7.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.352 1.032 . . . . 72.450000000000003 110.825 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -92.38 -16.74 25.57 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.156 0.982 . . . . 73.420000000000002 108.901 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -78.94 115.79 18.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.495 -0.928 . . . . 61.32 108.495 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.2 p -62.96 -37.73 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.642 -1.244 . . . . 73.420000000000002 107.642 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.79 -49.62 72.69 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.664 1.586 . . . . 62.399999999999999 108.718 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.3 -48.24 62.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.655 0.782 . . . . 75.409999999999997 110.949 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -52.74 -38.05 60.29 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.753 0.821 . . . . 75.200000000000003 111.243 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -54.86 -48.45 72.89 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.823 0.738 . . . . 75.5 109.335 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -64.0 -37.2 86.54 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.517 -0.739 . . . . 73.109999999999999 111.389 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.3 mt -63.66 -47.31 91.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.362 -0.977 . . . . 75.510000000000005 108.362 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.88 97.77 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.206 0.602 . . . . 74.439999999999998 109.894 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -57.39 -44.58 84.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.838 0.855 . . . . 74.430000000000007 109.82 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.7 -55.57 33.09 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.409 0.684 . . . . 74.439999999999998 110.237 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.47 -23.8 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 113.677 0.992 . . . . 74.450000000000003 113.677 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.5 tp -70.38 -38.7 74.76 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.561 -1.337 . . . . 74.540000000000006 110.626 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -55.15 -47.92 74.42 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.756 1.222 . . . . 61.32 114.014 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.75 -28.73 70.17 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.372 0.669 . . . . 74.120000000000005 111.509 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -77.42 -35.96 53.63 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.236 -0.915 . . . . 75.239999999999995 110.115 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.1 t -67.07 -33.99 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.151 -1.055 . . . . 75.140000000000001 108.151 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -56.59 -47.23 80.02 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.889 1.222 . . . . 71.450000000000003 108.894 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.64 -15.14 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.555 1.142 . . . . 74.439999999999998 111.891 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -82.49 -22.19 35.21 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.759 -1.213 . . . . 72.25 109.7 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -96.85 -53.29 3.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.301 1.441 . . . . 74.219999999999999 109.825 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -72.45 -16.41 61.82 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.634 0.605 . . . . 70.450000000000003 112.634 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.75 -156.62 0.7 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.587 1.955 . . . . 74.540000000000006 106.796 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.3 166.76 11.98 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 119.943 1.247 . . . . 60.109999999999999 110.615 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.08 -31.54 90.86 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.628 2.219 . . . . 62.240000000000002 111.877 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.4 t -67.92 -30.23 69.5 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.467 0.707 . . . . 73.209999999999994 110.553 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.0 t -94.04 -33.35 13.43 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.996 1.319 . . . . 74.329999999999998 113.385 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.847 0 CA-C-O 116.238 -2.423 . . . . 64.519999999999996 109.128 -178.897 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.146 0 N-CA-C 108.637 -1.785 . . . . 74.319999999999993 108.637 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 m -138.6 168.93 18.73 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.966 -1.124 . . . . 72.019999999999996 107.966 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.4 t -158.15 172.4 18.47 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.788 -1.189 . . . . 61.219999999999999 107.788 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.65 168.25 25.36 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 127.095 2.283 . . . . 75.450000000000003 107.847 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.1 p -159.22 165.81 32.79 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.547 1.173 . . . . 64.049999999999997 109.981 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.4 t -99.56 65.32 1.36 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.31 -1.737 . . . . 73.329999999999998 106.31 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.25 71.82 0.45 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 126.375 1.94 . . . . 74.129999999999995 112.441 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -85.01 142.33 29.68 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.749 -1.204 . . . . 75.040000000000006 107.749 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -151.26 177.57 10.1 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.849 1.66 . . . . 73.239999999999995 106.663 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.53 170.91 41.23 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.566 -1.414 . . . . 62.32 109.566 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 mp -83.63 160.87 21.29 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.664 -0.865 . . . . 71.310000000000002 108.664 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.0 tpt85 -111.62 131.04 55.54 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 104.943 -2.243 . . . . 75.120000000000005 104.943 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.2 152.65 20.78 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 105.824 -1.917 . . . . 75.310000000000002 105.824 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.05 -171.01 1.07 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 128.558 2.743 . . . . 73.200000000000003 105.592 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -143.34 158.58 43.52 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.515 -0.92 . . . . 74.400000000000006 108.515 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -63.07 152.47 83.93 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 128.318 2.647 . . . . 75.420000000000002 111.197 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.25 146.73 28.63 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.393 2.062 . . . . 74.010000000000005 108.96 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.06 127.86 32.54 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.87 -0.789 . . . . 73.239999999999995 108.87 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -83.94 171.13 13.3 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.153 0.581 . . . . 74.319999999999993 109.943 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -127.57 177.36 6.82 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.573 1.549 . . . . 74.439999999999998 109.864 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -127.23 156.85 74.04 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.078 1.751 . . . . 74.120000000000005 109.125 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.33 168.77 24.03 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.793 2.328 . . . . 71.340000000000003 111.787 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.71 -87.63 0.86 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.714 -1.355 . . . . 73.310000000000002 109.714 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.2 tpt -146.57 160.83 41.64 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.628 1.171 . . . . 73.140000000000001 107.896 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.54 61.73 1.15 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.304 1.041 . . . . 75.129999999999995 109.772 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.08 150.75 38.76 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.87 -0.789 . . . . 62.200000000000003 108.87 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.6 t -79.18 -178.98 6.46 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.772 0.796 . . . . 72.519999999999996 110.668 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 m -112.38 156.67 22.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.218 1.807 . . . . 73.510000000000005 106.914 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.7 t -118.11 159.53 18.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.302 -1.37 . . . . 72.299999999999997 107.302 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -102.66 138.77 39.13 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.513 -1.292 . . . . 71.430000000000007 107.513 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.01 146.75 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 122.006 0.908 . . . . 74.409999999999997 110.35 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.27 170.91 9.71 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 129.322 3.049 . . . . 73.030000000000001 106.342 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.16 -151.7 23.45 Favored Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 108.319 -1.912 . . . . 72.340000000000003 108.319 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.45 ' HD2' ' H ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -64.38 178.04 0.78 Allowed 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.755 0.788 . . . . 73.219999999999999 110.099 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -148.56 178.15 8.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.941 -1.503 . . . . 75.439999999999998 106.941 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 40.13 54.96 2.73 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.715 2.006 . . . . 74.120000000000005 113.172 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.57 -59.65 10.14 Favored Pre-proline 0 C--O 1.236 0.345 0 O-C-N 120.399 -1.438 . . . . 74.530000000000001 112.856 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -69.1 -176.08 1.19 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.85 2.367 . . . . 71.239999999999995 108.669 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.96 172.03 13.37 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.434 -0.791 . . . . 72.109999999999999 109.716 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.6 mt 48.84 68.12 0.76 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.706 2.402 . . . . 73.209999999999994 111.355 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 74.5 mt -49.07 147.26 5.03 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 124.653 1.181 . . . . 75.409999999999997 111.79 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.26 150.68 59.53 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.145 2.564 . . . . 75.140000000000001 109.314 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.576 0.2 OUTLIER -122.6 150.86 42.07 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.329 -0.857 . . . . 73.200000000000003 112.074 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -94.56 107.77 19.75 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.529 1.532 . . . . 73.129999999999995 112.034 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -70.16 -19.26 63.21 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.601 0.963 . . . . 73.420000000000002 113.601 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.5 m -87.95 10.36 19.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.325 1.45 . . . . 75.109999999999999 112.015 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -128.12 -1.52 5.79 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.5 1.12 . . . . 74.310000000000002 111.55 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -103.42 160.68 14.5 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.917 -1.142 . . . . 70.310000000000002 107.917 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -103.83 156.28 17.95 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 126.46 1.904 . . . . 74.5 108.126 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.71 136.5 53.91 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.582 -0.896 . . . . 73.030000000000001 108.582 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -152.25 156.55 39.92 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.187 0.994 . . . . 74.439999999999998 111.004 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -135.55 164.36 28.0 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 127.037 2.135 . . . . 74.040000000000006 109.679 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -130.93 106.72 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 102.816 -3.031 . . . . 74.040000000000006 102.816 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -85.6 -21.41 28.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.452 -1.249 . . . . 74.129999999999995 112.178 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.21 170.91 43.66 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.198 -1.161 . . . . 73.519999999999996 110.198 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -93.12 -35.57 13.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.792 0.437 . . . . 75.0 110.901 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.78 -173.03 33.2 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 108.392 -1.883 . . . . 54.119999999999997 108.392 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.69 176.7 9.01 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.251 2.634 . . . . 65.430000000000007 110.091 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.71 174.06 17.1 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.766 -1.734 . . . . 71.409999999999997 108.766 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.3 -3.12 8.29 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 115.602 1.001 . . . . 72.310000000000002 115.602 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -157.91 -70.57 0.09 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.74 -1.948 . . . . 75.25 105.74 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.16 164.53 38.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.27 1.828 . . . . 71.230000000000004 106.882 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.6 m -158.52 142.28 15.33 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 105.819 -1.919 . . . . 74.299999999999997 105.819 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -134.4 92.93 2.99 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 106.98 -1.489 . . . . 75.019999999999996 106.98 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -152.25 80.52 1.25 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.078 -1.082 . . . . 72.120000000000005 108.078 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 p -73.3 169.09 17.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.023 0.929 . . . . 72.310000000000002 109.977 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 t -161.66 170.92 18.84 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.584 1.154 . . . . 74.519999999999996 108.367 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -121.7 31.89 6.09 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.874 1.669 . . . . 72.099999999999994 108.206 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.6 m -57.98 131.3 50.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.07 1.348 . . . . 75.040000000000006 112.176 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.1 t -122.53 136.3 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.116 -1.809 . . . . 73.349999999999994 106.116 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.84 153.24 29.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.132 -1.803 . . . . 75.439999999999998 106.132 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp -141.22 142.89 33.93 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.177 -1.416 . . . . 64.420000000000002 107.177 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -136.11 134.12 38.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.796 -1.557 . . . . 73.530000000000001 106.796 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -86.03 140.05 30.62 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.756 -1.202 . . . . 73.239999999999995 107.756 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.3 t -71.67 -62.18 1.79 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 120.394 1.452 . . . . 72.409999999999997 111.616 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -70.4 -8.7 24.22 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.247 2.631 . . . . 74.349999999999994 116.242 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.0 m -120.74 -13.32 8.71 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.673 0.67 . . . . 74.25 112.509 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.04 -13.59 0.34 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.502 1.525 . . . . 65.530000000000001 115.584 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.4 mt -49.06 123.39 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 128.058 2.543 . . . . 74.319999999999993 110.316 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.25 142.63 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.863 1.265 . . . . 75.5 109.961 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.24 150.52 22.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.439 1.496 . . . . 74.420000000000002 108.018 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -122.87 115.02 21.28 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.298 1.439 . . . . 74.420000000000002 108.392 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 77.0 m -124.62 136.5 53.98 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.435 1.016 . . . . 75.420000000000002 111.982 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -156.34 111.81 2.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.241 -1.763 . . . . 75.340000000000003 106.241 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -147.43 -68.26 0.25 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.208 -1.404 . . . . 74.439999999999998 107.208 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -70.74 147.22 49.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.998 0.427 . . . . 72.109999999999999 110.287 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -67.83 -26.35 66.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.154 -0.684 . . . . 75.019999999999996 109.154 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 m -79.27 115.63 19.04 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 126.519 1.928 . . . . 61.25 111.25 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.68 -32.91 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 107.605 -1.258 . . . . 61.32 107.605 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -37.03 70.24 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.415 0.686 . . . . 73.040000000000006 110.986 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -79.61 -48.19 14.18 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.879 1.272 . . . . 74.140000000000001 109.738 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -53.24 -36.12 60.72 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.913 0.778 . . . . 74.439999999999998 110.085 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -57.3 -54.29 48.51 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.142 0.977 . . . . 73.430000000000007 109.424 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -59.45 -41.15 88.97 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 118.274 -0.869 . . . . 71.010000000000005 110.499 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.7 -49.09 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 124.554 1.159 . . . . 74.230000000000004 108.872 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.17 -43.46 98.85 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.981 -0.449 . . . . 74.430000000000007 110.608 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.63 -49.85 73.55 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.814 0.445 . . . . 75.329999999999998 111.112 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -44.09 97.0 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 118.448 -0.787 . . . . 73.140000000000001 112.013 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.85 -36.88 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 119.645 1.111 . . . . 72.099999999999994 109.027 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.18 -39.01 88.56 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 118.616 -0.707 . . . . 75.230000000000004 110.496 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -59.21 -23.75 62.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.247 0.93 . . . . 64.340000000000003 111.933 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -78.45 -25.96 46.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.807 1.185 . . . . 73.030000000000001 109.506 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -82.0 -44.35 16.79 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.896 1.279 . . . . 64.120000000000005 110.963 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.2 t -58.79 -41.92 83.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 N-CA-C 108.335 -0.987 . . . . 72.519999999999996 108.335 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.19 -64.9 0.69 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.095 0.558 . . . . 73.409999999999997 111.809 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.43 -32.6 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.409 1.084 . . . . 75.329999999999998 111.095 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -67.29 -42.97 82.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.395 0.543 . . . . 71.5 109.775 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -67.79 -29.52 68.73 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.538 0.735 . . . . 71.230000000000004 109.501 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -79.56 -35.36 39.9 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.555 0.742 . . . . 75.230000000000004 111.62 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t -126.67 98.52 5.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.161 1.384 . . . . 75.420000000000002 111.908 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.88 58.45 0.26 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-O 118.031 -1.427 . . . . 61.329999999999998 115.153 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.7 -27.58 18.13 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 CA-C-N 121.201 2.5 . . . . 73.239999999999995 110.429 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.8 t -88.54 -4.85 58.51 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.34 -0.85 . . . . 74.530000000000001 109.864 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.9 m -103.09 173.81 6.14 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.085 1.354 . . . . 75.299999999999997 110.088 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 N-CA-C 103.172 -3.971 . . . . 62.140000000000001 103.172 -179.735 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.137 0 N-CA-C 109.005 -1.638 . . . . 74.239999999999995 109.005 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.8 m -137.53 173.01 12.11 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.378 1.071 . . . . 63.130000000000003 108.492 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.9 m -154.19 178.81 9.57 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.061 1.744 . . . . 70.400000000000006 107.502 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.66 62.85 2.34 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.526 1.06 . . . . 64.129999999999995 111.966 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 t -63.53 109.36 1.62 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.208 1.403 . . . . 72.230000000000004 107.944 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t -156.45 178.9 9.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.629 1.171 . . . . 74.109999999999999 108.394 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 154.24 113.26 0.49 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 108.236 -1.945 . . . . 71.25 108.236 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -148.54 140.28 23.69 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 105.784 -1.932 . . . . 60.240000000000002 105.784 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -149.09 166.16 29.58 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.792 1.237 . . . . 75.129999999999995 108.336 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.11 154.24 6.65 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 109.3 -1.52 . . . . 71.219999999999999 109.3 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.6 mt -149.47 154.95 39.6 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.564 1.546 . . . . 71.329999999999998 107.293 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.15 117.36 1.93 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.083 -1.821 . . . . 72.439999999999998 106.083 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.32 164.56 12.21 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.254 -1.388 . . . . 70.319999999999993 107.254 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HA ' HE21 ' A' ' 14' ' ' GLN . 0.0 OUTLIER -158.46 66.04 0.44 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.752 1.16 . . . . 72.129999999999995 114.03 -177.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -85.23 177.47 7.84 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.723 0.773 . . . . 73.200000000000003 111.073 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -141.47 158.18 64.03 Favored Pre-proline 0 C--O 1.231 0.1 0 C-N-CA 124.378 1.071 . . . . 71.030000000000001 110.031 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.02 143.07 43.84 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.828 1.685 . . . . 75.230000000000004 108.065 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.48 154.29 38.76 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.081 -0.711 . . . . 74.510000000000005 109.081 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.6 tp -155.96 152.35 28.07 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.645 -1.613 . . . . 74.329999999999998 106.645 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.65 177.92 7.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.712 2.005 . . . . 71.549999999999997 108.041 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -125.48 152.4 71.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 125.04 1.336 . . . . 73.329999999999998 107.45 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.89 161.61 41.04 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.88 1.72 . . . . 70.349999999999994 109.92 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.56 165.49 20.63 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 108.021 -2.032 . . . . 42.109999999999999 108.021 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 42.5 ttm -144.69 130.91 19.55 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.548 -0.908 . . . . 74.530000000000001 108.548 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.9 58.99 0.92 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.576 -2.009 . . . . 72.310000000000002 105.576 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.27 178.21 7.57 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.548 1.139 . . . . 74.5 108.999 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.0 t -60.31 140.56 57.03 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.453 -1.314 . . . . 65.409999999999997 107.453 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 m -139.36 134.51 32.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.174 -1.788 . . . . 74.319999999999993 106.174 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.52 157.96 39.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.653 0.781 . . . . 75.340000000000003 109.272 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -144.61 172.91 12.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.159 1.383 . . . . 73.329999999999998 109.339 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.54 166.82 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.933 1.693 . . . . 72.010000000000005 107.828 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.04 175.24 9.75 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.658 1.183 . . . . 65.209999999999994 110.122 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -131.73 91.9 0.28 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.929 -1.268 . . . . 53.229999999999997 109.929 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -140.7 146.22 37.52 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.508 0.654 . . . . 74.150000000000006 109.71 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -150.4 23.07 0.82 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 127.0 2.12 . . . . 75.439999999999998 108.875 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -121.41 36.03 4.72 Favored 'General case' 0 N--CA 1.46 0.057 0 N-CA-C 114.256 1.206 . . . . 75.150000000000006 114.256 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -60.86 3.56 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.383 -1.34 . . . . 74.299999999999997 107.383 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -70.71 177.23 6.47 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.296 3.331 . . . . 75.200000000000003 111.299 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.0 144.4 31.65 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.353 1.061 . . . . 62.119999999999997 110.801 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.9 mt 11.88 77.61 0.01 OUTLIER 'General case' 0 C--O 1.241 0.641 0 C-N-CA 130.834 3.654 . . . . 74.439999999999998 113.832 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.8 mt -55.89 154.34 14.4 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 114.554 -1.203 . . . . 71.349999999999994 109.86 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.95 160.84 46.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.668 1.579 . . . . 75.109999999999999 111.901 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.26 143.45 17.86 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 127.801 2.44 . . . . 71.530000000000001 104.429 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -114.67 102.28 9.88 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.037 0.935 . . . . 73.0 109.586 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -57.15 -27.6 62.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.373 0.533 . . . . 73.319999999999993 112.32 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -78.78 7.27 7.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.491 1.917 . . . . 73.099999999999994 112.981 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -127.0 4.87 6.5 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.616 1.566 . . . . 75.409999999999997 111.656 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.4 mt -94.01 176.66 6.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 122.119 0.961 . . . . 75.430000000000007 113.029 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -108.5 131.55 54.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 102.223 -3.251 . . . . 64.040000000000006 102.223 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -128.8 164.63 22.62 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.213 1.005 . . . . 73.120000000000005 108.545 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.65 160.62 42.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.384 -0.969 . . . . 71.549999999999997 108.384 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -109.7 135.64 50.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.131 1.372 . . . . 65.219999999999999 108.08 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.3 t -87.3 139.61 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.048 -1.464 . . . . 75.540000000000006 107.048 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -125.44 4.56 7.66 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.756 1.021 . . . . 74.030000000000001 113.756 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.29 -133.14 13.5 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.838 -2.105 . . . . 45.409999999999997 107.838 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -61.32 146.22 48.8 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.626 0.727 . . . . 74.200000000000003 110.866 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.44 174.89 36.23 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 127.108 2.289 . . . . 54.219999999999999 107.618 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.7 167.52 24.11 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.189 1.926 . . . . 74.209999999999994 109.351 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.22 35.09 91.54 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.643 -1.383 . . . . 71.25 109.643 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.28 149.76 13.41 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 108.004 -2.038 . . . . 73.099999999999994 108.004 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -146.71 11.93 1.12 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.742 0.817 . . . . 72.510000000000005 112.541 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.06 -9.52 31.58 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.142 1.534 . . . . 74.099999999999994 115.142 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 m 61.75 7.38 1.93 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.603 1.161 . . . . 74.409999999999997 111.887 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -58.4 144.48 41.72 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.185 1.394 . . . . 71.310000000000002 111.728 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -78.95 165.6 23.29 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.804 1.242 . . . . 71.040000000000006 110.62 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.3 p -81.23 122.78 27.84 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.118 -1.808 . . . . 74.430000000000007 106.118 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.0 t -164.73 -177.14 4.59 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.964 0.906 . . . . 73.109999999999999 108.863 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -67.52 105.58 1.89 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.075 1.75 . . . . 70.25 107.936 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.9 m -143.47 148.76 36.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.985 1.714 . . . . 74.310000000000002 107.276 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t -144.63 157.3 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.891 -1.522 . . . . 73.310000000000002 106.891 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.17 139.61 26.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.766 -1.939 . . . . 73.25 105.766 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 tp -139.48 143.73 37.65 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.414 -1.328 . . . . 74.439999999999998 107.414 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -131.5 158.42 40.94 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 123.186 0.594 . . . . 74.329999999999998 109.407 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -104.16 114.45 28.7 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 102.443 -3.169 . . . . 74.109999999999999 102.443 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.99 -62.12 5.74 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 119.187 0.903 . . . . 75.430000000000007 111.69 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -65.04 -14.67 46.55 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.791 2.994 . . . . 53.439999999999998 116.622 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.2 t -112.3 -10.6 13.8 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.564 1.075 . . . . 72.099999999999994 111.123 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.2 3.47 6.67 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.268 1.413 . . . . 73.25 113.896 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -66.87 149.19 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 120.024 1.912 . . . . 74.439999999999998 108.179 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.4 t -136.69 135.32 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.154 -1.795 . . . . 73.319999999999993 106.154 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.0 146.94 24.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 106.888 -1.523 . . . . 74.040000000000006 106.888 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -127.44 119.75 26.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.136 0.974 . . . . 74.310000000000002 108.961 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.1 m -139.32 149.29 44.04 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.563 1.545 . . . . 72.329999999999998 109.767 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -155.11 121.25 5.21 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.455 -2.054 . . . . 72.349999999999994 105.455 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -133.22 -48.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.891 0.876 . . . . 75.530000000000001 110.769 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.3 p -101.73 158.33 16.19 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.51 1.124 . . . . 72.129999999999995 111.738 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -71.9 -30.21 65.14 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 118.065 -0.969 . . . . 74.049999999999997 111.373 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -79.44 123.92 27.98 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 119.917 1.235 . . . . 72.510000000000005 110.275 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.96 -38.77 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.346 1.058 . . . . 62.109999999999999 109.041 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -44.14 76.57 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.304 1.442 . . . . 75.409999999999997 110.721 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -40.23 62.04 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.718 0.807 . . . . 73.299999999999997 110.386 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -55.86 -32.94 64.08 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.741 0.7 . . . . 65.140000000000001 110.554 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -57.54 -45.19 85.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.593 0.633 . . . . 74.409999999999997 110.875 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -61.21 -31.76 71.53 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 118.679 0.672 . . . . 75.109999999999999 111.739 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.3 mt -74.06 -40.21 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.695 -0.854 . . . . 75.230000000000004 108.695 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.23 -47.59 73.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 122.897 0.479 . . . . 73.209999999999994 110.541 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -31.5 72.11 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 120.526 -0.47 . . . . 74.099999999999994 111.103 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -61.32 2.15 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.507 -1.294 . . . . 72.549999999999997 107.507 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -55.65 -35.83 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 118.683 0.674 . . . . 72.120000000000005 111.254 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.49 -32.57 74.06 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.455 -0.783 . . . . 71.329999999999998 111.474 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -61.17 -41.67 97.2 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 119.426 1.012 . . . . 74.239999999999995 110.531 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.81 -36.29 78.67 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.516 -0.92 . . . . 64.329999999999998 108.516 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -72.16 -51.8 19.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.433 -0.794 . . . . 75.430000000000007 111.403 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.06 -44.17 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 C-N-CA 124.352 1.061 . . . . 75.299999999999997 109.891 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -50.87 -63.74 1.03 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.003 0.921 . . . . 74.439999999999998 110.656 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.84 -24.56 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 112.589 0.589 . . . . 74.439999999999998 112.589 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -66.38 -45.28 80.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.617 1.099 . . . . 74.409999999999997 108.664 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -63.51 -46.22 87.07 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.513 -1.291 . . . . 75.329999999999998 107.513 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 -70.71 -3.27 17.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.219 1.407 . . . . 74.209999999999994 112.624 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.5 t -153.49 85.87 1.2 Allowed 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.416 1.086 . . . . 63.43 111.058 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -146.22 -170.76 15.06 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 108.96 -1.656 . . . . 72.200000000000003 108.96 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.74 -17.12 26.19 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.224 1.949 . . . . 73.400000000000006 110.725 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.8 p -148.97 -175.62 5.02 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 128.566 2.746 . . . . 75.129999999999995 107.336 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 t -153.45 145.76 23.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.225 2.21 . . . . 75.510000000000005 105.476 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 N-CA-C 108.437 -1.865 . . . . 63.009999999999998 108.437 -179.551 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 108.93 -0.767 . . . . 72.35 108.93 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -124.61 154.9 70.01 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.005 1.322 . . . . 74.41 108.67 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.29 166.18 30.1 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.553 2.168 . . . . 61.52 111.02 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.51 173.39 16.95 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.872 -1.291 . . . . 74.43 109.872 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.93 166.44 23.64 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.439 -0.448 . . . . 74.35 110.2 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.02 80.61 1.58 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.5 -2.407 . . . . 52.15 104.5 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.57 -174.42 4.27 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.853 0.861 . . . . 52.34 111.463 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -143.94 164.33 30.88 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.761 1.224 . . . . 74.53 108.708 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 t -147.98 165.71 29.9 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.403 0.62 . . . . 44.03 110.88 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.09 156.11 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 126.869 2.068 . . . . 64.31 111.04 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -119.3 173.85 6.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.487 1.515 . . . . 72.44 109.715 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.2 m -64.21 172.45 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.338 0.655 . . . . 54.04 110.578 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.74 -21.23 52.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 114.327 1.232 . . . . 73.43 114.327 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.57 -69.57 3.27 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 107.587 -2.205 . . . . 45.12 107.587 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? . . . . . 0 C--O 1.235 0.336 0 N-CA-C 106.953 -1.499 . . . . 63.31 106.953 177.648 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 C--O 1.233 0.214 0 N-CA-C 112.763 0.653 . . . . 54.02 112.763 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.87 112.21 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.859 2.373 . . . . 61.23 108.661 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.67 104.66 16.59 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.201 -1.407 . . . . 71.51 107.201 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -65.79 104.79 1.13 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.485 1.514 . . . . 72.44 109.923 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -62.86 -27.45 69.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.065 0.765 . . . . 62.21 113.065 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 m -79.4 6.57 9.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.396 0.998 . . . . 62.15 111.257 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -117.64 11.34 13.69 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.7 1.6 . . . . 61.55 111.743 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.0 mt -111.78 165.17 12.29 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.469 1.108 . . . . 52.42 111.16 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -132.22 127.0 34.85 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.441 -2.059 . . . . 73.44 105.441 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.23 165.47 11.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.487 1.515 . . . . 61.12 110.85 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -140.35 160.54 39.74 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.46 1.504 . . . . 53.15 107.277 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -130.53 139.45 50.48 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.472 -0.566 . . . . 61.52 109.472 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 85.3 t . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 107.246 -1.39 . . . . 72.11 107.246 179.49 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.8 t30 . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 121.522 0.677 . . . . 73.42 110.741 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.9 t -68.03 112.48 5.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.28 -1.512 . . . . 71.23 107.588 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.4 t -94.57 139.77 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 104.269 -2.493 . . . . 71.43 104.269 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.52 138.45 49.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.348 -2.093 . . . . 32.22 105.348 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.2 tp -142.32 147.31 36.13 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.871 -1.529 . . . . 71.21 106.871 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.99 158.18 43.87 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.432 -0.951 . . . . 62.31 108.432 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 77' ' ' SER . 4.3 t-80 -93.94 134.39 36.37 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.059 -2.2 . . . . 64.12 105.059 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.3 t -65.11 -65.97 1.66 Allowed Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 117.894 -1.051 . . . . 71.43 111.894 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.18 -35.41 52.59 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.744 2.296 . . . . 64.33 113.759 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' A' ' 74' ' ' HIS . 12.6 t -85.36 -21.13 29.01 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.777 0.658 . . . . 64.31 112.777 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.88 2.86 5.23 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.437 1.494 . . . . 41.32 114.525 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.5 mt -67.05 130.96 32.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 119.791 1.796 . . . . 53.01 107.087 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.6 t -112.61 153.45 14.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.463 1.105 . . . . 71.22 109.05 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -149.74 142.43 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.796 0.838 . . . . 72.33 110.059 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -124.92 106.84 10.29 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.19 1.796 . . . . 62.43 108.315 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 9.9 t -117.94 155.36 30.36 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.689 1.196 . . . . 74.45 110.159 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -155.03 100.66 2.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.594 -1.632 . . . . 63.23 106.594 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.48 -37.43 4.95 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 122.86 0.464 . . . . 72.11 111.413 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.8 p -139.04 176.73 8.44 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.983 0.913 . . . . 52.13 111.623 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -1.51 56.35 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.678 1.191 . . . . 64.33 111.011 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.4 m -98.2 115.75 28.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.132 1.373 . . . . 65.22 109.968 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.54 -53.89 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.874 0.869 . . . . 64.31 111.243 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -22.81 67.07 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.984 1.475 . . . . 60.22 114.984 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -77.75 -46.1 22.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.435 -2.061 . . . . 74.13 105.435 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -59.63 -37.3 78.26 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 118.397 -0.811 . . . . 73.11 109.974 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -54.88 -55.5 29.8 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.694 1.198 . . . . 61.51 108.582 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -54.64 -47.36 73.59 Favored 'General case' 0 CA--C 1.506 -0.733 0 O-C-N 121.641 -0.662 . . . . 65.24 112.366 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.8 mt -64.67 -36.8 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.596 -0.729 . . . . 72.45 110.443 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.24 -38.73 82.12 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.451 -0.781 . . . . 71.41 109.182 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -61.39 -49.38 77.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.617 1.167 . . . . 72.41 110.182 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -46.53 88.92 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.435 -0.793 . . . . 74.33 111.238 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.86 -37.42 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.107 1.321 . . . . 73.22 110.643 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.1 tp -65.67 -37.63 87.05 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.525 -0.734 . . . . 63.23 109.89 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -58.44 -42.11 86.61 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.703 0.801 . . . . 73.14 110.423 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -61.84 -43.47 98.77 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.426 0.631 . . . . 74.24 109.698 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -67.51 -42.46 82.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 113.915 1.08 . . . . 61.44 113.915 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.61 -32.77 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 123.219 0.608 . . . . 63.44 109.715 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -53.92 -60.75 2.92 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.702 0.683 . . . . 74.25 110.128 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 17.5 t -59.64 -32.59 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.784 0.834 . . . . 62.11 110.826 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -65.95 -22.64 66.49 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.516 1.053 . . . . 63.44 111.679 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -99.04 -36.92 9.55 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.4 1.08 . . . . 61.53 109.808 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -79.19 -16.78 56.05 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.523 1.129 . . . . 74.34 111.883 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.448 -0.54 0 C-N-CA 126.376 1.87 . . . . 54.04 108.692 -179.634 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 109.615 -0.513 . . . . 75.44 109.615 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -125.44 155.02 72.43 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.758 1.623 . . . . 72.41 108.961 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.62 166.06 29.18 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.6 2.2 . . . . 73.11 111.326 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.56 -178.32 35.37 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.177 -1.169 . . . . 64.35 110.177 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.6 ttt -138.14 162.27 34.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.842 1.257 . . . . 73.02 107.843 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.67 83.99 1.17 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.235 -2.506 . . . . 62.41 104.235 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.46 152.01 34.42 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.484 -0.561 . . . . 55.3 109.484 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 t -79.52 -174.51 4.29 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.603 0.716 . . . . 71.3 111.531 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.3 p -115.41 -175.85 2.8 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.642 1.577 . . . . 65.31 111.891 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.0 m -67.24 177.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.684 1.194 . . . . 71.44 109.303 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.02 164.02 28.25 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.71 0.804 . . . . 75.52 110.663 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 t -69.67 128.51 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.688 -1.597 . . . . 75.31 106.688 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.53 177.09 6.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.066 0.946 . . . . 73.31 111.581 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.13 -165.16 29.12 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 124.457 1.027 . . . . 62.42 111.916 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 . . . . . 0 C--O 1.232 0.176 0 C-N-CA 124.429 1.092 . . . . 60.25 111.362 -179.642 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 119.34 -0.362 . . . . 71.32 111.688 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -69.33 154.89 68.76 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.619 2.212 . . . . 54.2 109.262 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.0 mt -137.42 163.47 31.0 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.083 1.353 . . . . 72.11 113.728 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -119.84 101.85 8.17 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 106.891 -1.522 . . . . 75.13 106.891 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -61.06 -23.63 65.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.223 0.609 . . . . 64.44 112.53 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 m -87.97 10.38 19.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.993 1.317 . . . . 41.53 112.452 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -121.51 14.68 11.12 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.124 1.37 . . . . 74.23 111.095 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.2 mt -99.2 166.61 11.15 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.178 -0.951 . . . . 64.14 111.738 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -127.28 94.11 3.91 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.568 -0.901 . . . . 72.22 108.568 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -95.01 164.69 12.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.086 0.946 . . . . 75.44 112.689 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -143.17 171.09 14.56 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.707 2.803 . . . . 62.12 105.54 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -131.0 139.4 49.98 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 107.025 -1.472 . . . . 75.03 107.025 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.236 0.39 0 N-CA-C 109.27 -0.641 . . . . 63.41 109.27 -178.557 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 118.478 -0.772 . . . . 73.03 110.883 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.6 t -59.49 145.87 42.43 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.666 1.121 . . . . 75.2 110.91 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.6 t -120.44 149.83 23.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.311 1.845 . . . . 72.44 108.872 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.17 155.71 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.151 -1.796 . . . . 74.44 106.151 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.7 tp -141.3 148.54 39.93 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.152 -1.425 . . . . 62.14 107.152 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -143.51 130.68 20.75 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 125.473 1.509 . . . . 71.12 110.509 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -97.15 117.24 30.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.64 -1.985 . . . . 74.43 105.64 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.52 -59.96 11.3 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.069 -1.443 . . . . 65.42 111.921 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.47 -14.56 35.76 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.997 2.465 . . . . 52.53 116.611 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -111.69 -19.55 12.43 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.512 0.596 . . . . 75.13 111.236 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.13 21.22 69.78 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.007 0.813 . . . . 65.45 111.389 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -91.24 136.4 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 125.142 1.377 . . . . 64.31 107.805 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.01 137.41 57.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.069 -1.456 . . . . 72.43 107.069 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.0 p -136.75 151.39 27.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.961 -0.755 . . . . 62.53 108.961 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -110.16 125.62 53.22 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.166 -1.79 . . . . 52.24 106.166 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.1 t -138.54 132.13 30.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 118.374 0.534 . . . . 60.11 109.897 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -153.91 100.28 2.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.173 0.589 . . . . 71.3 109.494 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -115.77 -70.47 0.79 Allowed 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.309 -0.997 . . . . 73.14 108.309 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.5 p -73.04 177.59 4.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.391 1.476 . . . . 71.31 109.618 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -98.64 -20.14 17.15 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.254 -1.529 . . . . 75.43 108.802 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.3 m -79.09 132.2 36.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.328 2.251 . . . . 75.45 110.444 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.32 -55.86 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.7 0.8 . . . . 74.41 112.917 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.63 -39.85 74.35 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.853 1.206 . . . . 74.32 112.583 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -67.6 -43.28 80.85 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.755 -0.831 . . . . 53.31 108.755 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -64.89 -37.75 88.66 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.974 -0.751 . . . . 72.53 108.974 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -59.95 -52.06 67.04 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.225 1.01 . . . . 72.33 109.992 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -63.03 -32.23 73.55 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.505 1.502 . . . . 64.43 112.025 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.04 -46.33 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.307 -1.738 . . . . 74.22 106.307 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.27 78.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.976 0.91 . . . . 74.52 109.842 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -40.57 94.06 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.425 -0.583 . . . . 75.31 109.425 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.65 -53.17 61.12 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.599 -0.688 . . . . 72.34 109.739 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.5 p -66.56 -32.01 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 113.068 0.766 . . . . 75.11 113.068 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.7 tp -67.74 -30.64 70.17 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.348 -0.845 . . . . 74.3 109.823 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -58.99 -31.37 68.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.011 1.324 . . . . 75.01 110.726 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.55 -48.88 53.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.114 0.966 . . . . 73.24 109.062 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -60.26 -46.28 90.37 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.899 0.88 . . . . 72.33 110.284 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.4 t -64.39 -37.95 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 118.044 -0.979 . . . . 54.11 110.175 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.39 -61.37 2.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.894 1.224 . . . . 71.03 110.642 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.4 p -56.61 -37.23 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 O-C-N 123.886 0.741 . . . . 70.22 109.55 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -62.72 -35.82 81.0 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.012 0.745 . . . . 65.22 113.012 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -73.55 -41.55 62.82 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.725 -0.843 . . . . 73.11 108.725 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -79.28 -0.26 31.61 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.4 1.259 . . . . 74.52 114.4 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 C--N 1.325 -0.477 0 C-N-CA 125.72 1.608 . . . . 70.41 112.697 178.23 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 121.164 0.507 . . . . 75.23 109.803 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -102.18 155.87 35.93 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.342 1.457 . . . . 72.52 109.914 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.11 167.68 26.41 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.754 2.302 . . . . 71.41 110.919 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.16 168.85 13.51 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.701 -0.96 . . . . 74.22 110.701 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.9 ptm -77.58 165.86 23.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.368 0.667 . . . . 75.32 110.3 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.43 88.88 1.73 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.046 -2.205 . . . . 73.24 105.046 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.32 176.94 6.01 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.492 -0.559 . . . . 64.22 109.492 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.51 -171.73 2.91 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.483 0.713 . . . . 53.22 111.183 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.1 p -141.35 162.85 34.49 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.403 1.481 . . . . 74.32 108.48 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 m -119.04 173.14 5.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.047 1.339 . . . . 64.33 109.683 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.01 177.31 10.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.873 2.469 . . . . 72.2 106.755 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.6 t -90.53 142.91 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 121.384 -0.822 . . . . 73.52 109.046 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.05 168.2 10.23 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.169 0.587 . . . . 73.31 109.611 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.25 175.02 46.15 Favored Glycine 0 CA--C 1.523 0.545 0 O-C-N 121.401 -0.812 . . . . 43.42 112.813 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 . . . . . 0 C--O 1.235 0.338 0 C-N-CA 125.433 1.493 . . . . 72.12 107.018 179.329 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 105' ' ' ASP . 2.0 mm? . . . . . 0 C--O 1.239 0.501 0 N-CA-C 108.379 -0.971 . . . . 73.41 108.379 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.92 138.76 31.93 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.739 1.626 . . . . 74.11 112.204 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.2 mt -127.88 143.24 51.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.156 1.382 . . . . 71.33 111.295 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -120.69 103.81 9.41 Favored 'General case' 0 N--CA 1.461 0.085 0 C-N-CA 126.509 1.924 . . . . 51.42 107.935 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.15 -19.51 20.68 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.085 1.513 . . . . 75.24 115.085 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.8 m -83.39 -6.58 59.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.241 0.928 . . . . 73.54 111.937 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -114.23 0.83 14.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.579 1.152 . . . . 74.21 110.911 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 mt -102.65 154.97 18.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.098 0.559 . . . . 72.35 111.146 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -113.61 156.57 23.44 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.144 2.178 . . . . 63.12 108.243 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.58 165.07 30.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.532 1.933 . . . . 74.03 107.076 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -138.56 170.07 16.66 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.563 -0.903 . . . . 75.35 108.563 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -118.16 162.91 17.45 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.649 0.779 . . . . 75.44 111.833 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 102.567 -3.123 . . . . 72.51 102.567 178.61 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.457 -0.095 0 N-CA-C 106.998 -1.482 . . . . 74.41 106.998 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.6 t -154.4 144.13 21.64 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 104.499 -2.408 . . . . 75.23 104.499 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.78 134.57 64.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.437 -1.32 . . . . 72.13 107.437 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -118.88 130.36 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 106.667 -1.605 . . . . 55.35 106.667 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.2 tp -123.03 142.57 50.71 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.643 -0.873 . . . . 71.3 108.643 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -137.25 132.38 33.7 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.222 1.409 . . . . 73.25 109.695 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.19 134.17 34.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.657 1.183 . . . . 72.23 110.034 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.41 -59.9 1.5 Allowed Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 118.098 -0.953 . . . . 73.32 112.554 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.55 -18.85 60.25 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.643 2.229 . . . . 52.01 116.492 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.3 p -120.23 -10.42 9.37 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.403 1.261 . . . . 61.34 114.403 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.4 2.93 29.58 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.366 -1.241 . . . . 60.5 113.116 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.3 mt -64.54 134.6 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.98 1.89 . . . . 72.11 109.606 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.22 151.08 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 107.87 -1.159 . . . . 51.22 107.87 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p -152.6 154.9 7.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 120.979 -1.076 . . . . 70.24 108.644 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -122.26 134.44 54.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.778 -1.193 . . . . 72.52 107.778 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 29.1 m -137.19 150.84 48.18 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.492 1.117 . . . . 54.52 112.231 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -155.07 149.2 25.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.917 2.087 . . . . 75.34 108.321 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -162.41 -78.61 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.506 -1.665 . . . . 61.43 106.506 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 t -102.61 175.68 5.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.654 1.982 . . . . 75.11 109.072 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -84.74 -17.5 38.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.691 -1.147 . . . . 74.43 109.719 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.7 m -83.79 115.92 22.46 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.701 1.137 . . . . 75.25 111.946 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.91 -40.27 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 118.581 -0.723 . . . . 72.22 109.808 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -38.42 35.29 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.662 1.185 . . . . 63.25 112.078 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -76.28 -52.44 9.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.271 1.028 . . . . 72.33 109.022 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -52.23 -32.44 36.77 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.905 1.282 . . . . 75.54 111.158 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -54.47 -50.44 67.73 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.797 0.839 . . . . 72.54 109.978 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -75.09 -24.85 58.19 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.907 1.077 . . . . 74.23 113.907 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 94.7 mt -67.47 -48.33 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.243 -1.391 . . . . 73.4 107.243 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.45 99.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.554 -0.716 . . . . 53.1 110.888 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -63.55 -48.77 76.12 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 118.809 -0.615 . . . . 65.35 111.229 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -58.69 -41.03 85.32 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 117.395 -1.288 . . . . 73.3 111.688 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.7 -36.94 67.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.623 1.102 . . . . 75.53 111.141 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 tp -64.61 -38.2 90.19 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 118.741 -0.647 . . . . 62.45 110.67 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -57.15 -34.3 68.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.713 0.688 . . . . 74.04 110.381 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -68.36 -32.91 73.33 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.294 0.638 . . . . 72.15 110.64 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -77.9 -38.85 44.83 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.532 -0.544 . . . . 65.32 109.532 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.8 t -58.7 -40.4 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.683 -0.858 . . . . 73.52 108.683 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.467 ' HA ' HD23 ' A' ' 41' ' ' LEU . 6.4 t70 -58.31 -60.59 3.53 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.092 0.86 . . . . 64.21 109.419 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.99 -37.67 34.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 125.067 1.347 . . . . 63.42 110.452 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -69.83 -42.61 73.38 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.904 0.882 . . . . 75.3 111.343 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -68.92 -33.81 74.36 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.714 -0.847 . . . . 74.33 108.714 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.04 -50.88 15.05 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.52 0.728 . . . . 74.35 109.832 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 CA--C 1.532 0.278 0 C-N-CA 128.407 2.683 . . . . 72.34 111.062 -177.546 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 121.088 0.471 . . . . 64.55 110.204 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -116.02 157.86 43.93 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.938 1.695 . . . . 75.23 110.353 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.87 178.55 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.415 2.744 . . . . 74.23 111.288 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.55 -79.24 0.04 OUTLIER Glycine 0 C--N 1.339 0.722 0 N-CA-C 111.482 -0.647 . . . . 41.54 111.482 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 28.3 ptm -67.1 147.86 52.61 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.796 0.798 . . . . 75.02 110.494 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.4 71.64 0.65 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.828 1.251 . . . . 51.31 108.194 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.47 154.59 34.57 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.517 -0.919 . . . . 74.14 108.517 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.4 t -123.01 -176.02 3.31 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.602 1.161 . . . . 51.41 112.06 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -68.57 167.51 14.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.588 1.955 . . . . 74.4 110.031 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 m -66.11 145.45 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 121.353 -0.842 . . . . 75.22 108.762 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -74.89 175.9 7.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.317 1.047 . . . . 73.14 113.825 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.89 151.64 7.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 128.176 2.59 . . . . 75.11 108.96 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.57 153.87 20.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.789 0.268 . . . . 74.51 111.265 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.38 -83.07 0.37 Allowed Glycine 0 C--N 1.336 0.556 0 C-N-CA 125.022 1.296 . . . . 42.31 111.599 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.271 0 N-CA-C 108.647 -0.871 . . . . 72.35 108.647 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 112.761 0.652 . . . . 73.22 112.761 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.72 131.01 14.14 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.631 2.887 . . . . 65.14 111.821 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.0 mt -104.98 134.39 48.17 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.335 1.054 . . . . 75.24 109.041 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -73.25 107.5 5.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.804 -0.813 . . . . 72.54 108.804 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -59.09 -25.13 63.52 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 122.021 -0.424 . . . . 74.3 111.972 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 m -83.9 7.17 19.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.183 1.393 . . . . 70.43 112.7 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -116.24 -2.67 12.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.556 1.542 . . . . 73.44 109.8 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.417 HD22 ' CD2' ' A' ' 74' ' ' HIS . 0.9 OUTLIER -104.78 138.61 40.8 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.539 -1.282 . . . . 75.32 107.539 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -103.3 134.8 46.09 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.066 -1.457 . . . . 74.01 107.066 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.51 164.74 11.65 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.113 1.765 . . . . 55.33 112.811 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -140.87 172.57 12.51 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.703 2.001 . . . . 74.0 109.833 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -134.4 158.61 43.4 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.504 1.121 . . . . 74.42 109.493 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.456 -0.151 0 N-CA-C 107.529 -1.286 . . . . 72.21 107.529 179.216 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 113.584 0.957 . . . . 73.05 113.584 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 t -65.36 130.12 42.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 118.992 0.814 . . . . 63.42 109.852 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.3 t -111.24 137.26 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 103.309 -2.849 . . . . 71.01 103.309 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -130.5 117.95 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 105.816 -1.92 . . . . 75.4 105.816 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.2 tp -135.4 150.61 49.93 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 104.701 -2.333 . . . . 72.15 104.701 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.5 158.69 43.8 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 123.942 0.897 . . . . 74.02 109.971 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.417 ' CD2' HD22 ' A' ' 48' ' ' LEU . 3.1 t-80 -91.89 135.59 33.81 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.134 -2.173 . . . . 75.24 105.134 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.5 t -71.04 -61.94 2.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 119.864 1.211 . . . . 55.25 113.171 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.25 -25.11 72.07 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 121.68 1.587 . . . . 63.14 114.708 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 t -98.36 -16.7 19.2 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.281 0.492 . . . . 73.24 112.104 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.33 12.52 12.83 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.426 1.489 . . . . 61.1 113.257 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 62.3 mt -70.95 116.18 12.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 119.591 1.695 . . . . 72.31 106.527 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.3 t -105.32 146.4 12.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.68 -1.23 . . . . 72.13 107.68 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.12 148.08 17.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.051 -1.092 . . . . 62.22 108.051 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -120.85 107.04 12.23 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.747 1.219 . . . . 71.01 107.975 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 58.5 m -136.02 148.55 48.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.226 0.61 . . . . 70.44 110.211 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -155.48 150.6 26.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.624 -1.621 . . . . 73.45 106.624 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.79 -36.07 0.24 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.759 0.424 . . . . 74.21 110.455 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.8 p -123.63 -178.6 4.07 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.213 1.405 . . . . 74.45 108.457 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.76 -13.39 34.08 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.054 -0.721 . . . . 73.11 109.054 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -79.42 115.12 18.87 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.851 -1.166 . . . . 74.02 107.851 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.4 -41.34 84.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.94 -1.133 . . . . 72.02 107.94 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -56.5 -48.43 77.2 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.427 2.291 . . . . 70.14 110.371 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -65.88 -45.08 83.38 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.263 0.625 . . . . 64.3 109.465 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -64.0 -32.7 74.34 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.429 0.692 . . . . 71.14 111.249 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -59.61 -46.72 88.13 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.624 1.102 . . . . 74.4 110.336 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -58.87 -48.97 79.51 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 118.563 0.62 . . . . 73.41 110.553 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.6 mt -54.55 -48.79 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 O-C-N 124.417 1.073 . . . . 63.14 110.277 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.72 98.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 122.831 0.452 . . . . 70.13 111.418 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.4 ttm-85 -64.26 -46.62 82.92 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 118.224 -0.893 . . . . 72.22 110.28 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -50.71 69.8 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 119.438 1.017 . . . . 64.32 110.995 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.7 p -63.08 -33.39 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 120.178 1.354 . . . . 64.03 110.52 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.99 -42.19 90.1 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 120.998 -1.064 . . . . 70.35 108.486 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -56.8 -47.72 79.56 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.13 1.372 . . . . 72.15 110.569 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -59.64 -34.96 73.47 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.5 0.72 . . . . 64.11 110.403 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -79.62 -33.43 41.49 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.345 0.658 . . . . 71.11 111.812 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -74.01 -34.45 39.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 124.231 1.013 . . . . 75.45 109.763 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.01 -50.88 69.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.715 1.143 . . . . 73.5 109.019 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.8 t -57.97 -32.73 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.209 0.604 . . . . 64.23 109.661 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -77.34 -19.97 55.54 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.786 -1.196 . . . . 75.43 112.59 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -91.2 -22.32 20.69 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.992 0.814 . . . . 74.13 111.265 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -108.83 -17.17 14.0 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.995 0.816 . . . . 64.33 112.926 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.1 t . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 127.402 2.281 . . . . 62.04 108.13 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.101 -0.703 . . . . 65.42 109.101 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -109.38 151.73 42.28 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 124.444 1.098 . . . . 75.41 108.578 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.63 162.67 35.17 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.526 2.151 . . . . 71.14 110.561 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.58 172.58 37.67 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 109.196 -1.561 . . . . 71.21 109.196 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.3 tpt -134.46 135.28 42.37 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.772 -1.196 . . . . 72.33 107.772 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 64.57 1.11 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.618 1.167 . . . . 74.32 108.711 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.51 150.28 43.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.925 0.869 . . . . 71.31 109.227 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 t -93.59 129.1 39.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.189 -1.782 . . . . 74.04 106.189 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.1 t -69.05 -177.68 1.1 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.689 0.757 . . . . 65.44 109.67 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.9 m -94.72 -154.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.704 1.602 . . . . 75.05 110.682 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -131.6 171.13 13.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.568 2.747 . . . . 63.13 109.603 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.87 169.4 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.842 0.857 . . . . 71.15 109.69 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.53 152.72 23.87 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.061 0.846 . . . . 53.14 112.734 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.05 70.22 3.16 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 106.971 -2.452 . . . . 43.24 106.971 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 . . . . . 0 C--O 1.224 -0.28 0 C-N-CA 124.411 1.085 . . . . 63.14 109.863 -178.921 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 119.737 -0.173 . . . . 74.34 111.228 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.01 174.45 11.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.503 2.135 . . . . 65.33 110.93 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.701 HD11 HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -161.6 133.87 5.84 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 104.224 -2.509 . . . . 61.21 104.224 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.429 ' N ' HD12 ' A' ' 43' ' ' LEU . 52.9 t30 -66.31 116.15 7.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.18 1.178 . . . . 74.41 114.18 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' CB ' ' HD2' ' A' ' 97' ' ' ARG . 13.7 pt-20 -65.39 -32.13 73.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.142 0.793 . . . . 72.21 113.142 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 m -76.38 1.62 15.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.526 0.565 . . . . 73.34 112.526 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -107.57 6.61 28.12 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.984 1.714 . . . . 52.24 110.582 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.701 HD11 HD11 ' A' ' 43' ' ' LEU . 8.3 mt -110.31 176.37 5.07 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.839 1.052 . . . . 74.12 113.839 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -127.01 130.19 49.54 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.958 -1.497 . . . . 71.41 106.958 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.59 159.69 34.74 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.86 1.264 . . . . 72.41 108.87 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -137.82 154.89 49.48 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.818 -1.178 . . . . 61.33 107.818 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -119.94 122.47 41.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.809 1.244 . . . . 75.34 108.547 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.235 0.324 0 CA-C-O 122.282 1.039 . . . . 71.24 109.797 -179.004 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 112.191 0.441 . . . . 73.44 112.191 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 m -67.9 135.06 51.89 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.727 -1.212 . . . . 63.41 107.727 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.36 154.28 20.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.685 -1.228 . . . . 71.3 107.685 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.4 147.79 21.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.327 -2.101 . . . . 75.41 105.327 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.7 tp -140.47 150.42 43.77 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.366 1.066 . . . . 72.21 108.999 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.28 157.99 44.72 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 112.502 0.556 . . . . 74.11 112.502 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -100.89 118.4 36.86 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 103.643 -2.725 . . . . 74.22 103.643 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -63.29 -54.08 47.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 120.253 1.388 . . . . 74.34 112.875 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.41 -13.02 34.88 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.843 2.362 . . . . 70.43 116.509 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.6 m -121.14 -6.22 9.45 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.078 1.308 . . . . 71.25 113.698 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.02 17.01 34.98 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 123.949 0.785 . . . . 70.21 114.915 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.453 HD11 ' CD2' ' A' ' 107' ' ' PHE . 50.5 mt -74.04 134.57 29.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 104.325 -2.472 . . . . 74.41 104.325 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t -130.23 137.16 57.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.824 -1.176 . . . . 42.43 107.824 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.67 147.93 28.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.676 -0.861 . . . . 63.23 108.676 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -122.68 118.49 28.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.479 1.112 . . . . 74.2 110.422 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 99.3 m -127.67 144.47 51.07 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.247 0.619 . . . . 74.22 110.986 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -155.62 120.42 4.75 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.468 1.107 . . . . 74.03 108.541 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.69 -71.67 0.27 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.086 0.954 . . . . 70.45 108.496 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 p -78.77 156.54 28.78 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.37 1.868 . . . . 73.31 113.614 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.14 -15.55 52.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.331 -0.618 . . . . 63.32 109.331 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.48 123.25 27.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.521 -1.288 . . . . 64.13 107.521 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.3 p -60.41 -46.38 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 119.157 0.889 . . . . 74.51 110.211 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -55.06 -42.21 72.44 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.422 1.889 . . . . 74.32 112.354 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -23.01 41.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.225 -0.893 . . . . 73.33 111.223 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -77.94 -42.91 31.49 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.581 -1.636 . . . . 73.01 106.581 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -52.17 -45.94 65.29 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.471 1.108 . . . . 65.35 109.0 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -59.67 -34.03 72.32 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-O 117.649 -1.167 . . . . 62.24 113.233 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.5 mt -64.32 -53.17 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 120.087 1.312 . . . . 60.45 108.402 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.05 -47.05 75.32 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 108.404 -0.961 . . . . 70.53 108.404 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.43 ' HD2' ' CB ' ' A' ' 45' ' ' GLU . 33.3 ttp85 -59.87 -39.56 85.68 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.383 1.073 . . . . 74.33 111.984 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -63.49 -57.52 9.94 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.96 1.304 . . . . 62.54 109.622 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.57 -29.21 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 112.106 0.41 . . . . 73.51 112.106 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.94 -46.76 89.4 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.648 -0.658 . . . . 71.55 109.554 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -59.01 -31.45 68.83 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.556 0.342 . . . . 62.12 111.451 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.26 -24.96 64.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.319 0.509 . . . . 73.2 112.079 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -88.03 -44.12 11.22 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.956 0.903 . . . . 73.23 110.138 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.39 -39.25 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 118.675 -0.679 . . . . 63.31 110.064 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -53.4 -66.68 0.35 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.651 0.739 . . . . 73.44 109.929 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.8 p -57.53 -30.48 36.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 118.174 -0.917 . . . . 35.22 111.144 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.453 ' CD2' HD11 ' A' ' 79' ' ' ILE . 16.2 t80 -59.9 -44.65 94.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.22 1.373 . . . . 74.15 110.199 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -75.66 -39.47 57.61 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.992 0.517 . . . . 74.52 110.731 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -65.12 -54.74 25.22 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.575 -0.528 . . . . 75.12 109.575 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 CA--C 1.545 0.781 0 C-N-CA 126.522 1.929 . . . . 52.23 106.889 178.52 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 109.836 -0.431 . . . . 73.24 109.836 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -125.37 155.74 71.18 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.967 1.707 . . . . 73.31 109.184 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.39 164.33 34.26 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.568 2.179 . . . . 53.32 111.428 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.61 169.73 16.47 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.499 -1.041 . . . . 63.01 110.499 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.2 mtt -82.01 163.36 22.17 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.721 -0.474 . . . . 70.24 109.721 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.93 74.41 1.26 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.325 -1.732 . . . . 64.51 106.325 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.61 176.89 6.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.894 0.854 . . . . 65.43 112.651 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -64.68 168.14 6.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.183 0.993 . . . . 63.35 110.528 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.5 p -130.48 178.86 6.29 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.819 1.248 . . . . 74.33 112.377 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.67 145.9 3.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.591 1.156 . . . . 54.21 109.908 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -71.95 -171.78 0.76 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.071 -0.968 . . . . 74.02 110.912 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 m -55.85 170.66 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 126.667 1.987 . . . . 74.43 114.753 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.52 172.91 12.48 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.607 1.563 . . . . 72.04 110.733 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.44 -79.26 0.56 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 109.969 -1.252 . . . . 61.22 109.969 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 . . . . . 0 C--O 1.236 0.343 0 C-N-CA 124.703 1.201 . . . . 71.31 109.609 179.561 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 109.343 -0.614 . . . . 74.1 109.343 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.09 129.34 20.39 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.516 2.81 . . . . 74.03 111.092 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.4 mt -117.75 121.25 40.33 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.487 1.115 . . . . 62.42 109.663 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -77.93 101.89 7.06 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.29 -1.004 . . . . 72.34 108.29 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.07 -29.14 60.11 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.213 0.46 . . . . 75.53 111.441 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -73.06 -3.78 28.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.178 0.991 . . . . 74.15 112.139 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -118.4 0.1 11.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.33 2.252 . . . . 75.34 110.663 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.9 mt -98.98 176.78 5.46 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.252 1.021 . . . . 74.12 109.388 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -138.4 148.13 44.13 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.76 -1.2 . . . . 73.13 107.76 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -141.76 164.83 29.14 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.786 1.234 . . . . 74.44 108.955 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -126.04 174.87 8.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.004 -0.739 . . . . 73.23 109.004 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -133.94 113.62 12.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.348 -1.353 . . . . 71.41 107.348 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.0 t . . . . . 0 C--N 1.33 -0.253 0 N-CA-C 105.929 -1.878 . . . . 71.33 105.929 -179.282 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 p30 . . . . . 0 N--CA 1.461 0.097 0 N-CA-C 106.06 -1.83 . . . . 75.02 106.06 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.8 t 178.45 133.8 0.08 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.651 2.781 . . . . 71.34 106.067 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.2 t -118.08 114.38 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 106.129 -1.804 . . . . 63.33 106.129 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.57 138.14 33.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.667 0.746 . . . . 45.23 109.303 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.8 tp -135.59 148.58 49.1 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.409 1.883 . . . . 74.15 107.889 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.71 158.4 44.48 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.479 -1.304 . . . . 75.21 107.479 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -106.84 119.27 38.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.585 -0.894 . . . . 74.41 108.585 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 t -57.36 -61.11 7.79 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.689 1.196 . . . . 55.5 110.103 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.77 -12.02 33.44 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.29 2.66 . . . . 75.24 116.832 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -120.83 -10.61 9.1 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.403 1.261 . . . . 73.55 114.403 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.78 -5.38 2.49 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.625 1.107 . . . . 50.13 114.754 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.6 mt -60.55 140.46 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 126.022 1.729 . . . . 73.53 108.128 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 t -126.02 142.57 42.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 105.792 -1.929 . . . . 74.53 105.792 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.56 139.58 16.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.497 -0.927 . . . . 72.43 108.497 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 113.7 17.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.37 1.468 . . . . 54.4 107.388 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.6 p -100.04 164.58 11.93 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.522 1.529 . . . . 70.03 111.741 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -155.8 120.67 4.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.138 1.775 . . . . 73.54 106.874 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.01 -47.54 0.13 Allowed 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.677 0.791 . . . . 71.24 110.082 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.7 p -128.13 -170.63 2.28 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.784 -1.561 . . . . 73.44 106.784 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.08 9.0 15.83 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.306 -0.871 . . . . 70.13 110.897 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 75.3 m -103.46 115.05 29.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.946 -1.131 . . . . 75.33 107.946 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.62 -43.05 77.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 123.54 0.736 . . . . 52.31 110.245 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.19 -30.63 64.7 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.643 1.11 . . . . 70.21 112.32 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -86.52 -48.39 8.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.749 -0.834 . . . . 44.41 108.749 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -60.95 -26.58 67.62 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.234 0.614 . . . . 70.23 110.751 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -57.16 -40.71 77.82 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.202 0.91 . . . . 74.11 110.093 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -73.6 -29.17 62.22 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 118.288 -1.365 . . . . 75.03 110.48 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.05 -45.18 95.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 124.381 1.072 . . . . 54.22 108.526 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.06 -45.22 94.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.858 0.361 . . . . 63.43 110.596 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -66.05 -48.17 71.92 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 122.65 0.38 . . . . 74.21 111.705 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -40.34 92.36 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 117.894 -1.05 . . . . 74.03 110.453 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.82 -37.79 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.278 0.944 . . . . 63.25 109.291 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.8 tp -61.11 -38.56 86.77 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.087 0.858 . . . . 71.31 110.854 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -57.06 -34.28 68.1 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.936 0.789 . . . . 75.24 111.384 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -67.49 -31.08 70.98 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.842 0.829 . . . . 74.02 109.97 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -77.68 -47.03 20.18 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.764 0.826 . . . . 72.53 110.948 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.1 t -62.18 -37.85 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 123.681 0.793 . . . . 71.15 109.964 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -52.24 -65.88 0.48 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.258 1.023 . . . . 54.41 110.296 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.63 -28.65 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.597 -0.69 . . . . 75.51 111.42 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -68.85 -40.19 79.51 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 119.123 0.874 . . . . 70.11 110.832 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -72.24 -45.24 61.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.722 0.809 . . . . 71.34 110.021 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -63.86 -53.9 43.32 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.289 0.636 . . . . 74.51 111.082 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.453 -0.301 0 C-N-CA 123.779 0.832 . . . . 73.33 111.836 -179.253 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 108.629 -0.878 . . . . 74.22 108.629 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -129.15 153.29 80.36 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.027 1.331 . . . . 53.14 110.235 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -80.8 177.1 8.36 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.63 2.887 . . . . 74.35 110.85 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.89 160.24 27.97 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.649 -1.38 . . . . 62.11 109.649 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -145.81 124.09 12.27 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.838 -1.912 . . . . 65.4 105.838 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.98 56.49 1.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.622 1.169 . . . . 72.23 108.573 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.41 139.3 58.53 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.537 -0.727 . . . . 62.21 109.114 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 t -88.36 -170.0 2.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.897 1.279 . . . . 64.21 110.517 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.9 p -136.08 178.0 7.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.594 1.558 . . . . 64.33 109.467 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.71 -179.43 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 126.377 1.871 . . . . 74.3 109.514 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -130.48 169.47 15.5 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.082 1.753 . . . . 62.23 110.996 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.59 147.74 7.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.242 1.017 . . . . 64.4 109.265 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.92 -166.62 1.38 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.099 -1.445 . . . . 63.14 107.099 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.28 179.94 25.56 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-O 121.999 0.777 . . . . 71.14 112.223 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 . . . . . 0 C--N 1.33 -0.255 0 C-N-CA 124.632 1.173 . . . . 70.31 110.162 179.815 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.24 0.605 0 N-CA-C 109.77 -0.455 . . . . 70.53 109.77 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -62.41 140.95 85.12 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.137 1.225 . . . . 63.23 110.622 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.3 123.23 12.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.124 -1.806 . . . . 45.24 106.124 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -85.24 117.86 24.44 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.618 1.167 . . . . 74.3 109.664 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.35 -29.13 69.83 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.823 1.046 . . . . 73.14 113.823 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -82.68 -10.48 58.9 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.454 1.102 . . . . 64.31 112.849 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -91.59 2.25 56.58 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.768 0.713 . . . . 71.24 111.568 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mt -102.73 174.5 5.86 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.122 1.369 . . . . 61.44 112.106 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -126.79 156.23 41.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.346 2.258 . . . . 72.1 105.807 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.45 157.31 46.84 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.602 -0.686 . . . . 55.34 111.861 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -126.89 140.17 52.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.408 1.083 . . . . 74.24 111.134 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -106.38 132.34 52.52 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.562 1.145 . . . . 55.13 108.096 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.235 0.318 0 N-CA-C 107.975 -1.121 . . . . 73.43 107.975 -179.337 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 111.455 0.169 . . . . 72.01 111.455 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -104.46 156.39 17.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.714 1.206 . . . . 64.45 109.504 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.95 142.22 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.537 1.535 . . . . 71.23 107.473 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -137.56 95.47 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.23 -1.396 . . . . 34.14 107.23 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.4 tp -93.46 152.4 19.11 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.727 0.411 . . . . 52.2 110.229 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -141.45 137.3 32.07 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 124.574 1.149 . . . . 73.31 110.346 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -87.84 132.93 34.0 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 105.468 -2.049 . . . . 71.45 105.468 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.63 -64.95 2.25 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 119.297 0.953 . . . . 65.25 111.846 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.54 -7.74 21.78 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.801 3.0 . . . . 73.4 116.13 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 m -113.3 -17.36 12.32 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.86 1.209 . . . . 72.21 112.213 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.11 -7.03 0.86 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.363 1.459 . . . . 70.31 115.725 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.76 136.93 25.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 120.038 1.919 . . . . 74.32 107.523 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.0 t -121.6 137.29 55.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.818 1.647 . . . . 71.24 106.772 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.0 p -146.88 148.11 17.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.542 -0.911 . . . . 74.31 108.542 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.48 134.08 41.11 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 122.523 0.329 . . . . 73.34 111.291 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.1 t -140.77 155.35 46.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.181 1.793 . . . . 73.42 108.547 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -150.75 100.78 2.86 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.496 1.918 . . . . 62.42 108.173 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -120.55 -15.55 8.47 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.768 1.396 . . . . 74.33 114.768 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.3 p -134.2 168.18 19.33 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.53 1.514 . . . . 73.43 110.824 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -79.96 -10.61 59.79 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.633 -0.667 . . . . 72.42 110.851 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.37 114.65 26.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.827 1.651 . . . . 72.22 110.231 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.35 -44.45 98.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-O 119.18 -0.438 . . . . 54.45 110.707 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -58.15 -45.45 87.4 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.381 0.537 . . . . 74.42 110.952 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -42.2 97.21 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.47 -0.937 . . . . 60.41 108.47 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.56 -27.47 68.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 118.613 -0.708 . . . . 73.22 109.987 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -62.22 -46.59 88.18 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.077 1.308 . . . . 74.14 107.843 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -60.36 -37.39 80.56 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.344 0.52 . . . . 62.53 110.222 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.48 -48.27 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 108.612 -0.884 . . . . 74.01 108.612 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.5 -35.49 80.65 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.673 -0.642 . . . . 44.14 110.538 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -63.71 -52.06 62.25 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 123.758 0.823 . . . . 75.12 111.282 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -43.35 94.21 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.643 1.11 . . . . 73.12 110.66 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.11 -33.09 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.503 1.047 . . . . 74.1 109.326 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.11 -33.13 75.08 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 120.839 -1.163 . . . . 71.31 108.962 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -58.75 -45.64 89.22 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.958 1.254 . . . . 75.24 107.951 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -56.47 -37.58 70.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.399 1.08 . . . . 73.12 109.684 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -72.4 -39.02 68.27 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.621 -0.674 . . . . 73.15 111.911 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.94 -39.29 85.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.564 -0.902 . . . . 60.55 108.564 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.12 -62.89 1.44 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.604 1.561 . . . . 75.43 110.799 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.4 p -60.8 -27.62 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 119.246 -0.407 . . . . 65.02 110.819 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -66.69 -36.19 81.92 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.585 0.63 . . . . 74.14 109.786 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -74.53 -42.78 58.25 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.423 -0.584 . . . . 70.13 109.423 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -67.83 -58.47 4.53 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.026 0.931 . . . . 73.31 111.748 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.451 -0.419 0 C-N-CA 125.384 1.474 . . . . 50.42 109.544 -179.111 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 107.723 -1.214 . . . . 74.42 107.723 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -123.65 152.39 65.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 124.405 1.082 . . . . 70.51 110.222 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -80.74 -179.54 5.23 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.929 3.086 . . . . 70.23 110.903 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.75 167.99 25.15 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.397 -1.481 . . . . 62.23 109.397 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -147.82 140.0 24.28 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.998 -1.852 . . . . 74.33 105.998 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.46 59.95 0.82 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.665 0.666 . . . . 30.4 111.053 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.78 140.07 42.15 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.624 -0.88 . . . . 63.12 108.624 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 t -73.87 164.55 26.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.524 1.13 . . . . 74.43 111.59 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 p -102.69 165.48 11.04 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.345 1.458 . . . . 72.33 108.593 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.07 143.28 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 107.521 -1.289 . . . . 72.43 107.521 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -62.12 139.24 58.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.439 0.638 . . . . 62.44 110.518 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -82.87 169.22 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 125.439 1.496 . . . . 72.54 109.293 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.25 149.68 36.71 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.47 2.308 . . . . 44.41 107.077 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -136.36 -57.29 0.06 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 125.38 1.467 . . . . 75.35 111.195 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 117.675 -1.155 . . . . 75.44 109.035 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 108.657 -0.868 . . . . 73.1 108.657 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.77 146.8 67.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.096 1.864 . . . . 73.14 111.927 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 mt -111.86 159.25 18.52 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.741 1.217 . . . . 74.4 111.533 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -115.01 101.37 8.94 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 108.096 -1.076 . . . . 74.24 108.096 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -66.12 -20.79 66.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.311 0.645 . . . . 63.33 112.71 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -84.4 3.29 36.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.932 1.693 . . . . 63.25 112.599 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -124.15 22.81 8.59 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.299 1.039 . . . . 61.04 111.203 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -112.31 162.0 16.01 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.295 -0.878 . . . . 65.22 108.81 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -126.13 95.1 4.28 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.423 1.489 . . . . 75.41 107.094 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 1.3 pm0 -87.0 162.86 17.39 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.138 1.375 . . . . 74.15 112.271 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 -146.7 172.2 13.98 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.919 -1.511 . . . . 62.24 106.919 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -130.97 155.91 46.01 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.509 1.124 . . . . 74.1 108.789 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 CA--C 1.531 0.243 0 CA-C-O 121.741 0.782 . . . . 64.14 109.512 -179.439 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 114.469 1.285 . . . . 65.55 114.469 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.5 m -63.81 160.03 18.21 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.202 1.001 . . . . 70.44 110.611 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.08 148.53 30.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.07 -1.456 . . . . 75.12 107.07 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 p -133.78 115.88 22.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 105.953 -1.869 . . . . 63.12 105.953 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.77 151.66 40.32 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.18 1.792 . . . . 64.13 106.881 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.23 151.57 36.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.178 0.991 . . . . 72.33 111.78 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -87.26 134.28 33.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.995 -1.483 . . . . 74.14 106.995 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.66 -59.35 4.75 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.796 -1.097 . . . . 64.34 111.909 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.06 -9.29 23.33 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 124.268 3.312 . . . . 75.33 116.227 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.4 m -118.24 -12.38 9.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.742 0.701 . . . . 73.34 112.124 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.07 14.56 18.25 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.64 1.114 . . . . 50.54 113.361 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.1 mt -67.02 131.16 32.82 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 N-CA-C 106.048 -1.834 . . . . 60.54 106.048 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.71 140.18 48.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.826 -1.176 . . . . 74.02 107.826 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.81 144.14 24.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.375 -0.972 . . . . 42.51 108.375 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.66 111.16 17.28 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 105.929 -1.878 . . . . 64.44 105.929 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 81.3 m -124.28 158.12 33.29 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.008 0.908 . . . . 73.42 111.394 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -155.43 145.43 21.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.451 1.9 . . . . 64.04 108.627 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -154.2 -35.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.843 -0.535 . . . . 74.35 109.651 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.6 p -138.91 -178.76 5.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.42 -0.955 . . . . 74.34 108.42 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -93.33 -5.77 48.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.595 -0.891 . . . . 70.32 108.595 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' A' ' 91' ' ' GLN . 10.0 m -79.79 114.99 19.13 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.951 1.7 . . . . 54.43 107.812 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.37 -38.33 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 121.958 -0.464 . . . . 42.25 110.173 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -62.35 -33.7 75.23 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.893 1.277 . . . . 61.32 110.73 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 88' ' ' SER . 36.4 mt-30 -76.86 -54.82 6.1 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.215 -1.032 . . . . 74.12 108.215 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -52.46 -36.03 53.86 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.668 -0.682 . . . . 73.34 110.125 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -57.84 -58.28 9.07 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 118.212 -0.899 . . . . 72.14 110.294 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.21 -32.94 74.71 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.935 1.243 . . . . 75.52 113.31 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.47 -50.93 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.235 -1.394 . . . . 74.44 107.235 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.07 75.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.459 -0.941 . . . . 53.12 108.459 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.34 -47.0 62.85 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.648 1.179 . . . . 65.13 111.582 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -45.58 82.45 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 117.423 -1.275 . . . . 72.13 111.75 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.35 -29.93 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 120.397 1.453 . . . . 73.03 110.738 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -44.17 96.9 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 107.898 -1.149 . . . . 71.43 107.898 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -54.95 -39.62 69.11 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.564 1.146 . . . . 74.15 110.913 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -67.39 -30.18 69.88 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.076 0.95 . . . . 72.44 110.312 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.13 -46.9 17.07 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.078 -1.014 . . . . 65.54 110.021 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.28 -30.38 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.454 -0.943 . . . . 74.03 108.454 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -57.86 -62.43 1.81 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.685 -1.598 . . . . 72.13 106.685 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.5 t -59.55 -29.53 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.649 0.779 . . . . 65.33 110.39 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -66.6 -34.6 78.24 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.276 1.398 . . . . 73.44 111.805 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -87.52 -31.16 20.08 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 109.068 -0.716 . . . . 71.3 109.068 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -80.89 -15.92 55.01 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.086 0.554 . . . . 73.15 110.853 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.444 -0.774 0 C-N-CA 125.433 1.493 . . . . 74.21 109.727 -178.867 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.335 -0.616 . . . . 55.22 109.335 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -89.37 153.99 48.67 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 123.722 0.809 . . . . 75.01 109.087 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.77 163.81 33.0 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.722 2.281 . . . . 74.32 110.839 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.26 -176.36 34.54 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.822 -1.311 . . . . 44.04 109.822 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 53.9 ttm -121.02 145.47 47.73 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.638 -1.245 . . . . 62.34 107.638 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.26 68.6 1.04 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.72 -1.956 . . . . 51.31 105.72 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.4 172.91 7.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.9 -0.407 . . . . 44.42 109.9 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 t -154.77 177.09 11.65 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 122.194 -0.316 . . . . 74.22 110.476 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.8 m -138.1 173.65 11.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.725 2.41 . . . . 74.45 107.597 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.17 178.87 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.469 1.907 . . . . 53.02 109.09 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -71.0 142.12 50.97 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.388 -1.708 . . . . 74.5 106.388 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.77 177.45 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.467 0.651 . . . . 51.41 110.828 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 174.26 11.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.83 -0.623 . . . . 74.12 110.875 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.63 162.87 32.3 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 107.442 -2.263 . . . . 74.01 107.442 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 122.334 1.064 . . . . 63.3 111.839 -179.826 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 119.075 -0.488 . . . . 74.32 109.807 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.2 151.41 73.56 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.075 2.517 . . . . 63.24 113.931 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.0 mt -123.13 110.41 15.25 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.255 1.422 . . . . 72.03 108.046 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -79.62 101.97 8.64 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.122 1.369 . . . . 72.33 110.276 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.8 -29.88 42.48 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.487 0.921 . . . . 73.34 113.487 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.5 -22.83 60.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.14 0.427 . . . . 63.21 111.24 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -89.22 -21.84 23.05 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.568 1.147 . . . . 74.21 110.476 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.7 mt -84.16 176.62 8.66 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.756 0.822 . . . . 74.51 110.112 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.19 140.73 49.96 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.608 -1.627 . . . . 75.4 106.608 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -129.04 157.11 42.63 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.716 1.206 . . . . 63.11 109.679 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -137.3 118.71 14.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.799 -1.556 . . . . 61.54 106.799 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -74.45 163.16 28.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.808 -1.996 . . . . 72.03 109.8 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.7 t . . . . . 0 C--N 1.332 -0.172 0 N-CA-C 107.697 -1.223 . . . . 74.1 107.697 -179.604 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 111.763 0.282 . . . . 75.31 111.763 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.17 159.21 26.8 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.347 -0.846 . . . . 61.25 108.959 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.26 130.27 60.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.169 -2.16 . . . . 61.32 105.169 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 t -121.28 119.97 60.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.746 -1.205 . . . . 73.14 107.746 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.8 tp -118.78 142.31 47.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.217 -1.401 . . . . 61.51 107.217 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.17 152.3 45.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.69 -1.226 . . . . 71.32 107.69 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -100.3 116.62 32.7 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.03 -2.211 . . . . 71.13 105.03 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.82 -56.75 22.77 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 117.74 -1.124 . . . . 74.53 112.04 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -69.25 -10.4 28.87 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.468 2.112 . . . . 64.51 114.885 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 m -120.43 -11.92 9.05 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.843 1.053 . . . . 74.03 113.843 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.08 -4.02 3.68 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 127.69 2.566 . . . . 73.02 115.633 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.56 135.81 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 119.295 1.547 . . . . 75.22 108.748 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 t -123.35 148.19 27.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 126.258 1.823 . . . . 70.42 107.124 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 p -145.61 146.29 19.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 106.447 -1.686 . . . . 74.21 106.447 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -123.86 119.13 28.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.019 -1.104 . . . . 75.25 108.019 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 91.5 m -128.57 152.26 48.52 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.684 0.754 . . . . 72.13 111.094 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -155.68 100.64 2.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.177 2.191 . . . . 74.12 106.155 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -111.31 -41.53 4.12 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.328 -0.858 . . . . 61.31 110.779 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.3 t -140.76 179.11 6.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.446 1.099 . . . . 42.03 109.921 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.93 11.94 12.31 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.43 1.092 . . . . 64.23 109.902 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.9 m -107.23 115.54 30.34 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.992 -1.114 . . . . 74.01 107.992 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.7 -47.87 81.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.411 0.685 . . . . 64.5 109.314 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -49.69 -54.09 20.74 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.295 1.438 . . . . 61.24 112.406 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.49 -46.12 87.57 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.5 0.72 . . . . 73.4 109.618 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -56.91 -37.71 71.83 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.635 0.652 . . . . 54.13 111.108 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -57.91 -36.88 73.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.83 0.741 . . . . 74.02 109.531 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -55.85 25.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.496 0.589 . . . . 73.2 109.734 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.6 mp -52.67 -47.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.777 -0.453 . . . . 63.4 109.777 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.54 -50.96 71.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.932 0.893 . . . . 74.02 111.98 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -60.97 -43.83 98.2 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.799 -0.619 . . . . 74.24 110.26 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.06 -59.32 5.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.572 -0.899 . . . . 71.53 108.572 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 p -60.1 -35.07 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.819 0.736 . . . . 72.41 112.937 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -65.07 -42.89 93.76 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 119.011 0.823 . . . . 64.34 110.279 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -52.01 -42.25 62.88 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.643 1.577 . . . . 74.21 112.612 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.34 -43.16 78.79 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.621 0.724 . . . . 63.24 110.38 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -73.79 -41.17 62.77 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.176 1.79 . . . . 64.24 112.412 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.86 -34.11 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 118.146 -0.93 . . . . 64.3 110.585 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -54.7 -59.54 4.57 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.565 1.529 . . . . 72.42 106.928 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.29 -34.49 27.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.315 1.846 . . . . 65.21 110.291 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -66.26 -39.19 89.29 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.593 -0.692 . . . . 75.13 110.715 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -78.05 -38.63 44.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.585 0.63 . . . . 73.32 110.063 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -68.41 -58.76 3.86 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.318 1.047 . . . . 75.02 112.641 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 m . . . . . 0 N--CA 1.452 -0.37 0 C-N-CA 125.583 1.553 . . . . 52.32 114.017 -177.08 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 109.428 -0.582 . . . . 64.3 109.428 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -111.92 155.47 43.22 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.666 1.186 . . . . 43.45 109.76 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.78 171.34 18.38 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.977 2.451 . . . . 65.42 111.412 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.06 -176.2 47.8 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.814 -0.915 . . . . 61.33 110.814 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 50.3 ttp -133.17 156.53 47.32 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.197 1.399 . . . . 74.21 108.034 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.36 120.68 4.49 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 102.468 -3.16 . . . . 75.41 102.468 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.94 175.71 5.35 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.907 0.883 . . . . 71.43 109.251 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 t -74.07 152.58 39.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.934 0.874 . . . . 23.04 110.779 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 p -84.61 -162.61 0.7 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 129.787 3.235 . . . . 63.0 112.284 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.69 149.35 4.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 O-C-N 121.038 -1.039 . . . . 71.22 108.933 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -81.42 -168.0 1.69 Allowed 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.814 0.816 . . . . 63.14 109.226 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.72 155.47 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 125.675 1.59 . . . . 74.01 107.032 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.07 172.12 7.63 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.256 -0.903 . . . . 44.03 111.325 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.49 160.27 28.7 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.973 -1.251 . . . . 71.44 109.973 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 121.14 0.495 . . . . 74.11 110.371 179.847 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 109.856 -0.424 . . . . 64.41 109.856 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.13 106.22 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.266 3.311 . . . . 73.52 115.868 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -80.8 149.91 29.41 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.785 -0.45 . . . . 71.02 109.785 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -103.81 106.7 17.29 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 106.959 -1.497 . . . . 73.42 106.959 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -60.15 -13.63 13.09 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 115.417 1.636 . . . . 73.43 115.417 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.9 m -95.99 -13.07 24.08 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.237 0.926 . . . . 61.24 111.394 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -93.99 3.16 55.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.002 2.121 . . . . 73.13 111.449 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mt -98.64 166.62 11.25 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.723 1.209 . . . . 63.33 109.784 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -133.99 98.02 4.04 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.677 1.191 . . . . 73.33 107.806 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.59 164.72 17.58 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.024 0.93 . . . . 72.24 112.727 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -132.35 124.87 29.61 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.955 -1.128 . . . . 74.44 107.955 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -88.22 101.01 13.42 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.757 -0.831 . . . . 74.23 108.757 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.1 t . . . . . 0 C--N 1.323 -0.556 0 N-CA-C 106.252 -1.759 . . . . 73.12 106.252 178.734 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 . . . . . 0 C--O 1.232 0.162 0 N-CA-C 109.325 -0.62 . . . . 70.14 109.325 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.5 p -155.48 111.52 3.12 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.231 0.612 . . . . 63.23 111.157 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.66 137.38 40.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 105.569 -2.012 . . . . 62.44 105.569 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.15 123.24 63.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.689 -1.967 . . . . 70.04 105.689 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.37 142.65 45.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.93 -1.137 . . . . 55.02 107.93 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -140.39 139.43 35.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.343 1.857 . . . . 63.4 110.575 -178.578 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -103.07 124.08 47.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.026 -1.842 . . . . 73.54 106.026 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.421 ' HA ' ' HE2' ' A' ' 73' ' ' LYS . 69.3 t -64.58 -63.13 4.01 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 117.854 -1.07 . . . . 65.12 112.024 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.49 -11.62 32.8 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.909 2.406 . . . . 61.33 115.785 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -111.88 -13.51 13.65 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.091 0.86 . . . . 61.21 111.224 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.79 0.62 4.11 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.14 1.829 . . . . 52.12 115.616 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.7 mt -69.16 143.32 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 119.39 1.595 . . . . 72.02 109.376 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 t -136.56 136.94 48.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.229 -1.397 . . . . 63.33 107.229 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.07 147.74 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 121.543 -0.723 . . . . 63.32 109.259 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -129.64 107.52 9.51 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.431 1.092 . . . . 73.14 110.289 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 56.7 m -120.44 152.16 38.35 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.782 0.833 . . . . 62.15 109.86 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.69 100.41 2.08 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.79 1.236 . . . . 71.33 107.845 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -119.63 -14.04 9.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.359 0.664 . . . . 65.41 112.778 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.6 p -133.83 -176.83 4.3 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.18 0.992 . . . . 73.31 110.301 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -109.95 19.45 19.03 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.233 1.013 . . . . 74.45 112.644 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 t -125.63 132.02 52.55 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.44 1.096 . . . . 72.34 108.111 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.4 p -58.86 -47.25 90.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 N-CA-C 108.691 -0.855 . . . . 64.15 108.691 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -63.17 -25.87 68.54 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.892 1.071 . . . . 74.42 113.892 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -84.48 -44.73 13.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.033 -1.469 . . . . 71.31 107.033 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -64.34 -27.2 68.86 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.383 -0.823 . . . . 75.25 109.156 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -62.71 -58.3 7.95 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 126.351 1.86 . . . . 75.4 108.607 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -56.29 -37.21 69.55 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.141 0.428 . . . . 74.12 111.681 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 79.0 mt -63.9 -50.65 76.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.74 -0.837 . . . . 73.01 108.74 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.08 97.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.096 -0.478 . . . . 71.41 110.361 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -61.33 -49.14 78.17 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 118.699 0.681 . . . . 72.12 109.305 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -56.13 24.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.778 0.831 . . . . 74.34 110.452 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.36 -35.43 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 119.074 0.852 . . . . 61.24 111.544 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.1 tp -64.27 -41.19 97.04 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 121.187 -0.945 . . . . 71.4 109.15 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -58.3 -43.22 87.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.184 0.994 . . . . 72.32 109.672 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -60.81 -27.42 68.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.545 0.738 . . . . 71.24 111.234 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -88.09 -45.58 10.03 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.169 1.388 . . . . 52.2 111.84 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.6 t -63.35 -35.37 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 107.567 -1.272 . . . . 50.44 107.567 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.65 -64.23 0.9 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.71 1.204 . . . . 71.34 109.383 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.5 p -59.56 -30.53 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.518 -0.739 . . . . 71.11 111.727 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -68.87 -35.07 76.47 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.852 1.206 . . . . 63.52 111.203 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -83.08 -32.14 26.94 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.355 1.062 . . . . 74.34 109.869 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -77.11 -46.37 23.76 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.567 0.747 . . . . 62.42 110.281 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.45 -0.453 0 C-N-CA 123.641 0.776 . . . . 72.05 109.221 179.181 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 109.633 -0.506 . . . . 54.54 109.633 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -109.97 153.9 42.92 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.129 1.372 . . . . 74.4 109.497 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.61 168.64 23.31 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.805 2.337 . . . . 62.51 111.765 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.76 -172.33 39.27 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 109.866 -1.294 . . . . 64.24 109.866 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.2 mmt -125.44 158.9 33.25 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.65 1.18 . . . . 70.55 108.467 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.32 68.19 1.19 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.348 -1.352 . . . . 73.1 107.348 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.65 172.12 11.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.931 -0.577 . . . . 73.12 110.053 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.7 t -131.62 -173.23 3.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.844 0.858 . . . . 72.02 111.167 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.4 t -130.66 163.0 28.16 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.235 1.414 . . . . 64.54 109.632 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.0 m -67.6 -173.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.011 1.725 . . . . 74.3 112.293 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -132.45 176.87 8.05 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.423 1.889 . . . . 63.45 108.9 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.2 173.18 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 124.2 1.0 . . . . 72.42 110.57 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.84 162.86 28.27 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.773 -0.649 . . . . 73.53 111.569 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.85 141.07 15.36 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 106.069 -2.813 . . . . 43.51 106.069 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 118.365 1.082 . . . . 50.23 109.612 -179.467 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 118.959 -0.543 . . . . 75.31 111.212 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.51 159.0 55.26 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.452 2.768 . . . . 64.12 111.692 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 mt -136.91 122.34 19.5 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 123.189 0.595 . . . . 73.14 109.804 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -67.71 101.79 1.1 Allowed 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 106.839 -1.541 . . . . 73.44 106.839 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 45' ' ' GLU . 1.9 pm0 -57.34 -31.69 65.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.81 0.844 . . . . 72.53 112.361 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.2 m -77.56 -6.28 53.1 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.739 0.816 . . . . 62.24 112.686 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -99.83 7.11 45.22 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.235 1.414 . . . . 71.31 110.334 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mt -110.57 164.59 12.57 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.599 1.16 . . . . 75.34 110.456 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -120.96 137.73 54.48 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.167 -2.161 . . . . 65.35 105.167 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -123.78 155.19 38.39 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.818 1.647 . . . . 72.14 110.725 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -129.87 178.7 6.33 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.206 1.002 . . . . 73.14 108.829 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -135.43 163.5 29.9 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.476 1.91 . . . . 75.02 107.619 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.4 t . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 104.096 -2.557 . . . . 64.35 104.096 178.325 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 112.791 0.663 . . . . 54.44 112.791 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.9 m -64.25 144.61 57.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.031 1.333 . . . . 62.43 109.679 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.4 162.48 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 121.897 0.856 . . . . 61.23 109.96 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -141.34 156.26 21.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 126.996 2.118 . . . . 63.11 107.549 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.45 150.04 40.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.704 -1.961 . . . . 71.54 105.704 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.89 158.17 43.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.665 0.786 . . . . 72.34 109.337 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -107.34 126.38 52.38 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 104.828 -2.286 . . . . 75.51 104.828 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.1 t -68.28 -58.03 8.05 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 120.051 1.296 . . . . 73.12 111.593 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.09 -12.55 35.26 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.423 2.082 . . . . 73.13 115.628 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -112.4 -21.18 11.5 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.954 0.797 . . . . 61.42 109.719 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.39 -9.25 7.86 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.606 2.526 . . . . 74.51 113.686 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.408 HG21 ' HB3' ' A' ' 103' ' ' LYS . 11.7 mt -55.41 147.49 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.1 1.76 . . . . 72.11 109.918 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.2 t -134.35 146.94 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.468 1.507 . . . . 71.3 108.045 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -144.97 139.54 22.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.225 1.01 . . . . 53.25 108.896 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -110.64 127.89 55.46 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.156 1.382 . . . . 75.4 108.706 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.7 m -150.54 149.39 29.88 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.54 0.686 . . . . 73.43 112.799 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -155.23 139.72 16.85 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 129.584 3.154 . . . . 74.05 105.073 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -152.82 -68.97 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.719 -1.215 . . . . 63.04 107.719 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.0 p -77.93 151.66 33.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.564 1.146 . . . . 72.32 111.129 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -66.75 -25.83 66.69 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.83 0.678 . . . . 64.23 112.83 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 m -79.64 116.23 19.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.51 0.595 . . . . 72.42 109.845 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.8 p -54.07 -42.6 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.757 -0.831 . . . . 72.3 108.757 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.93 -44.42 78.35 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.132 0.973 . . . . 43.33 111.745 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -67.16 -39.55 86.51 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.043 -1.095 . . . . 73.15 108.043 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -60.86 -29.06 69.3 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.634 -0.698 . . . . 72.1 109.612 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -58.17 -40.91 82.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.801 1.182 . . . . 71.51 108.754 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -71.56 -46.51 59.23 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 125.098 1.359 . . . . 72.14 110.382 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 99.4 mt -56.97 -52.8 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.462 0.705 . . . . 72.32 111.277 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.5 -28.08 69.58 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.73 -0.606 . . . . 70.03 111.426 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -72.94 -45.76 56.28 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 118.554 -0.736 . . . . 74.44 109.883 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -64.82 -35.85 82.43 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.941 1.246 . . . . 74.2 111.101 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.3 p -71.79 -32.99 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 120.041 1.291 . . . . 74.23 108.375 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.4 tp -64.87 -32.77 74.64 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.602 -1.258 . . . . 52.43 107.602 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -55.75 -41.43 73.96 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.216 -0.661 . . . . 71.22 109.216 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -63.51 -39.58 94.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.733 0.697 . . . . 73.22 110.886 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HB3' HG21 ' A' ' 79' ' ' ILE . 73.4 mmtt -63.24 -48.19 79.27 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.773 0.829 . . . . 73.34 110.518 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 50.1 t -69.28 -41.01 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.872 0.869 . . . . 73.34 110.207 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.48 -62.01 1.89 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.183 1.393 . . . . 64.14 109.681 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.75 -22.44 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.027 0.931 . . . . 62.53 112.248 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -75.37 -27.2 59.04 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.771 -1.206 . . . . 74.24 111.293 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -98.94 -30.73 12.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.346 0.975 . . . . 73.24 109.655 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -75.89 -6.4 50.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.292 0.637 . . . . 71.15 110.597 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.237 0.401 0 C-N-CA 125.795 1.638 . . . . 73.42 110.145 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 C--O 1.233 0.2 0 N-CA-C 109.822 -0.436 . . . . 45.02 109.822 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -121.58 154.68 59.93 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.483 1.513 . . . . 72.14 109.411 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.54 169.65 22.06 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.745 2.297 . . . . 65.52 111.094 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.33 175.46 20.68 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.645 -1.382 . . . . 63.41 109.645 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.1 ttt -143.7 144.65 31.94 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.726 -1.212 . . . . 74.44 107.726 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.07 80.34 0.99 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.569 -1.641 . . . . 33.11 106.569 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.06 160.85 21.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.141 0.577 . . . . 53.43 110.807 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -103.31 -168.0 1.45 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.555 1.542 . . . . 74.43 108.29 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.3 p -124.37 -177.26 3.74 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.447 1.499 . . . . 65.24 109.977 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.72 157.96 41.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 125.203 1.401 . . . . 62.24 108.332 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.95 163.48 15.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.605 0.762 . . . . 54.43 110.987 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.0 -179.57 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.701 1.2 . . . . 72.21 108.788 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.06 161.22 20.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.956 1.302 . . . . 74.44 109.003 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.66 166.47 54.83 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.003 -1.239 . . . . 71.3 110.003 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? . . . . . 0 N--CA 1.47 0.535 0 C-N-CA 124.765 1.226 . . . . 74.2 110.067 -179.693 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 114.042 1.127 . . . . 73.45 114.042 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.04 154.6 33.23 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.907 2.405 . . . . 73.33 109.784 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.8 mt -134.35 136.81 43.67 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.717 0.807 . . . . 72.03 110.255 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.92 107.59 1.9 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.083 1.353 . . . . 72.34 108.668 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.58 -19.25 57.05 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.56 0.578 . . . . 72.25 112.56 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.9 m -85.27 -1.91 57.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.497 1.044 . . . . 52.45 112.033 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -114.63 -4.97 12.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.925 1.239 . . . . 72.1 112.585 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mt -86.33 140.99 29.55 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.911 -1.885 . . . . 71.4 105.911 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -109.0 126.11 52.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.779 0.718 . . . . 74.13 109.416 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.57 164.49 12.48 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.325 1.05 . . . . 64.24 112.613 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -141.61 143.86 33.9 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.31 -1.737 . . . . 73.34 106.31 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -103.83 123.39 47.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.085 -1.821 . . . . 73.23 106.085 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.1 t . . . . . 0 C--N 1.331 -0.226 0 N-CA-C 106.05 -1.833 . . . . 74.13 106.05 -179.878 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.495 HD21 ' HB ' ' A' ' 89' ' ' VAL . 22.2 t-20 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 107.97 -1.122 . . . . 54.45 107.97 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.8 m -150.49 152.38 34.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.024 -1.473 . . . . 60.4 107.024 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.4 124.15 70.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.051 -2.203 . . . . 61.24 105.051 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.96 96.21 4.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.817 -2.29 . . . . 71.01 104.817 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.9 tp -91.86 139.54 30.56 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.203 -1.777 . . . . 73.31 106.203 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.25 141.15 45.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.76 1.224 . . . . 74.42 110.56 -177.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -95.79 133.29 40.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.856 -1.535 . . . . 61.11 106.856 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.7 t -70.73 -66.5 0.78 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.307 1.043 . . . . 63.14 111.438 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.41 -7.63 21.24 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.858 3.038 . . . . 70.2 116.177 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 t -114.54 -20.43 10.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.524 0.602 . . . . 70.43 110.91 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.54 -3.97 4.34 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.604 -1.109 . . . . 64.42 114.807 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.99 139.52 20.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.261 -1.385 . . . . 73.13 107.261 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.64 147.93 33.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.223 -1.399 . . . . 63.12 107.223 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.464 HG21 HG13 ' A' ' 99' ' ' VAL . 9.8 p -143.12 140.82 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.986 -1.487 . . . . 52.21 106.986 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.68 107.79 13.66 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 106.515 -1.661 . . . . 61.22 106.515 -178.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 77.3 m -112.04 134.86 53.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 123.555 0.534 . . . . 74.43 110.567 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -147.28 109.87 4.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.66 2.384 . . . . 74.34 106.517 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -135.45 -20.71 1.59 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.49 1.116 . . . . 71.24 111.264 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.79 173.43 16.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.599 1.16 . . . . 72.55 107.914 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -86.63 -4.97 59.25 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.961 -1.087 . . . . 72.04 109.819 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.5 m -82.15 115.0 21.06 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.324 -1.362 . . . . 61.42 107.324 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.495 ' HB ' HD21 ' A' ' 68' ' ' ASN . 13.9 p -61.19 -38.7 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.796 -0.816 . . . . 51.1 108.796 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.479 ' HA ' ' HD3' ' A' ' 93' ' ' ARG . 9.9 m-20 -63.42 -23.05 67.24 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 113.859 1.059 . . . . 65.0 113.859 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -87.71 -46.84 9.14 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.321 -0.992 . . . . 63.12 108.321 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.11 -43.7 91.93 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.746 0.818 . . . . 61.13 110.945 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.479 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 4.0 ptm180 -57.74 -46.42 84.48 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 113.06 0.763 . . . . 74.11 113.06 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -64.41 -36.76 85.2 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 119.541 -0.863 . . . . 72.43 111.717 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.2 mt -60.89 -49.92 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.112 -1.44 . . . . 61.25 107.112 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.43 68.11 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.476 0.71 . . . . 32.33 111.684 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.9 ttm-85 -61.18 -53.78 52.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.11 0.414 . . . . 71.41 110.959 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -61.97 -39.8 93.43 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.68 -0.676 . . . . 75.31 112.409 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.464 HG13 HG21 ' A' ' 81' ' ' VAL . 13.8 p -72.19 -27.15 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 120.482 1.492 . . . . 72.22 109.495 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.9 tp -65.62 -47.48 75.48 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 120.329 -1.482 . . . . 74.25 107.445 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -56.91 -39.23 74.05 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.678 -1.153 . . . . 72.24 111.891 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.17 -50.2 74.93 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.775 1.17 . . . . 65.55 110.303 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -68.17 -44.6 75.58 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.844 -0.616 . . . . 75.21 112.084 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.6 t -62.91 -37.98 80.68 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-O 118.648 -0.692 . . . . 74.52 109.789 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -56.2 -52.23 65.18 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-N 119.354 0.979 . . . . 74.44 110.382 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.96 -18.15 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 121.647 -0.658 . . . . 72.3 112.434 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -87.48 -19.68 27.63 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.621 1.568 . . . . 74.2 110.224 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.26 -46.69 5.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.75 2.02 . . . . 73.01 110.928 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -77.07 -25.95 52.95 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.703 0.683 . . . . 62.02 111.937 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 CA--C 1.539 0.523 0 C-N-CA 127.895 2.478 . . . . 74.33 106.631 179.059 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.306 -0.627 . . . . 74.44 109.306 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -118.43 156.53 50.95 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 125.423 1.489 . . . . 74.41 108.712 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.81 166.34 29.95 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.431 2.087 . . . . 75.22 111.491 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.12 -175.92 50.98 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.241 -1.143 . . . . 63.23 110.241 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 60.7 mtt -122.84 168.26 12.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.962 0.905 . . . . 44.11 110.04 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.16 132.16 9.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 102.063 -3.31 . . . . 73.44 102.063 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -130.08 177.44 7.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.594 -1.262 . . . . 44.02 107.594 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.27 176.33 5.34 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.574 -0.704 . . . . 73.51 110.189 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -124.58 170.88 10.48 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.466 1.107 . . . . 54.34 108.865 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.74 -175.26 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.6 1.16 . . . . 60.25 109.996 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -132.52 173.65 11.1 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.22 1.008 . . . . 74.31 109.53 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.0 149.35 10.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 124.153 0.981 . . . . 75.05 109.357 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.13 173.54 7.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.37 1.068 . . . . 64.32 111.518 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.18 176.17 16.25 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 107.873 -2.091 . . . . 64.23 107.873 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.3 mmp_? . . . . . 0 C--O 1.235 0.294 0 O-C-N 121.182 -1.187 . . . . 52.13 111.639 -179.057 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 113.056 0.761 . . . . 71.55 113.056 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.11 112.59 2.84 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.19 2.594 . . . . 53.3 112.042 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mt -91.29 140.95 29.29 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.638 -0.664 . . . . 73.24 110.849 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -89.53 106.35 18.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.642 -1.984 . . . . 73.31 105.642 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -60.04 -11.49 6.01 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 114.879 1.437 . . . . 73.54 114.879 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.4 m -101.15 -3.44 29.15 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.208 1.003 . . . . 64.54 111.595 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -96.59 -8.83 30.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.433 1.093 . . . . 71.11 110.556 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.06 175.26 6.93 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.347 1.459 . . . . 74.23 109.709 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -130.1 122.65 28.7 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.39 0.676 . . . . 73.23 109.825 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -105.26 160.09 15.37 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.275 1.03 . . . . 73.2 111.182 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -142.05 131.17 23.29 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.139 1.376 . . . . 65.11 108.896 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -88.41 163.04 16.18 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.665 1.186 . . . . 65.42 107.933 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 N--CA 1.455 -0.222 0 C-N-CA 124.285 1.034 . . . . 43.31 108.865 -178.996 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 122.056 0.932 . . . . 64.24 111.185 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.2 m -99.51 158.39 15.77 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.401 0.68 . . . . 55.35 109.299 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.4 t -140.74 135.83 34.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.925 1.69 . . . . 74.43 106.583 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.28 142.27 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.201 -1.407 . . . . 72.0 107.201 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.4 tp -131.57 146.74 52.36 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.697 1.199 . . . . 51.41 107.976 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.56 148.59 49.15 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.476 0.655 . . . . 75.13 110.15 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -93.92 118.67 31.8 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 104.243 -2.503 . . . . 71.44 104.243 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.19 -61.53 7.66 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 118.531 -0.747 . . . . 74.34 112.077 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -69.91 -9.78 26.87 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.793 2.329 . . . . 51.02 116.197 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 m -120.95 -10.33 9.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.438 1.472 . . . . 73.02 114.614 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.74 9.67 27.52 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.737 1.161 . . . . 73.21 114.725 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 mt -70.81 131.5 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 104.772 -2.307 . . . . 71.22 104.772 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.1 t -126.52 143.93 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.55 -1.278 . . . . 62.13 107.55 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.54 142.57 25.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.525 -0.917 . . . . 71.02 108.525 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -115.42 118.5 33.38 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.751 1.62 . . . . 72.54 110.154 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.0 p -116.55 143.42 45.62 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.397 0.544 . . . . 72.11 110.135 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -157.41 100.32 1.81 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.704 1.202 . . . . 64.33 108.813 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -135.34 -24.62 1.39 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 119.989 1.268 . . . . 74.33 114.017 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.2 p -124.29 171.6 9.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.576 0.75 . . . . 74.13 110.025 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -91.25 0.85 57.45 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.56 -0.533 . . . . 61.23 109.56 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.0 m -100.28 114.97 28.85 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.11 1.364 . . . . 73.44 107.961 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.2 p -59.42 -38.41 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.538 -0.912 . . . . 70.41 108.538 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -59.4 -40.52 86.9 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.048 1.739 . . . . 61.01 112.318 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -79.11 -29.76 43.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.492 0.717 . . . . 73.54 110.662 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.418 ' HA ' HD12 ' A' ' 95' ' ' ILE . 89.9 m-20 -70.37 -40.44 73.99 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.275 -1.38 . . . . 51.31 107.275 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -48.61 -52.01 25.14 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.744 -1.223 . . . . 74.21 113.022 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -57.3 -35.16 69.48 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.174 0.897 . . . . 64.42 112.684 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 92' ' ' ASN . 54.6 mt -63.05 -50.39 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.221 1.008 . . . . 60.34 108.557 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.86 92.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 119.367 -0.349 . . . . 55.02 110.427 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -61.73 -51.65 67.51 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.051 0.541 . . . . 73.22 111.812 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -40.58 95.35 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 117.783 -1.103 . . . . 73.2 112.32 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.422 HG22 ' HE2' ' A' ' 103' ' ' LYS . 4.4 p -73.81 -38.77 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 119.676 1.126 . . . . 72.51 110.456 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 104' ' ' VAL . 56.3 tp -60.93 -44.99 96.45 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.86 -0.792 . . . . 72.1 108.86 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -50.28 -47.62 55.31 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 124.143 0.977 . . . . 72.33 112.095 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -59.27 -35.83 74.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.826 -1.171 . . . . 71.41 111.671 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.422 ' HE2' HG22 ' A' ' 99' ' ' VAL . 54.6 mttm -77.6 -33.55 53.79 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.586 1.154 . . . . 75.24 110.184 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 100' ' ' LEU . 60.8 t -66.12 -51.7 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 C-N-CA 125.712 1.605 . . . . 72.52 108.171 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -61.62 2.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 126.263 1.825 . . . . 74.32 111.234 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.3 p -59.52 -28.9 41.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 119.489 -0.291 . . . . 61.25 111.758 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -66.82 -37.58 84.79 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.579 -1.326 . . . . 74.33 109.996 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -81.84 -40.98 21.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.809 -0.557 . . . . 73.2 110.629 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -74.65 -15.14 60.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.643 1.577 . . . . 70.21 112.611 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 124.918 1.287 . . . . 53.12 109.364 -179.258 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.272 -0.64 . . . . 75.41 109.272 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -79.57 158.07 73.97 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.884 -0.784 . . . . 74.52 108.884 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.91 -176.61 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.749 2.3 . . . . 65.41 110.049 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.84 147.67 43.4 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 109.602 -1.399 . . . . 64.1 109.602 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 70.8 mtm -134.79 173.74 11.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.203 1.401 . . . . 75.53 108.704 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.31 119.17 10.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 100.847 -3.761 . . . . 61.22 100.847 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -123.8 175.61 6.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.846 0.459 . . . . 74.32 109.969 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.6 t -61.76 141.59 57.8 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.347 0.659 . . . . 71.23 109.57 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.9 p -73.37 -174.98 1.78 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.794 1.238 . . . . 75.44 109.602 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.2 m -62.58 153.74 6.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 O-C-N 121.041 -1.037 . . . . 50.22 109.873 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -130.55 -176.39 3.96 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.297 1.439 . . . . 61.04 109.521 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 t -70.77 163.72 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 122.007 0.908 . . . . 62.01 110.946 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.94 168.51 13.87 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 127.792 2.437 . . . . 52.42 107.779 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.04 -174.31 50.28 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 109.055 -1.618 . . . . 73.13 109.055 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 . . . . . 0 C--O 1.235 0.291 0 CA-C-N 118.15 0.975 . . . . 72.44 109.706 179.289 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 C--O 1.234 0.262 0 N-CA-C 109.864 -0.421 . . . . 63.45 109.864 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.76 122.95 10.95 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.072 2.515 . . . . 61.21 111.664 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -112.28 147.74 35.64 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.641 1.177 . . . . 62.43 110.341 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -110.49 115.48 29.7 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.663 -1.236 . . . . 53.12 107.663 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.52 -28.24 69.51 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.851 0.75 . . . . 70.14 111.675 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 m -75.36 0.05 18.17 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.514 1.126 . . . . 71.21 111.471 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -117.64 5.76 12.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.107 1.363 . . . . 74.32 113.305 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.435 HD22 ' CD2' ' A' ' 74' ' ' HIS . 6.1 mt -107.87 176.0 5.29 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.732 -1.21 . . . . 73.32 107.732 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -138.6 112.46 8.43 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.124 0.57 . . . . 63.44 109.661 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 157.26 17.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.003 -1.48 . . . . 73.54 107.003 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -142.04 -179.67 6.36 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.733 -1.21 . . . . 63.43 107.733 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.04 162.97 27.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.844 1.258 . . . . 64.4 108.476 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.8 t . . . . . 0 C--O 1.238 0.485 0 C-N-CA 125.64 1.576 . . . . 74.45 108.909 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 p30 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 108.697 -0.853 . . . . 72.35 108.697 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.7 p -156.67 103.71 2.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.906 -1.516 . . . . 62.44 106.906 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.0 t -94.38 158.73 2.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.16 -1.052 . . . . 73.13 108.16 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.02 146.35 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.49 1.116 . . . . 64.42 109.751 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.4 tp -146.12 149.7 34.52 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.447 1.499 . . . . 72.35 108.407 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -140.27 148.38 41.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.052 1.341 . . . . 74.15 109.812 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.435 ' CD2' HD22 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -100.02 126.06 46.16 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.564 1.546 . . . . 74.13 107.547 178.619 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.8 -56.1 5.01 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 118.084 -0.96 . . . . 54.41 111.511 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.31 -8.14 22.19 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.093 1.862 . . . . 64.54 116.081 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -120.73 -9.97 9.25 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.093 0.861 . . . . 64.31 112.614 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.78 4.14 9.71 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.518 -1.157 . . . . 32.13 115.132 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.1 mt -70.28 141.92 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 126.187 1.795 . . . . 75.33 107.746 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.6 148.08 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.745 1.218 . . . . 35.02 108.382 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.3 151.76 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.249 -0.648 . . . . 73.35 109.249 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -132.42 107.98 8.86 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.02 -1.474 . . . . 72.32 107.02 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.3 m -123.6 153.33 40.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 122.475 1.131 . . . . 60.42 112.869 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -154.3 148.41 25.81 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.909 2.084 . . . . 72.32 107.521 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -162.46 -26.79 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.159 0.983 . . . . 53.21 110.784 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.5 p -138.34 158.1 44.94 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.782 -0.574 . . . . 51.11 110.924 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -22.51 66.94 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.643 -0.661 . . . . 63.54 111.847 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -79.54 116.81 19.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.21 1.804 . . . . 63.54 112.217 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.4 p -58.72 -40.78 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.38 0.672 . . . . 44.32 110.162 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -58.72 -46.92 86.28 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.918 0.887 . . . . 61.55 111.425 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -65.06 -44.12 90.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.564 1.145 . . . . 70.54 109.837 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -61.36 -40.42 94.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.997 0.362 . . . . 64.11 110.353 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -59.09 -38.87 80.52 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.134 -0.936 . . . . 72.23 111.028 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -59.77 -48.22 82.54 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.383 0.992 . . . . 74.12 109.287 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.1 -48.2 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 123.844 0.858 . . . . 40.14 109.397 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.47 82.37 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.177 0.591 . . . . 74.1 110.343 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -62.39 -45.35 93.56 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.055 0.542 . . . . 64.43 110.12 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -55.65 -61.65 2.21 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.138 0.975 . . . . 74.23 109.202 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.73 -34.45 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.655 0.613 . . . . 73.13 112.655 -177.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.0 -47.78 81.64 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.032 0.933 . . . . 51.44 109.12 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -52.13 -41.41 62.5 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.937 0.895 . . . . 62.53 113.17 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.5 -33.15 75.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.609 0.719 . . . . 64.11 110.738 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -73.59 -34.45 65.08 Favored 'General case' 0 C--N 1.335 -0.053 0 O-C-N 121.355 -0.841 . . . . 73.11 110.137 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.1 t -68.07 -43.41 85.3 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 CA-C-O 118.354 -0.831 . . . . 71.2 109.112 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -50.28 -60.76 2.66 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.391 1.077 . . . . 74.25 109.604 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.96 -29.25 46.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-O 118.601 -0.714 . . . . 74.32 111.737 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -69.56 -38.79 77.56 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 120.104 1.32 . . . . 74.34 110.93 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -73.76 -56.08 5.43 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.472 -0.936 . . . . 74.54 108.472 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -67.82 -21.33 65.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 115.202 1.556 . . . . 53.33 115.202 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 C--N 1.327 -0.397 0 C-N-CA 125.708 1.603 . . . . 71.24 107.665 179.825 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 121.578 0.704 . . . . 65.21 112.169 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.25 152.72 92.37 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.125 -0.694 . . . . 74.34 109.125 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.68 3.8 5.13 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.448 2.765 . . . . 63.3 113.358 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.04 179.43 48.07 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.186 -1.966 . . . . 62.44 108.186 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 92.8 mtp -141.45 172.1 13.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.828 1.251 . . . . 71.51 107.975 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.48 144.69 25.54 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 101.571 -3.492 . . . . 61.5 101.571 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.58 173.52 11.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.314 -0.625 . . . . 74.01 109.314 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.4 t -77.35 179.53 6.37 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.343 -0.984 . . . . 63.12 108.343 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 m -142.38 150.04 40.17 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 106.803 -1.554 . . . . 74.23 106.803 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -66.33 169.95 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 123.75 0.82 . . . . 51.25 110.115 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -123.29 166.67 14.89 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.996 0.919 . . . . 73.24 108.814 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.9 m -112.13 -168.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.236 1.415 . . . . 71.33 108.506 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.49 -19.32 13.28 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.066 -0.493 . . . . 54.45 111.103 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.0 -107.68 2.11 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.164 -1.574 . . . . 33.33 109.164 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.334 -0.102 0 C-N-CA 125.942 1.697 . . . . 74.41 111.209 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 109.635 -0.506 . . . . 61.12 109.635 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.51 165.85 29.73 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.896 2.397 . . . . 71.2 113.696 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.605 HD12 ' C ' ' A' ' 43' ' ' LEU 0.423 0.2 OUTLIER -134.86 166.09 23.79 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.4 1.88 . . . . 72.51 111.541 179.801 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -120.16 101.56 7.91 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.103 -1.073 . . . . 71.34 108.103 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -67.28 -11.95 58.85 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.931 1.085 . . . . 75.12 113.931 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -0.66 57.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.159 1.384 . . . . 41.53 112.726 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -126.16 32.61 5.19 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.852 1.261 . . . . 73.03 109.757 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.1 mt -113.79 117.25 30.94 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.736 1.215 . . . . 63.4 108.036 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -102.76 103.95 14.22 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 104.802 -2.295 . . . . 74.12 104.802 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -84.63 163.78 19.06 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.537 1.062 . . . . 74.45 108.945 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -120.52 129.03 53.64 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.206 -1.776 . . . . 71.51 106.206 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -87.41 143.27 27.32 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.422 -0.955 . . . . 74.23 108.422 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 105.565 -2.013 . . . . 51.4 105.565 179.885 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.464 HD21 ' N ' ' A' ' 89' ' ' VAL . 33.4 t-20 . . . . . 0 C--O 1.237 0.403 0 N-CA-C 107.866 -1.161 . . . . 71.02 107.866 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.0 t -141.64 138.04 32.25 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.25 1.82 . . . . 61.35 106.491 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.7 t -121.67 150.56 24.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.709 -1.589 . . . . 72.11 106.709 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -137.71 128.91 39.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 102.699 -3.075 . . . . 51.34 102.699 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.1 tp -130.51 143.92 51.07 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.062 0.945 . . . . 72.34 110.633 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.488 ' CB ' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -144.05 143.98 31.42 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.261 -0.899 . . . . 74.03 112.631 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.73 ' HB2' HD11 ' A' ' 100' ' ' LEU . 2.4 t-80 -86.4 121.0 28.34 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.266 -2.124 . . . . 74.03 105.266 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.44 -57.75 23.16 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.588 1.086 . . . . 53.13 112.123 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -59.33 -34.14 97.76 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.615 1.543 . . . . 54.32 114.905 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -93.66 -16.04 24.7 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.523 0.934 . . . . 74.03 113.523 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.07 23.83 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.565 1.555 . . . . 73.41 113.737 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.1 mt -70.27 120.82 18.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.049 -1.463 . . . . 71.12 107.049 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.488 HG22 ' CB ' ' A' ' 73' ' ' LYS . 69.7 t -111.23 128.51 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 126.385 1.874 . . . . 71.15 107.647 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.5 157.96 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 123.385 1.564 . . . . 60.45 108.018 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -141.28 139.68 33.72 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.877 -2.268 . . . . 63.24 104.877 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.7 t -138.65 163.69 31.45 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.224 -1.769 . . . . 61.22 106.224 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -155.09 149.22 25.89 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 104.848 -2.279 . . . . 52.24 104.848 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -170.98 -40.51 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.138 -0.458 . . . . 73.14 110.153 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 p -127.25 -177.45 4.07 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.399 0.619 . . . . 72.52 112.426 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.9 mtm-85 -103.77 -0.41 29.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.991 0.917 . . . . 75.25 110.943 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m -98.44 115.72 29.13 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.644 -1.243 . . . . 73.32 107.644 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.464 ' N ' HD21 ' A' ' 68' ' ' ASN . 7.6 p -55.97 -45.82 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 122.878 0.471 . . . . 74.35 109.82 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.63 -32.62 67.43 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.832 1.253 . . . . 71.43 112.618 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -82.13 -44.48 16.44 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 120.582 -1.324 . . . . 72.12 108.127 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -57.35 -36.8 71.64 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.593 0.757 . . . . 65.42 109.632 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -60.12 -51.19 70.67 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 118.144 -0.932 . . . . 64.2 109.604 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -64.58 -36.57 84.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.837 1.199 . . . . 51.21 112.482 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.62 -43.07 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.157 -0.683 . . . . 61.03 109.157 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.19 -38.11 87.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.046 0.538 . . . . 74.44 110.814 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.496 HH11 ' HG3' ' A' ' 97' ' ' ARG . 0.9 OUTLIER -57.6 -52.72 64.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.047 0.939 . . . . 75.14 111.858 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.78 97.37 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 119.379 -0.929 . . . . 62.34 112.524 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.83 -32.45 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 120.113 1.324 . . . . 71.15 111.388 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.73 HD11 ' HB2' ' A' ' 74' ' ' HIS . 9.1 tp -62.39 -40.29 95.98 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.523 -0.736 . . . . 75.1 109.447 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -57.44 -42.59 82.73 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.217 0.607 . . . . 72.34 110.097 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -61.11 -20.52 62.74 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.474 0.916 . . . . 71.11 113.474 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -87.54 -38.83 15.66 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.475 -0.766 . . . . 73.31 109.458 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.0 t -67.39 -31.98 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.479 -0.934 . . . . 70.13 108.479 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -52.93 -57.61 9.72 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.098 1.359 . . . . 72.25 108.116 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.34 -38.68 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.521 1.128 . . . . 74.25 109.375 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -62.85 -37.23 86.01 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.896 1.226 . . . . 74.24 110.449 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -75.79 -33.62 60.16 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.64 0.978 . . . . 73.25 113.64 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -108.33 -9.46 15.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 116.369 1.989 . . . . 75.35 116.369 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 C--N 1.32 -0.677 0 C-N-CA 126.569 1.948 . . . . 73.05 110.138 -178.991 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 121.113 0.482 . . . . 64.23 109.778 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -75.2 155.24 86.22 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.851 0.86 . . . . 74.23 110.399 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.58 175.96 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.122 2.548 . . . . 74.05 110.586 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.59 163.02 53.47 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.031 -0.827 . . . . 71.22 111.031 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 95.6 mtp -73.46 163.92 27.38 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.088 0.555 . . . . 53.52 110.438 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.63 71.96 1.37 Allowed 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 105.546 -2.02 . . . . 65.23 105.546 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.49 -172.1 1.71 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.056 -0.975 . . . . 62.21 111.032 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.91 172.63 2.18 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.316 1.047 . . . . 62.3 110.434 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -130.05 177.36 7.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.634 1.174 . . . . 72.13 109.47 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 m -63.69 137.0 25.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.785 1.634 . . . . 72.1 108.672 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -132.36 -176.7 4.17 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.601 1.16 . . . . 65.12 111.531 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.2 t -54.84 151.87 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.235 1.814 . . . . 65.22 108.396 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.06 -167.08 1.14 Allowed 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.106 0.962 . . . . 64.43 109.573 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.49 -171.93 2.02 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.357 1.455 . . . . 62.03 113.034 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? . . . . . 0 CA--C 1.513 -0.45 0 C-N-CA 123.417 0.687 . . . . 73.1 109.72 -179.409 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.236 0.384 0 CA-C-O 119.444 -0.312 . . . . 72.13 111.344 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.21 165.58 26.19 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.141 2.56 . . . . 54.33 112.211 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 43' ' ' LEU 0.413 0.2 OUTLIER -136.39 164.17 28.76 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 114.06 1.133 . . . . 74.25 114.06 -179.074 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -120.84 101.1 7.48 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 104.455 -2.424 . . . . 74.03 104.455 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.41 -14.17 25.98 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.417 1.087 . . . . 71.21 113.922 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -98.53 6.8 46.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.352 1.061 . . . . 74.52 110.8 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -120.13 23.93 10.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.328 1.451 . . . . 74.42 110.178 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 mt -113.41 145.9 40.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.545 1.538 . . . . 72.31 107.388 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -116.74 106.44 13.51 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.036 -2.209 . . . . 75.54 105.036 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -100.89 154.05 18.99 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.414 1.085 . . . . 70.31 113.019 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -144.93 169.89 17.2 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.962 -1.125 . . . . 71.44 107.962 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -121.27 133.74 55.15 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.946 -1.872 . . . . 72.54 105.946 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.5 t . . . . . 0 C--N 1.331 -0.228 0 N-CA-C 107.315 -1.365 . . . . 54.33 107.315 -178.242 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.7 p30 . . . . . 0 N--CA 1.467 0.419 0 CA-C-O 118.573 -0.727 . . . . 75.44 112.476 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 55.6 m -67.17 142.1 57.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.082 0.856 . . . . 53.33 108.962 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.1 t -115.22 135.54 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.383 -2.081 . . . . 63.41 105.383 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.18 130.75 73.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 102.97 -2.974 . . . . 64.35 102.97 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.7 tp -139.01 151.58 46.93 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.123 0.569 . . . . 62.42 110.168 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 152.43 45.72 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 122.424 0.289 . . . . 52.33 110.458 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -95.61 122.95 38.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 103.326 -2.842 . . . . 75.2 103.326 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.48 -62.37 5.56 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 120.091 1.314 . . . . 60.22 112.017 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.6 -17.12 58.59 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.569 2.18 . . . . 63.45 115.581 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.21 -13.54 16.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.817 1.19 . . . . 75.45 110.665 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.41 -15.03 0.87 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.634 1.587 . . . . 61.15 115.498 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.1 mt -56.95 132.7 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.721 1.608 . . . . 73.3 110.851 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.2 t -124.14 138.39 53.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 126.868 2.067 . . . . 53.24 106.094 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.6 157.3 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.737 -0.468 . . . . 74.24 109.737 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -119.69 131.58 55.45 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 126.251 1.82 . . . . 75.51 109.134 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -141.24 153.61 45.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.186 0.994 . . . . 63.31 111.318 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -155.5 159.07 39.46 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 128.011 2.525 . . . . 64.55 107.356 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -161.8 -54.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.198 1.399 . . . . 73.12 108.321 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.47 179.13 6.22 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.89 0.853 . . . . 71.25 110.907 -178.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -13.23 62.28 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.753 0.821 . . . . 74.45 112.151 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.31 115.07 22.3 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.353 0.661 . . . . 72.15 112.777 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.82 -33.11 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.077 -1.453 . . . . 74.35 107.077 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.58 -38.36 84.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.178 1.791 . . . . 73.24 109.763 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.8 -52.29 9.79 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.683 -1.229 . . . . 64.35 107.683 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -52.8 -33.9 51.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.286 0.634 . . . . 73.23 110.104 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -59.26 -62.03 2.19 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.44 1.496 . . . . 73.4 108.19 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -62.67 -36.41 82.78 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 118.395 -0.812 . . . . 73.43 112.992 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.35 -51.44 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.245 -1.391 . . . . 71.22 107.245 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.54 -50.18 72.38 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.408 -0.59 . . . . 64.42 109.408 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -54.22 -39.93 67.19 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 118.035 -0.983 . . . . 64.31 112.164 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -44.6 47.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.288 -1.339 . . . . 71.51 110.831 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.16 -32.85 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.769 1.622 . . . . 52.12 112.256 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.5 tp -59.66 -35.8 75.14 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.485 -0.759 . . . . 71.3 109.434 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.76 -38.34 87.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.028 0.931 . . . . 73.1 109.479 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -68.12 -17.64 64.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.882 1.673 . . . . 64.14 111.136 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -97.17 -35.54 10.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.99 0.916 . . . . 65.14 109.001 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.5 t -69.16 -31.92 51.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.011 -1.107 . . . . 70.33 108.011 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -62.04 1.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.872 2.069 . . . . 61.21 109.174 177.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.64 -25.11 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 122.645 0.378 . . . . 61.42 111.475 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -77.77 -15.28 59.22 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.99 -1.069 . . . . 74.45 111.026 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -94.05 -42.31 9.09 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.045 1.338 . . . . 72.52 108.975 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -87.86 -14.58 39.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.781 1.03 . . . . 52.44 113.781 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.324 -0.517 0 C-N-CA 125.954 1.702 . . . . 74.12 108.049 179.625 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 109.16 -0.682 . . . . 75.01 109.16 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -123.47 154.7 66.18 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 125.314 1.446 . . . . 64.34 109.651 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.66 169.07 22.5 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.84 2.36 . . . . 50.01 111.441 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.22 171.02 49.83 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.434 -1.066 . . . . 44.21 110.434 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.3 tpt -154.72 142.65 20.1 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.411 -1.7 . . . . 74.52 106.411 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.12 65.75 0.77 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.022 0.929 . . . . 74.43 108.569 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 154.08 30.66 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.965 -0.46 . . . . 55.54 110.587 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -71.8 152.97 42.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.046 -0.724 . . . . 61.24 109.046 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -85.89 -170.62 3.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.021 1.728 . . . . 64.2 111.01 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 t -70.79 154.22 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.203 1.401 . . . . 65.13 109.36 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -90.5 -178.16 5.25 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.945 0.879 . . . . 71.32 109.788 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.24 165.92 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.785 1.634 . . . . 75.34 108.395 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.57 169.72 17.13 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.943 1.697 . . . . 75.52 108.122 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.7 76.76 1.34 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 107.867 -2.093 . . . . 61.42 107.867 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 108.102 -1.073 . . . . 71.23 108.102 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 119.41 -0.329 . . . . 72.45 111.279 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.21 99.11 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.197 2.598 . . . . 74.1 111.919 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.8 mt -89.86 133.35 34.79 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.951 1.3 . . . . 73.22 108.576 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -75.68 106.99 7.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.54 -0.911 . . . . 75.4 108.54 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -59.95 -9.86 3.48 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.003 1.483 . . . . 63.32 115.003 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -101.18 -14.23 17.81 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.036 1.334 . . . . 73.32 112.473 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -90.39 -4.11 57.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.849 1.26 . . . . 70.43 111.85 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mt -84.2 150.89 25.18 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.758 1.623 . . . . 74.1 113.722 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -103.45 105.69 16.01 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.519 1.128 . . . . 74.12 108.155 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -85.37 147.6 26.43 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.621 -1.252 . . . . 60.13 107.621 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.671 ' HB2' HG13 ' A' ' 71' ' ' VAL . 14.3 mm-40 -132.31 141.6 49.02 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.701 -1.222 . . . . 73.5 107.701 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -118.5 121.0 39.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.959 1.303 . . . . 73.32 108.621 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 C--O 1.238 0.457 0 N-CA-C 107.033 -1.469 . . . . 60.34 107.033 -179.074 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.5 m120 . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 105.982 -1.858 . . . . 72.31 105.982 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.9 t -98.89 169.42 9.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.134 -0.979 . . . . 73.41 110.011 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 t -139.19 143.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 104.594 -2.372 . . . . 72.4 104.594 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.671 HG13 ' HB2' ' A' ' 51' ' ' GLN 0.258 9.6 p -137.63 124.86 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 101.729 -3.434 . . . . 64.51 101.729 177.582 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 tp -120.29 148.86 43.18 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.042 0.937 . . . . 64.22 108.987 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -138.69 129.07 25.87 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.25 1.02 . . . . 74.4 110.083 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -88.69 144.18 26.44 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.33 -2.1 . . . . 74.4 105.33 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.1 t -73.82 -71.6 0.21 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.776 -1.107 . . . . 70.14 112.465 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.31 -36.63 78.11 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.496 2.797 . . . . 73.01 113.526 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.9 t -77.96 -25.02 47.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.999 -0.28 . . . . 72.52 111.246 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.01 -0.08 6.51 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 119.189 -0.784 . . . . 70.04 113.435 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.7 mt -68.37 137.88 23.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 119.113 1.457 . . . . 73.25 107.22 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.4 t -131.6 139.74 49.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 106.872 -1.529 . . . . 73.15 106.872 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.61 147.14 16.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.91 -1.144 . . . . 53.34 107.91 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -123.22 127.97 49.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 125.401 1.48 . . . . 73.43 108.26 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 49.3 m -144.81 162.26 37.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.143 0.973 . . . . 72.14 110.896 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -155.07 156.16 35.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.362 2.265 . . . . 75.52 106.392 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -158.32 -74.4 0.08 Allowed 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 105.729 -1.952 . . . . 62.52 105.729 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.2 p -83.13 -179.3 7.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.942 0.877 . . . . 73.24 109.559 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -96.68 1.09 50.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.389 0.675 . . . . 74.0 109.314 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.6 m -96.72 115.47 27.49 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.974 1.31 . . . . 74.41 108.006 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.8 p -57.35 -42.58 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 109.506 -0.553 . . . . 63.02 109.506 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.64 -47.3 84.86 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.004 0.921 . . . . 64.21 112.196 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -67.72 -32.92 73.88 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.748 -0.595 . . . . 74.13 109.402 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -71.49 -29.25 64.6 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.24 -0.913 . . . . 75.05 109.204 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -63.15 -48.78 77.01 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.805 1.184 . . . . 74.12 109.869 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -57.82 -38.47 75.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.926 0.785 . . . . 65.34 112.051 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.69 -49.2 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.05 -1.093 . . . . 50.15 108.05 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.39 -47.04 86.96 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.927 0.891 . . . . 51.32 110.785 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -60.0 -45.53 92.43 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.644 0.778 . . . . 71.12 109.706 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -51.03 71.49 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.208 0.603 . . . . 72.04 110.72 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.58 -32.47 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.732 0.697 . . . . 74.34 110.909 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.1 tp -63.72 -40.3 96.41 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 120.616 -1.302 . . . . 64.55 110.187 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -54.5 -40.1 68.22 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.058 1.343 . . . . 75.24 111.95 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.95 -36.53 83.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.372 1.069 . . . . 74.0 111.503 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -76.45 -42.08 45.12 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.93 -0.481 . . . . 74.13 110.21 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.2 -32.26 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 118.609 -0.71 . . . . 64.12 110.442 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -58.68 -56.31 23.83 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.862 1.21 . . . . 72.23 108.252 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 68.3 t -58.45 -28.38 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.241 1.016 . . . . 65.52 110.745 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -74.35 -18.36 60.69 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.156 -0.965 . . . . 51.31 112.256 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -99.35 -49.89 4.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.294 1.438 . . . . 74.41 110.322 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -71.68 -16.51 62.24 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.015 0.746 . . . . 74.35 113.015 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 CA--C 1.539 0.541 0 C-N-CA 128.693 2.797 . . . . 54.21 106.99 179.776 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 99.3 mt . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 121.112 0.482 . . . . 64.3 110.162 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -67.01 155.18 90.89 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.427 0.691 . . . . 72.52 110.082 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.11 176.84 9.0 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.932 2.422 . . . . 73.4 110.936 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.51 172.07 32.26 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 121.741 0.634 . . . . 71.43 111.526 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -58.55 135.39 57.31 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.312 1.045 . . . . 74.22 109.395 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.19 30.01 4.58 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.225 1.41 . . . . 42.35 110.136 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.31 175.7 2.09 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.264 1.026 . . . . 64.41 109.865 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.6 t -87.76 170.59 11.09 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.98 -1.075 . . . . 73.24 108.954 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.0 m -139.83 146.28 39.17 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.646 -1.242 . . . . 74.24 107.646 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 t -68.57 133.33 31.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 125.427 1.491 . . . . 54.44 111.546 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -75.66 154.66 36.42 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.206 -1.035 . . . . 62.35 108.206 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.5 t -72.53 146.67 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.963 -1.086 . . . . 74.51 108.42 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.76 166.47 23.21 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.487 1.515 . . . . 65.22 107.75 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -136.43 73.23 0.44 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 123.931 0.777 . . . . 43.34 111.447 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 . . . . . 0 C--O 1.238 0.447 0 C-N-CA 124.593 1.157 . . . . 71.23 109.483 179.221 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 109.616 -0.512 . . . . 50.13 109.616 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.82 147.94 57.11 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.436 2.091 . . . . 75.13 109.702 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.526 HD12 ' C ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -148.62 138.35 22.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.161 -1.051 . . . . 64.0 108.161 -179.419 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -91.9 111.01 22.38 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.488 1.515 . . . . 64.44 111.544 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -66.65 -25.92 66.81 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.964 1.706 . . . . 75.1 113.245 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -80.01 -11.19 59.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.423 1.01 . . . . 71.3 112.096 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -101.02 9.89 41.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.449 1.1 . . . . 75.2 111.315 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.3 175.82 5.58 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.359 -0.838 . . . . 64.2 112.847 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -125.38 135.63 52.61 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.424 2.29 . . . . 63.05 106.038 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -126.72 166.28 17.68 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.134 1.374 . . . . 72.32 111.464 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -137.66 177.51 7.81 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.025 1.33 . . . . 64.0 108.658 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -135.07 163.6 29.54 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.81 2.044 . . . . 72.4 107.256 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 106.479 -1.675 . . . . 63.33 106.479 179.787 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 m120 . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 109.395 -0.594 . . . . 71.03 109.395 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.3 p -150.18 154.73 38.51 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.693 -1.254 . . . . 71.41 107.939 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.3 152.49 27.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 123.813 0.845 . . . . 74.34 109.325 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.59 141.65 42.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.221 -1.399 . . . . 62.35 107.221 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.9 tp -129.03 154.6 46.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.495 0.718 . . . . 72.02 110.798 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 75' ' ' VAL . 1.5 tmtp? -143.71 155.59 44.26 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.369 1.068 . . . . 62.51 108.183 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -122.24 120.43 34.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.687 -1.968 . . . . 74.3 105.687 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.473 ' HA ' ' HE2' ' A' ' 73' ' ' LYS . 39.7 t -66.26 -56.46 16.1 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.746 1.218 . . . . 62.22 111.884 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.66 -12.96 38.0 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.634 2.222 . . . . 72.23 115.709 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 t -113.64 -16.44 12.34 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.846 0.748 . . . . 71.15 110.453 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.56 9.39 37.72 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.591 1.091 . . . . 52.44 113.662 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.8 mt -79.89 145.86 8.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.482 1.113 . . . . 74.21 108.283 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 t -131.3 143.69 39.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.103 -1.814 . . . . 74.34 106.103 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -146.95 155.06 11.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.283 -0.636 . . . . 74.12 109.283 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.87 133.23 41.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.415 -0.957 . . . . 73.14 108.415 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.98 160.35 41.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.153 0.981 . . . . 72.33 111.163 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -155.52 134.37 12.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.425 2.29 . . . . 75.44 106.001 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -153.13 -51.43 0.1 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.724 -0.843 . . . . 74.21 108.724 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.8 p -109.62 170.88 7.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.352 1.032 . . . . 62.03 110.825 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -92.38 -16.74 25.57 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.156 0.982 . . . . 61.22 108.901 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -78.94 115.79 18.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.495 -0.928 . . . . 61.32 108.495 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.2 p -62.96 -37.73 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.642 -1.244 . . . . 62.43 107.642 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.79 -49.62 72.69 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.664 1.586 . . . . 52.01 108.718 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.3 -48.24 62.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.655 0.782 . . . . 74.52 110.949 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -52.74 -38.05 60.29 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.753 0.821 . . . . 75.2 111.243 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -54.86 -48.45 72.89 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.823 0.738 . . . . 75.5 109.335 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -64.0 -37.2 86.54 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.517 -0.739 . . . . 70.44 111.389 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.3 mt -63.66 -47.31 91.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.362 -0.977 . . . . 73.53 108.362 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.88 97.77 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.206 0.602 . . . . 74.44 109.894 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -57.39 -44.58 84.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.838 0.855 . . . . 73.12 109.82 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.7 -55.57 33.09 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.409 0.684 . . . . 72.44 110.237 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.47 -23.8 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 113.677 0.992 . . . . 74.44 113.677 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.5 tp -70.38 -38.7 74.76 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.561 -1.337 . . . . 74.54 110.626 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -55.15 -47.92 74.42 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.756 1.222 . . . . 54.14 114.014 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.75 -28.73 70.17 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.372 0.669 . . . . 74.12 111.509 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -77.42 -35.96 53.63 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.236 -0.915 . . . . 62.14 110.115 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.1 t -67.07 -33.99 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.151 -1.055 . . . . 54.25 108.151 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -56.59 -47.23 80.02 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.889 1.222 . . . . 71.45 108.894 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.64 -15.14 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.555 1.142 . . . . 74.44 111.891 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -82.49 -22.19 35.21 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.759 -1.213 . . . . 71.43 109.7 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -96.85 -53.29 3.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.301 1.441 . . . . 74.22 109.825 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -72.45 -16.41 61.82 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.634 0.605 . . . . 63.42 112.634 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 126.587 1.955 . . . . 74.54 106.796 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--O 1.233 0.193 0 N-CA-C 109.864 -0.421 . . . . 74.44 109.864 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -127.23 156.85 74.04 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.078 1.751 . . . . 73.12 109.125 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.33 168.77 24.03 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.793 2.328 . . . . 71.34 111.787 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.71 -87.63 0.86 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.714 -1.355 . . . . 43.41 109.714 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.2 tpt -146.57 160.83 41.64 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.628 1.171 . . . . 73.14 107.896 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.54 61.73 1.15 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.304 1.041 . . . . 75.13 109.772 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.08 150.75 38.76 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.87 -0.789 . . . . 53.4 108.87 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.6 t -79.18 -178.98 6.46 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.772 0.796 . . . . 72.52 110.668 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 m -112.38 156.67 22.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.218 1.807 . . . . 64.52 106.914 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.7 t -118.11 159.53 18.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.302 -1.37 . . . . 72.24 107.302 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -102.66 138.77 39.13 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.513 -1.292 . . . . 71.43 107.513 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.01 146.75 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 122.006 0.908 . . . . 71.54 110.35 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.27 170.91 9.71 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 129.322 3.049 . . . . 60.01 106.342 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.16 -151.7 23.45 Favored Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 108.319 -1.912 . . . . 72.34 108.319 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.508 ' HD2' ' H ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.625 0 CA-C-O 121.755 0.788 . . . . 72.12 110.099 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 74.5 mt . . . . . 0 C--O 1.238 0.492 0 CA-C-O 119.38 -0.343 . . . . 75.41 111.79 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.26 150.68 59.53 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.145 2.564 . . . . 71.33 109.314 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 43' ' ' LEU 0.576 0.2 OUTLIER -122.6 150.86 42.07 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.329 -0.857 . . . . 73.2 112.074 179.854 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -94.56 107.77 19.75 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.529 1.532 . . . . 73.13 112.034 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -70.16 -19.26 63.21 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.601 0.963 . . . . 63.23 113.601 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.5 m -87.95 10.36 19.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.325 1.45 . . . . 75.11 112.015 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -128.12 -1.52 5.79 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.5 1.12 . . . . 74.31 111.55 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -103.42 160.68 14.5 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.917 -1.142 . . . . 61.41 107.917 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -103.83 156.28 17.95 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 126.46 1.904 . . . . 73.05 108.126 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.71 136.5 53.91 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.582 -0.896 . . . . 70.32 108.582 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -152.25 156.55 39.92 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.187 0.994 . . . . 74.44 111.004 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -135.55 164.36 28.0 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 127.037 2.135 . . . . 62.15 109.679 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 102.816 -3.031 . . . . 74.04 102.816 178.297 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 108.206 -1.035 . . . . 72.1 108.206 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.6 m -57.98 131.3 50.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.07 1.348 . . . . 45.44 112.176 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.1 t -122.53 136.3 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.116 -1.809 . . . . 53.45 106.116 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.84 153.24 29.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.132 -1.803 . . . . 62.22 106.132 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp -141.22 142.89 33.93 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.177 -1.416 . . . . 63.21 107.177 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -136.11 134.12 38.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.796 -1.557 . . . . 73.53 106.796 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -86.03 140.05 30.62 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.756 -1.202 . . . . 72.42 107.756 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.3 t -71.67 -62.18 1.79 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 120.394 1.452 . . . . 72.41 111.616 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -70.4 -8.7 24.22 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.247 2.631 . . . . 72.24 116.242 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.0 m -120.74 -13.32 8.71 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.673 0.67 . . . . 74.25 112.509 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.04 -13.59 0.34 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.502 1.525 . . . . 65.53 115.584 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.4 mt -49.06 123.39 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 128.058 2.543 . . . . 55.4 110.316 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.25 142.63 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.863 1.265 . . . . 53.45 109.961 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.24 150.52 22.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.439 1.496 . . . . 72.12 108.018 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -122.87 115.02 21.28 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.298 1.439 . . . . 74.42 108.392 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 77.0 m -124.62 136.5 53.98 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.435 1.016 . . . . 75.33 111.982 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -156.34 111.81 2.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.241 -1.763 . . . . 75.34 106.241 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -147.43 -68.26 0.25 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.208 -1.404 . . . . 74.35 107.208 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -70.74 147.22 49.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.998 0.427 . . . . 64.11 110.287 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -67.83 -26.35 66.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.154 -0.684 . . . . 74.41 109.154 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 m -79.27 115.63 19.04 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 126.519 1.928 . . . . 61.25 111.25 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.68 -32.91 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 107.605 -1.258 . . . . 52.11 107.605 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -37.03 70.24 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.415 0.686 . . . . 71.42 110.986 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -79.61 -48.19 14.18 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.879 1.272 . . . . 60.43 109.738 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -53.24 -36.12 60.72 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.913 0.778 . . . . 74.44 110.085 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -57.3 -54.29 48.51 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.142 0.977 . . . . 73.43 109.424 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -59.45 -41.15 88.97 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 118.274 -0.869 . . . . 70.22 110.499 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.7 -49.09 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 124.554 1.159 . . . . 74.23 108.872 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.17 -43.46 98.85 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.981 -0.449 . . . . 74.43 110.608 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.63 -49.85 73.55 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.814 0.445 . . . . 74.2 111.112 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -44.09 97.0 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 118.448 -0.787 . . . . 73.14 112.013 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.85 -36.88 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 119.645 1.111 . . . . 72.1 109.027 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.18 -39.01 88.56 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 118.616 -0.707 . . . . 74.24 110.496 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -59.21 -23.75 62.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.247 0.93 . . . . 60.14 111.933 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -78.45 -25.96 46.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.807 1.185 . . . . 73.03 109.506 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -82.0 -44.35 16.79 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.896 1.279 . . . . 64.12 110.963 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.2 t -58.79 -41.92 83.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 N-CA-C 108.335 -0.987 . . . . 72.52 108.335 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.19 -64.9 0.69 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.095 0.558 . . . . 73.41 111.809 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.43 -32.6 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.409 1.084 . . . . 65.04 111.095 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -67.29 -42.97 82.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.395 0.543 . . . . 70.11 109.775 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -67.79 -29.52 68.73 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.538 0.735 . . . . 71.23 109.501 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -79.56 -35.36 39.9 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.555 0.742 . . . . 75.23 111.62 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.161 1.384 . . . . 75.42 111.908 -176.977 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.446 -0.626 0 N-CA-C 108.041 -1.096 . . . . 70.14 108.041 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -125.48 152.4 71.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 125.04 1.336 . . . . 61.31 107.45 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.89 161.61 41.04 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.88 1.72 . . . . 54.3 109.92 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.56 165.49 20.63 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 108.021 -2.032 . . . . 42.11 108.021 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 42.5 ttm -144.69 130.91 19.55 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.548 -0.908 . . . . 64.01 108.548 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.9 58.99 0.92 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.576 -2.009 . . . . 72.31 105.576 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.27 178.21 7.57 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.548 1.139 . . . . 74.5 108.999 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.0 t -60.31 140.56 57.03 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.453 -1.314 . . . . 65.41 107.453 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 m -139.36 134.51 32.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.174 -1.788 . . . . 74.32 106.174 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.52 157.96 39.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.653 0.781 . . . . 75.1 109.272 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -144.61 172.91 12.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.159 1.383 . . . . 73.33 109.339 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.54 166.82 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.933 1.693 . . . . 72.01 107.828 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.04 175.24 9.75 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.658 1.183 . . . . 65.21 110.122 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -131.73 91.9 0.28 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.929 -1.268 . . . . 53.23 109.929 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 . . . . . 0 C--O 1.232 0.139 0 CA-C-N 117.508 0.654 . . . . 64.11 109.71 179.151 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 C--O 1.241 0.616 0 N-CA-C 109.86 -0.422 . . . . 54.23 109.86 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.95 160.84 46.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.668 1.579 . . . . 75.11 111.901 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -157.26 143.45 17.86 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 127.801 2.44 . . . . 71.53 104.429 179.039 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.421 ' N ' HD12 ' A' ' 43' ' ' LEU . 43.5 t30 -114.67 102.28 9.88 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.037 0.935 . . . . 73.0 109.586 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -57.15 -27.6 62.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.373 0.533 . . . . 73.32 112.32 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -78.78 7.27 7.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.491 1.917 . . . . 73.1 112.981 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -127.0 4.87 6.5 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.616 1.566 . . . . 75.41 111.656 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.4 mt -94.01 176.66 6.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 122.119 0.961 . . . . 75.43 113.029 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -108.5 131.55 54.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 102.223 -3.251 . . . . 63.12 102.223 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -128.8 164.63 22.62 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.213 1.005 . . . . 73.12 108.545 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.65 160.62 42.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.384 -0.969 . . . . 71.55 108.384 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -109.7 135.64 50.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.131 1.372 . . . . 64.22 108.08 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.3 t . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 107.048 -1.464 . . . . 63.14 107.048 -178.717 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 . . . . . 0 CA--C 1.529 0.163 0 N-CA-C 107.936 -1.135 . . . . 70.25 107.936 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.9 m -143.47 148.76 36.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.985 1.714 . . . . 74.22 107.276 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t -144.63 157.3 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.891 -1.522 . . . . 73.31 106.891 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.17 139.61 26.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.766 -1.939 . . . . 73.25 105.766 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 tp -139.48 143.73 37.65 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.414 -1.328 . . . . 74.44 107.414 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -131.5 158.42 40.94 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 123.186 0.594 . . . . 74.33 109.407 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -104.16 114.45 28.7 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 102.443 -3.169 . . . . 74.11 102.443 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.99 -62.12 5.74 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 119.187 0.903 . . . . 73.53 111.69 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -65.04 -14.67 46.55 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.791 2.994 . . . . 53.44 116.622 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.2 t -112.3 -10.6 13.8 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.564 1.075 . . . . 72.04 111.123 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.2 3.47 6.67 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.268 1.413 . . . . 73.25 113.896 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -66.87 149.19 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 120.024 1.912 . . . . 63.03 108.179 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.4 t -136.69 135.32 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.154 -1.795 . . . . 73.32 106.154 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.0 146.94 24.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 106.888 -1.523 . . . . 74.04 106.888 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -127.44 119.75 26.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.136 0.974 . . . . 74.14 108.961 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.1 m -139.32 149.29 44.04 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.563 1.545 . . . . 72.33 109.767 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -155.11 121.25 5.21 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.455 -2.054 . . . . 72.35 105.455 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -133.22 -48.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.891 0.876 . . . . 75.53 110.769 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.3 p -101.73 158.33 16.19 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.51 1.124 . . . . 61.44 111.738 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -71.9 -30.21 65.14 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 118.065 -0.969 . . . . 74.05 111.373 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -79.44 123.92 27.98 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 119.917 1.235 . . . . 50.52 110.275 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.96 -38.77 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.346 1.058 . . . . 51.11 109.041 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -55.57 -44.14 76.57 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.304 1.442 . . . . 75.41 110.721 -179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -40.23 62.04 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.718 0.807 . . . . 63.22 110.386 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -55.86 -32.94 64.08 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.741 0.7 . . . . 42.03 110.554 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 45.1 mtp85 -57.54 -45.19 85.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.593 0.633 . . . . 74.4 110.875 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -61.21 -31.76 71.53 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 118.679 0.672 . . . . 71.53 111.739 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.3 mt -74.06 -40.21 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.695 -0.854 . . . . 65.13 108.695 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.23 -47.59 73.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 122.897 0.479 . . . . 52.43 110.541 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -31.5 72.11 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 120.526 -0.47 . . . . 74.1 111.103 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -61.32 2.15 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.507 -1.294 . . . . 72.55 107.507 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -55.65 -35.83 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 118.683 0.674 . . . . 63.13 111.254 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.49 -32.57 74.06 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.455 -0.783 . . . . 45.2 111.474 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -61.17 -41.67 97.2 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 119.426 1.012 . . . . 74.24 110.531 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.81 -36.29 78.67 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.516 -0.92 . . . . 64.33 108.516 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -72.16 -51.8 19.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.433 -0.794 . . . . 75.43 111.403 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.06 -44.17 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 C-N-CA 124.352 1.061 . . . . 73.31 109.891 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -50.87 -63.74 1.03 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.003 0.921 . . . . 73.44 110.656 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.84 -24.56 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 112.589 0.589 . . . . 63.15 112.589 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -66.38 -45.28 80.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.617 1.099 . . . . 74.41 108.664 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -63.51 -46.22 87.07 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.513 -1.291 . . . . 65.05 107.513 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 -70.71 -3.27 17.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.219 1.407 . . . . 74.21 112.624 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 C--O 1.237 0.414 0 C-N-CA 124.416 1.086 . . . . 63.41 111.058 -179.611 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.219 0 N-CA-C 109.075 -1.61 . . . . 54.41 109.075 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 t -156.82 178.57 10.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 106.713 -1.588 . . . . 74.32 106.713 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 p -150.01 179.13 8.31 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.664 1.586 . . . . 72.23 108.512 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.76 179.0 48.76 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.82 -1.712 . . . . 73.42 108.82 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.0 t -156.22 172.34 18.63 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.749 -1.204 . . . . 74.31 107.749 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.1 m -159.91 95.83 1.2 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.766 1.227 . . . . 72.41 108.335 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.37 70.53 2.15 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 109.599 -1.4 . . . . 71.41 109.599 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -75.46 85.11 2.56 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.313 1.045 . . . . 74.22 110.007 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -76.8 174.34 10.62 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.79 -1.189 . . . . 61.43 107.79 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.05 172.88 45.09 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.209 -1.156 . . . . 74.52 110.209 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.57 168.08 20.54 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.153 1.781 . . . . 60.42 106.677 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.31 167.07 29.03 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.823 0.849 . . . . 72.22 109.004 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.34 163.87 34.19 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.94 1.296 . . . . 74.42 107.571 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.13 169.79 10.77 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 127.226 2.21 . . . . 75.22 107.111 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.71 170.3 17.26 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.72 1.608 . . . . 53.32 107.229 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -65.66 155.72 85.05 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 125.027 1.331 . . . . 72.14 110.903 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.52 169.7 21.94 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.468 2.112 . . . . 64.35 110.105 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.51 173.11 6.7 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.091 1.356 . . . . 54.05 109.698 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.8 168.97 18.59 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.61 0.764 . . . . 63.12 109.182 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -130.83 176.68 8.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.556 1.942 . . . . 72.35 108.93 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -124.61 154.9 70.01 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.005 1.322 . . . . 74.41 108.67 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.29 166.18 30.1 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.553 2.168 . . . . 61.52 111.02 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.51 173.39 16.95 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.872 -1.291 . . . . 74.43 109.872 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.93 166.44 23.64 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.439 -0.448 . . . . 74.35 110.2 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.02 80.61 1.58 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.5 -2.407 . . . . 52.15 104.5 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.57 -174.42 4.27 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.853 0.861 . . . . 52.34 111.463 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -143.94 164.33 30.88 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.761 1.224 . . . . 74.53 108.708 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 t -147.98 165.71 29.9 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.403 0.62 . . . . 44.03 110.88 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.09 156.11 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 126.869 2.068 . . . . 64.31 111.04 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -119.3 173.85 6.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.487 1.515 . . . . 72.44 109.715 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.2 m -64.21 172.45 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.338 0.655 . . . . 54.04 110.578 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.74 -21.23 52.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 114.327 1.232 . . . . 73.43 114.327 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.57 -69.57 3.27 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 107.587 -2.205 . . . . 45.12 107.587 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -80.32 175.43 10.66 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.953 -1.499 . . . . 63.31 106.953 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -151.87 4.28 0.41 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.289 0.636 . . . . 73.14 112.475 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.9 65.67 1.55 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 123.939 1.828 . . . . 32.32 111.003 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -59.84 5.08 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 112.748 -2.024 . . . . 73.35 108.277 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.14 163.59 35.43 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 121.932 1.755 . . . . 74.23 111.28 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.46 161.49 4.09 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 128.232 2.613 . . . . 63.24 107.442 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.9 mt 27.14 56.17 0.07 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 129.269 3.027 . . . . 75.44 112.269 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.6 mt -46.01 148.32 1.49 Allowed Pre-proline 0 C--O 1.233 0.214 0 C-N-CA 126.34 1.856 . . . . 54.02 112.763 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.87 112.21 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.859 2.373 . . . . 61.23 108.661 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.67 104.66 16.59 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.201 -1.407 . . . . 71.51 107.201 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -65.79 104.79 1.13 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.485 1.514 . . . . 72.44 109.923 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -62.86 -27.45 69.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.065 0.765 . . . . 62.21 113.065 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 m -79.4 6.57 9.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.396 0.998 . . . . 62.15 111.257 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -117.64 11.34 13.69 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.7 1.6 . . . . 61.55 111.743 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.0 mt -111.78 165.17 12.29 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.469 1.108 . . . . 52.42 111.16 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -132.22 127.0 34.85 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.441 -2.059 . . . . 73.44 105.441 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.23 165.47 11.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.487 1.515 . . . . 61.12 110.85 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -140.35 160.54 39.74 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.46 1.504 . . . . 53.15 107.277 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -130.53 139.45 50.48 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.472 -0.566 . . . . 61.52 109.472 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 85.3 t -88.49 135.97 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 107.246 -1.39 . . . . 72.11 107.246 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -122.18 -13.9 8.04 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.742 0.817 . . . . 65.41 110.211 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.51 -164.29 33.44 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 129.315 3.341 . . . . 73.22 105.003 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -137.23 149.67 47.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.294 -1.743 . . . . 64.43 106.294 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.03 176.77 49.11 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 109.792 -1.323 . . . . 52.34 109.792 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.25 117.07 3.83 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.092 1.862 . . . . 54.05 108.491 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.0 18.43 2.54 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 124.799 1.19 . . . . 62.44 112.762 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.48 -117.11 9.04 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.917 -1.273 . . . . 74.22 109.917 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -61.15 163.55 6.08 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.283 0.564 . . . . 61.13 110.286 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.91 -81.82 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.505 1.922 . . . . 64.21 110.421 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.5 m 41.99 80.33 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.656 2.382 . . . . 64.43 108.786 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -50.8 150.66 2.79 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.454 1.102 . . . . 64.44 112.651 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -113.85 166.24 11.77 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.096 0.959 . . . . 74.21 110.511 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -51.16 122.26 7.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.258 1.823 . . . . 62.21 109.112 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 p -156.99 163.16 39.41 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.789 -1.56 . . . . 64.35 106.789 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -78.95 30.06 0.2 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.115 0.87 . . . . 73.42 110.741 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.9 t -68.03 112.48 5.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.28 -1.512 . . . . 71.23 107.588 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.4 t -94.57 139.77 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 104.269 -2.493 . . . . 71.43 104.269 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.52 138.45 49.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.348 -2.093 . . . . 32.22 105.348 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.2 tp -142.32 147.31 36.13 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.871 -1.529 . . . . 71.21 106.871 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.99 158.18 43.87 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.432 -0.951 . . . . 62.31 108.432 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 77' ' ' SER . 4.3 t-80 -93.94 134.39 36.37 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.059 -2.2 . . . . 64.12 105.059 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.3 t -65.11 -65.97 1.66 Allowed Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 117.894 -1.051 . . . . 71.43 111.894 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.18 -35.41 52.59 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.744 2.296 . . . . 64.33 113.759 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' A' ' 74' ' ' HIS . 12.6 t -85.36 -21.13 29.01 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.777 0.658 . . . . 64.31 112.777 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.88 2.86 5.23 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.437 1.494 . . . . 41.32 114.525 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.5 mt -67.05 130.96 32.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 119.791 1.796 . . . . 53.01 107.087 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.6 t -112.61 153.45 14.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.463 1.105 . . . . 71.22 109.05 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -149.74 142.43 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.796 0.838 . . . . 72.33 110.059 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -124.92 106.84 10.29 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.19 1.796 . . . . 62.43 108.315 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 9.9 t -117.94 155.36 30.36 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.689 1.196 . . . . 74.45 110.159 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -155.03 100.66 2.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.594 -1.632 . . . . 63.23 106.594 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.48 -37.43 4.95 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 122.86 0.464 . . . . 72.11 111.413 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.8 p -139.04 176.73 8.44 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.983 0.913 . . . . 52.13 111.623 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -1.51 56.35 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.678 1.191 . . . . 64.33 111.011 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.4 m -98.2 115.75 28.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.132 1.373 . . . . 65.22 109.968 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.54 -53.89 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.874 0.869 . . . . 64.31 111.243 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -22.81 67.07 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.984 1.475 . . . . 60.22 114.984 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -77.75 -46.1 22.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.435 -2.061 . . . . 74.13 105.435 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -59.63 -37.3 78.26 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 118.397 -0.811 . . . . 73.11 109.974 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -54.88 -55.5 29.8 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.694 1.198 . . . . 61.51 108.582 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -54.64 -47.36 73.59 Favored 'General case' 0 CA--C 1.506 -0.733 0 O-C-N 121.641 -0.662 . . . . 65.24 112.366 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.8 mt -64.67 -36.8 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.596 -0.729 . . . . 72.45 110.443 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.24 -38.73 82.12 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.451 -0.781 . . . . 71.41 109.182 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -61.39 -49.38 77.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.617 1.167 . . . . 72.41 110.182 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -46.53 88.92 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.435 -0.793 . . . . 74.33 111.238 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.86 -37.42 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.107 1.321 . . . . 73.22 110.643 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.1 tp -65.67 -37.63 87.05 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.525 -0.734 . . . . 63.23 109.89 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -58.44 -42.11 86.61 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.703 0.801 . . . . 73.14 110.423 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -61.84 -43.47 98.77 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.426 0.631 . . . . 74.24 109.698 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -67.51 -42.46 82.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 113.915 1.08 . . . . 61.44 113.915 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.61 -32.77 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 123.219 0.608 . . . . 63.44 109.715 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -53.92 -60.75 2.92 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.702 0.683 . . . . 74.25 110.128 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 17.5 t -59.64 -32.59 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.784 0.834 . . . . 62.11 110.826 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -65.95 -22.64 66.49 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.516 1.053 . . . . 63.44 111.679 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -99.04 -36.92 9.55 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.4 1.08 . . . . 61.53 109.808 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -79.19 -16.78 56.05 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.523 1.129 . . . . 74.34 111.883 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 t -135.07 -165.33 1.66 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.376 1.87 . . . . 54.04 108.692 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.92 -163.59 21.31 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.813 1.197 . . . . 51.04 111.918 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.98 -177.94 2.19 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 123.369 2.713 . . . . 74.13 110.466 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 76.0 p -127.47 97.31 4.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.546 -1.65 . . . . 64.51 106.546 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.9 t 58.22 74.16 0.44 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.851 1.26 . . . . 75.15 109.899 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 116.86 -2.078 . . . . 72.42 109.267 179.715 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 N-CA-C 109.084 -1.607 . . . . 60.15 109.084 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 m -134.64 154.49 51.5 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.951 -1.5 . . . . 75.11 106.951 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -58.3 -48.36 80.75 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.395 1.078 . . . . 61.32 113.764 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.37 104.39 1.22 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 106.944 -2.462 . . . . 65.13 106.944 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 p -151.27 162.78 40.28 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 121.9 -0.765 . . . . 53.41 109.637 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.7 t -157.79 174.14 15.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.485 1.514 . . . . 52.31 107.11 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.62 -179.33 48.28 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.717 -1.353 . . . . 61.21 109.717 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -156.43 160.38 39.55 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 108.374 -0.972 . . . . 75.32 108.374 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -140.35 179.47 6.63 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.207 1.803 . . . . 74.12 107.853 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.95 163.81 37.02 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 109.318 -1.513 . . . . 73.33 109.318 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 mp -85.36 172.28 11.2 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.877 -0.786 . . . . 74.01 108.877 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -143.85 166.96 23.46 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 106.986 -1.487 . . . . 74.0 106.986 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.89 143.61 29.92 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.56 -1.645 . . . . 65.23 106.56 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.54 167.37 2.24 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 128.672 2.789 . . . . 74.3 106.503 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -154.76 170.68 21.03 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.602 -1.259 . . . . 70.21 107.602 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -66.97 167.52 13.82 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 128.562 2.745 . . . . 73.12 110.824 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -81.59 168.35 16.26 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.275 1.983 . . . . 74.31 110.236 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.82 173.7 12.02 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.929 -0.767 . . . . 65.11 108.929 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -146.11 173.77 11.9 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.022 1.329 . . . . 74.44 109.563 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.88 178.63 4.79 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.904 1.682 . . . . 75.44 109.615 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -125.44 155.02 72.43 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.758 1.623 . . . . 72.41 108.961 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.62 166.06 29.18 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.6 2.2 . . . . 73.11 111.326 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.56 -178.32 35.37 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.177 -1.169 . . . . 64.35 110.177 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.6 ttt -138.14 162.27 34.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.842 1.257 . . . . 73.02 107.843 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.67 83.99 1.17 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.235 -2.506 . . . . 62.41 104.235 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.46 152.01 34.42 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.484 -0.561 . . . . 55.3 109.484 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 t -79.52 -174.51 4.29 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.603 0.716 . . . . 71.3 111.531 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.3 p -115.41 -175.85 2.8 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.642 1.577 . . . . 65.31 111.891 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.0 m -67.24 177.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.684 1.194 . . . . 71.44 109.303 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.02 164.02 28.25 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.71 0.804 . . . . 75.52 110.663 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 t -69.67 128.51 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.688 -1.597 . . . . 75.31 106.688 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.53 177.09 6.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.066 0.946 . . . . 73.31 111.581 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.13 -165.16 29.12 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 124.457 1.027 . . . . 62.42 111.916 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -142.62 172.73 12.3 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.429 1.092 . . . . 60.25 111.362 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -155.28 162.27 40.92 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 106.425 -1.695 . . . . 71.43 106.425 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 40.29 62.25 1.36 Allowed 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.337 1.855 . . . . 70.13 111.118 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -65.32 1.31 Allowed Pre-proline 0 C--O 1.236 0.36 0 CA-C-O 117.974 -1.013 . . . . 73.12 109.501 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.33 135.89 38.26 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 120.902 1.068 . . . . 74.33 109.913 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.4 129.69 6.49 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.983 2.113 . . . . 72.24 105.841 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.4 mt 47.17 65.55 1.22 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 127.257 2.223 . . . . 64.22 112.096 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.7 mt -49.8 152.2 2.74 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 125.427 1.491 . . . . 71.32 111.688 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -69.33 154.89 68.76 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.619 2.212 . . . . 54.2 109.262 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.0 mt -137.42 163.47 31.0 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.083 1.353 . . . . 72.11 113.728 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -119.84 101.85 8.17 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 106.891 -1.522 . . . . 75.13 106.891 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -61.06 -23.63 65.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.223 0.609 . . . . 64.44 112.53 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 m -87.97 10.38 19.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.993 1.317 . . . . 41.53 112.452 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -121.51 14.68 11.12 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.124 1.37 . . . . 74.23 111.095 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.2 mt -99.2 166.61 11.15 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.178 -0.951 . . . . 64.14 111.738 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -127.28 94.11 3.91 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.568 -0.901 . . . . 72.22 108.568 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -95.01 164.69 12.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.086 0.946 . . . . 75.44 112.689 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -143.17 171.09 14.56 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.707 2.803 . . . . 62.12 105.54 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -131.0 139.4 49.98 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 107.025 -1.472 . . . . 75.03 107.025 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.08 136.54 22.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.27 -0.641 . . . . 63.41 109.27 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.59 -9.02 9.46 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.885 0.874 . . . . 53.03 112.029 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.88 -177.79 43.71 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 107.193 -2.363 . . . . 74.31 107.193 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -147.83 166.33 27.91 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.761 -1.57 . . . . 74.34 106.761 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.82 -169.96 44.34 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 109.734 -1.347 . . . . 65.51 109.734 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.43 -0.88 7.27 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.236 2.624 . . . . 72.54 113.96 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.55 5.61 24.22 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 119.809 1.186 . . . . 63.23 114.902 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -48.16 113.31 1.4 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 126.008 1.766 . . . . 41.32 111.766 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 56.3 15.25 1.85 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.078 1.751 . . . . 71.23 114.17 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.82 107.39 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.737 1.215 . . . . 61.21 111.369 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.5 p -72.37 -67.71 0.53 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.007 1.723 . . . . 63.42 111.344 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.85 84.07 0.21 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 129.226 3.01 . . . . 74.24 113.882 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -77.41 1.99 17.39 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.152 -0.967 . . . . 71.33 111.499 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.54 46.86 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 129.953 3.301 . . . . 75.3 113.242 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -84.93 115.69 22.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.67 -1.233 . . . . 72.31 107.67 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -105.27 -0.01 26.72 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.366 1.066 . . . . 73.03 110.883 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.6 t -59.49 145.87 42.43 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.666 1.121 . . . . 75.2 110.91 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.6 t -120.44 149.83 23.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.311 1.845 . . . . 72.44 108.872 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.17 155.71 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.151 -1.796 . . . . 74.44 106.151 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.7 tp -141.3 148.54 39.93 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.152 -1.425 . . . . 62.14 107.152 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -143.51 130.68 20.75 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 125.473 1.509 . . . . 71.12 110.509 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -97.15 117.24 30.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.64 -1.985 . . . . 74.43 105.64 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.52 -59.96 11.3 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.069 -1.443 . . . . 65.42 111.921 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.47 -14.56 35.76 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.997 2.465 . . . . 52.53 116.611 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -111.69 -19.55 12.43 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.512 0.596 . . . . 75.13 111.236 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.13 21.22 69.78 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.007 0.813 . . . . 65.45 111.389 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -91.24 136.4 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 125.142 1.377 . . . . 64.31 107.805 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.01 137.41 57.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.069 -1.456 . . . . 72.43 107.069 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.0 p -136.75 151.39 27.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.961 -0.755 . . . . 62.53 108.961 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -110.16 125.62 53.22 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.166 -1.79 . . . . 52.24 106.166 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.1 t -138.54 132.13 30.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 118.374 0.534 . . . . 60.11 109.897 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -153.91 100.28 2.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.173 0.589 . . . . 71.3 109.494 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -115.77 -70.47 0.79 Allowed 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.309 -0.997 . . . . 73.14 108.309 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.5 p -73.04 177.59 4.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.391 1.476 . . . . 71.31 109.618 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -98.64 -20.14 17.15 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.254 -1.529 . . . . 75.43 108.802 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.3 m -79.09 132.2 36.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.328 2.251 . . . . 75.45 110.444 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.32 -55.86 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.7 0.8 . . . . 74.41 112.917 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.63 -39.85 74.35 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.853 1.206 . . . . 74.32 112.583 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -67.6 -43.28 80.85 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.755 -0.831 . . . . 53.31 108.755 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -64.89 -37.75 88.66 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.974 -0.751 . . . . 72.53 108.974 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -59.95 -52.06 67.04 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.225 1.01 . . . . 72.33 109.992 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -63.03 -32.23 73.55 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.505 1.502 . . . . 64.43 112.025 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.04 -46.33 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.307 -1.738 . . . . 74.22 106.307 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.27 78.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.976 0.91 . . . . 74.52 109.842 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -40.57 94.06 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.425 -0.583 . . . . 75.31 109.425 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.65 -53.17 61.12 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.599 -0.688 . . . . 72.34 109.739 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.5 p -66.56 -32.01 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 113.068 0.766 . . . . 75.11 113.068 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.7 tp -67.74 -30.64 70.17 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.348 -0.845 . . . . 74.3 109.823 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -58.99 -31.37 68.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.011 1.324 . . . . 75.01 110.726 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.55 -48.88 53.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.114 0.966 . . . . 73.24 109.062 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -60.26 -46.28 90.37 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.899 0.88 . . . . 72.33 110.284 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.4 t -64.39 -37.95 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 118.044 -0.979 . . . . 54.11 110.175 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.39 -61.37 2.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.894 1.224 . . . . 71.03 110.642 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.4 p -56.61 -37.23 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 O-C-N 123.886 0.741 . . . . 70.22 109.55 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -62.72 -35.82 81.0 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.012 0.745 . . . . 65.22 113.012 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -73.55 -41.55 62.82 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.725 -0.843 . . . . 73.11 108.725 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -79.28 -0.26 31.61 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.4 1.259 . . . . 74.52 114.4 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.8 p -109.85 -17.0 13.75 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.72 1.608 . . . . 70.41 112.697 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.47 174.83 46.55 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 119.927 1.24 . . . . 71.01 112.454 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.64 173.44 9.94 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.928 2.419 . . . . 60.45 110.768 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 43.1 m -98.93 95.45 7.17 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.989 -1.115 . . . . 74.42 107.989 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.89 166.88 23.29 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.017 1.327 . . . . 62.5 109.68 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.29 0 N-CA-C 106.601 -2.6 . . . . 43.43 106.601 -179.669 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.05 0 N-CA-C 109.087 -1.605 . . . . 73.35 109.087 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 m -149.71 176.4 10.72 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.741 1.617 . . . . 75.42 107.078 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t -84.72 -88.08 0.11 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.588 -1.634 . . . . 72.13 106.588 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.8 179.13 48.77 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.583 -1.807 . . . . 72.13 108.583 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.2 p -152.29 155.72 38.25 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.381 1.072 . . . . 41.35 108.462 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.8 m -164.34 172.85 12.93 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.166 1.786 . . . . 70.45 107.638 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.17 157.15 25.94 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.14 -1.584 . . . . 75.11 109.14 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -84.32 158.52 21.14 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-O 121.909 0.861 . . . . 35.54 110.375 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -134.89 179.72 6.13 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 127.54 2.336 . . . . 71.4 106.508 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.38 145.38 10.85 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.257 -1.937 . . . . 53.22 108.257 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.2 mt -126.05 -178.26 4.24 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.343 1.457 . . . . 71.14 108.583 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.87 166.33 33.86 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.755 1.622 . . . . 62.12 108.46 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.407 HD13 ' H ' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -154.15 160.4 41.88 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.583 -2.006 . . . . 73.33 105.583 178.841 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.407 ' H ' HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -164.24 166.84 20.63 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.658 1.583 . . . . 74.03 107.858 179.242 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.54 -172.66 2.37 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.185 1.794 . . . . 54.1 111.709 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.512 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 11.0 mmpt? -136.96 135.03 19.4 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 128.001 2.521 . . . . 70.21 104.541 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.4 164.3 35.66 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.072 1.848 . . . . 54.02 111.208 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.39 170.69 12.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.063 0.945 . . . . 61.53 111.045 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mp -110.53 169.55 8.67 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.369 1.468 . . . . 70.03 108.632 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.59 160.3 32.92 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.164 0.507 . . . . 75.23 109.803 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -102.18 155.87 35.93 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.342 1.457 . . . . 72.52 109.914 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.11 167.68 26.41 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.754 2.302 . . . . 71.41 110.919 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.16 168.85 13.51 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.701 -0.96 . . . . 74.22 110.701 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.9 ptm -77.58 165.86 23.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.368 0.667 . . . . 75.32 110.3 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.43 88.88 1.73 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.046 -2.205 . . . . 73.24 105.046 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.32 176.94 6.01 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.492 -0.559 . . . . 64.22 109.492 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.51 -171.73 2.91 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.483 0.713 . . . . 53.22 111.183 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.1 p -141.35 162.85 34.49 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.403 1.481 . . . . 74.32 108.48 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 m -119.04 173.14 5.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.047 1.339 . . . . 64.33 109.683 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.01 177.31 10.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.873 2.469 . . . . 72.2 106.755 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.6 t -90.53 142.91 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 121.384 -0.822 . . . . 73.52 109.046 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.05 168.2 10.23 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.169 0.587 . . . . 73.31 109.611 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.25 175.02 46.15 Favored Glycine 0 CA--C 1.523 0.545 0 O-C-N 121.401 -0.812 . . . . 43.42 112.813 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -135.01 138.45 43.97 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.433 1.493 . . . . 72.12 107.018 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -152.39 42.34 0.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.626 1.57 . . . . 71.4 108.076 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -149.19 45.59 0.98 Allowed 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.715 0.769 . . . . 74.31 111.169 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -62.38 3.73 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-O 117.67 -1.157 . . . . 73.51 108.476 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.97 116.24 4.04 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.961 1.774 . . . . 52.41 107.677 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.89 144.8 6.05 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.034 1.734 . . . . 73.13 106.79 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt -38.61 102.75 0.03 OUTLIER 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.726 2.01 . . . . 72.42 111.823 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 105' ' ' ASP . 2.0 mm? -58.15 152.21 42.31 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 124.829 1.252 . . . . 73.41 108.379 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.92 138.76 31.93 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.739 1.626 . . . . 74.11 112.204 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.2 mt -127.88 143.24 51.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.156 1.382 . . . . 71.33 111.295 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -120.69 103.81 9.41 Favored 'General case' 0 N--CA 1.461 0.085 0 C-N-CA 126.509 1.924 . . . . 51.42 107.935 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.15 -19.51 20.68 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.085 1.513 . . . . 75.24 115.085 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.8 m -83.39 -6.58 59.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.241 0.928 . . . . 73.54 111.937 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -114.23 0.83 14.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.579 1.152 . . . . 74.21 110.911 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 mt -102.65 154.97 18.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.098 0.559 . . . . 72.35 111.146 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -113.61 156.57 23.44 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.144 2.178 . . . . 63.12 108.243 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.58 165.07 30.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.532 1.933 . . . . 74.03 107.076 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -138.56 170.07 16.66 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.563 -0.903 . . . . 75.35 108.563 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -118.16 162.91 17.45 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.649 0.779 . . . . 75.44 111.833 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.0 t -117.33 106.77 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 102.567 -3.123 . . . . 72.51 102.567 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 ttpp -134.35 26.52 3.8 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.168 1.387 . . . . 65.02 112.069 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.67 -169.79 34.57 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 108.595 -1.802 . . . . 63.1 108.595 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -114.9 160.92 18.95 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.492 1.117 . . . . 75.33 108.086 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.12 160.43 44.39 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 109.665 -1.374 . . . . 73.3 109.665 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -78.2 59.63 7.11 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.518 3.479 . . . . 73.21 110.573 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.65 118.03 0.85 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 107.844 -2.102 . . . . 33.02 107.844 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.22 21.33 0.86 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.876 1.227 . . . . 71.01 114.215 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -64.56 -20.71 66.4 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.629 1.215 . . . . 70.5 112.33 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -172.24 -176.22 1.57 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.433 2.693 . . . . 63.32 106.349 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -158.99 145.11 16.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.423 -1.695 . . . . 53.42 106.423 178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -159.26 167.72 28.26 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.619 1.168 . . . . 62.1 108.194 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.57 48.6 1.43 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.902 1.281 . . . . 72.22 108.749 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.1 p -71.04 104.63 3.06 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.052 -1.03 . . . . 53.01 110.88 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 t -74.0 -11.39 60.32 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.06 0.845 . . . . 71.45 112.337 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -143.65 99.93 3.5 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 125.781 1.632 . . . . 74.41 106.998 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.6 t -154.4 144.13 21.64 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 104.499 -2.408 . . . . 75.23 104.499 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.78 134.57 64.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.437 -1.32 . . . . 72.13 107.437 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -118.88 130.36 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 106.667 -1.605 . . . . 55.35 106.667 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.2 tp -123.03 142.57 50.71 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.643 -0.873 . . . . 71.3 108.643 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -137.25 132.38 33.7 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.222 1.409 . . . . 73.25 109.695 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.19 134.17 34.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.657 1.183 . . . . 72.23 110.034 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.41 -59.9 1.5 Allowed Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 118.098 -0.953 . . . . 73.32 112.554 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.55 -18.85 60.25 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.643 2.229 . . . . 52.01 116.492 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.3 p -120.23 -10.42 9.37 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.403 1.261 . . . . 61.34 114.403 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.4 2.93 29.58 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.366 -1.241 . . . . 60.5 113.116 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.3 mt -64.54 134.6 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.98 1.89 . . . . 72.11 109.606 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.22 151.08 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 107.87 -1.159 . . . . 51.22 107.87 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p -152.6 154.9 7.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 120.979 -1.076 . . . . 70.24 108.644 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -122.26 134.44 54.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.778 -1.193 . . . . 72.52 107.778 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 29.1 m -137.19 150.84 48.18 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.492 1.117 . . . . 54.52 112.231 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -155.07 149.2 25.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.917 2.087 . . . . 75.34 108.321 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -162.41 -78.61 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.506 -1.665 . . . . 61.43 106.506 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 t -102.61 175.68 5.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.654 1.982 . . . . 75.11 109.072 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -84.74 -17.5 38.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.691 -1.147 . . . . 74.43 109.719 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.7 m -83.79 115.92 22.46 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.701 1.137 . . . . 75.25 111.946 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.91 -40.27 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 118.581 -0.723 . . . . 72.22 109.808 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -38.42 35.29 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.662 1.185 . . . . 63.25 112.078 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -76.28 -52.44 9.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.271 1.028 . . . . 72.33 109.022 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -52.23 -32.44 36.77 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.905 1.282 . . . . 75.54 111.158 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -54.47 -50.44 67.73 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.797 0.839 . . . . 72.54 109.978 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -75.09 -24.85 58.19 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.907 1.077 . . . . 74.23 113.907 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 94.7 mt -67.47 -48.33 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.243 -1.391 . . . . 73.4 107.243 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.45 99.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.554 -0.716 . . . . 53.1 110.888 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -63.55 -48.77 76.12 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 118.809 -0.615 . . . . 65.35 111.229 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -58.69 -41.03 85.32 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 117.395 -1.288 . . . . 73.3 111.688 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.7 -36.94 67.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.623 1.102 . . . . 75.53 111.141 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 tp -64.61 -38.2 90.19 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 118.741 -0.647 . . . . 62.45 110.67 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -57.15 -34.3 68.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.713 0.688 . . . . 74.04 110.381 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -68.36 -32.91 73.33 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.294 0.638 . . . . 72.15 110.64 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -77.9 -38.85 44.83 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.532 -0.544 . . . . 65.32 109.532 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.8 t -58.7 -40.4 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.683 -0.858 . . . . 73.52 108.683 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.467 ' HA ' HD23 ' A' ' 41' ' ' LEU . 6.4 t70 -58.31 -60.59 3.53 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.092 0.86 . . . . 64.21 109.419 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.99 -37.67 34.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 125.067 1.347 . . . . 63.42 110.452 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -69.83 -42.61 73.38 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.904 0.882 . . . . 75.3 111.343 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -68.92 -33.81 74.36 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.714 -0.847 . . . . 74.33 108.714 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.04 -50.88 15.05 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.52 0.728 . . . . 74.35 109.832 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.0 m -129.42 98.91 5.01 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 128.407 2.683 . . . . 72.34 111.062 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.77 -179.35 10.89 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.172 0.891 . . . . 73.0 113.753 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.55 -18.0 58.38 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.44 2.76 . . . . 54.24 114.531 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.4 t 42.45 82.56 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.208 2.203 . . . . 71.42 112.633 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.1 p -74.46 84.12 1.99 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.315 0.646 . . . . 74.21 109.285 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.239 0 N-CA-C 108.543 -1.823 . . . . 15.22 108.543 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.076 0 N-CA-C 108.712 -1.755 . . . . 44.23 108.712 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -148.45 171.77 15.54 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.028 1.331 . . . . 53.12 107.508 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.2 m -131.62 169.35 16.26 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.895 1.278 . . . . 61.31 108.099 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.53 -178.39 45.32 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 108.327 -1.909 . . . . 72.34 108.327 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 p -149.89 175.75 11.37 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.693 0.797 . . . . 55.24 109.596 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.0 t -129.59 -132.95 0.21 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 104.266 -2.494 . . . . 73.24 104.266 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -135.41 170.37 23.02 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.563 -1.415 . . . . 73.22 109.563 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -80.67 51.51 1.51 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.63 0.772 . . . . 51.2 110.716 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -90.99 177.3 6.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.527 -0.916 . . . . 65.5 108.527 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.34 179.61 40.83 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.125 -1.19 . . . . 70.01 110.125 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.507 ' CD2' ' H ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -74.84 -167.43 0.58 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.484 1.114 . . . . 53.22 110.477 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.507 ' H ' ' CD2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -128.83 159.73 34.84 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.014 1.726 . . . . 71.51 107.372 178.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.27 148.9 24.88 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.125 -2.176 . . . . 64.35 105.125 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.12 -176.09 3.96 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.232 1.813 . . . . 73.53 106.859 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -139.24 178.02 7.49 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.961 -1.496 . . . . 65.34 106.961 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.482 ' H ' ' HE2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -121.48 164.52 24.02 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 123.623 0.769 . . . . 61.14 111.633 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -82.07 172.65 11.68 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.977 2.452 . . . . 73.24 111.245 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.29 168.53 19.46 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.448 -0.945 . . . . 41.14 108.448 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.17 161.37 15.05 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.762 0.825 . . . . 72.05 109.506 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mp -74.84 171.96 13.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.473 1.109 . . . . 64.55 110.204 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -116.02 157.86 43.93 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.938 1.695 . . . . 75.23 110.353 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.87 178.55 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.415 2.744 . . . . 74.23 111.288 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.55 -79.24 0.04 OUTLIER Glycine 0 C--N 1.339 0.722 0 N-CA-C 111.482 -0.647 . . . . 41.54 111.482 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 28.3 ptm -67.1 147.86 52.61 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.796 0.798 . . . . 75.02 110.494 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.4 71.64 0.65 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.828 1.251 . . . . 51.31 108.194 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.47 154.59 34.57 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.517 -0.919 . . . . 74.14 108.517 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.4 t -123.01 -176.02 3.31 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.602 1.161 . . . . 51.41 112.06 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -68.57 167.51 14.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.588 1.955 . . . . 74.4 110.031 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 m -66.11 145.45 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 121.353 -0.842 . . . . 75.22 108.762 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -74.89 175.9 7.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.317 1.047 . . . . 73.14 113.825 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.89 151.64 7.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 128.176 2.59 . . . . 75.11 108.96 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.57 153.87 20.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.789 0.268 . . . . 74.51 111.265 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.38 -83.07 0.37 Allowed Glycine 0 C--N 1.336 0.556 0 C-N-CA 125.022 1.296 . . . . 42.31 111.599 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.06 151.93 28.97 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.647 -0.871 . . . . 72.35 108.647 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.06 20.39 0.87 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.561 1.944 . . . . 71.34 110.909 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -132.81 57.82 1.79 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 122.113 0.958 . . . . 72.34 111.9 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -63.05 0.31 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.01 -0.995 . . . . 73.51 111.829 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.25 99.07 0.47 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.521 2.148 . . . . 74.54 110.928 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.35 157.54 37.29 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.114 1.366 . . . . 71.15 109.711 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt 38.13 50.61 1.4 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 128.034 2.534 . . . . 63.21 111.172 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -56.02 148.83 37.53 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 115.567 -0.742 . . . . 73.22 112.761 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.72 131.01 14.14 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.631 2.887 . . . . 65.14 111.821 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.0 mt -104.98 134.39 48.17 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.335 1.054 . . . . 75.24 109.041 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -73.25 107.5 5.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.804 -0.813 . . . . 72.54 108.804 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -59.09 -25.13 63.52 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 122.021 -0.424 . . . . 74.3 111.972 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 m -83.9 7.17 19.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.183 1.393 . . . . 70.43 112.7 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -116.24 -2.67 12.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.556 1.542 . . . . 73.44 109.8 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.417 HD22 ' CD2' ' A' ' 74' ' ' HIS . 0.9 OUTLIER -104.78 138.61 40.8 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.539 -1.282 . . . . 75.32 107.539 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -103.3 134.8 46.09 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.066 -1.457 . . . . 74.01 107.066 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.51 164.74 11.65 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.113 1.765 . . . . 55.33 112.811 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -140.87 172.57 12.51 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.703 2.001 . . . . 74.0 109.833 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -134.4 158.61 43.4 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.504 1.121 . . . . 74.42 109.493 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 t -135.57 106.55 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 107.529 -1.286 . . . . 72.21 107.529 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -87.96 2.42 51.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.577 0.954 . . . . 51.51 113.577 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.48 39.78 98.06 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 118.92 0.782 . . . . 42.24 111.806 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -121.11 164.36 16.97 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.246 1.018 . . . . 65.43 109.513 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.25 170.45 42.58 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 129.597 3.475 . . . . 62.24 106.451 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.83 -21.7 32.79 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.419 2.079 . . . . 70.11 113.654 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 134.31 -155.92 22.13 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.672 -1.771 . . . . 52.05 108.672 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.48 -152.81 18.84 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.406 -1.078 . . . . 53.21 110.406 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.6 161.21 4.8 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.553 1.141 . . . . 72.32 111.769 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.98 140.62 36.84 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.452 0.701 . . . . 45.22 110.216 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.6 t -100.47 172.43 7.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.733 1.213 . . . . 74.24 110.276 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -134.62 3.28 3.27 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.456 2.303 . . . . 62.13 110.089 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.2 73.91 9.21 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 107.618 -1.253 . . . . 54.53 107.618 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 p -63.73 156.45 27.02 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.697 0.799 . . . . 70.53 111.087 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -66.09 171.63 4.44 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.669 1.987 . . . . 73.23 110.281 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 65.95 -5.27 0.55 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.996 2.119 . . . . 73.05 113.584 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 t -65.36 130.12 42.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 118.992 0.814 . . . . 63.42 109.852 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.3 t -111.24 137.26 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 103.309 -2.849 . . . . 71.01 103.309 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -130.5 117.95 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 105.816 -1.92 . . . . 75.4 105.816 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.2 tp -135.4 150.61 49.93 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 104.701 -2.333 . . . . 72.15 104.701 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.5 158.69 43.8 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 123.942 0.897 . . . . 74.02 109.971 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.417 ' CD2' HD22 ' A' ' 48' ' ' LEU . 3.1 t-80 -91.89 135.59 33.81 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.134 -2.173 . . . . 75.24 105.134 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.5 t -71.04 -61.94 2.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 119.864 1.211 . . . . 55.25 113.171 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.25 -25.11 72.07 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 121.68 1.587 . . . . 63.14 114.708 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 t -98.36 -16.7 19.2 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.281 0.492 . . . . 73.24 112.104 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.33 12.52 12.83 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.426 1.489 . . . . 61.1 113.257 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 62.3 mt -70.95 116.18 12.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 119.591 1.695 . . . . 72.31 106.527 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.3 t -105.32 146.4 12.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.68 -1.23 . . . . 72.13 107.68 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.12 148.08 17.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.051 -1.092 . . . . 62.22 108.051 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -120.85 107.04 12.23 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.747 1.219 . . . . 71.01 107.975 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 58.5 m -136.02 148.55 48.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.226 0.61 . . . . 70.44 110.211 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -155.48 150.6 26.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.624 -1.621 . . . . 73.45 106.624 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.79 -36.07 0.24 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.759 0.424 . . . . 74.21 110.455 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.8 p -123.63 -178.6 4.07 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.213 1.405 . . . . 74.45 108.457 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.76 -13.39 34.08 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.054 -0.721 . . . . 73.11 109.054 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -79.42 115.12 18.87 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.851 -1.166 . . . . 74.02 107.851 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.4 -41.34 84.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.94 -1.133 . . . . 72.02 107.94 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -56.5 -48.43 77.2 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.427 2.291 . . . . 70.14 110.371 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -65.88 -45.08 83.38 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.263 0.625 . . . . 64.3 109.465 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -64.0 -32.7 74.34 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.429 0.692 . . . . 71.14 111.249 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -59.61 -46.72 88.13 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.624 1.102 . . . . 74.4 110.336 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -58.87 -48.97 79.51 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 118.563 0.62 . . . . 73.41 110.553 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.6 mt -54.55 -48.79 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 O-C-N 124.417 1.073 . . . . 63.14 110.277 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.72 98.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 122.831 0.452 . . . . 70.13 111.418 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.4 ttm-85 -64.26 -46.62 82.92 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 118.224 -0.893 . . . . 72.22 110.28 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -50.71 69.8 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 119.438 1.017 . . . . 64.32 110.995 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.7 p -63.08 -33.39 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 120.178 1.354 . . . . 64.03 110.52 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.99 -42.19 90.1 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 120.998 -1.064 . . . . 70.35 108.486 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -56.8 -47.72 79.56 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.13 1.372 . . . . 72.15 110.569 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -59.64 -34.96 73.47 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.5 0.72 . . . . 64.11 110.403 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -79.62 -33.43 41.49 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.345 0.658 . . . . 71.11 111.812 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -74.01 -34.45 39.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 124.231 1.013 . . . . 75.45 109.763 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.01 -50.88 69.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.715 1.143 . . . . 73.5 109.019 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.8 t -57.97 -32.73 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.209 0.604 . . . . 64.23 109.661 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -77.34 -19.97 55.54 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.786 -1.196 . . . . 75.43 112.59 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -91.2 -22.32 20.69 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.992 0.814 . . . . 74.13 111.265 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -108.83 -17.17 14.0 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.995 0.816 . . . . 64.33 112.926 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.1 t -137.03 178.86 6.76 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.402 2.281 . . . . 62.04 108.13 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.57 -175.57 54.85 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.893 -1.129 . . . . 70.41 110.48 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.21 156.78 46.51 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.395 2.063 . . . . 61.42 111.107 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.8 m -136.07 -26.37 1.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.898 1.279 . . . . 71.2 111.186 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.3 m -140.33 175.25 9.75 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 128.137 2.575 . . . . 73.34 106.632 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 N-CA-C 108.418 -1.873 . . . . 73.22 108.418 -179.871 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.048 0 N-CA-C 108.327 -1.909 . . . . 65.24 108.327 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -149.68 169.51 20.84 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.051 1.34 . . . . 75.34 107.41 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.2 p -152.47 -84.12 0.08 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.914 -0.773 . . . . 73.14 108.914 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.24 -175.95 50.44 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 109.271 -1.532 . . . . 43.42 109.271 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.7 p -166.85 167.54 14.85 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.497 1.119 . . . . 70.22 108.254 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 56.4 p -168.19 173.0 8.18 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.573 1.549 . . . . 70.45 107.401 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.18 164.87 35.03 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.159 -1.176 . . . . 70.43 110.159 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.54 169.76 23.13 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 129.047 2.939 . . . . 64.22 105.609 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -145.2 170.46 16.22 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.605 -1.628 . . . . 75.44 106.605 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.51 -179.76 36.71 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.014 -1.634 . . . . 72.55 109.014 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.1 160.85 37.75 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.278 -1.378 . . . . 75.01 107.278 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -69.95 129.05 38.43 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 107.748 -1.205 . . . . 74.13 107.748 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.75 124.11 30.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.305 -1.739 . . . . 73.14 106.305 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.58 167.4 27.36 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.43 1.092 . . . . 65.24 108.404 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' OE1' ' HE3' ' A' ' 16' ' ' LYS 0.38 6.2 mm-40 -111.14 163.37 13.96 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.96 0.788 . . . . 73.24 111.322 178.217 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.429 ' N ' ' CE ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -79.02 153.46 77.45 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 115.971 -0.558 . . . . 72.1 109.985 -176.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.47 148.5 79.15 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.561 1.508 . . . . 71.31 109.228 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.07 176.48 8.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.021 1.328 . . . . 75.05 108.847 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.7 175.56 10.29 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.83 1.652 . . . . 65.5 108.891 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -124.84 171.94 9.74 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.625 1.57 . . . . 65.42 109.101 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -109.38 151.73 42.28 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 124.444 1.098 . . . . 75.41 108.578 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.63 162.67 35.17 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.526 2.151 . . . . 71.14 110.561 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.58 172.58 37.67 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 109.196 -1.561 . . . . 71.21 109.196 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.3 tpt -134.46 135.28 42.37 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.772 -1.196 . . . . 72.33 107.772 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 64.57 1.11 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.618 1.167 . . . . 74.32 108.711 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.51 150.28 43.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.925 0.869 . . . . 71.31 109.227 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 t -93.59 129.1 39.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.189 -1.782 . . . . 74.04 106.189 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.1 t -69.05 -177.68 1.1 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.689 0.757 . . . . 65.44 109.67 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.9 m -94.72 -154.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.704 1.602 . . . . 75.05 110.682 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -131.6 171.13 13.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.568 2.747 . . . . 63.13 109.603 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.87 169.4 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.842 0.857 . . . . 71.15 109.69 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.53 152.72 23.87 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.061 0.846 . . . . 53.14 112.734 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.05 70.22 3.16 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 106.971 -2.452 . . . . 43.24 106.971 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -136.33 -73.23 0.44 Allowed 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 124.411 1.085 . . . . 63.14 109.863 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp 46.65 36.42 3.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.396 1.078 . . . . 75.11 111.823 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -129.44 -7.62 4.69 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.672 2.389 . . . . 71.42 110.936 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -61.34 3.23 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.024 1.73 . . . . 73.24 114.209 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.71 139.33 43.78 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.413 2.075 . . . . 74.23 111.348 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 170.51 3.59 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.942 0.877 . . . . 71.5 110.558 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.418 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 62.8 mt 53.14 46.81 25.84 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 127.191 2.196 . . . . 72.43 109.459 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -56.67 154.7 16.73 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.671 1.588 . . . . 74.34 111.228 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.01 174.45 11.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.503 2.135 . . . . 65.33 110.93 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.701 HD11 HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -161.6 133.87 5.84 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 104.224 -2.509 . . . . 61.21 104.224 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.429 ' N ' HD12 ' A' ' 43' ' ' LEU . 52.9 t30 -66.31 116.15 7.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.18 1.178 . . . . 74.41 114.18 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' CB ' ' HD2' ' A' ' 97' ' ' ARG . 13.7 pt-20 -65.39 -32.13 73.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.142 0.793 . . . . 72.21 113.142 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 m -76.38 1.62 15.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.526 0.565 . . . . 73.34 112.526 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -107.57 6.61 28.12 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.984 1.714 . . . . 52.24 110.582 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.701 HD11 HD11 ' A' ' 43' ' ' LEU . 8.3 mt -110.31 176.37 5.07 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.839 1.052 . . . . 74.12 113.839 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -127.01 130.19 49.54 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.958 -1.497 . . . . 71.41 106.958 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.59 159.69 34.74 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.86 1.264 . . . . 72.41 108.87 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -137.82 154.89 49.48 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.818 -1.178 . . . . 61.33 107.818 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -119.94 122.47 41.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.809 1.244 . . . . 75.34 108.547 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.83 120.03 36.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 122.282 1.039 . . . . 71.24 109.797 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.52 157.25 17.29 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.354 -1.35 . . . . 60.32 107.354 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.05 67.96 3.62 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.027 -1.629 . . . . 75.31 109.027 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -83.36 9.22 11.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 117.778 0.789 . . . . 74.33 112.524 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.61 173.51 44.45 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 109.509 -1.436 . . . . 60.42 109.509 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.19 1.27 6.2 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.003 3.136 . . . . 72.23 114.358 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.64 -47.43 3.64 Favored Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.11 -0.993 . . . . 74.31 110.955 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.16 -77.91 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 107.878 -2.089 . . . . 43.53 107.878 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -128.17 -60.98 1.12 Allowed 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.349 1.06 . . . . 74.41 108.366 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.33 140.23 20.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.123 -1.436 . . . . 72.12 107.123 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -162.11 171.48 17.4 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 105.903 -1.888 . . . . 63.43 105.903 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -142.68 164.13 30.94 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.817 -1.177 . . . . 73.15 108.406 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 49.76 23.27 0.97 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.24 2.216 . . . . 63.32 113.821 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 p -66.66 -49.28 66.68 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.094 1.757 . . . . 44.13 111.292 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 p -61.82 146.94 48.06 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.797 -0.816 . . . . 71.02 108.797 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 83.45 2.94 0.95 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.072 2.149 . . . . 73.44 112.191 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 m -67.9 135.06 51.89 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.727 -1.212 . . . . 63.41 107.727 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.36 154.28 20.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.685 -1.228 . . . . 71.3 107.685 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.4 147.79 21.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.327 -2.101 . . . . 75.41 105.327 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.7 tp -140.47 150.42 43.77 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.366 1.066 . . . . 72.21 108.999 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.28 157.99 44.72 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 112.502 0.556 . . . . 74.11 112.502 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -100.89 118.4 36.86 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 103.643 -2.725 . . . . 74.22 103.643 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -63.29 -54.08 47.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 120.253 1.388 . . . . 74.34 112.875 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.41 -13.02 34.88 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.843 2.362 . . . . 70.43 116.509 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.6 m -121.14 -6.22 9.45 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.078 1.308 . . . . 71.25 113.698 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.02 17.01 34.98 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 123.949 0.785 . . . . 70.21 114.915 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.453 HD11 ' CD2' ' A' ' 107' ' ' PHE . 50.5 mt -74.04 134.57 29.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 104.325 -2.472 . . . . 74.41 104.325 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t -130.23 137.16 57.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.824 -1.176 . . . . 42.43 107.824 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.67 147.93 28.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.676 -0.861 . . . . 63.23 108.676 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -122.68 118.49 28.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.479 1.112 . . . . 74.2 110.422 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 99.3 m -127.67 144.47 51.07 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.247 0.619 . . . . 74.22 110.986 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -155.62 120.42 4.75 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.468 1.107 . . . . 74.03 108.541 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.69 -71.67 0.27 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.086 0.954 . . . . 70.45 108.496 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 p -78.77 156.54 28.78 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.37 1.868 . . . . 73.31 113.614 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.14 -15.55 52.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.331 -0.618 . . . . 63.32 109.331 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.48 123.25 27.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.521 -1.288 . . . . 64.13 107.521 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.3 p -60.41 -46.38 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 119.157 0.889 . . . . 74.51 110.211 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -55.06 -42.21 72.44 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.422 1.889 . . . . 74.32 112.354 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -23.01 41.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.225 -0.893 . . . . 73.33 111.223 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -77.94 -42.91 31.49 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.581 -1.636 . . . . 73.01 106.581 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -52.17 -45.94 65.29 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.471 1.108 . . . . 65.35 109.0 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -59.67 -34.03 72.32 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-O 117.649 -1.167 . . . . 62.24 113.233 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.5 mt -64.32 -53.17 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 120.087 1.312 . . . . 60.45 108.402 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.05 -47.05 75.32 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 108.404 -0.961 . . . . 70.53 108.404 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.43 ' HD2' ' CB ' ' A' ' 45' ' ' GLU . 33.3 ttp85 -59.87 -39.56 85.68 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.383 1.073 . . . . 74.33 111.984 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -63.49 -57.52 9.94 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.96 1.304 . . . . 62.54 109.622 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.57 -29.21 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 112.106 0.41 . . . . 73.51 112.106 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.94 -46.76 89.4 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.648 -0.658 . . . . 71.55 109.554 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -59.01 -31.45 68.83 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.556 0.342 . . . . 62.12 111.451 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.26 -24.96 64.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.319 0.509 . . . . 73.2 112.079 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -88.03 -44.12 11.22 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.956 0.903 . . . . 73.23 110.138 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.39 -39.25 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 118.675 -0.679 . . . . 63.31 110.064 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 40' ' ' LEU . 5.4 t70 -53.4 -66.68 0.35 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.651 0.739 . . . . 73.44 109.929 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.8 p -57.53 -30.48 36.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 118.174 -0.917 . . . . 35.22 111.144 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.453 ' CD2' HD11 ' A' ' 79' ' ' ILE . 16.2 t80 -59.9 -44.65 94.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.22 1.373 . . . . 74.15 110.199 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -75.66 -39.47 57.61 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.992 0.517 . . . . 74.52 110.731 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -65.12 -54.74 25.22 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.575 -0.528 . . . . 75.12 109.575 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 66.1 m -84.18 -137.11 0.05 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.522 1.929 . . . . 52.23 106.889 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.55 -172.22 44.95 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 119.956 -1.715 . . . . 74.11 111.113 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.67 165.93 27.76 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.715 2.943 . . . . 73.41 112.203 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.1 p -112.04 -71.74 0.74 Allowed 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.973 0.909 . . . . 70.52 110.089 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.1 p -68.0 -5.01 15.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.332 1.453 . . . . 74.43 113.841 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.186 0 CA-C-O 115.965 -2.575 . . . . 62.03 110.611 -179.893 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.023 0 N-CA-C 108.991 -1.643 . . . . 42.23 108.991 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p -154.29 169.18 24.28 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.027 1.331 . . . . 65.02 107.576 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 m -135.58 177.64 7.66 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.86 1.264 . . . . 73.23 108.901 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.01 -179.89 36.94 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.199 -1.96 . . . . 54.52 108.199 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.1 m -155.94 169.56 24.15 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.712 1.205 . . . . 71.14 108.34 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.6 t -160.33 -179.7 7.92 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.99 1.316 . . . . 75.21 107.569 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.62 -178.07 42.45 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.226 -1.15 . . . . 73.34 110.226 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -143.63 163.27 33.71 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 106.547 -1.649 . . . . 72.03 106.547 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -125.46 150.54 47.25 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.244 0.618 . . . . 63.44 110.004 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.23 78.93 1.96 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 109.578 -1.409 . . . . 54.43 109.578 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.3 mt -65.22 141.37 58.67 Favored 'General case' 0 CA--C 1.526 0.055 0 N-CA-C 107.986 -1.116 . . . . 70.2 107.986 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.2 164.08 35.8 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.062 1.745 . . . . 53.32 108.461 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -131.06 167.01 19.8 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.078 1.351 . . . . 74.01 108.567 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.0 178.34 1.8 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 129.404 3.082 . . . . 71.14 106.074 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.432 ' CD ' ' HZ3' ' A' ' 16' ' ' LYS . 1.8 tm-20 -146.25 -177.91 5.86 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.913 -0.773 . . . . 62.22 108.913 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.432 ' HZ3' ' CD ' ' A' ' 15' ' ' GLU . 34.9 mtmm -71.98 154.05 92.64 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.911 1.684 . . . . 72.41 110.748 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.54 166.73 28.74 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.348 2.032 . . . . 73.44 110.281 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 165.44 24.66 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.329 0.651 . . . . 70.11 110.412 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -99.19 171.59 7.9 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.589 1.156 . . . . 73.13 109.001 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -125.1 178.19 5.68 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.958 1.703 . . . . 73.24 109.836 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -125.37 155.74 71.18 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.967 1.707 . . . . 73.31 109.184 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.39 164.33 34.26 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.568 2.179 . . . . 53.32 111.428 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.61 169.73 16.47 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.499 -1.041 . . . . 63.01 110.499 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.2 mtt -82.01 163.36 22.17 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.721 -0.474 . . . . 70.24 109.721 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.93 74.41 1.26 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.325 -1.732 . . . . 64.51 106.325 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.61 176.89 6.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.894 0.854 . . . . 65.43 112.651 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -64.68 168.14 6.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.183 0.993 . . . . 63.35 110.528 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.5 p -130.48 178.86 6.29 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.819 1.248 . . . . 74.33 112.377 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.67 145.9 3.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.591 1.156 . . . . 54.21 109.908 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -71.95 -171.78 0.76 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.071 -0.968 . . . . 74.02 110.912 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 m -55.85 170.66 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 126.667 1.987 . . . . 74.43 114.753 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.52 172.91 12.48 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.607 1.563 . . . . 72.04 110.733 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.44 -79.26 0.56 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 109.969 -1.252 . . . . 61.22 109.969 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -168.43 167.43 11.82 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.703 1.201 . . . . 71.31 109.609 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.2 171.72 13.34 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.157 1.383 . . . . 63.11 109.197 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.09 21.19 12.21 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 119.808 3.262 . . . . 62.53 119.808 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -48.17 -57.91 9.3 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.865 1.266 . . . . 74.32 112.503 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -63.63 107.98 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.545 2.163 . . . . 63.4 110.236 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.27 163.3 39.19 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 125.365 1.466 . . . . 64.0 110.375 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.5 mt -64.67 81.94 0.04 OUTLIER 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.187 1.795 . . . . 61.34 112.29 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.8 mt -55.41 145.09 49.81 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.646 0.779 . . . . 74.1 109.343 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.09 129.34 20.39 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.516 2.81 . . . . 74.03 111.092 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.4 mt -117.75 121.25 40.33 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.487 1.115 . . . . 62.42 109.663 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -77.93 101.89 7.06 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.29 -1.004 . . . . 72.34 108.29 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.07 -29.14 60.11 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.213 0.46 . . . . 75.53 111.441 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -73.06 -3.78 28.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.178 0.991 . . . . 74.15 112.139 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -118.4 0.1 11.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.33 2.252 . . . . 75.34 110.663 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.9 mt -98.98 176.78 5.46 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.252 1.021 . . . . 74.12 109.388 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -138.4 148.13 44.13 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.76 -1.2 . . . . 73.13 107.76 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -141.76 164.83 29.14 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.786 1.234 . . . . 74.44 108.955 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -126.04 174.87 8.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.004 -0.739 . . . . 73.23 109.004 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -133.94 113.62 12.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.348 -1.353 . . . . 71.41 107.348 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.0 t -87.37 133.61 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.929 -1.878 . . . . 71.33 105.929 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -127.26 -2.37 6.31 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.2 1.0 . . . . 71.33 112.691 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.19 -157.09 27.02 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 107.863 -2.095 . . . . 70.33 107.863 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -63.92 163.63 11.69 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.836 0.855 . . . . 71.33 109.111 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.76 -175.88 32.25 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 109.655 -1.378 . . . . 72.52 109.655 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.27 169.45 20.71 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.549 2.166 . . . . 64.11 109.449 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.89 -51.33 0.83 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.066 -1.213 . . . . 72.21 110.066 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 148.56 -109.86 0.47 Allowed Glycine 0 C--N 1.332 0.33 0 N-CA-C 108.498 -1.841 . . . . 73.23 108.498 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -73.02 58.24 0.48 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.885 1.674 . . . . 64.55 112.632 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.4 21.56 2.07 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.443 1.497 . . . . 75.42 110.313 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.63 11.5 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.793 1 C-N-CA 132.271 4.228 . . . . 55.51 115.284 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -66.19 96.4 0.33 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.181 1.792 . . . . 74.34 110.046 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.23 2.63 14.97 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.076 -1.015 . . . . 73.23 112.479 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 p -59.57 122.63 14.54 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.212 1.369 . . . . 70.21 108.209 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.1 m -78.05 2.17 18.64 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.991 0.916 . . . . 64.13 113.009 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -156.87 143.77 18.58 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 127.697 2.399 . . . . 75.02 106.06 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.8 t 178.45 133.8 0.08 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.651 2.781 . . . . 71.34 106.067 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.2 t -118.08 114.38 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 106.129 -1.804 . . . . 63.33 106.129 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.57 138.14 33.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.667 0.746 . . . . 45.23 109.303 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.8 tp -135.59 148.58 49.1 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.409 1.883 . . . . 74.15 107.889 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.71 158.4 44.48 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.479 -1.304 . . . . 75.21 107.479 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -106.84 119.27 38.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.585 -0.894 . . . . 74.41 108.585 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 t -57.36 -61.11 7.79 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.689 1.196 . . . . 55.5 110.103 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.77 -12.02 33.44 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.29 2.66 . . . . 75.24 116.832 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -120.83 -10.61 9.1 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.403 1.261 . . . . 73.55 114.403 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.78 -5.38 2.49 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.625 1.107 . . . . 50.13 114.754 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.6 mt -60.55 140.46 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 126.022 1.729 . . . . 73.53 108.128 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 t -126.02 142.57 42.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 105.792 -1.929 . . . . 74.53 105.792 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.56 139.58 16.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.497 -0.927 . . . . 72.43 108.497 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 113.7 17.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.37 1.468 . . . . 54.4 107.388 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.6 p -100.04 164.58 11.93 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.522 1.529 . . . . 70.03 111.741 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -155.8 120.67 4.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.138 1.775 . . . . 73.54 106.874 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.01 -47.54 0.13 Allowed 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.677 0.791 . . . . 71.24 110.082 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.7 p -128.13 -170.63 2.28 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.784 -1.561 . . . . 73.44 106.784 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.08 9.0 15.83 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.306 -0.871 . . . . 70.13 110.897 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 75.3 m -103.46 115.05 29.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.946 -1.131 . . . . 75.33 107.946 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.62 -43.05 77.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 123.54 0.736 . . . . 52.31 110.245 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.19 -30.63 64.7 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.643 1.11 . . . . 70.21 112.32 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -86.52 -48.39 8.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.749 -0.834 . . . . 44.41 108.749 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -60.95 -26.58 67.62 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.234 0.614 . . . . 70.23 110.751 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -57.16 -40.71 77.82 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.202 0.91 . . . . 74.11 110.093 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -73.6 -29.17 62.22 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 118.288 -1.365 . . . . 75.03 110.48 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.05 -45.18 95.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 124.381 1.072 . . . . 54.22 108.526 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.06 -45.22 94.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.858 0.361 . . . . 63.43 110.596 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -66.05 -48.17 71.92 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 122.65 0.38 . . . . 74.21 111.705 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -40.34 92.36 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 117.894 -1.05 . . . . 74.03 110.453 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.82 -37.79 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.278 0.944 . . . . 63.25 109.291 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.8 tp -61.11 -38.56 86.77 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.087 0.858 . . . . 71.31 110.854 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -57.06 -34.28 68.1 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.936 0.789 . . . . 75.24 111.384 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -67.49 -31.08 70.98 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.842 0.829 . . . . 74.02 109.97 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -77.68 -47.03 20.18 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.764 0.826 . . . . 72.53 110.948 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.1 t -62.18 -37.85 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 123.681 0.793 . . . . 71.15 109.964 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -52.24 -65.88 0.48 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.258 1.023 . . . . 54.41 110.296 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.63 -28.65 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.597 -0.69 . . . . 75.51 111.42 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -68.85 -40.19 79.51 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 119.123 0.874 . . . . 70.11 110.832 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -72.24 -45.24 61.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.722 0.809 . . . . 71.34 110.021 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -63.86 -53.9 43.32 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.289 0.636 . . . . 74.51 111.082 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.2 t -71.78 161.93 30.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.779 0.832 . . . . 73.33 111.836 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.5 176.27 45.38 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.999 1.285 . . . . 64.11 110.63 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.96 157.47 56.74 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.686 2.257 . . . . 74.15 110.198 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.5 p -66.05 -7.78 19.41 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.768 1.395 . . . . 75.34 114.768 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.2 t -77.62 -97.03 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.415 1.886 . . . . 50.42 109.32 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 N-CA-C 107.848 -2.101 . . . . 64.02 107.848 -179.785 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.081 0 N-CA-C 109.174 -1.57 . . . . 53.24 109.174 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p -154.78 173.33 16.59 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.337 1.455 . . . . 71.41 107.478 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.2 t -159.84 172.37 17.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.852 1.661 . . . . 55.14 106.621 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.77 -179.56 35.26 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.515 -1.434 . . . . 51.34 109.515 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.6 t -159.19 166.14 32.1 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.283 1.433 . . . . 63.53 107.155 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.7 m -142.13 168.81 18.87 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.948 1.299 . . . . 61.4 109.799 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.48 148.2 19.59 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.79 -1.324 . . . . 63.24 109.79 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.65 162.36 17.98 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.024 0.53 . . . . 73.12 110.975 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -144.14 -179.93 6.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.242 2.217 . . . . 74.2 106.911 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.82 88.43 0.07 OUTLIER Glycine 0 C--N 1.341 0.807 0 CA-C-N 119.58 1.082 . . . . 72.35 114.209 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.84 171.47 15.08 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.583 -1.265 . . . . 74.44 107.583 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.11 166.6 27.75 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 125.637 1.575 . . . . 70.43 108.075 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.14 164.52 35.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.338 1.855 . . . . 74.33 106.765 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -159.24 163.83 35.52 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 127.253 2.221 . . . . 74.14 106.252 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -138.6 178.43 7.15 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.212 0.605 . . . . 74.23 110.225 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -75.43 158.15 83.83 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.47 1.508 . . . . 71.34 109.851 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.69 159.03 54.05 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.333 2.022 . . . . 71.01 111.732 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.02 178.83 7.96 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.352 1.061 . . . . 72.24 110.161 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -139.31 174.37 10.59 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 126.208 1.803 . . . . 71.32 109.657 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.85 177.84 7.33 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.883 2.073 . . . . 74.22 108.629 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -129.15 153.29 80.36 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.027 1.331 . . . . 53.14 110.235 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -80.8 177.1 8.36 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.63 2.887 . . . . 74.35 110.85 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.89 160.24 27.97 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.649 -1.38 . . . . 62.11 109.649 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -145.81 124.09 12.27 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.838 -1.912 . . . . 65.4 105.838 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.98 56.49 1.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.622 1.169 . . . . 72.23 108.573 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.41 139.3 58.53 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.537 -0.727 . . . . 62.21 109.114 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 t -88.36 -170.0 2.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.897 1.279 . . . . 64.21 110.517 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.9 p -136.08 178.0 7.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.594 1.558 . . . . 64.33 109.467 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.71 -179.43 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 126.377 1.871 . . . . 74.3 109.514 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -130.48 169.47 15.5 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.082 1.753 . . . . 62.23 110.996 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.59 147.74 7.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.242 1.017 . . . . 64.4 109.265 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.92 -166.62 1.38 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.099 -1.445 . . . . 63.14 107.099 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.28 179.94 25.56 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-O 121.999 0.777 . . . . 71.14 112.223 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -66.64 -40.02 88.53 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.632 1.173 . . . . 70.31 110.162 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp 54.05 28.35 8.68 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.899 1.28 . . . . 70.33 111.037 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -125.29 13.98 8.3 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.833 2.053 . . . . 75.23 111.575 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -56.4 28.67 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 126.012 1.725 . . . . 71.43 110.382 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.29 161.17 44.25 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.08 1.854 . . . . 73.14 110.387 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.73 161.36 41.37 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.752 2.021 . . . . 74.43 106.621 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.6 mt 30.11 64.51 0.15 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.348 2.259 . . . . 73.5 112.803 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.79 157.85 18.34 Favored Pre-proline 0 C--O 1.24 0.605 0 C-N-CA 127.475 2.31 . . . . 70.53 109.77 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -62.41 140.95 85.12 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.137 1.225 . . . . 63.23 110.622 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.3 123.23 12.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.124 -1.806 . . . . 45.24 106.124 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -85.24 117.86 24.44 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.618 1.167 . . . . 74.3 109.664 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.35 -29.13 69.83 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.823 1.046 . . . . 73.14 113.823 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -82.68 -10.48 58.9 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.454 1.102 . . . . 64.31 112.849 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -91.59 2.25 56.58 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.768 0.713 . . . . 71.24 111.568 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mt -102.73 174.5 5.86 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.122 1.369 . . . . 61.44 112.106 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -126.79 156.23 41.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.346 2.258 . . . . 72.1 105.807 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.45 157.31 46.84 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.602 -0.686 . . . . 55.34 111.861 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -126.89 140.17 52.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.408 1.083 . . . . 74.24 111.134 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -106.38 132.34 52.52 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.562 1.145 . . . . 55.13 108.096 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.1 t -88.06 120.86 37.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.975 -1.121 . . . . 73.43 107.975 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 95.62 10.3 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.917 0.887 . . . . 32.31 109.5 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.48 -88.99 1.02 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.42 -0.895 . . . . 64.01 113.171 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -140.13 157.97 44.79 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.24 1.416 . . . . 74.54 110.464 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.65 -168.89 32.56 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.516 2.008 . . . . 43.21 110.414 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -65.65 170.48 11.15 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.399 2.733 . . . . 71.21 110.739 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.26 160.14 9.91 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 123.594 0.616 . . . . 75.1 112.207 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.13 -82.16 0.31 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 106.865 -2.494 . . . . 41.43 106.865 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -66.93 129.47 40.0 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.322 -1.733 . . . . 71.41 106.322 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.37 164.67 5.34 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.829 -0.434 . . . . 40.53 109.829 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.3 t -60.1 131.8 51.94 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.69 -1.226 . . . . 62.42 107.69 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -132.17 126.22 33.11 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.625 -1.991 . . . . 75.31 105.625 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -62.41 -21.79 65.66 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 118.856 -0.592 . . . . 74.03 111.293 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.2 p -75.77 72.47 2.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.86 1.664 . . . . 70.54 110.778 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -65.88 -6.17 11.43 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.135 -0.978 . . . . 63.43 111.956 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -72.93 62.96 0.63 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.726 2.811 . . . . 72.01 111.455 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -104.46 156.39 17.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.714 1.206 . . . . 64.45 109.504 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.95 142.22 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.537 1.535 . . . . 71.23 107.473 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -137.56 95.47 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.23 -1.396 . . . . 34.14 107.23 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.4 tp -93.46 152.4 19.11 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.727 0.411 . . . . 52.2 110.229 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -141.45 137.3 32.07 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 124.574 1.149 . . . . 73.31 110.346 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -87.84 132.93 34.0 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 105.468 -2.049 . . . . 71.45 105.468 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.63 -64.95 2.25 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 119.297 0.953 . . . . 65.25 111.846 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.54 -7.74 21.78 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.801 3.0 . . . . 73.4 116.13 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 m -113.3 -17.36 12.32 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.86 1.209 . . . . 72.21 112.213 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.11 -7.03 0.86 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.363 1.459 . . . . 70.31 115.725 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.76 136.93 25.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 120.038 1.919 . . . . 74.32 107.523 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.0 t -121.6 137.29 55.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.818 1.647 . . . . 71.24 106.772 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.0 p -146.88 148.11 17.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.542 -0.911 . . . . 74.31 108.542 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.48 134.08 41.11 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 122.523 0.329 . . . . 73.34 111.291 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.1 t -140.77 155.35 46.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.181 1.793 . . . . 73.42 108.547 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -150.75 100.78 2.86 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.496 1.918 . . . . 62.42 108.173 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -120.55 -15.55 8.47 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.768 1.396 . . . . 74.33 114.768 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.3 p -134.2 168.18 19.33 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.53 1.514 . . . . 73.43 110.824 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -79.96 -10.61 59.79 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.633 -0.667 . . . . 72.42 110.851 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.37 114.65 26.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.827 1.651 . . . . 72.22 110.231 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.35 -44.45 98.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-O 119.18 -0.438 . . . . 54.45 110.707 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -58.15 -45.45 87.4 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.381 0.537 . . . . 74.42 110.952 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -42.2 97.21 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.47 -0.937 . . . . 60.41 108.47 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.56 -27.47 68.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 118.613 -0.708 . . . . 73.22 109.987 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -62.22 -46.59 88.18 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.077 1.308 . . . . 74.14 107.843 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -60.36 -37.39 80.56 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.344 0.52 . . . . 62.53 110.222 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.48 -48.27 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 108.612 -0.884 . . . . 74.01 108.612 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.5 -35.49 80.65 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.673 -0.642 . . . . 44.14 110.538 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -63.71 -52.06 62.25 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 123.758 0.823 . . . . 75.12 111.282 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -43.35 94.21 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.643 1.11 . . . . 73.12 110.66 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.11 -33.09 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.503 1.047 . . . . 74.1 109.326 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.11 -33.13 75.08 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 120.839 -1.163 . . . . 71.31 108.962 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -58.75 -45.64 89.22 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.958 1.254 . . . . 75.24 107.951 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -56.47 -37.58 70.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.399 1.08 . . . . 73.12 109.684 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -72.4 -39.02 68.27 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.621 -0.674 . . . . 73.15 111.911 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.94 -39.29 85.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.564 -0.902 . . . . 60.55 108.564 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.12 -62.89 1.44 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.604 1.561 . . . . 75.43 110.799 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.4 p -60.8 -27.62 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 119.246 -0.407 . . . . 65.02 110.819 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -66.69 -36.19 81.92 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.585 0.63 . . . . 74.14 109.786 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -74.53 -42.78 58.25 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.423 -0.584 . . . . 70.13 109.423 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -67.83 -58.47 4.53 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.026 0.931 . . . . 73.31 111.748 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.2 t -96.18 64.38 2.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.384 1.474 . . . . 50.42 109.544 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.95 159.67 27.42 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.271 0.939 . . . . 63.02 110.988 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.53 128.16 23.9 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.727 2.952 . . . . 74.33 109.126 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.3 m -143.72 160.72 40.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.589 0.756 . . . . 64.42 110.413 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.9 t -141.63 59.82 1.49 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 104.469 -2.419 . . . . 62.43 104.469 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.85 0 N-CA-C 103.835 -3.706 . . . . 42.55 103.835 -178.658 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.082 0 N-CA-C 108.338 -1.905 . . . . 74.21 108.338 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 m -140.69 167.63 21.71 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.156 -1.053 . . . . 70.22 108.156 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 p -153.67 172.83 16.65 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.999 1.319 . . . . 72.12 108.099 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.26 -179.41 38.43 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.476 -1.85 . . . . 61.01 108.476 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.3 p -160.61 -179.58 7.75 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.207 -1.034 . . . . 73.03 108.207 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 m -128.53 8.88 5.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.865 0.866 . . . . 70.23 112.123 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 56.73 -148.68 30.78 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.221 -0.752 . . . . 40.33 111.221 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 164.85 168.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 1 C-N-CA 132.549 4.34 . . . . 70.32 106.89 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -156.54 175.83 13.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.587 1.155 . . . . 74.14 108.061 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.9 162.38 35.76 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.524 1.059 . . . . 54.41 111.188 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.9 mt -149.23 167.0 27.2 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.839 1.656 . . . . 60.12 108.278 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -153.16 132.94 13.16 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 107.949 -1.13 . . . . 71.43 107.949 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.453 ' CD1' ' H ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -159.28 -176.65 5.93 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 128.216 2.606 . . . . 75.32 106.0 179.052 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.453 ' H ' ' CD1' ' A' ' 13' ' ' LEU . 0.0 OUTLIER 147.01 168.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 1 C-N-CA 135.885 5.674 . . . . 74.4 106.627 179.654 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -138.39 170.9 15.2 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.378 -1.341 . . . . 71.02 107.378 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.43 154.72 47.66 Favored Pre-proline 0 N--CA 1.45 -0.43 0 C-N-CA 125.634 1.574 . . . . 74.43 111.622 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.59 163.79 36.57 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.976 2.451 . . . . 74.2 109.216 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.7 164.27 31.49 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.672 1.189 . . . . 61.22 109.154 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -160.06 176.41 11.85 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 126.197 1.799 . . . . 74.54 109.003 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.9 174.77 10.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.251 2.22 . . . . 74.42 107.723 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -123.65 152.39 65.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 124.405 1.082 . . . . 70.51 110.222 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -80.74 -179.54 5.23 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.929 3.086 . . . . 70.23 110.903 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.75 167.99 25.15 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.397 -1.481 . . . . 62.23 109.397 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -147.82 140.0 24.28 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.998 -1.852 . . . . 74.33 105.998 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.46 59.95 0.82 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.665 0.666 . . . . 30.4 111.053 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.78 140.07 42.15 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.624 -0.88 . . . . 63.12 108.624 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 t -73.87 164.55 26.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.524 1.13 . . . . 74.43 111.59 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 p -102.69 165.48 11.04 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.345 1.458 . . . . 72.33 108.593 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.07 143.28 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 107.521 -1.289 . . . . 72.43 107.521 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -62.12 139.24 58.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.439 0.638 . . . . 62.44 110.518 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -82.87 169.22 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 125.439 1.496 . . . . 72.54 109.293 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.25 149.68 36.71 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.47 2.308 . . . . 44.41 107.077 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -136.36 -57.29 0.06 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 125.38 1.467 . . . . 75.35 111.195 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.81 144.01 23.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 117.675 -1.155 . . . . 75.44 109.035 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HA ' ' CE1' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -158.39 5.71 0.12 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.966 2.106 . . . . 64.21 114.566 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -122.24 33.18 5.54 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 126.195 1.798 . . . . 73.14 109.93 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.448 ' CE1' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -52.45 -63.43 2.24 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.883 1.273 . . . . 70.44 111.617 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.0 92.9 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.026 2.484 . . . . 63.23 108.829 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.52 135.93 11.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.921 1.689 . . . . 62.4 107.562 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.2 mt -64.88 103.16 0.68 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.301 -1.37 . . . . 75.43 107.301 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.59 145.25 70.09 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.657 -0.868 . . . . 73.1 108.657 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.77 146.8 67.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.096 1.864 . . . . 73.14 111.927 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 mt -111.86 159.25 18.52 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.741 1.217 . . . . 74.4 111.533 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -115.01 101.37 8.94 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 108.096 -1.076 . . . . 74.24 108.096 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -66.12 -20.79 66.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.311 0.645 . . . . 63.33 112.71 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -84.4 3.29 36.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.932 1.693 . . . . 63.25 112.599 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -124.15 22.81 8.59 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.299 1.039 . . . . 61.04 111.203 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -112.31 162.0 16.01 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.295 -0.878 . . . . 65.22 108.81 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -126.13 95.1 4.28 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.423 1.489 . . . . 75.41 107.094 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 1.3 pm0 -87.0 162.86 17.39 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.138 1.375 . . . . 74.15 112.271 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 -146.7 172.2 13.98 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.919 -1.511 . . . . 62.24 106.919 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -130.97 155.91 46.01 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.509 1.124 . . . . 74.1 108.789 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.4 t -100.44 145.42 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.741 0.782 . . . . 64.14 109.512 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -146.0 30.05 1.07 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.239 2.215 . . . . 60.21 107.237 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.01 -143.12 32.84 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 104.5 -3.44 . . . . 55.31 104.5 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 54.97 -85.28 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 127.098 2.159 . . . . 72.12 112.213 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.92 -161.77 32.22 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.285 -1.526 . . . . 50.3 109.285 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.51 15.25 0.68 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.511 2.808 . . . . 73.32 111.26 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.57 -153.74 19.63 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.176 -1.169 . . . . 33.11 110.176 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.34 -176.71 54.07 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 122.085 0.825 . . . . 64.21 111.766 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.68 -1.88 0.45 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.528 1.531 . . . . 64.23 114.8 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.37 -11.48 20.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.635 -1.174 . . . . 74.22 112.932 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.3 t -48.53 -57.49 6.09 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.636 1.107 . . . . 75.42 113.444 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -73.67 -8.44 55.98 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.121 -0.987 . . . . 71.53 113.229 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -85.46 58.51 5.08 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 120.256 1.389 . . . . 73.25 112.005 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.7 t -59.6 130.05 44.94 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 105.984 -1.858 . . . . 74.13 105.984 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 p -152.68 156.78 39.86 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.81 -0.556 . . . . 61.12 110.65 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -68.81 14.19 0.08 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.861 2.864 . . . . 65.55 114.469 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.5 m -63.81 160.03 18.21 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.202 1.001 . . . . 70.44 110.611 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.08 148.53 30.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.07 -1.456 . . . . 75.12 107.07 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 p -133.78 115.88 22.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 105.953 -1.869 . . . . 63.12 105.953 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.77 151.66 40.32 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.18 1.792 . . . . 64.13 106.881 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.23 151.57 36.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.178 0.991 . . . . 72.33 111.78 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -87.26 134.28 33.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.995 -1.483 . . . . 74.14 106.995 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.66 -59.35 4.75 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.796 -1.097 . . . . 64.34 111.909 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.06 -9.29 23.33 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 124.268 3.312 . . . . 75.33 116.227 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.4 m -118.24 -12.38 9.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.742 0.701 . . . . 73.34 112.124 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.07 14.56 18.25 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.64 1.114 . . . . 50.54 113.361 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.1 mt -67.02 131.16 32.82 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 N-CA-C 106.048 -1.834 . . . . 60.54 106.048 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.71 140.18 48.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.826 -1.176 . . . . 74.02 107.826 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.81 144.14 24.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.375 -0.972 . . . . 42.51 108.375 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.66 111.16 17.28 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 105.929 -1.878 . . . . 64.44 105.929 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 81.3 m -124.28 158.12 33.29 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.008 0.908 . . . . 73.42 111.394 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -155.43 145.43 21.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.451 1.9 . . . . 64.04 108.627 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -154.2 -35.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.843 -0.535 . . . . 74.35 109.651 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.6 p -138.91 -178.76 5.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.42 -0.955 . . . . 74.34 108.42 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -93.33 -5.77 48.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.595 -0.891 . . . . 70.32 108.595 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' A' ' 91' ' ' GLN . 10.0 m -79.79 114.99 19.13 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.951 1.7 . . . . 54.43 107.812 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.37 -38.33 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 121.958 -0.464 . . . . 42.25 110.173 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -62.35 -33.7 75.23 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.893 1.277 . . . . 61.32 110.73 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 88' ' ' SER . 36.4 mt-30 -76.86 -54.82 6.1 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.215 -1.032 . . . . 74.12 108.215 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -52.46 -36.03 53.86 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.668 -0.682 . . . . 73.34 110.125 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -57.84 -58.28 9.07 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 118.212 -0.899 . . . . 72.14 110.294 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.21 -32.94 74.71 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.935 1.243 . . . . 75.52 113.31 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.47 -50.93 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.235 -1.394 . . . . 74.44 107.235 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.07 75.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.459 -0.941 . . . . 53.12 108.459 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.34 -47.0 62.85 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.648 1.179 . . . . 65.13 111.582 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -45.58 82.45 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 117.423 -1.275 . . . . 72.13 111.75 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.35 -29.93 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 120.397 1.453 . . . . 73.03 110.738 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -44.17 96.9 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 107.898 -1.149 . . . . 71.43 107.898 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -54.95 -39.62 69.11 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.564 1.146 . . . . 74.15 110.913 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -67.39 -30.18 69.88 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.076 0.95 . . . . 72.44 110.312 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.13 -46.9 17.07 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.078 -1.014 . . . . 65.54 110.021 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.28 -30.38 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.454 -0.943 . . . . 74.03 108.454 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -57.86 -62.43 1.81 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.685 -1.598 . . . . 72.13 106.685 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.5 t -59.55 -29.53 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.649 0.779 . . . . 65.33 110.39 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -66.6 -34.6 78.24 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.276 1.398 . . . . 73.44 111.805 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -87.52 -31.16 20.08 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 109.068 -0.716 . . . . 71.3 109.068 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -80.89 -15.92 55.01 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.086 0.554 . . . . 73.15 110.853 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 m -155.17 101.34 2.23 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.433 1.493 . . . . 74.21 109.727 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -159.22 -170.06 23.32 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.016 -1.634 . . . . 74.54 109.016 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -77.16 13.11 1.6 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.062 3.175 . . . . 74.41 113.477 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.9 t -80.2 117.51 21.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 119.729 1.15 . . . . 44.53 109.491 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.4 m -82.87 83.47 7.75 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.295 -1.743 . . . . 72.01 106.295 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.832 0 N-CA-C 108.139 -1.984 . . . . 63.01 108.139 -179.553 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.192 0 N-CA-C 109.086 -1.606 . . . . 54.43 109.086 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.5 t -156.84 168.3 27.86 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.458 -1.682 . . . . 72.1 106.458 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -162.42 166.89 24.47 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.242 1.417 . . . . 65.41 108.258 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.2 135.26 1.86 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 107.684 -2.167 . . . . 71.13 107.684 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.7 m -146.49 163.22 36.42 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.707 1.203 . . . . 53.02 108.151 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.5 p -156.27 173.34 17.0 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.233 1.013 . . . . 64.51 108.349 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.09 175.03 39.96 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.689 -1.364 . . . . 74.41 109.689 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -156.66 113.57 3.1 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 106.037 -1.838 . . . . 73.32 106.037 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -56.73 -70.31 0.12 Allowed 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 124.023 0.929 . . . . 73.21 112.554 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.13 -176.59 37.69 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.203 -1.559 . . . . 61.01 109.203 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 mp -142.73 149.03 38.23 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.217 -1.772 . . . . 74.12 106.217 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -156.31 146.88 21.71 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.529 -1.286 . . . . 75.45 107.529 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.94 147.83 30.49 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 105.594 -2.002 . . . . 73.13 105.594 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.5 -172.45 2.45 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.188 2.595 . . . . 70.23 106.862 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 16' ' ' LYS . 8.0 tp10 -132.92 169.29 17.0 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 106.241 -1.763 . . . . 73.53 106.241 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.404 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -79.08 151.09 75.54 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 125.003 1.321 . . . . 72.23 108.927 -179.304 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.7 139.25 33.5 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.905 1.737 . . . . 71.43 108.482 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.15 156.93 38.13 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.144 -0.687 . . . . 53.34 109.144 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.9 mt -142.23 170.47 15.66 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.754 1.622 . . . . 73.54 107.744 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pp -139.68 167.96 20.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.62 1.568 . . . . 55.22 109.335 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -89.37 153.99 48.67 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 123.722 0.809 . . . . 75.01 109.087 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.77 163.81 33.0 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.722 2.281 . . . . 74.32 110.839 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.26 -176.36 34.54 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.822 -1.311 . . . . 44.04 109.822 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 53.9 ttm -121.02 145.47 47.73 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.638 -1.245 . . . . 62.34 107.638 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.26 68.6 1.04 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.72 -1.956 . . . . 51.31 105.72 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.4 172.91 7.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.9 -0.407 . . . . 44.42 109.9 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 t -154.77 177.09 11.65 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 122.194 -0.316 . . . . 74.22 110.476 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.8 m -138.1 173.65 11.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.725 2.41 . . . . 74.45 107.597 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.17 178.87 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.469 1.907 . . . . 53.02 109.09 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -71.0 142.12 50.97 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.388 -1.708 . . . . 74.5 106.388 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.77 177.45 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.467 0.651 . . . . 51.41 110.828 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 174.26 11.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.83 -0.623 . . . . 74.12 110.875 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.63 162.87 32.3 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 107.442 -2.263 . . . . 74.01 107.442 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -97.65 169.24 9.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.334 1.064 . . . . 63.3 111.839 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -144.97 19.93 1.61 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.858 2.463 . . . . 73.11 109.095 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -108.46 9.42 27.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.354 2.261 . . . . 64.22 113.014 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.32 -58.94 11.55 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-O 118.615 -0.707 . . . . 74.44 109.548 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.87 108.3 1.45 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.516 2.144 . . . . 64.34 110.408 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.0 164.24 24.36 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.442 1.097 . . . . 44.23 109.855 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.5 mt 48.38 52.45 13.51 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.509 2.324 . . . . 64.31 109.084 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp -56.12 149.66 34.52 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.494 1.918 . . . . 74.32 109.807 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.2 151.41 73.56 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.075 2.517 . . . . 63.24 113.931 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.0 mt -123.13 110.41 15.25 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.255 1.422 . . . . 72.03 108.046 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -79.62 101.97 8.64 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.122 1.369 . . . . 72.33 110.276 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.8 -29.88 42.48 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.487 0.921 . . . . 73.34 113.487 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.5 -22.83 60.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.14 0.427 . . . . 63.21 111.24 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -89.22 -21.84 23.05 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.568 1.147 . . . . 74.21 110.476 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.7 mt -84.16 176.62 8.66 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.756 0.822 . . . . 74.51 110.112 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.19 140.73 49.96 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.608 -1.627 . . . . 75.4 106.608 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -129.04 157.11 42.63 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.716 1.206 . . . . 63.11 109.679 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -137.3 118.71 14.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.799 -1.556 . . . . 61.54 106.799 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -74.45 163.16 28.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.808 -1.996 . . . . 72.03 109.8 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.7 t -129.74 126.21 62.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 107.697 -1.223 . . . . 74.1 107.697 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -127.19 -11.67 5.81 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.247 1.819 . . . . 72.44 111.029 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.32 149.87 7.29 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 126.573 2.035 . . . . 73.05 110.339 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -167.98 130.43 1.52 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.632 1.973 . . . . 72.1 106.21 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.44 168.1 31.78 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.773 -0.931 . . . . 23.02 110.773 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.82 -17.1 29.4 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.763 2.308 . . . . 63.52 113.957 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.7 -160.69 53.83 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 118.545 0.611 . . . . 74.24 112.478 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.4 -126.98 41.22 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.187 -1.565 . . . . 65.02 109.187 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -66.91 -17.18 64.78 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.753 0.649 . . . . 74.45 112.753 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.68 86.15 5.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 119.139 0.881 . . . . 61.33 109.21 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.3 p -69.51 86.66 0.45 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.125 0.97 . . . . 72.31 109.012 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.09 165.84 12.8 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.984 1.714 . . . . 73.32 110.777 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.38 81.29 2.01 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.871 -1.159 . . . . 71.5 107.871 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -78.72 152.34 31.61 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.088 -1.449 . . . . 72.01 107.088 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 p -157.52 167.15 31.01 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.058 -1.09 . . . . 73.33 108.058 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -74.54 44.82 0.22 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.834 1.653 . . . . 75.31 111.763 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.17 159.21 26.8 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.347 -0.846 . . . . 61.25 108.959 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.26 130.27 60.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.169 -2.16 . . . . 61.32 105.169 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 t -121.28 119.97 60.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.746 -1.205 . . . . 73.14 107.746 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.8 tp -118.78 142.31 47.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.217 -1.401 . . . . 61.51 107.217 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.17 152.3 45.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.69 -1.226 . . . . 71.32 107.69 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -100.3 116.62 32.7 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.03 -2.211 . . . . 71.13 105.03 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.82 -56.75 22.77 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 117.74 -1.124 . . . . 74.53 112.04 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -69.25 -10.4 28.87 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.468 2.112 . . . . 64.51 114.885 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 m -120.43 -11.92 9.05 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.843 1.053 . . . . 74.03 113.843 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.08 -4.02 3.68 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 127.69 2.566 . . . . 73.02 115.633 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.56 135.81 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 119.295 1.547 . . . . 75.22 108.748 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 t -123.35 148.19 27.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 126.258 1.823 . . . . 70.42 107.124 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 p -145.61 146.29 19.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 106.447 -1.686 . . . . 74.21 106.447 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -123.86 119.13 28.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.019 -1.104 . . . . 75.25 108.019 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 91.5 m -128.57 152.26 48.52 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.684 0.754 . . . . 72.13 111.094 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -155.68 100.64 2.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.177 2.191 . . . . 74.12 106.155 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -111.31 -41.53 4.12 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.328 -0.858 . . . . 61.31 110.779 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.3 t -140.76 179.11 6.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.446 1.099 . . . . 42.03 109.921 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.93 11.94 12.31 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.43 1.092 . . . . 64.23 109.902 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.9 m -107.23 115.54 30.34 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.992 -1.114 . . . . 74.01 107.992 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.7 -47.87 81.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.411 0.685 . . . . 64.5 109.314 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -49.69 -54.09 20.74 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.295 1.438 . . . . 61.24 112.406 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.49 -46.12 87.57 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.5 0.72 . . . . 73.4 109.618 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -56.91 -37.71 71.83 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.635 0.652 . . . . 54.13 111.108 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -57.91 -36.88 73.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.83 0.741 . . . . 74.02 109.531 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -55.85 25.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.496 0.589 . . . . 73.2 109.734 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.6 mp -52.67 -47.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.777 -0.453 . . . . 63.4 109.777 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.54 -50.96 71.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.932 0.893 . . . . 74.02 111.98 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -60.97 -43.83 98.2 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.799 -0.619 . . . . 74.24 110.26 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.06 -59.32 5.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.572 -0.899 . . . . 71.53 108.572 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 p -60.1 -35.07 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.819 0.736 . . . . 72.41 112.937 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -65.07 -42.89 93.76 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 119.011 0.823 . . . . 64.34 110.279 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -52.01 -42.25 62.88 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.643 1.577 . . . . 74.21 112.612 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.34 -43.16 78.79 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.621 0.724 . . . . 63.24 110.38 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -73.79 -41.17 62.77 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.176 1.79 . . . . 64.24 112.412 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.86 -34.11 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 118.146 -0.93 . . . . 64.3 110.585 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -54.7 -59.54 4.57 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.565 1.529 . . . . 72.42 106.928 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.29 -34.49 27.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.315 1.846 . . . . 65.21 110.291 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -66.26 -39.19 89.29 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.593 -0.692 . . . . 75.13 110.715 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -78.05 -38.63 44.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.585 0.63 . . . . 73.32 110.063 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -68.41 -58.76 3.86 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.318 1.047 . . . . 75.02 112.641 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 m -88.74 176.79 6.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.583 1.553 . . . . 52.32 114.017 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -118.7 172.09 14.38 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.351 1.453 . . . . 75.34 111.668 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.11 175.4 10.4 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.414 3.41 . . . . 74.44 111.272 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.3 m -83.45 -18.1 39.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.362 0.665 . . . . 64.0 111.767 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.9 m -147.84 166.74 26.68 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.601 0.76 . . . . 71.11 112.272 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 C-N-CA 127.004 2.24 . . . . 24.13 110.707 -179.543 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.14 0 N-CA-C 109.193 -1.563 . . . . 71.44 109.193 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -65.32 161.34 19.79 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.889 0.845 . . . . 74.33 110.191 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 t -71.22 -1.2 11.83 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.69 1.196 . . . . 61.42 112.377 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 63.59 -154.67 45.34 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 107.93 -2.068 . . . . 71.11 107.93 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -12.63 61.82 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 117.159 0.479 . . . . 55.41 111.153 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 46.19 43.0 10.73 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.634 1.573 . . . . 44.1 111.584 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.64 137.73 49.22 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.916 -0.874 . . . . 61.23 110.916 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -159.77 171.74 18.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.406 1.883 . . . . 64.41 107.1 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -132.6 179.12 6.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.237 1.015 . . . . 71.43 109.489 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.28 -178.65 37.93 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.312 -1.515 . . . . 43.41 109.312 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.06 165.62 21.51 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.895 0.855 . . . . 74.2 110.563 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.45 163.53 35.38 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.267 1.827 . . . . 73.35 108.734 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.72 168.8 16.58 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.859 1.663 . . . . 71.23 107.64 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.1 164.9 18.05 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.593 1.557 . . . . 64.31 107.698 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 16' ' ' LYS . 5.2 tp10 -93.13 177.93 5.9 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.955 0.902 . . . . 52.44 110.566 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -108.54 160.08 28.47 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 126.3 1.84 . . . . 73.33 111.188 -178.326 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -71.45 166.99 27.6 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.748 2.299 . . . . 65.44 109.73 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.69 175.93 5.99 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.907 1.283 . . . . 52.52 109.919 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.69 173.76 11.79 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.095 1.758 . . . . 74.41 109.544 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -134.2 174.88 10.02 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.339 1.856 . . . . 64.3 109.428 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -111.92 155.47 43.22 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.666 1.186 . . . . 43.45 109.76 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.78 171.34 18.38 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.977 2.451 . . . . 65.42 111.412 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.06 -176.2 47.8 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.814 -0.915 . . . . 61.33 110.814 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 50.3 ttp -133.17 156.53 47.32 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.197 1.399 . . . . 74.21 108.034 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.36 120.68 4.49 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 102.468 -3.16 . . . . 75.41 102.468 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.94 175.71 5.35 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.907 0.883 . . . . 71.43 109.251 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 t -74.07 152.58 39.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.934 0.874 . . . . 23.04 110.779 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 p -84.61 -162.61 0.7 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 129.787 3.235 . . . . 63.0 112.284 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.69 149.35 4.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 O-C-N 121.038 -1.039 . . . . 71.22 108.933 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -81.42 -168.0 1.69 Allowed 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.814 0.816 . . . . 63.14 109.226 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.72 155.47 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 125.675 1.59 . . . . 74.01 107.032 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.07 172.12 7.63 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.256 -0.903 . . . . 44.03 111.325 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.49 160.27 28.7 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.973 -1.251 . . . . 71.44 109.973 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -68.17 158.47 33.13 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.14 0.495 . . . . 74.11 110.371 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -147.47 167.99 23.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.193 2.197 . . . . 54.31 106.524 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.7 t70 46.96 54.7 8.87 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.593 1.957 . . . . 65.43 113.628 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -59.74 3.84 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 117.659 -1.162 . . . . 63.33 108.619 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.37 125.99 16.82 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.722 1.614 . . . . 40.13 109.452 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -140.88 157.49 45.3 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.588 1.555 . . . . 75.11 107.306 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.8 mt -75.98 101.61 5.3 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.272 -1.381 . . . . 54.21 107.272 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 pp -53.71 140.63 48.27 Favored Pre-proline 0 CA--C 1.541 0.63 0 O-C-N 123.827 0.704 . . . . 64.41 109.856 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.13 106.22 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.266 3.311 . . . . 73.52 115.868 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -80.8 149.91 29.41 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.785 -0.45 . . . . 71.02 109.785 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -103.81 106.7 17.29 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 106.959 -1.497 . . . . 73.42 106.959 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -60.15 -13.63 13.09 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 115.417 1.636 . . . . 73.43 115.417 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.9 m -95.99 -13.07 24.08 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.237 0.926 . . . . 61.24 111.394 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -93.99 3.16 55.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.002 2.121 . . . . 73.13 111.449 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mt -98.64 166.62 11.25 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.723 1.209 . . . . 63.33 109.784 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -133.99 98.02 4.04 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.677 1.191 . . . . 73.33 107.806 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.59 164.72 17.58 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.024 0.93 . . . . 72.24 112.727 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -132.35 124.87 29.61 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.955 -1.128 . . . . 74.44 107.955 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -88.22 101.01 13.42 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.757 -0.831 . . . . 74.23 108.757 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.45 157.51 2.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.252 -1.759 . . . . 73.12 106.252 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.6 pttm -164.88 130.49 2.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.352 -1.721 . . . . 74.12 106.352 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.13 -140.84 38.48 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.818 -0.913 . . . . 72.02 110.818 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -136.16 155.24 50.44 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.149 2.18 . . . . 73.32 106.317 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.94 172.49 53.03 Favored Glycine 0 CA--C 1.536 1.382 0 N-CA-C 110.246 -1.142 . . . . 62.1 110.246 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.6 80.87 2.22 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.565 2.843 . . . . 73.43 110.088 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -139.99 93.2 0.19 Allowed Glycine 0 C--N 1.332 0.336 0 N-CA-C 107.493 -2.243 . . . . 53.42 107.493 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.62 -155.56 45.26 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.154 -1.579 . . . . 54.24 109.154 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -137.44 135.5 36.94 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.222 -1.77 . . . . 64.33 106.222 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -157.78 175.58 13.7 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.921 1.288 . . . . 70.5 108.07 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 m -79.17 87.69 4.89 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.554 -1.276 . . . . 75.54 107.554 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -54.6 106.2 0.2 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.218 1.407 . . . . 71.4 109.706 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.1 mmtm -73.79 166.61 23.0 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.928 0.394 . . . . 64.11 110.139 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.9 t -118.73 13.94 13.35 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.281 1.432 . . . . 72.03 109.928 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.85 158.19 36.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.87 1.268 . . . . 71.34 108.201 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -83.46 155.83 23.21 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.325 -0.62 . . . . 70.14 109.325 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.5 p -155.48 111.52 3.12 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.231 0.612 . . . . 63.23 111.157 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.66 137.38 40.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 105.569 -2.012 . . . . 62.44 105.569 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.15 123.24 63.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.689 -1.967 . . . . 70.04 105.689 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.37 142.65 45.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.93 -1.137 . . . . 55.02 107.93 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -140.39 139.43 35.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.343 1.857 . . . . 63.4 110.575 -178.578 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -103.07 124.08 47.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.026 -1.842 . . . . 73.54 106.026 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.421 ' HA ' ' HE2' ' A' ' 73' ' ' LYS . 69.3 t -64.58 -63.13 4.01 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 117.854 -1.07 . . . . 65.12 112.024 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.49 -11.62 32.8 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.909 2.406 . . . . 61.33 115.785 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -111.88 -13.51 13.65 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.091 0.86 . . . . 61.21 111.224 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.79 0.62 4.11 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.14 1.829 . . . . 52.12 115.616 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.7 mt -69.16 143.32 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 119.39 1.595 . . . . 72.02 109.376 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 t -136.56 136.94 48.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.229 -1.397 . . . . 63.33 107.229 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.07 147.74 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 121.543 -0.723 . . . . 63.32 109.259 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -129.64 107.52 9.51 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.431 1.092 . . . . 73.14 110.289 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 56.7 m -120.44 152.16 38.35 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.782 0.833 . . . . 62.15 109.86 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.69 100.41 2.08 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.79 1.236 . . . . 71.33 107.845 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -119.63 -14.04 9.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.359 0.664 . . . . 65.41 112.778 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.6 p -133.83 -176.83 4.3 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.18 0.992 . . . . 73.31 110.301 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -109.95 19.45 19.03 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.233 1.013 . . . . 74.45 112.644 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 t -125.63 132.02 52.55 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.44 1.096 . . . . 72.34 108.111 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.4 p -58.86 -47.25 90.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 N-CA-C 108.691 -0.855 . . . . 64.15 108.691 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -63.17 -25.87 68.54 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.892 1.071 . . . . 74.42 113.892 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -84.48 -44.73 13.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.033 -1.469 . . . . 71.31 107.033 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -64.34 -27.2 68.86 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.383 -0.823 . . . . 75.25 109.156 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -62.71 -58.3 7.95 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 126.351 1.86 . . . . 75.4 108.607 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -56.29 -37.21 69.55 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.141 0.428 . . . . 74.12 111.681 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 79.0 mt -63.9 -50.65 76.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.74 -0.837 . . . . 73.01 108.74 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.08 97.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.096 -0.478 . . . . 71.41 110.361 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -61.33 -49.14 78.17 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 118.699 0.681 . . . . 72.12 109.305 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -56.13 24.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.778 0.831 . . . . 74.34 110.452 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.36 -35.43 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 119.074 0.852 . . . . 61.24 111.544 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.1 tp -64.27 -41.19 97.04 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 121.187 -0.945 . . . . 71.4 109.15 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -58.3 -43.22 87.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.184 0.994 . . . . 72.32 109.672 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -60.81 -27.42 68.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.545 0.738 . . . . 71.24 111.234 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -88.09 -45.58 10.03 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.169 1.388 . . . . 52.2 111.84 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.6 t -63.35 -35.37 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 107.567 -1.272 . . . . 50.44 107.567 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.65 -64.23 0.9 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.71 1.204 . . . . 71.34 109.383 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.5 p -59.56 -30.53 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.518 -0.739 . . . . 71.11 111.727 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -68.87 -35.07 76.47 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.852 1.206 . . . . 63.52 111.203 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -83.08 -32.14 26.94 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.355 1.062 . . . . 74.34 109.869 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -77.11 -46.37 23.76 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.567 0.747 . . . . 62.42 110.281 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 t -76.12 174.14 10.43 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.641 0.776 . . . . 72.05 109.221 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.24 -105.34 2.81 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.369 -1.492 . . . . 64.4 109.369 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.54 116.25 4.64 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.142 1.895 . . . . 71.34 110.051 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 78.2 p -142.77 113.62 7.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.104 -1.813 . . . . 71.22 106.104 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.5 p -61.31 143.25 56.02 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 121.185 -0.947 . . . . 74.23 111.05 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.3 0 N-CA-C 109.8 -1.32 . . . . 74.02 109.8 179.544 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.386 0 N-CA-C 106.814 -2.514 . . . . 51.25 106.814 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t 53.14 42.04 32.16 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.5 1.65 . . . . 61.5 107.684 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 p -139.46 148.75 43.15 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.662 1.985 . . . . 71.33 108.725 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.17 -177.82 33.61 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 108.15 -1.98 . . . . 52.12 108.15 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.6 t -153.63 173.02 16.33 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.02 -1.104 . . . . 63.21 108.02 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.9 p -160.77 176.81 11.08 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.29 1.436 . . . . 74.25 108.573 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.01 167.97 40.62 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.618 -1.793 . . . . 62.44 108.618 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -158.52 168.83 25.88 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 117.966 0.883 . . . . 73.12 109.79 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -133.42 -159.74 0.99 Allowed 'General case' 0 C--O 1.243 0.741 0 C-N-CA 126.426 1.891 . . . . 74.24 106.409 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.68 -80.21 0.28 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 124.714 1.149 . . . . 72.12 111.436 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.9 mt 56.59 179.71 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.733 2.413 . . . . 73.2 111.63 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -159.31 118.08 2.89 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.612 -1.305 . . . . 60.42 108.338 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -99.5 151.71 20.83 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 106.15 -1.796 . . . . 74.21 106.15 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.1 pm0 -159.04 133.67 8.0 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.046 0.927 . . . . 74.55 111.032 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' N ' ' CD ' ' A' ' 15' ' ' GLU . 12.9 mp0 -88.72 -175.63 4.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 128.724 2.81 . . . . 74.4 110.315 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -143.23 156.8 61.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 126.23 1.812 . . . . 74.12 109.506 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.18 175.23 11.2 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.747 2.298 . . . . 74.44 109.051 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -125.2 -174.74 3.13 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.164 1.385 . . . . 62.14 108.552 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.23 175.91 8.08 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.143 1.377 . . . . 65.12 108.557 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.64 176.05 7.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.014 1.726 . . . . 54.54 109.633 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -109.97 153.9 42.92 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.129 1.372 . . . . 74.4 109.497 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.61 168.64 23.31 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.805 2.337 . . . . 62.51 111.765 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.76 -172.33 39.27 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 109.866 -1.294 . . . . 64.24 109.866 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.2 mmt -125.44 158.9 33.25 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.65 1.18 . . . . 70.55 108.467 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.32 68.19 1.19 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.348 -1.352 . . . . 73.1 107.348 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.65 172.12 11.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.931 -0.577 . . . . 73.12 110.053 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.7 t -131.62 -173.23 3.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.844 0.858 . . . . 72.02 111.167 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.4 t -130.66 163.0 28.16 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.235 1.414 . . . . 64.54 109.632 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.0 m -67.6 -173.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.011 1.725 . . . . 74.3 112.293 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -132.45 176.87 8.05 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.423 1.889 . . . . 63.45 108.9 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.2 173.18 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 124.2 1.0 . . . . 72.42 110.57 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.84 162.86 28.27 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.773 -0.649 . . . . 73.53 111.569 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.85 141.07 15.36 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 106.069 -2.813 . . . . 43.51 106.069 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -140.02 172.82 12.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 118.365 1.082 . . . . 50.23 109.612 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -157.86 168.97 25.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.236 1.415 . . . . 65.52 107.297 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 40.27 65.71 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 127.464 2.306 . . . . 74.43 113.633 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.03 -59.79 2.64 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 114.048 -1.433 . . . . 74.02 111.157 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.98 157.32 42.91 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.091 1.861 . . . . 70.04 115.548 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.16 177.08 3.43 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.508 1.523 . . . . 62.22 109.424 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.6 mt 58.45 49.08 11.23 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 128.821 2.849 . . . . 71.35 108.918 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -48.83 145.05 6.61 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.545 1.538 . . . . 75.31 111.212 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.51 159.0 55.26 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.452 2.768 . . . . 64.12 111.692 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 mt -136.91 122.34 19.5 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 123.189 0.595 . . . . 73.14 109.804 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -67.71 101.79 1.1 Allowed 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 106.839 -1.541 . . . . 73.44 106.839 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 45' ' ' GLU . 1.9 pm0 -57.34 -31.69 65.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.81 0.844 . . . . 72.53 112.361 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.2 m -77.56 -6.28 53.1 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.739 0.816 . . . . 62.24 112.686 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -99.83 7.11 45.22 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.235 1.414 . . . . 71.31 110.334 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mt -110.57 164.59 12.57 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.599 1.16 . . . . 75.34 110.456 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -120.96 137.73 54.48 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.167 -2.161 . . . . 65.35 105.167 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -123.78 155.19 38.39 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.818 1.647 . . . . 72.14 110.725 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -129.87 178.7 6.33 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.206 1.002 . . . . 73.14 108.829 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -135.43 163.5 29.9 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.476 1.91 . . . . 75.02 107.619 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.4 t -114.59 133.5 60.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 104.096 -2.557 . . . . 64.35 104.096 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -138.54 152.98 48.69 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.842 -1.17 . . . . 74.21 107.842 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 90.77 -175.38 40.23 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.414 -1.475 . . . . 74.05 109.414 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -143.18 124.29 14.47 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 102.704 -3.073 . . . . 73.13 102.704 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.66 -176.06 31.31 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 118.588 0.631 . . . . 63.44 111.624 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.77 175.97 4.83 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.297 2.665 . . . . 71.21 111.715 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.23 -63.82 4.37 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 107.634 -2.186 . . . . 55.33 107.634 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.22 -3.95 40.79 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-N 117.363 0.582 . . . . 43.21 112.201 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -60.05 -10.4 4.22 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.083 2.553 . . . . 60.24 113.163 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.71 -23.9 3.01 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.436 1.494 . . . . 74.01 114.734 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 t -153.57 146.35 24.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 119.813 1.188 . . . . 71.51 108.811 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.1 41.25 0.51 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.832 1.253 . . . . 61.14 109.373 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -141.73 -6.2 1.01 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.613 1.565 . . . . 74.22 112.485 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -55.62 100.47 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.618 1.567 . . . . 52.41 110.863 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 t -159.32 163.83 35.34 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.213 1.805 . . . . 74.14 106.48 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 51.26 21.66 1.18 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.245 1.418 . . . . 54.44 112.791 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.9 m -64.25 144.61 57.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.031 1.333 . . . . 62.43 109.679 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.4 162.48 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 121.897 0.856 . . . . 61.23 109.96 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -141.34 156.26 21.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 126.996 2.118 . . . . 63.11 107.549 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.45 150.04 40.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.704 -1.961 . . . . 71.54 105.704 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.89 158.17 43.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.665 0.786 . . . . 72.34 109.337 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -107.34 126.38 52.38 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 104.828 -2.286 . . . . 75.51 104.828 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.1 t -68.28 -58.03 8.05 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 120.051 1.296 . . . . 73.12 111.593 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.09 -12.55 35.26 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.423 2.082 . . . . 73.13 115.628 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -112.4 -21.18 11.5 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.954 0.797 . . . . 61.42 109.719 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.39 -9.25 7.86 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.606 2.526 . . . . 74.51 113.686 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.408 HG21 ' HB3' ' A' ' 103' ' ' LYS . 11.7 mt -55.41 147.49 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.1 1.76 . . . . 72.11 109.918 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.2 t -134.35 146.94 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.468 1.507 . . . . 71.3 108.045 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -144.97 139.54 22.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.225 1.01 . . . . 53.25 108.896 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -110.64 127.89 55.46 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.156 1.382 . . . . 75.4 108.706 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.7 m -150.54 149.39 29.88 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.54 0.686 . . . . 73.43 112.799 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -155.23 139.72 16.85 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 129.584 3.154 . . . . 74.05 105.073 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -152.82 -68.97 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.719 -1.215 . . . . 63.04 107.719 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.0 p -77.93 151.66 33.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.564 1.146 . . . . 72.32 111.129 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -66.75 -25.83 66.69 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.83 0.678 . . . . 64.23 112.83 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 m -79.64 116.23 19.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.51 0.595 . . . . 72.42 109.845 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.8 p -54.07 -42.6 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.757 -0.831 . . . . 72.3 108.757 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.93 -44.42 78.35 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.132 0.973 . . . . 43.33 111.745 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -67.16 -39.55 86.51 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.043 -1.095 . . . . 73.15 108.043 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -60.86 -29.06 69.3 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.634 -0.698 . . . . 72.1 109.612 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -58.17 -40.91 82.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.801 1.182 . . . . 71.51 108.754 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -71.56 -46.51 59.23 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 125.098 1.359 . . . . 72.14 110.382 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 99.4 mt -56.97 -52.8 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.462 0.705 . . . . 72.32 111.277 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.5 -28.08 69.58 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.73 -0.606 . . . . 70.03 111.426 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -72.94 -45.76 56.28 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 118.554 -0.736 . . . . 74.44 109.883 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -64.82 -35.85 82.43 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.941 1.246 . . . . 74.2 111.101 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.3 p -71.79 -32.99 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 120.041 1.291 . . . . 74.23 108.375 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.4 tp -64.87 -32.77 74.64 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.602 -1.258 . . . . 52.43 107.602 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -55.75 -41.43 73.96 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.216 -0.661 . . . . 71.22 109.216 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -63.51 -39.58 94.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.733 0.697 . . . . 73.22 110.886 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HB3' HG21 ' A' ' 79' ' ' ILE . 73.4 mmtt -63.24 -48.19 79.27 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.773 0.829 . . . . 73.34 110.518 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 50.1 t -69.28 -41.01 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.872 0.869 . . . . 73.34 110.207 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.48 -62.01 1.89 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.183 1.393 . . . . 64.14 109.681 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.75 -22.44 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.027 0.931 . . . . 62.53 112.248 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -75.37 -27.2 59.04 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.771 -1.206 . . . . 74.24 111.293 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -98.94 -30.73 12.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.346 0.975 . . . . 73.24 109.655 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -75.89 -6.4 50.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.292 0.637 . . . . 71.15 110.597 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.02 174.0 11.1 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.795 1.638 . . . . 73.42 110.145 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -75.98 165.13 54.04 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.954 -1.259 . . . . 51.43 109.954 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.96 137.72 19.98 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.263 1.975 . . . . 75.33 107.268 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.4 p -143.07 176.96 8.7 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.21 -1.033 . . . . 72.12 108.21 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.5 175.59 5.49 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.523 1.129 . . . . 70.34 110.11 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 116.238 -2.423 . . . . 70.31 108.517 -179.82 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.036 0 N-CA-C 109.218 -1.553 . . . . 61.33 109.218 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -155.73 175.19 14.25 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.13 1.372 . . . . 44.54 107.499 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.1 m -155.23 173.66 16.3 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.593 1.557 . . . . 73.15 107.33 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.73 -179.41 47.86 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.157 -1.577 . . . . 74.41 109.157 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.2 p -150.73 179.27 8.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.069 1.347 . . . . 75.21 108.34 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.1 m -160.19 168.73 24.77 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.048 1.339 . . . . 54.32 108.363 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.22 137.61 8.72 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 107.379 -2.289 . . . . 53.24 107.379 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -81.16 79.57 7.79 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 117.805 0.802 . . . . 70.43 109.203 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -72.08 170.52 13.74 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.571 0.749 . . . . 74.35 110.091 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.58 140.88 2.98 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.874 -1.29 . . . . 70.1 109.874 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.7 mp -143.1 170.2 16.16 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.799 1.64 . . . . 71.23 107.441 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.63 159.61 43.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.273 1.429 . . . . 72.53 107.146 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -129.67 160.54 33.05 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.375 1.07 . . . . 70.21 108.363 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -174.01 164.04 4.09 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.06 2.544 . . . . 71.53 106.543 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.81 179.48 7.06 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.487 1.115 . . . . 60.22 108.149 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.42 155.41 44.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.61 1.164 . . . . 74.23 109.823 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.48 148.62 60.77 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.066 1.844 . . . . 74.11 109.013 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.81 161.47 29.55 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.701 -0.481 . . . . 72.34 109.701 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.6 mt -142.66 174.48 10.61 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.924 1.689 . . . . 73.41 108.113 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -114.83 177.33 4.69 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.599 1.559 . . . . 45.02 109.822 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -121.58 154.68 59.93 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.483 1.513 . . . . 72.14 109.411 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.54 169.65 22.06 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.745 2.297 . . . . 65.52 111.094 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.33 175.46 20.68 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.645 -1.382 . . . . 63.41 109.645 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.1 ttt -143.7 144.65 31.94 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.726 -1.212 . . . . 74.44 107.726 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.07 80.34 0.99 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.569 -1.641 . . . . 33.11 106.569 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.06 160.85 21.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.141 0.577 . . . . 53.43 110.807 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -103.31 -168.0 1.45 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.555 1.542 . . . . 74.43 108.29 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.3 p -124.37 -177.26 3.74 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.447 1.499 . . . . 65.24 109.977 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.72 157.96 41.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 125.203 1.401 . . . . 62.24 108.332 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.95 163.48 15.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.605 0.762 . . . . 54.43 110.987 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.0 -179.57 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.701 1.2 . . . . 72.21 108.788 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.06 161.22 20.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.956 1.302 . . . . 74.44 109.003 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.66 166.47 54.83 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.003 -1.239 . . . . 71.3 110.003 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -123.67 162.34 23.26 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.765 1.226 . . . . 74.2 110.067 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -161.77 176.93 10.38 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.667 1.187 . . . . 63.54 108.404 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t70 71.02 -53.72 0.67 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 127.276 2.23 . . . . 74.4 111.226 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -59.87 12.41 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.476 1.51 . . . . 74.14 109.107 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.66 111.73 2.87 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.268 1.979 . . . . 75.13 110.595 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.26 164.61 30.25 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.369 1.468 . . . . 53.43 108.641 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.5 mt 44.07 50.32 7.37 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.158 1.783 . . . . 75.1 111.393 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp -53.97 152.46 10.44 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.383 1.473 . . . . 73.45 114.042 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.04 154.6 33.23 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.907 2.405 . . . . 73.33 109.784 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.8 mt -134.35 136.81 43.67 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.717 0.807 . . . . 72.03 110.255 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.92 107.59 1.9 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.083 1.353 . . . . 72.34 108.668 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.58 -19.25 57.05 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.56 0.578 . . . . 72.25 112.56 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.9 m -85.27 -1.91 57.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.497 1.044 . . . . 52.45 112.033 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -114.63 -4.97 12.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.925 1.239 . . . . 72.1 112.585 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mt -86.33 140.99 29.55 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.911 -1.885 . . . . 71.4 105.911 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -109.0 126.11 52.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.779 0.718 . . . . 74.13 109.416 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.57 164.49 12.48 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.325 1.05 . . . . 64.24 112.613 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -141.61 143.86 33.9 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.31 -1.737 . . . . 73.34 106.31 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -103.83 123.39 47.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.085 -1.821 . . . . 73.23 106.085 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.1 t -88.0 106.44 16.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.05 -1.833 . . . . 74.13 106.05 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -70.84 31.84 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.509 2.323 . . . . 74.44 113.372 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.56 -99.76 1.88 Allowed Glycine 0 CA--C 1.523 0.551 0 O-C-N 120.263 -1.523 . . . . 63.21 110.551 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 50.29 8.37 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.124 2.57 . . . . 73.42 117.296 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.24 141.14 45.82 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 120.705 1.593 . . . . 65.23 111.486 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -64.81 162.01 33.74 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.478 2.786 . . . . 61.4 111.928 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.97 58.16 5.38 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.563 -1.815 . . . . 42.11 108.563 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.58 -178.55 48.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 107.28 -2.328 . . . . 61.03 107.28 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -122.06 -52.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.627 1.171 . . . . 73.34 108.058 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.74 -104.37 0.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.781 0.832 . . . . 65.52 109.09 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -16.1 2.01 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.696 2.399 . . . . 75.4 114.36 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -55.97 -26.65 49.13 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.228 1.411 . . . . 61.0 112.247 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -127.43 54.86 1.64 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 119.095 0.861 . . . . 73.23 110.592 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.8 m -77.96 72.75 4.51 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.423 -0.954 . . . . 65.22 108.423 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.9 t -84.23 -176.23 6.16 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.109 -1.441 . . . . 65.13 107.109 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.495 HD21 ' HB ' ' A' ' 89' ' ' VAL . 22.2 t-20 -152.63 124.08 7.71 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.97 -1.122 . . . . 54.45 107.97 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.8 m -150.49 152.38 34.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.024 -1.473 . . . . 60.4 107.024 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.4 124.15 70.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.051 -2.203 . . . . 61.24 105.051 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.96 96.21 4.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.817 -2.29 . . . . 71.01 104.817 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.9 tp -91.86 139.54 30.56 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.203 -1.777 . . . . 73.31 106.203 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.25 141.15 45.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.76 1.224 . . . . 74.42 110.56 -177.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -95.79 133.29 40.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.856 -1.535 . . . . 61.11 106.856 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.7 t -70.73 -66.5 0.78 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.307 1.043 . . . . 63.14 111.438 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.41 -7.63 21.24 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.858 3.038 . . . . 70.2 116.177 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 t -114.54 -20.43 10.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.524 0.602 . . . . 70.43 110.91 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.54 -3.97 4.34 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.604 -1.109 . . . . 64.42 114.807 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.99 139.52 20.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.261 -1.385 . . . . 73.13 107.261 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.64 147.93 33.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.223 -1.399 . . . . 63.12 107.223 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.464 HG21 HG13 ' A' ' 99' ' ' VAL . 9.8 p -143.12 140.82 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.986 -1.487 . . . . 52.21 106.986 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.68 107.79 13.66 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 106.515 -1.661 . . . . 61.22 106.515 -178.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 77.3 m -112.04 134.86 53.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 123.555 0.534 . . . . 74.43 110.567 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -147.28 109.87 4.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.66 2.384 . . . . 74.34 106.517 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -135.45 -20.71 1.59 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.49 1.116 . . . . 71.24 111.264 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.79 173.43 16.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.599 1.16 . . . . 72.55 107.914 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -86.63 -4.97 59.25 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.961 -1.087 . . . . 72.04 109.819 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.5 m -82.15 115.0 21.06 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.324 -1.362 . . . . 61.42 107.324 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.495 ' HB ' HD21 ' A' ' 68' ' ' ASN . 13.9 p -61.19 -38.7 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.796 -0.816 . . . . 51.1 108.796 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.479 ' HA ' ' HD3' ' A' ' 93' ' ' ARG . 9.9 m-20 -63.42 -23.05 67.24 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 113.859 1.059 . . . . 65.0 113.859 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -87.71 -46.84 9.14 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.321 -0.992 . . . . 63.12 108.321 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.11 -43.7 91.93 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.746 0.818 . . . . 61.13 110.945 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.479 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 4.0 ptm180 -57.74 -46.42 84.48 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 113.06 0.763 . . . . 74.11 113.06 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -64.41 -36.76 85.2 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 119.541 -0.863 . . . . 72.43 111.717 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.2 mt -60.89 -49.92 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.112 -1.44 . . . . 61.25 107.112 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.43 68.11 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.476 0.71 . . . . 32.33 111.684 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.9 ttm-85 -61.18 -53.78 52.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.11 0.414 . . . . 71.41 110.959 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -61.97 -39.8 93.43 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.68 -0.676 . . . . 75.31 112.409 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.464 HG13 HG21 ' A' ' 81' ' ' VAL . 13.8 p -72.19 -27.15 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 120.482 1.492 . . . . 72.22 109.495 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.9 tp -65.62 -47.48 75.48 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 120.329 -1.482 . . . . 74.25 107.445 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -56.91 -39.23 74.05 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.678 -1.153 . . . . 72.24 111.891 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.17 -50.2 74.93 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.775 1.17 . . . . 65.55 110.303 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -68.17 -44.6 75.58 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.844 -0.616 . . . . 75.21 112.084 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.6 t -62.91 -37.98 80.68 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-O 118.648 -0.692 . . . . 74.52 109.789 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -56.2 -52.23 65.18 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-N 119.354 0.979 . . . . 74.44 110.382 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.96 -18.15 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 121.647 -0.658 . . . . 72.3 112.434 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -87.48 -19.68 27.63 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.621 1.568 . . . . 74.2 110.224 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.26 -46.69 5.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.75 2.02 . . . . 73.01 110.928 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -77.07 -25.95 52.95 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.703 0.683 . . . . 62.02 111.937 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.1 m -145.19 -172.75 3.93 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.895 2.478 . . . . 74.33 106.631 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.61 172.01 44.31 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 120.983 -1.073 . . . . 72.22 111.627 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.59 -38.03 8.74 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.381 2.721 . . . . 64.03 108.983 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.2 m -72.21 175.74 5.81 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.455 1.502 . . . . 55.23 109.377 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.2 t -162.1 130.02 4.03 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.736 -1.95 . . . . 54.13 105.736 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.044 -1.42 . . . . 54.11 109.961 -179.533 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.195 0 N-CA-C 109.296 -1.522 . . . . 74.41 109.296 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 p -149.89 164.84 34.32 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.81 1.644 . . . . 50.13 106.823 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 m -144.78 165.17 28.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.735 1.214 . . . . 72.2 108.501 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.63 160.84 26.34 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.279 -1.928 . . . . 34.4 108.279 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.8 t -170.46 167.37 8.21 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.964 1.706 . . . . 64.31 106.838 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 p -163.87 149.91 11.29 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.024 0.93 . . . . 75.15 108.725 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.44 156.34 26.69 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 108.82 -1.712 . . . . 73.01 108.82 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -154.8 120.39 5.1 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 106.424 -1.695 . . . . 72.35 106.424 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 67.2 p-90 -140.3 -176.3 4.57 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.496 1.119 . . . . 73.24 108.946 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.81 160.17 31.02 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.516 -1.434 . . . . 20.43 109.516 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.2 mt -127.47 176.76 7.22 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.467 1.507 . . . . 71.14 109.76 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.95 166.19 33.22 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 127.335 2.254 . . . . 72.33 107.417 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.35 167.7 27.1 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.0 2.12 . . . . 42.45 106.428 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -142.77 142.25 31.87 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.625 -1.25 . . . . 64.04 107.625 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.96 -175.82 3.8 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.695 1.598 . . . . 74.2 108.706 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -135.98 139.66 31.01 Favored Pre-proline 0 N--CA 1.455 -0.203 0 C-N-CA 124.303 1.041 . . . . 73.22 109.242 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.77 173.49 13.36 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.119 3.213 . . . . 62.02 111.371 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.11 176.11 4.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.039 0.936 . . . . 74.52 110.656 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.57 173.89 7.78 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.54 1.536 . . . . 50.35 108.615 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.81 175.32 9.45 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.288 1.835 . . . . 74.44 109.306 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -118.43 156.53 50.95 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 125.423 1.489 . . . . 74.41 108.712 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.81 166.34 29.95 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.431 2.087 . . . . 75.22 111.491 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.12 -175.92 50.98 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.241 -1.143 . . . . 63.23 110.241 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 60.7 mtt -122.84 168.26 12.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.962 0.905 . . . . 44.11 110.04 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.16 132.16 9.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 102.063 -3.31 . . . . 73.44 102.063 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -130.08 177.44 7.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.594 -1.262 . . . . 44.02 107.594 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.27 176.33 5.34 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.574 -0.704 . . . . 73.51 110.189 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -124.58 170.88 10.48 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.466 1.107 . . . . 54.34 108.865 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.74 -175.26 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.6 1.16 . . . . 60.25 109.996 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -132.52 173.65 11.1 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.22 1.008 . . . . 74.31 109.53 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.0 149.35 10.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 124.153 0.981 . . . . 75.05 109.357 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.13 173.54 7.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.37 1.068 . . . . 64.32 111.518 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.18 176.17 16.25 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 107.873 -2.091 . . . . 64.23 107.873 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.3 mmp_? -131.25 177.55 7.38 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.182 -1.187 . . . . 52.13 111.639 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -150.7 179.43 8.2 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 129.404 3.082 . . . . 74.3 105.527 177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.09 24.15 14.34 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.929 1.455 . . . . 74.24 114.929 177.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.78 -63.24 2.44 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.467 0.914 . . . . 74.51 113.467 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -67.67 101.95 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.707 2.271 . . . . 43.1 109.959 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -143.25 -166.4 2.3 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.509 1.124 . . . . 73.14 109.534 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.7 mt -137.33 90.32 2.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.988 2.115 . . . . 65.41 109.065 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 pp -63.43 153.77 81.38 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 126.69 1.996 . . . . 71.55 113.056 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.11 112.59 2.84 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.19 2.594 . . . . 53.3 112.042 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mt -91.29 140.95 29.29 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.638 -0.664 . . . . 73.24 110.849 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -89.53 106.35 18.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.642 -1.984 . . . . 73.31 105.642 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -60.04 -11.49 6.01 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 114.879 1.437 . . . . 73.54 114.879 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.4 m -101.15 -3.44 29.15 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.208 1.003 . . . . 64.54 111.595 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -96.59 -8.83 30.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.433 1.093 . . . . 71.11 110.556 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.06 175.26 6.93 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.347 1.459 . . . . 74.23 109.709 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -130.1 122.65 28.7 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.39 0.676 . . . . 73.23 109.825 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -105.26 160.09 15.37 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.275 1.03 . . . . 73.2 111.182 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -142.05 131.17 23.29 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.139 1.376 . . . . 65.11 108.896 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -88.41 163.04 16.18 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.665 1.186 . . . . 65.42 107.933 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.6 t -133.86 125.57 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.285 1.034 . . . . 43.31 108.865 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -119.49 -45.92 2.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.653 1.581 . . . . 61.14 108.97 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.44 79.98 0.05 OUTLIER Glycine 0 C--N 1.335 0.5 0 N-CA-C 108.888 -1.685 . . . . 64.01 108.888 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -77.18 109.28 10.92 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.363 -0.977 . . . . 72.55 108.363 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.75 -163.36 10.06 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 123.22 0.325 . . . . 40.4 112.507 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.68 13.57 0.94 Allowed 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.91 3.073 . . . . 64.04 112.578 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.37 -61.23 4.74 Favored Glycine 0 C--N 1.339 0.745 0 O-C-N 120.828 -1.17 . . . . 63.41 110.205 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.88 -175.01 16.23 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.223 1.392 . . . . 62.53 110.587 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -75.11 74.67 2.28 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.025 0.93 . . . . 74.53 108.962 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -146.22 166.96 24.69 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.472 1.509 . . . . 61.23 108.934 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.3 p -110.44 -1.98 16.79 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.243 1.017 . . . . 74.12 112.287 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -73.7 176.89 5.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.36 1.464 . . . . 71.12 111.031 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.28 96.55 3.4 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 105.044 -2.206 . . . . 64.21 105.044 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 p -68.92 9.01 0.44 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.387 2.275 . . . . 71.13 115.332 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 m -53.99 -17.89 3.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.75 2.02 . . . . 64.44 115.902 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -140.88 52.71 1.6 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.332 1.423 . . . . 64.24 111.185 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.2 m -99.51 158.39 15.77 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.401 0.68 . . . . 55.35 109.299 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.4 t -140.74 135.83 34.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.925 1.69 . . . . 74.43 106.583 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.28 142.27 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.201 -1.407 . . . . 72.0 107.201 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.4 tp -131.57 146.74 52.36 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.697 1.199 . . . . 51.41 107.976 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.56 148.59 49.15 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.476 0.655 . . . . 75.13 110.15 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -93.92 118.67 31.8 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 104.243 -2.503 . . . . 71.44 104.243 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.19 -61.53 7.66 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 118.531 -0.747 . . . . 74.34 112.077 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -69.91 -9.78 26.87 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.793 2.329 . . . . 51.02 116.197 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 m -120.95 -10.33 9.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.438 1.472 . . . . 73.02 114.614 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.74 9.67 27.52 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.737 1.161 . . . . 73.21 114.725 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 mt -70.81 131.5 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 104.772 -2.307 . . . . 71.22 104.772 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.1 t -126.52 143.93 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.55 -1.278 . . . . 62.13 107.55 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.54 142.57 25.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.525 -0.917 . . . . 71.02 108.525 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -115.42 118.5 33.38 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.751 1.62 . . . . 72.54 110.154 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.0 p -116.55 143.42 45.62 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.397 0.544 . . . . 72.11 110.135 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -157.41 100.32 1.81 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.704 1.202 . . . . 64.33 108.813 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -135.34 -24.62 1.39 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 119.989 1.268 . . . . 74.33 114.017 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.2 p -124.29 171.6 9.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.576 0.75 . . . . 74.13 110.025 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -91.25 0.85 57.45 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.56 -0.533 . . . . 61.23 109.56 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.0 m -100.28 114.97 28.85 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.11 1.364 . . . . 73.44 107.961 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.2 p -59.42 -38.41 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.538 -0.912 . . . . 70.41 108.538 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -59.4 -40.52 86.9 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.048 1.739 . . . . 61.01 112.318 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -79.11 -29.76 43.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.492 0.717 . . . . 73.54 110.662 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.418 ' HA ' HD12 ' A' ' 95' ' ' ILE . 89.9 m-20 -70.37 -40.44 73.99 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.275 -1.38 . . . . 51.31 107.275 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -48.61 -52.01 25.14 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.744 -1.223 . . . . 74.21 113.022 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -57.3 -35.16 69.48 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.174 0.897 . . . . 64.42 112.684 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 92' ' ' ASN . 54.6 mt -63.05 -50.39 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.221 1.008 . . . . 60.34 108.557 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.86 92.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 119.367 -0.349 . . . . 55.02 110.427 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -61.73 -51.65 67.51 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.051 0.541 . . . . 73.22 111.812 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -40.58 95.35 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 117.783 -1.103 . . . . 73.2 112.32 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.422 HG22 ' HE2' ' A' ' 103' ' ' LYS . 4.4 p -73.81 -38.77 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 119.676 1.126 . . . . 72.51 110.456 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 104' ' ' VAL . 56.3 tp -60.93 -44.99 96.45 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.86 -0.792 . . . . 72.1 108.86 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -50.28 -47.62 55.31 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 124.143 0.977 . . . . 72.33 112.095 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -59.27 -35.83 74.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.826 -1.171 . . . . 71.41 111.671 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.422 ' HE2' HG22 ' A' ' 99' ' ' VAL . 54.6 mttm -77.6 -33.55 53.79 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.586 1.154 . . . . 75.24 110.184 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 100' ' ' LEU . 60.8 t -66.12 -51.7 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 C-N-CA 125.712 1.605 . . . . 72.52 108.171 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -61.62 2.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 126.263 1.825 . . . . 74.32 111.234 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.3 p -59.52 -28.9 41.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 119.489 -0.291 . . . . 61.25 111.758 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -66.82 -37.58 84.79 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.579 -1.326 . . . . 74.33 109.996 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -81.84 -40.98 21.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.809 -0.557 . . . . 73.2 110.629 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -74.65 -15.14 60.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.643 1.577 . . . . 70.21 112.611 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 m -138.39 89.17 2.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.918 1.287 . . . . 53.12 109.364 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -168.21 178.09 42.03 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.196 -1.162 . . . . 52.43 110.196 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.18 163.05 39.91 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.457 2.105 . . . . 73.02 109.931 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.9 m -103.19 -42.93 5.61 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.992 0.917 . . . . 63.24 108.972 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.7 p -149.31 -2.8 0.43 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.047 0.758 . . . . 55.23 113.047 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.352 0 N-CA-C 108.246 -1.942 . . . . 72.22 108.246 -177.876 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.963 0 N-CA-C 108.411 -1.876 . . . . 74.5 108.411 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.92 -179.13 6.9 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.46 1.504 . . . . 74.31 107.481 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t -156.95 -166.68 2.15 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.128 -1.064 . . . . 73.02 108.128 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.85 171.7 22.29 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.769 1.652 . . . . 74.42 109.122 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.8 m -153.04 76.36 1.12 Allowed 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.667 -0.902 . . . . 74.41 108.891 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.3 p -68.31 153.07 44.47 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.871 -0.789 . . . . 74.54 108.871 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.63 -98.57 0.92 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 108.231 -1.948 . . . . 63.4 108.231 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.93 170.69 18.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.022 0.911 . . . . 73.22 110.838 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 30.9 p-90 -129.35 170.37 13.73 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.014 2.126 . . . . 74.23 107.956 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.41 -82.11 0.51 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.27 0.938 . . . . 74.2 112.035 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.4 mt 38.75 44.12 0.78 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.881 2.473 . . . . 64.12 114.971 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.3 157.79 18.07 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.304 -1.739 . . . . 65.21 106.304 177.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.98 150.53 35.66 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 105.936 -1.876 . . . . 74.43 105.936 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.3 139.17 26.89 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.188 -1.412 . . . . 73.22 107.188 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -148.92 164.22 35.16 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 126.158 1.783 . . . . 65.01 106.883 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -157.69 138.61 9.41 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 129.703 3.201 . . . . 72.34 103.528 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.92 152.21 68.43 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.507 1.471 . . . . 74.51 110.049 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.4 176.25 10.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.162 1.785 . . . . 70.34 107.874 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.2 tp -66.99 134.56 52.19 Favored 'General case' 0 CA--C 1.526 0.053 0 N-CA-C 107.884 -1.154 . . . . 35.03 107.884 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.33 167.34 20.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.797 1.639 . . . . 75.41 109.272 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -79.57 158.07 73.97 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.884 -0.784 . . . . 74.52 108.884 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.91 -176.61 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.749 2.3 . . . . 65.41 110.049 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.84 147.67 43.4 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 109.602 -1.399 . . . . 64.1 109.602 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 70.8 mtm -134.79 173.74 11.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.203 1.401 . . . . 75.53 108.704 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.31 119.17 10.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 100.847 -3.761 . . . . 61.22 100.847 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -123.8 175.61 6.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.846 0.459 . . . . 74.32 109.969 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.6 t -61.76 141.59 57.8 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.347 0.659 . . . . 71.23 109.57 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.9 p -73.37 -174.98 1.78 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.794 1.238 . . . . 75.44 109.602 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.2 m -62.58 153.74 6.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 O-C-N 121.041 -1.037 . . . . 50.22 109.873 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -130.55 -176.39 3.96 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.297 1.439 . . . . 61.04 109.521 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 t -70.77 163.72 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 122.007 0.908 . . . . 62.01 110.946 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.94 168.51 13.87 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 127.792 2.437 . . . . 52.42 107.779 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.04 -174.31 50.28 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 109.055 -1.618 . . . . 73.13 109.055 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -135.3 165.63 25.01 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.15 0.975 . . . . 72.44 109.706 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -148.87 -169.54 3.39 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.238 2.215 . . . . 74.45 105.893 178.119 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 52.8 26.42 4.54 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.281 1.832 . . . . 71.33 115.355 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -59.89 10.94 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 117.416 -1.278 . . . . 73.51 113.43 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.04 101.68 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.125 2.55 . . . . 73.53 107.557 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.64 173.78 16.33 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.645 1.178 . . . . 64.23 109.067 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.9 95.78 3.02 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.726 -1.212 . . . . 75.44 107.726 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.4 mt -56.51 145.03 61.55 Favored Pre-proline 0 C--O 1.234 0.262 0 N-CA-C 109.864 -0.421 . . . . 63.45 109.864 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.76 122.95 10.95 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.072 2.515 . . . . 61.21 111.664 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -112.28 147.74 35.64 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.641 1.177 . . . . 62.43 110.341 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -110.49 115.48 29.7 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.663 -1.236 . . . . 53.12 107.663 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.52 -28.24 69.51 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.851 0.75 . . . . 70.14 111.675 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 m -75.36 0.05 18.17 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.514 1.126 . . . . 71.21 111.471 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -117.64 5.76 12.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.107 1.363 . . . . 74.32 113.305 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.435 HD22 ' CD2' ' A' ' 74' ' ' HIS . 6.1 mt -107.87 176.0 5.29 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.732 -1.21 . . . . 73.32 107.732 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -138.6 112.46 8.43 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.124 0.57 . . . . 63.44 109.661 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 157.26 17.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.003 -1.48 . . . . 73.54 107.003 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -142.04 -179.67 6.36 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.733 -1.21 . . . . 63.43 107.733 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.04 162.97 27.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.844 1.258 . . . . 64.4 108.476 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.8 t -149.1 141.72 17.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.64 1.576 . . . . 74.45 108.909 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -114.71 -68.12 0.95 Allowed 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 104.661 -2.348 . . . . 65.25 104.661 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.47 136.41 4.21 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 107.532 -2.227 . . . . 73.12 107.532 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -159.1 -46.94 0.06 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.635 1.174 . . . . 64.1 109.712 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -105.33 -174.26 24.18 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.137 1.351 . . . . 53.45 110.914 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.92 3.68 1.84 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.415 3.41 . . . . 73.23 114.584 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.86 -149.05 34.52 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 110.663 -0.975 . . . . 44.41 110.663 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.11 25.96 25.98 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.997 -1.241 . . . . 73.1 109.997 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 54.75 45.55 26.46 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.11 1.364 . . . . 74.54 109.827 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -149.12 97.85 2.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.502 2.321 . . . . 73.41 105.659 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.81 76.9 2.75 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.457 1.503 . . . . 73.42 109.006 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -79.87 170.46 16.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.728 0.811 . . . . 24.02 110.577 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -83.87 -55.96 3.96 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 106.228 -1.767 . . . . 75.14 106.228 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 m -65.33 -38.5 90.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.989 1.316 . . . . 63.25 112.894 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 m 47.03 40.95 10.37 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.859 0.864 . . . . 70.05 110.919 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -70.47 125.26 26.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.098 -1.001 . . . . 72.35 108.697 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.7 p -156.67 103.71 2.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.906 -1.516 . . . . 62.44 106.906 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.0 t -94.38 158.73 2.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.16 -1.052 . . . . 73.13 108.16 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.02 146.35 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.49 1.116 . . . . 64.42 109.751 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.4 tp -146.12 149.7 34.52 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.447 1.499 . . . . 72.35 108.407 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -140.27 148.38 41.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.052 1.341 . . . . 74.15 109.812 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.435 ' CD2' HD22 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -100.02 126.06 46.16 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.564 1.546 . . . . 74.13 107.547 178.619 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.8 -56.1 5.01 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 118.084 -0.96 . . . . 54.41 111.511 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.31 -8.14 22.19 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.093 1.862 . . . . 64.54 116.081 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -120.73 -9.97 9.25 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.093 0.861 . . . . 64.31 112.614 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.78 4.14 9.71 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.518 -1.157 . . . . 32.13 115.132 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.1 mt -70.28 141.92 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 126.187 1.795 . . . . 75.33 107.746 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.6 148.08 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.745 1.218 . . . . 35.02 108.382 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.3 151.76 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.249 -0.648 . . . . 73.35 109.249 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -132.42 107.98 8.86 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.02 -1.474 . . . . 72.32 107.02 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.3 m -123.6 153.33 40.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 122.475 1.131 . . . . 60.42 112.869 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -154.3 148.41 25.81 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.909 2.084 . . . . 72.32 107.521 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -162.46 -26.79 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.159 0.983 . . . . 53.21 110.784 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.5 p -138.34 158.1 44.94 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.782 -0.574 . . . . 51.11 110.924 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -22.51 66.94 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.643 -0.661 . . . . 63.54 111.847 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -79.54 116.81 19.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.21 1.804 . . . . 63.54 112.217 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.4 p -58.72 -40.78 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.38 0.672 . . . . 44.32 110.162 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -58.72 -46.92 86.28 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.918 0.887 . . . . 61.55 111.425 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -65.06 -44.12 90.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.564 1.145 . . . . 70.54 109.837 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -61.36 -40.42 94.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.997 0.362 . . . . 64.11 110.353 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -59.09 -38.87 80.52 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.134 -0.936 . . . . 72.23 111.028 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -59.77 -48.22 82.54 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.383 0.992 . . . . 74.12 109.287 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.1 -48.2 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 123.844 0.858 . . . . 40.14 109.397 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.47 82.37 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.177 0.591 . . . . 74.1 110.343 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -62.39 -45.35 93.56 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.055 0.542 . . . . 64.43 110.12 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -55.65 -61.65 2.21 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.138 0.975 . . . . 74.23 109.202 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.73 -34.45 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.655 0.613 . . . . 73.13 112.655 -177.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.0 -47.78 81.64 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.032 0.933 . . . . 51.44 109.12 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -52.13 -41.41 62.5 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.937 0.895 . . . . 62.53 113.17 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.5 -33.15 75.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.609 0.719 . . . . 64.11 110.738 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -73.59 -34.45 65.08 Favored 'General case' 0 C--N 1.335 -0.053 0 O-C-N 121.355 -0.841 . . . . 73.11 110.137 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.1 t -68.07 -43.41 85.3 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 CA-C-O 118.354 -0.831 . . . . 71.2 109.112 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -50.28 -60.76 2.66 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.391 1.077 . . . . 74.25 109.604 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.96 -29.25 46.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-O 118.601 -0.714 . . . . 74.32 111.737 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -69.56 -38.79 77.56 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 120.104 1.32 . . . . 74.34 110.93 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -73.76 -56.08 5.43 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.472 -0.936 . . . . 74.54 108.472 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -67.82 -21.33 65.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 115.202 1.556 . . . . 53.33 115.202 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.9 t -142.03 76.07 1.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.708 1.603 . . . . 71.24 107.665 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.14 167.23 51.85 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 114.784 -1.098 . . . . 74.02 111.576 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.43 6.9 3.68 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.629 2.886 . . . . 72.43 113.161 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.7 p -144.17 -176.33 4.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.718 1.607 . . . . 60.02 109.681 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.5 m 57.92 15.47 3.11 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.261 1.949 . . . . 53.25 116.261 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 N-CA-C 108.46 -1.856 . . . . 33.42 108.46 -179.799 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.655 0 N-CA-C 110.575 -1.01 . . . . 63.02 110.575 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -91.84 72.93 5.72 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 124.33 1.052 . . . . 73.15 109.062 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.41 -11.02 59.04 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.444 0.905 . . . . 61.3 113.444 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.82 -58.48 3.04 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 125.504 1.526 . . . . 72.43 113.09 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.3 t 47.32 15.58 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.227 2.211 . . . . 53.23 116.411 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.1 m -93.44 174.03 7.41 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.477 1.111 . . . . 71.34 109.465 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.19 155.82 25.3 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.715 -1.354 . . . . 50.23 109.715 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -93.54 126.25 38.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 123.55 0.74 . . . . 73.2 109.006 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -149.5 -176.2 5.3 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.041 1.736 . . . . 63.5 107.681 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.96 -177.28 29.01 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.212 -1.555 . . . . 64.31 109.212 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.93 171.94 7.46 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.42 1.088 . . . . 70.5 108.375 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -136.25 101.45 4.69 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 108.517 -0.92 . . . . 74.23 108.517 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.48 HD13 ' H ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -159.26 150.08 19.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 105.763 -1.94 . . . . 51.34 105.763 178.813 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.48 ' H ' HD13 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -161.83 150.72 15.63 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 126.315 1.846 . . . . 73.51 106.534 179.36 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -86.37 170.26 12.18 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.787 -0.365 . . . . 54.51 111.308 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -112.43 155.18 44.1 Favored Pre-proline 0 CA--C 1.528 0.102 0 C-N-CA 124.495 1.118 . . . . 72.5 110.181 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.3 97.54 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.213 2.609 . . . . 74.2 106.867 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.95 -174.65 4.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.053 1.341 . . . . 61.41 109.923 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 tt -65.06 107.86 1.65 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 106.821 -1.548 . . . . 70.0 106.821 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -61.76 155.87 21.83 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.685 0.794 . . . . 65.21 112.169 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.25 152.72 92.37 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.125 -0.694 . . . . 74.34 109.125 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.68 3.8 5.13 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.448 2.765 . . . . 63.3 113.358 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.04 179.43 48.07 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.186 -1.966 . . . . 62.44 108.186 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 92.8 mtp -141.45 172.1 13.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.828 1.251 . . . . 71.51 107.975 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.48 144.69 25.54 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 101.571 -3.492 . . . . 61.5 101.571 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.58 173.52 11.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.314 -0.625 . . . . 74.01 109.314 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.4 t -77.35 179.53 6.37 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.343 -0.984 . . . . 63.12 108.343 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 m -142.38 150.04 40.17 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 106.803 -1.554 . . . . 74.23 106.803 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -66.33 169.95 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 123.75 0.82 . . . . 51.25 110.115 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -123.29 166.67 14.89 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.996 0.919 . . . . 73.24 108.814 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.9 m -112.13 -168.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.236 1.415 . . . . 71.33 108.506 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.49 -19.32 13.28 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.066 -0.493 . . . . 54.45 111.103 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.0 -107.68 2.11 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.164 -1.574 . . . . 33.33 109.164 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.18 151.86 4.77 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 125.942 1.697 . . . . 74.41 111.209 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -156.24 65.04 0.56 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 127.066 2.147 . . . . 54.11 105.695 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -165.62 23.54 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.898 0.479 . . . . 71.12 111.862 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -67.04 0.51 Allowed Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.191 1.796 . . . . 73.11 115.108 -177.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.41 99.16 0.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.48 2.12 . . . . 53.34 109.158 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.23 -170.01 2.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.029 2.132 . . . . 74.12 107.366 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.7 mt -91.15 110.49 21.76 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 103.047 -2.946 . . . . 71.54 103.047 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -82.45 155.48 68.93 Favored Pre-proline 0 C--N 1.322 -0.609 0 C-N-CA 123.531 0.732 . . . . 61.12 109.635 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.51 165.85 29.73 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.896 2.397 . . . . 71.2 113.696 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.605 HD12 ' C ' ' A' ' 43' ' ' LEU 0.423 0.2 OUTLIER -134.86 166.09 23.79 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.4 1.88 . . . . 72.51 111.541 179.801 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -120.16 101.56 7.91 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.103 -1.073 . . . . 71.34 108.103 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -67.28 -11.95 58.85 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.931 1.085 . . . . 75.12 113.931 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -0.66 57.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.159 1.384 . . . . 41.53 112.726 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -126.16 32.61 5.19 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.852 1.261 . . . . 73.03 109.757 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.1 mt -113.79 117.25 30.94 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.736 1.215 . . . . 63.4 108.036 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -102.76 103.95 14.22 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 104.802 -2.295 . . . . 74.12 104.802 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -84.63 163.78 19.06 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.537 1.062 . . . . 74.45 108.945 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -120.52 129.03 53.64 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.206 -1.776 . . . . 71.51 106.206 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -87.41 143.27 27.32 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.422 -0.955 . . . . 74.23 108.422 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.46 110.0 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 105.565 -2.013 . . . . 51.4 105.565 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -110.69 -7.8 14.64 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.73 0.812 . . . . 74.23 112.636 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.43 -152.0 10.28 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 108.431 -1.867 . . . . 74.53 108.431 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.7 t60 50.95 49.35 21.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.887 1.275 . . . . 71.13 111.025 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.72 160.87 53.81 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.153 -1.579 . . . . 74.32 109.153 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -78.13 30.49 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.724 3.616 . . . . 74.25 111.97 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.47 -173.16 49.61 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 109.885 -1.286 . . . . 71.35 109.885 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.7 -103.96 0.3 Allowed Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.667 -0.973 . . . . 63.51 110.667 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -79.0 166.28 22.52 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.682 0.753 . . . . 71.05 110.634 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.03 -5.19 16.15 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.605 1.162 . . . . 74.22 114.061 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.4 p -139.71 158.52 43.97 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 120.057 1.299 . . . . 52.43 108.66 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -126.88 28.05 5.89 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.615 1.966 . . . . 55.14 111.293 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -52.18 -41.97 63.06 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.224 0.61 . . . . 75.11 110.991 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -84.28 131.74 34.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.438 -2.06 . . . . 62.01 105.438 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.35 8.02 2.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.339 0.656 . . . . 73.3 112.694 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.464 HD21 ' N ' ' A' ' 89' ' ' VAL . 33.4 t-20 -84.61 107.35 16.78 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.866 -1.161 . . . . 71.02 107.866 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.0 t -141.64 138.04 32.25 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.25 1.82 . . . . 61.35 106.491 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.7 t -121.67 150.56 24.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.709 -1.589 . . . . 72.11 106.709 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -137.71 128.91 39.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 102.699 -3.075 . . . . 51.34 102.699 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.1 tp -130.51 143.92 51.07 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.062 0.945 . . . . 72.34 110.633 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.488 ' CB ' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -144.05 143.98 31.42 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.261 -0.899 . . . . 74.03 112.631 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.73 ' HB2' HD11 ' A' ' 100' ' ' LEU . 2.4 t-80 -86.4 121.0 28.34 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.266 -2.124 . . . . 74.03 105.266 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.44 -57.75 23.16 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.588 1.086 . . . . 53.13 112.123 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -59.33 -34.14 97.76 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.615 1.543 . . . . 54.32 114.905 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -93.66 -16.04 24.7 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.523 0.934 . . . . 74.03 113.523 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.07 23.83 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.565 1.555 . . . . 73.41 113.737 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.1 mt -70.27 120.82 18.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.049 -1.463 . . . . 71.12 107.049 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.488 HG22 ' CB ' ' A' ' 73' ' ' LYS . 69.7 t -111.23 128.51 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 126.385 1.874 . . . . 71.15 107.647 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.5 157.96 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 123.385 1.564 . . . . 60.45 108.018 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -141.28 139.68 33.72 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.877 -2.268 . . . . 63.24 104.877 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.7 t -138.65 163.69 31.45 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.224 -1.769 . . . . 61.22 106.224 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -155.09 149.22 25.89 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 104.848 -2.279 . . . . 52.24 104.848 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -170.98 -40.51 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.138 -0.458 . . . . 73.14 110.153 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 p -127.25 -177.45 4.07 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.399 0.619 . . . . 72.52 112.426 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.9 mtm-85 -103.77 -0.41 29.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.991 0.917 . . . . 75.25 110.943 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m -98.44 115.72 29.13 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.644 -1.243 . . . . 73.32 107.644 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.464 ' N ' HD21 ' A' ' 68' ' ' ASN . 7.6 p -55.97 -45.82 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 122.878 0.471 . . . . 74.35 109.82 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.63 -32.62 67.43 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.832 1.253 . . . . 71.43 112.618 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -82.13 -44.48 16.44 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 120.582 -1.324 . . . . 72.12 108.127 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -57.35 -36.8 71.64 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.593 0.757 . . . . 65.42 109.632 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -60.12 -51.19 70.67 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 118.144 -0.932 . . . . 64.2 109.604 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -64.58 -36.57 84.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.837 1.199 . . . . 51.21 112.482 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.62 -43.07 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.157 -0.683 . . . . 61.03 109.157 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.19 -38.11 87.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.046 0.538 . . . . 74.44 110.814 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.496 HH11 ' HG3' ' A' ' 97' ' ' ARG . 0.9 OUTLIER -57.6 -52.72 64.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.047 0.939 . . . . 75.14 111.858 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.78 97.37 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 119.379 -0.929 . . . . 62.34 112.524 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.83 -32.45 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 120.113 1.324 . . . . 71.15 111.388 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.73 HD11 ' HB2' ' A' ' 74' ' ' HIS . 9.1 tp -62.39 -40.29 95.98 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.523 -0.736 . . . . 75.1 109.447 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -57.44 -42.59 82.73 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.217 0.607 . . . . 72.34 110.097 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -61.11 -20.52 62.74 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.474 0.916 . . . . 71.11 113.474 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -87.54 -38.83 15.66 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.475 -0.766 . . . . 73.31 109.458 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.0 t -67.39 -31.98 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.479 -0.934 . . . . 70.13 108.479 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -52.93 -57.61 9.72 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.098 1.359 . . . . 72.25 108.116 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.34 -38.68 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.521 1.128 . . . . 74.25 109.375 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -62.85 -37.23 86.01 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.896 1.226 . . . . 74.24 110.449 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -75.79 -33.62 60.16 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.64 0.978 . . . . 73.25 113.64 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -108.33 -9.46 15.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 116.369 1.989 . . . . 75.35 116.369 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.1 t -148.31 33.93 0.8 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 126.569 1.948 . . . . 73.05 110.138 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.8 176.31 3.4 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.053 1.181 . . . . 22.13 116.053 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.4 -17.52 58.1 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.987 3.125 . . . . 75.14 111.605 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.06 98.64 3.68 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 102.869 -3.011 . . . . 50.54 102.869 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 p -136.39 29.92 2.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.765 1.226 . . . . 70.42 110.413 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 C-N-CA 125.709 1.623 . . . . 53.54 111.056 179.646 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.129 0 N-CA-C 109.104 -1.599 . . . . 54.11 109.104 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m -63.02 150.54 42.19 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.722 0.761 . . . . 62.21 110.142 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 t -167.87 174.82 7.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.102 1.761 . . . . 73.43 106.499 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.11 172.28 14.01 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.408 1.004 . . . . 72.42 110.944 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 p -157.09 167.3 30.82 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.399 1.48 . . . . 73.12 107.841 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 p -150.21 145.33 26.18 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.086 0.857 . . . . 72.14 110.684 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.27 171.92 31.42 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 108.022 -2.031 . . . . 60.23 108.022 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.06 164.28 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.862 1.665 . . . . 52.13 106.837 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -136.1 179.62 6.24 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.077 1.351 . . . . 73.15 108.972 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.69 166.58 23.48 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.4 -1.48 . . . . 44.02 109.4 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.7 mt -139.62 176.9 8.34 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.515 1.526 . . . . 62.12 108.127 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -109.15 138.38 45.58 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.261 -1.015 . . . . 72.32 108.261 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.91 158.02 17.07 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 104.96 -2.237 . . . . 61.32 104.96 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.05 171.46 19.27 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.008 0.923 . . . . 71.2 109.791 -178.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.61 -169.57 1.48 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.209 1.804 . . . . 71.32 112.057 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -139.15 152.76 70.44 Favored Pre-proline 0 CA--C 1.527 0.086 0 C-N-CA 125.13 1.372 . . . . 73.05 108.706 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.08 157.98 53.19 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.222 1.948 . . . . 72.11 110.904 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.84 -168.43 1.95 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.513 1.525 . . . . 64.45 109.638 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 pp -136.72 176.16 8.96 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.304 1.842 . . . . 74.31 108.769 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.6 mt -115.33 161.74 18.08 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.44 1.096 . . . . 64.23 109.778 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -75.2 155.24 86.22 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.851 0.86 . . . . 74.23 110.399 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.58 175.96 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.122 2.548 . . . . 74.05 110.586 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.59 163.02 53.47 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.031 -0.827 . . . . 71.22 111.031 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 95.6 mtp -73.46 163.92 27.38 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.088 0.555 . . . . 53.52 110.438 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.63 71.96 1.37 Allowed 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 105.546 -2.02 . . . . 65.23 105.546 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.49 -172.1 1.71 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.056 -0.975 . . . . 62.21 111.032 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.91 172.63 2.18 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.316 1.047 . . . . 62.3 110.434 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -130.05 177.36 7.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.634 1.174 . . . . 72.13 109.47 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 m -63.69 137.0 25.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.785 1.634 . . . . 72.1 108.672 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -132.36 -176.7 4.17 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.601 1.16 . . . . 65.12 111.531 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.2 t -54.84 151.87 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.235 1.814 . . . . 65.22 108.396 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.06 -167.08 1.14 Allowed 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.106 0.962 . . . . 64.43 109.573 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.49 -171.93 2.02 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.357 1.455 . . . . 62.03 113.034 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -132.24 170.64 14.74 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 123.417 0.687 . . . . 73.1 109.72 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -146.7 177.31 9.19 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.492 2.317 . . . . 71.35 105.819 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 44.04 61.83 2.19 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 125.904 1.682 . . . . 75.34 114.556 177.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.41 -59.25 1.65 Allowed Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.889 -1.053 . . . . 55.41 109.717 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.41 151.62 80.03 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.633 2.222 . . . . 41.33 111.86 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.04 160.49 42.97 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.72 2.008 . . . . 74.52 109.169 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.4 mt -71.43 94.13 1.23 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.13 0.572 . . . . 70.3 110.813 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -50.81 151.38 4.36 Favored Pre-proline 0 C--O 1.236 0.384 0 C-N-CA 125.228 1.411 . . . . 72.13 111.344 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.21 165.58 26.19 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.141 2.56 . . . . 54.33 112.211 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 43' ' ' LEU 0.413 0.2 OUTLIER -136.39 164.17 28.76 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 114.06 1.133 . . . . 74.25 114.06 -179.074 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -120.84 101.1 7.48 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 104.455 -2.424 . . . . 74.03 104.455 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.41 -14.17 25.98 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.417 1.087 . . . . 71.21 113.922 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -98.53 6.8 46.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.352 1.061 . . . . 74.52 110.8 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -120.13 23.93 10.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.328 1.451 . . . . 74.42 110.178 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 mt -113.41 145.9 40.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.545 1.538 . . . . 72.31 107.388 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -116.74 106.44 13.51 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.036 -2.209 . . . . 75.54 105.036 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -100.89 154.05 18.99 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.414 1.085 . . . . 70.31 113.019 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -144.93 169.89 17.2 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.962 -1.125 . . . . 71.44 107.962 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -121.27 133.74 55.15 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.946 -1.872 . . . . 72.54 105.946 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.5 t -86.26 133.57 29.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 107.315 -1.365 . . . . 54.33 107.315 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -136.72 162.87 31.99 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.822 2.049 . . . . 73.23 106.143 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.31 -152.97 51.13 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 109.55 -1.42 . . . . 31.13 109.55 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -135.09 169.05 18.03 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.467 1.507 . . . . 74.41 108.029 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.41 173.24 35.4 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.062 -1.215 . . . . 61.24 110.062 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -71.43 174.92 10.14 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.992 2.461 . . . . 52.51 112.457 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.86 30.1 32.98 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.269 -0.878 . . . . 55.23 111.258 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.68 162.63 35.07 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 127.823 2.63 . . . . 71.23 106.8 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -152.06 -69.79 0.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.811 0.806 . . . . 73.23 110.584 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.67 -30.2 65.26 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.835 0.68 . . . . 62.33 112.835 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.0 p -77.36 57.18 1.46 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.235 1.814 . . . . 70.2 110.06 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -43.22 -14.92 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 118.772 2.878 . . . . 72.42 118.772 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -120.11 -17.14 8.43 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.533 1.515 . . . . 74.34 114.109 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 47.54 -6.64 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 119.549 3.166 . . . . 73.43 119.549 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.9 p -54.97 -0.55 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 130.486 3.515 . . . . 64.11 119.574 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -133.14 -6.13 3.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.27 1.395 . . . . 75.44 112.476 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 55.6 m -67.17 142.1 57.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.082 0.856 . . . . 53.33 108.962 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.1 t -115.22 135.54 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.383 -2.081 . . . . 63.41 105.383 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.18 130.75 73.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 102.97 -2.974 . . . . 64.35 102.97 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.7 tp -139.01 151.58 46.93 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.123 0.569 . . . . 62.42 110.168 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 152.43 45.72 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 122.424 0.289 . . . . 52.33 110.458 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -95.61 122.95 38.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 103.326 -2.842 . . . . 75.2 103.326 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.48 -62.37 5.56 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 120.091 1.314 . . . . 60.22 112.017 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.6 -17.12 58.59 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.569 2.18 . . . . 63.45 115.581 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.21 -13.54 16.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.817 1.19 . . . . 75.45 110.665 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.41 -15.03 0.87 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.634 1.587 . . . . 61.15 115.498 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.1 mt -56.95 132.7 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.721 1.608 . . . . 73.3 110.851 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.2 t -124.14 138.39 53.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 126.868 2.067 . . . . 53.24 106.094 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.6 157.3 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.737 -0.468 . . . . 74.24 109.737 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -119.69 131.58 55.45 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 126.251 1.82 . . . . 75.51 109.134 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -141.24 153.61 45.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.186 0.994 . . . . 63.31 111.318 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -155.5 159.07 39.46 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 128.011 2.525 . . . . 64.55 107.356 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -161.8 -54.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.198 1.399 . . . . 73.12 108.321 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.47 179.13 6.22 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.89 0.853 . . . . 71.25 110.907 -178.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -13.23 62.28 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.753 0.821 . . . . 74.45 112.151 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.31 115.07 22.3 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.353 0.661 . . . . 72.15 112.777 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.82 -33.11 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.077 -1.453 . . . . 74.35 107.077 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.58 -38.36 84.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.178 1.791 . . . . 73.24 109.763 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.8 -52.29 9.79 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.683 -1.229 . . . . 64.35 107.683 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -52.8 -33.9 51.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.286 0.634 . . . . 73.23 110.104 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -59.26 -62.03 2.19 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.44 1.496 . . . . 73.4 108.19 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -62.67 -36.41 82.78 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 118.395 -0.812 . . . . 73.43 112.992 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.35 -51.44 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.245 -1.391 . . . . 71.22 107.245 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.54 -50.18 72.38 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.408 -0.59 . . . . 64.42 109.408 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -54.22 -39.93 67.19 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 118.035 -0.983 . . . . 64.31 112.164 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -44.6 47.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.288 -1.339 . . . . 71.51 110.831 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.16 -32.85 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.769 1.622 . . . . 52.12 112.256 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.5 tp -59.66 -35.8 75.14 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.485 -0.759 . . . . 71.3 109.434 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.76 -38.34 87.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.028 0.931 . . . . 73.1 109.479 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -68.12 -17.64 64.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.882 1.673 . . . . 64.14 111.136 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -97.17 -35.54 10.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.99 0.916 . . . . 65.14 109.001 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.5 t -69.16 -31.92 51.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.011 -1.107 . . . . 70.33 108.011 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -62.04 1.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.872 2.069 . . . . 61.21 109.174 177.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.64 -25.11 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 122.645 0.378 . . . . 61.42 111.475 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -77.77 -15.28 59.22 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.99 -1.069 . . . . 74.45 111.026 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -94.05 -42.31 9.09 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.045 1.338 . . . . 72.52 108.975 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -87.86 -14.58 39.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.781 1.03 . . . . 52.44 113.781 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.5 t -146.97 -172.08 3.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.954 1.702 . . . . 74.12 108.049 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 158.3 -177.12 35.12 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.043 -1.223 . . . . 64.45 110.043 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.57 -44.89 2.77 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 121.9 1.733 . . . . 73.33 108.043 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -83.3 171.2 13.81 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.08 2.152 . . . . 75.13 109.45 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -155.74 130.55 9.19 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.343 -1.725 . . . . 73.21 106.343 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 N-CA-C 108.929 -1.668 . . . . 32.34 108.929 -179.829 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.071 0 N-CA-C 108.312 -1.915 . . . . 73.31 108.312 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m -139.91 152.25 46.25 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.394 -1.336 . . . . 74.14 107.394 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 p -73.4 -44.69 57.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.252 1.021 . . . . 74.04 110.424 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.65 170.66 30.88 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 108.636 -1.786 . . . . 71.32 108.636 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 m -49.52 -39.81 35.57 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.895 1.278 . . . . 73.32 112.639 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.3 m 55.36 -27.03 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 129.201 3.0 . . . . 71.34 119.051 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.75 147.39 46.33 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 120.068 1.304 . . . . 52.32 111.957 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -150.41 160.19 43.93 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 127.694 2.398 . . . . 73.13 106.199 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -98.58 162.36 13.18 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.307 -0.997 . . . . 73.4 108.307 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.66 98.6 0.88 Allowed Glycine 0 C--N 1.333 0.378 0 N-CA-C 109.209 -1.557 . . . . 74.43 109.209 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.8 mt -66.21 152.09 45.59 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.504 0.668 . . . . 74.41 109.357 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -77.27 124.44 27.85 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 107.312 -1.366 . . . . 71.4 107.312 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.58 156.1 18.04 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 104.883 -2.266 . . . . 74.02 104.883 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.44 178.59 6.03 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.37 1.868 . . . . 64.0 107.7 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.4 179.33 9.35 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.254 -1.017 . . . . 74.44 108.254 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 158.74 81.05 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.168 0.987 . . . . 65.04 109.957 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.74 169.53 21.75 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.976 1.784 . . . . 70.23 109.942 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.0 166.65 17.56 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.239 0.616 . . . . 72.32 110.664 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.62 172.1 7.9 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.776 1.63 . . . . 75.23 108.575 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pp -130.73 178.87 6.32 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.762 2.025 . . . . 75.01 109.16 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -123.47 154.7 66.18 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 125.314 1.446 . . . . 64.34 109.651 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.66 169.07 22.5 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.84 2.36 . . . . 50.01 111.441 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.22 171.02 49.83 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.434 -1.066 . . . . 44.21 110.434 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.3 tpt -154.72 142.65 20.1 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.411 -1.7 . . . . 74.52 106.411 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.12 65.75 0.77 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.022 0.929 . . . . 74.43 108.569 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 154.08 30.66 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.965 -0.46 . . . . 55.54 110.587 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -71.8 152.97 42.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.046 -0.724 . . . . 61.24 109.046 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -85.89 -170.62 3.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.021 1.728 . . . . 64.2 111.01 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 t -70.79 154.22 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.203 1.401 . . . . 65.13 109.36 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -90.5 -178.16 5.25 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.945 0.879 . . . . 71.32 109.788 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.24 165.92 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.785 1.634 . . . . 75.34 108.395 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.57 169.72 17.13 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.943 1.697 . . . . 75.52 108.122 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.7 76.76 1.34 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 107.867 -2.093 . . . . 61.42 107.867 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -75.1 0.09 Allowed 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.102 -1.073 . . . . 71.23 108.102 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -174.94 143.32 0.71 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 129.483 3.113 . . . . 73.12 104.024 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 34.58 62.69 0.49 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 127.138 2.175 . . . . 73.1 112.551 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -66.12 -62.75 3.82 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 117.412 -1.28 . . . . 73.22 111.932 -179.348 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.6 105.74 0.96 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.092 2.528 . . . . 72.43 108.587 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.69 175.98 13.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.781 -0.575 . . . . 74.4 109.594 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.1 mt -73.13 87.62 1.42 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.203 -1.777 . . . . 64.22 106.203 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.9 mt -48.57 142.88 8.23 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 125.016 1.326 . . . . 72.45 111.279 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.21 99.11 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.197 2.598 . . . . 74.1 111.919 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.8 mt -89.86 133.35 34.79 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.951 1.3 . . . . 73.22 108.576 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -75.68 106.99 7.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.54 -0.911 . . . . 75.4 108.54 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -59.95 -9.86 3.48 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.003 1.483 . . . . 63.32 115.003 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -101.18 -14.23 17.81 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.036 1.334 . . . . 73.32 112.473 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -90.39 -4.11 57.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.849 1.26 . . . . 70.43 111.85 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mt -84.2 150.89 25.18 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.758 1.623 . . . . 74.1 113.722 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -103.45 105.69 16.01 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.519 1.128 . . . . 74.12 108.155 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -85.37 147.6 26.43 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.621 -1.252 . . . . 60.13 107.621 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.671 ' HB2' HG13 ' A' ' 71' ' ' VAL . 14.3 mm-40 -132.31 141.6 49.02 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.701 -1.222 . . . . 73.5 107.701 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -118.5 121.0 39.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.959 1.303 . . . . 73.32 108.621 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.89 131.38 35.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.033 -1.469 . . . . 60.34 107.033 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.17 164.16 29.87 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.228 1.411 . . . . 72.23 109.346 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.99 -82.86 1.08 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 106.536 -2.626 . . . . 53.02 106.536 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -146.04 168.67 20.37 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 127.806 2.442 . . . . 75.2 107.314 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -136.92 179.96 17.41 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.009 1.29 . . . . 53.02 111.193 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.45 ' HG3' ' HE2' ' A' ' 82' ' ' LYS . 97.3 Cg_endo -71.9 175.98 8.97 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.745 3.63 . . . . 75.0 111.842 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.43 -171.28 14.02 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.647 2.07 . . . . 33.12 110.305 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.38 15.69 62.69 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.505 1.05 . . . . 52.53 113.39 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.265 77.4 mm-40 56.72 -2.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 129.854 3.261 . . . . 74.11 116.627 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.96 -11.09 60.04 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.805 1.184 . . . . 72.23 109.06 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.2 p -127.61 122.2 32.5 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.399 1.879 . . . . 73.35 109.629 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -123.68 -14.05 7.34 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.547 1.539 . . . . 72.35 109.143 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -9.06 33.77 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.326 1.85 . . . . 63.31 112.549 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 p -106.86 14.81 26.2 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.825 1.65 . . . . 75.14 111.824 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 71.8 m -51.81 -19.36 1.65 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.137 1.532 . . . . 34.11 115.137 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -79.13 64.84 4.15 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 105.982 -1.858 . . . . 72.31 105.982 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.9 t -98.89 169.42 9.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.134 -0.979 . . . . 73.41 110.011 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 t -139.19 143.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 104.594 -2.372 . . . . 72.4 104.594 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.671 HG13 ' HB2' ' A' ' 51' ' ' GLN 0.258 9.6 p -137.63 124.86 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 101.729 -3.434 . . . . 64.51 101.729 177.582 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 tp -120.29 148.86 43.18 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.042 0.937 . . . . 64.22 108.987 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -138.69 129.07 25.87 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.25 1.02 . . . . 74.4 110.083 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -88.69 144.18 26.44 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.33 -2.1 . . . . 74.4 105.33 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.1 t -73.82 -71.6 0.21 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.776 -1.107 . . . . 70.14 112.465 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.31 -36.63 78.11 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.496 2.797 . . . . 73.01 113.526 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.9 t -77.96 -25.02 47.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.999 -0.28 . . . . 72.52 111.246 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.01 -0.08 6.51 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 119.189 -0.784 . . . . 70.04 113.435 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.7 mt -68.37 137.88 23.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 119.113 1.457 . . . . 73.25 107.22 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.4 t -131.6 139.74 49.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 106.872 -1.529 . . . . 73.15 106.872 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.61 147.14 16.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.91 -1.144 . . . . 53.34 107.91 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.45 ' HE2' ' HG3' ' A' ' 58' ' ' PRO . 5.8 ptpp? -123.22 127.97 49.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 125.401 1.48 . . . . 73.43 108.26 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 49.3 m -144.81 162.26 37.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.143 0.973 . . . . 72.14 110.896 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -155.07 156.16 35.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.362 2.265 . . . . 75.52 106.392 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -158.32 -74.4 0.08 Allowed 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 105.729 -1.952 . . . . 62.52 105.729 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.2 p -83.13 -179.3 7.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.942 0.877 . . . . 73.24 109.559 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -96.68 1.09 50.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.389 0.675 . . . . 74.0 109.314 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.6 m -96.72 115.47 27.49 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.974 1.31 . . . . 74.41 108.006 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.8 p -57.35 -42.58 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 109.506 -0.553 . . . . 63.02 109.506 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.64 -47.3 84.86 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.004 0.921 . . . . 64.21 112.196 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -67.72 -32.92 73.88 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.748 -0.595 . . . . 74.13 109.402 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -71.49 -29.25 64.6 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.24 -0.913 . . . . 75.05 109.204 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -63.15 -48.78 77.01 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.805 1.184 . . . . 74.12 109.869 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -57.82 -38.47 75.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.926 0.785 . . . . 65.34 112.051 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.69 -49.2 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.05 -1.093 . . . . 50.15 108.05 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.39 -47.04 86.96 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.927 0.891 . . . . 51.32 110.785 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -60.0 -45.53 92.43 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.644 0.778 . . . . 71.12 109.706 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -51.03 71.49 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.208 0.603 . . . . 72.04 110.72 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.58 -32.47 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.732 0.697 . . . . 74.34 110.909 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.1 tp -63.72 -40.3 96.41 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 120.616 -1.302 . . . . 64.55 110.187 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -54.5 -40.1 68.22 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.058 1.343 . . . . 75.24 111.95 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.95 -36.53 83.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.372 1.069 . . . . 74.0 111.503 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -76.45 -42.08 45.12 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.93 -0.481 . . . . 74.13 110.21 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.2 -32.26 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 118.609 -0.71 . . . . 64.12 110.442 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -58.68 -56.31 23.83 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.862 1.21 . . . . 72.23 108.252 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 68.3 t -58.45 -28.38 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.241 1.016 . . . . 65.52 110.745 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -74.35 -18.36 60.69 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.156 -0.965 . . . . 51.31 112.256 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -99.35 -49.89 4.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.294 1.438 . . . . 74.41 110.322 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -71.68 -16.51 62.24 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.015 0.746 . . . . 74.35 113.015 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.8 t -142.48 175.5 9.74 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.693 2.797 . . . . 54.21 106.99 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 138.94 -78.17 0.31 Allowed Glycine 0 C--N 1.335 0.499 0 O-C-N 120.748 -1.22 . . . . 64.21 110.827 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.36 162.15 40.02 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.093 2.529 . . . . 74.3 109.254 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.72 80.73 1.83 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.455 -0.943 . . . . 74.44 108.455 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.3 p -83.28 162.89 21.01 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.556 -1.646 . . . . 64.21 106.556 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 N-CA-C 108.663 -1.775 . . . . 73.04 108.663 179.426 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.204 0 N-CA-C 109.116 -1.593 . . . . 33.22 109.116 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 t -155.03 176.08 13.0 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 106.586 -1.635 . . . . 73.2 106.586 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 t -159.69 169.37 23.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.546 1.539 . . . . 55.53 107.388 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.99 168.48 18.97 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.005 -1.238 . . . . 75.44 110.005 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.0 m -139.85 159.15 42.82 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.25 1.42 . . . . 71.35 107.91 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 p -155.52 159.82 40.04 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 121.608 -0.682 . . . . 72.1 109.639 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.42 92.07 1.64 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 106.904 -2.478 . . . . 53.34 106.904 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.37 80.55 0.37 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.108 0.963 . . . . 72.31 110.053 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -65.53 -175.98 0.3 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.34 2.256 . . . . 75.31 112.341 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.8 173.35 33.84 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 120.808 -1.183 . . . . 50.4 110.278 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.81 171.42 7.65 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.781 1.233 . . . . 63.3 109.401 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.4 126.28 46.51 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 105.734 -1.95 . . . . 73.44 105.734 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.31 179.48 7.06 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.785 1.634 . . . . 55.53 107.296 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -165.27 -175.5 3.65 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.48 1.512 . . . . 74.31 108.694 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.48 -171.42 2.14 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.632 1.573 . . . . 75.13 110.912 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -78.31 155.47 79.28 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.575 0.75 . . . . 63.4 109.493 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.38 167.61 21.85 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.867 1.711 . . . . 71.45 110.11 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.36 156.36 16.0 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.752 -0.658 . . . . 72.43 110.684 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 168.79 18.14 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.809 1.644 . . . . 43.55 109.595 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 99.3 mt -86.0 164.48 17.36 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.557 0.743 . . . . 64.3 110.162 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -67.01 155.18 90.89 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.427 0.691 . . . . 72.52 110.082 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.11 176.84 9.0 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.932 2.422 . . . . 73.4 110.936 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.51 172.07 32.26 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 121.741 0.634 . . . . 71.43 111.526 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -58.55 135.39 57.31 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.312 1.045 . . . . 74.22 109.395 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.19 30.01 4.58 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.225 1.41 . . . . 42.35 110.136 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.31 175.7 2.09 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.264 1.026 . . . . 64.41 109.865 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.6 t -87.76 170.59 11.09 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.98 -1.075 . . . . 73.24 108.954 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.0 m -139.83 146.28 39.17 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.646 -1.242 . . . . 74.24 107.646 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 t -68.57 133.33 31.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 125.427 1.491 . . . . 54.44 111.546 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -75.66 154.66 36.42 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.206 -1.035 . . . . 62.35 108.206 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.5 t -72.53 146.67 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.963 -1.086 . . . . 74.51 108.42 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.76 166.47 23.21 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.487 1.515 . . . . 65.22 107.75 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -136.43 73.23 0.44 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 123.931 0.777 . . . . 43.34 111.447 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 -146.14 168.73 20.27 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 124.593 1.157 . . . . 71.23 109.483 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -147.54 -178.44 6.25 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 127.338 2.255 . . . . 73.03 108.462 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 52.59 38.37 25.68 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.191 2.197 . . . . 71.23 116.247 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -64.4 3.08 Favored Pre-proline 0 CA--C 1.537 0.448 0 O-C-N 121.212 -0.93 . . . . 62.53 113.487 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.07 133.27 24.62 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.137 1.891 . . . . 71.31 110.781 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.14 173.18 3.96 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.882 0.739 . . . . 55.23 110.025 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.9 mt 53.23 82.0 0.08 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 127.657 2.383 . . . . 70.13 111.237 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.8 154.73 87.11 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 109.616 -0.512 . . . . 50.13 109.616 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.82 147.94 57.11 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.436 2.091 . . . . 75.13 109.702 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.526 HD12 ' C ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -148.62 138.35 22.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.161 -1.051 . . . . 64.0 108.161 -179.419 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -91.9 111.01 22.38 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.488 1.515 . . . . 64.44 111.544 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -66.65 -25.92 66.81 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.964 1.706 . . . . 75.1 113.245 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -80.01 -11.19 59.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.423 1.01 . . . . 71.3 112.096 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -101.02 9.89 41.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.449 1.1 . . . . 75.2 111.315 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.3 175.82 5.58 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.359 -0.838 . . . . 64.2 112.847 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -125.38 135.63 52.61 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.424 2.29 . . . . 63.05 106.038 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -126.72 166.28 17.68 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.134 1.374 . . . . 72.32 111.464 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -137.66 177.51 7.81 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.025 1.33 . . . . 64.0 108.658 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -135.07 163.6 29.54 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.81 2.044 . . . . 72.4 107.256 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.38 117.09 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.479 -1.675 . . . . 63.33 106.479 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.48 11.17 38.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.41 1.084 . . . . 64.12 110.868 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.43 89.16 2.1 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 105.493 -3.043 . . . . 75.45 105.493 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -127.05 20.56 6.92 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.926 1.29 . . . . 73.22 110.754 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.27 170.7 38.54 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 128.537 2.97 . . . . 73.31 106.586 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.94 160.66 47.1 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.112 1.875 . . . . 60.22 110.519 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.69 -62.59 2.01 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 108.757 -1.737 . . . . 45.23 108.757 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.54 -59.78 1.6 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.879 1.704 . . . . 61.22 113.283 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -42.91 103.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 128.968 2.907 . . . . 74.52 110.32 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 47.82 34.94 4.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.977 1.311 . . . . 72.32 112.291 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.9 p 52.39 36.64 20.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.179 1.392 . . . . 42.13 111.533 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -51.65 100.82 0.03 OUTLIER 'General case' 0 C--N 1.342 0.241 0 C-N-CA 125.431 1.492 . . . . 53.21 112.723 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -66.94 -10.77 52.65 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.801 0.841 . . . . 71.15 111.514 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.3 p -122.16 123.56 41.8 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 106.189 -1.782 . . . . 71.33 106.189 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 m -72.59 45.66 0.14 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.294 1.837 . . . . 72.4 113.824 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -67.16 92.29 0.25 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.132 -0.98 . . . . 71.03 109.395 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.3 p -150.18 154.73 38.51 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.693 -1.254 . . . . 71.41 107.939 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.3 152.49 27.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 123.813 0.845 . . . . 74.34 109.325 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.59 141.65 42.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.221 -1.399 . . . . 62.35 107.221 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.9 tp -129.03 154.6 46.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.495 0.718 . . . . 72.02 110.798 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 75' ' ' VAL . 1.5 tmtp? -143.71 155.59 44.26 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.369 1.068 . . . . 62.51 108.183 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -122.24 120.43 34.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.687 -1.968 . . . . 74.3 105.687 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.473 ' HA ' ' HE2' ' A' ' 73' ' ' LYS . 39.7 t -66.26 -56.46 16.1 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.746 1.218 . . . . 62.22 111.884 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.66 -12.96 38.0 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.634 2.222 . . . . 72.23 115.709 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 t -113.64 -16.44 12.34 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.846 0.748 . . . . 71.15 110.453 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.56 9.39 37.72 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.591 1.091 . . . . 52.44 113.662 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.8 mt -79.89 145.86 8.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.482 1.113 . . . . 74.21 108.283 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 t -131.3 143.69 39.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.103 -1.814 . . . . 74.34 106.103 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -146.95 155.06 11.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.283 -0.636 . . . . 74.12 109.283 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.87 133.23 41.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.415 -0.957 . . . . 73.14 108.415 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.98 160.35 41.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.153 0.981 . . . . 72.33 111.163 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -155.52 134.37 12.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.425 2.29 . . . . 75.44 106.001 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -153.13 -51.43 0.1 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.724 -0.843 . . . . 74.21 108.724 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.8 p -109.62 170.88 7.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.352 1.032 . . . . 62.03 110.825 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -92.38 -16.74 25.57 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.156 0.982 . . . . 61.22 108.901 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -78.94 115.79 18.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.495 -0.928 . . . . 61.32 108.495 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.2 p -62.96 -37.73 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.642 -1.244 . . . . 62.43 107.642 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.79 -49.62 72.69 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.664 1.586 . . . . 52.01 108.718 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.3 -48.24 62.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.655 0.782 . . . . 74.52 110.949 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -52.74 -38.05 60.29 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.753 0.821 . . . . 75.2 111.243 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -54.86 -48.45 72.89 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.823 0.738 . . . . 75.5 109.335 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -64.0 -37.2 86.54 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.517 -0.739 . . . . 70.44 111.389 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.3 mt -63.66 -47.31 91.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.362 -0.977 . . . . 73.53 108.362 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.88 97.77 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.206 0.602 . . . . 74.44 109.894 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -57.39 -44.58 84.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.838 0.855 . . . . 73.12 109.82 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.7 -55.57 33.09 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.409 0.684 . . . . 72.44 110.237 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.47 -23.8 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 113.677 0.992 . . . . 74.44 113.677 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.5 tp -70.38 -38.7 74.76 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.561 -1.337 . . . . 74.54 110.626 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -55.15 -47.92 74.42 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.756 1.222 . . . . 54.14 114.014 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.75 -28.73 70.17 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.372 0.669 . . . . 74.12 111.509 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -77.42 -35.96 53.63 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.236 -0.915 . . . . 62.14 110.115 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.1 t -67.07 -33.99 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.151 -1.055 . . . . 54.25 108.151 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -56.59 -47.23 80.02 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.889 1.222 . . . . 71.45 108.894 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.64 -15.14 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.555 1.142 . . . . 74.44 111.891 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -82.49 -22.19 35.21 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.759 -1.213 . . . . 71.43 109.7 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -96.85 -53.29 3.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.301 1.441 . . . . 74.22 109.825 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -72.45 -16.41 61.82 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.634 0.605 . . . . 63.42 112.634 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.75 -156.62 0.7 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.587 1.955 . . . . 74.54 106.796 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.3 166.76 11.98 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 119.943 1.247 . . . . 60.11 110.615 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.08 -31.54 90.86 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.628 2.219 . . . . 61.12 111.877 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.4 t -67.92 -30.23 69.5 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.467 0.707 . . . . 73.21 110.553 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.0 t -94.04 -33.35 13.43 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.996 1.319 . . . . 74.33 113.385 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.847 0 CA-C-O 116.238 -2.423 . . . . 64.52 109.128 -178.897 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.146 0 N-CA-C 108.637 -1.785 . . . . 74.32 108.637 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 m -138.6 168.93 18.73 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.966 -1.124 . . . . 64.43 107.966 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.4 t -158.15 172.4 18.47 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.788 -1.189 . . . . 61.22 107.788 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.65 168.25 25.36 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 127.095 2.283 . . . . 75.45 107.847 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.1 p -159.22 165.81 32.79 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.547 1.173 . . . . 61.55 109.981 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.4 t -99.56 65.32 1.36 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.31 -1.737 . . . . 33.41 106.31 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.25 71.82 0.45 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 126.375 1.94 . . . . 73.11 112.441 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -85.01 142.33 29.68 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.749 -1.204 . . . . 75.04 107.749 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -151.26 177.57 10.1 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.849 1.66 . . . . 73.24 106.663 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.53 170.91 41.23 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.566 -1.414 . . . . 62.32 109.566 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 mp -83.63 160.87 21.29 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.664 -0.865 . . . . 62.45 108.664 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.0 tpt85 -111.62 131.04 55.54 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 104.943 -2.243 . . . . 75.12 104.943 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.2 152.65 20.78 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 105.824 -1.917 . . . . 75.31 105.824 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.05 -171.01 1.07 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 128.558 2.743 . . . . 73.2 105.592 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -143.34 158.58 43.52 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.515 -0.92 . . . . 74.4 108.515 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -63.07 152.47 83.93 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 128.318 2.647 . . . . 75.42 111.197 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.25 146.73 28.63 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.393 2.062 . . . . 74.01 108.96 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.06 127.86 32.54 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.87 -0.789 . . . . 73.24 108.87 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -83.94 171.13 13.3 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.153 0.581 . . . . 74.32 109.943 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -127.57 177.36 6.82 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.573 1.549 . . . . 74.44 109.864 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -127.23 156.85 74.04 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.078 1.751 . . . . 73.12 109.125 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.33 168.77 24.03 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.793 2.328 . . . . 71.34 111.787 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.71 -87.63 0.86 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.714 -1.355 . . . . 43.41 109.714 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.2 tpt -146.57 160.83 41.64 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.628 1.171 . . . . 73.14 107.896 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.54 61.73 1.15 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.304 1.041 . . . . 75.13 109.772 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.08 150.75 38.76 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.87 -0.789 . . . . 53.4 108.87 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.6 t -79.18 -178.98 6.46 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.772 0.796 . . . . 72.52 110.668 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 m -112.38 156.67 22.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.218 1.807 . . . . 64.52 106.914 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.7 t -118.11 159.53 18.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.302 -1.37 . . . . 72.24 107.302 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -102.66 138.77 39.13 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.513 -1.292 . . . . 71.43 107.513 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.01 146.75 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 122.006 0.908 . . . . 71.54 110.35 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.27 170.91 9.71 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 129.322 3.049 . . . . 60.01 106.342 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.16 -151.7 23.45 Favored Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 108.319 -1.912 . . . . 72.34 108.319 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.508 ' HD2' ' H ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -64.38 178.04 0.78 Allowed 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.755 0.788 . . . . 72.12 110.099 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -148.56 178.15 8.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.941 -1.503 . . . . 60.33 106.941 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 40.13 54.96 2.73 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.715 2.006 . . . . 74.12 113.172 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.57 -59.65 10.14 Favored Pre-proline 0 C--O 1.236 0.345 0 O-C-N 120.399 -1.438 . . . . 70.15 112.856 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -69.1 -176.08 1.19 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.85 2.367 . . . . 71.24 108.669 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.96 172.03 13.37 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.434 -0.791 . . . . 71.22 109.716 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.6 mt 48.84 68.12 0.76 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.706 2.402 . . . . 64.34 111.355 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 74.5 mt -49.07 147.26 5.03 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 124.653 1.181 . . . . 75.41 111.79 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.26 150.68 59.53 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.145 2.564 . . . . 71.33 109.314 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 43' ' ' LEU 0.576 0.2 OUTLIER -122.6 150.86 42.07 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.329 -0.857 . . . . 73.2 112.074 179.854 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -94.56 107.77 19.75 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.529 1.532 . . . . 73.13 112.034 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -70.16 -19.26 63.21 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.601 0.963 . . . . 63.23 113.601 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.5 m -87.95 10.36 19.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.325 1.45 . . . . 75.11 112.015 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -128.12 -1.52 5.79 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.5 1.12 . . . . 74.31 111.55 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -103.42 160.68 14.5 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.917 -1.142 . . . . 61.41 107.917 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -103.83 156.28 17.95 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 126.46 1.904 . . . . 73.05 108.126 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.71 136.5 53.91 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.582 -0.896 . . . . 70.32 108.582 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -152.25 156.55 39.92 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.187 0.994 . . . . 74.44 111.004 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -135.55 164.36 28.0 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 127.037 2.135 . . . . 62.15 109.679 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -130.93 106.72 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 102.816 -3.031 . . . . 74.04 102.816 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -85.6 -21.41 28.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.452 -1.249 . . . . 64.4 112.178 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.21 170.91 43.66 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.198 -1.161 . . . . 53.41 110.198 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -93.12 -35.57 13.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.792 0.437 . . . . 53.41 110.901 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.78 -173.03 33.2 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 108.392 -1.883 . . . . 54.12 108.392 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.69 176.7 9.01 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.251 2.634 . . . . 43.32 110.091 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.71 174.06 17.1 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.766 -1.734 . . . . 64.42 108.766 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.3 -3.12 8.29 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 115.602 1.001 . . . . 71.1 115.602 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -157.91 -70.57 0.09 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.74 -1.948 . . . . 74.11 105.74 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.16 164.53 38.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.27 1.828 . . . . 71.23 106.882 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.6 m -158.52 142.28 15.33 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 105.819 -1.919 . . . . 71.13 105.819 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -134.4 92.93 2.99 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 106.98 -1.489 . . . . 74.42 106.98 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -152.25 80.52 1.25 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.078 -1.082 . . . . 55.34 108.078 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 p -73.3 169.09 17.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.023 0.929 . . . . 72.31 109.977 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 t -161.66 170.92 18.84 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.584 1.154 . . . . 74.23 108.367 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -121.7 31.89 6.09 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.874 1.669 . . . . 72.1 108.206 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.6 m -57.98 131.3 50.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.07 1.348 . . . . 45.44 112.176 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.1 t -122.53 136.3 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.116 -1.809 . . . . 53.45 106.116 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.84 153.24 29.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.132 -1.803 . . . . 62.22 106.132 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp -141.22 142.89 33.93 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.177 -1.416 . . . . 63.21 107.177 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -136.11 134.12 38.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.796 -1.557 . . . . 73.53 106.796 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -86.03 140.05 30.62 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.756 -1.202 . . . . 72.42 107.756 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.3 t -71.67 -62.18 1.79 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 120.394 1.452 . . . . 72.41 111.616 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -70.4 -8.7 24.22 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.247 2.631 . . . . 72.24 116.242 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.0 m -120.74 -13.32 8.71 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.673 0.67 . . . . 74.25 112.509 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.04 -13.59 0.34 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.502 1.525 . . . . 65.53 115.584 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.4 mt -49.06 123.39 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 128.058 2.543 . . . . 55.4 110.316 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.25 142.63 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.863 1.265 . . . . 53.45 109.961 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.24 150.52 22.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.439 1.496 . . . . 72.12 108.018 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -122.87 115.02 21.28 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.298 1.439 . . . . 74.42 108.392 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 77.0 m -124.62 136.5 53.98 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.435 1.016 . . . . 75.33 111.982 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -156.34 111.81 2.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.241 -1.763 . . . . 75.34 106.241 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -147.43 -68.26 0.25 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.208 -1.404 . . . . 74.35 107.208 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -70.74 147.22 49.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.998 0.427 . . . . 64.11 110.287 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -67.83 -26.35 66.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.154 -0.684 . . . . 74.41 109.154 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 m -79.27 115.63 19.04 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 126.519 1.928 . . . . 61.25 111.25 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.68 -32.91 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 107.605 -1.258 . . . . 52.11 107.605 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -37.03 70.24 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.415 0.686 . . . . 71.42 110.986 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -79.61 -48.19 14.18 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.879 1.272 . . . . 60.43 109.738 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -53.24 -36.12 60.72 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.913 0.778 . . . . 74.44 110.085 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -57.3 -54.29 48.51 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.142 0.977 . . . . 73.43 109.424 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -59.45 -41.15 88.97 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 118.274 -0.869 . . . . 70.22 110.499 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.7 -49.09 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 124.554 1.159 . . . . 74.23 108.872 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.17 -43.46 98.85 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.981 -0.449 . . . . 74.43 110.608 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.63 -49.85 73.55 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.814 0.445 . . . . 74.2 111.112 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -44.09 97.0 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 118.448 -0.787 . . . . 73.14 112.013 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.85 -36.88 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 119.645 1.111 . . . . 72.1 109.027 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.18 -39.01 88.56 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 118.616 -0.707 . . . . 74.24 110.496 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -59.21 -23.75 62.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.247 0.93 . . . . 60.14 111.933 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -78.45 -25.96 46.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.807 1.185 . . . . 73.03 109.506 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -82.0 -44.35 16.79 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.896 1.279 . . . . 64.12 110.963 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.2 t -58.79 -41.92 83.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 N-CA-C 108.335 -0.987 . . . . 72.52 108.335 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.19 -64.9 0.69 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.095 0.558 . . . . 73.41 111.809 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.43 -32.6 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.409 1.084 . . . . 65.04 111.095 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -67.29 -42.97 82.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.395 0.543 . . . . 70.11 109.775 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -67.79 -29.52 68.73 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.538 0.735 . . . . 71.23 109.501 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -79.56 -35.36 39.9 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.555 0.742 . . . . 75.23 111.62 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t -126.67 98.52 5.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.161 1.384 . . . . 75.42 111.908 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.88 58.45 0.26 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-O 118.031 -1.427 . . . . 61.33 115.153 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.7 -27.58 18.13 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 CA-C-N 121.201 2.5 . . . . 55.51 110.429 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.8 t -88.54 -4.85 58.51 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.34 -0.85 . . . . 74.53 109.864 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.9 m -103.09 173.81 6.14 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.085 1.354 . . . . 75.3 110.088 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 N-CA-C 103.172 -3.971 . . . . 62.14 103.172 -179.735 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.137 0 N-CA-C 109.005 -1.638 . . . . 74.24 109.005 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.8 m -137.53 173.01 12.11 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.378 1.071 . . . . 63.13 108.492 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.9 m -154.19 178.81 9.57 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.061 1.744 . . . . 70.32 107.502 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.66 62.85 2.34 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.526 1.06 . . . . 64.13 111.966 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 t -63.53 109.36 1.62 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.208 1.403 . . . . 62.43 107.944 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t -156.45 178.9 9.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.629 1.171 . . . . 74.11 108.394 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 154.24 113.26 0.49 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 108.236 -1.945 . . . . 54.23 108.236 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -148.54 140.28 23.69 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 105.784 -1.932 . . . . 60.24 105.784 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -149.09 166.16 29.58 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.792 1.237 . . . . 65.11 108.336 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.11 154.24 6.65 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 109.3 -1.52 . . . . 54.21 109.3 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.6 mt -149.47 154.95 39.6 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.564 1.546 . . . . 62.31 107.293 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.15 117.36 1.93 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.083 -1.821 . . . . 71.33 106.083 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.32 164.56 12.21 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.254 -1.388 . . . . 64.3 107.254 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.46 66.04 0.44 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.752 1.16 . . . . 72.13 114.03 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -85.23 177.47 7.84 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.723 0.773 . . . . 73.2 111.073 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -141.47 158.18 64.03 Favored Pre-proline 0 C--O 1.231 0.1 0 C-N-CA 124.378 1.071 . . . . 55.21 110.031 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.02 143.07 43.84 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.828 1.685 . . . . 75.23 108.065 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.48 154.29 38.76 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.081 -0.711 . . . . 51.31 109.081 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.6 tp -155.96 152.35 28.07 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.645 -1.613 . . . . 74.33 106.645 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.65 177.92 7.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.712 2.005 . . . . 70.14 108.041 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -125.48 152.4 71.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 125.04 1.336 . . . . 61.31 107.45 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.89 161.61 41.04 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.88 1.72 . . . . 54.3 109.92 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.56 165.49 20.63 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 108.021 -2.032 . . . . 42.11 108.021 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 42.5 ttm -144.69 130.91 19.55 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.548 -0.908 . . . . 64.01 108.548 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.9 58.99 0.92 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.576 -2.009 . . . . 72.31 105.576 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.27 178.21 7.57 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.548 1.139 . . . . 74.5 108.999 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.0 t -60.31 140.56 57.03 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.453 -1.314 . . . . 65.41 107.453 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 m -139.36 134.51 32.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.174 -1.788 . . . . 74.32 106.174 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.52 157.96 39.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.653 0.781 . . . . 75.1 109.272 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -144.61 172.91 12.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.159 1.383 . . . . 73.33 109.339 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.54 166.82 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.933 1.693 . . . . 72.01 107.828 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.04 175.24 9.75 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.658 1.183 . . . . 65.21 110.122 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -131.73 91.9 0.28 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.929 -1.268 . . . . 53.23 109.929 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -140.7 146.22 37.52 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.508 0.654 . . . . 64.11 109.71 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -150.4 23.07 0.82 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 127.0 2.12 . . . . 75.44 108.875 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -121.41 36.03 4.72 Favored 'General case' 0 N--CA 1.46 0.057 0 N-CA-C 114.256 1.206 . . . . 70.05 114.256 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -60.86 3.56 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.383 -1.34 . . . . 74.3 107.383 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -70.71 177.23 6.47 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.296 3.331 . . . . 74.02 111.299 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.0 144.4 31.65 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.353 1.061 . . . . 62.12 110.801 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.9 mt 11.88 77.61 0.01 OUTLIER 'General case' 0 C--O 1.241 0.641 0 C-N-CA 130.834 3.654 . . . . 74.44 113.832 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.8 mt -55.89 154.34 14.4 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 114.554 -1.203 . . . . 54.23 109.86 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.95 160.84 46.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.668 1.579 . . . . 75.11 111.901 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -157.26 143.45 17.86 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 127.801 2.44 . . . . 71.53 104.429 179.039 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.421 ' N ' HD12 ' A' ' 43' ' ' LEU . 43.5 t30 -114.67 102.28 9.88 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.037 0.935 . . . . 73.0 109.586 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -57.15 -27.6 62.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.373 0.533 . . . . 73.32 112.32 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -78.78 7.27 7.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.491 1.917 . . . . 73.1 112.981 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -127.0 4.87 6.5 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.616 1.566 . . . . 75.41 111.656 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.4 mt -94.01 176.66 6.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 122.119 0.961 . . . . 75.43 113.029 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -108.5 131.55 54.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 102.223 -3.251 . . . . 63.12 102.223 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -128.8 164.63 22.62 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.213 1.005 . . . . 73.12 108.545 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.65 160.62 42.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.384 -0.969 . . . . 71.55 108.384 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -109.7 135.64 50.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.131 1.372 . . . . 64.22 108.08 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.3 t -87.3 139.61 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.048 -1.464 . . . . 63.14 107.048 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -125.44 4.56 7.66 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.756 1.021 . . . . 52.14 113.756 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.29 -133.14 13.5 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.838 -2.105 . . . . 34.11 107.838 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -61.32 146.22 48.8 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.626 0.727 . . . . 74.2 110.866 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.44 174.89 36.23 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 127.108 2.289 . . . . 54.22 107.618 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.7 167.52 24.11 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.189 1.926 . . . . 74.21 109.351 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.22 35.09 91.54 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.643 -1.383 . . . . 63.5 109.643 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.28 149.76 13.41 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 108.004 -2.038 . . . . 73.1 108.004 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -146.71 11.93 1.12 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.742 0.817 . . . . 70.43 112.541 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.06 -9.52 31.58 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.142 1.534 . . . . 61.02 115.142 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 m 61.75 7.38 1.93 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.603 1.161 . . . . 63.43 111.887 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -58.4 144.48 41.72 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.185 1.394 . . . . 71.31 111.728 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -78.95 165.6 23.29 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.804 1.242 . . . . 70.52 110.62 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.3 p -81.23 122.78 27.84 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.118 -1.808 . . . . 72.33 106.118 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.0 t -164.73 -177.14 4.59 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.964 0.906 . . . . 64.12 108.863 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -67.52 105.58 1.89 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.075 1.75 . . . . 70.25 107.936 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.9 m -143.47 148.76 36.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.985 1.714 . . . . 74.22 107.276 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t -144.63 157.3 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.891 -1.522 . . . . 73.31 106.891 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.17 139.61 26.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.766 -1.939 . . . . 73.25 105.766 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 tp -139.48 143.73 37.65 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.414 -1.328 . . . . 74.44 107.414 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -131.5 158.42 40.94 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 123.186 0.594 . . . . 74.33 109.407 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -104.16 114.45 28.7 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 102.443 -3.169 . . . . 74.11 102.443 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.99 -62.12 5.74 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 119.187 0.903 . . . . 73.53 111.69 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -65.04 -14.67 46.55 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.791 2.994 . . . . 53.44 116.622 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.2 t -112.3 -10.6 13.8 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.564 1.075 . . . . 72.04 111.123 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.2 3.47 6.67 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.268 1.413 . . . . 73.25 113.896 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -66.87 149.19 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 120.024 1.912 . . . . 63.03 108.179 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.4 t -136.69 135.32 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.154 -1.795 . . . . 73.32 106.154 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.0 146.94 24.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 106.888 -1.523 . . . . 74.04 106.888 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -127.44 119.75 26.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.136 0.974 . . . . 74.14 108.961 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.1 m -139.32 149.29 44.04 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.563 1.545 . . . . 72.33 109.767 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -155.11 121.25 5.21 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.455 -2.054 . . . . 72.35 105.455 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -133.22 -48.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.891 0.876 . . . . 75.53 110.769 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.3 p -101.73 158.33 16.19 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.51 1.124 . . . . 61.44 111.738 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -71.9 -30.21 65.14 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 118.065 -0.969 . . . . 74.05 111.373 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -79.44 123.92 27.98 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 119.917 1.235 . . . . 50.52 110.275 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.96 -38.77 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.346 1.058 . . . . 51.11 109.041 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -55.57 -44.14 76.57 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.304 1.442 . . . . 75.41 110.721 -179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -40.23 62.04 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.718 0.807 . . . . 63.22 110.386 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -55.86 -32.94 64.08 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.741 0.7 . . . . 42.03 110.554 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 45.1 mtp85 -57.54 -45.19 85.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.593 0.633 . . . . 74.4 110.875 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -61.21 -31.76 71.53 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 118.679 0.672 . . . . 71.53 111.739 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.3 mt -74.06 -40.21 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.695 -0.854 . . . . 65.13 108.695 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.23 -47.59 73.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 122.897 0.479 . . . . 52.43 110.541 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -31.5 72.11 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 120.526 -0.47 . . . . 74.1 111.103 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -61.32 2.15 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.507 -1.294 . . . . 72.55 107.507 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -55.65 -35.83 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 118.683 0.674 . . . . 63.13 111.254 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.49 -32.57 74.06 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.455 -0.783 . . . . 45.2 111.474 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -61.17 -41.67 97.2 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 119.426 1.012 . . . . 74.24 110.531 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.81 -36.29 78.67 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.516 -0.92 . . . . 64.33 108.516 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -72.16 -51.8 19.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.433 -0.794 . . . . 75.43 111.403 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.06 -44.17 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 C-N-CA 124.352 1.061 . . . . 73.31 109.891 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -50.87 -63.74 1.03 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.003 0.921 . . . . 73.44 110.656 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.84 -24.56 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 112.589 0.589 . . . . 63.15 112.589 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -66.38 -45.28 80.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.617 1.099 . . . . 74.41 108.664 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -63.51 -46.22 87.07 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.513 -1.291 . . . . 65.05 107.513 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 -70.71 -3.27 17.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.219 1.407 . . . . 74.21 112.624 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.5 t -153.49 85.87 1.2 Allowed 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.416 1.086 . . . . 63.41 111.058 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -146.22 -170.76 15.06 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 108.96 -1.656 . . . . 72.2 108.96 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.74 -17.12 26.19 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.224 1.949 . . . . 62.12 110.725 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.8 p -148.97 -175.62 5.02 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 128.566 2.746 . . . . 75.13 107.336 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 t -153.45 145.76 23.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.225 2.21 . . . . 54.34 105.476 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 N-CA-C 108.437 -1.865 . . . . 55.41 108.437 -179.551 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 108.93 -0.767 . . . . 72.35 108.93 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -124.61 154.9 70.01 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.005 1.322 . . . . 74.41 108.67 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.29 166.18 30.1 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.553 2.168 . . . . 61.52 111.02 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.51 173.39 16.95 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.872 -1.291 . . . . 74.43 109.872 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.93 166.44 23.64 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.439 -0.448 . . . . 74.35 110.2 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.02 80.61 1.58 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.5 -2.407 . . . . 52.15 104.5 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.57 -174.42 4.27 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.853 0.861 . . . . 52.34 111.463 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -143.94 164.33 30.88 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.761 1.224 . . . . 74.53 108.708 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 t -147.98 165.71 29.9 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.403 0.62 . . . . 44.03 110.88 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.09 156.11 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 126.869 2.068 . . . . 64.31 111.04 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -119.3 173.85 6.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.487 1.515 . . . . 72.44 109.715 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.2 m -64.21 172.45 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.338 0.655 . . . . 54.04 110.578 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.74 -21.23 52.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 114.327 1.232 . . . . 73.43 114.327 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.57 -69.57 3.27 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 107.587 -2.205 . . . . 45.12 107.587 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? . . . . . 0 C--O 1.235 0.336 0 N-CA-C 106.953 -1.499 . . . . 63.31 106.953 177.648 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 C--O 1.233 0.214 0 N-CA-C 112.763 0.653 . . . . 54.02 112.763 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.87 112.21 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.859 2.373 . . . . 61.23 108.661 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.67 104.66 16.59 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.201 -1.407 . . . . 71.51 107.201 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -65.79 104.79 1.13 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.485 1.514 . . . . 72.44 109.923 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -62.86 -27.45 69.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.065 0.765 . . . . 62.21 113.065 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 m -79.4 6.57 9.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.396 0.998 . . . . 62.15 111.257 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -117.64 11.34 13.69 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.7 1.6 . . . . 61.55 111.743 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.0 mt -111.78 165.17 12.29 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.469 1.108 . . . . 52.42 111.16 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -132.22 127.0 34.85 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.441 -2.059 . . . . 73.44 105.441 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.23 165.47 11.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.487 1.515 . . . . 61.12 110.85 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -140.35 160.54 39.74 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.46 1.504 . . . . 53.15 107.277 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -130.53 139.45 50.48 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.472 -0.566 . . . . 61.52 109.472 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 85.3 t . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 107.246 -1.39 . . . . 72.11 107.246 179.49 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.8 t30 . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 121.522 0.677 . . . . 73.42 110.741 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.9 t -68.03 112.48 5.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.28 -1.512 . . . . 71.23 107.588 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.4 t -94.57 139.77 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 104.269 -2.493 . . . . 71.43 104.269 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.52 138.45 49.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.348 -2.093 . . . . 32.22 105.348 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.2 tp -142.32 147.31 36.13 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.871 -1.529 . . . . 71.21 106.871 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.99 158.18 43.87 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.432 -0.951 . . . . 62.31 108.432 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 77' ' ' SER . 4.3 t-80 -93.94 134.39 36.37 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.059 -2.2 . . . . 64.12 105.059 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.3 t -65.11 -65.97 1.66 Allowed Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 117.894 -1.051 . . . . 71.43 111.894 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.18 -35.41 52.59 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.744 2.296 . . . . 64.33 113.759 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' A' ' 74' ' ' HIS . 12.6 t -85.36 -21.13 29.01 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.777 0.658 . . . . 64.31 112.777 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.88 2.86 5.23 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.437 1.494 . . . . 41.32 114.525 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.5 mt -67.05 130.96 32.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 119.791 1.796 . . . . 53.01 107.087 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.6 t -112.61 153.45 14.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.463 1.105 . . . . 71.22 109.05 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -149.74 142.43 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.796 0.838 . . . . 72.33 110.059 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -124.92 106.84 10.29 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.19 1.796 . . . . 62.43 108.315 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 9.9 t -117.94 155.36 30.36 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.689 1.196 . . . . 74.45 110.159 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -155.03 100.66 2.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.594 -1.632 . . . . 63.23 106.594 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.48 -37.43 4.95 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 122.86 0.464 . . . . 72.11 111.413 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.8 p -139.04 176.73 8.44 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.983 0.913 . . . . 52.13 111.623 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -1.51 56.35 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.678 1.191 . . . . 64.33 111.011 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.4 m -98.2 115.75 28.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.132 1.373 . . . . 65.22 109.968 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.54 -53.89 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.874 0.869 . . . . 64.31 111.243 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -22.81 67.07 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.984 1.475 . . . . 60.22 114.984 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -77.75 -46.1 22.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.435 -2.061 . . . . 74.13 105.435 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -59.63 -37.3 78.26 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 118.397 -0.811 . . . . 73.11 109.974 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -54.88 -55.5 29.8 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.694 1.198 . . . . 61.51 108.582 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -54.64 -47.36 73.59 Favored 'General case' 0 CA--C 1.506 -0.733 0 O-C-N 121.641 -0.662 . . . . 65.24 112.366 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.8 mt -64.67 -36.8 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.596 -0.729 . . . . 72.45 110.443 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.24 -38.73 82.12 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.451 -0.781 . . . . 71.41 109.182 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -61.39 -49.38 77.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.617 1.167 . . . . 72.41 110.182 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -46.53 88.92 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.435 -0.793 . . . . 74.33 111.238 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.86 -37.42 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.107 1.321 . . . . 73.22 110.643 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.1 tp -65.67 -37.63 87.05 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.525 -0.734 . . . . 63.23 109.89 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -58.44 -42.11 86.61 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.703 0.801 . . . . 73.14 110.423 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -61.84 -43.47 98.77 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.426 0.631 . . . . 74.24 109.698 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -67.51 -42.46 82.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 113.915 1.08 . . . . 61.44 113.915 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.61 -32.77 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 123.219 0.608 . . . . 63.44 109.715 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -53.92 -60.75 2.92 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.702 0.683 . . . . 74.25 110.128 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 17.5 t -59.64 -32.59 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.784 0.834 . . . . 62.11 110.826 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -65.95 -22.64 66.49 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.516 1.053 . . . . 63.44 111.679 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -99.04 -36.92 9.55 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.4 1.08 . . . . 61.53 109.808 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -79.19 -16.78 56.05 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.523 1.129 . . . . 74.34 111.883 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.448 -0.54 0 C-N-CA 126.376 1.87 . . . . 54.04 108.692 -179.634 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 109.615 -0.513 . . . . 75.44 109.615 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -125.44 155.02 72.43 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.758 1.623 . . . . 72.41 108.961 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.62 166.06 29.18 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.6 2.2 . . . . 73.11 111.326 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.56 -178.32 35.37 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.177 -1.169 . . . . 64.35 110.177 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.6 ttt -138.14 162.27 34.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.842 1.257 . . . . 73.02 107.843 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.67 83.99 1.17 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.235 -2.506 . . . . 62.41 104.235 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.46 152.01 34.42 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.484 -0.561 . . . . 55.3 109.484 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 t -79.52 -174.51 4.29 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.603 0.716 . . . . 71.3 111.531 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.3 p -115.41 -175.85 2.8 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.642 1.577 . . . . 65.31 111.891 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.0 m -67.24 177.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.684 1.194 . . . . 71.44 109.303 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.02 164.02 28.25 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.71 0.804 . . . . 75.52 110.663 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 t -69.67 128.51 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.688 -1.597 . . . . 75.31 106.688 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.53 177.09 6.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.066 0.946 . . . . 73.31 111.581 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.13 -165.16 29.12 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 124.457 1.027 . . . . 62.42 111.916 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 . . . . . 0 C--O 1.232 0.176 0 C-N-CA 124.429 1.092 . . . . 60.25 111.362 -179.642 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 119.34 -0.362 . . . . 71.32 111.688 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -69.33 154.89 68.76 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.619 2.212 . . . . 54.2 109.262 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.0 mt -137.42 163.47 31.0 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.083 1.353 . . . . 72.11 113.728 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -119.84 101.85 8.17 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 106.891 -1.522 . . . . 75.13 106.891 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -61.06 -23.63 65.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.223 0.609 . . . . 64.44 112.53 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 m -87.97 10.38 19.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.993 1.317 . . . . 41.53 112.452 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -121.51 14.68 11.12 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.124 1.37 . . . . 74.23 111.095 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.2 mt -99.2 166.61 11.15 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.178 -0.951 . . . . 64.14 111.738 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -127.28 94.11 3.91 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.568 -0.901 . . . . 72.22 108.568 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -95.01 164.69 12.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.086 0.946 . . . . 75.44 112.689 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -143.17 171.09 14.56 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.707 2.803 . . . . 62.12 105.54 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -131.0 139.4 49.98 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 107.025 -1.472 . . . . 75.03 107.025 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.236 0.39 0 N-CA-C 109.27 -0.641 . . . . 63.41 109.27 -178.557 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 118.478 -0.772 . . . . 73.03 110.883 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.6 t -59.49 145.87 42.43 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.666 1.121 . . . . 75.2 110.91 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.6 t -120.44 149.83 23.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.311 1.845 . . . . 72.44 108.872 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.17 155.71 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.151 -1.796 . . . . 74.44 106.151 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.7 tp -141.3 148.54 39.93 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.152 -1.425 . . . . 62.14 107.152 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -143.51 130.68 20.75 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 125.473 1.509 . . . . 71.12 110.509 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -97.15 117.24 30.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.64 -1.985 . . . . 74.43 105.64 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.52 -59.96 11.3 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.069 -1.443 . . . . 65.42 111.921 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.47 -14.56 35.76 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.997 2.465 . . . . 52.53 116.611 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -111.69 -19.55 12.43 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.512 0.596 . . . . 75.13 111.236 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.13 21.22 69.78 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.007 0.813 . . . . 65.45 111.389 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -91.24 136.4 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 125.142 1.377 . . . . 64.31 107.805 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.01 137.41 57.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.069 -1.456 . . . . 72.43 107.069 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.0 p -136.75 151.39 27.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.961 -0.755 . . . . 62.53 108.961 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -110.16 125.62 53.22 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.166 -1.79 . . . . 52.24 106.166 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.1 t -138.54 132.13 30.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 118.374 0.534 . . . . 60.11 109.897 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -153.91 100.28 2.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.173 0.589 . . . . 71.3 109.494 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -115.77 -70.47 0.79 Allowed 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.309 -0.997 . . . . 73.14 108.309 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.5 p -73.04 177.59 4.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.391 1.476 . . . . 71.31 109.618 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -98.64 -20.14 17.15 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.254 -1.529 . . . . 75.43 108.802 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.3 m -79.09 132.2 36.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.328 2.251 . . . . 75.45 110.444 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.32 -55.86 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.7 0.8 . . . . 74.41 112.917 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.63 -39.85 74.35 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.853 1.206 . . . . 74.32 112.583 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -67.6 -43.28 80.85 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.755 -0.831 . . . . 53.31 108.755 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -64.89 -37.75 88.66 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.974 -0.751 . . . . 72.53 108.974 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -59.95 -52.06 67.04 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.225 1.01 . . . . 72.33 109.992 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -63.03 -32.23 73.55 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.505 1.502 . . . . 64.43 112.025 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.04 -46.33 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.307 -1.738 . . . . 74.22 106.307 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.27 78.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.976 0.91 . . . . 74.52 109.842 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -40.57 94.06 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.425 -0.583 . . . . 75.31 109.425 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.65 -53.17 61.12 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.599 -0.688 . . . . 72.34 109.739 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.5 p -66.56 -32.01 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 113.068 0.766 . . . . 75.11 113.068 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.7 tp -67.74 -30.64 70.17 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.348 -0.845 . . . . 74.3 109.823 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -58.99 -31.37 68.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.011 1.324 . . . . 75.01 110.726 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.55 -48.88 53.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.114 0.966 . . . . 73.24 109.062 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -60.26 -46.28 90.37 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.899 0.88 . . . . 72.33 110.284 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.4 t -64.39 -37.95 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 118.044 -0.979 . . . . 54.11 110.175 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.39 -61.37 2.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.894 1.224 . . . . 71.03 110.642 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.4 p -56.61 -37.23 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 O-C-N 123.886 0.741 . . . . 70.22 109.55 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -62.72 -35.82 81.0 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.012 0.745 . . . . 65.22 113.012 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -73.55 -41.55 62.82 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.725 -0.843 . . . . 73.11 108.725 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -79.28 -0.26 31.61 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.4 1.259 . . . . 74.52 114.4 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 C--N 1.325 -0.477 0 C-N-CA 125.72 1.608 . . . . 70.41 112.697 178.23 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 121.164 0.507 . . . . 75.23 109.803 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -102.18 155.87 35.93 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.342 1.457 . . . . 72.52 109.914 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.11 167.68 26.41 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.754 2.302 . . . . 71.41 110.919 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.16 168.85 13.51 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.701 -0.96 . . . . 74.22 110.701 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.9 ptm -77.58 165.86 23.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.368 0.667 . . . . 75.32 110.3 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.43 88.88 1.73 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.046 -2.205 . . . . 73.24 105.046 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.32 176.94 6.01 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.492 -0.559 . . . . 64.22 109.492 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.51 -171.73 2.91 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.483 0.713 . . . . 53.22 111.183 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.1 p -141.35 162.85 34.49 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.403 1.481 . . . . 74.32 108.48 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 m -119.04 173.14 5.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.047 1.339 . . . . 64.33 109.683 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.01 177.31 10.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.873 2.469 . . . . 72.2 106.755 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.6 t -90.53 142.91 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 121.384 -0.822 . . . . 73.52 109.046 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.05 168.2 10.23 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.169 0.587 . . . . 73.31 109.611 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.25 175.02 46.15 Favored Glycine 0 CA--C 1.523 0.545 0 O-C-N 121.401 -0.812 . . . . 43.42 112.813 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 . . . . . 0 C--O 1.235 0.338 0 C-N-CA 125.433 1.493 . . . . 72.12 107.018 179.329 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 105' ' ' ASP . 2.0 mm? . . . . . 0 C--O 1.239 0.501 0 N-CA-C 108.379 -0.971 . . . . 73.41 108.379 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.92 138.76 31.93 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.739 1.626 . . . . 74.11 112.204 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.2 mt -127.88 143.24 51.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.156 1.382 . . . . 71.33 111.295 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -120.69 103.81 9.41 Favored 'General case' 0 N--CA 1.461 0.085 0 C-N-CA 126.509 1.924 . . . . 51.42 107.935 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.15 -19.51 20.68 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.085 1.513 . . . . 75.24 115.085 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.8 m -83.39 -6.58 59.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.241 0.928 . . . . 73.54 111.937 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -114.23 0.83 14.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.579 1.152 . . . . 74.21 110.911 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 mt -102.65 154.97 18.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.098 0.559 . . . . 72.35 111.146 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -113.61 156.57 23.44 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.144 2.178 . . . . 63.12 108.243 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.58 165.07 30.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.532 1.933 . . . . 74.03 107.076 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -138.56 170.07 16.66 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.563 -0.903 . . . . 75.35 108.563 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -118.16 162.91 17.45 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.649 0.779 . . . . 75.44 111.833 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 102.567 -3.123 . . . . 72.51 102.567 178.61 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.457 -0.095 0 N-CA-C 106.998 -1.482 . . . . 74.41 106.998 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.6 t -154.4 144.13 21.64 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 104.499 -2.408 . . . . 75.23 104.499 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.78 134.57 64.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.437 -1.32 . . . . 72.13 107.437 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -118.88 130.36 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 106.667 -1.605 . . . . 55.35 106.667 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.2 tp -123.03 142.57 50.71 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.643 -0.873 . . . . 71.3 108.643 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -137.25 132.38 33.7 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.222 1.409 . . . . 73.25 109.695 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.19 134.17 34.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.657 1.183 . . . . 72.23 110.034 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.41 -59.9 1.5 Allowed Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 118.098 -0.953 . . . . 73.32 112.554 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.55 -18.85 60.25 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.643 2.229 . . . . 52.01 116.492 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.3 p -120.23 -10.42 9.37 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.403 1.261 . . . . 61.34 114.403 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.4 2.93 29.58 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.366 -1.241 . . . . 60.5 113.116 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.3 mt -64.54 134.6 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.98 1.89 . . . . 72.11 109.606 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.22 151.08 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 107.87 -1.159 . . . . 51.22 107.87 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p -152.6 154.9 7.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 120.979 -1.076 . . . . 70.24 108.644 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -122.26 134.44 54.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.778 -1.193 . . . . 72.52 107.778 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 29.1 m -137.19 150.84 48.18 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.492 1.117 . . . . 54.52 112.231 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -155.07 149.2 25.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.917 2.087 . . . . 75.34 108.321 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -162.41 -78.61 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.506 -1.665 . . . . 61.43 106.506 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 t -102.61 175.68 5.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.654 1.982 . . . . 75.11 109.072 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -84.74 -17.5 38.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.691 -1.147 . . . . 74.43 109.719 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.7 m -83.79 115.92 22.46 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.701 1.137 . . . . 75.25 111.946 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.91 -40.27 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 118.581 -0.723 . . . . 72.22 109.808 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -38.42 35.29 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.662 1.185 . . . . 63.25 112.078 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -76.28 -52.44 9.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.271 1.028 . . . . 72.33 109.022 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -52.23 -32.44 36.77 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.905 1.282 . . . . 75.54 111.158 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -54.47 -50.44 67.73 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.797 0.839 . . . . 72.54 109.978 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -75.09 -24.85 58.19 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.907 1.077 . . . . 74.23 113.907 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 94.7 mt -67.47 -48.33 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.243 -1.391 . . . . 73.4 107.243 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.45 99.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.554 -0.716 . . . . 53.1 110.888 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -63.55 -48.77 76.12 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 118.809 -0.615 . . . . 65.35 111.229 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -58.69 -41.03 85.32 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 117.395 -1.288 . . . . 73.3 111.688 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.7 -36.94 67.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.623 1.102 . . . . 75.53 111.141 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 tp -64.61 -38.2 90.19 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 118.741 -0.647 . . . . 62.45 110.67 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -57.15 -34.3 68.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.713 0.688 . . . . 74.04 110.381 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -68.36 -32.91 73.33 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.294 0.638 . . . . 72.15 110.64 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -77.9 -38.85 44.83 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.532 -0.544 . . . . 65.32 109.532 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.8 t -58.7 -40.4 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.683 -0.858 . . . . 73.52 108.683 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.467 ' HA ' HD23 ' A' ' 41' ' ' LEU . 6.4 t70 -58.31 -60.59 3.53 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.092 0.86 . . . . 64.21 109.419 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.99 -37.67 34.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 125.067 1.347 . . . . 63.42 110.452 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -69.83 -42.61 73.38 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.904 0.882 . . . . 75.3 111.343 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -68.92 -33.81 74.36 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.714 -0.847 . . . . 74.33 108.714 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.04 -50.88 15.05 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.52 0.728 . . . . 74.35 109.832 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 CA--C 1.532 0.278 0 C-N-CA 128.407 2.683 . . . . 72.34 111.062 -177.546 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 121.088 0.471 . . . . 64.55 110.204 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -116.02 157.86 43.93 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.938 1.695 . . . . 75.23 110.353 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.87 178.55 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.415 2.744 . . . . 74.23 111.288 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.55 -79.24 0.04 OUTLIER Glycine 0 C--N 1.339 0.722 0 N-CA-C 111.482 -0.647 . . . . 41.54 111.482 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 28.3 ptm -67.1 147.86 52.61 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.796 0.798 . . . . 75.02 110.494 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.4 71.64 0.65 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.828 1.251 . . . . 51.31 108.194 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.47 154.59 34.57 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.517 -0.919 . . . . 74.14 108.517 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.4 t -123.01 -176.02 3.31 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.602 1.161 . . . . 51.41 112.06 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -68.57 167.51 14.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.588 1.955 . . . . 74.4 110.031 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 m -66.11 145.45 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 121.353 -0.842 . . . . 75.22 108.762 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -74.89 175.9 7.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.317 1.047 . . . . 73.14 113.825 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.89 151.64 7.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 128.176 2.59 . . . . 75.11 108.96 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.57 153.87 20.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.789 0.268 . . . . 74.51 111.265 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.38 -83.07 0.37 Allowed Glycine 0 C--N 1.336 0.556 0 C-N-CA 125.022 1.296 . . . . 42.31 111.599 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.271 0 N-CA-C 108.647 -0.871 . . . . 72.35 108.647 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 112.761 0.652 . . . . 73.22 112.761 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.72 131.01 14.14 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.631 2.887 . . . . 65.14 111.821 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.0 mt -104.98 134.39 48.17 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.335 1.054 . . . . 75.24 109.041 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -73.25 107.5 5.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.804 -0.813 . . . . 72.54 108.804 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -59.09 -25.13 63.52 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 122.021 -0.424 . . . . 74.3 111.972 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 m -83.9 7.17 19.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.183 1.393 . . . . 70.43 112.7 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -116.24 -2.67 12.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.556 1.542 . . . . 73.44 109.8 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.417 HD22 ' CD2' ' A' ' 74' ' ' HIS . 0.9 OUTLIER -104.78 138.61 40.8 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.539 -1.282 . . . . 75.32 107.539 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -103.3 134.8 46.09 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.066 -1.457 . . . . 74.01 107.066 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.51 164.74 11.65 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.113 1.765 . . . . 55.33 112.811 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -140.87 172.57 12.51 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.703 2.001 . . . . 74.0 109.833 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -134.4 158.61 43.4 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.504 1.121 . . . . 74.42 109.493 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.456 -0.151 0 N-CA-C 107.529 -1.286 . . . . 72.21 107.529 179.216 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 113.584 0.957 . . . . 73.05 113.584 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 t -65.36 130.12 42.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 118.992 0.814 . . . . 63.42 109.852 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.3 t -111.24 137.26 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 103.309 -2.849 . . . . 71.01 103.309 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -130.5 117.95 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 105.816 -1.92 . . . . 75.4 105.816 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.2 tp -135.4 150.61 49.93 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 104.701 -2.333 . . . . 72.15 104.701 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.5 158.69 43.8 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 123.942 0.897 . . . . 74.02 109.971 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.417 ' CD2' HD22 ' A' ' 48' ' ' LEU . 3.1 t-80 -91.89 135.59 33.81 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.134 -2.173 . . . . 75.24 105.134 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.5 t -71.04 -61.94 2.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 119.864 1.211 . . . . 55.25 113.171 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.25 -25.11 72.07 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 121.68 1.587 . . . . 63.14 114.708 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 t -98.36 -16.7 19.2 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.281 0.492 . . . . 73.24 112.104 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.33 12.52 12.83 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.426 1.489 . . . . 61.1 113.257 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 62.3 mt -70.95 116.18 12.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 119.591 1.695 . . . . 72.31 106.527 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.3 t -105.32 146.4 12.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.68 -1.23 . . . . 72.13 107.68 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.12 148.08 17.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.051 -1.092 . . . . 62.22 108.051 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -120.85 107.04 12.23 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.747 1.219 . . . . 71.01 107.975 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 58.5 m -136.02 148.55 48.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.226 0.61 . . . . 70.44 110.211 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -155.48 150.6 26.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.624 -1.621 . . . . 73.45 106.624 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.79 -36.07 0.24 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.759 0.424 . . . . 74.21 110.455 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.8 p -123.63 -178.6 4.07 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.213 1.405 . . . . 74.45 108.457 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.76 -13.39 34.08 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.054 -0.721 . . . . 73.11 109.054 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -79.42 115.12 18.87 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.851 -1.166 . . . . 74.02 107.851 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.4 -41.34 84.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.94 -1.133 . . . . 72.02 107.94 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -56.5 -48.43 77.2 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.427 2.291 . . . . 70.14 110.371 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -65.88 -45.08 83.38 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.263 0.625 . . . . 64.3 109.465 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -64.0 -32.7 74.34 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.429 0.692 . . . . 71.14 111.249 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -59.61 -46.72 88.13 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.624 1.102 . . . . 74.4 110.336 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -58.87 -48.97 79.51 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 118.563 0.62 . . . . 73.41 110.553 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.6 mt -54.55 -48.79 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 O-C-N 124.417 1.073 . . . . 63.14 110.277 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.72 98.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 122.831 0.452 . . . . 70.13 111.418 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.4 ttm-85 -64.26 -46.62 82.92 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 118.224 -0.893 . . . . 72.22 110.28 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -50.71 69.8 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 119.438 1.017 . . . . 64.32 110.995 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.7 p -63.08 -33.39 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 120.178 1.354 . . . . 64.03 110.52 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.99 -42.19 90.1 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 120.998 -1.064 . . . . 70.35 108.486 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -56.8 -47.72 79.56 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.13 1.372 . . . . 72.15 110.569 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -59.64 -34.96 73.47 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.5 0.72 . . . . 64.11 110.403 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -79.62 -33.43 41.49 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.345 0.658 . . . . 71.11 111.812 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -74.01 -34.45 39.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 124.231 1.013 . . . . 75.45 109.763 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.01 -50.88 69.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.715 1.143 . . . . 73.5 109.019 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.8 t -57.97 -32.73 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.209 0.604 . . . . 64.23 109.661 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -77.34 -19.97 55.54 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.786 -1.196 . . . . 75.43 112.59 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -91.2 -22.32 20.69 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.992 0.814 . . . . 74.13 111.265 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -108.83 -17.17 14.0 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.995 0.816 . . . . 64.33 112.926 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.1 t . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 127.402 2.281 . . . . 62.04 108.13 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 109.101 -0.703 . . . . 65.42 109.101 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -109.38 151.73 42.28 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 124.444 1.098 . . . . 75.41 108.578 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.63 162.67 35.17 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.526 2.151 . . . . 71.14 110.561 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.58 172.58 37.67 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 109.196 -1.561 . . . . 71.21 109.196 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.3 tpt -134.46 135.28 42.37 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.772 -1.196 . . . . 72.33 107.772 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 64.57 1.11 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.618 1.167 . . . . 74.32 108.711 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.51 150.28 43.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.925 0.869 . . . . 71.31 109.227 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 t -93.59 129.1 39.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.189 -1.782 . . . . 74.04 106.189 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.1 t -69.05 -177.68 1.1 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.689 0.757 . . . . 65.44 109.67 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.9 m -94.72 -154.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.704 1.602 . . . . 75.05 110.682 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -131.6 171.13 13.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.568 2.747 . . . . 63.13 109.603 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.87 169.4 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.842 0.857 . . . . 71.15 109.69 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.53 152.72 23.87 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.061 0.846 . . . . 53.14 112.734 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.05 70.22 3.16 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 106.971 -2.452 . . . . 43.24 106.971 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 . . . . . 0 C--O 1.224 -0.28 0 C-N-CA 124.411 1.085 . . . . 63.14 109.863 -178.921 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 119.737 -0.173 . . . . 74.34 111.228 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.01 174.45 11.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.503 2.135 . . . . 65.33 110.93 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.701 HD11 HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -161.6 133.87 5.84 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 104.224 -2.509 . . . . 61.21 104.224 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.429 ' N ' HD12 ' A' ' 43' ' ' LEU . 52.9 t30 -66.31 116.15 7.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.18 1.178 . . . . 74.41 114.18 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' CB ' ' HD2' ' A' ' 97' ' ' ARG . 13.7 pt-20 -65.39 -32.13 73.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.142 0.793 . . . . 72.21 113.142 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 m -76.38 1.62 15.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.526 0.565 . . . . 73.34 112.526 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -107.57 6.61 28.12 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.984 1.714 . . . . 52.24 110.582 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.701 HD11 HD11 ' A' ' 43' ' ' LEU . 8.3 mt -110.31 176.37 5.07 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.839 1.052 . . . . 74.12 113.839 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -127.01 130.19 49.54 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.958 -1.497 . . . . 71.41 106.958 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.59 159.69 34.74 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.86 1.264 . . . . 72.41 108.87 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -137.82 154.89 49.48 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.818 -1.178 . . . . 61.33 107.818 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -119.94 122.47 41.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.809 1.244 . . . . 75.34 108.547 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.235 0.324 0 CA-C-O 122.282 1.039 . . . . 71.24 109.797 -179.004 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 112.191 0.441 . . . . 73.44 112.191 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 m -67.9 135.06 51.89 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.727 -1.212 . . . . 63.41 107.727 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.36 154.28 20.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.685 -1.228 . . . . 71.3 107.685 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.4 147.79 21.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.327 -2.101 . . . . 75.41 105.327 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.7 tp -140.47 150.42 43.77 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.366 1.066 . . . . 72.21 108.999 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.28 157.99 44.72 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 112.502 0.556 . . . . 74.11 112.502 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -100.89 118.4 36.86 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 103.643 -2.725 . . . . 74.22 103.643 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -63.29 -54.08 47.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 120.253 1.388 . . . . 74.34 112.875 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.41 -13.02 34.88 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.843 2.362 . . . . 70.43 116.509 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.6 m -121.14 -6.22 9.45 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.078 1.308 . . . . 71.25 113.698 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.02 17.01 34.98 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 123.949 0.785 . . . . 70.21 114.915 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.453 HD11 ' CD2' ' A' ' 107' ' ' PHE . 50.5 mt -74.04 134.57 29.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 104.325 -2.472 . . . . 74.41 104.325 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t -130.23 137.16 57.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.824 -1.176 . . . . 42.43 107.824 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.67 147.93 28.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.676 -0.861 . . . . 63.23 108.676 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -122.68 118.49 28.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.479 1.112 . . . . 74.2 110.422 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 99.3 m -127.67 144.47 51.07 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.247 0.619 . . . . 74.22 110.986 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -155.62 120.42 4.75 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.468 1.107 . . . . 74.03 108.541 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.69 -71.67 0.27 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.086 0.954 . . . . 70.45 108.496 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 p -78.77 156.54 28.78 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.37 1.868 . . . . 73.31 113.614 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.14 -15.55 52.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.331 -0.618 . . . . 63.32 109.331 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.48 123.25 27.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.521 -1.288 . . . . 64.13 107.521 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.3 p -60.41 -46.38 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 119.157 0.889 . . . . 74.51 110.211 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -55.06 -42.21 72.44 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.422 1.889 . . . . 74.32 112.354 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -23.01 41.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.225 -0.893 . . . . 73.33 111.223 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -77.94 -42.91 31.49 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.581 -1.636 . . . . 73.01 106.581 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -52.17 -45.94 65.29 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.471 1.108 . . . . 65.35 109.0 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -59.67 -34.03 72.32 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-O 117.649 -1.167 . . . . 62.24 113.233 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.5 mt -64.32 -53.17 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 120.087 1.312 . . . . 60.45 108.402 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.05 -47.05 75.32 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 108.404 -0.961 . . . . 70.53 108.404 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.43 ' HD2' ' CB ' ' A' ' 45' ' ' GLU . 33.3 ttp85 -59.87 -39.56 85.68 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.383 1.073 . . . . 74.33 111.984 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -63.49 -57.52 9.94 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.96 1.304 . . . . 62.54 109.622 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.57 -29.21 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 112.106 0.41 . . . . 73.51 112.106 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.94 -46.76 89.4 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.648 -0.658 . . . . 71.55 109.554 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -59.01 -31.45 68.83 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.556 0.342 . . . . 62.12 111.451 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.26 -24.96 64.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.319 0.509 . . . . 73.2 112.079 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -88.03 -44.12 11.22 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.956 0.903 . . . . 73.23 110.138 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.39 -39.25 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 118.675 -0.679 . . . . 63.31 110.064 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -53.4 -66.68 0.35 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.651 0.739 . . . . 73.44 109.929 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.8 p -57.53 -30.48 36.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 118.174 -0.917 . . . . 35.22 111.144 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.453 ' CD2' HD11 ' A' ' 79' ' ' ILE . 16.2 t80 -59.9 -44.65 94.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.22 1.373 . . . . 74.15 110.199 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -75.66 -39.47 57.61 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.992 0.517 . . . . 74.52 110.731 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -65.12 -54.74 25.22 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.575 -0.528 . . . . 75.12 109.575 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 CA--C 1.545 0.781 0 C-N-CA 126.522 1.929 . . . . 52.23 106.889 178.52 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 109.836 -0.431 . . . . 73.24 109.836 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -125.37 155.74 71.18 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.967 1.707 . . . . 73.31 109.184 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.39 164.33 34.26 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.568 2.179 . . . . 53.32 111.428 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.61 169.73 16.47 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.499 -1.041 . . . . 63.01 110.499 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.2 mtt -82.01 163.36 22.17 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.721 -0.474 . . . . 70.24 109.721 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.93 74.41 1.26 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.325 -1.732 . . . . 64.51 106.325 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.61 176.89 6.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.894 0.854 . . . . 65.43 112.651 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -64.68 168.14 6.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.183 0.993 . . . . 63.35 110.528 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.5 p -130.48 178.86 6.29 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.819 1.248 . . . . 74.33 112.377 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.67 145.9 3.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.591 1.156 . . . . 54.21 109.908 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -71.95 -171.78 0.76 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.071 -0.968 . . . . 74.02 110.912 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 m -55.85 170.66 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 126.667 1.987 . . . . 74.43 114.753 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.52 172.91 12.48 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.607 1.563 . . . . 72.04 110.733 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.44 -79.26 0.56 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 109.969 -1.252 . . . . 61.22 109.969 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 . . . . . 0 C--O 1.236 0.343 0 C-N-CA 124.703 1.201 . . . . 71.31 109.609 179.561 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 109.343 -0.614 . . . . 74.1 109.343 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.09 129.34 20.39 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.516 2.81 . . . . 74.03 111.092 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.4 mt -117.75 121.25 40.33 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.487 1.115 . . . . 62.42 109.663 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -77.93 101.89 7.06 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.29 -1.004 . . . . 72.34 108.29 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.07 -29.14 60.11 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.213 0.46 . . . . 75.53 111.441 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -73.06 -3.78 28.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.178 0.991 . . . . 74.15 112.139 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -118.4 0.1 11.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.33 2.252 . . . . 75.34 110.663 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.9 mt -98.98 176.78 5.46 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.252 1.021 . . . . 74.12 109.388 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -138.4 148.13 44.13 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.76 -1.2 . . . . 73.13 107.76 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -141.76 164.83 29.14 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.786 1.234 . . . . 74.44 108.955 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -126.04 174.87 8.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.004 -0.739 . . . . 73.23 109.004 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -133.94 113.62 12.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.348 -1.353 . . . . 71.41 107.348 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.0 t . . . . . 0 C--N 1.33 -0.253 0 N-CA-C 105.929 -1.878 . . . . 71.33 105.929 -179.282 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 p30 . . . . . 0 N--CA 1.461 0.097 0 N-CA-C 106.06 -1.83 . . . . 75.02 106.06 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.8 t 178.45 133.8 0.08 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.651 2.781 . . . . 71.34 106.067 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.2 t -118.08 114.38 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 106.129 -1.804 . . . . 63.33 106.129 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.57 138.14 33.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.667 0.746 . . . . 45.23 109.303 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.8 tp -135.59 148.58 49.1 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.409 1.883 . . . . 74.15 107.889 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.71 158.4 44.48 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.479 -1.304 . . . . 75.21 107.479 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -106.84 119.27 38.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.585 -0.894 . . . . 74.41 108.585 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 t -57.36 -61.11 7.79 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.689 1.196 . . . . 55.5 110.103 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.77 -12.02 33.44 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.29 2.66 . . . . 75.24 116.832 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -120.83 -10.61 9.1 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.403 1.261 . . . . 73.55 114.403 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.78 -5.38 2.49 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.625 1.107 . . . . 50.13 114.754 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.6 mt -60.55 140.46 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 126.022 1.729 . . . . 73.53 108.128 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 t -126.02 142.57 42.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 105.792 -1.929 . . . . 74.53 105.792 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.56 139.58 16.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.497 -0.927 . . . . 72.43 108.497 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 113.7 17.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.37 1.468 . . . . 54.4 107.388 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.6 p -100.04 164.58 11.93 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.522 1.529 . . . . 70.03 111.741 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -155.8 120.67 4.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.138 1.775 . . . . 73.54 106.874 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.01 -47.54 0.13 Allowed 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.677 0.791 . . . . 71.24 110.082 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.7 p -128.13 -170.63 2.28 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.784 -1.561 . . . . 73.44 106.784 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.08 9.0 15.83 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.306 -0.871 . . . . 70.13 110.897 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 75.3 m -103.46 115.05 29.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.946 -1.131 . . . . 75.33 107.946 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.62 -43.05 77.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 123.54 0.736 . . . . 52.31 110.245 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.19 -30.63 64.7 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.643 1.11 . . . . 70.21 112.32 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -86.52 -48.39 8.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.749 -0.834 . . . . 44.41 108.749 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -60.95 -26.58 67.62 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.234 0.614 . . . . 70.23 110.751 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -57.16 -40.71 77.82 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.202 0.91 . . . . 74.11 110.093 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -73.6 -29.17 62.22 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 118.288 -1.365 . . . . 75.03 110.48 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.05 -45.18 95.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 124.381 1.072 . . . . 54.22 108.526 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.06 -45.22 94.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.858 0.361 . . . . 63.43 110.596 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -66.05 -48.17 71.92 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 122.65 0.38 . . . . 74.21 111.705 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -40.34 92.36 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 117.894 -1.05 . . . . 74.03 110.453 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.82 -37.79 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.278 0.944 . . . . 63.25 109.291 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.8 tp -61.11 -38.56 86.77 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.087 0.858 . . . . 71.31 110.854 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -57.06 -34.28 68.1 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.936 0.789 . . . . 75.24 111.384 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -67.49 -31.08 70.98 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.842 0.829 . . . . 74.02 109.97 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -77.68 -47.03 20.18 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.764 0.826 . . . . 72.53 110.948 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.1 t -62.18 -37.85 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 123.681 0.793 . . . . 71.15 109.964 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -52.24 -65.88 0.48 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.258 1.023 . . . . 54.41 110.296 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.63 -28.65 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.597 -0.69 . . . . 75.51 111.42 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -68.85 -40.19 79.51 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 119.123 0.874 . . . . 70.11 110.832 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -72.24 -45.24 61.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.722 0.809 . . . . 71.34 110.021 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -63.86 -53.9 43.32 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.289 0.636 . . . . 74.51 111.082 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.453 -0.301 0 C-N-CA 123.779 0.832 . . . . 73.33 111.836 -179.253 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 108.629 -0.878 . . . . 74.22 108.629 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -129.15 153.29 80.36 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.027 1.331 . . . . 53.14 110.235 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -80.8 177.1 8.36 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.63 2.887 . . . . 74.35 110.85 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.89 160.24 27.97 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.649 -1.38 . . . . 62.11 109.649 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -145.81 124.09 12.27 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.838 -1.912 . . . . 65.4 105.838 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.98 56.49 1.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.622 1.169 . . . . 72.23 108.573 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.41 139.3 58.53 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.537 -0.727 . . . . 62.21 109.114 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 t -88.36 -170.0 2.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.897 1.279 . . . . 64.21 110.517 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.9 p -136.08 178.0 7.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.594 1.558 . . . . 64.33 109.467 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.71 -179.43 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 126.377 1.871 . . . . 74.3 109.514 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -130.48 169.47 15.5 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.082 1.753 . . . . 62.23 110.996 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.59 147.74 7.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.242 1.017 . . . . 64.4 109.265 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.92 -166.62 1.38 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.099 -1.445 . . . . 63.14 107.099 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.28 179.94 25.56 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-O 121.999 0.777 . . . . 71.14 112.223 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 . . . . . 0 C--N 1.33 -0.255 0 C-N-CA 124.632 1.173 . . . . 70.31 110.162 179.815 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.24 0.605 0 N-CA-C 109.77 -0.455 . . . . 70.53 109.77 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -62.41 140.95 85.12 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.137 1.225 . . . . 63.23 110.622 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.3 123.23 12.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.124 -1.806 . . . . 45.24 106.124 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -85.24 117.86 24.44 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.618 1.167 . . . . 74.3 109.664 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.35 -29.13 69.83 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.823 1.046 . . . . 73.14 113.823 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -82.68 -10.48 58.9 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.454 1.102 . . . . 64.31 112.849 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -91.59 2.25 56.58 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.768 0.713 . . . . 71.24 111.568 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mt -102.73 174.5 5.86 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.122 1.369 . . . . 61.44 112.106 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -126.79 156.23 41.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.346 2.258 . . . . 72.1 105.807 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.45 157.31 46.84 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.602 -0.686 . . . . 55.34 111.861 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -126.89 140.17 52.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.408 1.083 . . . . 74.24 111.134 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -106.38 132.34 52.52 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.562 1.145 . . . . 55.13 108.096 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 C--O 1.235 0.318 0 N-CA-C 107.975 -1.121 . . . . 73.43 107.975 -179.337 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 111.455 0.169 . . . . 72.01 111.455 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -104.46 156.39 17.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.714 1.206 . . . . 64.45 109.504 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.95 142.22 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.537 1.535 . . . . 71.23 107.473 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -137.56 95.47 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.23 -1.396 . . . . 34.14 107.23 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.4 tp -93.46 152.4 19.11 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.727 0.411 . . . . 52.2 110.229 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -141.45 137.3 32.07 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 124.574 1.149 . . . . 73.31 110.346 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -87.84 132.93 34.0 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 105.468 -2.049 . . . . 71.45 105.468 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.63 -64.95 2.25 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 119.297 0.953 . . . . 65.25 111.846 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.54 -7.74 21.78 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.801 3.0 . . . . 73.4 116.13 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 m -113.3 -17.36 12.32 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.86 1.209 . . . . 72.21 112.213 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.11 -7.03 0.86 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.363 1.459 . . . . 70.31 115.725 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.76 136.93 25.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 120.038 1.919 . . . . 74.32 107.523 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.0 t -121.6 137.29 55.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.818 1.647 . . . . 71.24 106.772 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.0 p -146.88 148.11 17.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.542 -0.911 . . . . 74.31 108.542 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.48 134.08 41.11 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 122.523 0.329 . . . . 73.34 111.291 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.1 t -140.77 155.35 46.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.181 1.793 . . . . 73.42 108.547 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -150.75 100.78 2.86 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.496 1.918 . . . . 62.42 108.173 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -120.55 -15.55 8.47 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.768 1.396 . . . . 74.33 114.768 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.3 p -134.2 168.18 19.33 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.53 1.514 . . . . 73.43 110.824 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -79.96 -10.61 59.79 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.633 -0.667 . . . . 72.42 110.851 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.37 114.65 26.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.827 1.651 . . . . 72.22 110.231 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.35 -44.45 98.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-O 119.18 -0.438 . . . . 54.45 110.707 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -58.15 -45.45 87.4 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.381 0.537 . . . . 74.42 110.952 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -42.2 97.21 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.47 -0.937 . . . . 60.41 108.47 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.56 -27.47 68.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 118.613 -0.708 . . . . 73.22 109.987 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -62.22 -46.59 88.18 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.077 1.308 . . . . 74.14 107.843 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -60.36 -37.39 80.56 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.344 0.52 . . . . 62.53 110.222 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.48 -48.27 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 108.612 -0.884 . . . . 74.01 108.612 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.5 -35.49 80.65 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.673 -0.642 . . . . 44.14 110.538 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -63.71 -52.06 62.25 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 123.758 0.823 . . . . 75.12 111.282 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -43.35 94.21 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.643 1.11 . . . . 73.12 110.66 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.11 -33.09 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.503 1.047 . . . . 74.1 109.326 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.11 -33.13 75.08 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 120.839 -1.163 . . . . 71.31 108.962 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -58.75 -45.64 89.22 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.958 1.254 . . . . 75.24 107.951 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -56.47 -37.58 70.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.399 1.08 . . . . 73.12 109.684 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -72.4 -39.02 68.27 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.621 -0.674 . . . . 73.15 111.911 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.94 -39.29 85.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.564 -0.902 . . . . 60.55 108.564 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.12 -62.89 1.44 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.604 1.561 . . . . 75.43 110.799 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.4 p -60.8 -27.62 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 119.246 -0.407 . . . . 65.02 110.819 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -66.69 -36.19 81.92 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.585 0.63 . . . . 74.14 109.786 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -74.53 -42.78 58.25 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.423 -0.584 . . . . 70.13 109.423 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -67.83 -58.47 4.53 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.026 0.931 . . . . 73.31 111.748 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.451 -0.419 0 C-N-CA 125.384 1.474 . . . . 50.42 109.544 -179.111 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 107.723 -1.214 . . . . 74.42 107.723 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -123.65 152.39 65.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 124.405 1.082 . . . . 70.51 110.222 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -80.74 -179.54 5.23 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.929 3.086 . . . . 70.23 110.903 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.75 167.99 25.15 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.397 -1.481 . . . . 62.23 109.397 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -147.82 140.0 24.28 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.998 -1.852 . . . . 74.33 105.998 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.46 59.95 0.82 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.665 0.666 . . . . 30.4 111.053 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.78 140.07 42.15 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.624 -0.88 . . . . 63.12 108.624 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 t -73.87 164.55 26.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.524 1.13 . . . . 74.43 111.59 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 p -102.69 165.48 11.04 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.345 1.458 . . . . 72.33 108.593 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.07 143.28 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 107.521 -1.289 . . . . 72.43 107.521 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -62.12 139.24 58.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.439 0.638 . . . . 62.44 110.518 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -82.87 169.22 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 125.439 1.496 . . . . 72.54 109.293 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.25 149.68 36.71 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.47 2.308 . . . . 44.41 107.077 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -136.36 -57.29 0.06 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 125.38 1.467 . . . . 75.35 111.195 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 117.675 -1.155 . . . . 75.44 109.035 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 108.657 -0.868 . . . . 73.1 108.657 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.77 146.8 67.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.096 1.864 . . . . 73.14 111.927 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 mt -111.86 159.25 18.52 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.741 1.217 . . . . 74.4 111.533 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -115.01 101.37 8.94 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 108.096 -1.076 . . . . 74.24 108.096 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -66.12 -20.79 66.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.311 0.645 . . . . 63.33 112.71 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -84.4 3.29 36.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.932 1.693 . . . . 63.25 112.599 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -124.15 22.81 8.59 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.299 1.039 . . . . 61.04 111.203 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -112.31 162.0 16.01 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.295 -0.878 . . . . 65.22 108.81 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -126.13 95.1 4.28 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.423 1.489 . . . . 75.41 107.094 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 1.3 pm0 -87.0 162.86 17.39 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.138 1.375 . . . . 74.15 112.271 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.7 172.2 13.98 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.919 -1.511 . . . . 62.24 106.919 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -130.97 155.91 46.01 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.509 1.124 . . . . 74.1 108.789 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 CA--C 1.531 0.243 0 CA-C-O 121.741 0.782 . . . . 64.14 109.512 -179.439 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 114.469 1.285 . . . . 65.55 114.469 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.5 m -63.81 160.03 18.21 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.202 1.001 . . . . 70.44 110.611 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.08 148.53 30.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.07 -1.456 . . . . 75.12 107.07 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 p -133.78 115.88 22.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 105.953 -1.869 . . . . 63.12 105.953 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.77 151.66 40.32 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.18 1.792 . . . . 64.13 106.881 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.23 151.57 36.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.178 0.991 . . . . 72.33 111.78 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -87.26 134.28 33.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.995 -1.483 . . . . 74.14 106.995 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.66 -59.35 4.75 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.796 -1.097 . . . . 64.34 111.909 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.06 -9.29 23.33 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 124.268 3.312 . . . . 75.33 116.227 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.4 m -118.24 -12.38 9.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.742 0.701 . . . . 73.34 112.124 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.07 14.56 18.25 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.64 1.114 . . . . 50.54 113.361 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.1 mt -67.02 131.16 32.82 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 N-CA-C 106.048 -1.834 . . . . 60.54 106.048 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.71 140.18 48.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.826 -1.176 . . . . 74.02 107.826 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.81 144.14 24.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.375 -0.972 . . . . 42.51 108.375 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.66 111.16 17.28 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 105.929 -1.878 . . . . 64.44 105.929 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 81.3 m -124.28 158.12 33.29 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.008 0.908 . . . . 73.42 111.394 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -155.43 145.43 21.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.451 1.9 . . . . 64.04 108.627 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -154.2 -35.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.843 -0.535 . . . . 74.35 109.651 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.6 p -138.91 -178.76 5.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.42 -0.955 . . . . 74.34 108.42 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -93.33 -5.77 48.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.595 -0.891 . . . . 70.32 108.595 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' A' ' 91' ' ' GLN . 10.0 m -79.79 114.99 19.13 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.951 1.7 . . . . 54.43 107.812 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.37 -38.33 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 121.958 -0.464 . . . . 42.25 110.173 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -62.35 -33.7 75.23 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.893 1.277 . . . . 61.32 110.73 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 88' ' ' SER . 36.4 mt-30 -76.86 -54.82 6.1 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.215 -1.032 . . . . 74.12 108.215 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -52.46 -36.03 53.86 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.668 -0.682 . . . . 73.34 110.125 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -57.84 -58.28 9.07 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 118.212 -0.899 . . . . 72.14 110.294 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.21 -32.94 74.71 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.935 1.243 . . . . 75.52 113.31 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.47 -50.93 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.235 -1.394 . . . . 74.44 107.235 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.07 75.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.459 -0.941 . . . . 53.12 108.459 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.34 -47.0 62.85 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.648 1.179 . . . . 65.13 111.582 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -45.58 82.45 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 117.423 -1.275 . . . . 72.13 111.75 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.35 -29.93 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 120.397 1.453 . . . . 73.03 110.738 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -44.17 96.9 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 107.898 -1.149 . . . . 71.43 107.898 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -54.95 -39.62 69.11 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.564 1.146 . . . . 74.15 110.913 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -67.39 -30.18 69.88 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.076 0.95 . . . . 72.44 110.312 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.13 -46.9 17.07 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.078 -1.014 . . . . 65.54 110.021 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.28 -30.38 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.454 -0.943 . . . . 74.03 108.454 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -57.86 -62.43 1.81 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.685 -1.598 . . . . 72.13 106.685 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.5 t -59.55 -29.53 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.649 0.779 . . . . 65.33 110.39 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -66.6 -34.6 78.24 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.276 1.398 . . . . 73.44 111.805 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -87.52 -31.16 20.08 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 109.068 -0.716 . . . . 71.3 109.068 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -80.89 -15.92 55.01 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.086 0.554 . . . . 73.15 110.853 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.444 -0.774 0 C-N-CA 125.433 1.493 . . . . 74.21 109.727 -178.867 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.335 -0.616 . . . . 55.22 109.335 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -89.37 153.99 48.67 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 123.722 0.809 . . . . 75.01 109.087 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.77 163.81 33.0 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.722 2.281 . . . . 74.32 110.839 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.26 -176.36 34.54 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.822 -1.311 . . . . 44.04 109.822 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 53.9 ttm -121.02 145.47 47.73 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.638 -1.245 . . . . 62.34 107.638 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.26 68.6 1.04 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.72 -1.956 . . . . 51.31 105.72 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.4 172.91 7.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.9 -0.407 . . . . 44.42 109.9 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 t -154.77 177.09 11.65 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 122.194 -0.316 . . . . 74.22 110.476 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.8 m -138.1 173.65 11.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.725 2.41 . . . . 74.45 107.597 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.17 178.87 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.469 1.907 . . . . 53.02 109.09 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -71.0 142.12 50.97 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.388 -1.708 . . . . 74.5 106.388 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.77 177.45 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.467 0.651 . . . . 51.41 110.828 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 174.26 11.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.83 -0.623 . . . . 74.12 110.875 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.63 162.87 32.3 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 107.442 -2.263 . . . . 74.01 107.442 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 122.334 1.064 . . . . 63.3 111.839 -179.826 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 119.075 -0.488 . . . . 74.32 109.807 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.2 151.41 73.56 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.075 2.517 . . . . 63.24 113.931 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.0 mt -123.13 110.41 15.25 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.255 1.422 . . . . 72.03 108.046 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -79.62 101.97 8.64 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.122 1.369 . . . . 72.33 110.276 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.8 -29.88 42.48 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.487 0.921 . . . . 73.34 113.487 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.5 -22.83 60.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.14 0.427 . . . . 63.21 111.24 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -89.22 -21.84 23.05 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.568 1.147 . . . . 74.21 110.476 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.7 mt -84.16 176.62 8.66 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.756 0.822 . . . . 74.51 110.112 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.19 140.73 49.96 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.608 -1.627 . . . . 75.4 106.608 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -129.04 157.11 42.63 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.716 1.206 . . . . 63.11 109.679 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -137.3 118.71 14.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.799 -1.556 . . . . 61.54 106.799 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -74.45 163.16 28.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.808 -1.996 . . . . 72.03 109.8 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.7 t . . . . . 0 C--N 1.332 -0.172 0 N-CA-C 107.697 -1.223 . . . . 74.1 107.697 -179.604 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 111.763 0.282 . . . . 75.31 111.763 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.17 159.21 26.8 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.347 -0.846 . . . . 61.25 108.959 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.26 130.27 60.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.169 -2.16 . . . . 61.32 105.169 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 t -121.28 119.97 60.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.746 -1.205 . . . . 73.14 107.746 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.8 tp -118.78 142.31 47.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.217 -1.401 . . . . 61.51 107.217 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.17 152.3 45.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.69 -1.226 . . . . 71.32 107.69 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -100.3 116.62 32.7 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.03 -2.211 . . . . 71.13 105.03 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.82 -56.75 22.77 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 117.74 -1.124 . . . . 74.53 112.04 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -69.25 -10.4 28.87 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.468 2.112 . . . . 64.51 114.885 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 m -120.43 -11.92 9.05 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.843 1.053 . . . . 74.03 113.843 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.08 -4.02 3.68 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 127.69 2.566 . . . . 73.02 115.633 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.56 135.81 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 119.295 1.547 . . . . 75.22 108.748 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 t -123.35 148.19 27.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 126.258 1.823 . . . . 70.42 107.124 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 p -145.61 146.29 19.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 106.447 -1.686 . . . . 74.21 106.447 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -123.86 119.13 28.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.019 -1.104 . . . . 75.25 108.019 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 91.5 m -128.57 152.26 48.52 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.684 0.754 . . . . 72.13 111.094 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -155.68 100.64 2.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.177 2.191 . . . . 74.12 106.155 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -111.31 -41.53 4.12 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.328 -0.858 . . . . 61.31 110.779 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.3 t -140.76 179.11 6.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.446 1.099 . . . . 42.03 109.921 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.93 11.94 12.31 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.43 1.092 . . . . 64.23 109.902 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.9 m -107.23 115.54 30.34 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.992 -1.114 . . . . 74.01 107.992 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.7 -47.87 81.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.411 0.685 . . . . 64.5 109.314 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -49.69 -54.09 20.74 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.295 1.438 . . . . 61.24 112.406 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.49 -46.12 87.57 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.5 0.72 . . . . 73.4 109.618 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -56.91 -37.71 71.83 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.635 0.652 . . . . 54.13 111.108 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -57.91 -36.88 73.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.83 0.741 . . . . 74.02 109.531 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -55.85 25.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.496 0.589 . . . . 73.2 109.734 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.6 mp -52.67 -47.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.777 -0.453 . . . . 63.4 109.777 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.54 -50.96 71.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.932 0.893 . . . . 74.02 111.98 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -60.97 -43.83 98.2 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.799 -0.619 . . . . 74.24 110.26 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.06 -59.32 5.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.572 -0.899 . . . . 71.53 108.572 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 p -60.1 -35.07 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.819 0.736 . . . . 72.41 112.937 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -65.07 -42.89 93.76 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 119.011 0.823 . . . . 64.34 110.279 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -52.01 -42.25 62.88 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.643 1.577 . . . . 74.21 112.612 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.34 -43.16 78.79 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.621 0.724 . . . . 63.24 110.38 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -73.79 -41.17 62.77 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.176 1.79 . . . . 64.24 112.412 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.86 -34.11 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 118.146 -0.93 . . . . 64.3 110.585 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -54.7 -59.54 4.57 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.565 1.529 . . . . 72.42 106.928 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.29 -34.49 27.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.315 1.846 . . . . 65.21 110.291 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -66.26 -39.19 89.29 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.593 -0.692 . . . . 75.13 110.715 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -78.05 -38.63 44.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.585 0.63 . . . . 73.32 110.063 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -68.41 -58.76 3.86 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.318 1.047 . . . . 75.02 112.641 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 m . . . . . 0 N--CA 1.452 -0.37 0 C-N-CA 125.583 1.553 . . . . 52.32 114.017 -177.08 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 109.428 -0.582 . . . . 64.3 109.428 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -111.92 155.47 43.22 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.666 1.186 . . . . 43.45 109.76 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.78 171.34 18.38 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.977 2.451 . . . . 65.42 111.412 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.06 -176.2 47.8 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.814 -0.915 . . . . 61.33 110.814 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 50.3 ttp -133.17 156.53 47.32 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.197 1.399 . . . . 74.21 108.034 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.36 120.68 4.49 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 102.468 -3.16 . . . . 75.41 102.468 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.94 175.71 5.35 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.907 0.883 . . . . 71.43 109.251 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 t -74.07 152.58 39.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.934 0.874 . . . . 23.04 110.779 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 p -84.61 -162.61 0.7 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 129.787 3.235 . . . . 63.0 112.284 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.69 149.35 4.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 O-C-N 121.038 -1.039 . . . . 71.22 108.933 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -81.42 -168.0 1.69 Allowed 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.814 0.816 . . . . 63.14 109.226 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.72 155.47 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 125.675 1.59 . . . . 74.01 107.032 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.07 172.12 7.63 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.256 -0.903 . . . . 44.03 111.325 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.49 160.27 28.7 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.973 -1.251 . . . . 71.44 109.973 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 121.14 0.495 . . . . 74.11 110.371 179.847 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 109.856 -0.424 . . . . 64.41 109.856 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.13 106.22 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.266 3.311 . . . . 73.52 115.868 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -80.8 149.91 29.41 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.785 -0.45 . . . . 71.02 109.785 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -103.81 106.7 17.29 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 106.959 -1.497 . . . . 73.42 106.959 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -60.15 -13.63 13.09 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 115.417 1.636 . . . . 73.43 115.417 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.9 m -95.99 -13.07 24.08 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.237 0.926 . . . . 61.24 111.394 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -93.99 3.16 55.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.002 2.121 . . . . 73.13 111.449 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mt -98.64 166.62 11.25 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.723 1.209 . . . . 63.33 109.784 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -133.99 98.02 4.04 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.677 1.191 . . . . 73.33 107.806 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.59 164.72 17.58 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.024 0.93 . . . . 72.24 112.727 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -132.35 124.87 29.61 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.955 -1.128 . . . . 74.44 107.955 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -88.22 101.01 13.42 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.757 -0.831 . . . . 74.23 108.757 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.1 t . . . . . 0 C--N 1.323 -0.556 0 N-CA-C 106.252 -1.759 . . . . 73.12 106.252 178.734 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 . . . . . 0 C--O 1.232 0.162 0 N-CA-C 109.325 -0.62 . . . . 70.14 109.325 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.5 p -155.48 111.52 3.12 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.231 0.612 . . . . 63.23 111.157 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.66 137.38 40.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 105.569 -2.012 . . . . 62.44 105.569 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.15 123.24 63.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.689 -1.967 . . . . 70.04 105.689 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.37 142.65 45.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.93 -1.137 . . . . 55.02 107.93 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -140.39 139.43 35.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.343 1.857 . . . . 63.4 110.575 -178.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -103.07 124.08 47.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.026 -1.842 . . . . 73.54 106.026 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.421 ' HA ' ' HE2' ' A' ' 73' ' ' LYS . 69.3 t -64.58 -63.13 4.01 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 117.854 -1.07 . . . . 65.12 112.024 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.49 -11.62 32.8 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.909 2.406 . . . . 61.33 115.785 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -111.88 -13.51 13.65 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.091 0.86 . . . . 61.21 111.224 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.79 0.62 4.11 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.14 1.829 . . . . 52.12 115.616 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.7 mt -69.16 143.32 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 119.39 1.595 . . . . 72.02 109.376 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 t -136.56 136.94 48.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.229 -1.397 . . . . 63.33 107.229 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.07 147.74 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 121.543 -0.723 . . . . 63.32 109.259 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -129.64 107.52 9.51 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.431 1.092 . . . . 73.14 110.289 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 56.7 m -120.44 152.16 38.35 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.782 0.833 . . . . 62.15 109.86 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.69 100.41 2.08 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.79 1.236 . . . . 71.33 107.845 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -119.63 -14.04 9.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.359 0.664 . . . . 65.41 112.778 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.6 p -133.83 -176.83 4.3 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.18 0.992 . . . . 73.31 110.301 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -109.95 19.45 19.03 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.233 1.013 . . . . 74.45 112.644 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 t -125.63 132.02 52.55 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.44 1.096 . . . . 72.34 108.111 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.4 p -58.86 -47.25 90.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 N-CA-C 108.691 -0.855 . . . . 64.15 108.691 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -63.17 -25.87 68.54 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.892 1.071 . . . . 74.42 113.892 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -84.48 -44.73 13.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.033 -1.469 . . . . 71.31 107.033 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -64.34 -27.2 68.86 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.383 -0.823 . . . . 75.25 109.156 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -62.71 -58.3 7.95 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 126.351 1.86 . . . . 75.4 108.607 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -56.29 -37.21 69.55 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.141 0.428 . . . . 74.12 111.681 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 79.0 mt -63.9 -50.65 76.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.74 -0.837 . . . . 73.01 108.74 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.08 97.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.096 -0.478 . . . . 71.41 110.361 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -61.33 -49.14 78.17 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 118.699 0.681 . . . . 72.12 109.305 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -56.13 24.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.778 0.831 . . . . 74.34 110.452 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.36 -35.43 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 119.074 0.852 . . . . 61.24 111.544 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.1 tp -64.27 -41.19 97.04 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 121.187 -0.945 . . . . 71.4 109.15 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -58.3 -43.22 87.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.184 0.994 . . . . 72.32 109.672 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -60.81 -27.42 68.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.545 0.738 . . . . 71.24 111.234 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -88.09 -45.58 10.03 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.169 1.388 . . . . 52.2 111.84 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.6 t -63.35 -35.37 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 107.567 -1.272 . . . . 50.44 107.567 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.65 -64.23 0.9 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.71 1.204 . . . . 71.34 109.383 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.5 p -59.56 -30.53 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.518 -0.739 . . . . 71.11 111.727 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -68.87 -35.07 76.47 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.852 1.206 . . . . 63.52 111.203 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -83.08 -32.14 26.94 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.355 1.062 . . . . 74.34 109.869 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -77.11 -46.37 23.76 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.567 0.747 . . . . 62.42 110.281 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.45 -0.453 0 C-N-CA 123.641 0.776 . . . . 72.05 109.221 179.181 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 109.633 -0.506 . . . . 54.54 109.633 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -109.97 153.9 42.92 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.129 1.372 . . . . 74.4 109.497 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.61 168.64 23.31 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.805 2.337 . . . . 62.51 111.765 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.76 -172.33 39.27 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 109.866 -1.294 . . . . 64.24 109.866 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.2 mmt -125.44 158.9 33.25 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.65 1.18 . . . . 70.55 108.467 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.32 68.19 1.19 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.348 -1.352 . . . . 73.1 107.348 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.65 172.12 11.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.931 -0.577 . . . . 73.12 110.053 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.7 t -131.62 -173.23 3.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.844 0.858 . . . . 72.02 111.167 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.4 t -130.66 163.0 28.16 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.235 1.414 . . . . 64.54 109.632 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.0 m -67.6 -173.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.011 1.725 . . . . 74.3 112.293 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -132.45 176.87 8.05 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.423 1.889 . . . . 63.45 108.9 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.2 173.18 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 124.2 1.0 . . . . 72.42 110.57 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.84 162.86 28.27 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.773 -0.649 . . . . 73.53 111.569 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.85 141.07 15.36 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 106.069 -2.813 . . . . 43.51 106.069 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 118.365 1.082 . . . . 50.23 109.612 -179.467 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 118.959 -0.543 . . . . 75.31 111.212 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.51 159.0 55.26 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.452 2.768 . . . . 64.12 111.692 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 mt -136.91 122.34 19.5 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 123.189 0.595 . . . . 73.14 109.804 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -67.71 101.79 1.1 Allowed 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 106.839 -1.541 . . . . 73.44 106.839 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 45' ' ' GLU . 1.9 pm0 -57.34 -31.69 65.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.81 0.844 . . . . 72.53 112.361 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.2 m -77.56 -6.28 53.1 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.739 0.816 . . . . 62.24 112.686 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -99.83 7.11 45.22 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.235 1.414 . . . . 71.31 110.334 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mt -110.57 164.59 12.57 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.599 1.16 . . . . 75.34 110.456 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -120.96 137.73 54.48 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.167 -2.161 . . . . 65.35 105.167 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -123.78 155.19 38.39 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.818 1.647 . . . . 72.14 110.725 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -129.87 178.7 6.33 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.206 1.002 . . . . 73.14 108.829 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -135.43 163.5 29.9 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.476 1.91 . . . . 75.02 107.619 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.4 t . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 104.096 -2.557 . . . . 64.35 104.096 178.325 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 112.791 0.663 . . . . 54.44 112.791 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.9 m -64.25 144.61 57.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.031 1.333 . . . . 62.43 109.679 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.4 162.48 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 121.897 0.856 . . . . 61.23 109.96 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -141.34 156.26 21.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 126.996 2.118 . . . . 63.11 107.549 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.45 150.04 40.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.704 -1.961 . . . . 71.54 105.704 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.89 158.17 43.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.665 0.786 . . . . 72.34 109.337 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -107.34 126.38 52.38 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 104.828 -2.286 . . . . 75.51 104.828 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.1 t -68.28 -58.03 8.05 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 120.051 1.296 . . . . 73.12 111.593 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.09 -12.55 35.26 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.423 2.082 . . . . 73.13 115.628 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -112.4 -21.18 11.5 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.954 0.797 . . . . 61.42 109.719 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.39 -9.25 7.86 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.606 2.526 . . . . 74.51 113.686 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.408 HG21 ' HB3' ' A' ' 103' ' ' LYS . 11.7 mt -55.41 147.49 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.1 1.76 . . . . 72.11 109.918 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.2 t -134.35 146.94 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.468 1.507 . . . . 71.3 108.045 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -144.97 139.54 22.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.225 1.01 . . . . 53.25 108.896 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -110.64 127.89 55.46 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.156 1.382 . . . . 75.4 108.706 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.7 m -150.54 149.39 29.88 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.54 0.686 . . . . 73.43 112.799 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -155.23 139.72 16.85 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 129.584 3.154 . . . . 74.05 105.073 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -152.82 -68.97 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.719 -1.215 . . . . 63.04 107.719 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.0 p -77.93 151.66 33.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.564 1.146 . . . . 72.32 111.129 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -66.75 -25.83 66.69 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.83 0.678 . . . . 64.23 112.83 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 m -79.64 116.23 19.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.51 0.595 . . . . 72.42 109.845 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.8 p -54.07 -42.6 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.757 -0.831 . . . . 72.3 108.757 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.93 -44.42 78.35 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.132 0.973 . . . . 43.33 111.745 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -67.16 -39.55 86.51 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.043 -1.095 . . . . 73.15 108.043 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -60.86 -29.06 69.3 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.634 -0.698 . . . . 72.1 109.612 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -58.17 -40.91 82.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.801 1.182 . . . . 71.51 108.754 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -71.56 -46.51 59.23 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 125.098 1.359 . . . . 72.14 110.382 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 99.4 mt -56.97 -52.8 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.462 0.705 . . . . 72.32 111.277 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.5 -28.08 69.58 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.73 -0.606 . . . . 70.03 111.426 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -72.94 -45.76 56.28 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 118.554 -0.736 . . . . 74.44 109.883 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -64.82 -35.85 82.43 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.941 1.246 . . . . 74.2 111.101 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.3 p -71.79 -32.99 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 120.041 1.291 . . . . 74.23 108.375 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.4 tp -64.87 -32.77 74.64 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.602 -1.258 . . . . 52.43 107.602 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -55.75 -41.43 73.96 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.216 -0.661 . . . . 71.22 109.216 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -63.51 -39.58 94.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.733 0.697 . . . . 73.22 110.886 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HB3' HG21 ' A' ' 79' ' ' ILE . 73.4 mmtt -63.24 -48.19 79.27 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.773 0.829 . . . . 73.34 110.518 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 50.1 t -69.28 -41.01 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.872 0.869 . . . . 73.34 110.207 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.48 -62.01 1.89 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.183 1.393 . . . . 64.14 109.681 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.75 -22.44 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.027 0.931 . . . . 62.53 112.248 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -75.37 -27.2 59.04 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.771 -1.206 . . . . 74.24 111.293 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -98.94 -30.73 12.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.346 0.975 . . . . 73.24 109.655 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -75.89 -6.4 50.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.292 0.637 . . . . 71.15 110.597 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.237 0.401 0 C-N-CA 125.795 1.638 . . . . 73.42 110.145 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 C--O 1.233 0.2 0 N-CA-C 109.822 -0.436 . . . . 45.02 109.822 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -121.58 154.68 59.93 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.483 1.513 . . . . 72.14 109.411 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.54 169.65 22.06 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.745 2.297 . . . . 65.52 111.094 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.33 175.46 20.68 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.645 -1.382 . . . . 63.41 109.645 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.1 ttt -143.7 144.65 31.94 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.726 -1.212 . . . . 74.44 107.726 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.07 80.34 0.99 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.569 -1.641 . . . . 33.11 106.569 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.06 160.85 21.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.141 0.577 . . . . 53.43 110.807 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -103.31 -168.0 1.45 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.555 1.542 . . . . 74.43 108.29 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.3 p -124.37 -177.26 3.74 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.447 1.499 . . . . 65.24 109.977 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.72 157.96 41.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 125.203 1.401 . . . . 62.24 108.332 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.95 163.48 15.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.605 0.762 . . . . 54.43 110.987 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.0 -179.57 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.701 1.2 . . . . 72.21 108.788 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.06 161.22 20.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.956 1.302 . . . . 74.44 109.003 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.66 166.47 54.83 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.003 -1.239 . . . . 71.3 110.003 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? . . . . . 0 N--CA 1.47 0.535 0 C-N-CA 124.765 1.226 . . . . 74.2 110.067 -179.693 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 114.042 1.127 . . . . 73.45 114.042 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.04 154.6 33.23 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.907 2.405 . . . . 73.33 109.784 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.8 mt -134.35 136.81 43.67 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.717 0.807 . . . . 72.03 110.255 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.92 107.59 1.9 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.083 1.353 . . . . 72.34 108.668 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.58 -19.25 57.05 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.56 0.578 . . . . 72.25 112.56 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.9 m -85.27 -1.91 57.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.497 1.044 . . . . 52.45 112.033 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -114.63 -4.97 12.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.925 1.239 . . . . 72.1 112.585 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mt -86.33 140.99 29.55 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.911 -1.885 . . . . 71.4 105.911 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -109.0 126.11 52.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.779 0.718 . . . . 74.13 109.416 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.57 164.49 12.48 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.325 1.05 . . . . 64.24 112.613 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -141.61 143.86 33.9 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.31 -1.737 . . . . 73.34 106.31 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -103.83 123.39 47.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.085 -1.821 . . . . 73.23 106.085 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.1 t . . . . . 0 C--N 1.331 -0.226 0 N-CA-C 106.05 -1.833 . . . . 74.13 106.05 -179.878 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.495 HD21 ' HB ' ' A' ' 89' ' ' VAL . 22.2 t-20 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 107.97 -1.122 . . . . 54.45 107.97 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.8 m -150.49 152.38 34.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.024 -1.473 . . . . 60.4 107.024 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.4 124.15 70.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.051 -2.203 . . . . 61.24 105.051 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.96 96.21 4.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.817 -2.29 . . . . 71.01 104.817 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.9 tp -91.86 139.54 30.56 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.203 -1.777 . . . . 73.31 106.203 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.25 141.15 45.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.76 1.224 . . . . 74.42 110.56 -177.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -95.79 133.29 40.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.856 -1.535 . . . . 61.11 106.856 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.7 t -70.73 -66.5 0.78 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.307 1.043 . . . . 63.14 111.438 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.41 -7.63 21.24 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.858 3.038 . . . . 70.2 116.177 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 t -114.54 -20.43 10.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.524 0.602 . . . . 70.43 110.91 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.54 -3.97 4.34 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.604 -1.109 . . . . 64.42 114.807 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.99 139.52 20.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.261 -1.385 . . . . 73.13 107.261 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.64 147.93 33.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.223 -1.399 . . . . 63.12 107.223 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.464 HG21 HG13 ' A' ' 99' ' ' VAL . 9.8 p -143.12 140.82 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.986 -1.487 . . . . 52.21 106.986 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.68 107.79 13.66 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 106.515 -1.661 . . . . 61.22 106.515 -178.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 77.3 m -112.04 134.86 53.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 123.555 0.534 . . . . 74.43 110.567 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -147.28 109.87 4.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.66 2.384 . . . . 74.34 106.517 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -135.45 -20.71 1.59 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.49 1.116 . . . . 71.24 111.264 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.79 173.43 16.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.599 1.16 . . . . 72.55 107.914 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -86.63 -4.97 59.25 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.961 -1.087 . . . . 72.04 109.819 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.5 m -82.15 115.0 21.06 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.324 -1.362 . . . . 61.42 107.324 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.495 ' HB ' HD21 ' A' ' 68' ' ' ASN . 13.9 p -61.19 -38.7 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.796 -0.816 . . . . 51.1 108.796 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.479 ' HA ' ' HD3' ' A' ' 93' ' ' ARG . 9.9 m-20 -63.42 -23.05 67.24 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 113.859 1.059 . . . . 65.0 113.859 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -87.71 -46.84 9.14 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.321 -0.992 . . . . 63.12 108.321 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.11 -43.7 91.93 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.746 0.818 . . . . 61.13 110.945 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.479 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 4.0 ptm180 -57.74 -46.42 84.48 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 113.06 0.763 . . . . 74.11 113.06 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -64.41 -36.76 85.2 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 119.541 -0.863 . . . . 72.43 111.717 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.2 mt -60.89 -49.92 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.112 -1.44 . . . . 61.25 107.112 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.43 68.11 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.476 0.71 . . . . 32.33 111.684 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.9 ttm-85 -61.18 -53.78 52.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.11 0.414 . . . . 71.41 110.959 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -61.97 -39.8 93.43 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.68 -0.676 . . . . 75.31 112.409 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.464 HG13 HG21 ' A' ' 81' ' ' VAL . 13.8 p -72.19 -27.15 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 120.482 1.492 . . . . 72.22 109.495 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.9 tp -65.62 -47.48 75.48 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 120.329 -1.482 . . . . 74.25 107.445 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -56.91 -39.23 74.05 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.678 -1.153 . . . . 72.24 111.891 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.17 -50.2 74.93 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.775 1.17 . . . . 65.55 110.303 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -68.17 -44.6 75.58 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.844 -0.616 . . . . 75.21 112.084 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.6 t -62.91 -37.98 80.68 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-O 118.648 -0.692 . . . . 74.52 109.789 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -56.2 -52.23 65.18 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-N 119.354 0.979 . . . . 74.44 110.382 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.96 -18.15 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 121.647 -0.658 . . . . 72.3 112.434 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -87.48 -19.68 27.63 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.621 1.568 . . . . 74.2 110.224 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.26 -46.69 5.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.75 2.02 . . . . 73.01 110.928 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -77.07 -25.95 52.95 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.703 0.683 . . . . 62.02 111.937 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 CA--C 1.539 0.523 0 C-N-CA 127.895 2.478 . . . . 74.33 106.631 179.059 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.306 -0.627 . . . . 74.44 109.306 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -118.43 156.53 50.95 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 125.423 1.489 . . . . 74.41 108.712 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.81 166.34 29.95 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.431 2.087 . . . . 75.22 111.491 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.12 -175.92 50.98 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.241 -1.143 . . . . 63.23 110.241 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 60.7 mtt -122.84 168.26 12.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.962 0.905 . . . . 44.11 110.04 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.16 132.16 9.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 102.063 -3.31 . . . . 73.44 102.063 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -130.08 177.44 7.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.594 -1.262 . . . . 44.02 107.594 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.27 176.33 5.34 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.574 -0.704 . . . . 73.51 110.189 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -124.58 170.88 10.48 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.466 1.107 . . . . 54.34 108.865 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.74 -175.26 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.6 1.16 . . . . 60.25 109.996 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -132.52 173.65 11.1 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.22 1.008 . . . . 74.31 109.53 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.0 149.35 10.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 124.153 0.981 . . . . 75.05 109.357 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.13 173.54 7.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.37 1.068 . . . . 64.32 111.518 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.18 176.17 16.25 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 107.873 -2.091 . . . . 64.23 107.873 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.3 mmp_? . . . . . 0 C--O 1.235 0.294 0 O-C-N 121.182 -1.187 . . . . 52.13 111.639 -179.057 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 113.056 0.761 . . . . 71.55 113.056 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.11 112.59 2.84 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.19 2.594 . . . . 53.3 112.042 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mt -91.29 140.95 29.29 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.638 -0.664 . . . . 73.24 110.849 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -89.53 106.35 18.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.642 -1.984 . . . . 73.31 105.642 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -60.04 -11.49 6.01 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 114.879 1.437 . . . . 73.54 114.879 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.4 m -101.15 -3.44 29.15 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.208 1.003 . . . . 64.54 111.595 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -96.59 -8.83 30.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.433 1.093 . . . . 71.11 110.556 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.06 175.26 6.93 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.347 1.459 . . . . 74.23 109.709 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -130.1 122.65 28.7 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.39 0.676 . . . . 73.23 109.825 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -105.26 160.09 15.37 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.275 1.03 . . . . 73.2 111.182 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -142.05 131.17 23.29 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.139 1.376 . . . . 65.11 108.896 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -88.41 163.04 16.18 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.665 1.186 . . . . 65.42 107.933 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 N--CA 1.455 -0.222 0 C-N-CA 124.285 1.034 . . . . 43.31 108.865 -178.996 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 122.056 0.932 . . . . 64.24 111.185 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.2 m -99.51 158.39 15.77 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.401 0.68 . . . . 55.35 109.299 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.4 t -140.74 135.83 34.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.925 1.69 . . . . 74.43 106.583 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.28 142.27 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.201 -1.407 . . . . 72.0 107.201 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.4 tp -131.57 146.74 52.36 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.697 1.199 . . . . 51.41 107.976 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.56 148.59 49.15 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.476 0.655 . . . . 75.13 110.15 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -93.92 118.67 31.8 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 104.243 -2.503 . . . . 71.44 104.243 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.19 -61.53 7.66 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 118.531 -0.747 . . . . 74.34 112.077 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -69.91 -9.78 26.87 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.793 2.329 . . . . 51.02 116.197 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 m -120.95 -10.33 9.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.438 1.472 . . . . 73.02 114.614 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.74 9.67 27.52 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.737 1.161 . . . . 73.21 114.725 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 mt -70.81 131.5 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 104.772 -2.307 . . . . 71.22 104.772 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.1 t -126.52 143.93 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.55 -1.278 . . . . 62.13 107.55 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.54 142.57 25.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.525 -0.917 . . . . 71.02 108.525 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -115.42 118.5 33.38 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.751 1.62 . . . . 72.54 110.154 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.0 p -116.55 143.42 45.62 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.397 0.544 . . . . 72.11 110.135 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -157.41 100.32 1.81 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.704 1.202 . . . . 64.33 108.813 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -135.34 -24.62 1.39 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 119.989 1.268 . . . . 74.33 114.017 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.2 p -124.29 171.6 9.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.576 0.75 . . . . 74.13 110.025 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -91.25 0.85 57.45 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.56 -0.533 . . . . 61.23 109.56 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.0 m -100.28 114.97 28.85 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.11 1.364 . . . . 73.44 107.961 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.2 p -59.42 -38.41 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.538 -0.912 . . . . 70.41 108.538 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -59.4 -40.52 86.9 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.048 1.739 . . . . 61.01 112.318 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -79.11 -29.76 43.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.492 0.717 . . . . 73.54 110.662 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.418 ' HA ' HD12 ' A' ' 95' ' ' ILE . 89.9 m-20 -70.37 -40.44 73.99 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.275 -1.38 . . . . 51.31 107.275 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -48.61 -52.01 25.14 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.744 -1.223 . . . . 74.21 113.022 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -57.3 -35.16 69.48 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.174 0.897 . . . . 64.42 112.684 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 92' ' ' ASN . 54.6 mt -63.05 -50.39 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.221 1.008 . . . . 60.34 108.557 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.86 92.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 119.367 -0.349 . . . . 55.02 110.427 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -61.73 -51.65 67.51 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.051 0.541 . . . . 73.22 111.812 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -40.58 95.35 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 117.783 -1.103 . . . . 73.2 112.32 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.422 HG22 ' HE2' ' A' ' 103' ' ' LYS . 4.4 p -73.81 -38.77 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 119.676 1.126 . . . . 72.51 110.456 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 104' ' ' VAL . 56.3 tp -60.93 -44.99 96.45 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.86 -0.792 . . . . 72.1 108.86 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -50.28 -47.62 55.31 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 124.143 0.977 . . . . 72.33 112.095 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -59.27 -35.83 74.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.826 -1.171 . . . . 71.41 111.671 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.422 ' HE2' HG22 ' A' ' 99' ' ' VAL . 54.6 mttm -77.6 -33.55 53.79 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.586 1.154 . . . . 75.24 110.184 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 100' ' ' LEU . 60.8 t -66.12 -51.7 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 C-N-CA 125.712 1.605 . . . . 72.52 108.171 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -61.62 2.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 126.263 1.825 . . . . 74.32 111.234 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.3 p -59.52 -28.9 41.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 119.489 -0.291 . . . . 61.25 111.758 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -66.82 -37.58 84.79 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.579 -1.326 . . . . 74.33 109.996 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -81.84 -40.98 21.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.809 -0.557 . . . . 73.2 110.629 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -74.65 -15.14 60.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.643 1.577 . . . . 70.21 112.611 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 124.918 1.287 . . . . 53.12 109.364 -179.258 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.272 -0.64 . . . . 75.41 109.272 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -79.57 158.07 73.97 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.884 -0.784 . . . . 74.52 108.884 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.91 -176.61 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.749 2.3 . . . . 65.41 110.049 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.84 147.67 43.4 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 109.602 -1.399 . . . . 64.1 109.602 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 70.8 mtm -134.79 173.74 11.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.203 1.401 . . . . 75.53 108.704 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.31 119.17 10.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 100.847 -3.761 . . . . 61.22 100.847 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -123.8 175.61 6.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.846 0.459 . . . . 74.32 109.969 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.6 t -61.76 141.59 57.8 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.347 0.659 . . . . 71.23 109.57 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.9 p -73.37 -174.98 1.78 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.794 1.238 . . . . 75.44 109.602 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.2 m -62.58 153.74 6.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 O-C-N 121.041 -1.037 . . . . 50.22 109.873 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -130.55 -176.39 3.96 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.297 1.439 . . . . 61.04 109.521 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 t -70.77 163.72 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 122.007 0.908 . . . . 62.01 110.946 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.94 168.51 13.87 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 127.792 2.437 . . . . 52.42 107.779 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.04 -174.31 50.28 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 109.055 -1.618 . . . . 73.13 109.055 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 . . . . . 0 C--O 1.235 0.291 0 CA-C-N 118.15 0.975 . . . . 72.44 109.706 179.289 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 C--O 1.234 0.262 0 N-CA-C 109.864 -0.421 . . . . 63.45 109.864 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.76 122.95 10.95 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.072 2.515 . . . . 61.21 111.664 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -112.28 147.74 35.64 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.641 1.177 . . . . 62.43 110.341 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -110.49 115.48 29.7 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.663 -1.236 . . . . 53.12 107.663 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.52 -28.24 69.51 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.851 0.75 . . . . 70.14 111.675 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 m -75.36 0.05 18.17 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.514 1.126 . . . . 71.21 111.471 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -117.64 5.76 12.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.107 1.363 . . . . 74.32 113.305 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.435 HD22 ' CD2' ' A' ' 74' ' ' HIS . 6.1 mt -107.87 176.0 5.29 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.732 -1.21 . . . . 73.32 107.732 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -138.6 112.46 8.43 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.124 0.57 . . . . 63.44 109.661 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 157.26 17.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.003 -1.48 . . . . 73.54 107.003 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -142.04 -179.67 6.36 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.733 -1.21 . . . . 63.43 107.733 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.04 162.97 27.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.844 1.258 . . . . 64.4 108.476 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.8 t . . . . . 0 C--O 1.238 0.485 0 C-N-CA 125.64 1.576 . . . . 74.45 108.909 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 108.697 -0.853 . . . . 72.35 108.697 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.7 p -156.67 103.71 2.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.906 -1.516 . . . . 62.44 106.906 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.0 t -94.38 158.73 2.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.16 -1.052 . . . . 73.13 108.16 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.02 146.35 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.49 1.116 . . . . 64.42 109.751 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.4 tp -146.12 149.7 34.52 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.447 1.499 . . . . 72.35 108.407 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -140.27 148.38 41.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.052 1.341 . . . . 74.15 109.812 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.435 ' CD2' HD22 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -100.02 126.06 46.16 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.564 1.546 . . . . 74.13 107.547 178.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.8 -56.1 5.01 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 118.084 -0.96 . . . . 54.41 111.511 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.31 -8.14 22.19 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.093 1.862 . . . . 64.54 116.081 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -120.73 -9.97 9.25 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.093 0.861 . . . . 64.31 112.614 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.78 4.14 9.71 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.518 -1.157 . . . . 32.13 115.132 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.1 mt -70.28 141.92 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 126.187 1.795 . . . . 75.33 107.746 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.6 148.08 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.745 1.218 . . . . 35.02 108.382 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.3 151.76 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.249 -0.648 . . . . 73.35 109.249 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -132.42 107.98 8.86 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.02 -1.474 . . . . 72.32 107.02 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.3 m -123.6 153.33 40.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 122.475 1.131 . . . . 60.42 112.869 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -154.3 148.41 25.81 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.909 2.084 . . . . 72.32 107.521 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -162.46 -26.79 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.159 0.983 . . . . 53.21 110.784 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.5 p -138.34 158.1 44.94 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.782 -0.574 . . . . 51.11 110.924 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -22.51 66.94 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.643 -0.661 . . . . 63.54 111.847 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -79.54 116.81 19.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.21 1.804 . . . . 63.54 112.217 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.4 p -58.72 -40.78 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.38 0.672 . . . . 44.32 110.162 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -58.72 -46.92 86.28 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.918 0.887 . . . . 61.55 111.425 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -65.06 -44.12 90.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.564 1.145 . . . . 70.54 109.837 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -61.36 -40.42 94.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.997 0.362 . . . . 64.11 110.353 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -59.09 -38.87 80.52 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.134 -0.936 . . . . 72.23 111.028 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -59.77 -48.22 82.54 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.383 0.992 . . . . 74.12 109.287 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.1 -48.2 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 123.844 0.858 . . . . 40.14 109.397 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.47 82.37 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.177 0.591 . . . . 74.1 110.343 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -62.39 -45.35 93.56 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.055 0.542 . . . . 64.43 110.12 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -55.65 -61.65 2.21 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.138 0.975 . . . . 74.23 109.202 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.73 -34.45 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.655 0.613 . . . . 73.13 112.655 -177.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.0 -47.78 81.64 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.032 0.933 . . . . 51.44 109.12 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -52.13 -41.41 62.5 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.937 0.895 . . . . 62.53 113.17 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.5 -33.15 75.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.609 0.719 . . . . 64.11 110.738 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -73.59 -34.45 65.08 Favored 'General case' 0 C--N 1.335 -0.053 0 O-C-N 121.355 -0.841 . . . . 73.11 110.137 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.1 t -68.07 -43.41 85.3 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 CA-C-O 118.354 -0.831 . . . . 71.2 109.112 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -50.28 -60.76 2.66 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.391 1.077 . . . . 74.25 109.604 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.96 -29.25 46.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-O 118.601 -0.714 . . . . 74.32 111.737 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -69.56 -38.79 77.56 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 120.104 1.32 . . . . 74.34 110.93 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -73.76 -56.08 5.43 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.472 -0.936 . . . . 74.54 108.472 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -67.82 -21.33 65.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 115.202 1.556 . . . . 53.33 115.202 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 C--N 1.327 -0.397 0 C-N-CA 125.708 1.603 . . . . 71.24 107.665 179.825 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 121.578 0.704 . . . . 65.21 112.169 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.25 152.72 92.37 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.125 -0.694 . . . . 74.34 109.125 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.68 3.8 5.13 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.448 2.765 . . . . 63.3 113.358 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.04 179.43 48.07 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.186 -1.966 . . . . 62.44 108.186 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 92.8 mtp -141.45 172.1 13.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.828 1.251 . . . . 71.51 107.975 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.48 144.69 25.54 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 101.571 -3.492 . . . . 61.5 101.571 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.58 173.52 11.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.314 -0.625 . . . . 74.01 109.314 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.4 t -77.35 179.53 6.37 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.343 -0.984 . . . . 63.12 108.343 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 m -142.38 150.04 40.17 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 106.803 -1.554 . . . . 74.23 106.803 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -66.33 169.95 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 123.75 0.82 . . . . 51.25 110.115 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -123.29 166.67 14.89 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.996 0.919 . . . . 73.24 108.814 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.9 m -112.13 -168.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.236 1.415 . . . . 71.33 108.506 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.49 -19.32 13.28 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.066 -0.493 . . . . 54.45 111.103 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.0 -107.68 2.11 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.164 -1.574 . . . . 33.33 109.164 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.334 -0.102 0 C-N-CA 125.942 1.697 . . . . 74.41 111.209 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 109.635 -0.506 . . . . 61.12 109.635 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.51 165.85 29.73 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.896 2.397 . . . . 71.2 113.696 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.605 HD12 ' C ' ' A' ' 43' ' ' LEU 0.423 0.2 OUTLIER -134.86 166.09 23.79 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.4 1.88 . . . . 72.51 111.541 179.801 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -120.16 101.56 7.91 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.103 -1.073 . . . . 71.34 108.103 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -67.28 -11.95 58.85 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.931 1.085 . . . . 75.12 113.931 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -0.66 57.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.159 1.384 . . . . 41.53 112.726 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -126.16 32.61 5.19 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.852 1.261 . . . . 73.03 109.757 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.1 mt -113.79 117.25 30.94 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.736 1.215 . . . . 63.4 108.036 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -102.76 103.95 14.22 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 104.802 -2.295 . . . . 74.12 104.802 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -84.63 163.78 19.06 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.537 1.062 . . . . 74.45 108.945 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -120.52 129.03 53.64 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.206 -1.776 . . . . 71.51 106.206 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -87.41 143.27 27.32 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.422 -0.955 . . . . 74.23 108.422 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 105.565 -2.013 . . . . 51.4 105.565 179.885 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.464 HD21 ' N ' ' A' ' 89' ' ' VAL . 33.4 t-20 . . . . . 0 C--O 1.237 0.403 0 N-CA-C 107.866 -1.161 . . . . 71.02 107.866 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.0 t -141.64 138.04 32.25 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.25 1.82 . . . . 61.35 106.491 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.7 t -121.67 150.56 24.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.709 -1.589 . . . . 72.11 106.709 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -137.71 128.91 39.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 102.699 -3.075 . . . . 51.34 102.699 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.1 tp -130.51 143.92 51.07 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.062 0.945 . . . . 72.34 110.633 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.488 ' CB ' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -144.05 143.98 31.42 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.261 -0.899 . . . . 74.03 112.631 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.73 ' HB2' HD11 ' A' ' 100' ' ' LEU . 2.4 t-80 -86.4 121.0 28.34 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.266 -2.124 . . . . 74.03 105.266 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.44 -57.75 23.16 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.588 1.086 . . . . 53.13 112.123 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -59.33 -34.14 97.76 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.615 1.543 . . . . 54.32 114.905 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -93.66 -16.04 24.7 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.523 0.934 . . . . 74.03 113.523 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.07 23.83 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.565 1.555 . . . . 73.41 113.737 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.1 mt -70.27 120.82 18.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.049 -1.463 . . . . 71.12 107.049 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.488 HG22 ' CB ' ' A' ' 73' ' ' LYS . 69.7 t -111.23 128.51 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 126.385 1.874 . . . . 71.15 107.647 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.5 157.96 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 123.385 1.564 . . . . 60.45 108.018 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -141.28 139.68 33.72 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.877 -2.268 . . . . 63.24 104.877 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.7 t -138.65 163.69 31.45 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.224 -1.769 . . . . 61.22 106.224 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -155.09 149.22 25.89 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 104.848 -2.279 . . . . 52.24 104.848 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -170.98 -40.51 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.138 -0.458 . . . . 73.14 110.153 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 p -127.25 -177.45 4.07 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.399 0.619 . . . . 72.52 112.426 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.9 mtm-85 -103.77 -0.41 29.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.991 0.917 . . . . 75.25 110.943 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m -98.44 115.72 29.13 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.644 -1.243 . . . . 73.32 107.644 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.464 ' N ' HD21 ' A' ' 68' ' ' ASN . 7.6 p -55.97 -45.82 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 122.878 0.471 . . . . 74.35 109.82 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.63 -32.62 67.43 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.832 1.253 . . . . 71.43 112.618 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -82.13 -44.48 16.44 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 120.582 -1.324 . . . . 72.12 108.127 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -57.35 -36.8 71.64 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.593 0.757 . . . . 65.42 109.632 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -60.12 -51.19 70.67 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 118.144 -0.932 . . . . 64.2 109.604 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -64.58 -36.57 84.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.837 1.199 . . . . 51.21 112.482 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.62 -43.07 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.157 -0.683 . . . . 61.03 109.157 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.19 -38.11 87.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.046 0.538 . . . . 74.44 110.814 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.496 HH11 ' HG3' ' A' ' 97' ' ' ARG . 0.9 OUTLIER -57.6 -52.72 64.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.047 0.939 . . . . 75.14 111.858 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.78 97.37 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 119.379 -0.929 . . . . 62.34 112.524 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.83 -32.45 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 120.113 1.324 . . . . 71.15 111.388 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.73 HD11 ' HB2' ' A' ' 74' ' ' HIS . 9.1 tp -62.39 -40.29 95.98 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.523 -0.736 . . . . 75.1 109.447 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -57.44 -42.59 82.73 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.217 0.607 . . . . 72.34 110.097 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -61.11 -20.52 62.74 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.474 0.916 . . . . 71.11 113.474 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -87.54 -38.83 15.66 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.475 -0.766 . . . . 73.31 109.458 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.0 t -67.39 -31.98 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.479 -0.934 . . . . 70.13 108.479 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -52.93 -57.61 9.72 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.098 1.359 . . . . 72.25 108.116 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.34 -38.68 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.521 1.128 . . . . 74.25 109.375 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -62.85 -37.23 86.01 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.896 1.226 . . . . 74.24 110.449 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -75.79 -33.62 60.16 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.64 0.978 . . . . 73.25 113.64 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -108.33 -9.46 15.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 116.369 1.989 . . . . 75.35 116.369 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 C--N 1.32 -0.677 0 C-N-CA 126.569 1.948 . . . . 73.05 110.138 -178.991 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 121.113 0.482 . . . . 64.23 109.778 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -75.2 155.24 86.22 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.851 0.86 . . . . 74.23 110.399 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.58 175.96 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.122 2.548 . . . . 74.05 110.586 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.59 163.02 53.47 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.031 -0.827 . . . . 71.22 111.031 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 95.6 mtp -73.46 163.92 27.38 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.088 0.555 . . . . 53.52 110.438 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.63 71.96 1.37 Allowed 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 105.546 -2.02 . . . . 65.23 105.546 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.49 -172.1 1.71 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.056 -0.975 . . . . 62.21 111.032 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.91 172.63 2.18 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.316 1.047 . . . . 62.3 110.434 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -130.05 177.36 7.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.634 1.174 . . . . 72.13 109.47 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 m -63.69 137.0 25.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.785 1.634 . . . . 72.1 108.672 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -132.36 -176.7 4.17 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.601 1.16 . . . . 65.12 111.531 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.2 t -54.84 151.87 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.235 1.814 . . . . 65.22 108.396 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.06 -167.08 1.14 Allowed 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.106 0.962 . . . . 64.43 109.573 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.49 -171.93 2.02 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.357 1.455 . . . . 62.03 113.034 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? . . . . . 0 CA--C 1.513 -0.45 0 C-N-CA 123.417 0.687 . . . . 73.1 109.72 -179.409 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.236 0.384 0 CA-C-O 119.444 -0.312 . . . . 72.13 111.344 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.21 165.58 26.19 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.141 2.56 . . . . 54.33 112.211 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 43' ' ' LEU 0.413 0.2 OUTLIER -136.39 164.17 28.76 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 114.06 1.133 . . . . 74.25 114.06 -179.074 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.53 HD22 ' HB2' ' A' ' 47' ' ' GLU . 15.6 t30 -120.84 101.1 7.48 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 104.455 -2.424 . . . . 74.03 104.455 177.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.41 -14.17 25.98 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.417 1.087 . . . . 71.21 113.922 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -98.53 6.8 46.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.352 1.061 . . . . 74.52 110.8 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.53 ' HB2' HD22 ' A' ' 44' ' ' ASN . 6.7 tp10 -120.13 23.93 10.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.328 1.451 . . . . 74.42 110.178 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 mt -113.41 145.9 40.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.545 1.538 . . . . 72.31 107.388 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -116.74 106.44 13.51 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.036 -2.209 . . . . 75.54 105.036 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -100.89 154.05 18.99 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.414 1.085 . . . . 70.31 113.019 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -144.93 169.89 17.2 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.962 -1.125 . . . . 71.44 107.962 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -121.27 133.74 55.15 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.946 -1.872 . . . . 72.54 105.946 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.5 t . . . . . 0 C--N 1.331 -0.228 0 N-CA-C 107.315 -1.365 . . . . 54.33 107.315 -178.242 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.7 p30 . . . . . 0 N--CA 1.467 0.419 0 CA-C-O 118.573 -0.727 . . . . 75.44 112.476 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 55.6 m -67.17 142.1 57.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.082 0.856 . . . . 53.33 108.962 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.1 t -115.22 135.54 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.383 -2.081 . . . . 63.41 105.383 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.18 130.75 73.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 102.97 -2.974 . . . . 64.35 102.97 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.7 tp -139.01 151.58 46.93 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.123 0.569 . . . . 62.42 110.168 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 152.43 45.72 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 122.424 0.289 . . . . 52.33 110.458 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -95.61 122.95 38.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 103.326 -2.842 . . . . 75.2 103.326 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.48 -62.37 5.56 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 120.091 1.314 . . . . 60.22 112.017 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.6 -17.12 58.59 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.569 2.18 . . . . 63.45 115.581 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.21 -13.54 16.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.817 1.19 . . . . 75.45 110.665 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.41 -15.03 0.87 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.634 1.587 . . . . 61.15 115.498 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.1 mt -56.95 132.7 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.721 1.608 . . . . 73.3 110.851 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.2 t -124.14 138.39 53.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 126.868 2.067 . . . . 53.24 106.094 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.6 157.3 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.737 -0.468 . . . . 74.24 109.737 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -119.69 131.58 55.45 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 126.251 1.82 . . . . 75.51 109.134 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -141.24 153.61 45.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.186 0.994 . . . . 63.31 111.318 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -155.5 159.07 39.46 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 128.011 2.525 . . . . 64.55 107.356 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -161.8 -54.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.198 1.399 . . . . 73.12 108.321 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.47 179.13 6.22 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.89 0.853 . . . . 71.25 110.907 -178.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -13.23 62.28 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.753 0.821 . . . . 74.45 112.151 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.31 115.07 22.3 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.353 0.661 . . . . 72.15 112.777 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.82 -33.11 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.077 -1.453 . . . . 74.35 107.077 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.58 -38.36 84.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.178 1.791 . . . . 73.24 109.763 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.8 -52.29 9.79 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.683 -1.229 . . . . 64.35 107.683 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -52.8 -33.9 51.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.286 0.634 . . . . 73.23 110.104 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -59.26 -62.03 2.19 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.44 1.496 . . . . 73.4 108.19 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -62.67 -36.41 82.78 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 118.395 -0.812 . . . . 73.43 112.992 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.35 -51.44 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.245 -1.391 . . . . 71.22 107.245 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.54 -50.18 72.38 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.408 -0.59 . . . . 64.42 109.408 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -54.22 -39.93 67.19 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 118.035 -0.983 . . . . 64.31 112.164 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -44.6 47.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.288 -1.339 . . . . 71.51 110.831 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.16 -32.85 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.769 1.622 . . . . 52.12 112.256 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.5 tp -59.66 -35.8 75.14 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.485 -0.759 . . . . 71.3 109.434 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.76 -38.34 87.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.028 0.931 . . . . 73.1 109.479 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -68.12 -17.64 64.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.882 1.673 . . . . 64.14 111.136 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -97.17 -35.54 10.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.99 0.916 . . . . 65.14 109.001 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.5 t -69.16 -31.92 51.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.011 -1.107 . . . . 70.33 108.011 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -62.04 1.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.872 2.069 . . . . 61.21 109.174 177.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.64 -25.11 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 122.645 0.378 . . . . 61.42 111.475 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -77.77 -15.28 59.22 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.99 -1.069 . . . . 74.45 111.026 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -94.05 -42.31 9.09 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.045 1.338 . . . . 72.52 108.975 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -87.86 -14.58 39.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.781 1.03 . . . . 52.44 113.781 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.324 -0.517 0 C-N-CA 125.954 1.702 . . . . 74.12 108.049 179.625 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 109.16 -0.682 . . . . 75.01 109.16 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -123.47 154.7 66.18 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 125.314 1.446 . . . . 64.34 109.651 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.66 169.07 22.5 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.84 2.36 . . . . 50.01 111.441 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.22 171.02 49.83 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.434 -1.066 . . . . 44.21 110.434 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.3 tpt -154.72 142.65 20.1 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.411 -1.7 . . . . 74.52 106.411 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.12 65.75 0.77 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.022 0.929 . . . . 74.43 108.569 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 154.08 30.66 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.965 -0.46 . . . . 55.54 110.587 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -71.8 152.97 42.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.046 -0.724 . . . . 61.24 109.046 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -85.89 -170.62 3.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.021 1.728 . . . . 64.2 111.01 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 t -70.79 154.22 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.203 1.401 . . . . 65.13 109.36 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -90.5 -178.16 5.25 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.945 0.879 . . . . 71.32 109.788 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.24 165.92 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.785 1.634 . . . . 75.34 108.395 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.57 169.72 17.13 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.943 1.697 . . . . 75.52 108.122 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.7 76.76 1.34 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 107.867 -2.093 . . . . 61.42 107.867 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 108.102 -1.073 . . . . 71.23 108.102 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 119.41 -0.329 . . . . 72.45 111.279 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.21 99.11 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.197 2.598 . . . . 74.1 111.919 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.8 mt -89.86 133.35 34.79 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.951 1.3 . . . . 73.22 108.576 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -75.68 106.99 7.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.54 -0.911 . . . . 75.4 108.54 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -59.95 -9.86 3.48 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.003 1.483 . . . . 63.32 115.003 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -101.18 -14.23 17.81 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.036 1.334 . . . . 73.32 112.473 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -90.39 -4.11 57.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.849 1.26 . . . . 70.43 111.85 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mt -84.2 150.89 25.18 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.758 1.623 . . . . 74.1 113.722 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -103.45 105.69 16.01 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.519 1.128 . . . . 74.12 108.155 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -85.37 147.6 26.43 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.621 -1.252 . . . . 60.13 107.621 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.671 ' HB2' HG13 ' A' ' 71' ' ' VAL . 14.3 mm-40 -132.31 141.6 49.02 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.701 -1.222 . . . . 73.5 107.701 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -118.5 121.0 39.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.959 1.303 . . . . 73.32 108.621 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 C--O 1.238 0.457 0 N-CA-C 107.033 -1.469 . . . . 60.34 107.033 -179.074 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.5 m120 . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 105.982 -1.858 . . . . 72.31 105.982 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.9 t -98.89 169.42 9.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.134 -0.979 . . . . 73.41 110.011 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 t -139.19 143.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 104.594 -2.372 . . . . 72.4 104.594 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.671 HG13 ' HB2' ' A' ' 51' ' ' GLN 0.258 9.6 p -137.63 124.86 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 101.729 -3.434 . . . . 64.51 101.729 177.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 tp -120.29 148.86 43.18 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.042 0.937 . . . . 64.22 108.987 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -138.69 129.07 25.87 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.25 1.02 . . . . 74.4 110.083 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -88.69 144.18 26.44 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.33 -2.1 . . . . 74.4 105.33 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.1 t -73.82 -71.6 0.21 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.776 -1.107 . . . . 70.14 112.465 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.31 -36.63 78.11 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.496 2.797 . . . . 73.01 113.526 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.9 t -77.96 -25.02 47.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.999 -0.28 . . . . 72.52 111.246 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.01 -0.08 6.51 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 119.189 -0.784 . . . . 70.04 113.435 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.7 mt -68.37 137.88 23.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 119.113 1.457 . . . . 73.25 107.22 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.4 t -131.6 139.74 49.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 106.872 -1.529 . . . . 73.15 106.872 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.61 147.14 16.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.91 -1.144 . . . . 53.34 107.91 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -123.22 127.97 49.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 125.401 1.48 . . . . 73.43 108.26 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 49.3 m -144.81 162.26 37.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.143 0.973 . . . . 72.14 110.896 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -155.07 156.16 35.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.362 2.265 . . . . 75.52 106.392 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -158.32 -74.4 0.08 Allowed 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 105.729 -1.952 . . . . 62.52 105.729 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.2 p -83.13 -179.3 7.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.942 0.877 . . . . 73.24 109.559 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -96.68 1.09 50.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.389 0.675 . . . . 74.0 109.314 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.6 m -96.72 115.47 27.49 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.974 1.31 . . . . 74.41 108.006 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.8 p -57.35 -42.58 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 109.506 -0.553 . . . . 63.02 109.506 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.64 -47.3 84.86 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.004 0.921 . . . . 64.21 112.196 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -67.72 -32.92 73.88 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.748 -0.595 . . . . 74.13 109.402 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -71.49 -29.25 64.6 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.24 -0.913 . . . . 75.05 109.204 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -63.15 -48.78 77.01 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.805 1.184 . . . . 74.12 109.869 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -57.82 -38.47 75.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.926 0.785 . . . . 65.34 112.051 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.69 -49.2 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.05 -1.093 . . . . 50.15 108.05 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.39 -47.04 86.96 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.927 0.891 . . . . 51.32 110.785 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -60.0 -45.53 92.43 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.644 0.778 . . . . 71.12 109.706 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -51.03 71.49 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.208 0.603 . . . . 72.04 110.72 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.58 -32.47 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.732 0.697 . . . . 74.34 110.909 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.1 tp -63.72 -40.3 96.41 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 120.616 -1.302 . . . . 64.55 110.187 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -54.5 -40.1 68.22 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.058 1.343 . . . . 75.24 111.95 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.95 -36.53 83.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.372 1.069 . . . . 74.0 111.503 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -76.45 -42.08 45.12 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.93 -0.481 . . . . 74.13 110.21 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.2 -32.26 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 118.609 -0.71 . . . . 64.12 110.442 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -58.68 -56.31 23.83 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.862 1.21 . . . . 72.23 108.252 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 68.3 t -58.45 -28.38 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.241 1.016 . . . . 65.52 110.745 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -74.35 -18.36 60.69 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.156 -0.965 . . . . 51.31 112.256 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -99.35 -49.89 4.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.294 1.438 . . . . 74.41 110.322 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -71.68 -16.51 62.24 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.015 0.746 . . . . 74.35 113.015 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 CA--C 1.539 0.541 0 C-N-CA 128.693 2.797 . . . . 54.21 106.99 179.776 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 99.3 mt . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 121.112 0.482 . . . . 64.3 110.162 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -67.01 155.18 90.89 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.427 0.691 . . . . 72.52 110.082 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.11 176.84 9.0 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.932 2.422 . . . . 73.4 110.936 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.51 172.07 32.26 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 121.741 0.634 . . . . 71.43 111.526 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -58.55 135.39 57.31 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.312 1.045 . . . . 74.22 109.395 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.19 30.01 4.58 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.225 1.41 . . . . 42.35 110.136 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.31 175.7 2.09 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.264 1.026 . . . . 64.41 109.865 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.6 t -87.76 170.59 11.09 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.98 -1.075 . . . . 73.24 108.954 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.0 m -139.83 146.28 39.17 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.646 -1.242 . . . . 74.24 107.646 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 t -68.57 133.33 31.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 125.427 1.491 . . . . 54.44 111.546 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -75.66 154.66 36.42 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.206 -1.035 . . . . 62.35 108.206 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.5 t -72.53 146.67 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.963 -1.086 . . . . 74.51 108.42 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.76 166.47 23.21 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.487 1.515 . . . . 65.22 107.75 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -136.43 73.23 0.44 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 123.931 0.777 . . . . 43.34 111.447 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 . . . . . 0 C--O 1.238 0.447 0 C-N-CA 124.593 1.157 . . . . 71.23 109.483 179.221 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 109.616 -0.512 . . . . 50.13 109.616 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.82 147.94 57.11 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.436 2.091 . . . . 75.13 109.702 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.526 HD12 ' C ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -148.62 138.35 22.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.161 -1.051 . . . . 64.0 108.161 -179.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -91.9 111.01 22.38 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.488 1.515 . . . . 64.44 111.544 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -66.65 -25.92 66.81 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.964 1.706 . . . . 75.1 113.245 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -80.01 -11.19 59.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.423 1.01 . . . . 71.3 112.096 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -101.02 9.89 41.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.449 1.1 . . . . 75.2 111.315 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.3 175.82 5.58 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.359 -0.838 . . . . 64.2 112.847 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -125.38 135.63 52.61 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.424 2.29 . . . . 63.05 106.038 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -126.72 166.28 17.68 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.134 1.374 . . . . 72.32 111.464 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -137.66 177.51 7.81 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.025 1.33 . . . . 64.0 108.658 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -135.07 163.6 29.54 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.81 2.044 . . . . 72.4 107.256 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 106.479 -1.675 . . . . 63.33 106.479 179.787 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 m120 . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 109.395 -0.594 . . . . 71.03 109.395 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.3 p -150.18 154.73 38.51 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.693 -1.254 . . . . 71.41 107.939 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.3 152.49 27.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 123.813 0.845 . . . . 74.34 109.325 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.59 141.65 42.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.221 -1.399 . . . . 62.35 107.221 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.9 tp -129.03 154.6 46.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.495 0.718 . . . . 72.02 110.798 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 75' ' ' VAL . 1.5 tmtp? -143.71 155.59 44.26 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.369 1.068 . . . . 62.51 108.183 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -122.24 120.43 34.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.687 -1.968 . . . . 74.3 105.687 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.473 ' HA ' ' HE2' ' A' ' 73' ' ' LYS . 39.7 t -66.26 -56.46 16.1 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.746 1.218 . . . . 62.22 111.884 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.66 -12.96 38.0 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.634 2.222 . . . . 72.23 115.709 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 t -113.64 -16.44 12.34 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.846 0.748 . . . . 71.15 110.453 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.56 9.39 37.72 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.591 1.091 . . . . 52.44 113.662 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.8 mt -79.89 145.86 8.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.482 1.113 . . . . 74.21 108.283 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 t -131.3 143.69 39.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.103 -1.814 . . . . 74.34 106.103 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -146.95 155.06 11.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.283 -0.636 . . . . 74.12 109.283 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.87 133.23 41.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.415 -0.957 . . . . 73.14 108.415 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.98 160.35 41.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.153 0.981 . . . . 72.33 111.163 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -155.52 134.37 12.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.425 2.29 . . . . 75.44 106.001 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -153.13 -51.43 0.1 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.724 -0.843 . . . . 74.21 108.724 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.8 p -109.62 170.88 7.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.352 1.032 . . . . 62.03 110.825 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -92.38 -16.74 25.57 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.156 0.982 . . . . 61.22 108.901 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -78.94 115.79 18.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.495 -0.928 . . . . 61.32 108.495 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.2 p -62.96 -37.73 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.642 -1.244 . . . . 62.43 107.642 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.79 -49.62 72.69 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.664 1.586 . . . . 52.01 108.718 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.3 -48.24 62.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.655 0.782 . . . . 74.52 110.949 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -52.74 -38.05 60.29 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.753 0.821 . . . . 75.2 111.243 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -54.86 -48.45 72.89 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.823 0.738 . . . . 75.5 109.335 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -64.0 -37.2 86.54 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.517 -0.739 . . . . 70.44 111.389 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.3 mt -63.66 -47.31 91.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.362 -0.977 . . . . 73.53 108.362 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.88 97.77 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.206 0.602 . . . . 74.44 109.894 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -57.39 -44.58 84.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.838 0.855 . . . . 73.12 109.82 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.7 -55.57 33.09 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.409 0.684 . . . . 72.44 110.237 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.47 -23.8 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 113.677 0.992 . . . . 74.44 113.677 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.5 tp -70.38 -38.7 74.76 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.561 -1.337 . . . . 74.54 110.626 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -55.15 -47.92 74.42 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.756 1.222 . . . . 54.14 114.014 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.75 -28.73 70.17 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.372 0.669 . . . . 74.12 111.509 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -77.42 -35.96 53.63 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.236 -0.915 . . . . 62.14 110.115 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.1 t -67.07 -33.99 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.151 -1.055 . . . . 54.25 108.151 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -56.59 -47.23 80.02 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.889 1.222 . . . . 71.45 108.894 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.64 -15.14 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.555 1.142 . . . . 74.44 111.891 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -82.49 -22.19 35.21 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.759 -1.213 . . . . 71.43 109.7 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -96.85 -53.29 3.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.301 1.441 . . . . 74.22 109.825 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -72.45 -16.41 61.82 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.634 0.605 . . . . 63.42 112.634 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 126.587 1.955 . . . . 74.54 106.796 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--O 1.233 0.193 0 N-CA-C 109.864 -0.421 . . . . 74.44 109.864 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -127.23 156.85 74.04 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.078 1.751 . . . . 73.12 109.125 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.33 168.77 24.03 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.793 2.328 . . . . 71.34 111.787 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.71 -87.63 0.86 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.714 -1.355 . . . . 43.41 109.714 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.2 tpt -146.57 160.83 41.64 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.628 1.171 . . . . 73.14 107.896 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.54 61.73 1.15 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.304 1.041 . . . . 75.13 109.772 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.08 150.75 38.76 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.87 -0.789 . . . . 53.4 108.87 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.6 t -79.18 -178.98 6.46 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.772 0.796 . . . . 72.52 110.668 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 m -112.38 156.67 22.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.218 1.807 . . . . 64.52 106.914 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.7 t -118.11 159.53 18.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.302 -1.37 . . . . 72.24 107.302 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -102.66 138.77 39.13 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.513 -1.292 . . . . 71.43 107.513 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.01 146.75 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 122.006 0.908 . . . . 71.54 110.35 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.27 170.91 9.71 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 129.322 3.049 . . . . 60.01 106.342 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.16 -151.7 23.45 Favored Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 108.319 -1.912 . . . . 72.34 108.319 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.508 ' HD2' ' H ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.625 0 CA-C-O 121.755 0.788 . . . . 72.12 110.099 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 74.5 mt . . . . . 0 C--O 1.238 0.492 0 CA-C-O 119.38 -0.343 . . . . 75.41 111.79 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.26 150.68 59.53 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.145 2.564 . . . . 71.33 109.314 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 43' ' ' LEU 0.576 0.2 OUTLIER -122.6 150.86 42.07 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.329 -0.857 . . . . 73.2 112.074 179.854 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -94.56 107.77 19.75 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.529 1.532 . . . . 73.13 112.034 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -70.16 -19.26 63.21 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.601 0.963 . . . . 63.23 113.601 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.5 m -87.95 10.36 19.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.325 1.45 . . . . 75.11 112.015 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -128.12 -1.52 5.79 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.5 1.12 . . . . 74.31 111.55 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -103.42 160.68 14.5 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.917 -1.142 . . . . 61.41 107.917 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -103.83 156.28 17.95 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 126.46 1.904 . . . . 73.05 108.126 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.71 136.5 53.91 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.582 -0.896 . . . . 70.32 108.582 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -152.25 156.55 39.92 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.187 0.994 . . . . 74.44 111.004 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -135.55 164.36 28.0 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 127.037 2.135 . . . . 62.15 109.679 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 102.816 -3.031 . . . . 74.04 102.816 178.297 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 108.206 -1.035 . . . . 72.1 108.206 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.6 m -57.98 131.3 50.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.07 1.348 . . . . 45.44 112.176 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.1 t -122.53 136.3 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.116 -1.809 . . . . 53.45 106.116 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.84 153.24 29.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.132 -1.803 . . . . 62.22 106.132 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp -141.22 142.89 33.93 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.177 -1.416 . . . . 63.21 107.177 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -136.11 134.12 38.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.796 -1.557 . . . . 73.53 106.796 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -86.03 140.05 30.62 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.756 -1.202 . . . . 72.42 107.756 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.3 t -71.67 -62.18 1.79 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 120.394 1.452 . . . . 72.41 111.616 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -70.4 -8.7 24.22 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.247 2.631 . . . . 72.24 116.242 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.0 m -120.74 -13.32 8.71 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.673 0.67 . . . . 74.25 112.509 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.04 -13.59 0.34 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.502 1.525 . . . . 65.53 115.584 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.4 mt -49.06 123.39 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 128.058 2.543 . . . . 55.4 110.316 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.25 142.63 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.863 1.265 . . . . 53.45 109.961 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.24 150.52 22.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.439 1.496 . . . . 72.12 108.018 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -122.87 115.02 21.28 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.298 1.439 . . . . 74.42 108.392 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 77.0 m -124.62 136.5 53.98 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.435 1.016 . . . . 75.33 111.982 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -156.34 111.81 2.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.241 -1.763 . . . . 75.34 106.241 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -147.43 -68.26 0.25 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.208 -1.404 . . . . 74.35 107.208 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -70.74 147.22 49.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.998 0.427 . . . . 64.11 110.287 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -67.83 -26.35 66.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.154 -0.684 . . . . 74.41 109.154 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 m -79.27 115.63 19.04 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 126.519 1.928 . . . . 61.25 111.25 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.68 -32.91 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 107.605 -1.258 . . . . 52.11 107.605 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -37.03 70.24 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.415 0.686 . . . . 71.42 110.986 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -79.61 -48.19 14.18 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.879 1.272 . . . . 60.43 109.738 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -53.24 -36.12 60.72 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.913 0.778 . . . . 74.44 110.085 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -57.3 -54.29 48.51 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.142 0.977 . . . . 73.43 109.424 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -59.45 -41.15 88.97 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 118.274 -0.869 . . . . 70.22 110.499 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.7 -49.09 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 124.554 1.159 . . . . 74.23 108.872 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.17 -43.46 98.85 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.981 -0.449 . . . . 74.43 110.608 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.63 -49.85 73.55 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.814 0.445 . . . . 74.2 111.112 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -44.09 97.0 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 118.448 -0.787 . . . . 73.14 112.013 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.85 -36.88 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 119.645 1.111 . . . . 72.1 109.027 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.18 -39.01 88.56 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 118.616 -0.707 . . . . 74.24 110.496 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -59.21 -23.75 62.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.247 0.93 . . . . 60.14 111.933 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -78.45 -25.96 46.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.807 1.185 . . . . 73.03 109.506 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -82.0 -44.35 16.79 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.896 1.279 . . . . 64.12 110.963 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.2 t -58.79 -41.92 83.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 N-CA-C 108.335 -0.987 . . . . 72.52 108.335 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.19 -64.9 0.69 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.095 0.558 . . . . 73.41 111.809 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.43 -32.6 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.409 1.084 . . . . 65.04 111.095 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -67.29 -42.97 82.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.395 0.543 . . . . 70.11 109.775 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -67.79 -29.52 68.73 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.538 0.735 . . . . 71.23 109.501 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -79.56 -35.36 39.9 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.555 0.742 . . . . 75.23 111.62 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.161 1.384 . . . . 75.42 111.908 -176.977 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.446 -0.626 0 N-CA-C 108.041 -1.096 . . . . 70.14 108.041 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -125.48 152.4 71.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 125.04 1.336 . . . . 61.31 107.45 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.89 161.61 41.04 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.88 1.72 . . . . 54.3 109.92 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.56 165.49 20.63 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 108.021 -2.032 . . . . 42.11 108.021 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 42.5 ttm -144.69 130.91 19.55 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.548 -0.908 . . . . 64.01 108.548 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.9 58.99 0.92 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.576 -2.009 . . . . 72.31 105.576 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.27 178.21 7.57 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.548 1.139 . . . . 74.5 108.999 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.0 t -60.31 140.56 57.03 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.453 -1.314 . . . . 65.41 107.453 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 m -139.36 134.51 32.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.174 -1.788 . . . . 74.32 106.174 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.52 157.96 39.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.653 0.781 . . . . 75.1 109.272 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -144.61 172.91 12.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.159 1.383 . . . . 73.33 109.339 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.54 166.82 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.933 1.693 . . . . 72.01 107.828 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.04 175.24 9.75 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.658 1.183 . . . . 65.21 110.122 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -131.73 91.9 0.28 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.929 -1.268 . . . . 53.23 109.929 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 . . . . . 0 C--O 1.232 0.139 0 CA-C-N 117.508 0.654 . . . . 64.11 109.71 179.151 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 C--O 1.241 0.616 0 N-CA-C 109.86 -0.422 . . . . 54.23 109.86 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.95 160.84 46.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.668 1.579 . . . . 75.11 111.901 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -157.26 143.45 17.86 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 127.801 2.44 . . . . 71.53 104.429 179.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.421 ' N ' HD12 ' A' ' 43' ' ' LEU . 43.5 t30 -114.67 102.28 9.88 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.037 0.935 . . . . 73.0 109.586 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -57.15 -27.6 62.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.373 0.533 . . . . 73.32 112.32 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -78.78 7.27 7.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.491 1.917 . . . . 73.1 112.981 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -127.0 4.87 6.5 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.616 1.566 . . . . 75.41 111.656 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.4 mt -94.01 176.66 6.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 122.119 0.961 . . . . 75.43 113.029 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -108.5 131.55 54.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 102.223 -3.251 . . . . 63.12 102.223 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -128.8 164.63 22.62 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.213 1.005 . . . . 73.12 108.545 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.65 160.62 42.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.384 -0.969 . . . . 71.55 108.384 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -109.7 135.64 50.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.131 1.372 . . . . 64.22 108.08 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.3 t . . . . . 0 C--N 1.327 -0.387 0 N-CA-C 107.048 -1.464 . . . . 63.14 107.048 -178.717 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 . . . . . 0 CA--C 1.529 0.163 0 N-CA-C 107.936 -1.135 . . . . 70.25 107.936 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.9 m -143.47 148.76 36.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.985 1.714 . . . . 74.22 107.276 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t -144.63 157.3 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.891 -1.522 . . . . 73.31 106.891 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.17 139.61 26.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.766 -1.939 . . . . 73.25 105.766 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 tp -139.48 143.73 37.65 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.414 -1.328 . . . . 74.44 107.414 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -131.5 158.42 40.94 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 123.186 0.594 . . . . 74.33 109.407 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -104.16 114.45 28.7 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 102.443 -3.169 . . . . 74.11 102.443 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.99 -62.12 5.74 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 119.187 0.903 . . . . 73.53 111.69 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -65.04 -14.67 46.55 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.791 2.994 . . . . 53.44 116.622 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.2 t -112.3 -10.6 13.8 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.564 1.075 . . . . 72.04 111.123 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.2 3.47 6.67 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.268 1.413 . . . . 73.25 113.896 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -66.87 149.19 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 120.024 1.912 . . . . 63.03 108.179 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.4 t -136.69 135.32 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.154 -1.795 . . . . 73.32 106.154 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.0 146.94 24.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 106.888 -1.523 . . . . 74.04 106.888 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -127.44 119.75 26.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.136 0.974 . . . . 74.14 108.961 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.1 m -139.32 149.29 44.04 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.563 1.545 . . . . 72.33 109.767 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -155.11 121.25 5.21 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.455 -2.054 . . . . 72.35 105.455 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -133.22 -48.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.891 0.876 . . . . 75.53 110.769 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.3 p -101.73 158.33 16.19 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.51 1.124 . . . . 61.44 111.738 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -71.9 -30.21 65.14 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 118.065 -0.969 . . . . 74.05 111.373 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -79.44 123.92 27.98 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 119.917 1.235 . . . . 50.52 110.275 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.96 -38.77 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.346 1.058 . . . . 51.11 109.041 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -55.57 -44.14 76.57 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.304 1.442 . . . . 75.41 110.721 -179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -40.23 62.04 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.718 0.807 . . . . 63.22 110.386 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -55.86 -32.94 64.08 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.741 0.7 . . . . 42.03 110.554 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 45.1 mtp85 -57.54 -45.19 85.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.593 0.633 . . . . 74.4 110.875 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -61.21 -31.76 71.53 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 118.679 0.672 . . . . 71.53 111.739 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.3 mt -74.06 -40.21 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.695 -0.854 . . . . 65.13 108.695 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.23 -47.59 73.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 122.897 0.479 . . . . 52.43 110.541 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -31.5 72.11 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 120.526 -0.47 . . . . 74.1 111.103 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -61.32 2.15 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.507 -1.294 . . . . 72.55 107.507 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -55.65 -35.83 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 118.683 0.674 . . . . 63.13 111.254 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.49 -32.57 74.06 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.455 -0.783 . . . . 45.2 111.474 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -61.17 -41.67 97.2 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 119.426 1.012 . . . . 74.24 110.531 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.81 -36.29 78.67 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.516 -0.92 . . . . 64.33 108.516 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -72.16 -51.8 19.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.433 -0.794 . . . . 75.43 111.403 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.06 -44.17 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 C-N-CA 124.352 1.061 . . . . 73.31 109.891 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -50.87 -63.74 1.03 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.003 0.921 . . . . 73.44 110.656 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.84 -24.56 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 112.589 0.589 . . . . 63.15 112.589 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -66.38 -45.28 80.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.617 1.099 . . . . 74.41 108.664 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -63.51 -46.22 87.07 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.513 -1.291 . . . . 65.05 107.513 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 -70.71 -3.27 17.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.219 1.407 . . . . 74.21 112.624 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.5 t . . . . . 0 C--O 1.237 0.414 0 C-N-CA 124.416 1.086 . . . . 63.41 111.058 -179.611 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.219 0 N-CA-C 109.075 -1.61 . . . . 54.41 109.075 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 t -156.82 178.57 10.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 106.713 -1.588 . . . . 74.32 106.713 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 p -150.01 179.13 8.31 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.664 1.586 . . . . 72.23 108.512 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.76 179.0 48.76 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.82 -1.712 . . . . 73.42 108.82 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.0 t -156.22 172.34 18.63 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.749 -1.204 . . . . 74.31 107.749 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.1 m -159.91 95.83 1.2 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.766 1.227 . . . . 72.41 108.335 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.37 70.53 2.15 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 109.599 -1.4 . . . . 71.41 109.599 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -75.46 85.11 2.56 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.313 1.045 . . . . 74.22 110.007 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -76.8 174.34 10.62 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.79 -1.189 . . . . 61.43 107.79 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.05 172.88 45.09 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.209 -1.156 . . . . 74.52 110.209 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.57 168.08 20.54 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.153 1.781 . . . . 60.42 106.677 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.31 167.07 29.03 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.823 0.849 . . . . 72.22 109.004 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.34 163.87 34.19 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.94 1.296 . . . . 74.42 107.571 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.13 169.79 10.77 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 127.226 2.21 . . . . 75.22 107.111 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.71 170.3 17.26 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.72 1.608 . . . . 53.32 107.229 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -65.66 155.72 85.05 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 125.027 1.331 . . . . 72.14 110.903 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.52 169.7 21.94 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.468 2.112 . . . . 64.35 110.105 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.51 173.11 6.7 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.091 1.356 . . . . 54.05 109.698 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.8 168.97 18.59 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.61 0.764 . . . . 63.12 109.182 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -130.83 176.68 8.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.556 1.942 . . . . 72.35 108.93 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -124.61 154.9 70.01 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.005 1.322 . . . . 74.41 108.67 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.29 166.18 30.1 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.553 2.168 . . . . 61.52 111.02 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.51 173.39 16.95 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.872 -1.291 . . . . 74.43 109.872 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.93 166.44 23.64 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 122.439 -0.448 . . . . 74.35 110.2 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.02 80.61 1.58 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.5 -2.407 . . . . 52.15 104.5 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.57 -174.42 4.27 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.853 0.861 . . . . 52.34 111.463 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 t -143.94 164.33 30.88 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.761 1.224 . . . . 74.53 108.708 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 t -147.98 165.71 29.9 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.403 0.62 . . . . 44.03 110.88 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.09 156.11 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 126.869 2.068 . . . . 64.31 111.04 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -119.3 173.85 6.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.487 1.515 . . . . 72.44 109.715 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.2 m -64.21 172.45 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.338 0.655 . . . . 54.04 110.578 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.74 -21.23 52.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 114.327 1.232 . . . . 73.43 114.327 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.57 -69.57 3.27 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 107.587 -2.205 . . . . 45.12 107.587 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -80.32 175.43 10.66 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.953 -1.499 . . . . 63.31 106.953 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -151.87 4.28 0.41 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.289 0.636 . . . . 73.14 112.475 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.9 65.67 1.55 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 123.939 1.828 . . . . 32.32 111.003 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -59.84 5.08 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 112.748 -2.024 . . . . 73.35 108.277 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.14 163.59 35.43 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 121.932 1.755 . . . . 74.23 111.28 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.46 161.49 4.09 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 128.232 2.613 . . . . 63.24 107.442 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.9 mt 27.14 56.17 0.07 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 129.269 3.027 . . . . 75.44 112.269 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.6 mt -46.01 148.32 1.49 Allowed Pre-proline 0 C--O 1.233 0.214 0 C-N-CA 126.34 1.856 . . . . 54.02 112.763 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.87 112.21 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.859 2.373 . . . . 61.23 108.661 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.67 104.66 16.59 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.201 -1.407 . . . . 71.51 107.201 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -65.79 104.79 1.13 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.485 1.514 . . . . 72.44 109.923 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -62.86 -27.45 69.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.065 0.765 . . . . 62.21 113.065 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 m -79.4 6.57 9.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.396 0.998 . . . . 62.15 111.257 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -117.64 11.34 13.69 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.7 1.6 . . . . 61.55 111.743 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.0 mt -111.78 165.17 12.29 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.469 1.108 . . . . 52.42 111.16 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -132.22 127.0 34.85 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.441 -2.059 . . . . 73.44 105.441 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.23 165.47 11.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.487 1.515 . . . . 61.12 110.85 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -140.35 160.54 39.74 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.46 1.504 . . . . 53.15 107.277 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -130.53 139.45 50.48 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.472 -0.566 . . . . 61.52 109.472 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 85.3 t -88.49 135.97 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 107.246 -1.39 . . . . 72.11 107.246 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -122.18 -13.9 8.04 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.742 0.817 . . . . 65.41 110.211 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.51 -164.29 33.44 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 129.315 3.341 . . . . 73.22 105.003 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -137.23 149.67 47.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.294 -1.743 . . . . 64.43 106.294 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.03 176.77 49.11 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 109.792 -1.323 . . . . 52.34 109.792 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -61.25 117.07 3.83 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.092 1.862 . . . . 54.05 108.491 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.0 18.43 2.54 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 124.799 1.19 . . . . 62.44 112.762 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.48 -117.11 9.04 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.917 -1.273 . . . . 74.22 109.917 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -61.15 163.55 6.08 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.283 0.564 . . . . 61.13 110.286 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 65.91 -81.82 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.505 1.922 . . . . 64.21 110.421 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.5 m 41.99 80.33 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.656 2.382 . . . . 64.43 108.786 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -50.8 150.66 2.79 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.454 1.102 . . . . 64.44 112.651 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -113.85 166.24 11.77 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.096 0.959 . . . . 74.21 110.511 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -51.16 122.26 7.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.258 1.823 . . . . 62.21 109.112 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 p -156.99 163.16 39.41 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 106.789 -1.56 . . . . 64.35 106.789 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -78.95 30.06 0.2 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.115 0.87 . . . . 73.42 110.741 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.9 t -68.03 112.48 5.04 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 120.28 -1.512 . . . . 71.23 107.588 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.4 t -94.57 139.77 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 104.269 -2.493 . . . . 71.43 104.269 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.52 138.45 49.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.348 -2.093 . . . . 32.22 105.348 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.2 tp -142.32 147.31 36.13 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.871 -1.529 . . . . 71.21 106.871 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.99 158.18 43.87 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.432 -0.951 . . . . 62.31 108.432 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 77' ' ' SER . 4.3 t-80 -93.94 134.39 36.37 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.059 -2.2 . . . . 64.12 105.059 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.3 t -65.11 -65.97 1.66 Allowed Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 117.894 -1.051 . . . . 71.43 111.894 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.18 -35.41 52.59 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.744 2.296 . . . . 64.33 113.759 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' A' ' 74' ' ' HIS . 12.6 t -85.36 -21.13 29.01 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.777 0.658 . . . . 64.31 112.777 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.88 2.86 5.23 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.437 1.494 . . . . 41.32 114.525 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.5 mt -67.05 130.96 32.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 119.791 1.796 . . . . 53.01 107.087 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.6 t -112.61 153.45 14.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.463 1.105 . . . . 71.22 109.05 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -149.74 142.43 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.796 0.838 . . . . 72.33 110.059 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -124.92 106.84 10.29 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.19 1.796 . . . . 62.43 108.315 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 9.9 t -117.94 155.36 30.36 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.689 1.196 . . . . 74.45 110.159 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -155.03 100.66 2.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.594 -1.632 . . . . 63.23 106.594 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.48 -37.43 4.95 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 122.86 0.464 . . . . 72.11 111.413 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.8 p -139.04 176.73 8.44 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.983 0.913 . . . . 52.13 111.623 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -1.51 56.35 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.678 1.191 . . . . 64.33 111.011 177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.4 m -98.2 115.75 28.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.132 1.373 . . . . 65.22 109.968 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.54 -53.89 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.874 0.869 . . . . 64.31 111.243 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -22.81 67.07 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.984 1.475 . . . . 60.22 114.984 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -77.75 -46.1 22.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.435 -2.061 . . . . 74.13 105.435 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -59.63 -37.3 78.26 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 118.397 -0.811 . . . . 73.11 109.974 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -54.88 -55.5 29.8 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.694 1.198 . . . . 61.51 108.582 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -54.64 -47.36 73.59 Favored 'General case' 0 CA--C 1.506 -0.733 0 O-C-N 121.641 -0.662 . . . . 65.24 112.366 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.8 mt -64.67 -36.8 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.596 -0.729 . . . . 72.45 110.443 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.24 -38.73 82.12 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.451 -0.781 . . . . 71.41 109.182 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -61.39 -49.38 77.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.617 1.167 . . . . 72.41 110.182 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -46.53 88.92 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.435 -0.793 . . . . 74.33 111.238 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.86 -37.42 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 120.107 1.321 . . . . 73.22 110.643 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.1 tp -65.67 -37.63 87.05 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.525 -0.734 . . . . 63.23 109.89 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -58.44 -42.11 86.61 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.703 0.801 . . . . 73.14 110.423 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -61.84 -43.47 98.77 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.426 0.631 . . . . 74.24 109.698 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -67.51 -42.46 82.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 113.915 1.08 . . . . 61.44 113.915 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.61 -32.77 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 123.219 0.608 . . . . 63.44 109.715 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -53.92 -60.75 2.92 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.702 0.683 . . . . 74.25 110.128 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 17.5 t -59.64 -32.59 49.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.784 0.834 . . . . 62.11 110.826 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -65.95 -22.64 66.49 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.516 1.053 . . . . 63.44 111.679 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -99.04 -36.92 9.55 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.4 1.08 . . . . 61.53 109.808 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -79.19 -16.78 56.05 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.523 1.129 . . . . 74.34 111.883 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 t -135.07 -165.33 1.66 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.376 1.87 . . . . 54.04 108.692 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.92 -163.59 21.31 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.813 1.197 . . . . 51.04 111.918 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.98 -177.94 2.19 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 123.369 2.713 . . . . 74.13 110.466 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 76.0 p -127.47 97.31 4.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.546 -1.65 . . . . 64.51 106.546 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.9 t 58.22 74.16 0.44 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.851 1.26 . . . . 75.15 109.899 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 116.86 -2.078 . . . . 72.42 109.267 179.715 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 N-CA-C 109.084 -1.607 . . . . 60.15 109.084 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 m -134.64 154.49 51.5 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.951 -1.5 . . . . 75.11 106.951 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -58.3 -48.36 80.75 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.395 1.078 . . . . 61.32 113.764 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.37 104.39 1.22 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 106.944 -2.462 . . . . 65.13 106.944 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 p -151.27 162.78 40.28 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 121.9 -0.765 . . . . 53.41 109.637 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.7 t -157.79 174.14 15.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.485 1.514 . . . . 52.31 107.11 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.62 -179.33 48.28 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.717 -1.353 . . . . 61.21 109.717 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -156.43 160.38 39.55 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 108.374 -0.972 . . . . 75.32 108.374 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -140.35 179.47 6.63 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.207 1.803 . . . . 74.12 107.853 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.95 163.81 37.02 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 109.318 -1.513 . . . . 73.33 109.318 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 mp -85.36 172.28 11.2 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.877 -0.786 . . . . 74.01 108.877 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -143.85 166.96 23.46 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 106.986 -1.487 . . . . 74.0 106.986 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.89 143.61 29.92 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.56 -1.645 . . . . 65.23 106.56 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.54 167.37 2.24 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 128.672 2.789 . . . . 74.3 106.503 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -154.76 170.68 21.03 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.602 -1.259 . . . . 70.21 107.602 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -66.97 167.52 13.82 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 128.562 2.745 . . . . 73.12 110.824 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -81.59 168.35 16.26 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.275 1.983 . . . . 74.31 110.236 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.82 173.7 12.02 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.929 -0.767 . . . . 65.11 108.929 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -146.11 173.77 11.9 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.022 1.329 . . . . 74.44 109.563 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.88 178.63 4.79 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.904 1.682 . . . . 75.44 109.615 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -125.44 155.02 72.43 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.758 1.623 . . . . 72.41 108.961 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.62 166.06 29.18 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.6 2.2 . . . . 73.11 111.326 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.56 -178.32 35.37 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.177 -1.169 . . . . 64.35 110.177 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.6 ttt -138.14 162.27 34.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.842 1.257 . . . . 73.02 107.843 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.67 83.99 1.17 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.235 -2.506 . . . . 62.41 104.235 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.46 152.01 34.42 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.484 -0.561 . . . . 55.3 109.484 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 t -79.52 -174.51 4.29 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.603 0.716 . . . . 71.3 111.531 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.3 p -115.41 -175.85 2.8 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.642 1.577 . . . . 65.31 111.891 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.0 m -67.24 177.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.684 1.194 . . . . 71.44 109.303 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.02 164.02 28.25 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.71 0.804 . . . . 75.52 110.663 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 t -69.67 128.51 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.688 -1.597 . . . . 75.31 106.688 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.53 177.09 6.46 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.066 0.946 . . . . 73.31 111.581 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.13 -165.16 29.12 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 124.457 1.027 . . . . 62.42 111.916 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -142.62 172.73 12.3 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.429 1.092 . . . . 60.25 111.362 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -155.28 162.27 40.92 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 106.425 -1.695 . . . . 71.43 106.425 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 40.29 62.25 1.36 Allowed 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.337 1.855 . . . . 70.13 111.118 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -65.32 1.31 Allowed Pre-proline 0 C--O 1.236 0.36 0 CA-C-O 117.974 -1.013 . . . . 73.12 109.501 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.33 135.89 38.26 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 120.902 1.068 . . . . 74.33 109.913 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.4 129.69 6.49 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.983 2.113 . . . . 72.24 105.841 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.4 mt 47.17 65.55 1.22 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 127.257 2.223 . . . . 64.22 112.096 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.7 mt -49.8 152.2 2.74 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 125.427 1.491 . . . . 71.32 111.688 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -69.33 154.89 68.76 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.619 2.212 . . . . 54.2 109.262 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.0 mt -137.42 163.47 31.0 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.083 1.353 . . . . 72.11 113.728 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -119.84 101.85 8.17 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 106.891 -1.522 . . . . 75.13 106.891 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -61.06 -23.63 65.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.223 0.609 . . . . 64.44 112.53 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 m -87.97 10.38 19.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.993 1.317 . . . . 41.53 112.452 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -121.51 14.68 11.12 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.124 1.37 . . . . 74.23 111.095 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.2 mt -99.2 166.61 11.15 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.178 -0.951 . . . . 64.14 111.738 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -127.28 94.11 3.91 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.568 -0.901 . . . . 72.22 108.568 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -95.01 164.69 12.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.086 0.946 . . . . 75.44 112.689 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -143.17 171.09 14.56 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.707 2.803 . . . . 62.12 105.54 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -131.0 139.4 49.98 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 107.025 -1.472 . . . . 75.03 107.025 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.08 136.54 22.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.27 -0.641 . . . . 63.41 109.27 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.59 -9.02 9.46 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.885 0.874 . . . . 53.03 112.029 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.88 -177.79 43.71 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 107.193 -2.363 . . . . 74.31 107.193 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -147.83 166.33 27.91 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.761 -1.57 . . . . 74.34 106.761 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.82 -169.96 44.34 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 109.734 -1.347 . . . . 65.51 109.734 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.43 -0.88 7.27 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.236 2.624 . . . . 72.54 113.96 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.55 5.61 24.22 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 119.809 1.186 . . . . 63.23 114.902 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -48.16 113.31 1.4 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 126.008 1.766 . . . . 41.32 111.766 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 56.3 15.25 1.85 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.078 1.751 . . . . 71.23 114.17 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.82 107.39 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.737 1.215 . . . . 61.21 111.369 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.5 p -72.37 -67.71 0.53 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.007 1.723 . . . . 63.42 111.344 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.85 84.07 0.21 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 129.226 3.01 . . . . 74.24 113.882 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -77.41 1.99 17.39 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.152 -0.967 . . . . 71.33 111.499 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.54 46.86 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 129.953 3.301 . . . . 75.3 113.242 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -84.93 115.69 22.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.67 -1.233 . . . . 72.31 107.67 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -105.27 -0.01 26.72 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.366 1.066 . . . . 73.03 110.883 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 35.6 t -59.49 145.87 42.43 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.666 1.121 . . . . 75.2 110.91 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.6 t -120.44 149.83 23.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.311 1.845 . . . . 72.44 108.872 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.17 155.71 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 106.151 -1.796 . . . . 74.44 106.151 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.7 tp -141.3 148.54 39.93 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.152 -1.425 . . . . 62.14 107.152 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -143.51 130.68 20.75 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 125.473 1.509 . . . . 71.12 110.509 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -97.15 117.24 30.9 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.64 -1.985 . . . . 74.43 105.64 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.52 -59.96 11.3 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.069 -1.443 . . . . 65.42 111.921 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.47 -14.56 35.76 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.997 2.465 . . . . 52.53 116.611 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -111.69 -19.55 12.43 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.512 0.596 . . . . 75.13 111.236 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.13 21.22 69.78 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.007 0.813 . . . . 65.45 111.389 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.9 mt -91.24 136.4 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 125.142 1.377 . . . . 64.31 107.805 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.01 137.41 57.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.069 -1.456 . . . . 72.43 107.069 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.0 p -136.75 151.39 27.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.961 -0.755 . . . . 62.53 108.961 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -110.16 125.62 53.22 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.166 -1.79 . . . . 52.24 106.166 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.1 t -138.54 132.13 30.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 118.374 0.534 . . . . 60.11 109.897 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -153.91 100.28 2.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.173 0.589 . . . . 71.3 109.494 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -115.77 -70.47 0.79 Allowed 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.309 -0.997 . . . . 73.14 108.309 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.5 p -73.04 177.59 4.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.391 1.476 . . . . 71.31 109.618 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -98.64 -20.14 17.15 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.254 -1.529 . . . . 75.43 108.802 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.3 m -79.09 132.2 36.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.328 2.251 . . . . 75.45 110.444 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.32 -55.86 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.7 0.8 . . . . 74.41 112.917 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.63 -39.85 74.35 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.853 1.206 . . . . 74.32 112.583 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -67.6 -43.28 80.85 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.755 -0.831 . . . . 53.31 108.755 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -64.89 -37.75 88.66 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.974 -0.751 . . . . 72.53 108.974 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -59.95 -52.06 67.04 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.225 1.01 . . . . 72.33 109.992 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -63.03 -32.23 73.55 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.505 1.502 . . . . 64.43 112.025 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.04 -46.33 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.307 -1.738 . . . . 74.22 106.307 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.27 78.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.976 0.91 . . . . 74.52 109.842 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -40.57 94.06 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.425 -0.583 . . . . 75.31 109.425 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.65 -53.17 61.12 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.599 -0.688 . . . . 72.34 109.739 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.5 p -66.56 -32.01 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 113.068 0.766 . . . . 75.11 113.068 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.7 tp -67.74 -30.64 70.17 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.348 -0.845 . . . . 74.3 109.823 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -58.99 -31.37 68.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.011 1.324 . . . . 75.01 110.726 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.55 -48.88 53.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.114 0.966 . . . . 73.24 109.062 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -60.26 -46.28 90.37 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.899 0.88 . . . . 72.33 110.284 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.4 t -64.39 -37.95 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 118.044 -0.979 . . . . 54.11 110.175 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.39 -61.37 2.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.894 1.224 . . . . 71.03 110.642 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.4 p -56.61 -37.23 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 O-C-N 123.886 0.741 . . . . 70.22 109.55 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -62.72 -35.82 81.0 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.012 0.745 . . . . 65.22 113.012 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -73.55 -41.55 62.82 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.725 -0.843 . . . . 73.11 108.725 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -79.28 -0.26 31.61 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.4 1.259 . . . . 74.52 114.4 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.8 p -109.85 -17.0 13.75 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.72 1.608 . . . . 70.41 112.697 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.47 174.83 46.55 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 119.927 1.24 . . . . 71.01 112.454 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.64 173.44 9.94 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.928 2.419 . . . . 60.45 110.768 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 43.1 m -98.93 95.45 7.17 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.989 -1.115 . . . . 74.42 107.989 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.89 166.88 23.29 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.017 1.327 . . . . 62.5 109.68 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.29 0 N-CA-C 106.601 -2.6 . . . . 43.43 106.601 -179.669 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.05 0 N-CA-C 109.087 -1.605 . . . . 73.35 109.087 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 m -149.71 176.4 10.72 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.741 1.617 . . . . 75.42 107.078 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t -84.72 -88.08 0.11 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.588 -1.634 . . . . 72.13 106.588 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.8 179.13 48.77 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.583 -1.807 . . . . 72.13 108.583 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.2 p -152.29 155.72 38.25 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.381 1.072 . . . . 41.35 108.462 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.8 m -164.34 172.85 12.93 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.166 1.786 . . . . 70.45 107.638 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.17 157.15 25.94 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.14 -1.584 . . . . 75.11 109.14 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -84.32 158.52 21.14 Favored 'General case' 0 C--O 1.226 -0.144 0 CA-C-O 121.909 0.861 . . . . 35.54 110.375 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -134.89 179.72 6.13 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 127.54 2.336 . . . . 71.4 106.508 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.38 145.38 10.85 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.257 -1.937 . . . . 53.22 108.257 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.2 mt -126.05 -178.26 4.24 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.343 1.457 . . . . 71.14 108.583 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.87 166.33 33.86 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.755 1.622 . . . . 62.12 108.46 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.407 HD13 ' H ' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -154.15 160.4 41.88 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.583 -2.006 . . . . 73.33 105.583 178.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.407 ' H ' HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -164.24 166.84 20.63 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.658 1.583 . . . . 74.03 107.858 179.242 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.54 -172.66 2.37 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.185 1.794 . . . . 54.1 111.709 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.512 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 11.0 mmpt? -136.96 135.03 19.4 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 128.001 2.521 . . . . 70.21 104.541 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.4 164.3 35.66 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.072 1.848 . . . . 54.02 111.208 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.39 170.69 12.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.063 0.945 . . . . 61.53 111.045 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.4 mp -110.53 169.55 8.67 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.369 1.468 . . . . 70.03 108.632 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.59 160.3 32.92 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.164 0.507 . . . . 75.23 109.803 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -102.18 155.87 35.93 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.342 1.457 . . . . 72.52 109.914 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.11 167.68 26.41 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.754 2.302 . . . . 71.41 110.919 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.16 168.85 13.51 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.701 -0.96 . . . . 74.22 110.701 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.9 ptm -77.58 165.86 23.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.368 0.667 . . . . 75.32 110.3 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.43 88.88 1.73 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.046 -2.205 . . . . 73.24 105.046 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.32 176.94 6.01 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.492 -0.559 . . . . 64.22 109.492 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.51 -171.73 2.91 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.483 0.713 . . . . 53.22 111.183 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.1 p -141.35 162.85 34.49 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.403 1.481 . . . . 74.32 108.48 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 m -119.04 173.14 5.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.047 1.339 . . . . 64.33 109.683 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.01 177.31 10.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.873 2.469 . . . . 72.2 106.755 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.6 t -90.53 142.91 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 121.384 -0.822 . . . . 73.52 109.046 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.05 168.2 10.23 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.169 0.587 . . . . 73.31 109.611 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.25 175.02 46.15 Favored Glycine 0 CA--C 1.523 0.545 0 O-C-N 121.401 -0.812 . . . . 43.42 112.813 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -135.01 138.45 43.97 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.433 1.493 . . . . 72.12 107.018 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -152.39 42.34 0.65 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.626 1.57 . . . . 71.4 108.076 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -149.19 45.59 0.98 Allowed 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.715 0.769 . . . . 74.31 111.169 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -62.38 3.73 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-O 117.67 -1.157 . . . . 73.51 108.476 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.97 116.24 4.04 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.961 1.774 . . . . 52.41 107.677 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.89 144.8 6.05 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.034 1.734 . . . . 73.13 106.79 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt -38.61 102.75 0.03 OUTLIER 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.726 2.01 . . . . 72.42 111.823 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 105' ' ' ASP . 2.0 mm? -58.15 152.21 42.31 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 124.829 1.252 . . . . 73.41 108.379 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.92 138.76 31.93 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.739 1.626 . . . . 74.11 112.204 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.2 mt -127.88 143.24 51.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.156 1.382 . . . . 71.33 111.295 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -120.69 103.81 9.41 Favored 'General case' 0 N--CA 1.461 0.085 0 C-N-CA 126.509 1.924 . . . . 51.42 107.935 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.15 -19.51 20.68 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.085 1.513 . . . . 75.24 115.085 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.8 m -83.39 -6.58 59.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.241 0.928 . . . . 73.54 111.937 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -114.23 0.83 14.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.579 1.152 . . . . 74.21 110.911 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 mt -102.65 154.97 18.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.098 0.559 . . . . 72.35 111.146 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -113.61 156.57 23.44 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.144 2.178 . . . . 63.12 108.243 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.58 165.07 30.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 126.532 1.933 . . . . 74.03 107.076 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -138.56 170.07 16.66 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.563 -0.903 . . . . 75.35 108.563 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -118.16 162.91 17.45 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.649 0.779 . . . . 75.44 111.833 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.0 t -117.33 106.77 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 102.567 -3.123 . . . . 72.51 102.567 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 ttpp -134.35 26.52 3.8 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.168 1.387 . . . . 65.02 112.069 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.67 -169.79 34.57 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 108.595 -1.802 . . . . 63.1 108.595 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -114.9 160.92 18.95 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.492 1.117 . . . . 75.33 108.086 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.12 160.43 44.39 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 109.665 -1.374 . . . . 73.3 109.665 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -78.2 59.63 7.11 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.518 3.479 . . . . 73.21 110.573 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.65 118.03 0.85 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 107.844 -2.102 . . . . 33.02 107.844 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.22 21.33 0.86 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.876 1.227 . . . . 71.01 114.215 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -64.56 -20.71 66.4 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.629 1.215 . . . . 70.5 112.33 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -172.24 -176.22 1.57 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.433 2.693 . . . . 63.32 106.349 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -158.99 145.11 16.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.423 -1.695 . . . . 53.42 106.423 178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -159.26 167.72 28.26 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.619 1.168 . . . . 62.1 108.194 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.57 48.6 1.43 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.902 1.281 . . . . 72.22 108.749 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.1 p -71.04 104.63 3.06 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.052 -1.03 . . . . 53.01 110.88 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 t -74.0 -11.39 60.32 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.06 0.845 . . . . 71.45 112.337 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -143.65 99.93 3.5 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 125.781 1.632 . . . . 74.41 106.998 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.6 t -154.4 144.13 21.64 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 104.499 -2.408 . . . . 75.23 104.499 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.0 t -128.78 134.57 64.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.437 -1.32 . . . . 72.13 107.437 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -118.88 130.36 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 106.667 -1.605 . . . . 55.35 106.667 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.2 tp -123.03 142.57 50.71 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.643 -0.873 . . . . 71.3 108.643 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -137.25 132.38 33.7 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.222 1.409 . . . . 73.25 109.695 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.19 134.17 34.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.657 1.183 . . . . 72.23 110.034 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.8 t -74.41 -59.9 1.5 Allowed Pre-proline 0 CA--C 1.545 0.766 0 CA-C-O 118.098 -0.953 . . . . 73.32 112.554 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.55 -18.85 60.25 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.643 2.229 . . . . 52.01 116.492 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.3 p -120.23 -10.42 9.37 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.403 1.261 . . . . 61.34 114.403 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.4 2.93 29.58 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.366 -1.241 . . . . 60.5 113.116 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.3 mt -64.54 134.6 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.98 1.89 . . . . 72.11 109.606 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -123.22 151.08 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 107.87 -1.159 . . . . 51.22 107.87 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p -152.6 154.9 7.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 120.979 -1.076 . . . . 70.24 108.644 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -122.26 134.44 54.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.778 -1.193 . . . . 72.52 107.778 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 29.1 m -137.19 150.84 48.18 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.492 1.117 . . . . 54.52 112.231 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -155.07 149.2 25.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.917 2.087 . . . . 75.34 108.321 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -162.41 -78.61 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.506 -1.665 . . . . 61.43 106.506 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 t -102.61 175.68 5.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.654 1.982 . . . . 75.11 109.072 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -84.74 -17.5 38.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.691 -1.147 . . . . 74.43 109.719 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.7 m -83.79 115.92 22.46 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 119.701 1.137 . . . . 75.25 111.946 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.91 -40.27 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 118.581 -0.723 . . . . 72.22 109.808 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -38.42 35.29 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.662 1.185 . . . . 63.25 112.078 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -76.28 -52.44 9.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.271 1.028 . . . . 72.33 109.022 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -52.23 -32.44 36.77 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.905 1.282 . . . . 75.54 111.158 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -54.47 -50.44 67.73 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.797 0.839 . . . . 72.54 109.978 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -75.09 -24.85 58.19 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.907 1.077 . . . . 74.23 113.907 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 94.7 mt -67.47 -48.33 77.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.243 -1.391 . . . . 73.4 107.243 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.45 99.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.554 -0.716 . . . . 53.1 110.888 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -63.55 -48.77 76.12 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 118.809 -0.615 . . . . 65.35 111.229 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -58.69 -41.03 85.32 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 117.395 -1.288 . . . . 73.3 111.688 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.7 -36.94 67.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.623 1.102 . . . . 75.53 111.141 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 tp -64.61 -38.2 90.19 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 118.741 -0.647 . . . . 62.45 110.67 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -57.15 -34.3 68.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.713 0.688 . . . . 74.04 110.381 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -68.36 -32.91 73.33 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.294 0.638 . . . . 72.15 110.64 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -77.9 -38.85 44.83 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.532 -0.544 . . . . 65.32 109.532 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.8 t -58.7 -40.4 79.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.683 -0.858 . . . . 73.52 108.683 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.467 ' HA ' HD23 ' A' ' 41' ' ' LEU . 6.4 t70 -58.31 -60.59 3.53 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.092 0.86 . . . . 64.21 109.419 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.99 -37.67 34.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 125.067 1.347 . . . . 63.42 110.452 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -69.83 -42.61 73.38 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.904 0.882 . . . . 75.3 111.343 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -68.92 -33.81 74.36 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.714 -0.847 . . . . 74.33 108.714 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.04 -50.88 15.05 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.52 0.728 . . . . 74.35 109.832 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.0 m -129.42 98.91 5.01 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 128.407 2.683 . . . . 72.34 111.062 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.77 -179.35 10.89 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.172 0.891 . . . . 73.0 113.753 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.55 -18.0 58.38 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.44 2.76 . . . . 54.24 114.531 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.4 t 42.45 82.56 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.208 2.203 . . . . 71.42 112.633 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.1 p -74.46 84.12 1.99 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.315 0.646 . . . . 74.21 109.285 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.239 0 N-CA-C 108.543 -1.823 . . . . 15.22 108.543 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.076 0 N-CA-C 108.712 -1.755 . . . . 44.23 108.712 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -148.45 171.77 15.54 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.028 1.331 . . . . 53.12 107.508 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.2 m -131.62 169.35 16.26 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.895 1.278 . . . . 61.31 108.099 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.53 -178.39 45.32 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 108.327 -1.909 . . . . 72.34 108.327 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 p -149.89 175.75 11.37 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.693 0.797 . . . . 55.24 109.596 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.0 t -129.59 -132.95 0.21 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 104.266 -2.494 . . . . 73.24 104.266 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -135.41 170.37 23.02 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 109.563 -1.415 . . . . 73.22 109.563 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -80.67 51.51 1.51 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.63 0.772 . . . . 51.2 110.716 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -90.99 177.3 6.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.527 -0.916 . . . . 65.5 108.527 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.34 179.61 40.83 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.125 -1.19 . . . . 70.01 110.125 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.507 ' CD2' ' H ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -74.84 -167.43 0.58 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.484 1.114 . . . . 53.22 110.477 179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.507 ' H ' ' CD2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -128.83 159.73 34.84 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.014 1.726 . . . . 71.51 107.372 178.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.27 148.9 24.88 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.125 -2.176 . . . . 64.35 105.125 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.12 -176.09 3.96 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 126.232 1.813 . . . . 73.53 106.859 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -139.24 178.02 7.49 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.961 -1.496 . . . . 65.34 106.961 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.482 ' H ' ' HE2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -121.48 164.52 24.02 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 123.623 0.769 . . . . 61.14 111.633 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -82.07 172.65 11.68 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.977 2.452 . . . . 73.24 111.245 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.29 168.53 19.46 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.448 -0.945 . . . . 41.14 108.448 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.17 161.37 15.05 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.762 0.825 . . . . 72.05 109.506 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mp -74.84 171.96 13.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.473 1.109 . . . . 64.55 110.204 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -116.02 157.86 43.93 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.938 1.695 . . . . 75.23 110.353 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.87 178.55 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.415 2.744 . . . . 74.23 111.288 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.55 -79.24 0.04 OUTLIER Glycine 0 C--N 1.339 0.722 0 N-CA-C 111.482 -0.647 . . . . 41.54 111.482 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 28.3 ptm -67.1 147.86 52.61 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.796 0.798 . . . . 75.02 110.494 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.4 71.64 0.65 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.828 1.251 . . . . 51.31 108.194 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.47 154.59 34.57 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.517 -0.919 . . . . 74.14 108.517 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.4 t -123.01 -176.02 3.31 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.602 1.161 . . . . 51.41 112.06 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -68.57 167.51 14.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.588 1.955 . . . . 74.4 110.031 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 m -66.11 145.45 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 121.353 -0.842 . . . . 75.22 108.762 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -74.89 175.9 7.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.317 1.047 . . . . 73.14 113.825 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.89 151.64 7.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 128.176 2.59 . . . . 75.11 108.96 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.57 153.87 20.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.789 0.268 . . . . 74.51 111.265 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.38 -83.07 0.37 Allowed Glycine 0 C--N 1.336 0.556 0 C-N-CA 125.022 1.296 . . . . 42.31 111.599 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.06 151.93 28.97 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.647 -0.871 . . . . 72.35 108.647 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.06 20.39 0.87 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.561 1.944 . . . . 71.34 110.909 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -132.81 57.82 1.79 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 122.113 0.958 . . . . 72.34 111.9 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.79 -63.05 0.31 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.01 -0.995 . . . . 73.51 111.829 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.25 99.07 0.47 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.521 2.148 . . . . 74.54 110.928 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.35 157.54 37.29 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.114 1.366 . . . . 71.15 109.711 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt 38.13 50.61 1.4 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 128.034 2.534 . . . . 63.21 111.172 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.5 pp -56.02 148.83 37.53 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 115.567 -0.742 . . . . 73.22 112.761 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.72 131.01 14.14 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.631 2.887 . . . . 65.14 111.821 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.0 mt -104.98 134.39 48.17 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.335 1.054 . . . . 75.24 109.041 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -73.25 107.5 5.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.804 -0.813 . . . . 72.54 108.804 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -59.09 -25.13 63.52 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 122.021 -0.424 . . . . 74.3 111.972 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 m -83.9 7.17 19.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.183 1.393 . . . . 70.43 112.7 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -116.24 -2.67 12.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.556 1.542 . . . . 73.44 109.8 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.417 HD22 ' CD2' ' A' ' 74' ' ' HIS . 0.9 OUTLIER -104.78 138.61 40.8 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.539 -1.282 . . . . 75.32 107.539 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -103.3 134.8 46.09 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.066 -1.457 . . . . 74.01 107.066 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.51 164.74 11.65 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.113 1.765 . . . . 55.33 112.811 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -140.87 172.57 12.51 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.703 2.001 . . . . 74.0 109.833 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -134.4 158.61 43.4 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.504 1.121 . . . . 74.42 109.493 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 t -135.57 106.55 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 107.529 -1.286 . . . . 72.21 107.529 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -87.96 2.42 51.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.577 0.954 . . . . 51.51 113.577 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.48 39.78 98.06 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 118.92 0.782 . . . . 42.24 111.806 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -121.11 164.36 16.97 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.246 1.018 . . . . 65.43 109.513 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.25 170.45 42.58 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 129.597 3.475 . . . . 62.24 106.451 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.83 -21.7 32.79 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.419 2.079 . . . . 70.11 113.654 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 134.31 -155.92 22.13 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.672 -1.771 . . . . 52.05 108.672 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.48 -152.81 18.84 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.406 -1.078 . . . . 53.21 110.406 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.6 161.21 4.8 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.553 1.141 . . . . 72.32 111.769 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.98 140.62 36.84 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.452 0.701 . . . . 45.22 110.216 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.6 t -100.47 172.43 7.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.733 1.213 . . . . 74.24 110.276 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -134.62 3.28 3.27 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.456 2.303 . . . . 62.13 110.089 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.2 73.91 9.21 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 107.618 -1.253 . . . . 54.53 107.618 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 p -63.73 156.45 27.02 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.697 0.799 . . . . 70.53 111.087 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -66.09 171.63 4.44 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.669 1.987 . . . . 73.23 110.281 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 65.95 -5.27 0.55 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.996 2.119 . . . . 73.05 113.584 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 t -65.36 130.12 42.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 118.992 0.814 . . . . 63.42 109.852 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.3 t -111.24 137.26 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 103.309 -2.849 . . . . 71.01 103.309 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -130.5 117.95 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 105.816 -1.92 . . . . 75.4 105.816 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.2 tp -135.4 150.61 49.93 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 104.701 -2.333 . . . . 72.15 104.701 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.5 158.69 43.8 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 123.942 0.897 . . . . 74.02 109.971 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.417 ' CD2' HD22 ' A' ' 48' ' ' LEU . 3.1 t-80 -91.89 135.59 33.81 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.134 -2.173 . . . . 75.24 105.134 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.5 t -71.04 -61.94 2.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 119.864 1.211 . . . . 55.25 113.171 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.25 -25.11 72.07 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 121.68 1.587 . . . . 63.14 114.708 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 t -98.36 -16.7 19.2 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.281 0.492 . . . . 73.24 112.104 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.33 12.52 12.83 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.426 1.489 . . . . 61.1 113.257 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 62.3 mt -70.95 116.18 12.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 119.591 1.695 . . . . 72.31 106.527 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.3 t -105.32 146.4 12.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.68 -1.23 . . . . 72.13 107.68 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.12 148.08 17.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.051 -1.092 . . . . 62.22 108.051 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -120.85 107.04 12.23 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.747 1.219 . . . . 71.01 107.975 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 58.5 m -136.02 148.55 48.43 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.226 0.61 . . . . 70.44 110.211 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -155.48 150.6 26.77 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.624 -1.621 . . . . 73.45 106.624 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -146.79 -36.07 0.24 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.759 0.424 . . . . 74.21 110.455 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.8 p -123.63 -178.6 4.07 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.213 1.405 . . . . 74.45 108.457 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.76 -13.39 34.08 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.054 -0.721 . . . . 73.11 109.054 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -79.42 115.12 18.87 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.851 -1.166 . . . . 74.02 107.851 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.4 -41.34 84.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.94 -1.133 . . . . 72.02 107.94 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -56.5 -48.43 77.2 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 127.427 2.291 . . . . 70.14 110.371 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -65.88 -45.08 83.38 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.263 0.625 . . . . 64.3 109.465 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -64.0 -32.7 74.34 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.429 0.692 . . . . 71.14 111.249 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -59.61 -46.72 88.13 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.624 1.102 . . . . 74.4 110.336 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -58.87 -48.97 79.51 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 118.563 0.62 . . . . 73.41 110.553 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.6 mt -54.55 -48.79 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 O-C-N 124.417 1.073 . . . . 63.14 110.277 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.72 98.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 122.831 0.452 . . . . 70.13 111.418 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.4 ttm-85 -64.26 -46.62 82.92 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 118.224 -0.893 . . . . 72.22 110.28 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -50.71 69.8 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 119.438 1.017 . . . . 64.32 110.995 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.7 p -63.08 -33.39 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 120.178 1.354 . . . . 64.03 110.52 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.99 -42.19 90.1 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 120.998 -1.064 . . . . 70.35 108.486 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -56.8 -47.72 79.56 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.13 1.372 . . . . 72.15 110.569 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -59.64 -34.96 73.47 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.5 0.72 . . . . 64.11 110.403 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -79.62 -33.43 41.49 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.345 0.658 . . . . 71.11 111.812 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -74.01 -34.45 39.02 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 124.231 1.013 . . . . 75.45 109.763 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.01 -50.88 69.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.715 1.143 . . . . 73.5 109.019 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 56.8 t -57.97 -32.73 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.209 0.604 . . . . 64.23 109.661 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -77.34 -19.97 55.54 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.786 -1.196 . . . . 75.43 112.59 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -91.2 -22.32 20.69 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.992 0.814 . . . . 74.13 111.265 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -108.83 -17.17 14.0 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.995 0.816 . . . . 64.33 112.926 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.1 t -137.03 178.86 6.76 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.402 2.281 . . . . 62.04 108.13 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.57 -175.57 54.85 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.893 -1.129 . . . . 70.41 110.48 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -74.21 156.78 46.51 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.395 2.063 . . . . 61.42 111.107 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.8 m -136.07 -26.37 1.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.898 1.279 . . . . 71.2 111.186 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.3 m -140.33 175.25 9.75 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 128.137 2.575 . . . . 73.34 106.632 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 N-CA-C 108.418 -1.873 . . . . 73.22 108.418 -179.871 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.048 0 N-CA-C 108.327 -1.909 . . . . 65.24 108.327 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -149.68 169.51 20.84 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.051 1.34 . . . . 75.34 107.41 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.2 p -152.47 -84.12 0.08 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.914 -0.773 . . . . 73.14 108.914 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.24 -175.95 50.44 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 109.271 -1.532 . . . . 43.42 109.271 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.7 p -166.85 167.54 14.85 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.497 1.119 . . . . 70.22 108.254 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 56.4 p -168.19 173.0 8.18 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.573 1.549 . . . . 70.45 107.401 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.18 164.87 35.03 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.159 -1.176 . . . . 70.43 110.159 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.54 169.76 23.13 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 129.047 2.939 . . . . 64.22 105.609 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -145.2 170.46 16.22 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.605 -1.628 . . . . 75.44 106.605 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.51 -179.76 36.71 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.014 -1.634 . . . . 72.55 109.014 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.1 160.85 37.75 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.278 -1.378 . . . . 75.01 107.278 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -69.95 129.05 38.43 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 107.748 -1.205 . . . . 74.13 107.748 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.75 124.11 30.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.305 -1.739 . . . . 73.14 106.305 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.58 167.4 27.36 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.43 1.092 . . . . 65.24 108.404 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' OE1' ' HE3' ' A' ' 16' ' ' LYS 0.38 6.2 mm-40 -111.14 163.37 13.96 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.96 0.788 . . . . 73.24 111.322 178.217 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.429 ' N ' ' CE ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -79.02 153.46 77.45 Favored Pre-proline 0 N--CA 1.452 -0.341 0 CA-C-N 115.971 -0.558 . . . . 72.1 109.985 -176.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.47 148.5 79.15 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.561 1.508 . . . . 71.31 109.228 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.07 176.48 8.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.021 1.328 . . . . 75.05 108.847 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -145.7 175.56 10.29 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.83 1.652 . . . . 65.5 108.891 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -124.84 171.94 9.74 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.625 1.57 . . . . 65.42 109.101 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -109.38 151.73 42.28 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 124.444 1.098 . . . . 75.41 108.578 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.63 162.67 35.17 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.526 2.151 . . . . 71.14 110.561 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.58 172.58 37.67 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 109.196 -1.561 . . . . 71.21 109.196 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.3 tpt -134.46 135.28 42.37 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.772 -1.196 . . . . 72.33 107.772 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 64.57 1.11 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.618 1.167 . . . . 74.32 108.711 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.51 150.28 43.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.925 0.869 . . . . 71.31 109.227 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 t -93.59 129.1 39.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.189 -1.782 . . . . 74.04 106.189 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.1 t -69.05 -177.68 1.1 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.689 0.757 . . . . 65.44 109.67 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.9 m -94.72 -154.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.704 1.602 . . . . 75.05 110.682 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -131.6 171.13 13.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 128.568 2.747 . . . . 63.13 109.603 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.87 169.4 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.842 0.857 . . . . 71.15 109.69 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.53 152.72 23.87 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.061 0.846 . . . . 53.14 112.734 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.05 70.22 3.16 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 106.971 -2.452 . . . . 43.24 106.971 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -136.33 -73.23 0.44 Allowed 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 124.411 1.085 . . . . 63.14 109.863 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp 46.65 36.42 3.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.396 1.078 . . . . 75.11 111.823 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -129.44 -7.62 4.69 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.672 2.389 . . . . 71.42 110.936 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -48.27 -61.34 3.23 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.024 1.73 . . . . 73.24 114.209 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.71 139.33 43.78 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.413 2.075 . . . . 74.23 111.348 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 170.51 3.59 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.942 0.877 . . . . 71.5 110.558 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.418 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 62.8 mt 53.14 46.81 25.84 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 127.191 2.196 . . . . 72.43 109.459 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -56.67 154.7 16.73 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.671 1.588 . . . . 74.34 111.228 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.01 174.45 11.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.503 2.135 . . . . 65.33 110.93 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.701 HD11 HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -161.6 133.87 5.84 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 104.224 -2.509 . . . . 61.21 104.224 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.429 ' N ' HD12 ' A' ' 43' ' ' LEU . 52.9 t30 -66.31 116.15 7.03 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 114.18 1.178 . . . . 74.41 114.18 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' CB ' ' HD2' ' A' ' 97' ' ' ARG . 13.7 pt-20 -65.39 -32.13 73.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.142 0.793 . . . . 72.21 113.142 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 m -76.38 1.62 15.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.526 0.565 . . . . 73.34 112.526 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -107.57 6.61 28.12 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.984 1.714 . . . . 52.24 110.582 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.701 HD11 HD11 ' A' ' 43' ' ' LEU . 8.3 mt -110.31 176.37 5.07 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.839 1.052 . . . . 74.12 113.839 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -127.01 130.19 49.54 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.958 -1.497 . . . . 71.41 106.958 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.59 159.69 34.74 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.86 1.264 . . . . 72.41 108.87 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -137.82 154.89 49.48 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.818 -1.178 . . . . 61.33 107.818 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -119.94 122.47 41.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.809 1.244 . . . . 75.34 108.547 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.83 120.03 36.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 122.282 1.039 . . . . 71.24 109.797 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.52 157.25 17.29 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.354 -1.35 . . . . 60.32 107.354 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.05 67.96 3.62 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.027 -1.629 . . . . 75.31 109.027 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -83.36 9.22 11.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 117.778 0.789 . . . . 74.33 112.524 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.61 173.51 44.45 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 109.509 -1.436 . . . . 60.42 109.509 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.19 1.27 6.2 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.003 3.136 . . . . 72.23 114.358 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.64 -47.43 3.64 Favored Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.11 -0.993 . . . . 74.31 110.955 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.16 -77.91 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 107.878 -2.089 . . . . 43.53 107.878 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -128.17 -60.98 1.12 Allowed 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.349 1.06 . . . . 74.41 108.366 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.33 140.23 20.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.123 -1.436 . . . . 72.12 107.123 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -162.11 171.48 17.4 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 105.903 -1.888 . . . . 63.43 105.903 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -142.68 164.13 30.94 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.817 -1.177 . . . . 73.15 108.406 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 49.76 23.27 0.97 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.24 2.216 . . . . 63.32 113.821 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 p -66.66 -49.28 66.68 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.094 1.757 . . . . 44.13 111.292 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.5 p -61.82 146.94 48.06 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.797 -0.816 . . . . 71.02 108.797 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 83.45 2.94 0.95 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.072 2.149 . . . . 73.44 112.191 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.6 m -67.9 135.06 51.89 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.727 -1.212 . . . . 63.41 107.727 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.36 154.28 20.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.685 -1.228 . . . . 71.3 107.685 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.4 147.79 21.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.327 -2.101 . . . . 75.41 105.327 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.7 tp -140.47 150.42 43.77 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.366 1.066 . . . . 72.21 108.999 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.28 157.99 44.72 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 112.502 0.556 . . . . 74.11 112.502 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -100.89 118.4 36.86 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 103.643 -2.725 . . . . 74.22 103.643 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -63.29 -54.08 47.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 120.253 1.388 . . . . 74.34 112.875 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.41 -13.02 34.88 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.843 2.362 . . . . 70.43 116.509 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.6 m -121.14 -6.22 9.45 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.078 1.308 . . . . 71.25 113.698 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.02 17.01 34.98 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 123.949 0.785 . . . . 70.21 114.915 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.453 HD11 ' CD2' ' A' ' 107' ' ' PHE . 50.5 mt -74.04 134.57 29.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 104.325 -2.472 . . . . 74.41 104.325 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t -130.23 137.16 57.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.824 -1.176 . . . . 42.43 107.824 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.67 147.93 28.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.676 -0.861 . . . . 63.23 108.676 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -122.68 118.49 28.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.479 1.112 . . . . 74.2 110.422 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 99.3 m -127.67 144.47 51.07 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.247 0.619 . . . . 74.22 110.986 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -155.62 120.42 4.75 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.468 1.107 . . . . 74.03 108.541 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.69 -71.67 0.27 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.086 0.954 . . . . 70.45 108.496 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.0 p -78.77 156.54 28.78 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.37 1.868 . . . . 73.31 113.614 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.14 -15.55 52.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.331 -0.618 . . . . 63.32 109.331 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.48 123.25 27.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.521 -1.288 . . . . 64.13 107.521 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.3 p -60.41 -46.38 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 119.157 0.889 . . . . 74.51 110.211 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -55.06 -42.21 72.44 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.422 1.889 . . . . 74.32 112.354 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.05 -23.01 41.7 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.225 -0.893 . . . . 73.33 111.223 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -77.94 -42.91 31.49 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.581 -1.636 . . . . 73.01 106.581 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -52.17 -45.94 65.29 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.471 1.108 . . . . 65.35 109.0 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -59.67 -34.03 72.32 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-O 117.649 -1.167 . . . . 62.24 113.233 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.5 mt -64.32 -53.17 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 120.087 1.312 . . . . 60.45 108.402 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.05 -47.05 75.32 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 108.404 -0.961 . . . . 70.53 108.404 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.43 ' HD2' ' CB ' ' A' ' 45' ' ' GLU . 33.3 ttp85 -59.87 -39.56 85.68 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.383 1.073 . . . . 74.33 111.984 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -63.49 -57.52 9.94 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.96 1.304 . . . . 62.54 109.622 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.57 -29.21 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 112.106 0.41 . . . . 73.51 112.106 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.94 -46.76 89.4 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.648 -0.658 . . . . 71.55 109.554 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -59.01 -31.45 68.83 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.556 0.342 . . . . 62.12 111.451 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.26 -24.96 64.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.319 0.509 . . . . 73.2 112.079 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -88.03 -44.12 11.22 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.956 0.903 . . . . 73.23 110.138 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.39 -39.25 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 118.675 -0.679 . . . . 63.31 110.064 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 40' ' ' LEU . 5.4 t70 -53.4 -66.68 0.35 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.651 0.739 . . . . 73.44 109.929 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.8 p -57.53 -30.48 36.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 118.174 -0.917 . . . . 35.22 111.144 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.453 ' CD2' HD11 ' A' ' 79' ' ' ILE . 16.2 t80 -59.9 -44.65 94.15 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.22 1.373 . . . . 74.15 110.199 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -75.66 -39.47 57.61 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.992 0.517 . . . . 74.52 110.731 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -65.12 -54.74 25.22 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.575 -0.528 . . . . 75.12 109.575 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 66.1 m -84.18 -137.11 0.05 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.522 1.929 . . . . 52.23 106.889 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.55 -172.22 44.95 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 119.956 -1.715 . . . . 74.11 111.113 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.67 165.93 27.76 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.715 2.943 . . . . 73.41 112.203 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.1 p -112.04 -71.74 0.74 Allowed 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.973 0.909 . . . . 70.52 110.089 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.1 p -68.0 -5.01 15.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.332 1.453 . . . . 74.43 113.841 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.186 0 CA-C-O 115.965 -2.575 . . . . 62.03 110.611 -179.893 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.023 0 N-CA-C 108.991 -1.643 . . . . 42.23 108.991 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p -154.29 169.18 24.28 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.027 1.331 . . . . 65.02 107.576 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 m -135.58 177.64 7.66 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.86 1.264 . . . . 73.23 108.901 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.01 -179.89 36.94 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.199 -1.96 . . . . 54.52 108.199 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.1 m -155.94 169.56 24.15 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.712 1.205 . . . . 71.14 108.34 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.6 t -160.33 -179.7 7.92 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.99 1.316 . . . . 75.21 107.569 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.62 -178.07 42.45 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.226 -1.15 . . . . 73.34 110.226 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -143.63 163.27 33.71 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 106.547 -1.649 . . . . 72.03 106.547 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -125.46 150.54 47.25 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.244 0.618 . . . . 63.44 110.004 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.23 78.93 1.96 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 109.578 -1.409 . . . . 54.43 109.578 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.3 mt -65.22 141.37 58.67 Favored 'General case' 0 CA--C 1.526 0.055 0 N-CA-C 107.986 -1.116 . . . . 70.2 107.986 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.2 164.08 35.8 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.062 1.745 . . . . 53.32 108.461 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -131.06 167.01 19.8 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.078 1.351 . . . . 74.01 108.567 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.0 178.34 1.8 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 129.404 3.082 . . . . 71.14 106.074 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.432 ' CD ' ' HZ3' ' A' ' 16' ' ' LYS . 1.8 tm-20 -146.25 -177.91 5.86 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.913 -0.773 . . . . 62.22 108.913 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.432 ' HZ3' ' CD ' ' A' ' 15' ' ' GLU . 34.9 mtmm -71.98 154.05 92.64 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.911 1.684 . . . . 72.41 110.748 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.54 166.73 28.74 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.348 2.032 . . . . 73.44 110.281 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 165.44 24.66 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.329 0.651 . . . . 70.11 110.412 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -99.19 171.59 7.9 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.589 1.156 . . . . 73.13 109.001 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -125.1 178.19 5.68 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.958 1.703 . . . . 73.24 109.836 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -125.37 155.74 71.18 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.967 1.707 . . . . 73.31 109.184 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.39 164.33 34.26 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.568 2.179 . . . . 53.32 111.428 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.61 169.73 16.47 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.499 -1.041 . . . . 63.01 110.499 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.2 mtt -82.01 163.36 22.17 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.721 -0.474 . . . . 70.24 109.721 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.93 74.41 1.26 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.325 -1.732 . . . . 64.51 106.325 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.61 176.89 6.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.894 0.854 . . . . 65.43 112.651 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -64.68 168.14 6.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.183 0.993 . . . . 63.35 110.528 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.5 p -130.48 178.86 6.29 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.819 1.248 . . . . 74.33 112.377 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -53.67 145.9 3.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.591 1.156 . . . . 54.21 109.908 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -71.95 -171.78 0.76 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.071 -0.968 . . . . 74.02 110.912 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 m -55.85 170.66 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 126.667 1.987 . . . . 74.43 114.753 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.52 172.91 12.48 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.607 1.563 . . . . 72.04 110.733 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.44 -79.26 0.56 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 109.969 -1.252 . . . . 61.22 109.969 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -168.43 167.43 11.82 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.703 1.201 . . . . 71.31 109.609 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.2 171.72 13.34 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.157 1.383 . . . . 63.11 109.197 178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.09 21.19 12.21 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 119.808 3.262 . . . . 62.53 119.808 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -48.17 -57.91 9.3 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.865 1.266 . . . . 74.32 112.503 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -63.63 107.98 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.545 2.163 . . . . 63.4 110.236 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.27 163.3 39.19 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 125.365 1.466 . . . . 64.0 110.375 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.5 mt -64.67 81.94 0.04 OUTLIER 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.187 1.795 . . . . 61.34 112.29 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.8 mt -55.41 145.09 49.81 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.646 0.779 . . . . 74.1 109.343 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.09 129.34 20.39 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.516 2.81 . . . . 74.03 111.092 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.4 mt -117.75 121.25 40.33 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.487 1.115 . . . . 62.42 109.663 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -77.93 101.89 7.06 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.29 -1.004 . . . . 72.34 108.29 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -56.07 -29.14 60.11 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.213 0.46 . . . . 75.53 111.441 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -73.06 -3.78 28.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.178 0.991 . . . . 74.15 112.139 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -118.4 0.1 11.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.33 2.252 . . . . 75.34 110.663 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.9 mt -98.98 176.78 5.46 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.252 1.021 . . . . 74.12 109.388 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -138.4 148.13 44.13 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.76 -1.2 . . . . 73.13 107.76 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -141.76 164.83 29.14 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.786 1.234 . . . . 74.44 108.955 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -126.04 174.87 8.14 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.004 -0.739 . . . . 73.23 109.004 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -133.94 113.62 12.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.348 -1.353 . . . . 71.41 107.348 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.0 t -87.37 133.61 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.929 -1.878 . . . . 71.33 105.929 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -127.26 -2.37 6.31 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.2 1.0 . . . . 71.33 112.691 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.19 -157.09 27.02 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 107.863 -2.095 . . . . 70.33 107.863 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -63.92 163.63 11.69 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.836 0.855 . . . . 71.33 109.111 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.76 -175.88 32.25 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 109.655 -1.378 . . . . 72.52 109.655 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.27 169.45 20.71 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.549 2.166 . . . . 64.11 109.449 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.89 -51.33 0.83 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.066 -1.213 . . . . 72.21 110.066 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 148.56 -109.86 0.47 Allowed Glycine 0 C--N 1.332 0.33 0 N-CA-C 108.498 -1.841 . . . . 73.23 108.498 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -73.02 58.24 0.48 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.885 1.674 . . . . 64.55 112.632 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.4 21.56 2.07 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.443 1.497 . . . . 75.42 110.313 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.63 11.5 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.793 1 C-N-CA 132.271 4.228 . . . . 55.51 115.284 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -66.19 96.4 0.33 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.181 1.792 . . . . 74.34 110.046 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.23 2.63 14.97 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.076 -1.015 . . . . 73.23 112.479 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 p -59.57 122.63 14.54 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.212 1.369 . . . . 70.21 108.209 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.1 m -78.05 2.17 18.64 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.991 0.916 . . . . 64.13 113.009 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -156.87 143.77 18.58 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 127.697 2.399 . . . . 75.02 106.06 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.8 t 178.45 133.8 0.08 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.651 2.781 . . . . 71.34 106.067 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.2 t -118.08 114.38 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 106.129 -1.804 . . . . 63.33 106.129 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.57 138.14 33.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.667 0.746 . . . . 45.23 109.303 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.8 tp -135.59 148.58 49.1 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.409 1.883 . . . . 74.15 107.889 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.71 158.4 44.48 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.479 -1.304 . . . . 75.21 107.479 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -106.84 119.27 38.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.585 -0.894 . . . . 74.41 108.585 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 t -57.36 -61.11 7.79 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.689 1.196 . . . . 55.5 110.103 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.77 -12.02 33.44 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.29 2.66 . . . . 75.24 116.832 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -120.83 -10.61 9.1 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.403 1.261 . . . . 73.55 114.403 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.78 -5.38 2.49 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.625 1.107 . . . . 50.13 114.754 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.6 mt -60.55 140.46 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 126.022 1.729 . . . . 73.53 108.128 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 t -126.02 142.57 42.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 105.792 -1.929 . . . . 74.53 105.792 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.56 139.58 16.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.497 -0.927 . . . . 72.43 108.497 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 113.7 17.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.37 1.468 . . . . 54.4 107.388 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.6 p -100.04 164.58 11.93 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.522 1.529 . . . . 70.03 111.741 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -155.8 120.67 4.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.138 1.775 . . . . 73.54 106.874 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.01 -47.54 0.13 Allowed 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.677 0.791 . . . . 71.24 110.082 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.7 p -128.13 -170.63 2.28 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.784 -1.561 . . . . 73.44 106.784 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.08 9.0 15.83 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.306 -0.871 . . . . 70.13 110.897 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 75.3 m -103.46 115.05 29.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.946 -1.131 . . . . 75.33 107.946 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.62 -43.05 77.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 123.54 0.736 . . . . 52.31 110.245 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.19 -30.63 64.7 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.643 1.11 . . . . 70.21 112.32 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -86.52 -48.39 8.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.749 -0.834 . . . . 44.41 108.749 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -60.95 -26.58 67.62 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.234 0.614 . . . . 70.23 110.751 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -57.16 -40.71 77.82 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.202 0.91 . . . . 74.11 110.093 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -73.6 -29.17 62.22 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 118.288 -1.365 . . . . 75.03 110.48 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.05 -45.18 95.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 124.381 1.072 . . . . 54.22 108.526 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.06 -45.22 94.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.858 0.361 . . . . 63.43 110.596 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -66.05 -48.17 71.92 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 122.65 0.38 . . . . 74.21 111.705 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -40.34 92.36 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 117.894 -1.05 . . . . 74.03 110.453 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.82 -37.79 55.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.278 0.944 . . . . 63.25 109.291 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.8 tp -61.11 -38.56 86.77 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.087 0.858 . . . . 71.31 110.854 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -57.06 -34.28 68.1 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.936 0.789 . . . . 75.24 111.384 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -67.49 -31.08 70.98 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.842 0.829 . . . . 74.02 109.97 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -77.68 -47.03 20.18 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 123.764 0.826 . . . . 72.53 110.948 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.1 t -62.18 -37.85 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 123.681 0.793 . . . . 71.15 109.964 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -52.24 -65.88 0.48 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.258 1.023 . . . . 54.41 110.296 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.63 -28.65 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 121.597 -0.69 . . . . 75.51 111.42 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -68.85 -40.19 79.51 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 119.123 0.874 . . . . 70.11 110.832 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -72.24 -45.24 61.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.722 0.809 . . . . 71.34 110.021 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -63.86 -53.9 43.32 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.289 0.636 . . . . 74.51 111.082 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.2 t -71.78 161.93 30.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.779 0.832 . . . . 73.33 111.836 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.5 176.27 45.38 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.999 1.285 . . . . 64.11 110.63 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.96 157.47 56.74 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.686 2.257 . . . . 74.15 110.198 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.5 p -66.05 -7.78 19.41 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.768 1.395 . . . . 75.34 114.768 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.2 t -77.62 -97.03 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.415 1.886 . . . . 50.42 109.32 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 N-CA-C 107.848 -2.101 . . . . 64.02 107.848 -179.785 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.081 0 N-CA-C 109.174 -1.57 . . . . 53.24 109.174 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p -154.78 173.33 16.59 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.337 1.455 . . . . 71.41 107.478 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.2 t -159.84 172.37 17.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.852 1.661 . . . . 55.14 106.621 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.77 -179.56 35.26 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.515 -1.434 . . . . 51.34 109.515 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.6 t -159.19 166.14 32.1 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.283 1.433 . . . . 63.53 107.155 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.7 m -142.13 168.81 18.87 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.948 1.299 . . . . 61.4 109.799 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.48 148.2 19.59 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.79 -1.324 . . . . 63.24 109.79 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.65 162.36 17.98 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.024 0.53 . . . . 73.12 110.975 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -144.14 -179.93 6.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.242 2.217 . . . . 74.2 106.911 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.82 88.43 0.07 OUTLIER Glycine 0 C--N 1.341 0.807 0 CA-C-N 119.58 1.082 . . . . 72.35 114.209 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.84 171.47 15.08 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.583 -1.265 . . . . 74.44 107.583 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.11 166.6 27.75 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 125.637 1.575 . . . . 70.43 108.075 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.14 164.52 35.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.338 1.855 . . . . 74.33 106.765 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -159.24 163.83 35.52 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 127.253 2.221 . . . . 74.14 106.252 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -138.6 178.43 7.15 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.212 0.605 . . . . 74.23 110.225 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -75.43 158.15 83.83 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.47 1.508 . . . . 71.34 109.851 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.69 159.03 54.05 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.333 2.022 . . . . 71.01 111.732 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.02 178.83 7.96 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.352 1.061 . . . . 72.24 110.161 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -139.31 174.37 10.59 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 126.208 1.803 . . . . 71.32 109.657 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.85 177.84 7.33 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.883 2.073 . . . . 74.22 108.629 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -129.15 153.29 80.36 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.027 1.331 . . . . 53.14 110.235 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -80.8 177.1 8.36 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.63 2.887 . . . . 74.35 110.85 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.89 160.24 27.97 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.649 -1.38 . . . . 62.11 109.649 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -145.81 124.09 12.27 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.838 -1.912 . . . . 65.4 105.838 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.98 56.49 1.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.622 1.169 . . . . 72.23 108.573 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.41 139.3 58.53 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.537 -0.727 . . . . 62.21 109.114 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 t -88.36 -170.0 2.78 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.897 1.279 . . . . 64.21 110.517 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.9 p -136.08 178.0 7.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.594 1.558 . . . . 64.33 109.467 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.71 -179.43 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 126.377 1.871 . . . . 74.3 109.514 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -130.48 169.47 15.5 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.082 1.753 . . . . 62.23 110.996 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -100.59 147.74 7.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.242 1.017 . . . . 64.4 109.265 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.92 -166.62 1.38 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.099 -1.445 . . . . 63.14 107.099 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.28 179.94 25.56 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-O 121.999 0.777 . . . . 71.14 112.223 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -66.64 -40.02 88.53 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.632 1.173 . . . . 70.31 110.162 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp 54.05 28.35 8.68 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.899 1.28 . . . . 70.33 111.037 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -125.29 13.98 8.3 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.833 2.053 . . . . 75.23 111.575 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -56.4 28.67 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 126.012 1.725 . . . . 71.43 110.382 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.29 161.17 44.25 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.08 1.854 . . . . 73.14 110.387 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.73 161.36 41.37 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.752 2.021 . . . . 74.43 106.621 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.6 mt 30.11 64.51 0.15 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.348 2.259 . . . . 73.5 112.803 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.79 157.85 18.34 Favored Pre-proline 0 C--O 1.24 0.605 0 C-N-CA 127.475 2.31 . . . . 70.53 109.77 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -62.41 140.95 85.12 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.137 1.225 . . . . 63.23 110.622 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.3 123.23 12.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.124 -1.806 . . . . 45.24 106.124 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -85.24 117.86 24.44 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.618 1.167 . . . . 74.3 109.664 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.35 -29.13 69.83 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.823 1.046 . . . . 73.14 113.823 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -82.68 -10.48 58.9 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.454 1.102 . . . . 64.31 112.849 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -91.59 2.25 56.58 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.768 0.713 . . . . 71.24 111.568 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mt -102.73 174.5 5.86 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.122 1.369 . . . . 61.44 112.106 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -126.79 156.23 41.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.346 2.258 . . . . 72.1 105.807 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -137.45 157.31 46.84 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.602 -0.686 . . . . 55.34 111.861 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -126.89 140.17 52.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.408 1.083 . . . . 74.24 111.134 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -106.38 132.34 52.52 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.562 1.145 . . . . 55.13 108.096 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.1 t -88.06 120.86 37.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.975 -1.121 . . . . 73.43 107.975 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 95.62 10.3 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.917 0.887 . . . . 32.31 109.5 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.48 -88.99 1.02 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.42 -0.895 . . . . 64.01 113.171 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -140.13 157.97 44.79 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.24 1.416 . . . . 74.54 110.464 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.65 -168.89 32.56 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.516 2.008 . . . . 43.21 110.414 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -65.65 170.48 11.15 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.399 2.733 . . . . 71.21 110.739 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.26 160.14 9.91 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 123.594 0.616 . . . . 75.1 112.207 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.13 -82.16 0.31 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 106.865 -2.494 . . . . 41.43 106.865 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -66.93 129.47 40.0 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.322 -1.733 . . . . 71.41 106.322 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.37 164.67 5.34 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.829 -0.434 . . . . 40.53 109.829 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.3 t -60.1 131.8 51.94 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.69 -1.226 . . . . 62.42 107.69 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -132.17 126.22 33.11 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.625 -1.991 . . . . 75.31 105.625 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -62.41 -21.79 65.66 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 118.856 -0.592 . . . . 74.03 111.293 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.2 p -75.77 72.47 2.69 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.86 1.664 . . . . 70.54 110.778 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -65.88 -6.17 11.43 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.135 -0.978 . . . . 63.43 111.956 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -72.93 62.96 0.63 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.726 2.811 . . . . 72.01 111.455 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.1 m -104.46 156.39 17.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.714 1.206 . . . . 64.45 109.504 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.95 142.22 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.537 1.535 . . . . 71.23 107.473 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -137.56 95.47 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.23 -1.396 . . . . 34.14 107.23 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.4 tp -93.46 152.4 19.11 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.727 0.411 . . . . 52.2 110.229 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -141.45 137.3 32.07 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 124.574 1.149 . . . . 73.31 110.346 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -87.84 132.93 34.0 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 105.468 -2.049 . . . . 71.45 105.468 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.63 -64.95 2.25 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 119.297 0.953 . . . . 65.25 111.846 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.54 -7.74 21.78 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.801 3.0 . . . . 73.4 116.13 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 m -113.3 -17.36 12.32 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.86 1.209 . . . . 72.21 112.213 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.11 -7.03 0.86 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.363 1.459 . . . . 70.31 115.725 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.76 136.93 25.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 120.038 1.919 . . . . 74.32 107.523 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.0 t -121.6 137.29 55.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.818 1.647 . . . . 71.24 106.772 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.0 p -146.88 148.11 17.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.542 -0.911 . . . . 74.31 108.542 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.48 134.08 41.11 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 122.523 0.329 . . . . 73.34 111.291 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.1 t -140.77 155.35 46.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.181 1.793 . . . . 73.42 108.547 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -150.75 100.78 2.86 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.496 1.918 . . . . 62.42 108.173 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -120.55 -15.55 8.47 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 114.768 1.396 . . . . 74.33 114.768 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.3 p -134.2 168.18 19.33 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.53 1.514 . . . . 73.43 110.824 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -79.96 -10.61 59.79 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.633 -0.667 . . . . 72.42 110.851 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.37 114.65 26.34 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.827 1.651 . . . . 72.22 110.231 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.35 -44.45 98.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-O 119.18 -0.438 . . . . 54.45 110.707 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -58.15 -45.45 87.4 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.381 0.537 . . . . 74.42 110.952 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -42.2 97.21 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.47 -0.937 . . . . 60.41 108.47 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -61.56 -27.47 68.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 118.613 -0.708 . . . . 73.22 109.987 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -62.22 -46.59 88.18 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 120.077 1.308 . . . . 74.14 107.843 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -60.36 -37.39 80.56 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.344 0.52 . . . . 62.53 110.222 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.48 -48.27 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 108.612 -0.884 . . . . 74.01 108.612 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.5 -35.49 80.65 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.673 -0.642 . . . . 44.14 110.538 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -63.71 -52.06 62.25 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 123.758 0.823 . . . . 75.12 111.282 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -43.35 94.21 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.643 1.11 . . . . 73.12 110.66 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.11 -33.09 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.503 1.047 . . . . 74.1 109.326 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.11 -33.13 75.08 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 120.839 -1.163 . . . . 71.31 108.962 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -58.75 -45.64 89.22 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.958 1.254 . . . . 75.24 107.951 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -56.47 -37.58 70.53 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.399 1.08 . . . . 73.12 109.684 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -72.4 -39.02 68.27 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.621 -0.674 . . . . 73.15 111.911 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.94 -39.29 85.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.564 -0.902 . . . . 60.55 108.564 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.12 -62.89 1.44 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.604 1.561 . . . . 75.43 110.799 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.4 p -60.8 -27.62 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 119.246 -0.407 . . . . 65.02 110.819 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -66.69 -36.19 81.92 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.585 0.63 . . . . 74.14 109.786 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -74.53 -42.78 58.25 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.423 -0.584 . . . . 70.13 109.423 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -67.83 -58.47 4.53 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.026 0.931 . . . . 73.31 111.748 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.2 t -96.18 64.38 2.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.384 1.474 . . . . 50.42 109.544 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -142.95 159.67 27.42 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.271 0.939 . . . . 63.02 110.988 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -61.53 128.16 23.9 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.727 2.952 . . . . 74.33 109.126 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.3 m -143.72 160.72 40.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.589 0.756 . . . . 64.42 110.413 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.9 t -141.63 59.82 1.49 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 104.469 -2.419 . . . . 62.43 104.469 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.85 0 N-CA-C 103.835 -3.706 . . . . 42.55 103.835 -178.658 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.082 0 N-CA-C 108.338 -1.905 . . . . 74.21 108.338 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 m -140.69 167.63 21.71 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.156 -1.053 . . . . 70.22 108.156 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 p -153.67 172.83 16.65 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.999 1.319 . . . . 72.12 108.099 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.26 -179.41 38.43 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.476 -1.85 . . . . 61.01 108.476 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.3 p -160.61 -179.58 7.75 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.207 -1.034 . . . . 73.03 108.207 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 m -128.53 8.88 5.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.865 0.866 . . . . 70.23 112.123 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 56.73 -148.68 30.78 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.221 -0.752 . . . . 40.33 111.221 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 164.85 168.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 1 C-N-CA 132.549 4.34 . . . . 70.32 106.89 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -156.54 175.83 13.52 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.587 1.155 . . . . 74.14 108.061 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.9 162.38 35.76 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.524 1.059 . . . . 54.41 111.188 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.9 mt -149.23 167.0 27.2 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.839 1.656 . . . . 60.12 108.278 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -153.16 132.94 13.16 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 107.949 -1.13 . . . . 71.43 107.949 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.453 ' CD1' ' H ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -159.28 -176.65 5.93 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 128.216 2.606 . . . . 75.32 106.0 179.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.453 ' H ' ' CD1' ' A' ' 13' ' ' LEU . 0.0 OUTLIER 147.01 168.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 1 C-N-CA 135.885 5.674 . . . . 74.4 106.627 179.654 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -138.39 170.9 15.2 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.378 -1.341 . . . . 71.02 107.378 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.43 154.72 47.66 Favored Pre-proline 0 N--CA 1.45 -0.43 0 C-N-CA 125.634 1.574 . . . . 74.43 111.622 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.59 163.79 36.57 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.976 2.451 . . . . 74.2 109.216 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.7 164.27 31.49 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.672 1.189 . . . . 61.22 109.154 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -160.06 176.41 11.85 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 126.197 1.799 . . . . 74.54 109.003 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.9 174.77 10.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.251 2.22 . . . . 74.42 107.723 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -123.65 152.39 65.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 124.405 1.082 . . . . 70.51 110.222 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -80.74 -179.54 5.23 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.929 3.086 . . . . 70.23 110.903 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.75 167.99 25.15 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.397 -1.481 . . . . 62.23 109.397 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -147.82 140.0 24.28 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.998 -1.852 . . . . 74.33 105.998 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.46 59.95 0.82 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.665 0.666 . . . . 30.4 111.053 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.78 140.07 42.15 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.624 -0.88 . . . . 63.12 108.624 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 t -73.87 164.55 26.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.524 1.13 . . . . 74.43 111.59 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.1 p -102.69 165.48 11.04 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.345 1.458 . . . . 72.33 108.593 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.07 143.28 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 107.521 -1.289 . . . . 72.43 107.521 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -62.12 139.24 58.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.439 0.638 . . . . 62.44 110.518 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -82.87 169.22 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 125.439 1.496 . . . . 72.54 109.293 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.25 149.68 36.71 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.47 2.308 . . . . 44.41 107.077 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -136.36 -57.29 0.06 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 125.38 1.467 . . . . 75.35 111.195 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.81 144.01 23.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 117.675 -1.155 . . . . 75.44 109.035 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HA ' ' CE1' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -158.39 5.71 0.12 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.966 2.106 . . . . 64.21 114.566 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -122.24 33.18 5.54 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 126.195 1.798 . . . . 73.14 109.93 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.448 ' CE1' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -52.45 -63.43 2.24 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.883 1.273 . . . . 70.44 111.617 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.0 92.9 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.026 2.484 . . . . 63.23 108.829 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.52 135.93 11.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.921 1.689 . . . . 62.4 107.562 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.2 mt -64.88 103.16 0.68 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.301 -1.37 . . . . 75.43 107.301 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.59 145.25 70.09 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.657 -0.868 . . . . 73.1 108.657 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.77 146.8 67.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.096 1.864 . . . . 73.14 111.927 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 mt -111.86 159.25 18.52 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.741 1.217 . . . . 74.4 111.533 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -115.01 101.37 8.94 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 108.096 -1.076 . . . . 74.24 108.096 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -66.12 -20.79 66.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.311 0.645 . . . . 63.33 112.71 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -84.4 3.29 36.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.932 1.693 . . . . 63.25 112.599 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -124.15 22.81 8.59 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.299 1.039 . . . . 61.04 111.203 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -112.31 162.0 16.01 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.295 -0.878 . . . . 65.22 108.81 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -126.13 95.1 4.28 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.423 1.489 . . . . 75.41 107.094 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 1.3 pm0 -87.0 162.86 17.39 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.138 1.375 . . . . 74.15 112.271 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.7 172.2 13.98 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 106.919 -1.511 . . . . 62.24 106.919 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -130.97 155.91 46.01 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.509 1.124 . . . . 74.1 108.789 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.4 t -100.44 145.42 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.741 0.782 . . . . 64.14 109.512 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -146.0 30.05 1.07 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.239 2.215 . . . . 60.21 107.237 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.01 -143.12 32.84 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 104.5 -3.44 . . . . 55.31 104.5 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 54.97 -85.28 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 127.098 2.159 . . . . 72.12 112.213 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.92 -161.77 32.22 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.285 -1.526 . . . . 50.3 109.285 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.51 15.25 0.68 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.511 2.808 . . . . 73.32 111.26 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.57 -153.74 19.63 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 110.176 -1.169 . . . . 33.11 110.176 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.34 -176.71 54.07 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 122.085 0.825 . . . . 64.21 111.766 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.68 -1.88 0.45 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.528 1.531 . . . . 64.23 114.8 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.37 -11.48 20.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.635 -1.174 . . . . 74.22 112.932 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.3 t -48.53 -57.49 6.09 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.636 1.107 . . . . 75.42 113.444 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -73.67 -8.44 55.98 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.121 -0.987 . . . . 71.53 113.229 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -85.46 58.51 5.08 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 120.256 1.389 . . . . 73.25 112.005 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.7 t -59.6 130.05 44.94 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 105.984 -1.858 . . . . 74.13 105.984 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 p -152.68 156.78 39.86 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.81 -0.556 . . . . 61.12 110.65 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -68.81 14.19 0.08 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.861 2.864 . . . . 65.55 114.469 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.5 m -63.81 160.03 18.21 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.202 1.001 . . . . 70.44 110.611 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.08 148.53 30.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.07 -1.456 . . . . 75.12 107.07 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 p -133.78 115.88 22.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 105.953 -1.869 . . . . 63.12 105.953 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.77 151.66 40.32 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.18 1.792 . . . . 64.13 106.881 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.23 151.57 36.9 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.178 0.991 . . . . 72.33 111.78 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -87.26 134.28 33.57 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.995 -1.483 . . . . 74.14 106.995 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.66 -59.35 4.75 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.796 -1.097 . . . . 64.34 111.909 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.06 -9.29 23.33 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 124.268 3.312 . . . . 75.33 116.227 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.4 m -118.24 -12.38 9.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.742 0.701 . . . . 73.34 112.124 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.07 14.56 18.25 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.64 1.114 . . . . 50.54 113.361 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.1 mt -67.02 131.16 32.82 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 N-CA-C 106.048 -1.834 . . . . 60.54 106.048 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.71 140.18 48.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.826 -1.176 . . . . 74.02 107.826 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.81 144.14 24.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.375 -0.972 . . . . 42.51 108.375 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.66 111.16 17.28 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 105.929 -1.878 . . . . 64.44 105.929 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 81.3 m -124.28 158.12 33.29 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.008 0.908 . . . . 73.42 111.394 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -155.43 145.43 21.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.451 1.9 . . . . 64.04 108.627 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -154.2 -35.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.843 -0.535 . . . . 74.35 109.651 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.6 p -138.91 -178.76 5.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.42 -0.955 . . . . 74.34 108.42 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -93.33 -5.77 48.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.595 -0.891 . . . . 70.32 108.595 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' A' ' 91' ' ' GLN . 10.0 m -79.79 114.99 19.13 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.951 1.7 . . . . 54.43 107.812 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.37 -38.33 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 121.958 -0.464 . . . . 42.25 110.173 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -62.35 -33.7 75.23 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.893 1.277 . . . . 61.32 110.73 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 88' ' ' SER . 36.4 mt-30 -76.86 -54.82 6.1 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.215 -1.032 . . . . 74.12 108.215 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -52.46 -36.03 53.86 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.668 -0.682 . . . . 73.34 110.125 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -57.84 -58.28 9.07 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 118.212 -0.899 . . . . 72.14 110.294 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.21 -32.94 74.71 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.935 1.243 . . . . 75.52 113.31 -178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.47 -50.93 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.235 -1.394 . . . . 74.44 107.235 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.07 75.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.459 -0.941 . . . . 53.12 108.459 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.34 -47.0 62.85 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.648 1.179 . . . . 65.13 111.582 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -45.58 82.45 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 117.423 -1.275 . . . . 72.13 111.75 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.35 -29.93 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 120.397 1.453 . . . . 73.03 110.738 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -44.17 96.9 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 107.898 -1.149 . . . . 71.43 107.898 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -54.95 -39.62 69.11 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.564 1.146 . . . . 74.15 110.913 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -67.39 -30.18 69.88 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.076 0.95 . . . . 72.44 110.312 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.13 -46.9 17.07 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.078 -1.014 . . . . 65.54 110.021 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.28 -30.38 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.454 -0.943 . . . . 74.03 108.454 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -57.86 -62.43 1.81 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.685 -1.598 . . . . 72.13 106.685 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.5 t -59.55 -29.53 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.649 0.779 . . . . 65.33 110.39 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -66.6 -34.6 78.24 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 120.276 1.398 . . . . 73.44 111.805 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -87.52 -31.16 20.08 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 109.068 -0.716 . . . . 71.3 109.068 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -80.89 -15.92 55.01 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.086 0.554 . . . . 73.15 110.853 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 m -155.17 101.34 2.23 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.433 1.493 . . . . 74.21 109.727 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -159.22 -170.06 23.32 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 109.016 -1.634 . . . . 74.54 109.016 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -77.16 13.11 1.6 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.062 3.175 . . . . 74.41 113.477 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.9 t -80.2 117.51 21.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 119.729 1.15 . . . . 44.53 109.491 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.4 m -82.87 83.47 7.75 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.295 -1.743 . . . . 72.01 106.295 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.832 0 N-CA-C 108.139 -1.984 . . . . 63.01 108.139 -179.553 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.192 0 N-CA-C 109.086 -1.606 . . . . 54.43 109.086 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.5 t -156.84 168.3 27.86 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.458 -1.682 . . . . 72.1 106.458 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -162.42 166.89 24.47 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.242 1.417 . . . . 65.41 108.258 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.2 135.26 1.86 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 107.684 -2.167 . . . . 71.13 107.684 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.7 m -146.49 163.22 36.42 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.707 1.203 . . . . 53.02 108.151 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.5 p -156.27 173.34 17.0 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.233 1.013 . . . . 64.51 108.349 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.09 175.03 39.96 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.689 -1.364 . . . . 74.41 109.689 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -156.66 113.57 3.1 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 106.037 -1.838 . . . . 73.32 106.037 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -56.73 -70.31 0.12 Allowed 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 124.023 0.929 . . . . 73.21 112.554 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.13 -176.59 37.69 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.203 -1.559 . . . . 61.01 109.203 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 mp -142.73 149.03 38.23 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.217 -1.772 . . . . 74.12 106.217 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -156.31 146.88 21.71 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.529 -1.286 . . . . 75.45 107.529 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.94 147.83 30.49 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 105.594 -2.002 . . . . 73.13 105.594 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.5 -172.45 2.45 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.188 2.595 . . . . 70.23 106.862 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 16' ' ' LYS . 8.0 tp10 -132.92 169.29 17.0 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 106.241 -1.763 . . . . 73.53 106.241 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.404 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -79.08 151.09 75.54 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 125.003 1.321 . . . . 72.23 108.927 -179.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.7 139.25 33.5 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.905 1.737 . . . . 71.43 108.482 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.15 156.93 38.13 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.144 -0.687 . . . . 53.34 109.144 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.9 mt -142.23 170.47 15.66 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.754 1.622 . . . . 73.54 107.744 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pp -139.68 167.96 20.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.62 1.568 . . . . 55.22 109.335 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -89.37 153.99 48.67 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 123.722 0.809 . . . . 75.01 109.087 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.77 163.81 33.0 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.722 2.281 . . . . 74.32 110.839 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.26 -176.36 34.54 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.822 -1.311 . . . . 44.04 109.822 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 53.9 ttm -121.02 145.47 47.73 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.638 -1.245 . . . . 62.34 107.638 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.26 68.6 1.04 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.72 -1.956 . . . . 51.31 105.72 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.4 172.91 7.56 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.9 -0.407 . . . . 44.42 109.9 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 t -154.77 177.09 11.65 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 122.194 -0.316 . . . . 74.22 110.476 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 96.8 m -138.1 173.65 11.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.725 2.41 . . . . 74.45 107.597 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.17 178.87 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.469 1.907 . . . . 53.02 109.09 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -71.0 142.12 50.97 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.388 -1.708 . . . . 74.5 106.388 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.77 177.45 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.467 0.651 . . . . 51.41 110.828 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 174.26 11.8 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.83 -0.623 . . . . 74.12 110.875 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -157.63 162.87 32.3 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 107.442 -2.263 . . . . 74.01 107.442 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -97.65 169.24 9.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 122.334 1.064 . . . . 63.3 111.839 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.6 ttpt -144.97 19.93 1.61 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.858 2.463 . . . . 73.11 109.095 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -108.46 9.42 27.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.354 2.261 . . . . 64.22 113.014 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.32 -58.94 11.55 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-O 118.615 -0.707 . . . . 74.44 109.548 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.87 108.3 1.45 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.516 2.144 . . . . 64.34 110.408 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.0 164.24 24.36 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.442 1.097 . . . . 44.23 109.855 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.5 mt 48.38 52.45 13.51 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.509 2.324 . . . . 64.31 109.084 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp -56.12 149.66 34.52 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.494 1.918 . . . . 74.32 109.807 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.2 151.41 73.56 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.075 2.517 . . . . 63.24 113.931 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.0 mt -123.13 110.41 15.25 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.255 1.422 . . . . 72.03 108.046 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -79.62 101.97 8.64 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.122 1.369 . . . . 72.33 110.276 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -53.8 -29.88 42.48 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.487 0.921 . . . . 73.34 113.487 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.5 -22.83 60.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.14 0.427 . . . . 63.21 111.24 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -89.22 -21.84 23.05 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.568 1.147 . . . . 74.21 110.476 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.7 mt -84.16 176.62 8.66 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.756 0.822 . . . . 74.51 110.112 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.19 140.73 49.96 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.608 -1.627 . . . . 75.4 106.608 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -129.04 157.11 42.63 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 124.716 1.206 . . . . 63.11 109.679 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -137.3 118.71 14.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.799 -1.556 . . . . 61.54 106.799 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -74.45 163.16 28.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.808 -1.996 . . . . 72.03 109.8 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.7 t -129.74 126.21 62.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 107.697 -1.223 . . . . 74.1 107.697 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -127.19 -11.67 5.81 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.247 1.819 . . . . 72.44 111.029 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.32 149.87 7.29 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 126.573 2.035 . . . . 73.05 110.339 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -167.98 130.43 1.52 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.632 1.973 . . . . 72.1 106.21 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.44 168.1 31.78 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.773 -0.931 . . . . 23.02 110.773 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.82 -17.1 29.4 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.763 2.308 . . . . 63.52 113.957 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.7 -160.69 53.83 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 118.545 0.611 . . . . 74.24 112.478 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.4 -126.98 41.22 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.187 -1.565 . . . . 65.02 109.187 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -66.91 -17.18 64.78 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.753 0.649 . . . . 74.45 112.753 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.68 86.15 5.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 119.139 0.881 . . . . 61.33 109.21 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.3 p -69.51 86.66 0.45 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.125 0.97 . . . . 72.31 109.012 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.09 165.84 12.8 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.984 1.714 . . . . 73.32 110.777 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.38 81.29 2.01 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.871 -1.159 . . . . 71.5 107.871 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -78.72 152.34 31.61 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.088 -1.449 . . . . 72.01 107.088 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 p -157.52 167.15 31.01 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.058 -1.09 . . . . 73.33 108.058 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -74.54 44.82 0.22 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.834 1.653 . . . . 75.31 111.763 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.17 159.21 26.8 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.347 -0.846 . . . . 61.25 108.959 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.26 130.27 60.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 105.169 -2.16 . . . . 61.32 105.169 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 t -121.28 119.97 60.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.746 -1.205 . . . . 73.14 107.746 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.8 tp -118.78 142.31 47.82 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.217 -1.401 . . . . 61.51 107.217 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.17 152.3 45.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.69 -1.226 . . . . 71.32 107.69 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -100.3 116.62 32.7 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.03 -2.211 . . . . 71.13 105.03 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.82 -56.75 22.77 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 117.74 -1.124 . . . . 74.53 112.04 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -69.25 -10.4 28.87 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.468 2.112 . . . . 64.51 114.885 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 m -120.43 -11.92 9.05 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.843 1.053 . . . . 74.03 113.843 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.08 -4.02 3.68 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 127.69 2.566 . . . . 73.02 115.633 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.56 135.81 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 119.295 1.547 . . . . 75.22 108.748 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 t -123.35 148.19 27.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 126.258 1.823 . . . . 70.42 107.124 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 p -145.61 146.29 19.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 106.447 -1.686 . . . . 74.21 106.447 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -123.86 119.13 28.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.019 -1.104 . . . . 75.25 108.019 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 91.5 m -128.57 152.26 48.52 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.684 0.754 . . . . 72.13 111.094 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -155.68 100.64 2.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.177 2.191 . . . . 74.12 106.155 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -111.31 -41.53 4.12 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.328 -0.858 . . . . 61.31 110.779 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.3 t -140.76 179.11 6.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.446 1.099 . . . . 42.03 109.921 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.93 11.94 12.31 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.43 1.092 . . . . 64.23 109.902 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.9 m -107.23 115.54 30.34 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.992 -1.114 . . . . 74.01 107.992 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.7 -47.87 81.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.411 0.685 . . . . 64.5 109.314 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -49.69 -54.09 20.74 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.295 1.438 . . . . 61.24 112.406 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.49 -46.12 87.57 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 123.5 0.72 . . . . 73.4 109.618 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -56.91 -37.71 71.83 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.635 0.652 . . . . 54.13 111.108 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -57.91 -36.88 73.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.83 0.741 . . . . 74.02 109.531 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -55.85 25.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 118.496 0.589 . . . . 73.2 109.734 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.6 mp -52.67 -47.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.777 -0.453 . . . . 63.4 109.777 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.54 -50.96 71.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.932 0.893 . . . . 74.02 111.98 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -60.97 -43.83 98.2 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.799 -0.619 . . . . 74.24 110.26 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.06 -59.32 5.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.572 -0.899 . . . . 71.53 108.572 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.9 p -60.1 -35.07 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.819 0.736 . . . . 72.41 112.937 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -65.07 -42.89 93.76 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 119.011 0.823 . . . . 64.34 110.279 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -52.01 -42.25 62.88 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.643 1.577 . . . . 74.21 112.612 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -56.34 -43.16 78.79 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.621 0.724 . . . . 63.24 110.38 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -73.79 -41.17 62.77 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.176 1.79 . . . . 64.24 112.412 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.86 -34.11 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 118.146 -0.93 . . . . 64.3 110.585 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -54.7 -59.54 4.57 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.565 1.529 . . . . 72.42 106.928 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 79.2 t -54.29 -34.49 27.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 126.315 1.846 . . . . 65.21 110.291 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -66.26 -39.19 89.29 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.593 -0.692 . . . . 75.13 110.715 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -78.05 -38.63 44.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.585 0.63 . . . . 73.32 110.063 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -68.41 -58.76 3.86 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.318 1.047 . . . . 75.02 112.641 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 m -88.74 176.79 6.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.583 1.553 . . . . 52.32 114.017 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -118.7 172.09 14.38 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.351 1.453 . . . . 75.34 111.668 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -80.11 175.4 10.4 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.414 3.41 . . . . 74.44 111.272 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.3 m -83.45 -18.1 39.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.362 0.665 . . . . 64.0 111.767 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.9 m -147.84 166.74 26.68 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.601 0.76 . . . . 71.11 112.272 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 C-N-CA 127.004 2.24 . . . . 24.13 110.707 -179.543 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.14 0 N-CA-C 109.193 -1.563 . . . . 71.44 109.193 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -65.32 161.34 19.79 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.889 0.845 . . . . 74.33 110.191 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 t -71.22 -1.2 11.83 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.69 1.196 . . . . 61.42 112.377 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 63.59 -154.67 45.34 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 107.93 -2.068 . . . . 71.11 107.93 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -12.63 61.82 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 117.159 0.479 . . . . 55.41 111.153 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 46.19 43.0 10.73 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.634 1.573 . . . . 44.1 111.584 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.64 137.73 49.22 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.916 -0.874 . . . . 61.23 110.916 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -159.77 171.74 18.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.406 1.883 . . . . 64.41 107.1 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -132.6 179.12 6.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.237 1.015 . . . . 71.43 109.489 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.28 -178.65 37.93 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.312 -1.515 . . . . 43.41 109.312 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.06 165.62 21.51 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.895 0.855 . . . . 74.2 110.563 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.45 163.53 35.38 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.267 1.827 . . . . 73.35 108.734 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.72 168.8 16.58 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.859 1.663 . . . . 71.23 107.64 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.1 164.9 18.05 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.593 1.557 . . . . 64.31 107.698 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 16' ' ' LYS . 5.2 tp10 -93.13 177.93 5.9 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.955 0.902 . . . . 52.44 110.566 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -108.54 160.08 28.47 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 126.3 1.84 . . . . 73.33 111.188 -178.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -71.45 166.99 27.6 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.748 2.299 . . . . 65.44 109.73 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.69 175.93 5.99 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.907 1.283 . . . . 52.52 109.919 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.69 173.76 11.79 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.095 1.758 . . . . 74.41 109.544 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -134.2 174.88 10.02 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.339 1.856 . . . . 64.3 109.428 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -111.92 155.47 43.22 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.666 1.186 . . . . 43.45 109.76 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.78 171.34 18.38 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.977 2.451 . . . . 65.42 111.412 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.06 -176.2 47.8 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.814 -0.915 . . . . 61.33 110.814 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 50.3 ttp -133.17 156.53 47.32 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.197 1.399 . . . . 74.21 108.034 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.36 120.68 4.49 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 102.468 -3.16 . . . . 75.41 102.468 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -113.94 175.71 5.35 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.907 0.883 . . . . 71.43 109.251 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 t -74.07 152.58 39.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.934 0.874 . . . . 23.04 110.779 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 p -84.61 -162.61 0.7 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 129.787 3.235 . . . . 63.0 112.284 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.69 149.35 4.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 O-C-N 121.038 -1.039 . . . . 71.22 108.933 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -81.42 -168.0 1.69 Allowed 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.814 0.816 . . . . 63.14 109.226 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.72 155.47 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 125.675 1.59 . . . . 74.01 107.032 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.07 172.12 7.63 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.256 -0.903 . . . . 44.03 111.325 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.49 160.27 28.7 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.973 -1.251 . . . . 71.44 109.973 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -68.17 158.47 33.13 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.14 0.495 . . . . 74.11 110.371 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -147.47 167.99 23.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.193 2.197 . . . . 54.31 106.524 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.7 t70 46.96 54.7 8.87 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.593 1.957 . . . . 65.43 113.628 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -59.74 3.84 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 117.659 -1.162 . . . . 63.33 108.619 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.37 125.99 16.82 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.722 1.614 . . . . 40.13 109.452 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -140.88 157.49 45.3 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.588 1.555 . . . . 75.11 107.306 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.8 mt -75.98 101.61 5.3 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.272 -1.381 . . . . 54.21 107.272 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 pp -53.71 140.63 48.27 Favored Pre-proline 0 CA--C 1.541 0.63 0 O-C-N 123.827 0.704 . . . . 64.41 109.856 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.13 106.22 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.266 3.311 . . . . 73.52 115.868 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -80.8 149.91 29.41 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.785 -0.45 . . . . 71.02 109.785 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -103.81 106.7 17.29 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 106.959 -1.497 . . . . 73.42 106.959 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -60.15 -13.63 13.09 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 115.417 1.636 . . . . 73.43 115.417 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.9 m -95.99 -13.07 24.08 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.237 0.926 . . . . 61.24 111.394 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -93.99 3.16 55.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.002 2.121 . . . . 73.13 111.449 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mt -98.64 166.62 11.25 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.723 1.209 . . . . 63.33 109.784 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -133.99 98.02 4.04 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.677 1.191 . . . . 73.33 107.806 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.59 164.72 17.58 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 124.024 0.93 . . . . 72.24 112.727 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -132.35 124.87 29.61 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.955 -1.128 . . . . 74.44 107.955 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -88.22 101.01 13.42 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.757 -0.831 . . . . 74.23 108.757 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.45 157.51 2.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.252 -1.759 . . . . 73.12 106.252 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.6 pttm -164.88 130.49 2.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.352 -1.721 . . . . 74.12 106.352 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.13 -140.84 38.48 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.818 -0.913 . . . . 72.02 110.818 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -136.16 155.24 50.44 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.149 2.18 . . . . 73.32 106.317 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.94 172.49 53.03 Favored Glycine 0 CA--C 1.536 1.382 0 N-CA-C 110.246 -1.142 . . . . 62.1 110.246 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.6 80.87 2.22 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.565 2.843 . . . . 73.43 110.088 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -139.99 93.2 0.19 Allowed Glycine 0 C--N 1.332 0.336 0 N-CA-C 107.493 -2.243 . . . . 53.42 107.493 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.62 -155.56 45.26 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.154 -1.579 . . . . 54.24 109.154 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -137.44 135.5 36.94 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.222 -1.77 . . . . 64.33 106.222 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -157.78 175.58 13.7 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.921 1.288 . . . . 70.5 108.07 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 m -79.17 87.69 4.89 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.554 -1.276 . . . . 75.54 107.554 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -54.6 106.2 0.2 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.218 1.407 . . . . 71.4 109.706 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.1 mmtm -73.79 166.61 23.0 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.928 0.394 . . . . 64.11 110.139 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.9 t -118.73 13.94 13.35 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.281 1.432 . . . . 72.03 109.928 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.85 158.19 36.02 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.87 1.268 . . . . 71.34 108.201 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -83.46 155.83 23.21 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.325 -0.62 . . . . 70.14 109.325 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.5 p -155.48 111.52 3.12 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.231 0.612 . . . . 63.23 111.157 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.66 137.38 40.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 105.569 -2.012 . . . . 62.44 105.569 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.15 123.24 63.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.689 -1.967 . . . . 70.04 105.689 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.37 142.65 45.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.93 -1.137 . . . . 55.02 107.93 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -140.39 139.43 35.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.343 1.857 . . . . 63.4 110.575 -178.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -103.07 124.08 47.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.026 -1.842 . . . . 73.54 106.026 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.421 ' HA ' ' HE2' ' A' ' 73' ' ' LYS . 69.3 t -64.58 -63.13 4.01 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 117.854 -1.07 . . . . 65.12 112.024 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.49 -11.62 32.8 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.909 2.406 . . . . 61.33 115.785 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -111.88 -13.51 13.65 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.091 0.86 . . . . 61.21 111.224 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.79 0.62 4.11 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.14 1.829 . . . . 52.12 115.616 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.7 mt -69.16 143.32 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 119.39 1.595 . . . . 72.02 109.376 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 t -136.56 136.94 48.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.229 -1.397 . . . . 63.33 107.229 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.07 147.74 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 121.543 -0.723 . . . . 63.32 109.259 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -129.64 107.52 9.51 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.431 1.092 . . . . 73.14 110.289 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 56.7 m -120.44 152.16 38.35 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.782 0.833 . . . . 62.15 109.86 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.69 100.41 2.08 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.79 1.236 . . . . 71.33 107.845 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -119.63 -14.04 9.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.359 0.664 . . . . 65.41 112.778 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 80.6 p -133.83 -176.83 4.3 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.18 0.992 . . . . 73.31 110.301 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -109.95 19.45 19.03 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.233 1.013 . . . . 74.45 112.644 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 t -125.63 132.02 52.55 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.44 1.096 . . . . 72.34 108.111 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.4 p -58.86 -47.25 90.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 N-CA-C 108.691 -0.855 . . . . 64.15 108.691 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -63.17 -25.87 68.54 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.892 1.071 . . . . 74.42 113.892 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -84.48 -44.73 13.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.033 -1.469 . . . . 71.31 107.033 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -64.34 -27.2 68.86 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.383 -0.823 . . . . 75.25 109.156 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -62.71 -58.3 7.95 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 126.351 1.86 . . . . 75.4 108.607 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -56.29 -37.21 69.55 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.141 0.428 . . . . 74.12 111.681 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 79.0 mt -63.9 -50.65 76.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.74 -0.837 . . . . 73.01 108.74 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.08 97.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.096 -0.478 . . . . 71.41 110.361 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -61.33 -49.14 78.17 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 118.699 0.681 . . . . 72.12 109.305 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -56.13 24.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.778 0.831 . . . . 74.34 110.452 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.36 -35.43 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 119.074 0.852 . . . . 61.24 111.544 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.1 tp -64.27 -41.19 97.04 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 121.187 -0.945 . . . . 71.4 109.15 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -58.3 -43.22 87.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.184 0.994 . . . . 72.32 109.672 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -60.81 -27.42 68.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.545 0.738 . . . . 71.24 111.234 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -88.09 -45.58 10.03 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.169 1.388 . . . . 52.2 111.84 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.6 t -63.35 -35.37 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 107.567 -1.272 . . . . 50.44 107.567 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.65 -64.23 0.9 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.71 1.204 . . . . 71.34 109.383 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.5 p -59.56 -30.53 44.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.518 -0.739 . . . . 71.11 111.727 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -68.87 -35.07 76.47 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.852 1.206 . . . . 63.52 111.203 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -83.08 -32.14 26.94 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.355 1.062 . . . . 74.34 109.869 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -77.11 -46.37 23.76 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.567 0.747 . . . . 62.42 110.281 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 t -76.12 174.14 10.43 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.641 0.776 . . . . 72.05 109.221 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.24 -105.34 2.81 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.369 -1.492 . . . . 64.4 109.369 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.54 116.25 4.64 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.142 1.895 . . . . 71.34 110.051 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 78.2 p -142.77 113.62 7.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.104 -1.813 . . . . 71.22 106.104 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.5 p -61.31 143.25 56.02 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 121.185 -0.947 . . . . 74.23 111.05 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.3 0 N-CA-C 109.8 -1.32 . . . . 74.02 109.8 179.544 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.386 0 N-CA-C 106.814 -2.514 . . . . 51.25 106.814 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t 53.14 42.04 32.16 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.5 1.65 . . . . 61.5 107.684 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 p -139.46 148.75 43.15 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.662 1.985 . . . . 71.33 108.725 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.17 -177.82 33.61 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 108.15 -1.98 . . . . 52.12 108.15 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.6 t -153.63 173.02 16.33 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.02 -1.104 . . . . 63.21 108.02 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.9 p -160.77 176.81 11.08 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.29 1.436 . . . . 74.25 108.573 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.01 167.97 40.62 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.618 -1.793 . . . . 62.44 108.618 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -158.52 168.83 25.88 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 117.966 0.883 . . . . 73.12 109.79 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -133.42 -159.74 0.99 Allowed 'General case' 0 C--O 1.243 0.741 0 C-N-CA 126.426 1.891 . . . . 74.24 106.409 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.68 -80.21 0.28 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 124.714 1.149 . . . . 72.12 111.436 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.9 mt 56.59 179.71 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.733 2.413 . . . . 73.2 111.63 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -159.31 118.08 2.89 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.612 -1.305 . . . . 60.42 108.338 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.408 ' C ' HE21 ' A' ' 14' ' ' GLN . 4.4 mm? -99.5 151.71 20.83 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 106.15 -1.796 . . . . 74.21 106.15 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.408 HE21 ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -159.04 133.67 8.0 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.046 0.927 . . . . 74.55 111.032 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' N ' ' CD ' ' A' ' 15' ' ' GLU . 12.9 mp0 -88.72 -175.63 4.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 128.724 2.81 . . . . 74.4 110.315 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -143.23 156.8 61.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 126.23 1.812 . . . . 74.12 109.506 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.18 175.23 11.2 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.747 2.298 . . . . 74.44 109.051 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -125.2 -174.74 3.13 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.164 1.385 . . . . 62.14 108.552 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.23 175.91 8.08 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.143 1.377 . . . . 65.12 108.557 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.64 176.05 7.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.014 1.726 . . . . 54.54 109.633 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -109.97 153.9 42.92 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.129 1.372 . . . . 74.4 109.497 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.61 168.64 23.31 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.805 2.337 . . . . 62.51 111.765 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.76 -172.33 39.27 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 109.866 -1.294 . . . . 64.24 109.866 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.2 mmt -125.44 158.9 33.25 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 124.65 1.18 . . . . 70.55 108.467 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.32 68.19 1.19 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.348 -1.352 . . . . 73.1 107.348 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.65 172.12 11.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.931 -0.577 . . . . 73.12 110.053 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.7 t -131.62 -173.23 3.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.844 0.858 . . . . 72.02 111.167 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.4 t -130.66 163.0 28.16 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.235 1.414 . . . . 64.54 109.632 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.0 m -67.6 -173.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.011 1.725 . . . . 74.3 112.293 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -132.45 176.87 8.05 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.423 1.889 . . . . 63.45 108.9 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.2 173.18 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 124.2 1.0 . . . . 72.42 110.57 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.84 162.86 28.27 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.773 -0.649 . . . . 73.53 111.569 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.85 141.07 15.36 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 106.069 -2.813 . . . . 43.51 106.069 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -140.02 172.82 12.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 118.365 1.082 . . . . 50.23 109.612 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -157.86 168.97 25.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.236 1.415 . . . . 65.52 107.297 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 40.27 65.71 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 127.464 2.306 . . . . 74.43 113.633 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.03 -59.79 2.64 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 114.048 -1.433 . . . . 74.02 111.157 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.98 157.32 42.91 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.091 1.861 . . . . 70.04 115.548 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.16 177.08 3.43 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.508 1.523 . . . . 62.22 109.424 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.6 mt 58.45 49.08 11.23 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 128.821 2.849 . . . . 71.35 108.918 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 pp -48.83 145.05 6.61 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.545 1.538 . . . . 75.31 111.212 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.51 159.0 55.26 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.452 2.768 . . . . 64.12 111.692 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.0 mt -136.91 122.34 19.5 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 123.189 0.595 . . . . 73.14 109.804 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -67.71 101.79 1.1 Allowed 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 106.839 -1.541 . . . . 73.44 106.839 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 45' ' ' GLU . 1.9 pm0 -57.34 -31.69 65.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.81 0.844 . . . . 72.53 112.361 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.2 m -77.56 -6.28 53.1 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.739 0.816 . . . . 62.24 112.686 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -99.83 7.11 45.22 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.235 1.414 . . . . 71.31 110.334 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mt -110.57 164.59 12.57 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.599 1.16 . . . . 75.34 110.456 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -120.96 137.73 54.48 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.167 -2.161 . . . . 65.35 105.167 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -123.78 155.19 38.39 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.818 1.647 . . . . 72.14 110.725 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -129.87 178.7 6.33 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.206 1.002 . . . . 73.14 108.829 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -135.43 163.5 29.9 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.476 1.91 . . . . 75.02 107.619 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.4 t -114.59 133.5 60.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 104.096 -2.557 . . . . 64.35 104.096 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -138.54 152.98 48.69 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.842 -1.17 . . . . 74.21 107.842 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 90.77 -175.38 40.23 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.414 -1.475 . . . . 74.05 109.414 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -143.18 124.29 14.47 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 102.704 -3.073 . . . . 73.13 102.704 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.66 -176.06 31.31 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 118.588 0.631 . . . . 63.44 111.624 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.77 175.97 4.83 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.297 2.665 . . . . 71.21 111.715 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.23 -63.82 4.37 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 107.634 -2.186 . . . . 55.33 107.634 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.22 -3.95 40.79 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-N 117.363 0.582 . . . . 43.21 112.201 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -60.05 -10.4 4.22 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.083 2.553 . . . . 60.24 113.163 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.71 -23.9 3.01 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.436 1.494 . . . . 74.01 114.734 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 t -153.57 146.35 24.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 119.813 1.188 . . . . 71.51 108.811 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -80.1 41.25 0.51 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.832 1.253 . . . . 61.14 109.373 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -141.73 -6.2 1.01 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.613 1.565 . . . . 74.22 112.485 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.9 m -55.62 100.47 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.618 1.567 . . . . 52.41 110.863 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 t -159.32 163.83 35.34 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.213 1.805 . . . . 74.14 106.48 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 51.26 21.66 1.18 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.245 1.418 . . . . 54.44 112.791 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.9 m -64.25 144.61 57.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.031 1.333 . . . . 62.43 109.679 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.4 162.48 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 121.897 0.856 . . . . 61.23 109.96 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -141.34 156.26 21.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 126.996 2.118 . . . . 63.11 107.549 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.45 150.04 40.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.704 -1.961 . . . . 71.54 105.704 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.89 158.17 43.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.665 0.786 . . . . 72.34 109.337 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -107.34 126.38 52.38 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 104.828 -2.286 . . . . 75.51 104.828 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.1 t -68.28 -58.03 8.05 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 120.051 1.296 . . . . 73.12 111.593 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.09 -12.55 35.26 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.423 2.082 . . . . 73.13 115.628 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -112.4 -21.18 11.5 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.954 0.797 . . . . 61.42 109.719 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.39 -9.25 7.86 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.606 2.526 . . . . 74.51 113.686 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.408 HG21 ' HB3' ' A' ' 103' ' ' LYS . 11.7 mt -55.41 147.49 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.1 1.76 . . . . 72.11 109.918 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.2 t -134.35 146.94 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.468 1.507 . . . . 71.3 108.045 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -144.97 139.54 22.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.225 1.01 . . . . 53.25 108.896 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -110.64 127.89 55.46 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.156 1.382 . . . . 75.4 108.706 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.7 m -150.54 149.39 29.88 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.54 0.686 . . . . 73.43 112.799 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -155.23 139.72 16.85 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 129.584 3.154 . . . . 74.05 105.073 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -152.82 -68.97 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.719 -1.215 . . . . 63.04 107.719 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.0 p -77.93 151.66 33.62 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.564 1.146 . . . . 72.32 111.129 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -66.75 -25.83 66.69 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.83 0.678 . . . . 64.23 112.83 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 m -79.64 116.23 19.71 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.51 0.595 . . . . 72.42 109.845 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.8 p -54.07 -42.6 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.757 -0.831 . . . . 72.3 108.757 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -55.93 -44.42 78.35 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.132 0.973 . . . . 43.33 111.745 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -67.16 -39.55 86.51 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.043 -1.095 . . . . 73.15 108.043 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -60.86 -29.06 69.3 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.634 -0.698 . . . . 72.1 109.612 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -58.17 -40.91 82.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.801 1.182 . . . . 71.51 108.754 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -71.56 -46.51 59.23 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 125.098 1.359 . . . . 72.14 110.382 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 99.4 mt -56.97 -52.8 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 123.462 0.705 . . . . 72.32 111.277 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.5 -28.08 69.58 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.73 -0.606 . . . . 70.03 111.426 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -72.94 -45.76 56.28 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 118.554 -0.736 . . . . 74.44 109.883 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -64.82 -35.85 82.43 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.941 1.246 . . . . 74.2 111.101 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.3 p -71.79 -32.99 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 120.041 1.291 . . . . 74.23 108.375 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.4 tp -64.87 -32.77 74.64 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.602 -1.258 . . . . 52.43 107.602 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -55.75 -41.43 73.96 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.216 -0.661 . . . . 71.22 109.216 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -63.51 -39.58 94.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.733 0.697 . . . . 73.22 110.886 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HB3' HG21 ' A' ' 79' ' ' ILE . 73.4 mmtt -63.24 -48.19 79.27 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.773 0.829 . . . . 73.34 110.518 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 50.1 t -69.28 -41.01 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.872 0.869 . . . . 73.34 110.207 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.48 -62.01 1.89 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.183 1.393 . . . . 64.14 109.681 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.3 p -63.75 -22.44 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.027 0.931 . . . . 62.53 112.248 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -75.37 -27.2 59.04 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.771 -1.206 . . . . 74.24 111.293 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -98.94 -30.73 12.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.346 0.975 . . . . 73.24 109.655 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -75.89 -6.4 50.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.292 0.637 . . . . 71.15 110.597 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.02 174.0 11.1 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.795 1.638 . . . . 73.42 110.145 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -75.98 165.13 54.04 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.954 -1.259 . . . . 51.43 109.954 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.96 137.72 19.98 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.263 1.975 . . . . 75.33 107.268 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.4 p -143.07 176.96 8.7 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.21 -1.033 . . . . 72.12 108.21 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.5 175.59 5.49 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.523 1.129 . . . . 70.34 110.11 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 116.238 -2.423 . . . . 70.31 108.517 -179.82 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.036 0 N-CA-C 109.218 -1.553 . . . . 61.33 109.218 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -155.73 175.19 14.25 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.13 1.372 . . . . 44.54 107.499 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.1 m -155.23 173.66 16.3 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.593 1.557 . . . . 73.15 107.33 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.73 -179.41 47.86 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.157 -1.577 . . . . 74.41 109.157 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.2 p -150.73 179.27 8.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.069 1.347 . . . . 75.21 108.34 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.1 m -160.19 168.73 24.77 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.048 1.339 . . . . 54.32 108.363 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.22 137.61 8.72 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 107.379 -2.289 . . . . 53.24 107.379 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -81.16 79.57 7.79 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 117.805 0.802 . . . . 70.43 109.203 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -72.08 170.52 13.74 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.571 0.749 . . . . 74.35 110.091 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.58 140.88 2.98 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.874 -1.29 . . . . 70.1 109.874 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.7 mp -143.1 170.2 16.16 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.799 1.64 . . . . 71.23 107.441 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.63 159.61 43.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.273 1.429 . . . . 72.53 107.146 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -129.67 160.54 33.05 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.375 1.07 . . . . 70.21 108.363 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.01 164.04 4.09 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.06 2.544 . . . . 71.53 106.543 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.81 179.48 7.06 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.487 1.115 . . . . 60.22 108.149 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.42 155.41 44.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.61 1.164 . . . . 74.23 109.823 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.48 148.62 60.77 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.066 1.844 . . . . 74.11 109.013 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.81 161.47 29.55 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.701 -0.481 . . . . 72.34 109.701 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.6 mt -142.66 174.48 10.61 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.924 1.689 . . . . 73.41 108.113 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -114.83 177.33 4.69 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.599 1.559 . . . . 45.02 109.822 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -121.58 154.68 59.93 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.483 1.513 . . . . 72.14 109.411 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.54 169.65 22.06 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.745 2.297 . . . . 65.52 111.094 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.33 175.46 20.68 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.645 -1.382 . . . . 63.41 109.645 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.1 ttt -143.7 144.65 31.94 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.726 -1.212 . . . . 74.44 107.726 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.07 80.34 0.99 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.569 -1.641 . . . . 33.11 106.569 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.06 160.85 21.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.141 0.577 . . . . 53.43 110.807 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -103.31 -168.0 1.45 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.555 1.542 . . . . 74.43 108.29 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.3 p -124.37 -177.26 3.74 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.447 1.499 . . . . 65.24 109.977 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.72 157.96 41.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 125.203 1.401 . . . . 62.24 108.332 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.95 163.48 15.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.605 0.762 . . . . 54.43 110.987 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.0 -179.57 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.701 1.2 . . . . 72.21 108.788 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.06 161.22 20.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.956 1.302 . . . . 74.44 109.003 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.66 166.47 54.83 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.003 -1.239 . . . . 71.3 110.003 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -123.67 162.34 23.26 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.765 1.226 . . . . 74.2 110.067 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -161.77 176.93 10.38 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.667 1.187 . . . . 63.54 108.404 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t70 71.02 -53.72 0.67 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 127.276 2.23 . . . . 74.4 111.226 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -59.87 12.41 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.476 1.51 . . . . 74.14 109.107 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.66 111.73 2.87 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.268 1.979 . . . . 75.13 110.595 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.26 164.61 30.25 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.369 1.468 . . . . 53.43 108.641 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.5 mt 44.07 50.32 7.37 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.158 1.783 . . . . 75.1 111.393 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp -53.97 152.46 10.44 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.383 1.473 . . . . 73.45 114.042 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.04 154.6 33.23 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.907 2.405 . . . . 73.33 109.784 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.8 mt -134.35 136.81 43.67 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.717 0.807 . . . . 72.03 110.255 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.92 107.59 1.9 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.083 1.353 . . . . 72.34 108.668 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.58 -19.25 57.05 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.56 0.578 . . . . 72.25 112.56 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.9 m -85.27 -1.91 57.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.497 1.044 . . . . 52.45 112.033 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -114.63 -4.97 12.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.925 1.239 . . . . 72.1 112.585 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mt -86.33 140.99 29.55 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.911 -1.885 . . . . 71.4 105.911 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -109.0 126.11 52.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.779 0.718 . . . . 74.13 109.416 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.57 164.49 12.48 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.325 1.05 . . . . 64.24 112.613 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -141.61 143.86 33.9 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.31 -1.737 . . . . 73.34 106.31 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -103.83 123.39 47.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.085 -1.821 . . . . 73.23 106.085 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.1 t -88.0 106.44 16.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.05 -1.833 . . . . 74.13 106.05 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -70.84 31.84 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.509 2.323 . . . . 74.44 113.372 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.56 -99.76 1.88 Allowed Glycine 0 CA--C 1.523 0.551 0 O-C-N 120.263 -1.523 . . . . 63.21 110.551 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 50.29 8.37 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.124 2.57 . . . . 73.42 117.296 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.24 141.14 45.82 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 120.705 1.593 . . . . 65.23 111.486 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -64.81 162.01 33.74 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.478 2.786 . . . . 61.4 111.928 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.97 58.16 5.38 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.563 -1.815 . . . . 42.11 108.563 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.58 -178.55 48.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 107.28 -2.328 . . . . 61.03 107.28 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -122.06 -52.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.627 1.171 . . . . 73.34 108.058 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.74 -104.37 0.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.781 0.832 . . . . 65.52 109.09 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -16.1 2.01 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.696 2.399 . . . . 75.4 114.36 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -55.97 -26.65 49.13 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.228 1.411 . . . . 61.0 112.247 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -127.43 54.86 1.64 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 119.095 0.861 . . . . 73.23 110.592 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.8 m -77.96 72.75 4.51 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.423 -0.954 . . . . 65.22 108.423 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.9 t -84.23 -176.23 6.16 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.109 -1.441 . . . . 65.13 107.109 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.495 HD21 ' HB ' ' A' ' 89' ' ' VAL . 22.2 t-20 -152.63 124.08 7.71 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.97 -1.122 . . . . 54.45 107.97 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.8 m -150.49 152.38 34.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.024 -1.473 . . . . 60.4 107.024 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.4 124.15 70.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.051 -2.203 . . . . 61.24 105.051 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.3 t -102.96 96.21 4.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 104.817 -2.29 . . . . 71.01 104.817 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.9 tp -91.86 139.54 30.56 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.203 -1.777 . . . . 73.31 106.203 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.25 141.15 45.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.76 1.224 . . . . 74.42 110.56 -177.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -95.79 133.29 40.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.856 -1.535 . . . . 61.11 106.856 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.7 t -70.73 -66.5 0.78 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.307 1.043 . . . . 63.14 111.438 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.41 -7.63 21.24 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.858 3.038 . . . . 70.2 116.177 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 t -114.54 -20.43 10.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.524 0.602 . . . . 70.43 110.91 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.54 -3.97 4.34 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.604 -1.109 . . . . 64.42 114.807 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.99 139.52 20.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.261 -1.385 . . . . 73.13 107.261 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.64 147.93 33.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.223 -1.399 . . . . 63.12 107.223 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.464 HG21 HG13 ' A' ' 99' ' ' VAL . 9.8 p -143.12 140.82 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.986 -1.487 . . . . 52.21 106.986 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.68 107.79 13.66 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 106.515 -1.661 . . . . 61.22 106.515 -178.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 77.3 m -112.04 134.86 53.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 123.555 0.534 . . . . 74.43 110.567 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -147.28 109.87 4.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.66 2.384 . . . . 74.34 106.517 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -135.45 -20.71 1.59 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.49 1.116 . . . . 71.24 111.264 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.79 173.43 16.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.599 1.16 . . . . 72.55 107.914 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -86.63 -4.97 59.25 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.961 -1.087 . . . . 72.04 109.819 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.5 m -82.15 115.0 21.06 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.324 -1.362 . . . . 61.42 107.324 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.495 ' HB ' HD21 ' A' ' 68' ' ' ASN . 13.9 p -61.19 -38.7 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.796 -0.816 . . . . 51.1 108.796 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.479 ' HA ' ' HD3' ' A' ' 93' ' ' ARG . 9.9 m-20 -63.42 -23.05 67.24 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 113.859 1.059 . . . . 65.0 113.859 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -87.71 -46.84 9.14 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.321 -0.992 . . . . 63.12 108.321 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -59.11 -43.7 91.93 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.746 0.818 . . . . 61.13 110.945 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.479 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 4.0 ptm180 -57.74 -46.42 84.48 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 113.06 0.763 . . . . 74.11 113.06 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -64.41 -36.76 85.2 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 119.541 -0.863 . . . . 72.43 111.717 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 38.2 mt -60.89 -49.92 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.112 -1.44 . . . . 61.25 107.112 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.43 68.11 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.476 0.71 . . . . 32.33 111.684 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.9 ttm-85 -61.18 -53.78 52.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.11 0.414 . . . . 71.41 110.959 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -61.97 -39.8 93.43 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.68 -0.676 . . . . 75.31 112.409 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.464 HG13 HG21 ' A' ' 81' ' ' VAL . 13.8 p -72.19 -27.15 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 120.482 1.492 . . . . 72.22 109.495 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.9 tp -65.62 -47.48 75.48 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 120.329 -1.482 . . . . 74.25 107.445 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -56.91 -39.23 74.05 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.678 -1.153 . . . . 72.24 111.891 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.17 -50.2 74.93 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.775 1.17 . . . . 65.55 110.303 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -68.17 -44.6 75.58 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.844 -0.616 . . . . 75.21 112.084 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.6 t -62.91 -37.98 80.68 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-O 118.648 -0.692 . . . . 74.52 109.789 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -56.2 -52.23 65.18 Favored 'General case' 0 CA--C 1.523 -0.085 0 CA-C-N 119.354 0.979 . . . . 74.44 110.382 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.96 -18.15 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 121.647 -0.658 . . . . 72.3 112.434 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -87.48 -19.68 27.63 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.621 1.568 . . . . 74.2 110.224 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.26 -46.69 5.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.75 2.02 . . . . 73.01 110.928 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -77.07 -25.95 52.95 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.703 0.683 . . . . 62.02 111.937 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.1 m -145.19 -172.75 3.93 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.895 2.478 . . . . 74.33 106.631 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.61 172.01 44.31 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 120.983 -1.073 . . . . 72.22 111.627 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.59 -38.03 8.74 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.381 2.721 . . . . 64.03 108.983 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.2 m -72.21 175.74 5.81 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.455 1.502 . . . . 55.23 109.377 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.2 t -162.1 130.02 4.03 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 105.736 -1.95 . . . . 54.13 105.736 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.044 -1.42 . . . . 54.11 109.961 -179.533 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.195 0 N-CA-C 109.296 -1.522 . . . . 74.41 109.296 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 p -149.89 164.84 34.32 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.81 1.644 . . . . 50.13 106.823 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 m -144.78 165.17 28.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.735 1.214 . . . . 72.2 108.501 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.63 160.84 26.34 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.279 -1.928 . . . . 34.4 108.279 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.8 t -170.46 167.37 8.21 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.964 1.706 . . . . 64.31 106.838 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 p -163.87 149.91 11.29 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.024 0.93 . . . . 75.15 108.725 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.44 156.34 26.69 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 108.82 -1.712 . . . . 73.01 108.82 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -154.8 120.39 5.1 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 106.424 -1.695 . . . . 72.35 106.424 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 67.2 p-90 -140.3 -176.3 4.57 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.496 1.119 . . . . 73.24 108.946 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.81 160.17 31.02 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.516 -1.434 . . . . 20.43 109.516 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.2 mt -127.47 176.76 7.22 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.467 1.507 . . . . 71.14 109.76 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.95 166.19 33.22 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 127.335 2.254 . . . . 72.33 107.417 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.35 167.7 27.1 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.0 2.12 . . . . 42.45 106.428 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.4 ' HA ' HE21 ' A' ' 14' ' ' GLN . 0.0 OUTLIER -142.77 142.25 31.87 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.625 -1.25 . . . . 64.04 107.625 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -130.96 -175.82 3.8 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.695 1.598 . . . . 74.2 108.706 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -135.98 139.66 31.01 Favored Pre-proline 0 N--CA 1.455 -0.203 0 C-N-CA 124.303 1.041 . . . . 73.22 109.242 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.77 173.49 13.36 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.119 3.213 . . . . 62.02 111.371 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.11 176.11 4.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.039 0.936 . . . . 74.52 110.656 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.57 173.89 7.78 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.54 1.536 . . . . 50.35 108.615 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.81 175.32 9.45 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.288 1.835 . . . . 74.44 109.306 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -118.43 156.53 50.95 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 125.423 1.489 . . . . 74.41 108.712 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.81 166.34 29.95 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.431 2.087 . . . . 75.22 111.491 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.12 -175.92 50.98 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.241 -1.143 . . . . 63.23 110.241 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 60.7 mtt -122.84 168.26 12.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.962 0.905 . . . . 44.11 110.04 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.16 132.16 9.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 102.063 -3.31 . . . . 73.44 102.063 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -130.08 177.44 7.29 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.594 -1.262 . . . . 44.02 107.594 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.27 176.33 5.34 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.574 -0.704 . . . . 73.51 110.189 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -124.58 170.88 10.48 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.466 1.107 . . . . 54.34 108.865 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.5 m -72.74 -175.26 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.6 1.16 . . . . 60.25 109.996 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -132.52 173.65 11.1 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.22 1.008 . . . . 74.31 109.53 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.0 149.35 10.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 124.153 0.981 . . . . 75.05 109.357 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.13 173.54 7.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.37 1.068 . . . . 64.32 111.518 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.18 176.17 16.25 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 107.873 -2.091 . . . . 64.23 107.873 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.3 mmp_? -131.25 177.55 7.38 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.182 -1.187 . . . . 52.13 111.639 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -150.7 179.43 8.2 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 129.404 3.082 . . . . 74.3 105.527 177.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.09 24.15 14.34 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.929 1.455 . . . . 74.24 114.929 177.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.78 -63.24 2.44 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.467 0.914 . . . . 74.51 113.467 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -67.67 101.95 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.707 2.271 . . . . 43.1 109.959 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -143.25 -166.4 2.3 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.509 1.124 . . . . 73.14 109.534 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.7 mt -137.33 90.32 2.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.988 2.115 . . . . 65.41 109.065 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 pp -63.43 153.77 81.38 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 126.69 1.996 . . . . 71.55 113.056 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.11 112.59 2.84 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.19 2.594 . . . . 53.3 112.042 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mt -91.29 140.95 29.29 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.638 -0.664 . . . . 73.24 110.849 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -89.53 106.35 18.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 105.642 -1.984 . . . . 73.31 105.642 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -60.04 -11.49 6.01 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 114.879 1.437 . . . . 73.54 114.879 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.4 m -101.15 -3.44 29.15 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.208 1.003 . . . . 64.54 111.595 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -96.59 -8.83 30.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.433 1.093 . . . . 71.11 110.556 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.06 175.26 6.93 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.347 1.459 . . . . 74.23 109.709 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -130.1 122.65 28.7 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.39 0.676 . . . . 73.23 109.825 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -105.26 160.09 15.37 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.275 1.03 . . . . 73.2 111.182 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -142.05 131.17 23.29 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.139 1.376 . . . . 65.11 108.896 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -88.41 163.04 16.18 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.665 1.186 . . . . 65.42 107.933 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.6 t -133.86 125.57 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.285 1.034 . . . . 43.31 108.865 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -119.49 -45.92 2.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.653 1.581 . . . . 61.14 108.97 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.44 79.98 0.05 OUTLIER Glycine 0 C--N 1.335 0.5 0 N-CA-C 108.888 -1.685 . . . . 64.01 108.888 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -77.18 109.28 10.92 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.363 -0.977 . . . . 72.55 108.363 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.75 -163.36 10.06 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 123.22 0.325 . . . . 40.4 112.507 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.68 13.57 0.94 Allowed 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.91 3.073 . . . . 64.04 112.578 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.37 -61.23 4.74 Favored Glycine 0 C--N 1.339 0.745 0 O-C-N 120.828 -1.17 . . . . 63.41 110.205 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.88 -175.01 16.23 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.223 1.392 . . . . 62.53 110.587 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -75.11 74.67 2.28 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.025 0.93 . . . . 74.53 108.962 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -146.22 166.96 24.69 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.472 1.509 . . . . 61.23 108.934 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.3 p -110.44 -1.98 16.79 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.243 1.017 . . . . 74.12 112.287 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -73.7 176.89 5.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.36 1.464 . . . . 71.12 111.031 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.28 96.55 3.4 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 105.044 -2.206 . . . . 64.21 105.044 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.7 p -68.92 9.01 0.44 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.387 2.275 . . . . 71.13 115.332 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 m -53.99 -17.89 3.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.75 2.02 . . . . 64.44 115.902 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -140.88 52.71 1.6 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.332 1.423 . . . . 64.24 111.185 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.2 m -99.51 158.39 15.77 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.401 0.68 . . . . 55.35 109.299 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.4 t -140.74 135.83 34.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 125.925 1.69 . . . . 74.43 106.583 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.28 142.27 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.201 -1.407 . . . . 72.0 107.201 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.4 tp -131.57 146.74 52.36 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.697 1.199 . . . . 51.41 107.976 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.56 148.59 49.15 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.476 0.655 . . . . 75.13 110.15 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -93.92 118.67 31.8 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 104.243 -2.503 . . . . 71.44 104.243 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.19 -61.53 7.66 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 118.531 -0.747 . . . . 74.34 112.077 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -69.91 -9.78 26.87 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.793 2.329 . . . . 51.02 116.197 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 m -120.95 -10.33 9.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.438 1.472 . . . . 73.02 114.614 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.74 9.67 27.52 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.737 1.161 . . . . 73.21 114.725 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 mt -70.81 131.5 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 104.772 -2.307 . . . . 71.22 104.772 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.1 t -126.52 143.93 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.55 -1.278 . . . . 62.13 107.55 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.54 142.57 25.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.525 -0.917 . . . . 71.02 108.525 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -115.42 118.5 33.38 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.751 1.62 . . . . 72.54 110.154 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.0 p -116.55 143.42 45.62 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.397 0.544 . . . . 72.11 110.135 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -157.41 100.32 1.81 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.704 1.202 . . . . 64.33 108.813 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -135.34 -24.62 1.39 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 119.989 1.268 . . . . 74.33 114.017 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.2 p -124.29 171.6 9.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.576 0.75 . . . . 74.13 110.025 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -91.25 0.85 57.45 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.56 -0.533 . . . . 61.23 109.56 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.0 m -100.28 114.97 28.85 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.11 1.364 . . . . 73.44 107.961 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.2 p -59.42 -38.41 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.538 -0.912 . . . . 70.41 108.538 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -59.4 -40.52 86.9 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.048 1.739 . . . . 61.01 112.318 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -79.11 -29.76 43.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.492 0.717 . . . . 73.54 110.662 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.418 ' HA ' HD12 ' A' ' 95' ' ' ILE . 89.9 m-20 -70.37 -40.44 73.99 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.275 -1.38 . . . . 51.31 107.275 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -48.61 -52.01 25.14 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.744 -1.223 . . . . 74.21 113.022 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -57.3 -35.16 69.48 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.174 0.897 . . . . 64.42 112.684 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 92' ' ' ASN . 54.6 mt -63.05 -50.39 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.221 1.008 . . . . 60.34 108.557 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.86 92.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 119.367 -0.349 . . . . 55.02 110.427 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -61.73 -51.65 67.51 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.051 0.541 . . . . 73.22 111.812 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -40.58 95.35 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 117.783 -1.103 . . . . 73.2 112.32 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.422 HG22 ' HE2' ' A' ' 103' ' ' LYS . 4.4 p -73.81 -38.77 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 119.676 1.126 . . . . 72.51 110.456 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 104' ' ' VAL . 56.3 tp -60.93 -44.99 96.45 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.86 -0.792 . . . . 72.1 108.86 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -50.28 -47.62 55.31 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 124.143 0.977 . . . . 72.33 112.095 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -59.27 -35.83 74.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.826 -1.171 . . . . 71.41 111.671 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.422 ' HE2' HG22 ' A' ' 99' ' ' VAL . 54.6 mttm -77.6 -33.55 53.79 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.586 1.154 . . . . 75.24 110.184 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 100' ' ' LEU . 60.8 t -66.12 -51.7 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 C-N-CA 125.712 1.605 . . . . 72.52 108.171 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -61.62 2.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 126.263 1.825 . . . . 74.32 111.234 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.3 p -59.52 -28.9 41.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-O 119.489 -0.291 . . . . 61.25 111.758 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -66.82 -37.58 84.79 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.579 -1.326 . . . . 74.33 109.996 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -81.84 -40.98 21.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.809 -0.557 . . . . 73.2 110.629 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -74.65 -15.14 60.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.643 1.577 . . . . 70.21 112.611 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.9 m -138.39 89.17 2.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.918 1.287 . . . . 53.12 109.364 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -168.21 178.09 42.03 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.196 -1.162 . . . . 52.43 110.196 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.18 163.05 39.91 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.457 2.105 . . . . 73.02 109.931 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.9 m -103.19 -42.93 5.61 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.992 0.917 . . . . 63.24 108.972 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.7 p -149.31 -2.8 0.43 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.047 0.758 . . . . 55.23 113.047 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.352 0 N-CA-C 108.246 -1.942 . . . . 72.22 108.246 -177.876 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.963 0 N-CA-C 108.411 -1.876 . . . . 74.5 108.411 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.92 -179.13 6.9 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.46 1.504 . . . . 74.31 107.481 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t -156.95 -166.68 2.15 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.128 -1.064 . . . . 73.02 108.128 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.85 171.7 22.29 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.769 1.652 . . . . 74.42 109.122 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.8 m -153.04 76.36 1.12 Allowed 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.667 -0.902 . . . . 74.41 108.891 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.3 p -68.31 153.07 44.47 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.871 -0.789 . . . . 74.54 108.871 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.63 -98.57 0.92 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 108.231 -1.948 . . . . 63.4 108.231 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.93 170.69 18.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.022 0.911 . . . . 73.22 110.838 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 30.9 p-90 -129.35 170.37 13.73 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.014 2.126 . . . . 74.23 107.956 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.41 -82.11 0.51 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.27 0.938 . . . . 74.2 112.035 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.4 mt 38.75 44.12 0.78 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.881 2.473 . . . . 64.12 114.971 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.3 157.79 18.07 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.304 -1.739 . . . . 65.21 106.304 177.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.98 150.53 35.66 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 105.936 -1.876 . . . . 74.43 105.936 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.3 139.17 26.89 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.188 -1.412 . . . . 73.22 107.188 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -148.92 164.22 35.16 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 126.158 1.783 . . . . 65.01 106.883 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -157.69 138.61 9.41 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 129.703 3.201 . . . . 72.34 103.528 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.92 152.21 68.43 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.507 1.471 . . . . 74.51 110.049 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.4 176.25 10.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.162 1.785 . . . . 70.34 107.874 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.2 tp -66.99 134.56 52.19 Favored 'General case' 0 CA--C 1.526 0.053 0 N-CA-C 107.884 -1.154 . . . . 35.03 107.884 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.33 167.34 20.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.797 1.639 . . . . 75.41 109.272 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -79.57 158.07 73.97 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.884 -0.784 . . . . 74.52 108.884 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.91 -176.61 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.749 2.3 . . . . 65.41 110.049 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.84 147.67 43.4 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 109.602 -1.399 . . . . 64.1 109.602 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 70.8 mtm -134.79 173.74 11.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.203 1.401 . . . . 75.53 108.704 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.31 119.17 10.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 100.847 -3.761 . . . . 61.22 100.847 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -123.8 175.61 6.79 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.846 0.459 . . . . 74.32 109.969 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.6 t -61.76 141.59 57.8 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.347 0.659 . . . . 71.23 109.57 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.9 p -73.37 -174.98 1.78 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.794 1.238 . . . . 75.44 109.602 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.2 m -62.58 153.74 6.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 O-C-N 121.041 -1.037 . . . . 50.22 109.873 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -130.55 -176.39 3.96 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.297 1.439 . . . . 61.04 109.521 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 t -70.77 163.72 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 122.007 0.908 . . . . 62.01 110.946 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.94 168.51 13.87 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 127.792 2.437 . . . . 52.42 107.779 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.04 -174.31 50.28 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 109.055 -1.618 . . . . 73.13 109.055 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -135.3 165.63 25.01 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.15 0.975 . . . . 72.44 109.706 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -148.87 -169.54 3.39 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.238 2.215 . . . . 74.45 105.893 178.119 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 52.8 26.42 4.54 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.281 1.832 . . . . 71.33 115.355 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -59.89 10.94 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 117.416 -1.278 . . . . 73.51 113.43 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.04 101.68 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.125 2.55 . . . . 73.53 107.557 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.64 173.78 16.33 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.645 1.178 . . . . 64.23 109.067 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.9 95.78 3.02 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.726 -1.212 . . . . 75.44 107.726 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.4 mt -56.51 145.03 61.55 Favored Pre-proline 0 C--O 1.234 0.262 0 N-CA-C 109.864 -0.421 . . . . 63.45 109.864 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.76 122.95 10.95 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.072 2.515 . . . . 61.21 111.664 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -112.28 147.74 35.64 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.641 1.177 . . . . 62.43 110.341 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -110.49 115.48 29.7 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.663 -1.236 . . . . 53.12 107.663 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.52 -28.24 69.51 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.851 0.75 . . . . 70.14 111.675 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 m -75.36 0.05 18.17 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.514 1.126 . . . . 71.21 111.471 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -117.64 5.76 12.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.107 1.363 . . . . 74.32 113.305 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.435 HD22 ' CD2' ' A' ' 74' ' ' HIS . 6.1 mt -107.87 176.0 5.29 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.732 -1.21 . . . . 73.32 107.732 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -138.6 112.46 8.43 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.124 0.57 . . . . 63.44 109.661 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 157.26 17.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.003 -1.48 . . . . 73.54 107.003 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -142.04 -179.67 6.36 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.733 -1.21 . . . . 63.43 107.733 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.04 162.97 27.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.844 1.258 . . . . 64.4 108.476 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.8 t -149.1 141.72 17.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.64 1.576 . . . . 74.45 108.909 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -114.71 -68.12 0.95 Allowed 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 104.661 -2.348 . . . . 65.25 104.661 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.47 136.41 4.21 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 107.532 -2.227 . . . . 73.12 107.532 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -159.1 -46.94 0.06 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.635 1.174 . . . . 64.1 109.712 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -105.33 -174.26 24.18 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.137 1.351 . . . . 53.45 110.914 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.92 3.68 1.84 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.415 3.41 . . . . 73.23 114.584 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.86 -149.05 34.52 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 110.663 -0.975 . . . . 44.41 110.663 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.11 25.96 25.98 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.997 -1.241 . . . . 73.1 109.997 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 54.75 45.55 26.46 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.11 1.364 . . . . 74.54 109.827 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -149.12 97.85 2.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.502 2.321 . . . . 73.41 105.659 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.81 76.9 2.75 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.457 1.503 . . . . 73.42 109.006 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -79.87 170.46 16.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.728 0.811 . . . . 24.02 110.577 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -83.87 -55.96 3.96 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 106.228 -1.767 . . . . 75.14 106.228 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 m -65.33 -38.5 90.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.989 1.316 . . . . 63.25 112.894 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 m 47.03 40.95 10.37 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.859 0.864 . . . . 70.05 110.919 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -70.47 125.26 26.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.098 -1.001 . . . . 72.35 108.697 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.7 p -156.67 103.71 2.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.906 -1.516 . . . . 62.44 106.906 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.0 t -94.38 158.73 2.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.16 -1.052 . . . . 73.13 108.16 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.02 146.35 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.49 1.116 . . . . 64.42 109.751 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.4 tp -146.12 149.7 34.52 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.447 1.499 . . . . 72.35 108.407 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -140.27 148.38 41.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.052 1.341 . . . . 74.15 109.812 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.435 ' CD2' HD22 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -100.02 126.06 46.16 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.564 1.546 . . . . 74.13 107.547 178.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.8 -56.1 5.01 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 118.084 -0.96 . . . . 54.41 111.511 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.31 -8.14 22.19 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.093 1.862 . . . . 64.54 116.081 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.6 m -120.73 -9.97 9.25 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.093 0.861 . . . . 64.31 112.614 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.78 4.14 9.71 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.518 -1.157 . . . . 32.13 115.132 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.1 mt -70.28 141.92 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 126.187 1.795 . . . . 75.33 107.746 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.6 148.08 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.745 1.218 . . . . 35.02 108.382 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.8 p -149.3 151.76 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.249 -0.648 . . . . 73.35 109.249 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -132.42 107.98 8.86 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.02 -1.474 . . . . 72.32 107.02 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.3 m -123.6 153.33 40.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 122.475 1.131 . . . . 60.42 112.869 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -154.3 148.41 25.81 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.909 2.084 . . . . 72.32 107.521 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -162.46 -26.79 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.159 0.983 . . . . 53.21 110.784 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.5 p -138.34 158.1 44.94 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.782 -0.574 . . . . 51.11 110.924 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -22.51 66.94 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.643 -0.661 . . . . 63.54 111.847 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -79.54 116.81 19.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.21 1.804 . . . . 63.54 112.217 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.4 p -58.72 -40.78 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.38 0.672 . . . . 44.32 110.162 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -58.72 -46.92 86.28 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.918 0.887 . . . . 61.55 111.425 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -65.06 -44.12 90.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.564 1.145 . . . . 70.54 109.837 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -61.36 -40.42 94.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.997 0.362 . . . . 64.11 110.353 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -59.09 -38.87 80.52 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.134 -0.936 . . . . 72.23 111.028 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -59.77 -48.22 82.54 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.383 0.992 . . . . 74.12 109.287 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.9 mt -59.1 -48.2 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 123.844 0.858 . . . . 40.14 109.397 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.47 82.37 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.177 0.591 . . . . 74.1 110.343 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -62.39 -45.35 93.56 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.055 0.542 . . . . 64.43 110.12 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -55.65 -61.65 2.21 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.138 0.975 . . . . 74.23 109.202 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.73 -34.45 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.655 0.613 . . . . 73.13 112.655 -177.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.0 -47.78 81.64 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.032 0.933 . . . . 51.44 109.12 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -52.13 -41.41 62.5 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.937 0.895 . . . . 62.53 113.17 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.5 -33.15 75.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.609 0.719 . . . . 64.11 110.738 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -73.59 -34.45 65.08 Favored 'General case' 0 C--N 1.335 -0.053 0 O-C-N 121.355 -0.841 . . . . 73.11 110.137 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.1 t -68.07 -43.41 85.3 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 CA-C-O 118.354 -0.831 . . . . 71.2 109.112 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -50.28 -60.76 2.66 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.391 1.077 . . . . 74.25 109.604 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.96 -29.25 46.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-O 118.601 -0.714 . . . . 74.32 111.737 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -69.56 -38.79 77.56 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 120.104 1.32 . . . . 74.34 110.93 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -73.76 -56.08 5.43 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.472 -0.936 . . . . 74.54 108.472 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -67.82 -21.33 65.22 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 115.202 1.556 . . . . 53.33 115.202 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.9 t -142.03 76.07 1.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.708 1.603 . . . . 71.24 107.665 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.14 167.23 51.85 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 114.784 -1.098 . . . . 74.02 111.576 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.43 6.9 3.68 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.629 2.886 . . . . 72.43 113.161 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.7 p -144.17 -176.33 4.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.718 1.607 . . . . 60.02 109.681 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.5 m 57.92 15.47 3.11 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.261 1.949 . . . . 53.25 116.261 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 N-CA-C 108.46 -1.856 . . . . 33.42 108.46 -179.799 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.655 0 N-CA-C 110.575 -1.01 . . . . 63.02 110.575 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -91.84 72.93 5.72 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 124.33 1.052 . . . . 73.15 109.062 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.41 -11.02 59.04 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.444 0.905 . . . . 61.3 113.444 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.82 -58.48 3.04 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 125.504 1.526 . . . . 72.43 113.09 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.3 t 47.32 15.58 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.227 2.211 . . . . 53.23 116.411 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.1 m -93.44 174.03 7.41 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.477 1.111 . . . . 71.34 109.465 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.19 155.82 25.3 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.715 -1.354 . . . . 50.23 109.715 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -93.54 126.25 38.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 123.55 0.74 . . . . 73.2 109.006 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -149.5 -176.2 5.3 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.041 1.736 . . . . 63.5 107.681 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.96 -177.28 29.01 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.212 -1.555 . . . . 64.31 109.212 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.93 171.94 7.46 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.42 1.088 . . . . 70.5 108.375 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -136.25 101.45 4.69 Favored 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 108.517 -0.92 . . . . 74.23 108.517 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.48 HD13 ' H ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -159.26 150.08 19.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 105.763 -1.94 . . . . 51.34 105.763 178.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.48 ' H ' HD13 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -161.83 150.72 15.63 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 126.315 1.846 . . . . 73.51 106.534 179.36 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -86.37 170.26 12.18 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.787 -0.365 . . . . 54.51 111.308 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -112.43 155.18 44.1 Favored Pre-proline 0 CA--C 1.528 0.102 0 C-N-CA 124.495 1.118 . . . . 72.5 110.181 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.3 97.54 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.213 2.609 . . . . 74.2 106.867 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.95 -174.65 4.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.053 1.341 . . . . 61.41 109.923 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 tt -65.06 107.86 1.65 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 106.821 -1.548 . . . . 70.0 106.821 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -61.76 155.87 21.83 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.685 0.794 . . . . 65.21 112.169 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -72.25 152.72 92.37 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.125 -0.694 . . . . 74.34 109.125 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.68 3.8 5.13 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.448 2.765 . . . . 63.3 113.358 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.04 179.43 48.07 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.186 -1.966 . . . . 62.44 108.186 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 92.8 mtp -141.45 172.1 13.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.828 1.251 . . . . 71.51 107.975 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.48 144.69 25.54 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 101.571 -3.492 . . . . 61.5 101.571 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.58 173.52 11.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.314 -0.625 . . . . 74.01 109.314 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.4 t -77.35 179.53 6.37 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.343 -0.984 . . . . 63.12 108.343 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 m -142.38 150.04 40.17 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 106.803 -1.554 . . . . 74.23 106.803 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -66.33 169.95 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 123.75 0.82 . . . . 51.25 110.115 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -123.29 166.67 14.89 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.996 0.919 . . . . 73.24 108.814 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.9 m -112.13 -168.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.236 1.415 . . . . 71.33 108.506 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.49 -19.32 13.28 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.066 -0.493 . . . . 54.45 111.103 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.0 -107.68 2.11 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.164 -1.574 . . . . 33.33 109.164 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.18 151.86 4.77 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 125.942 1.697 . . . . 74.41 111.209 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -156.24 65.04 0.56 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 127.066 2.147 . . . . 54.11 105.695 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -165.62 23.54 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.898 0.479 . . . . 71.12 111.862 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -67.04 0.51 Allowed Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.191 1.796 . . . . 73.11 115.108 -177.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.41 99.16 0.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.48 2.12 . . . . 53.34 109.158 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.23 -170.01 2.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.029 2.132 . . . . 74.12 107.366 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.7 mt -91.15 110.49 21.76 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 103.047 -2.946 . . . . 71.54 103.047 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -82.45 155.48 68.93 Favored Pre-proline 0 C--N 1.322 -0.609 0 C-N-CA 123.531 0.732 . . . . 61.12 109.635 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.51 165.85 29.73 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.896 2.397 . . . . 71.2 113.696 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.605 HD12 ' C ' ' A' ' 43' ' ' LEU 0.423 0.2 OUTLIER -134.86 166.09 23.79 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.4 1.88 . . . . 72.51 111.541 179.801 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -120.16 101.56 7.91 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 108.103 -1.073 . . . . 71.34 108.103 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -67.28 -11.95 58.85 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.931 1.085 . . . . 75.12 113.931 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -0.66 57.7 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.159 1.384 . . . . 41.53 112.726 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -126.16 32.61 5.19 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.852 1.261 . . . . 73.03 109.757 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.1 mt -113.79 117.25 30.94 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.736 1.215 . . . . 63.4 108.036 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -102.76 103.95 14.22 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 104.802 -2.295 . . . . 74.12 104.802 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -84.63 163.78 19.06 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.537 1.062 . . . . 74.45 108.945 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -120.52 129.03 53.64 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.206 -1.776 . . . . 71.51 106.206 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -87.41 143.27 27.32 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.422 -0.955 . . . . 74.23 108.422 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.46 110.0 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 105.565 -2.013 . . . . 51.4 105.565 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -110.69 -7.8 14.64 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.73 0.812 . . . . 74.23 112.636 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.43 -152.0 10.28 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 108.431 -1.867 . . . . 74.53 108.431 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.7 t60 50.95 49.35 21.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.887 1.275 . . . . 71.13 111.025 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.72 160.87 53.81 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.153 -1.579 . . . . 74.32 109.153 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -78.13 30.49 0.44 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.724 3.616 . . . . 74.25 111.97 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.47 -173.16 49.61 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 109.885 -1.286 . . . . 71.35 109.885 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 145.7 -103.96 0.3 Allowed Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.667 -0.973 . . . . 63.51 110.667 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -79.0 166.28 22.52 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.682 0.753 . . . . 71.05 110.634 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.03 -5.19 16.15 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.605 1.162 . . . . 74.22 114.061 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.4 p -139.71 158.52 43.97 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 120.057 1.299 . . . . 52.43 108.66 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -126.88 28.05 5.89 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.615 1.966 . . . . 55.14 111.293 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -52.18 -41.97 63.06 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.224 0.61 . . . . 75.11 110.991 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -84.28 131.74 34.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.438 -2.06 . . . . 62.01 105.438 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.35 8.02 2.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.339 0.656 . . . . 73.3 112.694 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.464 HD21 ' N ' ' A' ' 89' ' ' VAL . 33.4 t-20 -84.61 107.35 16.78 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.866 -1.161 . . . . 71.02 107.866 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.0 t -141.64 138.04 32.25 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.25 1.82 . . . . 61.35 106.491 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.7 t -121.67 150.56 24.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.709 -1.589 . . . . 72.11 106.709 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -137.71 128.91 39.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 102.699 -3.075 . . . . 51.34 102.699 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.1 tp -130.51 143.92 51.07 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.062 0.945 . . . . 72.34 110.633 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.488 ' CB ' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -144.05 143.98 31.42 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.261 -0.899 . . . . 74.03 112.631 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.73 ' HB2' HD11 ' A' ' 100' ' ' LEU . 2.4 t-80 -86.4 121.0 28.34 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.266 -2.124 . . . . 74.03 105.266 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.44 -57.75 23.16 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.588 1.086 . . . . 53.13 112.123 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -59.33 -34.14 97.76 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.615 1.543 . . . . 54.32 114.905 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -93.66 -16.04 24.7 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 113.523 0.934 . . . . 74.03 113.523 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.32 7.07 23.83 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.565 1.555 . . . . 73.41 113.737 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.1 mt -70.27 120.82 18.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.049 -1.463 . . . . 71.12 107.049 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.488 HG22 ' CB ' ' A' ' 73' ' ' LYS . 69.7 t -111.23 128.51 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 126.385 1.874 . . . . 71.15 107.647 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.5 157.96 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 123.385 1.564 . . . . 60.45 108.018 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -141.28 139.68 33.72 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.877 -2.268 . . . . 63.24 104.877 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 15.7 t -138.65 163.69 31.45 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.224 -1.769 . . . . 61.22 106.224 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -155.09 149.22 25.89 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 104.848 -2.279 . . . . 52.24 104.848 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -170.98 -40.51 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.138 -0.458 . . . . 73.14 110.153 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.8 p -127.25 -177.45 4.07 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.399 0.619 . . . . 72.52 112.426 -177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.9 mtm-85 -103.77 -0.41 29.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.991 0.917 . . . . 75.25 110.943 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m -98.44 115.72 29.13 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.644 -1.243 . . . . 73.32 107.644 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.464 ' N ' HD21 ' A' ' 68' ' ' ASN . 7.6 p -55.97 -45.82 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 122.878 0.471 . . . . 74.35 109.82 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.63 -32.62 67.43 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.832 1.253 . . . . 71.43 112.618 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -82.13 -44.48 16.44 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 120.582 -1.324 . . . . 72.12 108.127 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -57.35 -36.8 71.64 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.593 0.757 . . . . 65.42 109.632 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -60.12 -51.19 70.67 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 118.144 -0.932 . . . . 64.2 109.604 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -64.58 -36.57 84.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.837 1.199 . . . . 51.21 112.482 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.62 -43.07 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.157 -0.683 . . . . 61.03 109.157 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.19 -38.11 87.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.046 0.538 . . . . 74.44 110.814 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.496 HH11 ' HG3' ' A' ' 97' ' ' ARG . 0.9 OUTLIER -57.6 -52.72 64.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.047 0.939 . . . . 75.14 111.858 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -40.78 97.37 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 119.379 -0.929 . . . . 62.34 112.524 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.83 -32.45 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 120.113 1.324 . . . . 71.15 111.388 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.73 HD11 ' HB2' ' A' ' 74' ' ' HIS . 9.1 tp -62.39 -40.29 95.98 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.523 -0.736 . . . . 75.1 109.447 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -57.44 -42.59 82.73 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.217 0.607 . . . . 72.34 110.097 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -61.11 -20.52 62.74 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.474 0.916 . . . . 71.11 113.474 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -87.54 -38.83 15.66 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.475 -0.766 . . . . 73.31 109.458 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.0 t -67.39 -31.98 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.479 -0.934 . . . . 70.13 108.479 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -52.93 -57.61 9.72 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.098 1.359 . . . . 72.25 108.116 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.34 -38.68 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.521 1.128 . . . . 74.25 109.375 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -62.85 -37.23 86.01 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.896 1.226 . . . . 74.24 110.449 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -75.79 -33.62 60.16 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 113.64 0.978 . . . . 73.25 113.64 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -108.33 -9.46 15.46 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 116.369 1.989 . . . . 75.35 116.369 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.1 t -148.31 33.93 0.8 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 126.569 1.948 . . . . 73.05 110.138 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.8 176.31 3.4 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.053 1.181 . . . . 22.13 116.053 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.4 -17.52 58.1 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.987 3.125 . . . . 75.14 111.605 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.06 98.64 3.68 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 102.869 -3.011 . . . . 50.54 102.869 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 p -136.39 29.92 2.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.765 1.226 . . . . 70.42 110.413 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 C-N-CA 125.709 1.623 . . . . 53.54 111.056 179.646 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.129 0 N-CA-C 109.104 -1.599 . . . . 54.11 109.104 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m -63.02 150.54 42.19 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.722 0.761 . . . . 62.21 110.142 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 t -167.87 174.82 7.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.102 1.761 . . . . 73.43 106.499 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.11 172.28 14.01 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.408 1.004 . . . . 72.42 110.944 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 p -157.09 167.3 30.82 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.399 1.48 . . . . 73.12 107.841 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 p -150.21 145.33 26.18 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.086 0.857 . . . . 72.14 110.684 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.27 171.92 31.42 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 108.022 -2.031 . . . . 60.23 108.022 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.06 164.28 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.862 1.665 . . . . 52.13 106.837 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -136.1 179.62 6.24 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.077 1.351 . . . . 73.15 108.972 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.69 166.58 23.48 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.4 -1.48 . . . . 44.02 109.4 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.7 mt -139.62 176.9 8.34 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.515 1.526 . . . . 62.12 108.127 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -109.15 138.38 45.58 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.261 -1.015 . . . . 72.32 108.261 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.91 158.02 17.07 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 104.96 -2.237 . . . . 61.32 104.96 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.05 171.46 19.27 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.008 0.923 . . . . 71.2 109.791 -178.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.61 -169.57 1.48 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.209 1.804 . . . . 71.32 112.057 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -139.15 152.76 70.44 Favored Pre-proline 0 CA--C 1.527 0.086 0 C-N-CA 125.13 1.372 . . . . 73.05 108.706 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.08 157.98 53.19 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.222 1.948 . . . . 72.11 110.904 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.84 -168.43 1.95 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.513 1.525 . . . . 64.45 109.638 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 pp -136.72 176.16 8.96 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.304 1.842 . . . . 74.31 108.769 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.6 mt -115.33 161.74 18.08 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.44 1.096 . . . . 64.23 109.778 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -75.2 155.24 86.22 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 123.851 0.86 . . . . 74.23 110.399 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.58 175.96 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.122 2.548 . . . . 74.05 110.586 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.59 163.02 53.47 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.031 -0.827 . . . . 71.22 111.031 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 95.6 mtp -73.46 163.92 27.38 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.088 0.555 . . . . 53.52 110.438 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.63 71.96 1.37 Allowed 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 105.546 -2.02 . . . . 65.23 105.546 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.49 -172.1 1.71 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.056 -0.975 . . . . 62.21 111.032 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.91 172.63 2.18 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.316 1.047 . . . . 62.3 110.434 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -130.05 177.36 7.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.634 1.174 . . . . 72.13 109.47 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 m -63.69 137.0 25.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.785 1.634 . . . . 72.1 108.672 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -132.36 -176.7 4.17 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.601 1.16 . . . . 65.12 111.531 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.2 t -54.84 151.87 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.235 1.814 . . . . 65.22 108.396 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.06 -167.08 1.14 Allowed 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.106 0.962 . . . . 64.43 109.573 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.49 -171.93 2.02 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.357 1.455 . . . . 62.03 113.034 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -132.24 170.64 14.74 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 123.417 0.687 . . . . 73.1 109.72 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -146.7 177.31 9.19 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.492 2.317 . . . . 71.35 105.819 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 44.04 61.83 2.19 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 125.904 1.682 . . . . 75.34 114.556 177.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.41 -59.25 1.65 Allowed Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.889 -1.053 . . . . 55.41 109.717 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.41 151.62 80.03 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.633 2.222 . . . . 41.33 111.86 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.04 160.49 42.97 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.72 2.008 . . . . 74.52 109.169 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.4 mt -71.43 94.13 1.23 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.13 0.572 . . . . 70.3 110.813 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -50.81 151.38 4.36 Favored Pre-proline 0 C--O 1.236 0.384 0 C-N-CA 125.228 1.411 . . . . 72.13 111.344 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.21 165.58 26.19 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.141 2.56 . . . . 54.33 112.211 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 43' ' ' LEU 0.413 0.2 OUTLIER -136.39 164.17 28.76 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 114.06 1.133 . . . . 74.25 114.06 -179.074 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.53 HD22 ' HB2' ' A' ' 47' ' ' GLU . 15.6 t30 -120.84 101.1 7.48 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 104.455 -2.424 . . . . 74.03 104.455 177.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.41 -14.17 25.98 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.417 1.087 . . . . 71.21 113.922 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -98.53 6.8 46.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.352 1.061 . . . . 74.52 110.8 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.53 ' HB2' HD22 ' A' ' 44' ' ' ASN . 6.7 tp10 -120.13 23.93 10.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.328 1.451 . . . . 74.42 110.178 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 mt -113.41 145.9 40.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.545 1.538 . . . . 72.31 107.388 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -116.74 106.44 13.51 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 105.036 -2.209 . . . . 75.54 105.036 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -100.89 154.05 18.99 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.414 1.085 . . . . 70.31 113.019 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -144.93 169.89 17.2 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.962 -1.125 . . . . 71.44 107.962 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -121.27 133.74 55.15 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.946 -1.872 . . . . 72.54 105.946 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.5 t -86.26 133.57 29.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 107.315 -1.365 . . . . 54.33 107.315 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -136.72 162.87 31.99 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.822 2.049 . . . . 73.23 106.143 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.31 -152.97 51.13 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 109.55 -1.42 . . . . 31.13 109.55 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -135.09 169.05 18.03 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.467 1.507 . . . . 74.41 108.029 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.41 173.24 35.4 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.062 -1.215 . . . . 61.24 110.062 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -71.43 174.92 10.14 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.992 2.461 . . . . 52.51 112.457 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.86 30.1 32.98 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.269 -0.878 . . . . 55.23 111.258 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.68 162.63 35.07 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 127.823 2.63 . . . . 71.23 106.8 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -152.06 -69.79 0.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.811 0.806 . . . . 73.23 110.584 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.67 -30.2 65.26 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.835 0.68 . . . . 62.33 112.835 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.0 p -77.36 57.18 1.46 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.235 1.814 . . . . 70.2 110.06 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -43.22 -14.92 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 118.772 2.878 . . . . 72.42 118.772 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -120.11 -17.14 8.43 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.533 1.515 . . . . 74.34 114.109 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 47.54 -6.64 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 119.549 3.166 . . . . 73.43 119.549 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.9 p -54.97 -0.55 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 130.486 3.515 . . . . 64.11 119.574 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -133.14 -6.13 3.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.27 1.395 . . . . 75.44 112.476 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 55.6 m -67.17 142.1 57.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.082 0.856 . . . . 53.33 108.962 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.1 t -115.22 135.54 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.383 -2.081 . . . . 63.41 105.383 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.18 130.75 73.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 102.97 -2.974 . . . . 64.35 102.97 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.7 tp -139.01 151.58 46.93 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.123 0.569 . . . . 62.42 110.168 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 152.43 45.72 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 122.424 0.289 . . . . 52.33 110.458 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -95.61 122.95 38.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 103.326 -2.842 . . . . 75.2 103.326 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.3 t -63.48 -62.37 5.56 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 120.091 1.314 . . . . 60.22 112.017 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.6 -17.12 58.59 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.569 2.18 . . . . 63.45 115.581 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.21 -13.54 16.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.817 1.19 . . . . 75.45 110.665 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.41 -15.03 0.87 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.634 1.587 . . . . 61.15 115.498 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.1 mt -56.95 132.7 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.721 1.608 . . . . 73.3 110.851 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.2 t -124.14 138.39 53.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 126.868 2.067 . . . . 53.24 106.094 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 p -149.6 157.3 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.737 -0.468 . . . . 74.24 109.737 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -119.69 131.58 55.45 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 126.251 1.82 . . . . 75.51 109.134 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -141.24 153.61 45.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.186 0.994 . . . . 63.31 111.318 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -155.5 159.07 39.46 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 128.011 2.525 . . . . 64.55 107.356 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -161.8 -54.16 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.198 1.399 . . . . 73.12 108.321 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.47 179.13 6.22 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.89 0.853 . . . . 71.25 110.907 -178.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -13.23 62.28 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.753 0.821 . . . . 74.45 112.151 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.31 115.07 22.3 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 123.353 0.661 . . . . 72.15 112.777 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.82 -33.11 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.077 -1.453 . . . . 74.35 107.077 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -60.58 -38.36 84.37 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.178 1.791 . . . . 73.24 109.763 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.8 -52.29 9.79 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.683 -1.229 . . . . 64.35 107.683 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -52.8 -33.9 51.12 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.286 0.634 . . . . 73.23 110.104 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -59.26 -62.03 2.19 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.44 1.496 . . . . 73.4 108.19 177.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -62.67 -36.41 82.78 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 118.395 -0.812 . . . . 73.43 112.992 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.35 -51.44 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.245 -1.391 . . . . 71.22 107.245 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.54 -50.18 72.38 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.408 -0.59 . . . . 64.42 109.408 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -54.22 -39.93 67.19 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 118.035 -0.983 . . . . 64.31 112.164 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -44.6 47.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.288 -1.339 . . . . 71.51 110.831 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.16 -32.85 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 120.769 1.622 . . . . 52.12 112.256 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.5 tp -59.66 -35.8 75.14 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.485 -0.759 . . . . 71.3 109.434 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -61.76 -38.34 87.64 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.028 0.931 . . . . 73.1 109.479 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -68.12 -17.64 64.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.882 1.673 . . . . 64.14 111.136 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -97.17 -35.54 10.74 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.99 0.916 . . . . 65.14 109.001 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.5 t -69.16 -31.92 51.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.011 -1.107 . . . . 70.33 108.011 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.4 -62.04 1.87 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.872 2.069 . . . . 61.21 109.174 177.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.64 -25.11 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 122.645 0.378 . . . . 61.42 111.475 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -77.77 -15.28 59.22 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.99 -1.069 . . . . 74.45 111.026 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -94.05 -42.31 9.09 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.045 1.338 . . . . 72.52 108.975 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -87.86 -14.58 39.08 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.781 1.03 . . . . 52.44 113.781 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.5 t -146.97 -172.08 3.91 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.954 1.702 . . . . 74.12 108.049 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 158.3 -177.12 35.12 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.043 -1.223 . . . . 64.45 110.043 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.57 -44.89 2.77 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 121.9 1.733 . . . . 73.33 108.043 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -83.3 171.2 13.81 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.08 2.152 . . . . 75.13 109.45 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -155.74 130.55 9.19 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.343 -1.725 . . . . 73.21 106.343 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 N-CA-C 108.929 -1.668 . . . . 32.34 108.929 -179.829 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.071 0 N-CA-C 108.312 -1.915 . . . . 73.31 108.312 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m -139.91 152.25 46.25 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.394 -1.336 . . . . 74.14 107.394 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 p -73.4 -44.69 57.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.252 1.021 . . . . 74.04 110.424 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.65 170.66 30.88 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 108.636 -1.786 . . . . 71.32 108.636 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 m -49.52 -39.81 35.57 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.895 1.278 . . . . 73.32 112.639 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.3 m 55.36 -27.03 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 129.201 3.0 . . . . 71.34 119.051 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.75 147.39 46.33 Favored Glycine 0 CA--C 1.528 0.872 0 CA-C-N 120.068 1.304 . . . . 52.32 111.957 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -150.41 160.19 43.93 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 127.694 2.398 . . . . 73.13 106.199 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -98.58 162.36 13.18 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.307 -0.997 . . . . 73.4 108.307 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.66 98.6 0.88 Allowed Glycine 0 C--N 1.333 0.378 0 N-CA-C 109.209 -1.557 . . . . 74.43 109.209 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.8 mt -66.21 152.09 45.59 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.504 0.668 . . . . 74.41 109.357 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -77.27 124.44 27.85 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 107.312 -1.366 . . . . 71.4 107.312 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.58 156.1 18.04 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 104.883 -2.266 . . . . 74.02 104.883 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.44 178.59 6.03 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.37 1.868 . . . . 64.0 107.7 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.4 179.33 9.35 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.254 -1.017 . . . . 74.44 108.254 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 158.74 81.05 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.168 0.987 . . . . 65.04 109.957 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.74 169.53 21.75 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.976 1.784 . . . . 70.23 109.942 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.0 166.65 17.56 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.239 0.616 . . . . 72.32 110.664 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.62 172.1 7.9 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.776 1.63 . . . . 75.23 108.575 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pp -130.73 178.87 6.32 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.762 2.025 . . . . 75.01 109.16 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -123.47 154.7 66.18 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 125.314 1.446 . . . . 64.34 109.651 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.66 169.07 22.5 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.84 2.36 . . . . 50.01 111.441 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.22 171.02 49.83 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.434 -1.066 . . . . 44.21 110.434 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.3 tpt -154.72 142.65 20.1 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.411 -1.7 . . . . 74.52 106.411 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.12 65.75 0.77 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.022 0.929 . . . . 74.43 108.569 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 154.08 30.66 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.965 -0.46 . . . . 55.54 110.587 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.2 t -71.8 152.97 42.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.046 -0.724 . . . . 61.24 109.046 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -85.89 -170.62 3.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.021 1.728 . . . . 64.2 111.01 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 t -70.79 154.22 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.203 1.401 . . . . 65.13 109.36 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -90.5 -178.16 5.25 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.945 0.879 . . . . 71.32 109.788 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.24 165.92 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.785 1.634 . . . . 75.34 108.395 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.57 169.72 17.13 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.943 1.697 . . . . 75.52 108.122 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.7 76.76 1.34 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 107.867 -2.093 . . . . 61.42 107.867 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -75.1 0.09 Allowed 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 108.102 -1.073 . . . . 71.23 108.102 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -174.94 143.32 0.71 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 129.483 3.113 . . . . 73.12 104.024 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 34.58 62.69 0.49 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 127.138 2.175 . . . . 73.1 112.551 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -66.12 -62.75 3.82 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 117.412 -1.28 . . . . 73.22 111.932 -179.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.6 105.74 0.96 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.092 2.528 . . . . 72.43 108.587 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.69 175.98 13.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.781 -0.575 . . . . 74.4 109.594 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.1 mt -73.13 87.62 1.42 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.203 -1.777 . . . . 64.22 106.203 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 85.9 mt -48.57 142.88 8.23 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 125.016 1.326 . . . . 72.45 111.279 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.21 99.11 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.197 2.598 . . . . 74.1 111.919 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.8 mt -89.86 133.35 34.79 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.951 1.3 . . . . 73.22 108.576 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -75.68 106.99 7.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.54 -0.911 . . . . 75.4 108.54 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -59.95 -9.86 3.48 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 115.003 1.483 . . . . 63.32 115.003 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 m -101.18 -14.23 17.81 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.036 1.334 . . . . 73.32 112.473 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -90.39 -4.11 57.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.849 1.26 . . . . 70.43 111.85 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mt -84.2 150.89 25.18 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.758 1.623 . . . . 74.1 113.722 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -103.45 105.69 16.01 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.519 1.128 . . . . 74.12 108.155 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -85.37 147.6 26.43 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.621 -1.252 . . . . 60.13 107.621 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.671 ' HB2' HG13 ' A' ' 71' ' ' VAL . 14.3 mm-40 -132.31 141.6 49.02 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.701 -1.222 . . . . 73.5 107.701 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -118.5 121.0 39.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.959 1.303 . . . . 73.32 108.621 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.89 131.38 35.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.033 -1.469 . . . . 60.34 107.033 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.17 164.16 29.87 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.228 1.411 . . . . 72.23 109.346 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.99 -82.86 1.08 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 106.536 -2.626 . . . . 53.02 106.536 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -146.04 168.67 20.37 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 127.806 2.442 . . . . 75.2 107.314 178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -136.92 179.96 17.41 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.009 1.29 . . . . 53.02 111.193 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.45 ' HG3' ' HE2' ' A' ' 82' ' ' LYS . 97.3 Cg_endo -71.9 175.98 8.97 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.745 3.63 . . . . 75.0 111.842 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.43 -171.28 14.02 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.647 2.07 . . . . 33.12 110.305 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -94.38 15.69 62.69 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.505 1.05 . . . . 52.53 113.39 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.265 77.4 mm-40 56.72 -2.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 129.854 3.261 . . . . 74.11 116.627 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.96 -11.09 60.04 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.805 1.184 . . . . 72.23 109.06 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.2 p -127.61 122.2 32.5 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.399 1.879 . . . . 73.35 109.629 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -123.68 -14.05 7.34 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.547 1.539 . . . . 72.35 109.143 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -9.06 33.77 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.326 1.85 . . . . 63.31 112.549 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 p -106.86 14.81 26.2 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.825 1.65 . . . . 75.14 111.824 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 71.8 m -51.81 -19.36 1.65 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.137 1.532 . . . . 34.11 115.137 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -79.13 64.84 4.15 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 105.982 -1.858 . . . . 72.31 105.982 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.9 t -98.89 169.42 9.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.134 -0.979 . . . . 73.41 110.011 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 t -139.19 143.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 104.594 -2.372 . . . . 72.4 104.594 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.671 HG13 ' HB2' ' A' ' 51' ' ' GLN 0.258 9.6 p -137.63 124.86 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 101.729 -3.434 . . . . 64.51 101.729 177.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 tp -120.29 148.86 43.18 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.042 0.937 . . . . 64.22 108.987 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -138.69 129.07 25.87 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.25 1.02 . . . . 74.4 110.083 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -88.69 144.18 26.44 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.33 -2.1 . . . . 74.4 105.33 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.1 t -73.82 -71.6 0.21 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.776 -1.107 . . . . 70.14 112.465 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.31 -36.63 78.11 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.496 2.797 . . . . 73.01 113.526 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.9 t -77.96 -25.02 47.94 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.999 -0.28 . . . . 72.52 111.246 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.01 -0.08 6.51 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 119.189 -0.784 . . . . 70.04 113.435 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.7 mt -68.37 137.88 23.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 119.113 1.457 . . . . 73.25 107.22 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.4 t -131.6 139.74 49.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 106.872 -1.529 . . . . 73.15 106.872 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.61 147.14 16.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 107.91 -1.144 . . . . 53.34 107.91 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.45 ' HE2' ' HG3' ' A' ' 58' ' ' PRO . 5.8 ptpp? -123.22 127.97 49.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 125.401 1.48 . . . . 73.43 108.26 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 49.3 m -144.81 162.26 37.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.143 0.973 . . . . 72.14 110.896 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -155.07 156.16 35.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.362 2.265 . . . . 75.52 106.392 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -158.32 -74.4 0.08 Allowed 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 105.729 -1.952 . . . . 62.52 105.729 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.2 p -83.13 -179.3 7.38 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.942 0.877 . . . . 73.24 109.559 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -96.68 1.09 50.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.389 0.675 . . . . 74.0 109.314 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.6 m -96.72 115.47 27.49 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.974 1.31 . . . . 74.41 108.006 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.8 p -57.35 -42.58 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 109.506 -0.553 . . . . 63.02 109.506 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.64 -47.3 84.86 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.004 0.921 . . . . 64.21 112.196 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -67.72 -32.92 73.88 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.748 -0.595 . . . . 74.13 109.402 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -71.49 -29.25 64.6 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.24 -0.913 . . . . 75.05 109.204 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -63.15 -48.78 77.01 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.805 1.184 . . . . 74.12 109.869 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -57.82 -38.47 75.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.926 0.785 . . . . 65.34 112.051 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.69 -49.2 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.05 -1.093 . . . . 50.15 108.05 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.39 -47.04 86.96 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.927 0.891 . . . . 51.32 110.785 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -60.0 -45.53 92.43 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.644 0.778 . . . . 71.12 109.706 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -51.03 71.49 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.208 0.603 . . . . 72.04 110.72 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.58 -32.47 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.732 0.697 . . . . 74.34 110.909 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.1 tp -63.72 -40.3 96.41 Favored 'General case' 0 C--O 1.227 -0.101 0 O-C-N 120.616 -1.302 . . . . 64.55 110.187 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -54.5 -40.1 68.22 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.058 1.343 . . . . 75.24 111.95 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.95 -36.53 83.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.372 1.069 . . . . 74.0 111.503 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.9 mttm -76.45 -42.08 45.12 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.93 -0.481 . . . . 74.13 110.21 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.2 -32.26 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 118.609 -0.71 . . . . 64.12 110.442 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -58.68 -56.31 23.83 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.862 1.21 . . . . 72.23 108.252 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 68.3 t -58.45 -28.38 35.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.241 1.016 . . . . 65.52 110.745 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -74.35 -18.36 60.69 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.156 -0.965 . . . . 51.31 112.256 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -99.35 -49.89 4.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.294 1.438 . . . . 74.41 110.322 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -71.68 -16.51 62.24 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.015 0.746 . . . . 74.35 113.015 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.8 t -142.48 175.5 9.74 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.693 2.797 . . . . 54.21 106.99 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 138.94 -78.17 0.31 Allowed Glycine 0 C--N 1.335 0.499 0 O-C-N 120.748 -1.22 . . . . 64.21 110.827 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.36 162.15 40.02 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.093 2.529 . . . . 74.3 109.254 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.72 80.73 1.83 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.455 -0.943 . . . . 74.44 108.455 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.3 p -83.28 162.89 21.01 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.556 -1.646 . . . . 64.21 106.556 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 N-CA-C 108.663 -1.775 . . . . 73.04 108.663 179.426 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.204 0 N-CA-C 109.116 -1.593 . . . . 33.22 109.116 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 t -155.03 176.08 13.0 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 106.586 -1.635 . . . . 73.2 106.586 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 t -159.69 169.37 23.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.546 1.539 . . . . 55.53 107.388 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.99 168.48 18.97 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.005 -1.238 . . . . 75.44 110.005 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.0 m -139.85 159.15 42.82 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.25 1.42 . . . . 71.35 107.91 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.7 p -155.52 159.82 40.04 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 121.608 -0.682 . . . . 72.1 109.639 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.42 92.07 1.64 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 106.904 -2.478 . . . . 53.34 106.904 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.37 80.55 0.37 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.108 0.963 . . . . 72.31 110.053 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -65.53 -175.98 0.3 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.34 2.256 . . . . 75.31 112.341 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.8 173.35 33.84 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 120.808 -1.183 . . . . 50.4 110.278 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.81 171.42 7.65 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.781 1.233 . . . . 63.3 109.401 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.436 ' CD ' HE22 ' A' ' 14' ' ' GLN . 0.2 OUTLIER -123.4 126.28 46.51 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 105.734 -1.95 . . . . 73.44 105.734 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.31 179.48 7.06 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.785 1.634 . . . . 55.53 107.296 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.436 HE22 ' CD ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -165.27 -175.5 3.65 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.48 1.512 . . . . 74.31 108.694 -179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.48 -171.42 2.14 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.632 1.573 . . . . 75.13 110.912 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -78.31 155.47 79.28 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.575 0.75 . . . . 63.4 109.493 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.38 167.61 21.85 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.867 1.711 . . . . 71.45 110.11 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.36 156.36 16.0 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.752 -0.658 . . . . 72.43 110.684 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 168.79 18.14 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.809 1.644 . . . . 43.55 109.595 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 99.3 mt -86.0 164.48 17.36 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.557 0.743 . . . . 64.3 110.162 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -67.01 155.18 90.89 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.427 0.691 . . . . 72.52 110.082 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.11 176.84 9.0 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.932 2.422 . . . . 73.4 110.936 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.51 172.07 32.26 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 121.741 0.634 . . . . 71.43 111.526 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -58.55 135.39 57.31 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.312 1.045 . . . . 74.22 109.395 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.19 30.01 4.58 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.225 1.41 . . . . 42.35 110.136 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.31 175.7 2.09 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.264 1.026 . . . . 64.41 109.865 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.6 t -87.76 170.59 11.09 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.98 -1.075 . . . . 73.24 108.954 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.0 m -139.83 146.28 39.17 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.646 -1.242 . . . . 74.24 107.646 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 t -68.57 133.33 31.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 125.427 1.491 . . . . 54.44 111.546 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -75.66 154.66 36.42 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.206 -1.035 . . . . 62.35 108.206 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.5 t -72.53 146.67 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 O-C-N 120.963 -1.086 . . . . 74.51 108.42 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.76 166.47 23.21 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.487 1.515 . . . . 65.22 107.75 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -136.43 73.23 0.44 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 123.931 0.777 . . . . 43.34 111.447 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 -146.14 168.73 20.27 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 124.593 1.157 . . . . 71.23 109.483 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -147.54 -178.44 6.25 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 127.338 2.255 . . . . 73.03 108.462 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 52.59 38.37 25.68 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.191 2.197 . . . . 71.23 116.247 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -64.4 3.08 Favored Pre-proline 0 CA--C 1.537 0.448 0 O-C-N 121.212 -0.93 . . . . 62.53 113.487 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.07 133.27 24.62 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.137 1.891 . . . . 71.31 110.781 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.14 173.18 3.96 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.882 0.739 . . . . 55.23 110.025 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.9 mt 53.23 82.0 0.08 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 127.657 2.383 . . . . 70.13 111.237 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.8 154.73 87.11 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 109.616 -0.512 . . . . 50.13 109.616 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.82 147.94 57.11 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.436 2.091 . . . . 75.13 109.702 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.526 HD12 ' C ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -148.62 138.35 22.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.161 -1.051 . . . . 64.0 108.161 -179.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -91.9 111.01 22.38 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.488 1.515 . . . . 64.44 111.544 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -66.65 -25.92 66.81 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.964 1.706 . . . . 75.1 113.245 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -80.01 -11.19 59.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.423 1.01 . . . . 71.3 112.096 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -101.02 9.89 41.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.449 1.1 . . . . 75.2 111.315 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.3 175.82 5.58 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.359 -0.838 . . . . 64.2 112.847 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -125.38 135.63 52.61 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.424 2.29 . . . . 63.05 106.038 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -126.72 166.28 17.68 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.134 1.374 . . . . 72.32 111.464 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -137.66 177.51 7.81 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.025 1.33 . . . . 64.0 108.658 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -135.07 163.6 29.54 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.81 2.044 . . . . 72.4 107.256 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.2 t -123.38 117.09 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.479 -1.675 . . . . 63.33 106.479 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.48 11.17 38.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.41 1.084 . . . . 64.12 110.868 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.43 89.16 2.1 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 105.493 -3.043 . . . . 75.45 105.493 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -127.05 20.56 6.92 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.926 1.29 . . . . 73.22 110.754 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.27 170.7 38.54 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 128.537 2.97 . . . . 73.31 106.586 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.94 160.66 47.1 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.112 1.875 . . . . 60.22 110.519 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.69 -62.59 2.01 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 108.757 -1.737 . . . . 45.23 108.757 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.54 -59.78 1.6 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.879 1.704 . . . . 61.22 113.283 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -42.91 103.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 128.968 2.907 . . . . 74.52 110.32 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 47.82 34.94 4.24 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.977 1.311 . . . . 72.32 112.291 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.9 p 52.39 36.64 20.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.179 1.392 . . . . 42.13 111.533 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -51.65 100.82 0.03 OUTLIER 'General case' 0 C--N 1.342 0.241 0 C-N-CA 125.431 1.492 . . . . 53.21 112.723 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -66.94 -10.77 52.65 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.801 0.841 . . . . 71.15 111.514 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.3 p -122.16 123.56 41.8 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 106.189 -1.782 . . . . 71.33 106.189 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 m -72.59 45.66 0.14 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.294 1.837 . . . . 72.4 113.824 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -67.16 92.29 0.25 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.132 -0.98 . . . . 71.03 109.395 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.3 p -150.18 154.73 38.51 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.693 -1.254 . . . . 71.41 107.939 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.3 152.49 27.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 123.813 0.845 . . . . 74.34 109.325 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.59 141.65 42.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.221 -1.399 . . . . 62.35 107.221 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.9 tp -129.03 154.6 46.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.495 0.718 . . . . 72.02 110.798 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 75' ' ' VAL . 1.5 tmtp? -143.71 155.59 44.26 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.369 1.068 . . . . 62.51 108.183 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -122.24 120.43 34.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.687 -1.968 . . . . 74.3 105.687 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.473 ' HA ' ' HE2' ' A' ' 73' ' ' LYS . 39.7 t -66.26 -56.46 16.1 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.746 1.218 . . . . 62.22 111.884 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.66 -12.96 38.0 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.634 2.222 . . . . 72.23 115.709 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 t -113.64 -16.44 12.34 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.846 0.748 . . . . 71.15 110.453 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.56 9.39 37.72 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.591 1.091 . . . . 52.44 113.662 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.8 mt -79.89 145.86 8.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.482 1.113 . . . . 74.21 108.283 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 t -131.3 143.69 39.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.103 -1.814 . . . . 74.34 106.103 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -146.95 155.06 11.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.283 -0.636 . . . . 74.12 109.283 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.87 133.23 41.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.415 -0.957 . . . . 73.14 108.415 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 m -144.98 160.35 41.48 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.153 0.981 . . . . 72.33 111.163 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -155.52 134.37 12.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.425 2.29 . . . . 75.44 106.001 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -153.13 -51.43 0.1 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.724 -0.843 . . . . 74.21 108.724 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.8 p -109.62 170.88 7.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.352 1.032 . . . . 62.03 110.825 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -92.38 -16.74 25.57 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.156 0.982 . . . . 61.22 108.901 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -78.94 115.79 18.85 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.495 -0.928 . . . . 61.32 108.495 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.2 p -62.96 -37.73 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.642 -1.244 . . . . 62.43 107.642 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.79 -49.62 72.69 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.664 1.586 . . . . 52.01 108.718 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.3 -48.24 62.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.655 0.782 . . . . 74.52 110.949 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -52.74 -38.05 60.29 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.753 0.821 . . . . 75.2 111.243 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -54.86 -48.45 72.89 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.823 0.738 . . . . 75.5 109.335 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -64.0 -37.2 86.54 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.517 -0.739 . . . . 70.44 111.389 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.3 mt -63.66 -47.31 91.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.362 -0.977 . . . . 73.53 108.362 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.88 97.77 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.206 0.602 . . . . 74.44 109.894 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -57.39 -44.58 84.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.838 0.855 . . . . 73.12 109.82 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.7 -55.57 33.09 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.409 0.684 . . . . 72.44 110.237 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.47 -23.8 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 113.677 0.992 . . . . 74.44 113.677 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.5 tp -70.38 -38.7 74.76 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.561 -1.337 . . . . 74.54 110.626 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -55.15 -47.92 74.42 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.756 1.222 . . . . 54.14 114.014 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -62.75 -28.73 70.17 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.372 0.669 . . . . 74.12 111.509 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -77.42 -35.96 53.63 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.236 -0.915 . . . . 62.14 110.115 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.1 t -67.07 -33.99 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.151 -1.055 . . . . 54.25 108.151 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -56.59 -47.23 80.02 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.889 1.222 . . . . 71.45 108.894 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.64 -15.14 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.555 1.142 . . . . 74.44 111.891 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -82.49 -22.19 35.21 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.759 -1.213 . . . . 71.43 109.7 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -96.85 -53.29 3.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.301 1.441 . . . . 74.22 109.825 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -72.45 -16.41 61.82 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.634 0.605 . . . . 63.42 112.634 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.75 -156.62 0.7 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.587 1.955 . . . . 74.54 106.796 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.3 166.76 11.98 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 119.943 1.247 . . . . 60.11 110.615 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.08 -31.54 90.86 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.628 2.219 . . . . 61.12 111.877 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.4 t -67.92 -30.23 69.5 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.467 0.707 . . . . 73.21 110.553 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.0 t -94.04 -33.35 13.43 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.996 1.319 . . . . 74.33 113.385 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.847 0 CA-C-O 116.238 -2.423 . . . . 64.52 109.128 -178.897 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.146 0 N-CA-C 108.637 -1.785 . . . . 74.32 108.637 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 m -138.6 168.93 18.73 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.966 -1.124 . . . . 64.43 107.966 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.4 t -158.15 172.4 18.47 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.788 -1.189 . . . . 61.22 107.788 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.65 168.25 25.36 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 127.095 2.283 . . . . 75.45 107.847 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.1 p -159.22 165.81 32.79 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.547 1.173 . . . . 61.55 109.981 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.4 t -99.56 65.32 1.36 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.31 -1.737 . . . . 33.41 106.31 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.25 71.82 0.45 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 126.375 1.94 . . . . 73.11 112.441 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -85.01 142.33 29.68 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.749 -1.204 . . . . 75.04 107.749 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -151.26 177.57 10.1 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.849 1.66 . . . . 73.24 106.663 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.53 170.91 41.23 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.566 -1.414 . . . . 62.32 109.566 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 mp -83.63 160.87 21.29 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.664 -0.865 . . . . 62.45 108.664 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.0 tpt85 -111.62 131.04 55.54 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 104.943 -2.243 . . . . 75.12 104.943 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.2 152.65 20.78 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 105.824 -1.917 . . . . 75.31 105.824 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.05 -171.01 1.07 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 128.558 2.743 . . . . 73.2 105.592 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -143.34 158.58 43.52 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.515 -0.92 . . . . 74.4 108.515 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -63.07 152.47 83.93 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 128.318 2.647 . . . . 75.42 111.197 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.25 146.73 28.63 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.393 2.062 . . . . 74.01 108.96 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.06 127.86 32.54 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.87 -0.789 . . . . 73.24 108.87 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -83.94 171.13 13.3 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.153 0.581 . . . . 74.32 109.943 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -127.57 177.36 6.82 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.573 1.549 . . . . 74.44 109.864 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -127.23 156.85 74.04 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.078 1.751 . . . . 73.12 109.125 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.33 168.77 24.03 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.793 2.328 . . . . 71.34 111.787 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.71 -87.63 0.86 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.714 -1.355 . . . . 43.41 109.714 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.2 tpt -146.57 160.83 41.64 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.628 1.171 . . . . 73.14 107.896 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.54 61.73 1.15 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.304 1.041 . . . . 75.13 109.772 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.08 150.75 38.76 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.87 -0.789 . . . . 53.4 108.87 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.6 t -79.18 -178.98 6.46 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.772 0.796 . . . . 72.52 110.668 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 m -112.38 156.67 22.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.218 1.807 . . . . 64.52 106.914 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.7 t -118.11 159.53 18.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.302 -1.37 . . . . 72.24 107.302 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -102.66 138.77 39.13 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.513 -1.292 . . . . 71.43 107.513 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.01 146.75 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 122.006 0.908 . . . . 71.54 110.35 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.27 170.91 9.71 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 129.322 3.049 . . . . 60.01 106.342 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 153.16 -151.7 23.45 Favored Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 108.319 -1.912 . . . . 72.34 108.319 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.508 ' HD2' ' H ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -64.38 178.04 0.78 Allowed 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.755 0.788 . . . . 72.12 110.099 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -148.56 178.15 8.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.941 -1.503 . . . . 60.33 106.941 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 40.13 54.96 2.73 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.715 2.006 . . . . 74.12 113.172 178.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.57 -59.65 10.14 Favored Pre-proline 0 C--O 1.236 0.345 0 O-C-N 120.399 -1.438 . . . . 70.15 112.856 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -69.1 -176.08 1.19 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.85 2.367 . . . . 71.24 108.669 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.96 172.03 13.37 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.434 -0.791 . . . . 71.22 109.716 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.6 mt 48.84 68.12 0.76 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.706 2.402 . . . . 64.34 111.355 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 74.5 mt -49.07 147.26 5.03 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 124.653 1.181 . . . . 75.41 111.79 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.26 150.68 59.53 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.145 2.564 . . . . 71.33 109.314 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 43' ' ' LEU 0.576 0.2 OUTLIER -122.6 150.86 42.07 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.329 -0.857 . . . . 73.2 112.074 179.854 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -94.56 107.77 19.75 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.529 1.532 . . . . 73.13 112.034 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -70.16 -19.26 63.21 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.601 0.963 . . . . 63.23 113.601 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.5 m -87.95 10.36 19.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.325 1.45 . . . . 75.11 112.015 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -128.12 -1.52 5.79 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.5 1.12 . . . . 74.31 111.55 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -103.42 160.68 14.5 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.917 -1.142 . . . . 61.41 107.917 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -103.83 156.28 17.95 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 126.46 1.904 . . . . 73.05 108.126 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.71 136.5 53.91 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.582 -0.896 . . . . 70.32 108.582 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -152.25 156.55 39.92 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.187 0.994 . . . . 74.44 111.004 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -135.55 164.36 28.0 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 127.037 2.135 . . . . 62.15 109.679 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -130.93 106.72 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 102.816 -3.031 . . . . 74.04 102.816 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -85.6 -21.41 28.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.452 -1.249 . . . . 64.4 112.178 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.21 170.91 43.66 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.198 -1.161 . . . . 53.41 110.198 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -93.12 -35.57 13.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.792 0.437 . . . . 53.41 110.901 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.78 -173.03 33.2 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 108.392 -1.883 . . . . 54.12 108.392 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.69 176.7 9.01 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.251 2.634 . . . . 43.32 110.091 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.71 174.06 17.1 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.766 -1.734 . . . . 64.42 108.766 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.3 -3.12 8.29 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 115.602 1.001 . . . . 71.1 115.602 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -157.91 -70.57 0.09 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.74 -1.948 . . . . 74.11 105.74 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.16 164.53 38.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.27 1.828 . . . . 71.23 106.882 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.6 m -158.52 142.28 15.33 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 105.819 -1.919 . . . . 71.13 105.819 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -134.4 92.93 2.99 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 106.98 -1.489 . . . . 74.42 106.98 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -152.25 80.52 1.25 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.078 -1.082 . . . . 55.34 108.078 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 p -73.3 169.09 17.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.023 0.929 . . . . 72.31 109.977 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 t -161.66 170.92 18.84 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.584 1.154 . . . . 74.23 108.367 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -121.7 31.89 6.09 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.874 1.669 . . . . 72.1 108.206 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.6 m -57.98 131.3 50.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.07 1.348 . . . . 45.44 112.176 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.1 t -122.53 136.3 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.116 -1.809 . . . . 53.45 106.116 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.84 153.24 29.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.132 -1.803 . . . . 62.22 106.132 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp -141.22 142.89 33.93 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.177 -1.416 . . . . 63.21 107.177 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -136.11 134.12 38.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.796 -1.557 . . . . 73.53 106.796 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -86.03 140.05 30.62 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.756 -1.202 . . . . 72.42 107.756 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.3 t -71.67 -62.18 1.79 Allowed Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 120.394 1.452 . . . . 72.41 111.616 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -70.4 -8.7 24.22 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.247 2.631 . . . . 72.24 116.242 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.0 m -120.74 -13.32 8.71 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.673 0.67 . . . . 74.25 112.509 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.04 -13.59 0.34 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.502 1.525 . . . . 65.53 115.584 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.4 mt -49.06 123.39 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 128.058 2.543 . . . . 55.4 110.316 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.25 142.63 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.863 1.265 . . . . 53.45 109.961 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.24 150.52 22.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.439 1.496 . . . . 72.12 108.018 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -122.87 115.02 21.28 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.298 1.439 . . . . 74.42 108.392 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 77.0 m -124.62 136.5 53.98 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.435 1.016 . . . . 75.33 111.982 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -156.34 111.81 2.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.241 -1.763 . . . . 75.34 106.241 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -147.43 -68.26 0.25 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.208 -1.404 . . . . 74.35 107.208 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.3 p -70.74 147.22 49.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.998 0.427 . . . . 64.11 110.287 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -67.83 -26.35 66.01 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.154 -0.684 . . . . 74.41 109.154 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 m -79.27 115.63 19.04 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 126.519 1.928 . . . . 61.25 111.25 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.68 -32.91 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 107.605 -1.258 . . . . 52.11 107.605 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -37.03 70.24 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 123.415 0.686 . . . . 71.42 110.986 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -79.61 -48.19 14.18 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.879 1.272 . . . . 60.43 109.738 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -53.24 -36.12 60.72 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.913 0.778 . . . . 74.44 110.085 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -57.3 -54.29 48.51 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.142 0.977 . . . . 73.43 109.424 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -59.45 -41.15 88.97 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 118.274 -0.869 . . . . 70.22 110.499 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 90.2 mt -59.7 -49.09 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 O-C-N 124.554 1.159 . . . . 74.23 108.872 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.17 -43.46 98.85 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.981 -0.449 . . . . 74.43 110.608 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.63 -49.85 73.55 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.814 0.445 . . . . 74.2 111.112 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -44.09 97.0 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 118.448 -0.787 . . . . 73.14 112.013 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.2 p -64.85 -36.88 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 119.645 1.111 . . . . 72.1 109.027 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.18 -39.01 88.56 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-O 118.616 -0.707 . . . . 74.24 110.496 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -59.21 -23.75 62.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.247 0.93 . . . . 60.14 111.933 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -78.45 -25.96 46.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.807 1.185 . . . . 73.03 109.506 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -82.0 -44.35 16.79 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.896 1.279 . . . . 64.12 110.963 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.2 t -58.79 -41.92 83.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 N-CA-C 108.335 -0.987 . . . . 72.52 108.335 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.19 -64.9 0.69 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.095 0.558 . . . . 73.41 111.809 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.43 -32.6 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.409 1.084 . . . . 65.04 111.095 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -67.29 -42.97 82.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.395 0.543 . . . . 70.11 109.775 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -67.79 -29.52 68.73 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.538 0.735 . . . . 71.23 109.501 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -79.56 -35.36 39.9 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.555 0.742 . . . . 75.23 111.62 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t -126.67 98.52 5.42 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.161 1.384 . . . . 75.42 111.908 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.88 58.45 0.26 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-O 118.031 -1.427 . . . . 61.33 115.153 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.7 -27.58 18.13 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 CA-C-N 121.201 2.5 . . . . 55.51 110.429 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.8 t -88.54 -4.85 58.51 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.34 -0.85 . . . . 74.53 109.864 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.9 m -103.09 173.81 6.14 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.085 1.354 . . . . 75.3 110.088 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 N-CA-C 103.172 -3.971 . . . . 62.14 103.172 -179.735 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.137 0 N-CA-C 109.005 -1.638 . . . . 74.24 109.005 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.8 m -137.53 173.01 12.11 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.378 1.071 . . . . 63.13 108.492 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.9 m -154.19 178.81 9.57 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.061 1.744 . . . . 70.32 107.502 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.66 62.85 2.34 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.526 1.06 . . . . 64.13 111.966 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 t -63.53 109.36 1.62 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.208 1.403 . . . . 62.43 107.944 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t -156.45 178.9 9.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.629 1.171 . . . . 74.11 108.394 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 154.24 113.26 0.49 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 108.236 -1.945 . . . . 54.23 108.236 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -148.54 140.28 23.69 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 105.784 -1.932 . . . . 60.24 105.784 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -149.09 166.16 29.58 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.792 1.237 . . . . 65.11 108.336 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.11 154.24 6.65 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 109.3 -1.52 . . . . 54.21 109.3 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.6 mt -149.47 154.95 39.6 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.564 1.546 . . . . 62.31 107.293 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.15 117.36 1.93 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.083 -1.821 . . . . 71.33 106.083 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.32 164.56 12.21 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.254 -1.388 . . . . 64.3 107.254 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.46 66.04 0.44 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.752 1.16 . . . . 72.13 114.03 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -85.23 177.47 7.84 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.723 0.773 . . . . 73.2 111.073 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -141.47 158.18 64.03 Favored Pre-proline 0 C--O 1.231 0.1 0 C-N-CA 124.378 1.071 . . . . 55.21 110.031 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.02 143.07 43.84 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.828 1.685 . . . . 75.23 108.065 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.48 154.29 38.76 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.081 -0.711 . . . . 51.31 109.081 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.6 tp -155.96 152.35 28.07 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.645 -1.613 . . . . 74.33 106.645 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.65 177.92 7.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.712 2.005 . . . . 70.14 108.041 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -125.48 152.4 71.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 125.04 1.336 . . . . 61.31 107.45 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.89 161.61 41.04 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.88 1.72 . . . . 54.3 109.92 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.56 165.49 20.63 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 108.021 -2.032 . . . . 42.11 108.021 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 42.5 ttm -144.69 130.91 19.55 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.548 -0.908 . . . . 64.01 108.548 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.9 58.99 0.92 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.576 -2.009 . . . . 72.31 105.576 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.27 178.21 7.57 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.548 1.139 . . . . 74.5 108.999 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.0 t -60.31 140.56 57.03 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.453 -1.314 . . . . 65.41 107.453 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 m -139.36 134.51 32.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.174 -1.788 . . . . 74.32 106.174 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.52 157.96 39.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.653 0.781 . . . . 75.1 109.272 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -144.61 172.91 12.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.159 1.383 . . . . 73.33 109.339 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.54 166.82 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.933 1.693 . . . . 72.01 107.828 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.04 175.24 9.75 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.658 1.183 . . . . 65.21 110.122 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -131.73 91.9 0.28 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.929 -1.268 . . . . 53.23 109.929 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -140.7 146.22 37.52 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.508 0.654 . . . . 64.11 109.71 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -150.4 23.07 0.82 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 127.0 2.12 . . . . 75.44 108.875 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -121.41 36.03 4.72 Favored 'General case' 0 N--CA 1.46 0.057 0 N-CA-C 114.256 1.206 . . . . 70.05 114.256 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -60.86 3.56 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.383 -1.34 . . . . 74.3 107.383 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -70.71 177.23 6.47 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 124.296 3.331 . . . . 74.02 111.299 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.0 144.4 31.65 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.353 1.061 . . . . 62.12 110.801 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 94.9 mt 11.88 77.61 0.01 OUTLIER 'General case' 0 C--O 1.241 0.641 0 C-N-CA 130.834 3.654 . . . . 74.44 113.832 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.8 mt -55.89 154.34 14.4 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 114.554 -1.203 . . . . 54.23 109.86 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.95 160.84 46.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.668 1.579 . . . . 75.11 111.901 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -157.26 143.45 17.86 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 127.801 2.44 . . . . 71.53 104.429 179.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.421 ' N ' HD12 ' A' ' 43' ' ' LEU . 43.5 t30 -114.67 102.28 9.88 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.037 0.935 . . . . 73.0 109.586 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -57.15 -27.6 62.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.373 0.533 . . . . 73.32 112.32 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -78.78 7.27 7.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.491 1.917 . . . . 73.1 112.981 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -127.0 4.87 6.5 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.616 1.566 . . . . 75.41 111.656 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.4 mt -94.01 176.66 6.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 122.119 0.961 . . . . 75.43 113.029 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -108.5 131.55 54.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 102.223 -3.251 . . . . 63.12 102.223 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -128.8 164.63 22.62 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.213 1.005 . . . . 73.12 108.545 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.65 160.62 42.47 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.384 -0.969 . . . . 71.55 108.384 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -109.7 135.64 50.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.131 1.372 . . . . 64.22 108.08 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.3 t -87.3 139.61 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.048 -1.464 . . . . 63.14 107.048 -178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -125.44 4.56 7.66 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.756 1.021 . . . . 52.14 113.756 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.29 -133.14 13.5 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.838 -2.105 . . . . 34.11 107.838 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -61.32 146.22 48.8 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.626 0.727 . . . . 74.2 110.866 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.44 174.89 36.23 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 127.108 2.289 . . . . 54.22 107.618 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.7 167.52 24.11 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.189 1.926 . . . . 74.21 109.351 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.22 35.09 91.54 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.643 -1.383 . . . . 63.5 109.643 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.28 149.76 13.41 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 108.004 -2.038 . . . . 73.1 108.004 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -146.71 11.93 1.12 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.742 0.817 . . . . 70.43 112.541 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.06 -9.52 31.58 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.142 1.534 . . . . 61.02 115.142 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 m 61.75 7.38 1.93 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.603 1.161 . . . . 63.43 111.887 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -58.4 144.48 41.72 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.185 1.394 . . . . 71.31 111.728 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -78.95 165.6 23.29 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.804 1.242 . . . . 70.52 110.62 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.3 p -81.23 122.78 27.84 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.118 -1.808 . . . . 72.33 106.118 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.0 t -164.73 -177.14 4.59 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.964 0.906 . . . . 64.12 108.863 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -67.52 105.58 1.89 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.075 1.75 . . . . 70.25 107.936 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.9 m -143.47 148.76 36.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.985 1.714 . . . . 74.22 107.276 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.9 t -144.63 157.3 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 106.891 -1.522 . . . . 73.31 106.891 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.17 139.61 26.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.766 -1.939 . . . . 73.25 105.766 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 tp -139.48 143.73 37.65 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.414 -1.328 . . . . 74.44 107.414 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -131.5 158.42 40.94 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 123.186 0.594 . . . . 74.33 109.407 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -104.16 114.45 28.7 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 102.443 -3.169 . . . . 74.11 102.443 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.99 -62.12 5.74 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 119.187 0.903 . . . . 73.53 111.69 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -65.04 -14.67 46.55 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.791 2.994 . . . . 53.44 116.622 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.2 t -112.3 -10.6 13.8 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.564 1.075 . . . . 72.04 111.123 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.2 3.47 6.67 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.268 1.413 . . . . 73.25 113.896 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -66.87 149.19 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 120.024 1.912 . . . . 63.03 108.179 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.4 t -136.69 135.32 48.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.154 -1.795 . . . . 73.32 106.154 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.0 146.94 24.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 106.888 -1.523 . . . . 74.04 106.888 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -127.44 119.75 26.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.136 0.974 . . . . 74.14 108.961 -178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.1 m -139.32 149.29 44.04 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.563 1.545 . . . . 72.33 109.767 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -155.11 121.25 5.21 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.455 -2.054 . . . . 72.35 105.455 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -133.22 -48.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.891 0.876 . . . . 75.53 110.769 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.3 p -101.73 158.33 16.19 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.51 1.124 . . . . 61.44 111.738 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -71.9 -30.21 65.14 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 118.065 -0.969 . . . . 74.05 111.373 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -79.44 123.92 27.98 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 119.917 1.235 . . . . 50.52 110.275 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.96 -38.77 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.346 1.058 . . . . 51.11 109.041 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -55.57 -44.14 76.57 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.304 1.442 . . . . 75.41 110.721 -179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -40.23 62.04 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.718 0.807 . . . . 63.22 110.386 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -55.86 -32.94 64.08 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.741 0.7 . . . . 42.03 110.554 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 45.1 mtp85 -57.54 -45.19 85.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.593 0.633 . . . . 74.4 110.875 178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -61.21 -31.76 71.53 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 118.679 0.672 . . . . 71.53 111.739 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.3 mt -74.06 -40.21 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.695 -0.854 . . . . 65.13 108.695 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.23 -47.59 73.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 122.897 0.479 . . . . 52.43 110.541 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -31.5 72.11 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 120.526 -0.47 . . . . 74.1 111.103 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -61.32 2.15 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.507 -1.294 . . . . 72.55 107.507 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -55.65 -35.83 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 118.683 0.674 . . . . 63.13 111.254 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.49 -32.57 74.06 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.455 -0.783 . . . . 45.2 111.474 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -61.17 -41.67 97.2 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 119.426 1.012 . . . . 74.24 110.531 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.81 -36.29 78.67 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.516 -0.92 . . . . 64.33 108.516 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -72.16 -51.8 19.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.433 -0.794 . . . . 75.43 111.403 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.06 -44.17 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 C-N-CA 124.352 1.061 . . . . 73.31 109.891 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -50.87 -63.74 1.03 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.003 0.921 . . . . 73.44 110.656 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.84 -24.56 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 112.589 0.589 . . . . 63.15 112.589 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -66.38 -45.28 80.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.617 1.099 . . . . 74.41 108.664 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -63.51 -46.22 87.07 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.513 -1.291 . . . . 65.05 107.513 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 -70.71 -3.27 17.74 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.219 1.407 . . . . 74.21 112.624 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.5 t -153.49 85.87 1.2 Allowed 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.416 1.086 . . . . 63.41 111.058 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -146.22 -170.76 15.06 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 108.96 -1.656 . . . . 72.2 108.96 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.74 -17.12 26.19 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.224 1.949 . . . . 62.12 110.725 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.8 p -148.97 -175.62 5.02 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 128.566 2.746 . . . . 75.13 107.336 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 t -153.45 145.76 23.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.225 2.21 . . . . 54.34 105.476 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 N-CA-C 108.437 -1.865 . . . . 55.41 108.437 -179.551 . . . . . . . . 0 0 . 1 stop_ save_